"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A,US 5885590 A,034-655-197-334-670,1999-03-23,1999,US 37608895 A,1995-01-20,US 37608895 A;;US 7855193 A;;US 89739092 A;;US 86982292 A;;US 72181091 A,1991-06-27,Oral vaccines comprising multiple emulsions and methods of preparation,"The present invention relates to water-in-oil and water-in-oil-in-water multiple emulsions and methods of preparation which overcome many of the limitations of previous emulsions and are superior preparations for use in numerous applications including, but not limited to, vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial uses.",HUNTER; ROBERT L.;;BENNETT; CAROL ELIZABETH,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/034-655-197-334-670,Granted Patent,yes,66,48,2,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61Q19/00;;B01F23/4105;;A61K8/90;;A61Q19/00;;A61K8/06;;A61K8/064;;A61K8/066;;B01F23/4105,A61K8/06;;A61Q19/00;;B01F3/08,424/280.1;;424/278.1;;424/279.1;;424/283.1;;514/723;;514/772.3,9,5,162-978-272-667-30X;;029-404-401-401-256;;049-385-821-729-826;;062-518-163-311-432;;113-193-286-535-159,6491284;;10.1016/0264-410x(87)90105-8;;3499713;;7251192;;10.1159/000232780;;7264301;;3952469;;10.1111/j.1365-3083.1986.tb01970.x,"Hunter et al., J. Immunol., vol. 133, No. 6, pp. 3167 3175 (1984).;;Byars et al., Vaccine, vol. 5, pp. 223 227 (1987).;;Snippe et al., Int. Arch. Allergy Appl. Immunol., vol. 65, pp. 390 398 (1981).;;Hunter et al., J. Immunol., vol. 127, No. 3, pp. 1244 1250 (1981).;;Hunter et al., Immunol. Adjuvants and Vaccines, G. Gregoriadis et al., eds., Plenum Publ. Corp., pp. 1330140 (1989).;;Hunter et al., Scan. J. Immunol., vol. 23, pp. 287 300 (1986).;;Becher, Paul, Editor, Encyclopedia of Emulsion Technology, vol. 2, pp. 159 238 (1985), Chapter 3 Davis et al Medical and Pharmaceutical Application of Emulsions .;;Hackh s Chemical Dictionary (McGraw Hill, Inc., 1972), p. 431.;;Hunter et al (1989) in Immunological Adjuvants and Vaccines Gregory Gregoriadis et al eds Plenum Publishing Corp, 1989 pp. 133 144.",EXPIRED
2,CN,A,CN 1096224 A,170-011-120-146-185,1994-12-14,1994,CN 93117235 A,1993-08-20,US 72181091 A;;US 86982292 A;;US 89739092 A,1991-06-27,Multile emulsions and methods of preparation,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",UNIV EMORY,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/170-011-120-146-185,Patent Application,no,0,0,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K9/107;;A61K/;;A61K8/06;;A61K9/00;;A61K9/113;;A61K39/02;;A61K39/12;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00;;C09K23/00;;C09K23/42,,0,0,,,,DISCONTINUED
3,WO,A1,WO 2000/061599 A1,196-757-227-721-754,2000-10-19,2000,US 9923170 W,1999-10-05,US 28936899 A,1999-04-08,ANTISENSE MODULATION OF MICROTUBULE-ASSOCIATED PROTEIN 4 EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of microtubule-associated protein 4. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding microtubule-associated protein 4. Methods of using these compounds for modulation of microtubule-associated protein 4 expression and for treatment of diseases associated with expression of microtubule-associated protein 4 are provided.",ISIS PHARMACEUTICALS INC;;BENNETT C FRANK;;ACKERMANN ELIZABETH J,BENNETT C FRANK;;ACKERMANN ELIZABETH J,,https://lens.org/196-757-227-721-754,Patent Application,yes,0,0,3,3,0,A61K38/00;;A61K38/00;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,A61K38/00;;C12N15/113,,1,1,040-020-176-260-711,9538686;;10.1016/s0968-0004(97)01155-9,"BRANCH.: ""A good antisense molecule is hard to find"", TIBS,, vol. 23, February 1998 (1998-02-01), pages 45 - 50, XP002925157",PENDING
4,ES,T3,ES 2116340 T3,079-247-528-718-143,1998-07-16,1998,ES 92915365 T,1992-06-25,US 72181091 A;;US 86982292 A;;US 89739092 A,1991-06-27,EMULSIONES MULTIPLES Y METODOS DE PREPARACION.,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",UNIV EMORY,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/079-247-528-718-143,Granted Patent,no,0,0,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K/;;A61K8/06;;A61K9/00;;A61K9/113;;A61K39/02;;A61K39/12;;A61K9/107;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00;;C09K23/00;;C09K23/42,,0,0,,,,EXPIRED
5,HK,A1,HK 1010450 A1,068-774-132-591-751,1999-06-17,1999,HK 98111383 A,1998-10-21,US 72181091 A;;US 86982292 A;;US 89739092 A;;US 9205419 W,1991-06-27,Multiple emulsions and methods of preparation,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",UNIV EMORY,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/068-774-132-591-751,Patent Application,no,0,0,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K/;;A61K8/06;;A61K9/00;;A61K9/107;;A61K9/113;;A61K39/02;;A61K39/12;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00;;C09K23/00;;C09K23/42,,0,0,,,,DISCONTINUED
6,AU,A,AU 1999/065084 A,185-264-201-106-695,2000-11-14,2000,AU 1999/065084 A,1999-10-05,US 28936899 A;;US 9923170 W,1999-04-08,Antisense modulation of microtubule-associated protein 4 expression,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J,,https://lens.org/185-264-201-106-695,Patent Application,no,0,0,3,3,0,A61K38/00;;A61K38/00;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,A61K38/00;;C12N15/113,,0,0,,,,DISCONTINUED
7,US,A,US 5998148 A,072-384-260-132-446,1999-12-07,1999,US 28936899 A,1999-04-08,US 28936899 A,1999-04-08,Antisense modulation of microtubule-associated protein 4 expression,"Antisense compounds, compositions and methods are provided for modulating the expression of microtubule-associated protein 4. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding microtubule-associated protein 4. Methods of using these compounds for modulation of microtubule-associated protein 4 expression and for treatment of diseases associated with expression of microtubule-associated protein 4 are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J,IONIS PHARMACEUTICALS INC (1999-04-05),https://lens.org/072-384-260-132-446,Granted Patent,yes,0,503,3,3,87,A61K38/00;;A61K38/00;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,A61K38/00;;C12N15/113,435/6;;435/6;;435/325;;536/24.5,12,12,051-656-246-991-548;;033-156-324-817-518;;145-478-814-050-869;;047-254-881-838-036;;008-262-063-328-152;;043-666-901-181-648;;042-456-914-108-982;;080-215-049-141-809;;118-576-062-408-134;;017-594-139-626-306;;021-326-390-406-286;;032-733-498-368-83X,10.1242/jcs.110.24.3055;;9365275;;10.1016/0378-1119(92)90228-h;;1487151;;8631898;;10.1074/jbc.271.18.10834;;7480164;;10.1152/physrev.1995.75.4.835;;8631255;;10.1242/dev.122.3.771;;10.1242/jcs.110.2.281;;9044058;;3548773;;10.1146/annurev.cb.02.110186.002225;;9398320;;10.1021/bi971251w;;6501426;;pmc2113581;;10.1083/jcb.99.6.2287;;8636213;;10.1083/jcb.132.3.345;;pmc2120719;;1718985;;10.1016/s0021-9258(18)54720-7;;9569030;;10.1038/sj.onc.1201658,"Bulinski et al., Overexpression of MAP4 inhibits organelle motility and trafficking in vivo, J. Cell Sci. , 1997, 110:3055 3064.;;Code et al., Mouse microtubule associated protein 4 (MAP4) transcript diversity generated by alternative polyadenylation, Gene , 1992, 122:367 370.;;Illenberger et al., Phosphorylation of microtubule associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics, J. Biol. Chem. , 1996, 271:10834 10843.;;Maccioni et al., Role of microtubule associated proteins in the control of microtubule assembly, Physiol. Rev. , 1995, 75:835 864.;;Mangan et al., A muscle specific variant of microtubule associated protein 4 (MAP4) is required in myogenesis, Development , 1996, 122:771 781.;;Nguyen et al., Overexpression of Full or partial length MAP4 stabilizes microtubules and alters cell growth, J. Cell Sci. , 1997, 110:281 294.;;Olmsted, Microtubule associated proteins, Annu. Rev. Cell Biol. , 1986, 2:421 457.;;Ookata et al., MAP4 is the in vivo substrate for CDC2 kinase in HeLa cells: identification of an M phase specific and a cell cycle independent phosphorylation site in MAP4, Biochemistry , 1997, 36:15873 15883.;;Parysek et al., MAP 4: a microtubule associated protein specific for a subset of tissue microtubules, J. Cell Biol. , 1984, 99:2287 2296.;;Wang et al., Removal of MAP4 from microtubules in vivo produces no observable phenotype at the cellular level, J. Cell Biol. , 1996, 132:345 357.;;West et al., A model for microtubule associated protein 4 structure. Domains defined by comparisons of human, mouse, and bovine sequences, J. Biol. Chem. , 1991, 266:21886 21896.;;Zhang et al., The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells, Oncogene , 1998, 16:1617 1624.",EXPIRED
8,IE,B1,IE 67066 B1,076-603-219-180-609,1996-02-21,1996,IE 930898 A,1992-07-01,IE 922095 A;;US 72181091 A;;US 86982292 A;;US 89739092 A,1991-06-27,Oral vaccines comprising multiple emulsions and methods of preparation,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",UNIV EMORY,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/076-603-219-180-609,Granted Patent,no,0,0,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K/;;A61K8/06;;A61K9/00;;A61K9/113;;A61K9/107;;A61K39/02;;A61K39/12;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00;;C09K23/00;;C09K23/42,,0,0,,,,EXPIRED
9,AT,T1,AT E165749 T1,010-459-487-095-437,1998-05-15,1998,AT 92915365 T,1992-06-25,US 72181091 A;;US 86982292 A;;US 89739092 A,1991-06-27,MEHRKOMPONENTEMULSIONEN UND VERFAHREN ZUR DEREN HERSTELLUNG,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",UNIV EMORY,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/010-459-487-095-437,Granted Patent,no,0,0,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K9/107;;A61K/;;A61K8/06;;A61K9/00;;A61K9/113;;A61K39/02;;A61K39/12;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00,,0,0,,,,DISCONTINUED
10,EP,B1,EP 0591452 B1,096-651-832-812-741,1998-05-06,1998,EP 92915365 A,1992-06-25,US 9205419 W;;US 72181091 A;;US 86982292 A;;US 89739092 A,1991-06-27,MULTIPLE EMULSIONS AND METHODS OF PREPARATION,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",UNIV EMORY,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/096-651-832-812-741,Granted Patent,yes,7,0,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K9/107;;A61K/;;A61K8/06;;A61K9/00;;A61K9/113;;A61K39/02;;A61K39/12;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00;;C09K23/00;;C09K23/42,,0,0,,,,EXPIRED
11,DK,T3,DK 0591452 T3,152-695-574-844-778,1999-01-25,1999,DK 92915365 T,1992-06-25,US 72181091 A;;US 86982292 A;;US 89739092 A;;US 9205419 W,1991-06-27,Flerkomponentemulsioner og fremgangsmåde til fremstilling deraf,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",UNIV EMORY,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/152-695-574-844-778,Granted Patent,no,0,0,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K9/107;;A61K/;;A61K8/06;;A61K9/00;;A61K9/113;;A61K39/02;;A61K39/12;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00;;C09K23/00;;C09K23/42,,0,0,,,,EXPIRED
12,AU,A,AU 1992/023168 A,023-221-871-584-472,1993-01-25,1993,AU 1992/023168 A,1992-06-25,US 72181091 A;;US 86982292 A;;US 89739092 A,1991-06-27,MULTIPLE EMULSIONS AND METHODS OF PREPARATION,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",EMORY UNIVERSITY,ROBERT L. HUNTER;;CAROL ELIZABETH BENNETT,,https://lens.org/023-221-871-584-472,Patent Application,no,0,0,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K9/107;;A61K/;;A61K8/06;;A61K9/00;;A61K9/113;;A61K39/02;;A61K39/12;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00;;C09K23/00;;C09K23/42,,0,0,,,,PENDING
13,EP,A4,EP 0591452 A4,020-974-975-801-715,1994-07-20,1994,EP 92915365 A,1992-06-25,US 9205419 W;;US 72181091 A;;US 86982292 A;;US 89739092 A,1991-06-27,MULTIPLE EMULSIONS AND METHODS OF PREPARATION,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",UNIV EMORY,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/020-974-975-801-715,Search Report,no,0,0,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K9/107;;A61K/;;A61K8/06;;A61K9/00;;A61K9/113;;A61K39/02;;A61K39/12;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00;;C09K23/00;;C09K23/42,,1,0,,,No further relevant documents disclosed,EXPIRED
14,WO,A1,WO 1993/000160 A1,016-576-872-495-462,1993-01-07,1993,US 9205419 W,1992-06-25,US 72181091 A;;US 86982292 A;;US 89739092 A,1991-06-27,MULTIPLE EMULSIONS AND METHODS OF PREPARATION,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",UNIV EMORY,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/016-576-872-495-462,Patent Application,yes,7,21,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K/;;A61K8/06;;A61K9/107;;A61K9/00;;A61K9/113;;A61K39/02;;A61K39/12;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00;;C09K23/00;;C09K23/42,,0,0,,,,PATENTED
15,IE,A1,IE 922095 A1,014-603-068-427-125,1992-12-30,1992,IE 922095 A,1992-07-01,US 72181091 A;;US 86982292 A;;US 89739092 A,1991-06-27,MULTILE EMULSIONS AND METHODS OF PREPARATION,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",UNIV EMORY,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/014-603-068-427-125,Patent Application,no,0,0,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K/;;A61K8/06;;A61K9/107;;A61K9/00;;A61K9/113;;A61K39/02;;A61K39/12;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00;;C09K23/00;;C09K23/42,,0,0,,,,DISCONTINUED
16,EP,A1,EP 0591452 A1,101-902-461-880-448,1994-04-13,1994,EP 92915365 A,1992-06-25,US 9205419 W;;US 72181091 A;;US 86982292 A;;US 89739092 A,1991-06-27,MULTIPLE EMULSIONS AND METHODS OF PREPARATION.,"The present invention relates to water-in-oil and water-in-oil multiple emulsions and methods of preparation for use in numerous applications including vaccine adjuvants, pharmaceuticals, cosmetics, foods, and various household and industrial applications.",UNIV EMORY,HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/101-902-461-880-448,Patent Application,yes,0,1,20,22,0,A61K8/06;;A61K8/064;;A61K8/066;;A61K8/90;;A61K9/113;;A61K39/39;;A61K2039/55566;;A61Q19/00;;Y02A50/30,A61K9/107;;A61K/;;A61K8/06;;A61K9/00;;A61K9/113;;A61K39/02;;A61K39/12;;A61K39/39;;A61K47/08;;A61K47/32;;A61K47/44;;A61Q19/00;;B01J13/00;;C09K23/00;;C09K23/42,,0,0,,,,EXPIRED
17,WO,A1,WO 2004/007772 A1,129-661-670-759-718,2004-01-22,2004,US 0321410 W,2003-07-10,US 19729002 A,2002-07-16,ANTISENSE MODULATION OF CELLULAR INHIBITOR OF APOPTOSIS-2 EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of Cellular Inhibitor of Apoptosis-2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Cellular Inhibitor of Apoptosis-2. Methods of using these compounds for modulation of Cellular Inhibitor of Apoptosis-2 expression and for treatment of diseases associated.with expression of Cellular Inhibitor of Apoptosis-2 are provided.",ISIS PHARMACEUTICALS INC;;BENNETT FRANK C;;ACKERMANN ELIZABETH J,BENNETT FRANK C;;ACKERMANN ELIZABETH J,,https://lens.org/129-661-670-759-718,Patent Application,yes,1,4,4,286,0,A61K31/7088;;A61K31/7088;;A61K38/00;;A61K38/00;;C12N15/113;;C12N15/113;;C07H21/04;;C07H21/04;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,A61K31/7088;;A61K38/00;;C07H21/04;;C12N15/113,,2,2,040-020-176-260-711;;120-000-992-286-241,9538686;;10.1016/s0968-0004(97)01155-9;;10.1634/stemcells.18-5-307;;11007915,"BRANCH A.: ""A good antisense is hard to find"", TIBS, vol. 23, February 1998 (1998-02-01), pages 45 - 50, XP002910466;;JEN ET AL.: ""Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies"", STEM CELLS, vol. 18, 2000, pages 307 - 319, XP002948605",PENDING
18,US,A1,US 2004/0009599 A1,165-906-034-084-762,2004-01-15,2004,US 46415803 A,2003-06-18,US 46415803 A;;US 85727801 A;;US 9913624 W;;US 20520498 A,1998-12-03,Antisense modulation of cellular inhibitor of apoptosis-1 expression,"
   Antisense compounds, compositions and methods are provided for modulating the expression of Cellular Inhibitor of Apoptosis-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Cellular Inhibitor of Apoptosis-1. Methods of using these compounds for induction of cellular apoptosis are provided. 
",BENNETT C. FRANK;;ACKERMANN ELIZABETH J.,BENNETT C FRANK;;ACKERMANN ELIZABETH J,ISIS PHARMACEUTICALS INC (2003-09-10),https://lens.org/165-906-034-084-762,Patent Application,yes,2,0,1,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/316;;C12N2310/318;;C12N2310/3181;;C12N2310/321;;C12N2310/334;;C12N2310/341;;C12N2310/346;;C12N15/113;;A61K38/00;;C12N2310/316;;C12N2310/346;;C12N2310/315;;C12N2310/321;;C12N2310/341;;C12N2310/3181;;C12N2310/334;;C12N2310/318,A61K38/00;;C12N15/113,435/375;;514/44,0,0,,,,DISCONTINUED
19,AU,A1,AU 2003/251807 A1,186-113-653-641-179,2004-02-02,2004,AU 2003/251807 A,2003-07-10,US 19729002 A;;US 0321410 W,2002-07-16,ANTISENSE MODULATION OF CELLULAR INHIBITOR OF APOPTOSIS-2 EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT FRANK C;;ACKERMANN ELIZABETH J,,https://lens.org/186-113-653-641-179,Patent Application,no,0,0,4,286,0,A61K31/7088;;A61K31/7088;;A61K38/00;;A61K38/00;;C12N15/113;;C12N15/113;;C07H21/04;;C07H21/04;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,A61K31/7088;;A61K38/00;;C07H21/04;;C12N15/113,,0,0,,,,PENDING
20,US,B2,US 6933359 B2,043-277-152-592-052,2005-08-23,2005,US 75182504 A,2004-01-05,US 75182504 A;;US 71267300 A;;US 16641699 P,1999-11-19,Copolymerization of ethylene and dienes,"Ethylene, dienes and optionally α-olefins are copolymerized by selected iron complexes of 2,6-pyridinecarbox-aldehydebis(imines) and 2,6-diacylpyridinebis(imines). The resulting copolymers contain residual olefinic unsaturation from the diene monomers, and some of these copolymers contain cyclic units in the main chain.",DU PONT,BENNETT ALISON MARGARET ANNE;;MCCORD ELIZABETH FORRESTER,,https://lens.org/043-277-152-592-052,Granted Patent,yes,4,2,3,7,0,C08F10/00;;C08F210/02;;C08F210/18;;C08F210/02;;C08F10/00;;C08F210/18,C08F210/02;;C08F210/18,526/339;;526/161;;526/169.1;;526/171;;526/172,1,0,,,"International Search Report (PCT/US00/31604) dated Feb. 28, 2001.",EXPIRED
21,ZA,B,ZA 898235 B,072-822-752-837-159,1991-06-26,1991,ZA 898235 A,1989-10-30,GB 8825366 A,1988-10-29,PREVENTION OF COPPER DISSOLUTION DURING CYANIDATION OF GOLD ORES,,BRITISH PETROLEUM CO PLC,BENNETT CHARLES ANDREW;;CHARLES ANDREW BENNETT;;CRATHORNE ELIZABETH ANNE;;ELIZABETH ANNE CRATHORNE;;EDWARDS RAYMOND;;RAYMOND EDWARDS,,https://lens.org/072-822-752-837-159,Granted Patent,no,0,0,4,4,0,,C22B/;;C22B11/00;;C22B11/08,,0,0,,,,EXPIRED
22,AU,A,AU 2001/017727 A,181-625-939-334-286,2001-05-30,2001,AU 2001/017727 A,2000-11-16,US 16641699 P;;US 0031604 W,1999-11-19,Copolymerization of ethylene and dienes,,DU PONT,BENNETT ALISON MARGARET ANNE;;MCCORD ELIZABETH FORRESTER,,https://lens.org/181-625-939-334-286,Patent Application,no,0,0,4,7,0,C08F210/02;;C08F10/00;;C08F210/18,C08F4/602;;C08F4/70;;C08F210/02;;C08F210/18;;C08F236/02,,0,0,,,,DISCONTINUED
23,US,B1,US 6699955 B1,045-366-409-438-702,2004-03-02,2004,US 71267300 A,2000-11-14,US 71267300 A;;US 16641699 P,1999-11-19,Copolymerization of ethylene and dienes,"
    Ethylene, dienes and optionally -olefins are copolym-erized by selected iron complexes of 2,6-pyridinecarbox-aldehydebis(imines) and 2,6-diacylpyridinebis(imines). The resulting copolymers contain residual olefinic unsaturation from the diene monomers, and some of these copolymers contain cyclic units in the main chain. 
",DU PONT,BENNETT ALISON MARGARET ANNE;;MCCORD ELIZABETH FORRESTER,E.I. DU PONT DE NEMOURS AND COMPANY (2001-01-26),https://lens.org/045-366-409-438-702,Granted Patent,yes,15,2,3,7,0,C08F10/00;;C08F210/02;;C08F210/18;;C08F210/02;;C08F10/00;;C08F210/18,C08F210/02;;C08F210/18,526/336;;526/340.2;;526/340.3;;526/339;;526/308;;528/396,0,0,,,,EXPIRED
24,EP,A1,EP 1237964 A1,154-938-129-350-936,2002-09-11,2002,EP 00980472 A,2000-11-16,US 0031604 W;;US 16641699 P,1999-11-19,COPOLYMERIZATION OF ETHYLENE AND DIENES,,DU PONT,BENNETT ALISON MARGARET ANNE;;MCCORD ELIZABETH FORRESTER,,https://lens.org/154-938-129-350-936,Patent Application,yes,0,0,4,7,0,C08F210/02;;C08F10/00;;C08F210/18,C08F4/602;;C08F4/70;;C08F210/02;;C08F210/18;;C08F236/02,,1,0,,,See references of WO 0136503A1,DISCONTINUED
25,US,A1,US 2004/0138395 A1,017-912-570-903-885,2004-07-15,2004,US 75182504 A,2004-01-05,US 75182504 A;;US 71267300 A;;US 16641699 P,1999-11-19,Copolymerization of ethylene and dienes,"
   Ethylene, dienes and optionally -olefins are copolymerized by selected iron complexes of 2,6-pyridinecarbox-aldehydebis(imines) and 2,6-diacylpyridinebis(imines). The resulting copolymers contain residual olefinic unsaturation from the diene monomers, and some of these copolymers contain cyclic units in the main chain. 
",BENNETT ALISON MARGARET ANNE;;MCCORD ELIZABETH FORRESTER,BENNETT ALISON MARGARET ANNE;;MCCORD ELIZABETH FORRESTER,,https://lens.org/017-912-570-903-885,Patent Application,yes,4,4,3,7,0,C08F10/00;;C08F210/02;;C08F210/18;;C08F210/02;;C08F10/00;;C08F210/18,C08F210/02;;C08F210/18,526 336000;;526 340200;;526 340300;;526 339000;;526 308000,0,0,,,,EXPIRED
26,WO,A1,WO 2001/036503 A1,080-248-420-913-123,2001-05-25,2001,US 0031604 W,2000-11-16,US 16641699 P,1999-11-19,COPOLYMERIZATION OF ETHYLENE AND DIENES,"Ethylene, dienes and optionally α-olefins are copolymerized by selected iron complexes of 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The resulting copolymers contain residual olefinic unsaturation from the diene monomers, and some of these copolymers contain cyclic units in the main chain.",DU PONT;;BENNETT ALISON MARGARET ANNE;;MCCORD ELIZABETH FORRESTER,BENNETT ALISON MARGARET ANNE;;MCCORD ELIZABETH FORRESTER,,https://lens.org/080-248-420-913-123,Patent Application,yes,4,7,4,7,0,C08F210/02;;C08F10/00;;C08F210/18,C08F4/602;;C08F4/70;;C08F210/02;;C08F210/18;;C08F236/02,,0,0,,,,PENDING
27,CA,A1,CA 2001632 A1,014-991-708-434-196,1990-04-29,1990,CA 2001632 A,1989-10-27,GB 8825366 A,1988-10-29,PREVENTION OF COPPER DISSOLUTION DURING CYANIDATION OF GOLD ORES,"PREVENTION OF COPPER DISSOLUTION DURING CYANIDATION OF GOLD ORES A process for treating copper containing precious metal ores prior to cyanidation and recovery of the precious metal eg gold. The process involves addition to the ore before or after milling of a water soluble or water dispersible surface active agent in the form of a fatty alkyl amine preferably an ethoxylated fatty alkyl amine. The agent reduces the high cyanide consumption, which is caused by copper dissolution, by passivating the mineral surface.",BRITISH PETROLEUM CO PLC,BENNETT CHARLES A;;CRATHORNE ELIZABETH A;;EDWARDS RAYMOND,,https://lens.org/014-991-708-434-196,Patent Application,no,0,0,4,4,0,,C22B/;;C22B11/00;;C22B11/08,D20530229    M;;0530168    S,0,0,,,,DISCONTINUED
28,AU,A,AU 1989/043851 A,148-882-878-475-229,1990-05-03,1990,AU 1989/043851 A,1989-10-27,GB 8825366 A,1988-10-29,PREVENTION OF COPPER DISSOLUTION CYANIDATION OF GOLD ORES,,BRITISH PETROLEUM CO PLC,BENNETT CHARLES ANDREW;;CRATHORNE ELIZABETH ANNE;;EDWARDS RAYMOND,,https://lens.org/148-882-878-475-229,Patent Application,no,0,1,4,4,0,,C22B/;;C22B11/00;;C22B11/08,,0,0,,,,PENDING
29,EP,B1,EP 0478347 B1,177-119-702-791-503,1996-04-24,1996,EP 91308826 A,1991-09-27,US 59012590 A,1990-09-28,Printing system with automatic statistical compilation and billing,,XEROX CORP,BENNETT ELIZABETH A;;RAVEN CLAUDIA;;ROURKE JOHN L,,https://lens.org/177-119-702-791-503,Granted Patent,yes,3,0,8,8,0,G03G15/50;;G03G15/50;;G03G21/02;;G03G21/02;;G06Q20/04;;G06Q20/04;;G06Q20/14;;G06Q20/14;;G06Q30/04;;G06Q30/04;;G07F17/0014;;G07F17/0014;;G07F17/26;;G07F17/26;;H04N1/34;;H04N1/34,B41F13/00;;G03G15/00;;G03G15/36;;G03G21/00;;G03G21/02;;G03G21/04;;G06Q20/04;;G06Q20/14;;G06Q30/04;;G07F7/00;;G07F17/26;;H04N1/00;;H04N1/34,,2,0,,,"IBM TECHNICAL DISCLOSURE BULLETIN vol. 26, no. 3A, August 1983, NEW YORK, U.S. A. page 1202; STROLE: 'STORE SYSTEM WITH DISTRIBUTED PRICE LOOK-UP FUNCTION';;IBM TECHNICAL DISCLOSURE BULLETIN vol. 26, no. 1, June 1983, NEW YORK, U.S.A. pages 211 - 212; HUBBARD: 'SELF-BILLING FEATURE FOR MICROPROCESSOR-CONTROLLED MACHINE'",EXPIRED
30,US,A,US 5061459 A,169-592-917-961-577,1991-10-29,1991,US 42827789 A,1989-10-27,US 42827789 A,1989-10-27,Prevention of copper dissolution during cyanidation of gold ores,"A process for treating copper containing precious metal ores prior to cyanidation and recovery of the precious metal eg gold. The process involves addition to the ore before or after milling of a water soluble or water dispersible surface active agent in the form of a fatty alkyl amine preferably an ethoxylated fatty alkyl amine. The agent reduces the high cyanide consumption, which is caused by copper dissolution, by passivating the mineral surface.",BRITISH PETROLEUM CO PLC,BENNETT CHARLES A;;CRATHORNE ELIZABETH A;;EDWARDS RAYMOND,,https://lens.org/169-592-917-961-577,Granted Patent,yes,11,25,1,1,0,C22B11/08;;C22B11/08,C22B11/08,423/29;;423/32,0,0,,,,EXPIRED
31,US,A,US 5146344 A,021-935-847-885-680,1992-09-08,1992,US 59012590 A,1990-09-28,US 59012590 A,1990-09-28,PRINTING SYSTEM WITH AUTOMATIC STATISTICAL COMPILATION AND BILLING,"An electronic reprographic printing system which is capable of scanning a set of documents, electronically storing in memory images of the scan documents, and printing the electronic images in accordance with operator specified reprographic system functions for the print job. Customer accounts are set up within the reprographic printing system, and billing rates for the various system functions are specified within each account. When a print job is to be performed, the system operator of the reprographic system can allocate the cost of the system functions of the print job to a default account, or to a particular customer account. The billing rates for the various accounts can be changed by the system operator, and statistical and billing reports can be generated covering many different time frames.",XEROX CORP,BENNETT ELIZABETH A;;RAVEN CLAUDIA;;ROURKE JOHN L,XEROX CORPORATION STAMFORD A CORP. OF NEW YORK (1990-09-18),https://lens.org/021-935-847-885-680,Granted Patent,yes,8,86,8,8,0,G03G15/50;;G03G15/50;;G03G21/02;;G03G21/02;;G06Q20/04;;G06Q20/04;;G06Q20/14;;G06Q20/14;;G06Q30/04;;G06Q30/04;;G07F17/0014;;G07F17/0014;;G07F17/26;;G07F17/26;;H04N1/34;;H04N1/34,B41F13/00;;G03G15/00;;G03G15/36;;G03G21/00;;G03G21/02;;G03G21/04;;G06Q20/04;;G06Q20/14;;G06Q30/04;;G07F7/00;;G07F17/26;;H04N1/00;;H04N1/34,358/296;;355/202;;355/323,0,0,,,,EXPIRED
32,EP,A3,EP 0478347 A3,028-828-106-255-615,1992-11-04,1992,EP 91308826 A,1991-09-27,US 59012590 A,1990-09-28,PRINTING SYSTEM WITH AUTOMATIC STATISTICAL COMPILATION AND BILLING,"An electronic reprographic printing system which is capable of scanning (6) a set of documents, electronically storing (7) in memory (56) images of the scanned documents, and printing (8) the electronic images in accordance with operator specified reprographic system functions for the print job. Customer accounts are set up within the reprographic printing system, and billing rates for the various system functions are specified within each account. When a print job is to be performed, the system operator of the reprographic system, by means of a user interface (52), can allocate the cost of the system functions of the print job to a default account, or to a particular customer account. The billing rates for the various accounts can be changed by the system operator, and statistical and billing reports can be generated covering many different time frames.",XEROX CORPORATION,"BENNETT, ELIZABETH A.;;RAVEN, CLAUDIA;;ROURKE, JOHN L.",,https://lens.org/028-828-106-255-615,Search Report,yes,3,0,8,8,0,G03G15/50;;G03G15/50;;G03G21/02;;G03G21/02;;G06Q20/04;;G06Q20/04;;G06Q20/14;;G06Q20/14;;G06Q30/04;;G06Q30/04;;G07F17/0014;;G07F17/0014;;G07F17/26;;G07F17/26;;H04N1/34;;H04N1/34,B41F13/00;;G03G15/00;;G03G15/36;;G03G21/00;;G03G21/02;;G03G21/04;;G06Q20/04;;G06Q20/14;;G06Q30/04;;G07F7/00;;G07F17/26;;H04N1/00;;H04N1/34,,2,0,,,"IBM TECHNICAL DISCLOSURE BULLETIN vol. 26, no. 3A, August 1983, NEW YORK, U.S.A. page 1202; STROLE: 'STORE SYSTEM WITH DISTRIBUTED PRICE LOOK-UP FUNCTION';;IBM TECHNICAL DISCLOSURE BULLETIN vol. 26, no. 1, June 1983, NEW YORK, U.S.A. pages 211 - 212; HUBBARD: 'SELF-BILLING FEATURE FOR MICROPROCESSOR-CONTROLLED MACHINE'",EXPIRED
33,AT,T1,AT E446363 T1,145-552-009-788-863,2009-11-15,2009,AT 99948416 T,1999-09-23,US 16316298 A;;US 28640799 A;;US 9922076 W,1998-09-29,ANTISENSE-MODULATION DER SURVIVIN-EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT C;;ACKERMANN ELIZABETH;;SWAYZE ERIC;;COWSERT LEX,,https://lens.org/145-552-009-788-863,Granted Patent,no,0,0,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,0,0,,,,EXPIRED
34,DE,T2,DE 69119015 T2,110-269-074-012-785,1996-11-21,1996,DE 69119015 T,1991-09-27,US 59012590 A,1990-09-28,Drucksystem mit automatischer statistischer Kompilation und Fakturierung,,XEROX CORP,BENNETT ELIZABETH A;;RAVEN CLAUDIA;;ROURKE JOHN L,,https://lens.org/110-269-074-012-785,Granted Patent,no,0,2,8,8,0,G03G15/50;;G03G15/50;;G03G21/02;;G03G21/02;;G06Q20/04;;G06Q20/04;;G06Q20/14;;G06Q20/14;;G06Q30/04;;G06Q30/04;;G07F17/0014;;G07F17/0014;;G07F17/26;;G07F17/26;;H04N1/34;;H04N1/34,B41F13/00;;G03G15/00;;G03G15/36;;G03G21/00;;G03G21/02;;G03G21/04;;G06Q20/04;;G06Q20/14;;G06Q30/04;;G07F7/00;;G07F17/26;;H04N1/00;;H04N1/34,,0,0,,,,EXPIRED
35,DE,D1,DE 69119015 D1,005-543-804-675-12X,1996-05-30,1996,DE 69119015 T,1991-09-27,US 59012590 A,1990-09-28,Drucksystem mit automatischer statistischer Kompilation und Fakturierung,,XEROX CORP,BENNETT ELIZABETH A;;RAVEN CLAUDIA;;ROURKE JOHN L,,https://lens.org/005-543-804-675-12X,Granted Patent,no,0,0,8,8,0,G03G15/50;;G03G15/50;;G03G21/02;;G03G21/02;;G06Q20/04;;G06Q20/04;;G06Q20/14;;G06Q20/14;;G06Q30/04;;G06Q30/04;;G07F17/0014;;G07F17/0014;;G07F17/26;;G07F17/26;;H04N1/34;;H04N1/34,B41F13/00;;G03G15/00;;G03G15/36;;G03G21/00;;G03G21/02;;G03G21/04;;G06Q20/04;;G06Q20/14;;G06Q30/04;;G07F7/00;;G07F17/26;;H04N1/00;;H04N1/34,,0,0,,,,EXPIRED
36,EP,A2,EP 0478347 A2,154-387-701-589-801,1992-04-01,1992,EP 91308826 A,1991-09-27,US 59012590 A,1990-09-28,Printing system with automatic statistical compilation and billing.,"An electronic reprographic printing system which is capable of scanning (6) a set of documents, electronically storing (7) in memory (56) images of the scanned documents, and printing (8) the electronic images in accordance with operator specified reprographic system functions for the print job. Customer accounts are set up within the reprographic printing system, and billing rates for the various system functions are specified within each account. When a print job is to be performed, the system operator of the reprographic system, by means of a user interface (52), can allocate the cost of the system functions of the print job to a default account, or to a particular customer account. The billing rates for the various accounts can be changed by the system operator, and statistical and billing reports can be generated covering many different time frames.",XEROX CORP,BENNETT ELIZABETH A;;RAVEN CLAUDIA;;ROURKE JOHN L,,https://lens.org/154-387-701-589-801,Patent Application,yes,0,9,8,8,0,G03G15/50;;G03G15/50;;G03G21/02;;G03G21/02;;G06Q20/04;;G06Q20/04;;G06Q20/14;;G06Q20/14;;G06Q30/04;;G06Q30/04;;G07F17/0014;;G07F17/0014;;G07F17/26;;G07F17/26;;H04N1/34;;H04N1/34,B41F13/00;;G03G15/00;;G03G15/36;;G03G21/00;;G03G21/02;;G03G21/04;;G06Q20/04;;G06Q20/14;;G06Q30/04;;G07F7/00;;G07F17/26;;H04N1/00;;H04N1/34,,0,0,,,,EXPIRED
37,US,A,US 5958772 A,013-896-884-243-813,1999-09-28,1999,US 20520498 A,1998-12-03,US 20520498 A,1998-12-03,Antisense inhibition of cellular inhibitor of apoptosis-1 expression,"Antisense compounds, compositions and methods are provided for modulating the expression of Cellular Inhibitor of Apoptosis-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Cellular Inhibitor of Apoptosis-1. Methods of using these compounds for modulation of Cellular Inhibitor of Apoptosis-1 expression and for treatment of diseases associated with expression of Cellular Inhibitor of Apoptosis-1 are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,IONIS PHARMACEUTICALS INC (1998-12-01),https://lens.org/013-896-884-243-813,Granted Patent,yes,0,27,9,286,47,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/316;;C12N2310/318;;C12N2310/3181;;C12N2310/321;;C12N2310/334;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;C12N2310/346;;C12N2310/318;;C12N2310/3181;;C12N2310/315;;C12N2310/341;;C12N2310/316;;C12N2310/321;;A61K38/00;;C12N2310/334;;Y02P20/582,A61K31/7115;;A61K31/712;;A61K31/7125;;C12N15/09;;A61K38/00;;A61K48/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,435/375;;435/6;;435/91.1;;435/325;;435/366;;536/23.1;;536/24.31;;536/24.33;;536/245,11,11,010-552-396-212-710;;018-584-086-475-096;;005-628-420-250-15X;;046-373-385-763-51X;;001-088-214-362-513;;067-472-310-200-742;;097-003-233-121-552;;030-877-667-114-874;;009-738-818-382-710;;040-020-176-260-711;;114-600-590-399-827,9545235;;10.1093/emboj/17.8.2215;;pmc1170566;;10.1210/endo.139.3.5850;;10.1210/en.139.3.1321;;9492068;;10.1016/0092-8674(95)90149-3;;8548810;;10.1016/0092-8674(94)90532-0;;8069916;;10.1093/emboj/16.23.6914;;pmc1170295;;9384571;;pmc19479;;10.1073/pnas.93.24.13973;;8943045;;7878464;;10.1126/science.7878464;;pmc39390;;8643514;;10.1073/pnas.93.10.4974;;9733516;;10.1126/science.281.5383.1680;;9538686;;10.1016/s0968-0004(97)01155-9;;10.1007/978-3-642-58785-6_1,"Deveraux et al., IAPs block apoptotic events induced by caspase 8 and cytochrome c by direct inhibition of distinct caspases, Embo J. , 1998, 17:2215 2223.;;Li et al., Expression of inhibitor of apoptosis proteins (IAPs) in rat granulosa cells during ovarian follicular development and atresia, Endocrinology , 1998, 139:1321 1328.;;Rothe et al., The TNFR2 TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins, Cell , 1995, 83:1243 1252.;;Rothe et al., A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor, Cell , 1994, 78:681 692.;;Roy et al., The c IAP 1 and c IAP 2 proteins are direct inhibitors of specific caspases, Embo J. , 1997, 16:6914 6925.;;Shu et al., The tumor necrosis factor receptor 2 signal transducers TRAF2 and c IAP1 are components of the tumor necrosis factor receptor 1 signaling complex, Proc. Natl. Acad. Sci. U S A , 1996, 93:13973 13978.;;Thompson, Apoptosis in the pathogenesis and treatment of disease, Science , 1995, 267:1456 1462.;;Uren et al., Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor associated factors, Proc. Natl. Acad. Sci. U S A , 1996, 93:4974 4978.;;Wang et al., NF kappaB Antiapoptosis: Induction of TRAF1 and TRAF2 and c IAP1 and c IAP2 to Suppress Caspase 8 Activation, Science , 1998, 281:1680 1683.;;Branch TIBS 23:45 50, Feb. 1998.;;Crooke, S.T. In Antisense Research & Application , Ch1, pp. 1 50, Springer, 1998.",EXPIRED
38,AU,A,AU 1999/043133 A,009-652-634-095-496,1999-12-20,1999,AU 1999/043133 A,1999-05-26,US 8715298 P;;US 9911549 W,1998-05-29,Copolymerization of olefins,"Ethylene and/or propylene, and alpha-olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,,https://lens.org/009-652-634-095-496,Patent Application,no,0,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,,0,0,,,,EXPIRED
39,WO,A2,WO 2023/148311 A2,010-589-885-836-865,2023-08-10,2023,EP 2023052649 W,2023-02-03,GB 202201494 A,2022-02-04,APPARATUS FOR USE IN GENERATING ELECTRICITY,"Apparatus for Use in Generating Electricity Apparatus (101, 1101), for use in electricity generation, comprises a drive belt (102, 1102) rotatable, in an upright orientation, in a drive direction (D). When in motion, at least one part of the drive belt (102, 1102) moves through a first volume of a fluid (F1) having a first density and, at the same time, at least one other part moves through a second volume of a fluid (F2) having a second density; the forces of gravity and buoyancy being utilised to generate first and second motion-contributing forces that encourage continuing rotation of the drive belt (101, 1101) in the drive direction (D). An energy storage arrangement (1301) comprises a vessel (1302) for retaining a volume of a liquid (1303) and an object (1304) that is floatable by the liquid, and constrained, and further comprises a fluid control arrangement (1305) for controlling rising and falling of the object (1304).",GRAVITY ENGINES INTERNATIONAL LTD,JEFFERIES ROY;;THOMAS CHRISTOPHER NOEL BENNETT;;GWYTHER SUSAN ELIZABETH,,https://lens.org/010-589-885-836-865,Patent Application,yes,0,0,3,3,0,F03B17/04;;F05B2260/422;;F03B17/02;;F03B17/04,F03B17/02;;F03B17/04,,0,0,,,,PENDING
40,US,A1,US 2005/0020789 A1,118-867-276-942-076,2005-01-27,2005,US 91918104 A,2004-08-16,US 91918104 A;;US 25104102 A;;US 94617001 A;;US 31756399 A;;US 8715298 P,1998-05-29,COPOLYMERIZATION OF OLEFINS,"Ethylene and/or propylene, and α-olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,DUPONT POLYMERS INC (2019-06-17),https://lens.org/118-867-276-942-076,Patent Application,yes,8,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,526/161;;526/169;;526/171;;526/172;;526/134,0,0,,,,EXPIRED
41,US,A,US 5958771 A,122-565-620-298-541,1999-09-28,1999,US 20514498 A,1998-12-03,US 20514498 A,1998-12-03,Antisense modulation of cellular inhibitor of Apoptosis-2 expression,"Antisense compounds, compositions and methods are provided for modulating the expression of Cellular Inhibitor of Apoptosis-2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Cellular Inhibitor of Apoptosis-2. Methods of using these compounds for modulation of Cellular Inhibitor of Apoptosis-2 expression and for treatment of diseases associated with expression of Cellular Inhibitor of Apoptosis-2 are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,IONIS PHARMACEUTICALS INC (1998-12-01),https://lens.org/122-565-620-298-541,Granted Patent,yes,0,31,9,286,47,A61K38/00;;A61K38/00;;A61P35/00;;A61P37/00;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K31/713;;A61K38/00;;A61K48/00;;A61P35/00;;A61P37/00;;C12N15/113,435/375;;435/6;;435/91.1;;435/366;;536/23.1;;536/24.31;;536/24.33;;536/24.5,11,11,101-742-397-764-759;;010-552-396-212-710;;005-628-420-250-15X;;046-373-385-763-51X;;001-088-214-362-513;;097-003-233-121-552;;030-877-667-114-874;;009-738-818-382-710;;040-020-176-260-711;;142-600-468-277-469;;114-600-590-399-827,9294162;;10.1073/pnas.94.19.10057;;pmc23303;;9545235;;10.1093/emboj/17.8.2215;;pmc1170566;;10.1016/0092-8674(95)90149-3;;8548810;;10.1016/0092-8674(94)90532-0;;8069916;;10.1093/emboj/16.23.6914;;pmc1170295;;9384571;;7878464;;10.1126/science.7878464;;pmc39390;;8643514;;10.1073/pnas.93.10.4974;;9733516;;10.1126/science.281.5383.1680;;9538686;;10.1016/s0968-0004(97)01155-9;;9920268;;10.1038/5220;;10.1007/978-3-642-58785-6_1,"Chu et al., Suppression of tumor necrosis factor induced cell death by inhibitor of apoptosis c IAP2 is under NF kappaB control, Proc. Natl. Acad. Sci. U S A , 1997, 94:10057 10062.;;Deveraux et al., IAPs block apoptotic events induced by caspase 8 and cytochrome c by direct inhibition of distinct caspases, Embo J. , 1998, 17:2215 2223.;;Rothe et al. The TNFR2 TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins, Cell , 1995, 83:1243 1252.;;Rothe et al., A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor, Cell , 1994, 78:681 692.;;Roy et al., The c IAP 1 and c IAP 2 proteins are direct inhibitors of specific caspases, Embo J. , 1997, 16:6914 6925.;;Thompson, Apoptosis in the pathogenesis and treatment of disease, Science , 1995, 267:1456 1462.;;Uren et al., Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor associated factors, Proc. Natl. Acad. Sci. U S A , 1996, 93:4974 4978.;;Wang et al., NF kappaB Antiapoptosis: Induction of TRAF1 and TRAF2 and c IAP1 and c IAP2 to Suppress Caspase 8 Activation, Science , 1998, 281:1680 1683.;;Branch, TIBS 23 pp. 45 50, Feb. 1998.;;Flanagan et al., Nature Biotech. 17:48 52, Jan. 1999.;;Crooke, Antisense Research and Application , pp. 1 50, 1998.",EXPIRED
42,AU,A,AU 1999/045727 A,144-105-442-339-881,2000-06-19,2000,AU 1999/045727 A,1999-06-16,US 20520498 A;;US 9913624 W,1998-12-03,Antisense modulation of cellular inhibitor of apoptosis-1 expression,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH A;;COWSERT LEX M,,https://lens.org/144-105-442-339-881,Patent Application,no,0,0,9,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/316;;C12N2310/318;;C12N2310/3181;;C12N2310/321;;C12N2310/334;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;C12N2310/346;;C12N2310/318;;C12N2310/3181;;C12N2310/315;;C12N2310/341;;C12N2310/316;;C12N2310/321;;A61K38/00;;C12N2310/334;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,,0,0,,,,EXPIRED
43,US,B2,US 7288530 B2,133-664-481-142-311,2007-10-30,2007,US 98339204 A,2004-11-08,US 98339204 A;;US 91818601 A;;US 49669400 A;;US 28640799 A;;US 16316298 A,1998-09-29,Antisense modulation of survivin expression,"Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/133-664-481-142-311,Granted Patent,yes,4,14,4,34,250,A61K38/00;;C07B2200/11;;C07H21/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;C12N15/113;;A61K38/00;;C12N2310/321;;C12N2310/315;;C07B2200/11;;C12N2310/341;;C07H21/00;;C12N2310/346;;C12N2310/3341,C07H21/02;;A61K31/70;;A61K38/00;;C07H21/00;;C07H21/04;;C12N15/113;;C12Q1/68,514/44;;435/6;;435/375;;435/377;;536/23.1;;536/24.1;;536/24.5,21,18,014-399-256-774-591;;001-537-947-431-812;;021-849-999-191-396;;040-020-176-260-711;;120-000-992-286-241;;000-086-958-485-588;;097-682-313-785-241;;041-609-157-035-98X;;011-212-836-532-853;;107-388-804-822-645;;090-314-175-677-432;;053-522-668-738-074;;048-813-329-204-640;;014-632-321-904-726;;043-635-448-141-899;;051-108-083-786-111;;021-432-000-664-28X;;043-996-397-736-270,10.1074/jbc.273.18.11177;;9556606;;10496530;;10587640;;10.1038/70242;;9538686;;10.1016/s0968-0004(97)01155-9;;10.1634/stemcells.18-5-307;;11007915;;10.1016/s0140-6736(05)70294-4;;9525374;;10.1038/nm0897-917;;9256286;;9337844;;pmc1218630;;10.1042/bj3260001;;9581817;;10.1096/fasebj.9.10.7615156;;7615156;;10.1021/bi00250a039;;7947793;;9859993;;10.1038/25141;;8872395;;10.1093/bioinformatics/12.3.247;;10850418;;10.1038/nbt915;;14647331;;10.1517/17425247.2.1.3;;16296732;;10.1093/neuonc/2.1.45;;pmc1920694;;10.1215/15228517-2-1-45;;10.1215/s1522851799000307;;11302254;;10.1146/annurev.med.55.091902.104408;;14746510,"Ambrosini et al., ""Induction of Apoptosis and Inhibition of Cell Proliferation by Survivin Gene Targeting,"" J. Biol. Chem., 273:11177-11182 (1996).;;Genbank Accession No. AW247335 (Dec. 16, 1999).;;Grossman et al., ""Expression of the Apoptosis Inhibitor, Survivin, in Nonmelanoma Skin Cancer and Gene Targeting in a Keratinocyte Cell Line,"" Laboratory Investigation, 29:1121-1126 (1999).;;Li et al., ""Pleiotropic Cell-Division Defects and Apoptosis Induced by Interference with Survivin Function,"" Nature Cell Biology, 1:461-466 (1999).;;European Supplementary Search Report. European Application No. EP 01 90 8740.;;Branch, A.D., ""A Good Antisense Molecule is Hard to Find,"" TIBS 23, 45-50 (1998).;;Jen et al., ""Suppression of Gene Expression by Targeted Disruption of Messenger RNA: Available Options and Current Strategies,"" Stem Cells, 18, 307-319 (2000).;;Adida et al., ""Anti-apoptosis Gene, Survivin, and Prognosis of Neuroblastoma,"" Lancet, 351:882-883 (1998).;;Ambrosini et al., ""A Novel Anti-apoptosis Gene, Survivin, Expressed in Cancer and Lymphoma,"" Nat. Med., 3:917-921 (1997).;;Cohen, G.M., ""Caspases: The Executioners of Apoptosis,"" Biochem. J., 326:1-6 (1997).;;Lu et al., ""Expression of a Novel Antiapoptosis Gene, Survivin, Correlated with Tumor Cell Apoptosis and p53 Accumulation in Gastric Carcinomas,"" Cancer Res., 58:1808-1812 (1998).;;Altieri, D., ""Xa Receptor ERP-1,"" FASEB, 9:860-865 (1995).;;Altieri, D., ""Splicing of Effector Cell Protease Receptor-1 mRNA is Modulated by an Unusual Retained Intron,"" Biochemistry, 33:13848-13855 (1994).;;Li, F., et al., ""Control of apoptosis and mitotic spindle checkpoint by surviving"", Nature, 1998 386: 580-584.;;Matzura, et al., ""RNA draw: an integrated program for RNA secondary structure calculation and analysis under 32-bit Microsoft Windows,"" Comput. Appl. Biosci. 12(3):247-249 (1996).;;Olie, et al., ""A Novel Antisense Oligonucleaotide Targeting Survivin Expression Induces Apoptosis and Sensitizes Lung Cancer Cells to Chemotherapy,"" Cancer Research 60:2805-2809 (Jun. 2000).;;Scherer, et al., ""Approaches for the sequence-specific knockdown of mRNA,"" Nature Biotechnology 21(12):1457-1465 (2003).;;Mahato, et al., Modulation of gene expression by antisense and entigene oligodeoxynucleotides and small interfering RNA, Expert Opinion on Drug Delivery, 2(1):3-28 (2005).;;Groothuis, ""The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery."" Neuro-Oncology 2(1):45-59 (2000).;;Crooke, S.T., ""Progress in Antisense Technology,"" Annual Review of Medicine: Selected Topics in the Clinical Science, 55:61-95 (2004).;;GenBank record for accession No. L32866. Dec. 13, 1994.",EXPIRED
44,AT,T1,AT E253598 T1,159-487-526-261-621,2003-11-15,2003,AT 99955275 T,1999-05-26,US 8715298 P;;US 9911549 W,1998-05-29,COPOLYMERISATION VON OLEFINE,"Ethylene and/or propylene, and alpha-olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,,https://lens.org/159-487-526-261-621,Granted Patent,no,0,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,,0,0,,,,DISCONTINUED
45,CN,A,CN 1663972 A,046-991-814-145-25X,2005-09-07,2005,CN 200510062493 A,1999-05-26,US 8715298 P,1998-05-29,Copolymerization of olefins,"Ethylene and/or propylene, and alpha-olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,ANNE BENNETT ALISON MARGARETA;;JERALD FELDMAN;;FORRESTER MCCORD ELIZABETH,,https://lens.org/046-991-814-145-25X,Patent Application,no,0,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,,0,0,,,,EXPIRED
46,EP,B1,EP 1082361 B1,068-920-970-629-571,2003-11-05,2003,EP 99955275 A,1999-05-26,US 9911549 W;;US 8715298 P,1998-05-29,COPOLYMERIZATION OF OLEFINS,"Ethylene and/or propylene, and alpha-olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,,https://lens.org/068-920-970-629-571,Granted Patent,yes,3,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,,1,0,,,"B.L. SMALL, M. BROOKHART AND A.M.A. BENNETT: ""HIghly Active Iron and Cobalt Catalysts for the Polymerization of Ethylene"" J. AM. CHEM. SOC., vol. 120, no. 16, 29 April 1998 (1998-04-29), pages 4049-4050, XP002119954 cited in the application",EXPIRED
47,US,B2,US 7041764 B2,149-307-525-936-46X,2006-05-09,2006,US 91918104 A,2004-08-16,US 91918104 A;;US 25104102 A;;US 94617001 A;;US 31756399 A;;US 8715298 P,1998-05-29,Copolymerization of olefins,"Ethylene and/or propylene, and α-olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,DUPONT POLYMERS INC (2019-06-17),https://lens.org/149-307-525-936-46X,Granted Patent,yes,13,3,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F210/16;;C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00,526/348;;526/161;;526/172;;526/169.1;;526/171,3,2,142-862-132-189-406;;010-770-511-931-741,10.1021/ja9802100;;10.1039/a801933i,"PCT/US99/11549 International Search Report dated 2 Fenruary 2000.;;Brooke L. Small, et al., Highly Active Iron and Cobalt Catalysts for the Polymerization of Ethylene, J. Am. Chem. Soc., 120, 4049-4050, 1998.;;George J. P. Britovsek, et al., Novel Olefin Polymerization Catalysts based on Iron and Cobalt, Chem. Commun., 849-850, 1998.",EXPIRED
48,AU,C,AU 753245 C,041-577-905-983-907,2004-02-05,2004,AU 1999/045727 A,1999-06-16,US 20520498 A;;US 9913624 W,1998-12-03,Antisense modulation of Cellular Inhibitor of Apoptosis-1 expression,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH A;;COWSERT LEX M,,https://lens.org/041-577-905-983-907,Amended Patent,no,0,0,9,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/316;;C12N2310/318;;C12N2310/3181;;C12N2310/321;;C12N2310/334;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;C12N2310/346;;C12N2310/318;;C12N2310/3181;;C12N2310/315;;C12N2310/341;;C12N2310/316;;C12N2310/321;;A61K38/00;;C12N2310/334;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,,0,0,,,,EXPIRED
49,US,A,US 5208814 A,106-324-113-771-229,1993-05-04,1993,US 58968490 A,1990-09-28,US 58968490 A,1990-09-28,Method and apparatus for operating an electronic reprographic printing system containing a job submit counter,"An apparatus provides for operating an electronic reprographic system containing a method for recovering from crashes in an electronic reprographic system in which multiple jobs are active concurrently. The system provides for the monitoring of jobs active in the system, and of the number of times a specific job is active and the system crashes. By comparing the number of times a crash occurs when a specific job is active with a predetermined threshold number the operator can evaluate whether the system may be corrupted by a specific job or by the concurrency of jobs. The method further provides the operator with instructions to activate the jobs one at a time to determine which job is corrupt and permits the operator to delete a corrupt job.",XEROX CORP,ULRICH DENNIS B;;SALGADO DAVID L;;BENNETT ELIZABETH A,XEROX CORPORATION STAMFORD FAIRFIELD CT A CORP OF NY (1990-09-17),https://lens.org/106-324-113-771-229,Granted Patent,yes,8,18,3,3,0,G06F11/076;;G06F11/076;;G03G15/5012;;G03G15/5012;;H04N1/00002;;H04N1/00002;;H04N1/0096;;H04N1/0096;;H04N1/32609;;H04N1/32609,G03G21/00;;G03G15/00;;G06F11/00;;G06F11/34;;H04N1/00;;H04N1/32,371/16.4;;371/7;;371/5.1,0,0,,,,EXPIRED
50,CA,A1,CA 2353108 A1,198-029-738-428-098,2000-06-08,2000,CA 2353108 A,1999-09-23,US 20514498 A;;US 9922083 W,1998-12-03,ANTISENSE MODULATION OF CELLULAR INHIBITOR OF APOPTOSIS-2 EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating th e expression of Cellular Inhibitor of Apoptosis-2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Cellular Inhibitor of Apoptosis-2. Methods of using these compounds for modulation of Cellular Inhibitor of Apoptosis-2 expressi on and for treatment of diseases associated with expression of Cellular Inhibit or of Apoptosis-2 are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/198-029-738-428-098,Patent Application,no,0,5,9,286,47,A61K38/00;;A61K38/00;;A61P35/00;;A61P37/00;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K31/713;;A61K38/00;;A61K48/00;;A61P35/00;;A61P37/00;;C12N15/113,,0,0,,,,DISCONTINUED
51,EP,A4,EP 1163373 A4,009-310-743-958-262,2002-08-07,2002,EP 99928729 A,1999-06-16,US 9913624 W;;US 20520498 A,1998-12-03,ANTISENSE MODULATION OF CELLULAR INHIBITOR OF APOPTOSIS-1 EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH A;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2005-06-29)",https://lens.org/009-310-743-958-262,Search Report,no,3,0,9,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/316;;C12N2310/318;;C12N2310/3181;;C12N2310/321;;C12N2310/334;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;C12N2310/346;;C12N2310/318;;C12N2310/3181;;C12N2310/315;;C12N2310/341;;C12N2310/316;;C12N2310/321;;A61K38/00;;C12N2310/334;;Y02P20/582,A61K31/7115;;A61K31/712;;A61K31/7125;;C12N15/09;;A61K38/00;;A61K48/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,,3,3,063-662-992-172-786;;050-126-017-981-878;;033-275-711-890-944,8390996;;10.1016/s0021-9258(19)85268-7;;8878817;;10.1042/bst0240630;;10189354;;10.1161/01.res.84.6.668,"MONIA B P ET AL: ""EVALUATION OF 2'-MODIFIED OLIGONUCLEOTIDES CONTAINING 2'-DEOXY GAPS AS ANTISENSE INHIBITORS OF GENE EXPRESSION"", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 268, no. 19, 5 July 1993 (1993-07-05), pages 14514 - 14522, XP000576145, ISSN: 0021-9258;;ALTMANN K H ET AL: ""SECOND-GENERATION ANTISENSE OLIGONUCLEOTIDES: STRUCTURE-ACTIVITY RELATIONSHIPS AND THE DESIGN OF IMPROVED SIGNAL-TRANSDUCTION INHIBITORS"", BIOCHEMICAL SOCIETY TRANSACTIONS, COLCHESTER, ESSEX, GB, vol. 24, no. 3, 1 August 1996 (1996-08-01), pages 630 - 637, XP000671118, ISSN: 0300-5127;;ERL WOLFGANG ET AL: ""Nuclear factor-kappaB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells."", CIRCULATION RESEARCH, vol. 84, no. 6, 2 April 1999 (1999-04-02), pages 668 - 677, XP001079701, ISSN: 0009-7330",DISCONTINUED
52,AT,T1,AT E294811 T1,020-828-946-384-048,2005-05-15,2005,AT 00904275 T,2000-01-11,US 39258099 A;;US 0000583 W,1999-09-09,ANTISENSE-MODULATION VON X-VERBUNDENEN INHIBITOREN DER APOPTOSIS-EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of X-linked inhibitor of apoptosis. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding X-linked inhibitor of apoptosis. Methods of using these compounds for modulation of X-linked inhibitor of apoptosis expression and for treatment of diseases associated with expression of X-linked inhibitor of apoptosis are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/020-828-946-384-048,Granted Patent,no,0,0,11,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N2310/321;;C12N2310/315;;C12N2310/341;;A61K38/00;;C12N2310/3341;;C12N2310/346;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N15/15,,0,0,,,,DISCONTINUED
53,EP,A4,EP 1144690 A4,018-300-524-183-986,2004-09-22,2004,EP 99949811 A,1999-09-23,US 9922083 W;;US 20514498 A,1998-12-03,ANTISENSE MODULATION OF CELLULAR INHIBITOR OF APOPTOSIS-2 EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/018-300-524-183-986,Search Report,no,6,0,9,286,0,A61K38/00;;A61K38/00;;A61P35/00;;A61P37/00;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K31/713;;A61K38/00;;A61K48/00;;A61P35/00;;A61P37/00;;C12N15/113,,1,0,,,See also references of WO 0032818A1,DISCONTINUED
54,EP,A1,EP 1144690 A1,069-570-598-578-93X,2001-10-17,2001,EP 99949811 A,1999-09-23,US 9922083 W;;US 20514498 A,1998-12-03,ANTISENSE MODULATION OF CELLULAR INHIBITOR OF APOPTOSIS-2 EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/069-570-598-578-93X,Patent Application,yes,0,0,9,286,47,A61K38/00;;A61K38/00;;A61P35/00;;A61P37/00;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K31/713;;A61K38/00;;A61K48/00;;A61P35/00;;A61P37/00;;C12N15/113,,0,0,,,,DISCONTINUED
55,WO,A1,WO 2000/032818 A1,006-531-961-611-662,2000-06-08,2000,US 9922083 W,1999-09-23,US 20514498 A,1998-12-03,ANTISENSE MODULATION OF CELLULAR INHIBITOR OF APOPTOSIS-2 EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of Cellular Inhibitor of Apoptosis-2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Cellular Inhibitor of Apoptosis-2. Methods of using these compounds for modulation of Cellular Inhibitor of Apoptosis-2 expression and for treatment of diseases associated with expression of Cellular Inhibitor of Apoptosis-2 are provided.",ISIS PHARMACEUTICALS INC;;BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/006-531-961-611-662,Patent Application,yes,0,9,9,286,0,A61K38/00;;A61K38/00;;A61P35/00;;A61P37/00;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K31/713;;A61K38/00;;A61K48/00;;A61P35/00;;A61P37/00;;C12N15/113,,2,1,040-020-176-260-711,9538686;;10.1016/s0968-0004(97)01155-9,"BRANCH A.D.: ""A good antisense molecule is hard to find"", TIBS, vol. 23, February 1998 (1998-02-01), pages 45 - 50, XP002922013;;See also references of EP 1144690A4",PATENTED
56,BR,A,BR 9911200 A,066-765-572-835-062,2001-10-09,2001,BR 9911200 A,1999-05-26,US 8715298 P;;US 9911549 W,1998-05-29,Processo de polimerização e copolìmero de etileno e uma ou mais olefinas da fórmula h2c=chr21,"Ethylene and/or propylene, and alpha-olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,,https://lens.org/066-765-572-835-062,Patent Application,no,0,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,,0,0,,,,DISCONTINUED
57,WO,A3,WO 1999/062967 A3,178-657-944-731-962,2000-03-30,2000,US 9911549 W,1999-05-26,US 8715298 P,1998-05-29,COPOLYMERIZATION OF OLEFINS,"Ethylene and/or propylene, and α-olefins may be copolymerized by contacting them with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,,https://lens.org/178-657-944-731-962,Search Report,yes,3,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,,1,1,142-862-132-189-406,10.1021/ja9802100,"B.L. SMALL, M. BROOKHART AND A.M.A. BENNETT: ""HIghly Active Iron and Cobalt Catalysts for the Polymerization of Ethylene"", J. AM. CHEM. SOC., vol. 120, no. 16, 29 April 1998 (1998-04-29), pages 4049 - 4050, XP002119954",PATENTED
58,EP,A4,EP 0583359 A4,011-077-115-124-308,1994-01-06,1994,EP 92911368 A,1992-05-01,US 69428391 A,1991-05-01,METHOD FOR TREATING HYPOTHERMIA.,,UNIV EMORY,MEZROW CRAIG K;;HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/011-077-115-124-308,Search Report,no,1,0,7,7,0,A61K31/765;;A61K38/166;;A61K38/446;;A61K38/49;;A61P43/00;;A61K31/765;;A61K38/446;;A61K38/49;;A61K38/166,A61K31/77;;A01N1/02;;A61K31/765;;A61K38/16;;A61K38/44;;A61K38/49;;A61P43/00,,6,4,018-980-816-039-603;;041-716-461-777-324;;166-484-202-415-188;;018-076-349-650-626,10.1016/0011-2240(74)90112-6;;4452277;;10.2974/kmj1951.23.231;;10.1055/s-0038-1645676;;2339361;;1597978;;10.1016/s0022-5223(19)34879-2,"Y.KONDO ET AL.: ""Prolonged Suspended Animation in Puppies"", CRYOBIOLOGY, vol. 11, no. 5, 1974, pages 446 - 451;;G.SAKAUCHI: ""PREVENTION OF EXCESS HEMOLYSIS DURING CARDIOPULMONARY BYPASS BY THE USE OF PLORONIC F-68"", KITAKANTO MED. J., vol. 23, no. 3, 1973, pages 231 - 238;;C.PAPADEA ET AL.: ""EFFECT OF RHEOTHRX (TM) COPOLYMER ON BLOOD VISCOSITY RELATED TO FIBRIN(OGEN) CONCENTRATION"", FASEB J., vol. 2, no. 4, 15 March 1988 (1988-03-15), pages A384;;R.L.HUNTER ET AL.: ""Increased Whole Blood Viscosity during Coronary Bypass Surgery"", THROMB.HAEMOST., vol. 63, no. 1, 19 February 1990 (1990-02-19), pages 6 - 12;;Y.NAGATA ET AL.: ""Clinical evaluation on the effect of Poloxamer 188 on the hemolysis during cardiopulmonary bypass"", J.AICHI MED. UNIV. ASSOC., vol. 11, no. 1, 1983, pages 48 - 54;;C.K.MEZROW ET AL.: ""Poloxamer 188 improves neurologic outcome after hypothermic circulatory arrest"", J.THORAC.CARDIOVASC.SURG., vol. 103, no. 6, June 1992 (1992-06-01), pages 1143 - 1146",DISCONTINUED
59,CN,C,CN 100441604 C,184-971-346-129-931,2008-12-10,2008,CN 200510062493 A,1999-05-26,US 8715298 P,1998-05-29,Copolymerization of olefins,"Ethylene and/or propylene, and alpha-olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,ANNE BENNETT ALISON MARGARETA;;JERALD FELDMAN;;FORRESTER MCCORD ELIZABETH,,https://lens.org/184-971-346-129-931,Granted Patent,no,3,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F210/16;;C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00,,0,0,,,,EXPIRED
60,EP,A4,EP 1218395 A4,007-307-795-687-863,2003-07-30,2003,EP 00904275 A,2000-01-11,US 0000583 W;;US 39258099 A,1999-09-09,ANTISENSE MODULATION OF X-LINKED INHIBITOR OF APOPTOSIS EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of X-linked inhibitor of apoptosis. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding X-linked inhibitor of apoptosis. Methods of using these compounds for modulation of X-linked inhibitor of apoptosis expression and for treatment of diseases associated with expression of X-linked inhibitor of apoptosis are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2005-06-29)",https://lens.org/007-307-795-687-863,Search Report,no,0,0,11,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N2310/321;;C12N2310/315;;C12N2310/341;;A61K38/00;;C12N2310/3341;;C12N2310/346;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N15/15,,1,1,007-364-753-364-223,10.1089/oli.1.1998.8.129;;9593051,"STEIN C A: ""How to design an antisense oligodeoxynucleotide experiment: A consensus approach"", ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, MARY ANN LIEBERT, INC., NEW YORK, US, vol. 8, no. 2, April 1998 (1998-04-01), pages 129 - 132, XP002210583, ISSN: 1087-2906",EXPIRED
61,CA,A1,CA 2330151 A1,071-927-328-777-446,1999-12-09,1999,CA 2330151 A,1999-05-26,US 8715298 P;;US 9911549 W,1998-05-29,COPOLYMERIZATION OF OLEFINS,"Ethylene and/or propylene, and .alpha.-olefins may be copolymerized by contacting them with certain iron or cobalt complexes of selected 2,6pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,MCCORD ELIZABETH FORRESTER;;BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD,,https://lens.org/071-927-328-777-446,Patent Application,no,0,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,,0,0,,,,DISCONTINUED
62,WO,A1,WO 1992/019250 A1,160-917-638-049-417,1992-11-12,1992,US 9203605 W,1992-05-01,US 69428391 A,1991-05-01,METHOD FOR TREATING HYPOTHERMIA,"In accordance with the present invention, a method is provided for treating hypothermia and for protecting a human or animal against hypothermia. The present invention relates to a method for protecting a human or animal from damage during hypothermia such as occurs in hypothermic bypass surgery. The surface-active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula: HO(C2H4O)b(C3H6O)a(C2H4O)bH, wherein a is an integer such that the hydrophobe represented by (C3H6O) has a molecular weight of approximately 950 to 4000 daltons, preferably approximately 1200 to 3500 daltons, and b is an integer such that the hydrophile portion represented by (C2H4O) constitutes approximately 50 % to 90 % by weight of the compound.",UNIV EMORY,MEZROW CRAIG K;;HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/160-917-638-049-417,Patent Application,yes,5,10,7,7,0,A61K31/765;;A61K38/166;;A61K38/446;;A61K38/49;;A61P43/00;;A61K31/765;;A61K38/446;;A61K38/49;;A61K38/166,A61K31/77;;A01N1/02;;A61K31/765;;A61K38/16;;A61K38/44;;A61K38/49;;A61P43/00,,2,0,,,"Journal of the American Oil Chemists Society, Volume 34, No. 3, issued 1977, I.R. SCHMOLKA, ""A Review of Block Polymer Surfactants"", pages 110-116, entire document.;;Journal of Applied Cardiology, Volume 2, No. 2, issued 1987, A. HARJULA et al., ""Perfluorocarbon Solution as A Myocardial Preservative"", pages 121-136, entire document.",PENDING
63,AU,A,AU 1999/062604 A,104-550-430-096-944,2000-06-19,2000,AU 1999/062604 A,1999-09-23,US 20514498 A;;US 9922083 W,1998-12-03,Antisense modulation of cellular inhibitor of apoptosis-2 expression,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/104-550-430-096-944,Patent Application,no,0,0,9,286,0,A61K38/00;;A61K38/00;;A61P35/00;;A61P37/00;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K31/713;;A61K38/00;;A61K48/00;;A61P35/00;;A61P37/00;;C12N15/113,,0,0,,,,EXPIRED
64,AU,A,AU 1992/019129 A,169-001-276-412-860,1992-12-21,1992,AU 1992/019129 A,1992-05-01,US 69428391 A,1991-05-01,METHOD FOR TREATING HYPOTHERMIA,,UNIV EMORY,CRAIG K MEZROW;;ROBERT L. HUNTER;;CAROL ELIZABETH BENNETT,,https://lens.org/169-001-276-412-860,Patent Application,no,0,0,7,7,0,A61K31/765;;A61K38/166;;A61K38/446;;A61K38/49;;A61P43/00;;A61K31/765;;A61K38/446;;A61K38/49;;A61K38/166,A61K31/77;;A01N1/02;;A61K31/765;;A61K38/16;;A61K38/44;;A61K38/49;;A61P43/00,,0,0,,,,PENDING
65,US,A,US 6087173 A,182-829-070-249-739,2000-07-11,2000,US 39258099 A,1999-09-09,US 39258099 A,1999-09-09,Antisense modulation of X-linked inhibitor of apoptosis expression,"Antisense compounds, compositions and methods are provided for modulating the expression of X-linked inhibitor of apoptosis. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding X-linked inhibitor of apoptosis. Methods of using these compounds for modulation of X-linked inhibitor of apoptosis expression and for treatment of diseases associated with expression of X-linked inhibitor of apoptosis are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,IONIS PHARMACEUTICALS INC (1999-08-23),https://lens.org/182-829-070-249-739,Granted Patent,yes,4,26,11,286,47,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N2310/321;;C12N2310/315;;C12N2310/341;;A61K38/00;;C12N2310/3341;;C12N2310/346;;Y02P20/582,A61K31/7115;;A61K31/712;;A61K31/7125;;C12N15/09;;A61K38/00;;A61K48/00;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N15/15,435/375;;435/6;;536/23.1;;536/24.1;;536/24.5,9,9,010-552-396-212-710;;081-529-585-075-049;;018-584-086-475-096;;001-088-214-362-513;;104-908-347-168-808;;048-556-277-875-586;;097-003-233-121-552;;030-877-667-114-874;;092-914-238-370-844,9545235;;10.1093/emboj/17.8.2215;;pmc1170566;;10.1038/40901;;9230442;;10.1210/endo.139.3.5850;;10.1210/en.139.3.1321;;9492068;;10.1093/emboj/16.23.6914;;pmc1170295;;9384571;;10.1084/jem.188.1.211;;pmc2525542;;9653098;;10.1074/jbc.273.14.7787;;9525868;;7878464;;10.1126/science.7878464;;pmc39390;;8643514;;10.1073/pnas.93.10.4974;;9878061;;10.1093/emboj/18.1.179;;pmc1171113,"Deveraux et al., IAPs block apoptotic events induced by caspase 8 and cytochrome c by direct inhibition of distinct caspases, Embo J. , 1998, 17:2215 2223.;;Deveraux et al., X linked IAP is a direct inhibitor of cell death proteases, Nature , 1997, 388:300 304.;;Li et al., Expression of inhibitor of apoptosis proteins (IAPs) in rat granulosa cells during ovarian follicular development and atresia, Endocrinology , 1998, 139:1321 1328.;;Roy et al., The c IAP 1 and c IAP 2 proteins are direct inhibitors of specific caspases, Embo J. , 1997, 16:6914 6925.;;Stehlik et al., Nuclear factor (NF) kappaB regulated X chromosome linked iap gene expression protects endothelial cells from tumor necrosis factor alpha induced apoptosis, J. Exp. Med. , 1998, 188:211 216.;;Takahashi et al., A single BIR domain of XIAP sufficient for inhibiting caspases, J. Biol. Chem. , 1998, 273:7787 7790.;;Thompson, Apoptosis in the pathogenesis and treatment of disease, Science , 1995, 267:1456 1462.;;Uren et al., Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor associated factors, Proc. Natl. Acad. Sci. USA , 1996, 93:4974 4978.;;Yamaguchi et al., XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB 1TAK1 in the BMP Signaling pathway, Embo. J. , 1999, 18:179 187.",EXPIRED
66,US,B1,US 6437565 B1,106-484-965-432-991,2002-08-20,2002,US 61404800 A,2000-07-11,US 61404800 A,2000-07-11,Method and system to determine physical properties,"
    A method and system are provided that can be used at any stage of a manufacturing process to determine physical properties such as crosslink density. The method and system require little or no sample manipulation. The method and system are independent of rubber particle size and matrix composition. In the method and system, physical properties of a material are determined by NMR measurement. A T _{ 1 } (spin lattice relaxation time) is measured for a material, a T _{ 2 } (spin-spin relaxation time) is measured for the material and a value T _{ 1 } /T _{ 2 } is calculated that is representative of a physical property of material. 
",GEN ELECTRIC,EARLY THOMAS ALAN;;WILLIAMS ELIZABETH ANNE;;BENNETT BERNADETTE MONDRAGON,SABIC INNOVATIVE PLASTICS IP B.V (2007-08-31);;GENERAL ELECTRIC COMPANY (2000-07-03),https://lens.org/106-484-965-432-991,Granted Patent,yes,7,14,2,2,0,G01R33/50;;G01R33/50;;G01N33/445;;G01N33/445;;Y10S977/775;;Y10S977/775,G01N33/44;;G01R33/50,324/309;;324/307;;324/312,3,2,003-537-466-933-267;;082-578-986-623-349,9469890;;10.1006/jmre.1997.1282;;10.1002/macp.1996.021970214,"Beall et al (chapter 4) in NMR Data Handbook for Biomedical Applications. Pergamon Press (1984), pp. 32-39.*;;""A Guthausen et al., Analysis of Polymer Materials by Surface NMR via the Mouse"", by A. Guthausen et al., Journal of Magnetic Resonance 130, 1-7 (1998).;;""The Effect of Crosslinking in Elastomers Investigated by NMR Analysis of 13C Edited Transverse 1H NMR Relaxation, Macromolecular Chemistry, 197, 581-592 (1996)"", Fullber et al,.",EXPIRED
67,US,A1,US 2002/0077432 A1,155-830-863-606-061,2002-06-20,2002,US 82497701 A,2001-04-03,US 82497701 A;;US 31756399 A;;US 8715298 P,1998-05-29,Copolymerization of olefins,"
   The invention relates to a catalyst composition containing at least two different polymerization catalysts of which a) at least one is a polymerization catalyst based on an early transition metal constituent and b) at least one is a polymerization catalyst based on a late transition metal constituent. 
",BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,,https://lens.org/155-830-863-606-061,Patent Application,yes,4,2,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,526/113;;526/352;;502/113,0,0,,,,DISCONTINUED
68,WO,A2,WO 1999/062967 A2,061-704-523-259-344,1999-12-09,1999,US 9911549 W,1999-05-26,US 8715298 P,1998-05-29,COPOLYMERIZATION OF OLEFINS,"Ethylene and/or propylene, and alpha -olefins may be copolymerized by contacting them with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,,https://lens.org/061-704-523-259-344,Patent Application,no,0,14,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,,0,0,,,,PATENTED
69,WO,A3,WO 2023/148311 A3,119-650-681-137-416,2023-09-28,2023,EP 2023052649 W,2023-02-03,GB 202201494 A,2022-02-04,APPARATUS FOR USE IN GENERATING ELECTRICITY,"Apparatus for Use in Generating Electricity Apparatus (101, 1101), for use in electricity generation, comprises a drive belt (102, 1102) rotatable, in an upright orientation, in a drive direction (D). When in motion, at least one part of the drive belt (102, 1102) moves through a first volume of a fluid (F1) having a first density and, at the same time, at least one other part moves through a second volume of a fluid (F2) having a second density; the forces of gravity and buoyancy being utilised to generate first and second motion-contributing forces that encourage continuing rotation of the drive belt (101, 1101) in the drive direction (D). An energy storage arrangement (1301) comprises a vessel (1302) for retaining a volume of a liquid (1303) and an object (1304) that is floatable by the liquid, and constrained, and further comprises a fluid control arrangement (1305) for controlling rising and falling of the object (1304).",GRAVITY ENGINES INTERNATIONAL LTD,JEFFERIES ROY;;THOMAS CHRISTOPHER NOEL BENNETT;;GWYTHER SUSAN ELIZABETH,,https://lens.org/119-650-681-137-416,Search Report,yes,4,0,3,3,0,F03B17/04;;F05B2260/422;;F03B17/02;;F03B17/04,F03B17/02;;F03B17/04,,1,0,,,"ANONYMOUS: ""The Museum of Unworkable Devices"", LOCKHAVEN, 1 January 2014 (2014-01-01), pages 1 - 31, XP093035294, Retrieved from the Internet <URL:.> [retrieved on 20230328]",PENDING
70,EP,A2,EP 1082361 A2,127-674-921-116-785,2001-03-14,2001,EP 99955275 A,1999-05-26,US 9911549 W;;US 8715298 P,1998-05-29,COPOLYMERIZATION OF OLEFINS,"Ethylene and/or propylene, and alpha-olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,,https://lens.org/127-674-921-116-785,Patent Application,yes,0,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,,0,0,,,,EXPIRED
71,WO,A1,WO 2000/032816 A1,142-052-935-577-598,2000-06-08,2000,US 9913624 W,1999-06-16,US 20520498 A,1998-12-03,ANTISENSE MODULATION OF CELLULAR INHIBITOR OF APOPTOSIS-1 EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of Cellular Inhibitor of Apoptosis-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Cellular Inhibitor of Apoptosis-1. Methods of using these compounds for modulation of Cellular Inhibitor of Apoptosis-1 expression and for treatment of diseases associated with expression of Cellular Inhibitor of Apoptosis-1 are provided.",ISIS PHARMACEUTICALS INC;;BENNETT C FRANK;;ACKERMANN ELIZABETH A;;COWSERT LEX M,BENNETT C FRANK;;ACKERMANN ELIZABETH A;;COWSERT LEX M,,https://lens.org/142-052-935-577-598,Patent Application,yes,0,8,9,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/316;;C12N2310/318;;C12N2310/3181;;C12N2310/321;;C12N2310/334;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;C12N2310/346;;C12N2310/318;;C12N2310/3181;;C12N2310/315;;C12N2310/341;;C12N2310/316;;C12N2310/321;;A61K38/00;;C12N2310/334;;Y02P20/582,A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;C12N15/09;;A61K48/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,,1,1,040-020-176-260-711,9538686;;10.1016/s0968-0004(97)01155-9,"BRANCH A.D.: ""A Good Antisense Molecule is Hard to Find"", TIBS, vol. 23, February 1998 (1998-02-01), pages 45 - 50, XP002913553",PATENTED
72,US,A1,US 2003/0114610 A1,002-135-154-637-022,2003-06-19,2003,US 25104102 A,2002-09-20,US 25104102 A;;US 94617001 A;;US 31756399 A;;US 8715298 P,1998-05-29,Copolymerization of olefins,"
   Ethylene and/or propylene, and -olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins. 
",DU PONT,BENNETT ALISON MARGARETA ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,DUPONT POLYMERS INC (2019-06-17),https://lens.org/002-135-154-637-022,Patent Application,yes,2,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,526/161;;526/352,0,0,,,,EXPIRED
73,WO,A1,WO 1994/023406 A1,064-124-690-563-94X,1994-10-13,1994,US 9403572 W,1994-04-01,US 4149393 A,1993-04-01,NON-CONTACT AUDIO DELIVERY SYSTEM FOR A THREE-DIMENSIONAL SOUND PRESENTATION,"A non-contact audio delivery system (20) which delivers a three-dimensional sound presentation to a listener. The non-contact audio delivery system comprises a support structure such as a hood (26) with speakers (38) mounted in the support structure. In the embodiment using the hood (20), the hood (26) surrounds a portion of the head of the listener (44) to block out external audio and visual distractions from the listener (44). The support structure is also designed to focus the listener's attention in a preferred forward looking position which ensures the placement of the audio delivery speakers (38) proximate the ears (50) of the listener (44). The delivery system (20) also includes an ambient noise measurement system which automatically adjusts the volume level of the presentation depending on a measured level of external ambient noise. Additional improvements to a typical three-dimensional sound presentation include the scaling of the three-dimensional sound effects based on the determination of an approximate head size of the listener (44). Finally, a method of reducing the required amount of data that is stored in order to implement a three-dimensional sound presentation is disclosed.",ATARI GAMES CORP,MONCRIEF RICK L;;HANSEN RAYMOND S;;BENNETT ELIZABETH M,,https://lens.org/064-124-690-563-94X,Patent Application,yes,5,10,1,1,0,A63F2300/6063;;A63F2300/8017;;G09B9/05;;G09B9/22;;H04R5/02;;H04S2420/01;;A63F13/90;;A63F2300/6081;;A63F2300/1081;;A63F13/215;;A63F13/54;;A63F13/803;;A63F13/803;;A63F13/54;;H04R5/02;;H04S2420/01,A63F13/08;;G09B9/05;;G09B9/22;;H04S5/00,,1,0,,,"""ieee 1990 national aerospace and electronics conference naecon 1990"", 21 May 1990, DAYTON SECTION OF THE IEEE, DAYTON",PENDING
74,AU,B2,AU 763066 B2,093-873-525-100-626,2003-07-10,2003,AU 1999/062604 A,1999-09-23,US 20514498 A;;US 9922083 W,1998-12-03,Antisense modulation of cellular inhibitor of apoptosis-2 expression,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/093-873-525-100-626,Granted Patent,no,0,0,9,286,0,A61K38/00;;A61K38/00;;A61P35/00;;A61P37/00;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K31/713;;A61K38/00;;A61K48/00;;A61P35/00;;A61P37/00;;C12N15/113,,0,0,,,,EXPIRED
75,EP,A1,EP 1218395 A1,170-411-934-276-66X,2002-07-03,2002,EP 00904275 A,2000-01-11,US 0000583 W;;US 39258099 A,1999-09-09,ANTISENSE MODULATION OF X-LINKED INHIBITOR OF APOPTOSIS EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of X-linked inhibitor of apoptosis. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding X-linked inhibitor of apoptosis. Methods of using these compounds for modulation of X-linked inhibitor of apoptosis expression and for treatment of diseases associated with expression of X-linked inhibitor of apoptosis are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2005-06-29)",https://lens.org/170-411-934-276-66X,Patent Application,yes,0,0,11,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N2310/321;;C12N2310/315;;C12N2310/341;;A61K38/00;;C12N2310/3341;;C12N2310/346;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N15/15,,0,0,,,,EXPIRED
76,AU,A,AU 2000/026060 A,039-978-112-984-358,2001-04-10,2001,AU 2000/026060 A,2000-01-10,US 39258099 A;;US 0000583 W,1999-09-09,Antisense modulation of x-linked inhibitor of apoptosis expression,"Antisense compounds, compositions and methods are provided for modulating the expression of X-linked inhibitor of apoptosis. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding X-linked inhibitor of apoptosis. Methods of using these compounds for modulation of X-linked inhibitor of apoptosis expression and for treatment of diseases associated with expression of X-linked inhibitor of apoptosis are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/039-978-112-984-358,Patent Application,no,0,0,11,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N2310/321;;C12N2310/315;;C12N2310/341;;A61K38/00;;C12N2310/3341;;C12N2310/346;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N15/15,,0,0,,,,DISCONTINUED
77,AU,A1,AU 2003/252907 A1,085-213-285-395-256,2003-11-06,2003,AU 2003/252907 A,2003-10-10,US 9922083 W;;US 20514498 A,1998-12-03,Antisense modulation of Cellular Inhibitor of Apoptosis-2 expression,,ISIS PHARMACEUTICALS INC,COWSERT LEX M;;ACKERMANN ELIZABETH J;;BENNETT C FRANK,,https://lens.org/085-213-285-395-256,Patent Application,no,0,0,9,286,0,A61K38/00;;A61K38/00;;A61P35/00;;A61P37/00;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K31/713;;A61K38/00;;A61K48/00;;A61P35/00;;A61P37/00;;C12N15/113,,0,0,,,,DISCONTINUED
78,EP,A1,EP 0583359 A1,127-140-656-963-636,1994-02-23,1994,EP 92911368 A,1992-05-01,US 69428391 A,1991-05-01,METHOD FOR TREATING HYPOTHERMIA.,"Méthode destinée à traiter l'hypothermie et à protéger l'être humain ou l'animal contre l'hypothermie. La présente invention se rapporte à une méthode conçue pour protéger un être humain ou un animal contre les lésions provoquées par l'hypothermie comme cela se produit lors d'interventions chirurgicales de pontage hypothermiques. Le copolymère tensioactif peut être un produit de condensation d'oxyde d'éthylène-oxyde de propylène de la formule générale: HO(C2H4O)b(C3H6O)a(C2H4O)bH dans laquelle a est un nombre entier tel que l'hydrophobe représenté par (C3H6O) possède un poids moléculaire d'approximativement 950 à 4000 daltons, de préférence approximativement 1200 à 3500 daltons, et b est un nombre entier tel que la partie hydrophile représentée par (C2H4O) constitue approximativement 50 % à 90 % en poids du composé.",UNIV EMORY,MEZROW CRAIG K;;HUNTER ROBERT L;;BENNETT CAROL ELIZABETH,,https://lens.org/127-140-656-963-636,Patent Application,yes,0,0,7,7,0,A61K31/765;;A61K38/166;;A61K38/446;;A61K38/49;;A61P43/00;;A61K31/765;;A61K38/446;;A61K38/49;;A61K38/166,A61K31/77;;A01N1/02;;A61K31/765;;A61K38/16;;A61K38/44;;A61K38/49;;A61P43/00,,0,0,,,,DISCONTINUED
79,US,A1,US 2002/0111445 A1,198-917-294-586-014,2002-08-15,2002,US 94617001 A,2001-09-04,US 94617001 A;;US 31756399 A;;US 8715298 P,1998-05-29,Copolymerization of olefins,"
   Ethylene and/or propylene, and -olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins. 
",DU PONT,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,,https://lens.org/198-917-294-586-014,Patent Application,yes,0,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,526/161;;526/352,0,0,,,,DISCONTINUED
80,WO,A3,WO 1999/062967 A3,196-777-740-089-065,1999-12-09,1999,US US9911549,1999-05-26,"US 60/0/087,152",1998-05-29,COPOLYMERIZATION OF OLEFINS,"Ethylene and/or propylene, and α-olefins may be copolymerized by contacting them with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",E.I. DU PONT DE NEMOURS AND COMPANY,"BENNETT, Alison, Margaret, Anne;;FELDMAN, Jerald;;MCCORD, Elizabeth, Forrester",,https://lens.org/196-777-740-089-065,Search Report,yes,0,0,1,1,0,,C08F10/00;;C08F210/16,,0,0,,,,UNKNOWN
81,EP,A1,EP 1163373 A1,068-378-339-194-601,2001-12-19,2001,EP 99928729 A,1999-06-16,US 9913624 W;;US 20520498 A,1998-12-03,ANTISENSE MODULATION OF CELLULAR INHIBITOR OF APOPTOSIS-1 EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH A;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2005-06-29)",https://lens.org/068-378-339-194-601,Patent Application,yes,0,0,9,286,47,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/316;;C12N2310/318;;C12N2310/3181;;C12N2310/321;;C12N2310/334;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;C12N2310/346;;C12N2310/318;;C12N2310/3181;;C12N2310/315;;C12N2310/341;;C12N2310/316;;C12N2310/321;;A61K38/00;;C12N2310/334;;Y02P20/582,A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;C12N15/09;;A61K48/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,,0,0,,,,DISCONTINUED
82,CA,A1,CA 2384456 A1,194-845-465-769-857,2001-03-15,2001,CA 2384456 A,2000-01-11,US 39258099 A;;US 0000583 W,1999-09-09,ANTISENSE MODULATION OF X-LINKED INHIBITOR OF APOPTOSIS EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating th e expression of X-linked inhibitor of apoptosis. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding X-linked inhibitor of apoptosis. Methods of using the se compounds for modulation of X-linked inhibitor of apoptosis expression and f or treatment of diseases associated with expression of X-linked inhibitor of apoptosis are provided.",ISIS PHARMACEUTICALS INC,COWSERT LEX M;;ACKERMANN ELIZABETH J;;BENNETT C FRANK,,https://lens.org/194-845-465-769-857,Patent Application,no,0,0,11,286,47,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N2310/321;;C12N2310/315;;C12N2310/341;;A61K38/00;;C12N2310/3341;;C12N2310/346;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N15/15,,0,0,,,,DISCONTINUED
83,WO,A1,WO 2001/018024 A1,002-900-576-695-906,2001-03-15,2001,US 0000583 W,2000-01-11,US 39258099 A,1999-09-09,ANTISENSE MODULATION OF X-LINKED INHIBITOR OF APOPTOSIS EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of X-linked inhibitor of apoptosis. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding X-linked inhibitor of apoptosis. Methods of using these compounds for modulation of X-linked inhibitor of apoptosis expression and for treatment of diseases associated with expression of X-linked inhibitor of apoptosis are provided.",ISIS PHARMACEUTICALS INC;;BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/002-900-576-695-906,Patent Application,yes,1,7,11,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N2310/321;;C12N2310/315;;C12N2310/341;;A61K38/00;;C12N2310/3341;;C12N2310/346;;Y02P20/582,A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P15/00;;C12N15/09;;A61P29/00;;A61P35/00;;C12N15/113;;C12N15/15,,1,0,,,"CROOKE S. T.: ""ANTISENSE MEDICINAL CHEMISTRY."", ANTISENSE RESEARCH AND APPLICATIONS., CRC PRESS., GB, 1 January 1998 (1998-01-01), GB, pages 69 - 76., XP002924844",PATENTED
84,WO,A1,WO 2002/004972 A1,026-740-717-326-559,2002-01-17,2002,US 0114995 W,2001-05-09,US 61404800 A,2000-07-11,METHOD AND SYSTEM TO DETERMINE PHYSICAL PROPERTIES BY NMR RELAXATION-TIME MEASUREMENTS,"A method and system are provided that can be used at any stage of a manufacturing process to determine physical properties such as crosslink density. The method and system require little or no sample manipulation. The method and system are independent of rubber particle size and matrix composition. In the method and system, physical properties of a material are determined by NMR measurement. A T1 (spin lattice relaxation time) is measured for a material, a T2 (spin-spin relaxation time) is measured for the material and a value T1/T2 is calculated that is representative of a physical property of material.",GEN ELECTRIC,EARLY THOMAS ALAN;;WILLIAMS ELIZABETH ANNE;;BENNETT BERNADETTE MONDRAGON,,https://lens.org/026-740-717-326-559,Patent Application,yes,1,4,2,2,0,G01R33/50;;G01R33/50;;G01N33/445;;G01N33/445;;Y10S977/775;;Y10S977/775,G01N33/44;;G01R33/50,,3,3,142-176-649-924-67X;;088-889-306-715-124;;082-578-986-623-349,10.1016/s0032-3861(99)00457-7;;10.1016/s0032-3861(99)00097-x;;10.1002/macp.1996.021970214,"MENGE H ET AL: ""Investigation of partially deuterated poly(butadiene) elastomers. Part 1. 1H and 2H nmr transverse relaxation data"", POLYMER, ELSEVIER SCIENCE PUBLISHERS B.V, GB, vol. 41, no. 8, April 2000 (2000-04-01), pages 3019 - 3027, XP004244307, ISSN: 0032-3861;;OH S J ET AL: ""Proton spin-spin relaxation and n.m.r. imaging of peroxide/coagent crosslinked cis-1,4-polyisoprene"", POLYMER, ELSEVIER SCIENCE PUBLISHERS B.V, GB, vol. 40, no. 16, July 1999 (1999-07-01), pages 4703 - 4708, XP004205858, ISSN: 0032-3861;;FÜLBER C. ET AL.: ""The effect of crosslinking in elastomers investigated by NMR analysis of 13C edited transverse 1H NMR relaxation"", MACROMOLECULAR CHEMISTRY, 1996, Zug, pages 581 - 583, XP001022318",PENDING
85,US,A1,US 2003/0083300 A1,023-930-709-324-500,2003-05-01,2003,US 19729002 A,2002-07-16,US 19729002 A;;US 85729901 A;;US 9922083 W;;US 20514498 A,1998-12-03,Antisense modulation of cellular inhibitor of Apoptosis-2 expression,"
   Antisense compounds, compositions and methods are provided for modulating the expression of Cellular Inhibitor of Apoptosis-2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Cellular Inhibitor of Apoptosis-2. Methods of using these compounds for modulation of Cellular Inhibitor of Apoptosis-2 expression and for treatment of diseases associated with expression of Cellular Inhibitor of Apoptosis-2 are provided. 
",BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,ISIS PHARMACEUTICALS INC (2002-10-11),https://lens.org/023-930-709-324-500,Patent Application,yes,8,0,4,286,46,A61K31/7088;;A61K31/7088;;A61K38/00;;A61K38/00;;C12N15/113;;C12N15/113;;C07H21/04;;C07H21/04;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,A61K31/7088;;A61K38/00;;C07H21/04;;C12N15/113,514 044000;;514 375000;;514 023200,0,0,,,,DISCONTINUED
86,AU,B2,AU 753245 B2,049-943-284-477-232,2002-10-10,2002,AU 1999/045727 A,1999-06-16,US 20520498 A;;US 9913624 W,1998-12-03,Antisense modulation of Cellular Inhibitor of Apoptosis-1 expression,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH A;;COWSERT LEX M,,https://lens.org/049-943-284-477-232,Granted Patent,no,0,0,9,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/316;;C12N2310/318;;C12N2310/3181;;C12N2310/321;;C12N2310/334;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;C12N2310/346;;C12N2310/318;;C12N2310/3181;;C12N2310/315;;C12N2310/341;;C12N2310/316;;C12N2310/321;;A61K38/00;;C12N2310/334;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,,0,0,,,,EXPIRED
87,AU,B2,AU 748513 B2,092-477-918-517-333,2002-06-06,2002,AU 1999/043133 A,1999-05-26,US 8715298 P;;US 9911549 W,1998-05-29,Copolymerization of olefins,"Ethylene and/or propylene, and alpha-olefins may be copolymerized by contacting then with certain iron or cobalt complexes of selected 2,6-pyridinecarboxaldehydebis(imines) and 2,6-diacylpyridinebis(imines). The polymers produced, some of which are novel, are useful as molding resins.",DU PONT,BENNETT ALISON MARGARET ANNE;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER,,https://lens.org/092-477-918-517-333,Granted Patent,no,2,0,23,23,0,C08F10/00;;C08F210/16;;C08F210/16;;C08F210/02;;C08F210/06;;C08F4/7054;;C08F10/00;;C08F210/16,C08F4/26;;C08F4/44;;C08F4/70;;C08F4/80;;C08F10/00;;C08F210/16,,0,0,,,,EXPIRED
88,EP,B1,EP 1218395 B1,099-604-127-938-75X,2005-05-04,2005,EP 00904275 A,2000-01-11,US 0000583 W;;US 39258099 A,1999-09-09,ANTISENSE MODULATION OF X-LINKED INHIBITOR OF APOPTOSIS EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of X-linked inhibitor of apoptosis. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding X-linked inhibitor of apoptosis. Methods of using these compounds for modulation of X-linked inhibitor of apoptosis expression and for treatment of diseases associated with expression of X-linked inhibitor of apoptosis are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2005-06-29)",https://lens.org/099-604-127-938-75X,Granted Patent,yes,1,0,11,286,0,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N2310/321;;C12N2310/315;;C12N2310/341;;A61K38/00;;C12N2310/3341;;C12N2310/346;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P15/00;;A61P29/00;;A61P35/00;;C12N15/113;;C12N15/15,,2,0,,,"STEIN C A: ""How to design an antisense oligodeoxynucleotide experiment: A consensus approach"" ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, MARY ANN LIEBERT, INC., NEW YORK, US, vol. 8, no. 2, April 1998 (1998-04), pages 129-132, XP002210583 ISSN: 1087-2906;;COOK S.T., ""Antisense Medicinal Chemistry"", In: Antisense Research and Application. Edited by STANLEY CROOKE. New York: Springer. 1998, pages 69-76, ISBN: 3-540-63833-4, XP002924844.",EXPIRED
89,CA,A1,CA 2353090 A1,107-548-423-744-057,2000-06-08,2000,CA 2353090 A,1999-06-16,US 20520498 A;;US 9913624 W,1998-12-03,ANTISENSE MODULATION OF CELLULAR INHIBITOR OF APOPTOSIS-1 EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating th e expression of Cellular Inhibitor of Apoptosis-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Cellular Inhibitor of Apoptosis-1. Methods of using these compounds for modulation of Cellular Inhibitor of Apoptosis-1 expressi on and for treatment of diseases associated with expression of Cellular Inhibit or of Apoptosis-1 are provided.",ISIS PHARMACEUTICALS INC,COWSERT LEX M;;ACKERMANN ELIZABETH J;;BENNETT C FRANK,,https://lens.org/107-548-423-744-057,Patent Application,no,0,0,9,286,47,A61K38/00;;C12N15/113;;C12N2310/315;;C12N2310/316;;C12N2310/318;;C12N2310/3181;;C12N2310/321;;C12N2310/334;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;C12N2310/346;;C12N2310/318;;C12N2310/3181;;C12N2310/315;;C12N2310/341;;C12N2310/316;;C12N2310/321;;A61K38/00;;C12N2310/334;;Y02P20/582,C12N15/09;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,,0,0,,,,DISCONTINUED
90,US,A1,US 2005/0203045 A1,103-790-916-919-281,2005-09-15,2005,US 4827105 A,2005-02-01,US 4827105 A;;US 19729002 A;;US 85729901 A;;US 9922083 W;;US 20514498 A,1998-12-03,Antisense modulation of cellular inhibitor of Apoptosis-2 expression,"Antisense compounds, compositions and methods are provided for modulating the expression of Cellular Inhibitor of Apoptosis-2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Cellular Inhibitor of Apoptosis-2. Methods of using these compounds for modulation of Cellular Inhibitor of Apoptosis-2 expression and for treatment of diseases associated with expression of Cellular Inhibitor of Apoptosis-2 are provided.",BENNETT C. F.;;ACKERMANN ELIZABETH J.;;COWSERT LEX M.,BENNETT C F;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/103-790-916-919-281,Patent Application,yes,4,0,4,286,47,A61K31/7088;;A61K31/7088;;A61K38/00;;A61K38/00;;C12N15/113;;C12N15/113;;C07H21/04;;C07H21/04;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,A61K31/7088;;A61K38/00;;C07H21/04;;C12N15/113,514/44;;536/23.1,0,0,,,,DISCONTINUED
91,US,A1,US 2021/0253719 A1,078-417-283-019-119,2021-08-19,2021,US 202117191651 A,2021-03-03,US 202117191651 A;;US 2020/0048350 W;;US 201962892849 P,2019-08-28,METHODS FOR THE TREATMENT OF THYROID EYE DISEASE,"Provided herein are methods of treating or reducing the severity of thyroid eye disease (TED), also known as thyroid-associated ophthalmopathy (TAO), or Graves' ophthalmopathy or orbitopathy (GO), as well as antibodies, or antigen binding fragments thereof, and pharmaceutical compositions comprising them, useful in the methods.",HZNP LTD,SHERMAN JEFFREY W;;BENNETT DENNIS A;;RAMANATHAN SRINI;;XIN YAN;;THOMPSON ELIZABETH;;O'NEILL ELIZABETH,HORIZON THERAPEUTICS IRELAND DAC (2019-12-31),https://lens.org/078-417-283-019-119,Patent Application,yes,0,3,11,11,83,A61K39/3955;;C07K16/2863;;C07K2317/76;;A61K2039/505;;A61K2039/545;;A61K2039/55;;A61P27/02;;A61K31/4985;;A61K31/365;;A61K31/5377;;A61K31/277;;A61K31/4545;;A61K31/506;;A61K31/517;;A61K31/519;;A61K31/53;;A61P27/02;;A61K2039/505;;A61K2039/545;;C07K16/2863;;C07K2317/56;;C07K2317/565;;C07K2317/76,C07K16/28;;A61P27/02,,0,0,,,,DISCONTINUED
92,US,A1,US 2022/0356257 A1,000-047-041-165-441,2022-11-10,2022,US 202217654318 A,2022-03-10,US 202217654318 A;;US 202117191651 A;;US 2020/0048350 W;;US 201962892849 P,2019-08-28,METHODS FOR THE TREATMENT OF THYROID EYE DISEASE,"Provided herein are methods of treating or reducing the severity of thyroid eye disease (TED), also known as thyroid-associated ophthalmopathy (TAO), or Graves' ophthalmopathy or orbitopathy (GO), as well as antibodies, or antigen binding fragments thereof, and pharmaceutical compositions comprising them, useful in the methods.",HORIZON THERAPEUTICS IRELAND DAC,SHERMAN JEFFREY W;;BENNETT DENNIS A;;RAMANATHAN SRINI;;XIN YAN;;THOMPSON ELIZABETH;;O'NEILL ELIZABETH,HORIZON THERAPEUTICS IRELAND DAC (2023-01-18),https://lens.org/000-047-041-165-441,Patent Application,yes,0,0,11,11,83,A61K39/3955;;C07K16/2863;;C07K2317/76;;A61K2039/505;;A61K2039/545;;A61K2039/55;;A61P27/02;;A61K31/4985;;A61K31/365;;A61K31/5377;;A61K31/277;;A61K31/4545;;A61K31/506;;A61K31/517;;A61K31/519;;A61K31/53;;A61P27/02;;A61K2039/505;;A61K2039/545;;C07K16/2863;;C07K2317/56;;C07K2317/565;;C07K2317/76,A61P27/02;;C07K16/28,,0,0,,,,PENDING
93,US,A1,US 2004/0199102 A1,083-123-316-290-157,2004-10-07,2004,US 61989203 A,2003-07-15,US 61989203 A;;US 40785503 A,2003-04-04,Tampon applicator assembly,"
   A tampon applicator assembly having a barrel, a plunger, and a pledget is provided. The barrel has an insertion tip, a main section, and a finger grip. The main section can have a maximum outer dimension located closer to the finger grip than to the insertion tip and/or can have a main section taper ratio of about 1.07 to about 1.15. The insertion tip can have a taper ratio of more than about 0.66 and/or a plurality of petals with a petal length-to-width ratio over about 2 to less than about 3. 
",PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;JARMON GEORGE S;;BENNETT KATHRYN,PLAYTEX PRODUCTS INC (2003-08-28);;EGDEWELL PERSONAL CARE BRANDS LLC (2015-06-29);;EDGEWELL PERSONAL CARE BRANDS LLC (2015-06-29),https://lens.org/083-123-316-290-157,Patent Application,yes,38,53,4,11,0,A61F13/26;;A61F13/26,A61F13/26,604/11,0,0,,,,EXPIRED
94,US,A1,US 2015/0310634 A1,047-377-319-934-231,2015-10-29,2015,US 201514622282 A,2015-02-13,US 201514622282 A;;US 201461939509 P,2014-02-13,CLOUD-BASED SYSTEM FOR WATER ANALYSIS,"A cross-platform web-based system for water testing capable of measuring, analyzing and maintaining the quality of water using a plurality of different test strip readers each configured to obtain a digital image of a reagent test strip, normalize and analyze color information in the digital image by colorimetric analysis, and to transmit a set of colorimetric values corresponding to said digital image to a cross-platform cloud-based system for analysis. The cloud-based server(s) receive the colorimetric values, calculate analyte parts-per-million (ppm), and return the calculated analyte ppm with consistant results no matter which reader is used.",BABCOCK JAMES BENNETT;;PETRUCCY REBECCA ELIZABETH;;WADE BRETTON;;KENNEDY DOMINIC,BABCOCK JAMES BENNETT;;PETRUCCY REBECCA ELIZABETH;;WADE BRETTON;;KENNEDY DOMINIC,TAYLOR TECHNOLOGIES INC (2021-10-04),https://lens.org/047-377-319-934-231,Patent Application,yes,2,40,2,2,0,G01N21/274;;G01N21/78;;G01N2021/7759;;G01N33/18;;G06T2207/10024;;G06T2207/30108;;G06T7/90;;G01N33/18;;G06T2207/10024;;G06T2207/30108;;G01N21/274;;G01N21/78;;G01N2021/7759;;G06T7/90,G06T7/40;;G01N21/25;;G01N33/18;;G06T7/00,,0,0,,,,ACTIVE
95,US,B2,US 8221375 B2,168-485-004-503-037,2012-07-17,2012,US 66096910 A,2010-03-08,US 66096910 A;;US 61967703 A;;US 40715903 A,2003-04-04,Barrel for a tampon application assembly and methods of forming,"A method of forming a barrel for a tampon applicator assembly including molding a barrel then forming a rearward taper region in an area of the barrel is provided. The method includes molding a first portion of the barrel in a first mold part and a second portion of the barrel in a second mold part, the first and second mold parts meeting at a maximum outer dimension of the first portion, ejecting the barrel from the first and second mold parts, and forming a flared region in an area of the second portion.",LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;MELVIN WAYNE DAVID;;BENNETT KATHRYN;;PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;MELVIN WAYNE DAVID;;BENNETT KATHRYN,PLAYTEX PRODUCTS LLC (2008-10-01);;EVEREADY BATTERY COMAPNY LLC (2013-09-05);;EDGEWELL PERSONAL CAREBRANDS LLC (2015-06-29);;EVEREADY BATTERY COPMPANY INC (2013-09-05),https://lens.org/168-485-004-503-037,Granted Patent,yes,42,14,6,14,0,A61F13/26;;A61F13/26;;Y10S604/904;;Y10S604/904;;Y10T156/1013;;Y10T156/1013;;Y10T156/1038;;Y10T156/1038,A61F13/20;;A61F13/15;;A61F13/26;;B29C53/00;;B29C59/00;;B29C59/02,604/385.17;;604/385.18;;604/11;;604/15;;604/904;;264/320;;264/293;;156/203;;156/218,1,0,,,"Examiner's First Report from corresponding Australian Application No. 2004228005, dated Oct. 13, 2008.",EXPIRED
96,US,A1,US 2019/0273508 A1,011-712-713-097-274,2019-09-05,2019,US 201815910573 A,2018-03-02,US 201815910573 A,2018-03-02,USE OF DATA PREFIXES TO INCREASE COMPRESSION RATIOS,"A data compression system includes a memory to store a plurality of predetermined prefixes corresponding to a plurality of classes of data. A classifying module is configured to receive data, receive a class of the data, and select a prefix to compress the data from the plurality of predetermined prefixes based on the data and the class of the data. A compressing module is configured to compress the data using the prefix. A header generating module is configured to generate a header including an indication of the prefix used to compress the data, and to output the header and the compressed data for storage or transmission. Using the prefix from the predetermined prefixes to compress the data eliminates an overhead of fetching the prefix from outside the data compression system.",MICROSOFT TECHNOLOGY LICENSING LLC,BENNETT JOHN GRANT;;CARRIE SUSAN ELIZABETH;;KOLLI RAVI SHANKAR REDDY,MICROSOFT TECHNOLOGY LICENSING LLC (2018-02-27),https://lens.org/011-712-713-097-274,Patent Application,yes,0,6,2,2,0,G06F16/1744;;G06N3/08;;H03M7/3086;;H03M7/4037;;H03M7/3079;;H03M7/3086;;H03M7/40;;H03M7/42;;H03M7/6082,H03M7/40;;G06N3/08;;H03M7/30;;H03M7/42,,0,0,,,,ACTIVE
97,WO,A2,WO 2004/089241 A2,078-009-132-965-64X,2004-10-21,2004,US 2004/0010192 W,2004-04-02,US 40785503 A;;US 61989203 A,2003-04-04,IMPROVED TAMPON APPLICATOR ASSEMBLY,"A tampon applicator assembly having a barrel, a plunger, and a pledget is provided. The barrel has an insertion tip, a main section, and a finger grip. The main section can have a maximum outer dimension located closer to the finger grip than to the insertion tip and/or can have a main section taper ratio of about 1.07 to about 1.15. The insertion tip can have a taper ratio of more than about 0.66 and/or a plurality of petals with a petal length-to-width ratio over about 2 to less than about 3.",PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;JARMON GEORGE S;;BENNETT KATHRYN,,https://lens.org/078-009-132-965-64X,Patent Application,yes,0,3,7,11,0,A61F13/26,A61F13/26,,0,0,,,,PENDING
98,US,B2,US 9569858 B2,111-127-228-794-883,2017-02-14,2017,US 201514622282 A,2015-02-13,US 201514622282 A;;US 201461939509 P,2014-02-13,Cloud-based system for water analysis,"A cross-platform web-based system for water testing capable of measuring, analyzing and maintaining the quality of water using a plurality of different test strip readers each configured to obtain a digital image of a reagent test strip, normalize and analyze color information in the digital image by colorimetric analysis, and to transmit a set of colorimetric values corresponding to said digital image to a cross-platform cloud-based system for analysis. The cloud-based server(s) receive the colorimetric values, calculate analyte parts-per-million (ppm), and return the calculated analyte ppm with consistant results no matter which reader is used.",BABCOCK JAMES BENNETT;;PETRUCCY REBECCA ELIZABETH;;WADE BRETTON;;KENNEDY DOMINIC,BABCOCK JAMES BENNETT;;PETRUCCY REBECCA ELIZABETH;;WADE BRETTON;;KENNEDY DOMINIC,TAYLOR TECHNOLOGIES INC (2021-10-04),https://lens.org/111-127-228-794-883,Granted Patent,yes,15,41,2,2,0,G01N21/274;;G01N21/78;;G01N2021/7759;;G01N33/18;;G06T2207/10024;;G06T2207/30108;;G06T7/90;;G01N33/18;;G06T2207/10024;;G06T2207/30108;;G01N21/274;;G01N21/78;;G01N2021/7759;;G06T7/90,G06K9/00;;G01N21/27;;G01N21/77;;G01N21/78;;G01N33/18;;G06T7/40,,0,0,,,,ACTIVE
99,US,B2,US 10735025 B2,144-261-281-613-708,2020-08-04,2020,US 201815910573 A,2018-03-02,US 201815910573 A,2018-03-02,Use of data prefixes to increase compression ratios,"A data compression system includes a memory to store a plurality of predetermined prefixes corresponding to a plurality of classes of data. A classifying module is configured to receive data, receive a class of the data, and select a prefix to compress the data from the plurality of predetermined prefixes based on the data and the class of the data. A compressing module is configured to compress the data using the prefix. A header generating module is configured to generate a header including an indication of the prefix used to compress the data, and to output the header and the compressed data for storage or transmission. Using the prefix from the predetermined prefixes to compress the data eliminates an overhead of fetching the prefix from outside the data compression system.",MICROSOFT TECHNOLOGY LICENSING LLC,BENNETT JOHN GRANT;;CARRIE SUSAN ELIZABETH;;KOLLI RAVI SHANKAR REDDY,MICROSOFT TECHNOLOGY LICENSING LLC (2018-02-27),https://lens.org/144-261-281-613-708,Granted Patent,yes,8,0,2,2,0,G06F16/1744;;G06N3/08;;H03M7/3086;;H03M7/4037;;H03M7/3079;;H03M7/3086;;H03M7/40;;H03M7/42;;H03M7/6082,H03M7/40;;G06F16/174;;G06N3/08;;H03M7/30;;H03M7/42,,0,0,,,,ACTIVE
100,US,B2,US 7704242 B2,004-637-705-113-165,2010-04-27,2010,US 61967703 A,2003-07-15,US 61967703 A;;US 40715903 A,2003-04-04,Barrel for a tampon applicator assembly and methods of forming,"A method of forming a barrel for a tampon applicator assembly including molding a barrel then forming a rearward taper region in an area of the barrel is provided. The method includes molding a first portion of the barrel in a first mold part and a second portion of the barrel in a second mold part, the first and second mold parts meeting at a maximum outer dimension of the first portion, ejecting the barrel from the first and second mold parts, and forming a flared region in an area of the second portion.",PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;MELVIN WAYNE DAVID;;BENNETT KATHRYN,PLAYTEX PRODUCTS INC (2003-08-25);;EGDEWELL PERSONAL CARE BRANDS LLC (2015-06-29),https://lens.org/004-637-705-113-165,Granted Patent,yes,39,24,6,14,0,A61F13/26;;A61F13/26;;Y10S604/904;;Y10S604/904;;Y10T156/1013;;Y10T156/1013;;Y10T156/1038;;Y10T156/1038,A61F13/20;;A61F13/26,604/385.17;;604/385.18;;604/904;;604/11;;604/15;;604/18,4,0,,,"U.S. Appl. No. 10/619,892, filed Jul. 15, 2003, LeMay et al.;;Examiner's First Report from corresponding Australian Application No. 2004228005, dated Oct. 13, 2008.;;Office Action dated Apr. 29, 2008, from U.S. Appl. No. 10/619,892.;;U.S. Appl. No. 10/242,474, filed Sep. 12, 2002, LeMay et al.",EXPIRED
101,CA,A1,CA 2521246 A1,009-198-355-318-514,2004-10-21,2004,CA 2521246 A,2004-04-02,US 40785503 A;;US 61989203 A;;US 2004/0010192 W,2003-04-04,IMPROVED TAMPON APPLICATOR ASSEMBLY,"A tampon applicator assembly having a barrel, a plunger, and a pledget is provided. The barrel has an insertion tip, a main section, and a finger grip . The main section can have a maximum outer dimension located closer to the finger grip than to the insertion tip and/or can have a main section taper ratio of about 1.07 to about 1.15. The insertion tip can have a taper ratio of more than about 0.66 and/or a plurality of petals with a petal length-to-wid th ratio over about 2 to less than about 3.",PLAYTEX PRODUCTS INC,EDGETT KEITH;;LEMAY JESSICA ELIZABETH;;JARMON GEORGE S;;BENNETT KATHRYN,,https://lens.org/009-198-355-318-514,Patent Application,no,0,0,7,11,0,A61F13/26,A61F13/26,,0,0,,,,ACTIVE
102,US,B2,US 8372027 B2,009-267-271-813-047,2013-02-12,2013,US 61989203 A,2003-07-15,US 61989203 A;;US 40785503 A,2003-04-04,Tampon applicator assembly,"A tampon applicator assembly having a barrel, a plunger, and a pledget is provided. The barrel has an insertion tip, a main section, and a finger grip. The main section can have a maximum outer dimension located closer to the finger grip than to the insertion tip and/or can have a main section taper ratio of about 1.07 to about 1.15. The insertion tip can have a taper ratio of more than about 0.66 and/or a plurality of petals with a petal length-to-width ratio over about 2 to less than about 3.",PLAYTEX PRODUCTS INC;;LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;JARMON GEORGE S;;BENNETT KATHRYN,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;JARMON GEORGE S;;BENNETT KATHRYN,PLAYTEX PRODUCTS INC (2003-08-28);;EGDEWELL PERSONAL CARE BRANDS LLC (2015-06-29);;EDGEWELL PERSONAL CARE BRANDS LLC (2015-06-29),https://lens.org/009-267-271-813-047,Granted Patent,yes,45,14,4,11,0,A61F13/26;;A61F13/26,A61F13/20;;A61F13/26,604/15;;604/14,6,0,,,"Office Action from related U.S. Appl. No. 10/619,677 dated Oct. 9, 2007.;;U.S. Appl. No. 10/242,474, filed Sep. 12, 2002, LeMay et al.;;Second Examiner's Report from Australian Patent Application No. 2004228004 dated Jan. 4, 2010.;;Notice on Reasons for Rejection from Japanese Patent Application No. 2006-509630 dated Dec. 2, 2009.;;Decision of Rejection (with Decision of Rejection of Amendment) from corresponding Japanese Application No. 2006-509630 mailed Aug. 17, 2010.;;Japanese Office Action dated Jun. 26, 2012 from JP Appln No. 2010-281744.",EXPIRED
103,WO,A3,WO 2004/089241 A3,085-818-363-620-116,2006-07-27,2006,US 2004/0010192 W,2004-04-02,US 40785503 A;;US 61989203 A,2003-04-04,IMPROVED TAMPON APPLICATOR ASSEMBLY,"A tampon applicator assembly having a barrel, a plunger, and a pledget is provided. The barrel has an insertion tip, a main section, and a finger grip. The main section can have a maximum outer dimension located closer to the finger grip than to the insertion tip and/or can have a main section taper ratio of about 1.07 to about 1.15. The insertion tip can have a taper ratio of more than about 0.66 and/or a plurality of petals with a petal length-to-width ratio over about 2 to less than about 3.",PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;JARMON GEORGE S;;BENNETT KATHRYN,,https://lens.org/085-818-363-620-116,Search Report,yes,6,0,7,11,0,A61F13/26,A61F13/20;;A61F13/26,,0,0,,,,PENDING
104,US,A1,US 2010/0164139 A1,164-766-126-211-345,2010-07-01,2010,US 66096910 A,2010-03-08,US 66096910 A;;US 61967703 A;;US 40715903 A,2003-04-04,Barrel for a tampon application assembly and methods of forming,"A method of forming a barrel for a tampon applicator assembly including molding a barrel then forming a rearward taper region in an area of the barrel is provided. The method includes molding a first portion of the barrel in a first mold part and a second portion of the barrel in a second mold part, the first and second mold parts meeting at a maximum outer dimension of the first portion, ejecting the barrel from the first and second mold parts, and forming a flared region in an area of the second portion.",PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;MELVIN WAYNE DAVID;;BENNETT KATHRYN,PLAYTEX PRODUCTS LLC (2008-10-01);;EVEREADY BATTERY COMAPNY LLC (2013-09-05);;EDGEWELL PERSONAL CARE BRANDS LLC (2015-06-29);;EVEREADY BATTERY COPMPANY INC (2013-09-05),https://lens.org/164-766-126-211-345,Patent Application,yes,39,4,6,14,0,A61F13/26;;A61F13/26;;Y10S604/904;;Y10S604/904;;Y10T156/1013;;Y10T156/1013;;Y10T156/1038;;Y10T156/1038,B29C57/02;;A61F13/26,264/296,0,0,,,,EXPIRED
105,CA,C,CA 2521252 C,063-229-239-247-20X,2011-03-15,2011,CA 2521252 A,2004-04-02,US 40715903 A;;US 61967703 A;;US 2004/0010194 W,2003-04-04,A BARREL FOR A TAMPON APPLICATOR ASSEMBLY AND METHODS OF FORMING,"A method of forming a barrel for a tampon applicator assembly including molding a barrel then forming a rearward taper region in an area of the barrel is provided. The method includes molding a first portion of the barrel in a first mold part and a second portion of the barrel in a second mold part, the first and second mold parts meeting at a maximum outer dimension of the first portion, ejecting the barrel from the first and second mold parts, and forming a flared region in an area of the second portion.",PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;MELVIN WAYNE DAVID;;BENNETT KATHRYN,,https://lens.org/063-229-239-247-20X,Granted Patent,no,0,0,8,14,0,A61F13/26,A61F13/26;;A61F13/30,,0,0,,,,ACTIVE
106,CA,A1,CA 2521252 A1,137-840-667-599-075,2004-10-21,2004,CA 2521252 A,2004-04-02,US 40715903 A;;US 61967703 A;;US 2004/0010194 W,2003-04-04,A BARREL FOR A TAMPON APPLICATOR ASSEMBLY AND METHODS OF FORMING,"A method of forming a barrel for a tampon applicator assembly including molding a barrel then forming a rearward taper region in an area of the barr el is provided. The method includes molding a first portion of the barrel in a first mold part and a second portion of the barrel in a second mold part, th e first and second mold parts meeting at a maximum outer dimension of the firs t portion, ejecting the barrel from the first and second mold parts, and formi ng a flared region in an area of the second portion.",PLAYTEX PRODUCTS INC,MELVIN WAYNE DAVID;;BENNETT KATHRYN;;EDGETT KEITH;;LEMAY JESSICA ELIZABETH,,https://lens.org/137-840-667-599-075,Patent Application,no,0,0,8,14,0,A61F13/26,A61F13/26,,0,0,,,,ACTIVE
107,CA,C,CA 2521246 C,145-906-837-972-08X,2010-06-29,2010,CA 2521246 A,2004-04-02,US 40785503 A;;US 61989203 A;;US 2004/0010192 W,2003-04-04,IMPROVED TAMPON APPLICATOR ASSEMBLY,"A tampon applicator assembly having a barrel, a plunger, and a pledget is provided. The barrel has an insertion tip, a main section, and a finger grip. The main section can have a maximum outer dimension located closer to the finger grip than to the insertion tip and/or can have a main section taper ratio of about 1.07 to about 1.15. The insertion tip can have a taper ratio of more than about 0.66 and/or a plurality of petals with a petal length-to-width ratio over about 2 to less than about 3.",PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;JARMON GEORGE S;;BENNETT KATHRYN,,https://lens.org/145-906-837-972-08X,Granted Patent,no,0,0,7,11,0,A61F13/26,A61F13/32;;A61F13/26;;A61F13/30,,0,0,,,,ACTIVE
108,AU,A1,AU 2004/228004 A1,177-757-006-865-595,2004-10-21,2004,AU 2004/228004 A,2004-04-02,US 61989203 A;;US 40785503 A;;US 2004/0010192 W,2003-04-04,Improved tampon applicator assembly,,PLAYTEX PRODUCTS INC,EDGETT KEITH;;BENNETT KATHRYN;;JARMON GEORGE S;;LEMAY JESSICA ELIZABETH,"EDGEWELL PERSONAL CARE BRANDS, LLC (2015-09-17)",https://lens.org/177-757-006-865-595,Patent Application,no,0,0,7,11,0,A61F13/26,A61F13/26,,0,0,,,,ACTIVE
109,AU,A1,AU 2004/228005 A1,086-873-553-950-579,2004-10-21,2004,AU 2004/228005 A,2004-04-02,US 61967703 A;;US 40715903 A;;US 2004/0010194 W,2003-04-04,A barrel for a tampon applicator assembly and methods of forming,,PLAYTEX PRODUCTS INC,BENNETT KATHRYN;;LEMAY JESSICA ELIZABETH;;MELVIN WAYNE DAVID;;EDGETT KEITH,"EDGEWELL PERSONAL CARE BRANDS, LLC (2015-09-17)",https://lens.org/086-873-553-950-579,Patent Application,no,0,0,8,14,0,A61F13/26,A61F13/26,,0,0,,,,INACTIVE
110,AU,B2,AU 2004/228004 B2,111-243-514-483-697,2010-05-13,2010,AU 2004/228004 A,2004-04-02,US 61989203 A;;US 40785503 A;;US 2004/0010192 W,2003-04-04,Improved tampon applicator assembly,,EDGEWELL PERSONAL CARE BRANDS LLC,EDGETT KEITH;;BENNETT KATHRYN;;JARMON GEORGE S;;LEMAY JESSICA ELIZABETH,"EDGEWELL PERSONAL CARE BRANDS, LLC (2015-09-17)",https://lens.org/111-243-514-483-697,Granted Patent,no,3,0,7,11,0,A61F13/26,A61F13/20;;A61F13/26,,0,0,,,,ACTIVE
111,GB,A,GB 2615345 A,010-102-863-538-560,2023-08-09,2023,GB 202201494 A,2022-02-04,GB 202201494 A,2022-02-04,Apparatus for use in generating electricity,"An apparatus 101, intended to generate electricity, comprises a drive belt 102 rotatable, in an upright orientation, in a drive direction D. Part of the drive belt 102 passes through a first volume of a fluid F1 having a first density and another part passes through a second volume of a fluid F2 having a second density. It is proposed that the forces of gravity and buoyancy will generate first and second motion-contributing forces that encourage continuing rotation of the drive belt 101 in the drive direction D. The belt 102 also passes through a third fluid portion, and one of the fluid portions may be pressurised. The belt 102 may be replaced by separate cylinders 202, 203, 204. An energy storage arrangement is also disclosed (figure 13) with a vessel 1302 for retaining a volume of a liquid 1303 and a floatable object 1304, and a fluid control arrangement 1305 for controlling rising and falling of the object 1304.",GRAVITY ENGINES INTERNATIONAL LTD,ROY STEPHEN JEFFERIES;;CHRISTOPHER NOEL BENNETT THOMAS;;SUSAN ELIZABETH GWYTHER,,https://lens.org/010-102-863-538-560,Patent Application,no,8,0,3,3,0,F03B17/04;;F05B2260/422;;F03B17/02;;F03B17/04,F03B17/04,,1,0,,,The museum or unworkable devices: buoyancy motor #1 https://www.lockhaven.edu/~dsimanek/museum/unwork.htm accessed 11/02/2022,PENDING
112,JP,A,JP 2011056266 A,021-762-406-562-373,2011-03-24,2011,JP 2010204834 A,2010-09-13,US 40715903 A;;US 61967703 A,2003-04-04,BARREL FOR TAMPON APPLICATION ASSEMBLY AND METHOD OF FORMING,"<P>PROBLEM TO BE SOLVED: To provide a simple, low-cost method of forming a tampon applicator assembly which is improved to increase the user's comfort. <P>SOLUTION: The method of forming a barrel for the tampon applicator assembly includes molding the barrel and then forming a rearward taper region in a predetermined area of the barrel. The method includes molding a first portion of the barrel in a first mold part and a second portion of the barrel in a second mold part, so that the first and second mold parts meet at a maximum outer dimension of the first portion, ejecting the barrel from the first and second mold parts, and forming a flared region in an area of the second portion. <P>COPYRIGHT: (C)2011,JPO&INPIT",PLAYTEX PRODUCTS LLC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;MELVIN WAYNE DAVID;;BENNETT KATHRYN,,https://lens.org/021-762-406-562-373,Patent Application,no,7,0,6,14,0,A61F13/26;;A61F13/26;;Y10S604/904;;Y10S604/904;;Y10T156/1013;;Y10T156/1013;;Y10T156/1038;;Y10T156/1038,A61F13/26;;B29C33/44;;B29C33/76;;B29C45/44;;B29L31/48,,0,0,,,,DISCONTINUED
113,JP,A,JP 2013255817 A,076-130-563-728-568,2013-12-26,2013,JP 2013156063 A,2013-07-26,US 40715903 A;;US 61967703 A,2003-04-04,BARREL FOR TAMPON APPLICATION ASSEMBLY AND METHOD OF FORMING,"PROBLEM TO BE SOLVED: To provide a method of forming a tampon applicator assembly, improving the comfort of a user in use.SOLUTION: A method of forming a barrel 14 for a tampon applicator assembly 10 includes forming a rear taper region inside a prescribed region of the barrel 14 after molding the barrel 14. The method includes: molding a first portion 26 of the barrel inside a first cast part, and a second portion 28 inside a second cast part such that the first and second cast parts come into contact with each other in a position of a maximum outside dimension of the first portion; taking out the barrel 14 from the first and second cast parts; and forming a projection region inside a prescribed region of the second portion 28.",PLAYTEX PRODUCTS LLC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;MELVIN WAYNE DAVID;;BENNETT KATHRYN,,https://lens.org/076-130-563-728-568,Patent Application,no,4,0,6,14,0,A61F13/26;;A61F13/26;;Y10S604/904;;Y10S604/904;;Y10T156/1013;;Y10T156/1013;;Y10T156/1038;;Y10T156/1038,A61F13/26;;A61F13/32,,0,0,,,,PENDING
114,WO,A2,WO 2004/089242 A2,063-278-057-932-506,2004-10-21,2004,US 2004/0010194 W,2004-04-02,US 40715903 A;;US 61967703 A,2003-04-04,A BARREL FOR A TAMPON APPLICATOR ASSEMBLY AND METHODS OF FORMING,"A method of forming a barrel for a tampon applicator assembly including molding a barrel then forming a rearward taper region in an area of the barrel is provided. The method includes molding a first portion of the barrel in a first mold part and a second portion of the barrel in a second mold part, the first and second mold parts meeting at a maximum outer dimension of the first portion, ejecting the barrel from the first and second mold parts, and forming a flared region in an area of the second portion.",PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;MELVIN WAYNE DAVID;;BENNETT KATHRYN,,https://lens.org/063-278-057-932-506,Patent Application,yes,0,1,8,14,0,A61F13/26,A61F13/26,,0,0,,,,PENDING
115,JP,A,JP 2011078823 A,020-755-242-762-528,2011-04-21,2011,JP 2010281744 A,2010-12-17,US 40785503 A;;US 61989203 A,2003-04-04,IMPROVED TAMPON APPLICATOR ASSEMBLY,"<P>PROBLEM TO BE SOLVED: To provide a tampon applicator assembly which can be held and controlled easily not only when discharging a pledget but also when inserting and removing the applicator assembly. <P>SOLUTION: The applicator assembly 10 has an outer cylinder 14, a plunger 16, and the pledget 12. The outer cylinder has an insertion tip part 20, a main part 22, and a finger grip part 24. The main part has a maximum outer dimension at a position nearer to the finger grip part than to the insertion tip part, and/or may have a main part taper ratio of about 1.07 to about 1.15. The insertion tip part may have a taper ratio larger than about 0.66, and/or two or more petals each having a ratio of length to width of petal larger than about 2 and smaller than about 3. <P>COPYRIGHT: (C)2011,JPO&INPIT",PLAYTEX PRODUCTS LLC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;JARMON GEORGE S;;BENNETT KATHRYN,,https://lens.org/020-755-242-762-528,Patent Application,no,12,0,4,11,0,A61F13/26;;A61F13/26,A61F13/30;;A61F13/26,,0,0,,,,ACTIVE
116,AU,B2,AU 2004/228005 B2,065-491-074-753-046,2009-12-10,2009,AU 2004/228005 A,2004-04-02,US 61967703 A;;US 40715903 A;;US 2004/0010194 W,2003-04-04,A barrel for a tampon applicator assembly and methods of forming,,EDGEWELL PERSONAL CARE BRANDS LLC,BENNETT KATHRYN;;LEMAY JESSICA ELIZABETH;;MELVIN WAYNE DAVID;;EDGETT KEITH,"EDGEWELL PERSONAL CARE BRANDS, LLC (2015-09-17)",https://lens.org/065-491-074-753-046,Granted Patent,no,3,0,8,14,0,A61F13/26,A61F13/26,,0,0,,,,INACTIVE
117,WO,A3,WO 2004/089242 A3,141-186-238-557-118,2006-01-26,2006,US 2004/0010194 W,2004-04-02,US 40715903 A;;US 61967703 A,2003-04-04,A BARREL FOR A TAMPON APPLICATOR ASSEMBLY AND METHODS OF FORMING,"A method of forming a barrel for a tampon applicator assembly including molding a barrel then forming a rearward taper region in an area of the barrel is provided. The method includes molding a first portion of the barrel in a first mold part and a second portion of the barrel in a second mold part, the first and second mold parts meeting at a maximum outer dimension of the first portion, ejecting the barrel from the first and second mold parts, and forming a flared region in an area of the second portion.",PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;MELVIN WAYNE DAVID;;BENNETT KATHRYN,,https://lens.org/141-186-238-557-118,Search Report,yes,1,0,8,14,0,A61F13/26,A61F13/26,,0,0,,,,PENDING
118,US,A1,US 2004/0199101 A1,175-475-649-835-260,2004-10-07,2004,US 61967703 A,2003-07-15,US 61967703 A;;US 40715903 A,2003-04-04,Barrel for a tampon applicator assembly and methods of forming,"
   A method of forming a barrel for a tampon applicator assembly including molding a barrel then forming a rearward taper region in an area of the barrel is provided. The method includes molding a first portion of the barrel in a first mold part and a second portion of the barrel in a second mold part, the first and second mold parts meeting at a maximum outer dimension of the first portion, ejecting the barrel from the first and second mold parts, and forming a flared region in an area of the second portion. 
",PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH;;MELVIN WAYNE DAVID;;BENNETT KATHRYN,PLAYTEX PRODUCTS INC (2003-08-25);;EGDEWELL PERSONAL CARE BRANDS LLC (2015-06-29),https://lens.org/175-475-649-835-260,Patent Application,yes,29,29,6,14,0,A61F13/26;;A61F13/26;;Y10S604/904;;Y10S604/904;;Y10T156/1013;;Y10T156/1013;;Y10T156/1038;;Y10T156/1038,A61F13/26,604/11;;264/296;;X26432,0,0,,,,EXPIRED
119,DK,T3,DK 3177160 T3,036-442-893-814-532,2019-07-15,2019,DK 15829471 T,2015-08-03,AU 2014/903013 A;;AU 2015/000461 W,2014-08-04,ANORDNING TIL FORMULERING AF FØDEVARER TIL DIÆTKOST,,COMMW SCIENT IND RES ORG;;HORTICULTURE INNOVATION AUSTRALIA LTD,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,,https://lens.org/036-442-893-814-532,Granted Patent,no,0,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,A23L33/10,,0,0,,,,ACTIVE
120,WO,A1,WO 2016/019413 A1,087-379-333-137-706,2016-02-11,2016,AU 2015/000461 W,2015-08-03,AU 2014/903013 A,2014-08-04,METHODS FOR FORMULATING DIETARY FOODSTUFFS,"Generating an optimised formulation for a foodstuff, comprises receiving at a processor physicochemical data pertaining to one or more plant extracts and operating the processor to calculate a time, T max , representing a time to reach a maximum concentration in plasma of at least one metabolite of the one or more plant extracts by applying the received physicochemical data to a mathematical model stored in memory. The processor is then operated to identify ones of the metabolites for which the calculated T max substantially corresponds with a target absorption time for the foodstuff; and to generate an optimised formulation for the foodstuff comprising the one or more plant extracts containing the identified metabolites. The physicochemical data include one or more of molecular mass (M), liphophilicity (logP) and Polar Surface Area (PSA).",COMMW SCIENT IND RES ORG;;HORTICULTURE AUSTRALIA LTD,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,,https://lens.org/087-379-333-137-706,Patent Application,yes,1,1,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,G06N7/00;;G06Q50/00,,3,2,012-730-682-690-539;;059-930-879-481-601,24410651;;10.1586/17512433.2.2.195;;17968736;;10.1080/00498250701502114,"FOTAKI, N.: ""Pros and Cons of Methods Used for the Prediction of Oral Drug Absorption."", EXPERT REV. CLIN. PHARMACOL., vol. 2, no. 2, 2009, pages 195 - 208, XP008185368;;DOKOUMETZIDIS, A ET AL.: ""Modelling and Simulation in Drug Absorption Processes."", XENOBIOTICA, vol. 37, no. 10-11, October 2007 (2007-10-01), pages 1052 - 1065, XP008185363;;ALMINGER, M ET AL.: ""In Vitro Models for Studying Secondary Plant Metabolite Digestion and Bioaccessibility."", COMP. REV. FOOD SCI. F., vol. 13, July 2014 (2014-07-01), pages 413 - 436, XP055394738",PENDING
121,CN,A,CN 107209875 A,104-805-921-331-357,2017-09-26,2017,CN 201580053847 A,2015-08-03,AU 2014/903013 A;;AU 2015/000461 W,2014-08-04,Methods for formulating dietary foodstuffs,"Generating an optimised formulation for a foodstuff, comprises receiving at a processor physicochemical data pertaining to one or more plant extracts and operating the processor to calculate a time, Tmax, representing a time to reach a maximum concentration in plasma of at least one metabolite of the one or more plant extracts by applying the received physicochemical data to a mathematical model stored in memory. The processor is then operated to identify ones of the metabolites for which the calculated Tmax substantially corresponds with a target absorption time for the foodstuff; and to generate an optimised formulation for the foodstuff comprising the one or more plant extracts containing the identified metabolites. The physicochemical data include one or more of molecular mass (M), liphophilicity (logP) and Polar Surface Area (PSA).",COMMW SCIENT IND RES ORG;;HORTICULTURE AUSTRALIA LTD,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,,https://lens.org/104-805-921-331-357,Patent Application,no,3,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,G06N7/00;;A23L33/00;;G06Q50/00,,1,1,012-730-682-690-539,24410651;;10.1586/17512433.2.2.195,"FOTAKI,N: ""pros and cons of methods used for the prediction of oral drug absorption"", 《EXPERTREV.CLIN.PHARMACOL》",ACTIVE
122,US,A1,US 2017/0215463 A1,056-151-984-945-963,2017-08-03,2017,US 201515501680 A,2015-08-03,AU 2014/903013 A;;AU 2015/000461 W,2014-08-04,METHODS FOR FORMULATING DIETARY FOODSTUFFS,"Generating an optimised formulation for a foodstuff, comprises receiving at a processor physicochemical data pertaining to one or more plant extracts and operating the processor to calculate a time, T max , representing a time to reach a maximum concentration in plasma of at least one metabolite of the one or more plant extracts by applying the received physicochemical data to a mathematical model stored in memory. The processor is then operated to identify ones of the metabolites for which the calculated T max substantially corresponds with a target absorption time for the foodstuff; and to generate an optimised formulation for the foodstuff comprising the one or more plant extracts containing the identified metabolites. The physicochemical data include one or more of molecular mass (M), liphophilicity (log P) and Polar Surface Area (PSA).",COMMW SCIENT IND RES ORG;;HORTICULTURE AUSTRALIA LTD,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,HORTICULTURE AUSTRALIA LIMITED (2013-07-15);;HORTICULTURE INNOVATION AUSTRALIA LIMITED (2020-12-17);;COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGNISATION (2015-02-18),https://lens.org/056-151-984-945-963,Patent Application,yes,2,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,A23L33/105;;A23L5/30;;A23L33/00;;G06N7/00,,0,0,,,,ACTIVE
123,CA,A1,CA 2956963 A1,161-723-656-060-856,2016-02-11,2016,CA 2956963 A,2015-08-03,AU 2014/903013 A;;AU 2015/000461 W,2014-08-04,METHODS FOR FORMULATING DIETARY FOODSTUFFS,"Generating an optimised formulation for a foodstuff, comprises receiving at a processor physicochemical data pertaining to one or more plant extracts and operating the processor to calculate a time, Tmax, representing a time to reach a maximum concentration in plasma of at least one metabolite of the one or more plant extracts by applying the received physicochemical data to a mathematical model stored in memory. The processor is then operated to identify ones of the metabolites for which the calculated Tmax substantially corresponds with a target absorption time for the foodstuff; and to generate an optimised formulation for the foodstuff comprising the one or more plant extracts containing the identified metabolites. The physicochemical data include one or more of molecular mass (M), liphophilicity (logP) and Polar Surface Area (PSA).",HORTICULTURE AUSTRALIA LTD;;COMMW SCIENT IND RES ORG,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,,https://lens.org/161-723-656-060-856,Patent Application,no,0,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,A23L33/105;;A23L5/00;;A23L33/00;;A23P30/00;;G06F17/10;;G06F19/00,,0,0,,,,PENDING
124,CN,A,CN 104010699 A,181-575-118-779-971,2014-08-27,2014,CN 201280062783 A,2012-11-06,GB 2012052764 W;;GB 201119171 A;;US 201161556329 P,2011-11-07,Apparatus for the treatment of air,"A gas treatment apparatus, suitable for use in an air purifying apparatus for the production of breathable air, comprises a catalyst comprising palladium and iron oxide and a source of a volatile nitrogen-containing compound. The apparatus is useful in gas masks, emergency escape hoods and static air treatment apparatus.",JOHNSON MATTHEY PLC,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/181-575-118-779-971,Patent Application,no,6,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J23/89,,1,0,,,"LEQUAN LIU等，: ""“Low-temperature CO oxidation over supported Pt,Pd catalysts: Particular role of FeOx support for oxygen supply during reactions”"", 《JOURNAL OF CATALYSIS》",ACTIVE
125,RS,B1,RS 60588 B1,029-384-116-922-938,2020-08-31,2020,RS P20200871 A,2012-11-06,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W;;EP 12784663 A,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,,ANGLO PLATINUM MARKETING LTD,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/029-384-116-922-938,Granted Patent,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J21/18;;B01J23/52;;B01J23/89;;B01J35/00;;B01J37/02;;B01J37/03;;B01J37/06;;B01J37/14;;B01J37/18,,0,0,,,,ACTIVE
126,SG,A,SG 11201402101U A,123-201-809-525-495,2014-06-27,2014,SG 11201402101U A,2012-11-06,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,,JOHNSON MATTHEY PLC,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/123-201-809-525-495,Unknown,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J23/89,,0,0,,,,PENDING
127,SI,T1,SI 2776132 T1,033-326-413-013-924,2020-10-30,2020,SI 201231795 T,2012-11-06,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W;;EP 12784663 A,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,,ANGLO PLATINUM MARKETING LTD,ROWSELL ELIZABETH;;POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES,,https://lens.org/033-326-413-013-924,Granted Patent,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/00;;A62D9/00;;B01D53/00;;B01J21/00;;B01J23/00;;B01J35/00;;B01J37/00,,0,0,,,,ACTIVE
128,ZA,B,ZA 201403421 B,057-863-302-407-239,2017-06-28,2017,ZA 201403421 A,2014-05-13,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,,JOHNSON MATTHEY PLC A PLC REGISTERED IN ENGLAND,STEPHEN CHARLES BENNETT;;ANDREW WILLIAM JOHN SMITH;;ELIZABETH ROWSELL;;STEPHEN POULSTON,,https://lens.org/057-863-302-407-239,Granted Patent,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,,,0,0,,,,ACTIVE
129,GB,B,GB 2496317 B,174-789-021-331-775,2016-05-25,2016,GB 201219987 A,2012-11-06,GB 201119171 A,2011-11-07,Apparatus for the treatment of air,,ANGLO PLATINUM MARKETING LTD,STEPHEN POULSTON;;ANDREW WILLIAM JOHN SMITH;;STEPHEN CHARLES BENNETT;;ELIZABETH ROWSELL,,https://lens.org/174-789-021-331-775,Granted Patent,no,7,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,B01D53/86;;A62D9/00;;B01J23/89,,1,1,089-944-711-889-465,10.1016/j.jcat.2008.11.012,"Journal of Catalysis, Vol.261, 2009, Qiao et al., pages 241-244.",ACTIVE
130,IN,A,IN 4130CHN2014 A,096-280-187-532-893,2015-07-17,2015,IN 4130CHN2014 A,2014-06-03,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,A gas treatment apparatus suitable for use in an air purifying apparatus for the production of breathable air comprises a catalyst comprising palladium and iron oxide and a source of a volatile nitrogen containing compound. The apparatus is useful in gas masks emergency escape hoods and static air treatment apparatus.,JOHNSON MATTHEY PLC,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/096-280-187-532-893,Patent Application,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62,,0,0,,,,PENDING
131,DK,T3,DK 2776132 T3,106-850-032-601-906,2020-07-27,2020,DK 12784663 T,2012-11-06,US 201161556329 P;;GB 201119171 A;;GB 2012052764 W,2011-11-07,Apparat til behandling af luft,,ANGLO PLATINUM MARKETING LTD,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/106-850-032-601-906,Granted Patent,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J21/18;;B01J23/52;;B01J23/89;;B01J35/00;;B01J37/02;;B01J37/03;;B01J37/06;;B01J37/14;;B01J37/18,,0,0,,,,ACTIVE
132,CA,C,CA 2854714 C,145-942-716-145-887,2020-08-25,2020,CA 2854714 A,2012-11-06,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,"A gas treatment apparatus, suitable for use in an air purifying apparatus for the production of breathable air, comprises a catalyst comprising palladium and iron oxide and a source of a volatile nitrogen-containing compound. The apparatus is useful in gas masks, emergency escape hoods and static air treatment apparatus.",JOHNSON MATTHEY PLC,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/145-942-716-145-887,Granted Patent,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J23/89,,0,0,,,,ACTIVE
133,EP,A1,EP 3177160 A1,003-616-227-953-987,2017-06-14,2017,EP 15829471 A,2015-08-03,AU 2014/903013 A;;AU 2015/000461 W,2014-08-04,APPARATUS FOR FORMULATING DIETARY FOODSTUFFS,,COMMW SCIENT IND RES ORG;;HORTICULTURE INNOVATION AUSTRALIA LTD,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,"HORTICULTURE INNOVATION AUSTRALIA LIMITED, AU (2019-08-26);;HORTICULTURE INNOVATION AUSTRALIA LIMITED (2020-04-15);;COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (2020-04-15)",https://lens.org/003-616-227-953-987,Patent Application,yes,0,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,A23L33/10,,0,0,,,,ACTIVE
134,HR,T1,HR P20200765 T1,106-509-302-859-263,2020-07-24,2020,HR P20200765 T,2020-05-12,GB 201119171 A;;US 201161556329 P;;EP 12784663 A;;GB 2012052764 W,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,,ANGLO PLATINUM MARKETING LTD,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/106-509-302-859-263,Granted Patent,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J21/18;;B01J23/52;;B01J23/89;;B01J35/00;;B01J37/02;;B01J37/03;;B01J37/06;;B01J37/14;;B01J37/18,,0,0,,,,ACTIVE
135,HU,T2,HU E051086 T2,177-543-418-972-828,2021-03-01,2021,HU E12784663 A,2012-11-06,GB 201119171 A;;US 201161556329 P,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,,ANGLO PLATINUM MARKETING LTD,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/177-543-418-972-828,Amended Patent,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J21/18;;B01J23/52;;B01J23/89;;B01J35/00;;B01J37/02;;B01J37/03;;B01J37/06;;B01J37/14;;B01J37/18,,0,0,,,,PENDING
136,CA,A1,CA 2854714 A1,064-814-285-860-893,2013-05-16,2013,CA 2854714 A,2012-11-06,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,"A gas treatment apparatus, suitable for use in an air purifying apparatus for the production of breathable air, comprises a catalyst comprising palladium and iron oxide and a source of a volatile nitrogen-containing compound. The apparatus is useful in gas masks, emergency escape hoods and static air treatment apparatus.",JOHNSON MATTHEY PLC,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/064-814-285-860-893,Patent Application,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J23/89,,0,0,,,,ACTIVE
137,EP,A4,EP 3177160 A4,102-613-216-112-109,2017-12-13,2017,EP 15829471 A,2015-08-03,AU 2014/903013 A;;AU 2015/000461 W,2014-08-04,METHODS FOR FORMULATING DIETARY FOODSTUFFS,,COMMW SCIENT IND RES ORG;;HORTICULTURE INNOVATION AUSTRALIA LTD,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,"HORTICULTURE INNOVATION AUSTRALIA LIMITED, AU (2019-08-26);;HORTICULTURE INNOVATION AUSTRALIA LIMITED (2020-04-15);;COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (2020-04-15)",https://lens.org/102-613-216-112-109,Search Report,no,2,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,A23L33/10,,1,0,,,See also references of WO 2016019413A1,ACTIVE
138,AU,A1,AU 2015/299739 A1,128-565-494-949-793,2017-03-02,2017,AU 2015/299739 A,2015-08-03,AU 2014/903013 A;;AU 2015/000461 W,2014-08-04,Methods for formulating dietary foodstuffs,"Generating an optimised formulation for a foodstuff, comprises receiving at a processor physicochemical data pertaining to one or more plant extracts and operating the processor to calculate a time, T",COMMW SCIENT IND RES ORG;;HORTICULTURE INNOVATION AUSTRALIA LTD HIA,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH OR (2019-09-05);;HORTICULTURE INNOVATION AUSTRALIA LIMITED (HIA) (2019-09-05),https://lens.org/128-565-494-949-793,Patent Application,no,0,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,G06N7/00;;G06Q50/00,,0,0,,,,ACTIVE
139,WO,A2,WO 2013/068737 A2,076-400-429-339-104,2013-05-16,2013,GB 2012052764 W,2012-11-06,GB 201119171 A;;US 201161556329 P,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,"A gas treatment apparatus, suitable for use in an air purifying apparatus for the production of breathable air, comprises a catalyst comprising palladium and iron oxide and a source of a volatile nitrogen-containing compound. The apparatus is useful in gas masks, emergency escape hoods and static air treatment apparatus.",JOHNSON MATTHEY PLC,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/076-400-429-339-104,Patent Application,yes,6,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02,,1,1,089-944-711-889-465,10.1016/j.jcat.2008.11.012,"B. QIAO ET AL., JOURNAL OF CATALYSIS, vol. 261, 2009, pages 241 - 244",PENDING
140,US,A1,US 2020/0001234 A1,083-912-424-594-870,2020-01-02,2020,US 201916526279 A,2019-07-30,US 201916526279 A;;GB 201119171 A;;US 201414356498 A;;GB 2012052764 W;;US 201161556329 P,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,"A gas treatment apparatus, suitable for use in an air purifying apparatus for the production of breathable air, includes a catalyst including palladium and iron oxide and a source of a volatile nitrogen-containing compound. The apparatus is useful in gas masks, emergency escape hoods and static air treatment apparatus.",ANGLO PLATINUM MARKETING LTD,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,ANGLO PLATINUM MARKETING LIMITED (2015-03-13),https://lens.org/083-912-424-594-870,Patent Application,yes,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,B01D53/86,,0,0,,,,DISCONTINUED
141,PL,T3,PL 3177160 T3,084-625-129-151-764,2020-05-18,2020,PL 15829471 T,2015-08-03,AU 2014/903013 A;;EP 15829471 A;;AU 2015/000461 W,2014-08-04,APPARATUS FOR FORMULATING DIETARY FOODSTUFFS,,COMMW SCIENT IND RES ORG;;HORTICULTURE INNOVATION AUSTRALIA LTD,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,,https://lens.org/084-625-129-151-764,Patent Application,no,0,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,A23L33/10,,0,0,,,,PENDING
142,EP,A4,EP 2812862 A4,158-922-164-277-526,2015-11-11,2015,EP 12867799 A,2012-02-13,US 201213371355 A;;US 2012/0024873 W,2012-02-10,MOBILE MONEY ORDER,,INTUIT INC,ZAFAR ABRAHAM;;BLANK BENNETT R;;BOUSSAROV MIROSLAV SVETOSLAVOV;;BOEHM SARA ELIZABETH,,https://lens.org/158-922-164-277-526,Search Report,no,6,0,7,7,0,G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326;;G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326,G06Q20/10;;G06Q20/04;;G06Q20/32;;G06Q20/40;;G06Q40/02,,1,0,,,See also references of WO 2013119256A1,DISCONTINUED
143,EP,A2,EP 2776132 A2,191-115-905-803-286,2014-09-17,2014,EP 12784663 A,2012-11-06,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,,JOHNSON MATTHEY PLC,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,ANGLO PLATINUM MARKETING LIMITED (2015-12-02),https://lens.org/191-115-905-803-286,Patent Application,yes,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J23/89,,0,0,,,,ACTIVE
144,EP,B1,EP 2776132 B1,016-213-494-863-789,2020-04-29,2020,EP 12784663 A,2012-11-06,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,,ANGLO PLATINUM MARKETING LTD,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,ANGLO PLATINUM MARKETING LIMITED (2015-12-02),https://lens.org/016-213-494-863-789,Granted Patent,yes,5,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J21/18;;B01J23/52;;B01J23/89;;B01J35/00;;B01J37/02;;B01J37/03;;B01J37/06;;B01J37/14;;B01J37/18,,0,0,,,,ACTIVE
145,GB,A,GB 2496317 A,050-388-505-176-405,2013-05-08,2013,GB 201219987 A,2012-11-06,GB 201119171 A,2011-11-07,Apparatus for the treatment of carbon monoxide in air,"A gas treatment apparatus e.g. a gas filter, suitable for use in an air purifying apparatus for the production of breathable air, comprises a catalyst comprising palladium and iron oxide and a source of a volatile nitrogen-containing compound. The apparatus is useful in gas masks, emergency escape hoods and static air treatment apparatus. The catalyst is preferably made by precipitating a mixed oxide and hydroxide containing iron and palladium is from an acid solution comprising soluble iron and palladium compounds (preferably iron and palladium nitrates). The iron oxide and palladium may be supported on a porous solid support material. The source of a volatile nitrogen-containing compound may be an absorbent material impregnated with an amine or ammonia, and is preferably activated carbon impregnated with triethylenediamine (TEDA). A method of treating air using the apparatus is also outlined.",JOHNSON MATTHEY PLC,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/050-388-505-176-405,Patent Application,no,7,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,B01D53/86;;A62D9/00;;B01J23/89,,1,1,089-944-711-889-465,10.1016/j.jcat.2008.11.012,"Journal of Catalysis, Vol.261, 2009, Qiao et al., pages 241-244.",ACTIVE
146,AU,B2,AU 2015/299739 B2,191-220-325-191-222,2020-05-14,2020,AU 2015/299739 A,2015-08-03,AU 2014/903013 A;;AU 2015/000461 W,2014-08-04,Methods for formulating dietary foodstuffs,"Generating an optimised formulation for a foodstuff, comprises receiving at a processor physicochemical data pertaining to one or more plant extracts and operating the processor to calculate a time, T",COMMW SCIENT IND RES ORG;;HORTICULTURE INNOVATION AUSTRALIA LTD,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH OR (2019-09-05);;HORTICULTURE INNOVATION AUSTRALIA LIMITED (HIA) (2019-09-05),https://lens.org/191-220-325-191-222,Granted Patent,no,1,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,G06N7/00;;G06Q50/00,,3,2,012-730-682-690-539;;059-930-879-481-601,24410651;;10.1586/17512433.2.2.195;;17968736;;10.1080/00498250701502114,"FOTAKI, N.: ""Pros and Cons of Methods Used for the Prediction of Oral Drug Absorption."", EXPERT REVIEW OF CLINICAL PHARMACOLOGY 20141101 EXPERT REVIEWS LTD. GBR, TAYLOR & FRANCIS, UK, vol. 2, no. 2, 1 January 2009 (2009-01-01), UK, pages 195 - 208, XP008185368, ISSN: 1751-2433, DOI: 10.1586/17512433.2.2.195;;ALMINGER, M et al., ""In Vitro Models for Studying Secondary Plant Metabolite Digestion and Bioaccessibility."", Comp. Rev. Food Sci. F., (2014-07), vol. 13, pages 413 - 436;;DOKOUMETZIDIS A, VALSAMI G, MACHERAS P.: ""Modelling and Simulation in Drug Absorption Processes."", XENOBIOTICA, TAYLOR AND FRANCIS, LONDON,, UK, vol. 37, no. 10-11, 1 October 2007 (2007-10-01), UK, pages 1052 - 1065, XP008185363, ISSN: 0049-8254, DOI: 10.1080/00498250701502114",ACTIVE
147,AU,A1,AU 2012/335391 A1,107-936-578-222-960,2014-05-29,2014,AU 2012/335391 A,2012-11-06,US 201161556329 P;;GB 201119171 A;;GB 2012052764 W,2011-11-07,Apparatus for the treatment of air,"A gas treatment apparatus, suitable for use in an air purifying apparatus for the production of breathable air, comprises a catalyst comprising palladium and iron oxide and a source of a volatile nitrogen-containing compound. The apparatus is useful in gas masks, emergency escape hoods and static air treatment apparatus.",JOHNSON MATTHEY PLC,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,ANGLO PLATINUM MARKETING LIMITED (2015-09-03),https://lens.org/107-936-578-222-960,Patent Application,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J23/89,,0,0,,,,ACTIVE
148,AU,B2,AU 2012/335391 B2,090-173-833-240-181,2017-05-04,2017,AU 2012/335391 A,2012-11-06,US 201161556329 P;;GB 201119171 A;;GB 2012052764 W,2011-11-07,Apparatus for the treatment of air,"A gas treatment apparatus, suitable for use in an air purifying apparatus for the production of breathable air, comprises a catalyst comprising palladium and iron oxide and a source of a volatile nitrogen-containing compound. The apparatus is useful in gas masks, emergency escape hoods and static air treatment apparatus.",ANGLO PLATINUM MARKETING LTD,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,ANGLO PLATINUM MARKETING LIMITED (2015-09-03),https://lens.org/090-173-833-240-181,Granted Patent,no,2,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J23/89,,0,0,,,,ACTIVE
149,CA,A1,CA 2864343 A1,102-505-291-781-048,2013-08-15,2013,CA 2864343 A,2012-02-13,US 201213371355 A;;US 2012/0024873 W,2012-02-10,MOBILE MONEY ORDER,"A method to track a money order transaction, including receiving, from a mobile device, a request to send the money order to a recipient, initiating, by a computer server in response to the request, a first transaction to transfer a money order amount from a funding account of the payer to a third party account held at a bank, initiating, in response to completing the first transaction, a second transaction to generate the money order by the bank, receiving, from the bank, an indication that the money order amount is paid out by the bank as a result of the recipient cashing the money order, and sending, in response to the indication, a message alerting the payer that the recipient has cashed the money order.",INTUIT INC,ZAFAR ABRAHAM;;BLANK BENNETT R;;BOUSSAROV MIROSLAV SVETOSLAVOV;;BOEHM SARA ELIZABETH,,https://lens.org/102-505-291-781-048,Patent Application,no,0,0,7,7,0,G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326;;G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326,G06Q20/10;;G06Q40/02,,0,0,,,,DISCONTINUED
150,AU,A1,AU 2012/369168 A1,107-536-364-629-973,2014-09-25,2014,AU 2012/369168 A,2012-02-13,US 201213371355 A;;US 2012/0024873 W,2012-02-10,Mobile money order,"A method to track a money order transaction, including receiving, from a mobile device, a request to send the money order to a recipient, initiating, by a computer server in response to the request, a first transaction to transfer a money order amount from a funding account of the payer to a third party account held at a bank, initiating, in response to completing the first transaction, a second transaction to generate the money order by the bank, receiving, from the bank, an indication that the money order amount is paid out by the bank as a result of the recipient cashing the money order, and sending, in response to the indication, a message alerting the payer that the recipient has cashed the money order.",INTUIT INC,ZAFAR ABRAHAM;;BLANK BENNETT R;;BOUSSAROV MIROSLAV SVETOSLAVOV;;BOEHM SARA ELIZABETH,,https://lens.org/107-536-364-629-973,Patent Application,no,0,0,7,7,0,G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326;;G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326,G06Q20/10;;G06Q40/02,,0,0,,,,ACTIVE
151,EP,A1,EP 2812862 A1,142-093-301-999-968,2014-12-17,2014,EP 12867799 A,2012-02-13,US 201213371355 A;;US 2012/0024873 W,2012-02-10,MOBILE MONEY ORDER,,INTUIT INC,ZAFAR ABRAHAM;;BLANK BENNETT R;;BOUSSAROV MIROSLAV SVETOSLAVOV;;BOEHM SARA ELIZABETH,,https://lens.org/142-093-301-999-968,Patent Application,yes,0,0,7,7,0,G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326;;G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326,G06Q20/10;;G06Q20/04;;G06Q20/32;;G06Q20/40;;G06Q40/02,,0,0,,,,DISCONTINUED
152,CA,C,CA 2956963 C,157-545-642-408-459,2022-05-24,2022,CA 2956963 A,2015-08-03,AU 2014/903013 A;;AU 2015/000461 W,2014-08-04,METHODS FOR FORMULATING DIETARY FOODSTUFFS,"Generating an optimised formulation for a foodstuff, comprises receiving at a processor physicochemical data pertaining to one or more plant extracts and operating the processor to calculate a time, Tmax, representing a time to reach a maximum concentration in plasma of at least one metabolite of the one or more plant extracts by applying the received physicochemical data to a mathematical model stored in memory. The processor is then operated to identify ones of the metabolites for which the calculated Tmax substantially corresponds with a target absorption time for the foodstuff; and to generate an optimised formulation for the foodstuff comprising the one or more plant extracts containing the identified metabolites. The physicochemical data include one or more of molecular mass (M), liphophilicity (logP) and Polar Surface Area (PSA).",HORTICULTURE AUSTRALIA LTD;;COMMW SCIENT IND RES ORG,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,,https://lens.org/157-545-642-408-459,Granted Patent,no,0,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,A23L33/105;;A23L5/00;;A23L33/00;;A23P30/00;;G06F17/10,,0,0,,,,PENDING
153,US,A1,US 2013/0212003 A1,066-686-682-473-917,2013-08-15,2013,US 201213371355 A,2012-02-10,US 201213371355 A,2012-02-10,MOBILE MONEY ORDER,"A method to track a money order transaction, including receiving, from a mobile device, a request to send the money order to a recipient, initiating, by a computer server in response to the request, a first transaction to transfer a money order amount from a funding account of the payer to a third party account held at a bank, initiating, in response to completing the first transaction, a second transaction to generate the money order by the bank, receiving, from the bank, an indication that the money order amount is paid out by the bank as a result of the recipient cashing the money order, and sending, in response to the indication, a message alerting the payer that the recipient has cashed the money order.",ZAFAR ABRAHAM;;BLANK BENNETT R;;BOUSSAROV MIROSLAV SVETOSLAVOV;;BOEHM SARA ELIZABETH;;INTUIT INC,ZAFAR ABRAHAM;;BLANK BENNETT R;;BOUSSAROV MIROSLAV SVETOSLAVOV;;BOEHM SARA ELIZABETH,INTUIT INC (2012-02-09),https://lens.org/066-686-682-473-917,Patent Application,yes,8,2,7,7,0,G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326;;G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326,G06Q20/08,705/39,1,0,,,Payko Webpages. 21 June 2010. https://web.archive.org/web/20100621062359/http://www.payko.com/,DISCONTINUED
154,AU,B2,AU 2012/369168 B2,082-971-513-529-644,2015-12-03,2015,AU 2012/369168 A,2012-02-13,US 201213371355 A;;US 2012/0024873 W,2012-02-10,Mobile money order,"A method to track a money order transaction, including receiving, from a mobile device, a request to send the money order to a recipient, initiating, by a computer server in response to the request, a first transaction to transfer a money order amount from a funding account of the payer to a third party account held at a bank, initiating, in response to completing the first transaction, a second transaction to generate the money order by the bank, receiving, from the bank, an indication that the money order amount is paid out by the bank as a result of the recipient cashing the money order, and sending, in response to the indication, a message alerting the payer that the recipient has cashed the money order.",INTUIT INC,ZAFAR ABRAHAM;;BLANK BENNETT R;;BOUSSAROV MIROSLAV SVETOSLAVOV;;BOEHM SARA ELIZABETH,,https://lens.org/082-971-513-529-644,Granted Patent,no,3,0,7,7,0,G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326;;G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326,G06Q20/10;;G06Q40/02,,0,0,,,,ACTIVE
155,PL,T3,PL 2776132 T3,165-959-657-305-735,2020-08-24,2020,PL 12784663 T,2012-11-06,GB 201119171 A;;US 201161556329 P;;EP 12784663 A;;GB 2012052764 W,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,,ANGLO PLATINUM MARKETING LTD,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/165-959-657-305-735,Patent Application,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J21/18;;B01J23/52;;B01J23/89;;B01J35/00;;B01J37/02;;B01J37/03;;B01J37/06;;B01J37/14;;B01J37/18,,0,0,,,,PENDING
156,US,B2,US 10918125 B2,080-460-871-812-039,2021-02-16,2021,US 201515501680 A,2015-08-03,AU 2014/903013 A;;AU 2015/000461 W,2014-08-04,Methods for formulating dietary foodstuffs,"Generating an optimised formulation for a foodstuff, comprises receiving at a processor physicochemical data pertaining to one or more plant extracts and operating the processor to calculate a time, T max , representing a time to reach a maximum concentration in plasma of at least one metabolite of the one or more plant extracts by applying the received physicochemical data to a mathematical model stored in memory. The processor is then operated to identify ones of the metabolites for which the calculated T max substantially corresponds with a target absorption time for the foodstuff; and to generate an optimised formulation for the foodstuff comprising the one or more plant extracts containing the identified metabolites. The physicochemical data include one or more of molecular mass (M), liphophilicity (log P) and Polar Surface Area (PSA).",COMMW SCIENT IND RES ORG;;HORTICULTURE INNOVATION AUSTRALIA LTD,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,HORTICULTURE AUSTRALIA LIMITED (2013-07-15);;HORTICULTURE INNOVATION AUSTRALIA LIMITED (2020-12-17);;COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGNISATION (2015-02-18),https://lens.org/080-460-871-812-039,Granted Patent,yes,12,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,A61K38/17;;A23L5/30;;A23L33/00;;A23L33/105;;G06N7/00,,5,3,096-511-797-676-427;;059-930-879-481-601;;012-730-682-690-539,10.1111/1541-4337.12081;;33412708;;17968736;;10.1080/00498250701502114;;24410651;;10.1586/17512433.2.2.195,"International Search Report and Written Opinion for International Patent Application No. PCT/AU2015/000461, dated Oct. 28, 2015 (9 pages).;;Notification of Transmittal of International Preliminary Report on Patentability for International Application No. PCT/AU2015/000461, dated Jul. 11, 2016 (30 pages).;;Alminger, M. et al., “In Vitro Models for Studying Secondary Plant Metabolite Digestion and Bioaccessibility,” Comprehensive Reviews in Food Science and Food Safety, vol. 13, (2014) pp. 413-436.;;Dokoumetzidis, A. et al., “Modelling and Simulation in Drug Absorption Processes,” Xenobiotica, 37(10-11) (2007) pp. 1052-1065.;;Fotaki, N. “Pros and Cons of Methods Used for the Prediction of Oral Drug Absorption,” Expert Rev. Clin. Pharmacol, 2(22), (2009) pp. 195-208.",ACTIVE
157,WO,A3,WO 2013/068737 A3,074-452-516-339-681,2014-02-27,2014,GB 2012052764 W,2012-11-06,GB 201119171 A;;US 201161556329 P,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,"A gas treatment apparatus, suitable for use in an air purifying apparatus for the production of breathable air, comprises a catalyst comprising palladium and iron oxide and a source of a volatile nitrogen-containing compound. The apparatus is useful in gas masks, emergency escape hoods and static air treatment apparatus.",JOHNSON MATTHEY PLC,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/074-452-516-339-681,Search Report,yes,5,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62D9/00;;A62B19/02;;B01D53/62;;B01D53/86;;B01J23/89,,0,0,,,,PENDING
158,CY,T1,CY 1123540 T1,092-249-230-283-167,2022-03-24,2022,CY 201100651 T,2020-07-17,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W,2011-11-07,ΣΥΣΚΕΥΗ ΓΙΑ ΤΗΝ ΕΠΕΞΕΡΓΑΣΙΑ ΤΟΥ ΑΕΡΑ,"Μια συσκευή επεξεργασίας αερίου, κατάλληλη για χρήση σε μια συσκευή καθαρισμού αέρα για την παραγωγή εισπνεύσιμου αέρα, περιλαμβάνει έναν καταλύτη που περιέχει παλλάδιο και οξείδιο του σιδήρου και μια πηγή μιας πτητικής ένωσης που περιέχει άζωτο. Η συσκευή είναι χρήσιμη στις μάσκες αερίου, τις κουκούλες διαφυγής κινδύνου και τις συσκευές επεξεργασίας στατικού αέρα.",ANGLO PLATINUM MARKETING LTD,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/092-249-230-283-167,Granted Patent,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J21/18;;B01J23/52;;B01J23/89;;B01J35/00;;B01J37/02;;B01J37/03;;B01J37/06;;B01J37/14;;B01J37/18,,0,0,,,,ACTIVE
159,WO,A1,WO 2013/119256 A1,115-160-734-229-57X,2013-08-15,2013,US 2012/0024873 W,2012-02-13,US 201213371355 A,2012-02-10,MOBILE MONEY ORDER,"A method to track a money order transaction, including receiving, from a mobile device, a request to send the money order to a recipient, initiating, by a computer server in response to the request, a first transaction to transfer a money order amount from a funding account of the payer to a third party account held at a bank, initiating, in response to completing the first transaction, a second transaction to generate the money order by the bank, receiving, from the bank, an indication that the money order amount is paid out by the bank as a result of the recipient cashing the money order, and sending, in response to the indication, a message alerting the payer that the recipient has cashed the money order.",INTUIT INC;;ZAFAR ABRAHAM;;BLANK BENNETT R;;BOUSSAROV MIROSLAV SVETOSLAVOV;;BOEHM SARA ELIZABETH,ZAFAR ABRAHAM;;BLANK BENNETT R;;BOUSSAROV MIROSLAV SVETOSLAVOV;;BOEHM SARA ELIZABETH,,https://lens.org/115-160-734-229-57X,Patent Application,yes,4,0,7,7,0,G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326;;G06Q20/04;;G06Q20/10;;G06Q20/40;;G06Q20/326,G06Q20/10;;G06Q40/02,,1,0,,,See also references of EP 2812862A4,PENDING
160,ES,T3,ES 2804452 T3,155-031-361-256-873,2021-02-08,2021,ES 12784663 T,2012-11-06,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W,2011-11-07,Aparato para el tratamiento de aire,"Aparato para el tratamiento de aire, en el que aire que tiene una primera concentración de monóxido de carbono entra en el aparato y aire respirable que tiene una segunda concentración de monóxido de carbono sale del aparato, siendo dicha primera concentración mayor que dicha segunda concentración, comprendiendo el aparato un medio de tratamiento de gas, que comprende: i) un catalizador para la oxidación de monóxido de carbono que comprende paladio y óxido de hierro y ii) una fuente de un compuesto volátil que contiene nitrógeno, comprendiendo la fuente de compuesto volátil que contiene nitrógeno un material absorbente impregnado con una amina o amoniaco.",ANGLO PLATINUM MARKETING LTD,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/155-031-361-256-873,Granted Patent,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J21/18;;B01J23/52;;B01J23/89;;B01J35/00;;B01J37/02;;B01J37/03;;B01J37/06;;B01J37/14;;B01J37/18,,0,0,,,,ACTIVE
161,EP,B1,EP 3177160 B1,069-503-449-904-922,2019-04-03,2019,EP 15829471 A,2015-08-03,AU 2014/903013 A;;AU 2015/000461 W,2014-08-04,APPARATUS FOR FORMULATING DIETARY FOODSTUFFS,,COMMW SCIENT IND RES ORG;;HORTICULTURE INNOVATION AUSTRALIA LTD,MILLER ROSALIND B;;BENNETT LOUISE ELIZABETH;;SELBY-PHAM SOPHIE NGOC BICH,"HORTICULTURE INNOVATION AUSTRALIA LIMITED, AU (2019-08-26);;HORTICULTURE INNOVATION AUSTRALIA LIMITED (2020-04-15);;COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (2020-04-15)",https://lens.org/069-503-449-904-922,Granted Patent,yes,3,0,17,17,0,A23L33/30;;A23L33/105;;A23L33/30;;A23L33/105;;A23L5/30;;G06N7/00,A23L33/10,,3,0,,,"FOTAKI, N.: 'Pros and Cons of Methods Used for the Prediction of Oral Drug Absorption.' EXPERT REV. CLIN. PHARMACOL. vol. 2, no. 2, 2009, pages 195 - 208, XP008185368;;DOKOUMETZIDIS, A ET AL.: 'Modelling and Simulation in Drug Absorption Processes.' XENOBIOTICA vol. 37, no. 10-11, October 2007, pages 1052 - 1065, XP008185363;;ALMINGER, M ET AL.: 'In Vitro Models for Studying Secondary Plant Metabolite Digestion and Bioaccessibility.' COMP. REV. FOOD SCI. F. vol. 13, no. 4, 01 July 2014, pages 413 - 436, XP055394738 DOI: 10.1111/1541-4337.12081",ACTIVE
162,LT,T,LT 2776132 T,189-919-888-843-914,2020-07-10,2020,LT 12784663 T,2012-11-06,GB 201119171 A;;US 201161556329 P;;GB 2012052764 W,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,,ANGLO PLATINUM MARKETING LTD,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,,https://lens.org/189-919-888-843-914,Unknown,no,0,0,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,A62B19/02;;A62D9/00;;B01D53/62;;B01D53/86;;B01J21/18;;B01J23/52;;B01J23/89;;B01J35/00;;B01J37/02;;B01J37/03;;B01J37/06;;B01J37/14;;B01J37/18,,0,0,,,,PENDING
163,US,A1,US 2015/0086459 A1,192-592-251-665-221,2015-03-26,2015,US 201214356498 A,2012-11-06,US 201214356498 A;;GB 201119171 A;;US 201161556329 P;;GB 2012052764 W,2011-11-07,APPARATUS FOR THE TREATMENT OF AIR,"A gas treatment apparatus, suitable for use in an air purifying apparatus for the production of breathable air, includes a catalyst including palladium and iron oxide and a source of a volatile nitrogen-containing compound. The apparatus is useful in gas masks, emergency escape hoods and static air treatment apparatus.",JOHNSON MATTHEY PLC,POULSTON STEPHEN;;SMITH ANDREW WILLIAM JOHN;;BENNETT STEPHEN CHARLES;;ROWSELL ELIZABETH,ANGLO PLATINUM MARKETING LIMITED (2015-03-13),https://lens.org/192-592-251-665-221,Patent Application,yes,10,2,31,31,0,A62B19/02;;A62D9/00;;B01J23/8906;;B01D53/62;;B01D2252/102;;B01D2252/2041;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2255/1023;;B01D2255/20738;;B01D2255/9202;;B01D2257/502;;B01D2258/06;;B01D2259/4541;;B01D2259/4566;;B01J37/031;;B01J37/06;;B01J37/14;;B01J37/18;;B01J21/18;;B01J23/52;;B01J37/0201;;B01D53/864;;Y02A50/20;;B01J35/393;;B01J35/23;;A62D9/00;;B01D53/864;;B01J23/8906;;B01D2255/1023;;B01D2255/20738;;B01D2257/502;;A62B19/02;;B01D2252/2041;;A62D9/00;;B01J23/8906;;B01D2255/9202;;B01D2258/06;;B01D2252/20426;;B01D2253/102;;B01D2253/25;;B01D2259/4566;;B01D2252/102;;B01D53/62;;B01D2259/4541;;B01J37/0201;;B01J21/18;;B01J37/031;;B01J23/52;;B01J37/06;;B01J37/18;;B01J37/14;;Y02A50/20;;B01J35/23;;B01J35/393;;B01D53/864,B01D53/86,423/247;;422/120;;422/122,0,0,,,,DISCONTINUED
164,AU,B2,AU 2001/236581 B2,056-156-387-710-552,2004-06-24,2004,AU 2001/236581 A,2001-01-30,US 49669400 A;;US 0102939 W,2000-02-02,Antisense modulation of survivin expression,,ISIS PHARMACEUTICALS INC,COWSERT LEX M;;SWAYZE ERIC E;;ACKERMANN ELIZABETH J;;BENNETT C FRANK,,https://lens.org/056-156-387-710-552,Granted Patent,no,2,0,12,34,0,A61K38/00;;A61K38/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C12N15/113;;C12N15/113;;C07B2200/11;;C07B2200/11;;C07H21/00;;C07H21/00;;C12N15/1135;;C12N15/1135;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,C07H21/04;;A61K9/10;;A61K31/337;;A61K31/7088;;A61K31/711;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K38/00;;A61K45/00;;A61K48/00;;A61P35/00;;A61P43/00;;C07H21/00;;C12N15/09;;C12N15/113;;C12P21/04,,0,0,,,,EXPIRED
165,AU,B2,AU 2004/228007 B2,090-556-715-333-502,2009-12-10,2009,AU 2004/228007 A,2004-04-02,US 40786103 A;;US 2004/0010226 W,2003-04-04,Tampon applicator assembly having an improved plunger and methods of making,,EDGEWELL PERSONAL CARE BRANDS LLC,BENNETT KATHRYN G;;LEMAY JESSICA ELIZABETH;;MELVIN WAYNE DAVID;;EDGETT KEITH J,"EDGEWELL PERSONAL CARE BRANDS, LLC (2015-09-17)",https://lens.org/090-556-715-333-502,Granted Patent,no,1,0,12,12,0,A61F13/26;;A61F13/2097;;A61F13/26;;A61F13/2097,A61F13/26,,0,0,,,,INACTIVE
166,EP,A1,EP 1140971 A1,136-782-612-031-15X,2001-10-10,2001,EP 99966205 A,1999-12-14,US 9929593 W;;US 22656899 A,1999-01-07,ANTISENSE MODULATION OF NOVEL ANTI-APOPTOTIC BCL-2-RELATED PROTEINS,,ISIS PHARMACEUTICALS INC,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;DEAN NICHOLAS M;;MARCUSSON ERIC G,"ISIS PHARMACEUTICALS, INC. (2005-06-29)",https://lens.org/136-782-612-031-15X,Patent Application,yes,0,0,8,286,40,A61P35/00;;C12N15/1135;;C12N15/1135;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/318;;C12N2310/318;;C12N2310/3181;;C12N2310/3181;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/345;;C12N2310/345;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7105;;A61K31/711;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K45/00;;A61K48/00;;A61P35/00;;C12N5/10;;C12N15/113,,0,0,,,,DISCONTINUED
167,DE,D1,DE 69941576 D1,027-971-298-884-779,2009-12-03,2009,DE 69941576 T,1999-09-23,US 16316298 A;;US 28640799 A;;US 9922076 W,1998-09-29,ANTISENSE-MODULATION DER SURVIVIN-EXPRESSION,,ISIS PHARMACEUTICAL INC,BENNETT FRANK C;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/027-971-298-884-779,Granted Patent,no,0,0,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;C12N15/11;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,0,0,,,,EXPIRED
168,DK,T3,DK 1117672 T3,044-221-807-779-138,2009-12-07,2009,DK 99948416 T,1999-09-23,US 16316298 A;;US 28640799 A;;US 9922076 W,1998-09-29,Antisense-modulation af survivin-ekpression,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/044-221-807-779-138,Granted Patent,no,0,0,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;C12N15/11;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,0,0,,,,EXPIRED
169,JP,A,JP 2006028188 A,174-061-742-569-116,2006-02-02,2006,JP 2005216823 A,2005-07-27,US 49669400 A,2000-02-02,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,"<P>PROBLEM TO BE SOLVED: To obtain an antisense compound, a composition and to provide a method for modulating the expression of Survivin. <P>SOLUTION: The composition comprises the antisense compound targeted to a nucleic acid encoding Survivin, particularly a pharmaceutical composition containing an antisense oligonucleotide and modulation of Survivin expression is provided, and methods for using the compounds and for treatment of diseases associated with the expression of Survivin are provided. <P>COPYRIGHT: (C)2006,JPO&NCIPI",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/174-061-742-569-116,Patent Application,no,0,0,12,34,250,A61K38/00;;A61K38/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C12N15/113;;C12N15/113;;C07B2200/11;;C07B2200/11;;C07H21/00;;C07H21/00;;C12N15/1135;;C12N15/1135;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,A61K31/7088;;C07H21/04;;A61K9/10;;A61K31/337;;A61K31/711;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K38/00;;A61K45/00;;A61K48/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C07H21/00;;C12N15/09;;C12N15/113;;C12P21/04,,0,0,,,,DISCONTINUED
170,US,B2,US 6838283 B2,027-811-126-743-846,2005-01-04,2005,US 91818601 A,2001-07-30,US 91818601 A;;US 49669400 A;;US 28640799 A;;US 16316298 A,1998-09-29,Antisense modulation of survivin expression,"Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;SWAYZE ERIC E;;ACKERMANN ELIZABETH J;;COWSERT LEX M,ISIS PHARMACEUTICALS INC (2001-09-10),https://lens.org/027-811-126-743-846,Granted Patent,yes,3,26,4,34,250,A61K38/00;;C07B2200/11;;C07H21/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;C12N15/113;;A61K38/00;;C12N2310/321;;C12N2310/315;;C07B2200/11;;C12N2310/341;;C07H21/00;;C12N2310/346;;C12N2310/3341,A61K38/00;;C07H21/00;;C12N15/113,435375;;435  6;;435377;;536 245;;514 44,14,12,040-020-176-260-711;;120-000-992-286-241;;000-086-958-485-588;;097-682-313-785-241;;014-399-256-774-591;;041-609-157-035-98X;;053-522-668-738-074;;011-212-836-532-853;;001-537-947-431-812;;021-849-999-191-396;;107-388-804-822-645;;090-314-175-677-432,9538686;;10.1016/s0968-0004(97)01155-9;;10.1634/stemcells.18-5-307;;11007915;;10.1016/s0140-6736(05)70294-4;;9525374;;10.1038/nm0897-917;;9256286;;10.1074/jbc.273.18.11177;;9556606;;9337844;;pmc1218630;;10.1042/bj3260001;;9859993;;10.1038/25141;;9581817;;10496530;;10587640;;10.1038/70242;;10.1096/fasebj.9.10.7615156;;7615156;;10.1021/bi00250a039;;7947793,"Andrea D. Branch, TIBS 23-Feb. 1998, pp. 45-50.*;;Kuang-Yu Jen et al., Stem Cells 2000; pp. 307-319.*;;Adida et al., ""Anti-apoptosis gene, survivin, and prognosis of neuroblastoma"", Lancet 1998 351-882-883.;;Ambrosini et al., ""A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma"", Nat. Med. 1997 3:917-921.;;Ambrosini et al., ""Induction of Apoptosis and Inhibition of Cell Proliferation by Survivin Gene Targeting"", J. Bio. Chem. 1998 273:11177-11182.;;Cohen G.M., ""Caspases:the executioners of apoptosis"", Biochemistry Journal 1997 326:1-16.;;Li F., et al., ""Control of apoptosis and mitotic spindle checkpoint by survivin"", Nature 1998 386: 580-584.;;Lu et al., ""Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas"", Cancer Res., 1998 58:1808-1812.;;Genbank Accession No. AW247335, Dec. 16, 1999.;;Grossman et al., ""Expression of the Apoptosis Inhibitor, Survivin, in Nonmelanoma Skin Cancer and Gene Targeting in a Keratinocyte Cell Line,"" Laboratory Investigation, United States and Canadian Academy og Pathology, 29:1121-1126 (1999).;;Li et al., ""Pleiotropic Cell-Division Defects and Apoptosis Induced by Interference with Survivin Function,"" Nature Cell Biology, 1:461-466 (1999).;;European Supplementary Search Report. European Application No. EP 01 90 8740.;;Altieri, D., ""Xa Receptor ERP-1,"" FASEB, 9:860-865 (1995).;;Altieri, D., ""Splicing of Effector Cell Protease Receptor-1 mRNA is Modulated by an Unusual Retained Intron,"" Biochemistry, 33:13848-13855 (1994).",EXPIRED
171,WO,A1,WO 2000/040595 A1,061-121-811-140-693,2000-07-13,2000,US 9929593 W,1999-12-14,US 22656899 A,1999-01-07,ANTISENSE MODULATION OF NOVEL ANTI-APOPTOTIC BCL-2-RELATED PROTEINS,Compositions and methods are provided for modulating the expression of novel anti-apoptotic bcl-2-related proteins. Antisense oligonucleotides targeted to nucleic acids encoding the human novel anti-apoptotic bcl-2-related proteins A1 and mcl-1 are preferred. Methods of using these compounds for modulation of novel anti-apoptotic bcl-2-related protein expression and for treatment of diseases associated with expression of novel anti-apoptotic blc-2-related proteins are also provided. Also provided are methods of using these compounds for promoting apoptosis and for treatment of diseases for which promotion of apoptosis is desired.,ISIS PHARMACEUTICALS INC;;ACKERMANN ELIZABETH J;;BENNETT C FRANK;;DEAN NICHOLAS M;;MARCUSSON ERIC G,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;DEAN NICHOLAS M;;MARCUSSON ERIC G,,https://lens.org/061-121-811-140-693,Patent Application,yes,1,11,8,286,0,A61P35/00;;C12N15/1135;;C12N15/1135;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/318;;C12N2310/318;;C12N2310/3181;;C12N2310/3181;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/345;;C12N2310/345;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7105;;A61K31/711;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K45/00;;A61K48/00;;A61P35/00;;C12N5/10;;C12N15/113,,3,1,001-873-073-418-360,9671497;;pmc109073;;10.1128/mcb.18.8.4883,"CHAO J.R.: ""Mcl-1 is an Immediate-Early Gene Activated by the Granulocyte-Macrophage Colony -Stimulating Factor(GM-CSF) Signaling Pathway and is One Component of the GM-CSF Viability Response"", MOLECULAR AND CELLULAR BIOLOGY, vol. 18, no. 8, August 1998 (1998-08-01), pages 4883 - 4898, XP002922992;;CROOKE S.T.: ""BASIC PRINCIPLES OF ANTISENSE THERAPEUTICS."", ANTISENSE RESEARCH AND APPLICATIONS., CRC PRESS., GB, 7 July 1998 (1998-07-07), GB, pages 01 - 50., XP002922993;;See also references of EP 1140971A4",PENDING
172,US,A,US 5170397 A,069-537-654-977-94X,1992-12-08,1992,US 58969190 A,1990-09-28,US 58969190 A,1990-09-28,Method and apparatus for recovering from object faults in an electronic reprographic printing system,"A method and apparatus for recovering from faults occurring in an electronic reprographic system capable of processing and printing a multiplicity of jobs is described. The invention provides for the monitoring of the system for the occurrence of faults in a job, interrupting printing of the job upon the occurrence of a fault and determining in which of two fault categories the fault belongs, including an automatic resumption category and a manual resumption category. The invention further provides for automatically resuming the printing of the job without operator intervention in response to clearance of a fault categorized in the automatic resumption category.",XEROX CORP,HURTZ ROBERT W;;KIRCHNER KRIS D;;BENNETT ELIZABETH A;;GAURONSKI JOHN F,XEROX CORPORATION (1990-09-14),https://lens.org/069-537-654-977-94X,Granted Patent,yes,6,21,3,3,0,G03G15/5012;;H04N1/32609;;H04N1/32635;;H04N1/32667;;H04N2201/0081;;H04N2201/0082;;H04N2201/0089;;G06F11/0733;;G06F11/0793;;H04N1/32609;;H04N1/32667;;H04N2201/0082;;H04N2201/0089;;H04N1/32635;;H04N2201/0081;;G03G15/5012;;G06F11/0733;;G06F11/0793,G03G15/00;;G06F11/00;;G03G21/00;;G06F11/30;;H04N1/00;;H04N1/32,371/16.4;;355/204;;355/207;;395/575,0,0,,,,EXPIRED
173,AU,A1,AU 2004/228007 A1,115-642-348-464-530,2004-10-21,2004,AU 2004/228007 A,2004-04-02,US 40786103 A;;US 2004/0010226 W,2003-04-04,Tampon applicator assembly having an improved plunger and methods of making,,PLAYTEX PRODUCTS INC,BENNETT KATHRYN G;;LEMAY JESSICA ELIZABETH;;MELVIN WAYNE DAVID;;EDGETT KEITH J,"EDGEWELL PERSONAL CARE BRANDS, LLC (2015-09-17)",https://lens.org/115-642-348-464-530,Patent Application,no,0,0,12,12,0,A61F13/26;;A61F13/2097;;A61F13/26;;A61F13/2097,A61F13/26,,0,0,,,,INACTIVE
174,US,A1,US 2003/0211607 A1,018-328-644-447-944,2003-11-13,2003,US 18131602 A,2002-11-21,US 18131602 A;;US 49669400 A;;US 0102939 W,2000-02-02,Antisense modulation of survivin expression,"
   Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided. 
",BENNETT C. FRANK;;ACKERMANN ELIZABETH J.;;SWAYZE ERIC E.;;COWSERT LEX M.,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/018-328-644-447-944,Patent Application,yes,2,1,12,34,249,A61K38/00;;A61K38/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C12N15/113;;C12N15/113;;C07B2200/11;;C07B2200/11;;C07H21/00;;C07H21/00;;C12N15/1135;;C12N15/1135;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,C07H21/04;;A61K9/10;;A61K31/337;;A61K31/7088;;A61K31/711;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K38/00;;A61K45/00;;A61K48/00;;A61P35/00;;A61P43/00;;C07H21/00;;C12N15/09;;C12N15/113;;C12P21/04,435/375;;514/44;;536/23.5,0,0,,,,DISCONTINUED
175,WO,A1,WO 2001/057059 A1,057-582-374-366-746,2001-08-09,2001,US 0102939 W,2001-01-30,US 49669400 A,2000-02-02,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC;;BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/057-582-374-366-746,Patent Application,yes,1,16,12,34,0,A61K38/00;;A61K38/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C12N15/113;;C12N15/113;;C07B2200/11;;C07B2200/11;;C07H21/00;;C07H21/00;;C12N15/1135;;C12N15/1135;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,C07H21/04;;A61K9/10;;A61K31/337;;A61K31/7088;;A61K31/711;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K38/00;;A61K45/00;;A61K48/00;;A61P35/00;;A61P43/00;;C07H21/00;;C12N15/09;;C12N15/113;;C12P21/04,,1,0,,,See also references of EP 1252175A4,PATENTED
176,EP,B1,EP 1117672 B1,081-848-111-457-799,2009-10-21,2009,EP 99948416 A,1999-09-23,US 9922076 W;;US 16316298 A;;US 28640799 A,1998-09-29,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2011-09-28)",https://lens.org/081-848-111-457-799,Granted Patent,yes,1,0,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;C12N15/11;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,3,0,,,"AMBROSINI ET AL.: 'Induction of Apoptosis and Inhibition of Cell Proliferation by Survivin gene Targeting' THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 273, no. 18, 01 May 1998, pages 11177 - 11182, XP002926501;;GROSSMAN ET AL.: 'Expression of the Apoptosis Inhibitor Survivin, in Nonmelanoma Skin Cancer and gene Targeting in a Keratinocyte Cell Line' LABORATORY INVESTIGATION, vol. 79, no. 9, September 1999, pages 1121 - 1126, XP002926502;;MILNER ET AL.: 'Selecting Effective Antisense Reagents on Combinatorial Oligonucleotide Arrays' NATURE BIOTECHNOLOGY, vol. 15, June 1997, pages 537 - 541, XP002926503",EXPIRED
177,AU,B2,AU 758545 B2,032-839-245-169-328,2003-03-27,2003,AU 1999/061598 A,1999-09-23,US 16316298 A;;US 28640799 A;;US 9922076 W,1998-09-29,Antisense modulation of survivin expression,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/032-839-245-169-328,Granted Patent,no,1,1,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,2,2,014-399-256-774-591;;097-682-313-785-241,10.1074/jbc.273.18.11177;;9556606;;10.1038/nm0897-917;;9256286,AMBROSINI ET AL (1998) J. BIOL. CHEM. 273:11177-82;;AMBROSINI ET AL (1997) NAT. MED 3:917-21,EXPIRED
178,EP,A4,EP 1252175 A4,104-467-903-467-139,2003-03-12,2003,EP 01908740 A,2001-01-30,US 0102939 W;;US 49669400 A,2000-02-02,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2005-06-29)",https://lens.org/104-467-903-467-139,Search Report,no,1,0,12,34,0,A61K38/00;;A61K38/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C12N15/113;;C12N15/113;;C07B2200/11;;C07B2200/11;;C07H21/00;;C07H21/00;;C12N15/1135;;C12N15/1135;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,C07H21/04;;A61K9/10;;A61K31/337;;A61K31/7088;;A61K31/711;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K38/00;;A61K45/00;;A61K48/00;;A61P35/00;;A61P43/00;;C07H21/00;;C12N15/09;;C12N15/113;;C12P21/04,,5,3,021-849-999-191-396;;001-537-947-431-812;;014-399-256-774-591,10587640;;10.1038/70242;;10496530;;10.1074/jbc.273.18.11177;;9556606,"LI F ET AL: ""PLEIOTROPIC CELL-DIVISION DEFECTS AND APOPTOSIS INDUCED BY INTERFERENCE WITH SURVIVIN FUNCTION"", NATURE CELL BIOLOGY, MACMILLAN PUBLISHERS, GB, vol. 1, December 1999 (1999-12-01), pages 461 - 466, XP001034788, ISSN: 1465-7392;;GROSSMAN D ET AL: ""EXPRESSION OF THE APOPTOSIS INHIBITOR, SURVIVIN, IN NONMELANOMA SKIN CANCER AND GENE TARGETING IN A KERATINOCYTE CELL LINE"", LABORATORY INVESTIGATION, UNITED STATES AND CANADIAN ACADEMY OF PATHOLOGY, BALTIMORE,, US, vol. 29, no. 9, 1999, pages 1121 - 1126, XP002926502, ISSN: 0023-6837;;AMBROSINI G ET AL: ""INDUCTION OF APOPTOSIS AND INHIBITION OF CELL PROLIFERATION BY SURVIVIN GENE TARGETING"", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 273, no. 18, 1996, pages 11177 - 11182, XP002926501, ISSN: 0021-9258;;DATABASE EMBL [online] XP002248603, retrieved from EBI Database accession no. AW247335;;See also references of WO 0157059A1",DISCONTINUED
179,EP,A1,EP 1806353 A1,152-214-084-754-462,2007-07-11,2007,EP 07001466 A,1999-12-14,EP 99966205 A;;US 22656899 A,1999-01-07,Antisense modulation of novel anti-apoptotic BCL-2-related proteins,Compositions and methods are provided for modulating the expression of novel anti-apoptotic bcl-2-related proteins. Antisense oligonucleotides targeted to nucleic acids encoding the human novel anti-apoptotic bcl-2-related proteins A1 and mcl-1 are preferred. Methods of using these compounds for modulation of novel anti-apoptotic bcl-2-related protein expression and for treatment of diseases associated with expression of novel anti-apoptotic blc-2-related proteins are also provided. Also provided are methods of using these compounds for promoting apoptosis and for treatment of diseases for which promotion of apoptosis is desired.,ISIS PHARMACEUTICALS INC,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;DEAN NICHOLAS M;;MARCUSSON ERIC G,,https://lens.org/152-214-084-754-462,Patent Application,yes,3,0,8,286,40,C12N15/113;;C12N15/1135;;C12N2310/315;;C12N2310/318;;C12N2310/3181;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/345;;C12N2310/346;;Y02P20/582;;A61P35/00;;C12N15/1135;;C12N2310/315;;C12N2310/3341;;C12N2310/318;;C12N2310/321;;C12N2310/3181;;C12N15/113;;C12N2310/346;;C12N2310/341;;C12N2310/345;;Y02P20/582,C07H21/04;;A61K31/7105;;C12N15/09;;A61K31/711;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K45/00;;A61K48/00;;A61P35/00;;C07H21/02;;C12N5/10;;C12N15/113;;C12Q1/68,,4,3,010-691-770-941-797;;016-841-948-362-872;;028-339-089-468-370,10.1182/blood.v87.8.3089.bloodjournal8783089;;8605321;;10.1016/s0140-6736(96)11103-x;;9113013;;10196212;;10.1074/jbc.274.16.11245,"CALABRESSE C ET AL: ""Antisense oligonucleotide of the MCL-L gene, A BCL-2 related gene, blocks granulocytic and macrophagic differentiation."", ANTICANCER RESEARCH, vol. 17, no. 5C, 1997, Seventh International Conference on Differentiation Therapy;Versailles, France; October 5-8, 1997, pages 3954 - 3955, XP001056659, ISSN: 0250-7005;;KARSAN A ET AL: ""CLONING OF A HUMAN BCL-2 HOMOLOGUE: INFLAMMARORY CYTOKINES INDUCE HUMAN A1 IN CULTURED ENDOTHELIAL CELLS"", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, vol. 87, no. 8, 15 April 1996 (1996-04-15), pages 3089 - 3096, XP000197498, ISSN: 0006-4971;;WEBB A ET AL: ""BCL-2 antisense therapy in patients with non-Hodgkin lymphoma."", LANCET (NORTH AMERICAN EDITION), vol. 349, no. 9059, 1997, pages 1137 - 1141, XP002192502, ISSN: 0099-5355;;ACKERMANN ELIZABETH J ET AL: ""The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides."", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 16, 16 April 1999 (1999-04-16), pages 11245 - 11252, XP002192503, ISSN: 0021-9258",DISCONTINUED
180,EP,A4,EP 1140971 A4,001-020-891-646-520,2002-05-15,2002,EP 99966205 A,1999-12-14,US 9929593 W;;US 22656899 A,1999-01-07,ANTISENSE MODULATION OF NOVEL ANTI-APOPTOTIC BCL-2-RELATED PROTEINS,,ISIS PHARMACEUTICALS INC,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;DEAN NICHOLAS M;;MARCUSSON ERIC G,"ISIS PHARMACEUTICALS, INC. (2005-06-29)",https://lens.org/001-020-891-646-520,Search Report,no,3,0,8,286,0,A61P35/00;;C12N15/1135;;C12N15/1135;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/318;;C12N2310/318;;C12N2310/3181;;C12N2310/3181;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/345;;C12N2310/345;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7105;;A61K31/711;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K45/00;;A61K48/00;;A61P35/00;;C12N5/10;;C12N15/113,,5,3,010-691-770-941-797;;016-841-948-362-872;;028-339-089-468-370,10.1182/blood.v87.8.3089.bloodjournal8783089;;8605321;;10.1016/s0140-6736(96)11103-x;;9113013;;10196212;;10.1074/jbc.274.16.11245,"CALABRESSE C ET AL: ""Antisense oligonucleotide of the MCL-L gene, A BCL-2 related gene, blocks granulocytic and macrophagic differentiation."", ANTICANCER RESEARCH, vol. 17, no. 5C, 1997, Seventh International Conference on Differentiation Therapy;Versailles, France; October 5-8, 1997, pages 3954 - 3955, XP001056659, ISSN: 0250-7005;;KARSAN A ET AL: ""CLONING OF A HUMAN BCL-2 HOMOLOGUE: INFLAMMARORY CYTOKINES INDUCE HUMAN A1 IN CULTURED ENDOTHELIAL CELLS"", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, vol. 87, no. 8, 15 April 1996 (1996-04-15), pages 3089 - 3096, XP000197498, ISSN: 0006-4971;;WEBB A ET AL: ""BCL-2 antisense therapy in patients with non-Hodgkin lymphoma."", LANCET (NORTH AMERICAN EDITION), vol. 349, no. 9059, 1997, pages 1137 - 1141, XP002192502, ISSN: 0099-5355;;ACKERMANN ELIZABETH J ET AL: ""The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides."", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 16, 16 April 1999 (1999-04-16), pages 11245 - 11252, XP002192503, ISSN: 0021-9258;;See also references of WO 0040595A1",DISCONTINUED
181,EP,A1,EP 1117672 A1,046-040-187-233-811,2001-07-25,2001,EP 99948416 A,1999-09-23,US 9922076 W;;US 16316298 A;;US 28640799 A,1998-09-29,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2011-09-28)",https://lens.org/046-040-187-233-811,Patent Application,yes,0,0,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,0,0,,,,EXPIRED
182,US,A,US 6001992 A,124-742-805-502-972,1999-12-14,1999,US 22656899 A,1999-01-07,US 22656899 A,1999-01-07,Antisense modulation of novel anti-apoptotic bcl-2-related proteins,Compositions and methods are provided for modulating the expression of novel anti-apoptotic bcl-2-related proteins. Antisense oligonucleotides targeted to nucleic acids encoding the human novel anti-apoptotic bcl-2-related proteins A1 and mcl-1 are preferred. Methods of using these compounds for modulation of novel anti-apoptotic bcl-2-related protein expression and for treatment of diseases associated with expression of novel anti-apoptotic bcl-2-related proteins are also provided. Also provided are methods of using these compounds for promoting apoptosis and for treatment of diseases for which promotion of apoptosis is desired.,ISIS PHARMACEUTICALS INC,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;DEAN NICHOLAS M;;MARCUSSON ERIC G,ISIS PHARMACEUTICALS INC (1999-02-04),https://lens.org/124-742-805-502-972,Granted Patent,yes,8,229,8,286,39,A61P35/00;;C12N15/1135;;C12N15/1135;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/318;;C12N2310/318;;C12N2310/3181;;C12N2310/3181;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/345;;C12N2310/345;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7105;;A61K31/711;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K45/00;;A61K48/00;;A61P35/00;;C12N5/10;;C12N15/113,536/24.5;;536/23.1;;536/24.3;;435/91.1;;435/375;;435/6;;435/440;;514/44,10,7,040-020-176-260-711;;055-818-108-670-644;;018-050-687-374-307;;001-873-073-418-360;;017-923-651-425-831;;074-906-162-249-69X;;088-473-688-431-215,9538686;;10.1016/s0968-0004(97)01155-9;;7570012;;10.1126/science.270.5236.575;;10.1038/sj.onc.1201664;;9525737;;9671497;;pmc109073;;10.1128/mcb.18.8.4883;;pmc508141;;10.1172/jci119484;;9185513;;10.1038/nm0298-222;;9461197;;7561075,"Andrea D. Branch, A good antisense molecule is hard to find, TIBS, 47 48, Feb. 1998.;;Trisha Gura, Antisense Has Growing Pains, Science, pp. 575 577, Oct. 1995.;;Stanley Crooke, Antisense 97: A roundtable on the state of the industry, Nature Biotechnology, p. 522, Jun. 1997.;;Stanley Crooke, Antisense Research and Applications, Chapter 1, Basic Principles of Antisense Therapeutics, Springer Verlag Press, Berlin, Heidelberg, New York, p. 3, Jul. 1998.;;Uhlman et al., Antisense oligonucleotides: A New therapeutic principle, Chemical Reviews, vol. 90, No. 4, pp. 544 560, Jun. 1990.;;Amarante Mendes, et al., Bcl 2 independent Bcr Abl mediated resistance to apoptosis: protection is correlated with up regulation of Bcl x 1 , Oncogene 1998 16, 1383 1390.;;Chao, et al., mcl 1 Is an Immediate Early Gene Activated by the Granulocyte Macrophage Colony Stimulating Factor (GM CSF) Signaling Pathway and Is One Component of the Gm CSF Viability Response , Mole. Cell. Biol. 1998 18, 4883 4898.;;Fujio, et al., Signals Through gp130 Upregulate bcl x Gene Expression Via STAT1 binding cis Element in Cardiac Myocytes , J. Clin. Invest . 1997 99, 2898 2905.;;Pollman, et al., Inhibition of neointimal cel bcl x expression induces apoptosis and regression of vascular disease , Nature Med. 1998 4, 222 227.;;Wang, et al., Induction of bcl x by CD40 Engagement Rescues slg Induced Apoptosis in Murine B Cells 1 , J. Immunol. 1995 155, 3722 3725.",EXPIRED
183,AU,A,AU 2001/036581 A,015-051-125-300-221,2001-08-14,2001,AU 2001/036581 A,2001-01-30,US 49669400 A;;US 0102939 W,2000-02-02,Antisense modulation of survivin expression,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/015-051-125-300-221,Patent Application,no,0,0,12,34,0,A61K38/00;;A61K38/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C12N15/113;;C12N15/113;;C07B2200/11;;C07B2200/11;;C07H21/00;;C07H21/00;;C12N15/1135;;C12N15/1135;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,C07H21/04;;A61K9/10;;A61K31/337;;A61K31/7088;;A61K31/711;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K38/00;;A61K45/00;;A61K48/00;;A61P35/00;;A61P43/00;;C07H21/00;;C12N15/09;;C12N15/113;;C12P21/04,,0,0,,,,PENDING
184,WO,A2,WO 2004/089243 A2,037-088-813-298-417,2004-10-21,2004,US 2004/0010226 W,2004-04-02,US 40786103 A,2003-04-04,TAMPON APPLICATOR ASSEMBLY HAVING AN IMPROVED PLUNGER AND METHODS OF MAKING,"A plunger having a first end, a second end, and a main body is provided. The first end of the plunger is about 10 % to about 15 % larger than the main body and the second end is more than about 50 % larger than the main body.",PLAYTEX PRODUCTS INC;;LEMAY JESSICA ELIZABETH;;EDGETT KEITH J;;BENNETT KATHRYN G;;MELVIN WAYNE DAVID,LEMAY JESSICA ELIZABETH;;EDGETT KEITH J;;BENNETT KATHRYN G;;MELVIN WAYNE DAVID,,https://lens.org/037-088-813-298-417,Patent Application,yes,0,0,12,12,0,A61F13/26;;A61F13/2097;;A61F13/26;;A61F13/2097,A61F13/26,,0,0,,,,PENDING
185,US,A,US 6165788 A,062-317-598-944-916,2000-12-26,2000,US 28640799 A,1999-04-05,US 28640799 A;;US 16316298 A,1998-09-29,Antisense modulation of Survivin expression,"Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,ISIS PHARMACEUTICALS INC (1999-06-04),https://lens.org/062-317-598-944-916,Granted Patent,yes,1,17,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,435/375;;435/6;;435/377;;435/455;;536/23.1;;536/24.1;;536/24.5,4,4,040-020-176-260-711;;082-930-617-454-05X;;036-796-541-068-079;;053-522-668-738-074,9538686;;10.1016/s0968-0004(97)01155-9;;8987636;;10.1016/0167-7799(96)10053-6;;9181575;;10.1038/nbt0697-537;;9859993;;10.1038/25141,"Branch, A. A Good Antisense Molecule is Hard to Find TIBS vol. 23:45 50, Feb. 1998.;;Agrawal, S. Antisense oligonucleotides: Towards Clinical Trials TIBTECH vol. 14:376 387, Oct. 1996.;;Milner et al. Selecting Effective Antisense Reagents on Combinitorial Arrays Nature Biotechnology vol. 14: 537 541, Jun. 1997.;;Li F., et al., Control of apoptosis and mitotic spindle checkpoint by survivin , Nature, 1998, 386: 580 584.",EXPIRED
186,WO,A1,WO 2000/018781 A1,003-653-913-430-775,2000-04-06,2000,US 9922076 W,1999-09-23,US 16316298 A;;US 28640799 A,1998-09-29,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC;;BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/003-653-913-430-775,Patent Application,yes,216,7,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,30,21,014-399-256-774-591;;001-537-947-431-812;;036-796-541-068-079;;097-682-313-785-241;;041-609-157-035-98X;;053-522-668-738-074;;122-163-646-804-412;;064-342-722-122-563;;004-141-611-451-05X;;033-950-248-815-892;;072-134-452-621-066;;068-152-830-532-197;;003-287-872-593-043;;051-226-937-192-323;;119-325-388-100-295;;007-210-965-226-461;;011-811-359-064-683;;114-916-177-247-492;;007-364-858-655-289;;002-168-381-924-022;;074-458-381-494-234,10.1074/jbc.273.18.11177;;9556606;;10496530;;9181575;;10.1038/nbt0697-537;;10.1038/nm0897-917;;9256286;;9337844;;pmc1218630;;10.1042/bj3260001;;9859993;;10.1038/25141;;10.1002/hlca.19950780219;;10.1073/pnas.86.17.6553;;2771942;;pmc297882;;10.1111/j.1749-6632.1992.tb21095.x;;1364095;;1741287;;pmc310419;;10.1093/nar/20.3.533;;pmc452764;;10.1002/j.1460-2075.1991.tb08051.x;;1850694;;1688418;;10.1016/0014-5793(90)80039-l;;8504177;;10.1016/0300-9084(93)90024-m;;10.1016/0040-4039(95)00597-6;;pmc331077;;2165251;;10.1093/nar/18.13.3777;;10.1080/15257779508012513;;7495868;;10.1016/0167-4781(95)00145-7;;8627575;;10.1002/jps.2600660104;;833720;;8527843;;10.1016/0958-1669(95)80115-4;;8689239;;10.1016/0968-0896(95)00171-9,"AMBROSINI ET AL.: ""Induction of Apoptosis and Inhibition of Cell Proliferation by Survivin gene Targeting"", THE JOURNAL OF BIOLOGICAL CHEMISTRY,, vol. 273, no. 18, 1 May 1998 (1998-05-01), pages 11177 - 11182, XP002926501;;GROSSMAN ET AL.: ""Expression of the Apoptosis Inhibitor Survivin, in Nonmelanoma Skin Cancer and gene Targeting in a Keratinocyte Cell Line"", LABORATORY INVESTIGATION,, vol. 79, no. 9, September 1999 (1999-09-01), pages 1121 - 1126, XP002926502;;MILNER ET AL.: ""Selecting Effective Antisense Reagents on Combinatorial Oligonucleotide Arrays"", NATURE BIOTECHNOLOGY,, vol. 15, June 1997 (1997-06-01), pages 537 - 541, XP002926503;;AMBROSINI ET AL., NAT. MED., vol. 3, 1997, pages 917 - 921;;COHEN, BIOCHEMISTRY JOURNAL, vol. 326, 1997, pages 1 - 16;;LI ET AL., NATURE, vol. 396, 1998, pages 580 - 584;;MARTIN ET AL., HELV. CHIM. ACTA, vol. 78, 1995, pages 486 - 504;;""The Concise Encyclopedia Of Polymer Science And Engineering"", 1990, JOHN WILEY & SONS, pages: 858 - 859;;ENGLISCH ET AL.: ""Angewandte Chemie"", vol. 30, 1991, pages: 613;;SANGHVI, Y.S.: ""Antisense Research and Applications"", 1993, CRC PRESS, pages: 289 - 302;;""Antisense Research and Applications"", 1993, CRC PRESS, pages: 276 - 278;;LETSINGER ET AL., PROC. NATL. ACAD. SCI., vol. 86, 1989, pages 6553 - 6556;;MANOHARAN ET AL., BIOORG. MED. CHEM. LET., vol. 4, 1994, pages 1053 - 1060;;MANOHARAN ET AL., ANN. N.Y. ACAD. SCI., vol. 660, 1992, pages 306 - 309;;MANOHARAN ET AL., BIOORG. MED. CHEM. LET., vol. 3, 1993, pages 2765 - 2770;;OBERHAUSER ET AL., NUCL. ACIDS RES, vol. 20, 1992, pages 533 - 538;;SAISON-BEHMOARAS ET AL., EMBO J., vol. 10, 1991, pages 1111 - 1118;;KABANOV ET AL., FEBS LETT., vol. 259, 1990, pages 327 - 330;;SVINARCHUK ET AL., BIOCHIMIE, vol. 75, 1993, pages 49 - 54;;MANOHARAN ET AL., TETRAHEDRON LETT., vol. 36, 1995, pages 3651 - 3654;;SHEA ET AL., NUCL. ACIDS RES, vol. 18, 1990, pages 3777 - 3783;;MANOHARAN ET AL., NUCLEOSIDES & NUCLEOTIDES, vol. 14, 1995, pages 969 - 973;;MISHRA ET AL., BIOCHIM. BIOPHYS. ACTA, vol. 1264, 1995, pages 229 - 237;;CROOKE ET AL., J. PHARMACOL. EXP. THER., vol. 277, 1996, pages 923 - 937;;BERGE ET AL.: ""Pharmaceutical Salts"", J. OF PHARMA SCI., vol. 66, 1977, pages 1 - 19;;CHONN ET AL., CURRENT OP. BIOTECH., vol. 6, 1995, pages 698 - 708;;""The Merck Manual of Diagnosis and Therapy"", 1987, pages: 1206 - 1228;;""The Merck Manual of Diagnosis and Therapy"", 1987, pages: 2499 - 2506;;PEPTIDE NUCLEIC ACIDS (PNA): SYNTHESIS, PROPERTIES AND POTENTIAL APPLICATIONS, BIOORGANIC & MEDICINAL CHEMISTRY, vol. 4, 1996, pages 5 - 23;;See also references of EP 1117672A4",PATENTED
187,US,A1,US 2005/0143335 A1,052-547-722-272-688,2005-06-30,2005,US 98339204 A,2004-11-08,US 98339204 A;;US 91818601 A;;US 49669400 A;;US 28640799 A;;US 16316298 A,1998-09-29,Antisense modulation of survivin expression,"Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC,BENNETT C F;;SWAYZE ERIC E;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/052-547-722-272-688,Patent Application,yes,2,3,4,34,250,A61K38/00;;C07B2200/11;;C07H21/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;C12N15/113;;A61K38/00;;C12N2310/321;;C12N2310/315;;C07B2200/11;;C12N2310/341;;C07H21/00;;C12N2310/346;;C12N2310/3341,A61K38/00;;C07H21/00;;C12N15/113,514/44;;435/455,0,0,,,,EXPIRED
188,CA,C,CA 2343102 C,185-111-311-533-869,2010-11-09,2010,CA 2343102 A,1999-09-23,US 16316298 A;;US 28640799 A;;US 9922076 W,1998-09-29,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/185-111-311-533-869,Granted Patent,no,0,0,18,34,47,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/02;;C07H21/04;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07C21/04;;C07H21/00;;C12P21/04;;C12Q1/68,,0,0,,,,EXPIRED
189,US,A1,US 2002/0137708 A1,045-989-733-868-326,2002-09-26,2002,US 91818601 A,2001-07-30,US 91818601 A;;US 49669400 A;;US 28640799 A;;US 16316298 A,1998-09-29,Antisense modulation of survivin expression,"
   Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided. 
",BENNETT C. FRANK;;SWAYZE ERIC E.;;ACKERMANN ELIZABETH J.;;COWSERT LEX M.,BENNETT C FRANK;;SWAYZE ERIC E;;ACKERMANN ELIZABETH J;;COWSERT LEX M,ISIS PHARMACEUTICALS INC (2001-09-10),https://lens.org/045-989-733-868-326,Patent Application,yes,1,22,4,34,250,A61K38/00;;C07B2200/11;;C07H21/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;C12N15/113;;A61K38/00;;C12N2310/321;;C12N2310/315;;C07B2200/11;;C12N2310/341;;C07H21/00;;C12N2310/346;;C12N2310/3341,A61K38/00;;C07H21/00;;C12N15/113,514/44;;435/375;;514/449;;424/649,0,0,,,,EXPIRED
190,AU,A,AU 1999/061598 A,125-213-621-943-928,2000-04-17,2000,AU 1999/061598 A,1999-09-23,US 16316298 A;;US 28640799 A;;US 9922076 W,1998-09-29,Antisense modulation of survivin expression,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/125-213-621-943-928,Patent Application,no,0,0,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,0,0,,,,EXPIRED
191,US,A1,US 2004/0204380 A1,153-426-475-635-664,2004-10-14,2004,US 84447004 A,2004-05-12,US 84447004 A;;US 86989402 A;;US 9929593 W;;US 22656899 A,1999-01-07,Antisense modulation of novel anti-apoptotic bcl-2-related proteins,"
   Compositions and methods are provided for modulating the expression of novel anti-apoptotic bcl-2-related proteins. Antisense oligonucleotides targeted to nucleic acids encoding the human novel anti-apoptotic bcl-2-related proteins A1 and mcl-1 are preferred. Methods of using these compounds for modulation of novel anti-apoptotic bcl-2-related protein expression and for treatment of diseases associated with expression of novel anti-apoptotic bcl-2-related proteins are also provided. Also provided are methods of using these compounds for promoting apoptosis and for treatment of diseases for which promotion of apoptosis is desired. 
",ACKERMANN ELIZABETH J;;BENNETT C FRANK;;DEAN NICHOLAS M;;MARCUSSON ERIC G,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;DEAN NICHOLAS M;;MARCUSSON ERIC G,,https://lens.org/153-426-475-635-664,Patent Application,yes,1,151,1,286,40,C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/318;;C12N2310/318;;C12N2310/3181;;C12N2310/3181;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/345;;C12N2310/345;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/113,514 044000;;514 023200,0,0,,,,DISCONTINUED
192,CA,C,CA 2521257 C,178-742-861-205-330,2010-06-22,2010,CA 2521257 A,2004-04-02,US 40786103 A;;US 2004/0010226 W,2003-04-04,TAMPON APPLICATOR ASSEMBLY HAVING AN IMPROVED PLUNGER AND METHODS OF MAKING,"A plunger having a first end, a second end, and a main body is provided. The first end of the plunger is about 10 % to about 15 % larger than the main body and the second end is more than about 50 % larger than the main body.",PLAYTEX PRODUCTS INC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH J;;BENNETT KATHRYN G;;MELVIN WAYNE DAVID,,https://lens.org/178-742-861-205-330,Granted Patent,no,0,0,12,12,0,A61F13/26;;A61F13/2097;;A61F13/26;;A61F13/2097,A61F13/20;;A61F13/26,,0,0,,,,INACTIVE
193,CA,A1,CA 2521257 A1,054-030-260-304-374,2004-10-21,2004,CA 2521257 A,2004-04-02,US 40786103 A;;US 2004/0010226 W,2003-04-04,TAMPON APPLICATOR ASSEMBLY HAVING AN IMPROVED PLUNGER AND METHODS OF MAKING,"A plunger having a first end, a second end, and a main body is provided. The first end of the plunger is about 10 % to about 15 % larger than the main bo dy and the second end is more than about 50 % larger than the main body.</SDOAB >",PLAYTEX PRODUCTS INC,EDGETT KEITH J;;LEMAY JESSICA ELIZABETH;;MELVIN WAYNE DAVID;;BENNETT KATHRYN G,,https://lens.org/054-030-260-304-374,Patent Application,no,0,0,12,12,0,A61F13/26;;A61F13/2097;;A61F13/26;;A61F13/2097,A61F13/26,,0,0,,,,INACTIVE
194,EP,A2,EP 2199299 A2,186-565-846-953-707,2010-06-23,2010,EP 09162114 A,2001-01-30,EP 01908740 A;;US 49669400 A,2000-02-02,Antisense modulation of survivin expression,"Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC,BENNETT FRANK C;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2011-09-28)",https://lens.org/186-565-846-953-707,Patent Application,yes,18,0,12,34,249,A61K38/00;;A61K38/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C12N15/113;;C12N15/113;;C07B2200/11;;C07B2200/11;;C07H21/00;;C07H21/00;;C12N15/1135;;C12N15/1135;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,C07H21/04;;A61K9/10;;A61K31/337;;A61K31/7088;;A61K31/711;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K38/00;;A61K45/00;;A61K48/00;;A61P35/00;;A61P43/00;;C07H21/00;;C12N15/00;;C12N15/09;;C12N15/113;;C12P21/04;;C12Q1/68,,22,16,097-682-313-785-241;;041-609-157-035-98X;;053-522-668-738-074;;064-342-722-122-563;;004-141-611-451-05X;;033-950-248-815-892;;072-134-452-621-066;;068-152-830-532-197;;003-287-872-593-043;;051-226-937-192-323;;119-325-388-100-295;;007-210-965-226-461;;051-226-937-192-323;;011-811-359-064-683;;114-916-177-247-492;;037-532-137-715-067,10.1038/nm0897-917;;9256286;;9337844;;pmc1218630;;10.1042/bj3260001;;9859993;;10.1038/25141;;10.1073/pnas.86.17.6553;;2771942;;pmc297882;;10.1111/j.1749-6632.1992.tb21095.x;;1364095;;1741287;;pmc310419;;10.1093/nar/20.3.533;;pmc452764;;10.1002/j.1460-2075.1991.tb08051.x;;1850694;;1688418;;10.1016/0014-5793(90)80039-l;;8504177;;10.1016/0300-9084(93)90024-m;;10.1016/0040-4039(95)00597-6;;pmc331077;;2165251;;10.1093/nar/18.13.3777;;10.1080/15257779508012513;;10.1016/0040-4039(95)00597-6;;7495868;;10.1016/0167-4781(95)00145-7;;8627575;;1934087,"AMBROSINI ET AL., NAT. MED., vol. 3, 1997, pages 917 - 921;;COHEN, BIOCHEMISTRY JOURNAL, vol. 326, 1997, pages 1 - 16;;LI ET AL., NATURE, vol. 396, 1998, pages 580 - 584;;KROSCHWITZ, J.I.: ""The Concise Encyclopedia Of Polymer Science And Engineering"", 1990, JOHN WILEY & SONS, pages: 858 - 859;;ENGLISCH ET AL., ANGEWANDTE CHEMIE, INTERNATIONAL EDITION, vol. 30, 1991, pages 613;;SANGHVI, Y.S.: ""Antisense Research and Applications"", 1993, CRC PRESS, pages: 289 - 302;;""Antisense Research and Applications"", 1993, CRC PRESS, pages: 276 - 278;;LETSINGER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 6553 - 6556;;MANOHARAN ET AL., BIOORG. MED. CHEM. LET., vol. 4, 1994, pages 1053 - 1060;;MANOHARAN ET AL., ANN. N.Y. ACAD. SCI., vol. 660, 1992, pages 306 - 309;;MANOHARAN ET AL., BIOORG. MED. CHEM. LET., vol. 3, 1993, pages 2765 - 2770;;OBERHAUSER ET AL., NUCL. ACIDS RES., vol. 20, 1992, pages 533 - 538;;SAISON-BEHMOARAS ET AL., EMBO J., vol. 10, 1991, pages 1111 - 1118;;KABANOV ET AL., FEBS LETT., vol. 259, 1990, pages 327 - 330;;SVINARCHUK ET AL., BIOCHIMIE, vol. 75, 1993, pages 49 - 54;;MANOHARAN ET AL., TETRAHEDRON LETT., vol. 36, 1995, pages 3651 - 3654;;SHEA ET AL., NUCL. ACIDS RES., vol. 18, 1990, pages 3777 - 3783;;MANOHARAN ET AL., NUCLEOSIDES & NUCLEOTIDES, vol. 14, 1995, pages 969 - 973;;MANOHARAM ET AL., TETRAHEDRON LETT., vol. 36, 1995, pages 3651 - 3654;;MISHRA ET AL., BIOCHIM. BIOPHYS. ACTA, vol. 1264, 1995, pages 229 - 237;;CROOKE ET AL., J. PHARMACAL. EXP. THER., vol. 277, 1996, pages 923 - 937;;LEE ET AL.: ""Critical Reviews"", THERAPEUTIC DRUG CARRIER SYSTEMS, vol. 8, no. 2, 1991, pages 91 - 192",DISCONTINUED
195,JP,A,JP 2010148889 A,196-159-407-710-622,2010-07-08,2010,JP 2010025845 A,2010-02-08,US 40786103 A,2003-04-04,TAMPON APPLICATOR ASSEMBLY HAVING AN IMPROVED PLUNGER AND METHODS OF MAKING,"<P>PROBLEM TO BE SOLVED: To provide a tampon applicator assembly having an improved plunger that increases the ease of use and user comfort, and to provide an improved tampon applicator plunger, which is easy to grip and control during expulsion of the pledget. <P>SOLUTION: A plunger 16 having a first end, a second end 28, and a body is provided. The first end of the plunger is about 10% to about 15% larger than the body and the second end is more than about 50% larger than the body. <P>COPYRIGHT: (C)2010,JPO&INPIT",PLAYTEX PRODUCTS LLC,LEMAY JESSICA ELIZABETH;;EDGETT KEITH J;;MELVIN WAYNE DAVID;;BENNETT KATHRYN G,,https://lens.org/196-159-407-710-622,Patent Application,no,5,0,12,12,0,A61F13/26;;A61F13/2097;;A61F13/26;;A61F13/2097,A61F13/26;;A61F13/32,,0,0,,,,ACTIVE
196,US,B1,US 6335194 B1,040-236-442-776-407,2002-01-01,2002,US 49669400 A,2000-02-02,US 49669400 A;;US 28640799 A;;US 16316298 A,1998-09-29,Antisense modulation of survivin expression,"
    Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided. 
",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,IONIS PHARMACEUTICALS INC (2000-03-03),https://lens.org/040-236-442-776-407,Granted Patent,yes,1,69,12,34,249,A61K38/00;;A61K38/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C12N15/113;;C12N15/113;;C07B2200/11;;C07B2200/11;;C07H21/00;;C07H21/00;;C12N15/1135;;C12N15/1135;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,C07H21/04;;A61K9/10;;A61K31/337;;A61K31/7088;;A61K31/711;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K38/00;;A61K45/00;;A61K48/00;;A61P35/00;;A61P43/00;;C07H21/00;;C12N15/09;;C12N15/113;;C12P21/04,435/375;;436/6;;436/377;;436/455;;536/23.1;;536/24.1;;536/24.5;;514/44,3,3,082-930-617-454-05X;;053-522-668-738-074;;040-020-176-260-711,8987636;;10.1016/0167-7799(96)10053-6;;9859993;;10.1038/25141;;9538686;;10.1016/s0968-0004(97)01155-9,"Agrawal S., ""Antisense Oligonucleotides: Towards Clinical Trials"" TIBTECH vol. 14: 376-387, Feb. 1998.;;Li F., et al., ""Control of apoptosis and mitotic spindle checkpoint by survivin"", Nature, 1998, 386: 580-584.;;Branch et al., ""A Good Antisense Molecule is Hard to Find"" TIBS vol. 23:45-50, Feb. 1998.*",EXPIRED
197,EP,A1,EP 1252175 A1,097-729-027-126-128,2002-10-30,2002,EP 01908740 A,2001-01-30,US 0102939 W;;US 49669400 A,2000-02-02,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2005-06-29)",https://lens.org/097-729-027-126-128,Patent Application,yes,0,0,12,34,249,A61K38/00;;A61K38/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C12N15/113;;C12N15/113;;C07B2200/11;;C07B2200/11;;C07H21/00;;C07H21/00;;C12N15/1135;;C12N15/1135;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,C07H21/04;;A61K9/10;;A61K31/337;;A61K31/7088;;A61K31/711;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K38/00;;A61K45/00;;A61K48/00;;A61P35/00;;A61P43/00;;C07H21/00;;C12N15/09;;C12N15/113;;C12P21/04,,0,0,,,,DISCONTINUED
198,EP,A3,EP 2199299 A3,193-857-479-482-701,2010-10-20,2010,EP 09162114 A,2001-01-30,EP 01908740 A;;US 49669400 A,2000-02-02,Antisense modulation of survivin expression,"Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC,BENNETT FRANK C;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2011-09-28)",https://lens.org/193-857-479-482-701,Search Report,yes,0,0,12,34,0,A61K38/00;;A61K38/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C12N15/113;;C12N15/113;;C07B2200/11;;C07B2200/11;;C07H21/00;;C07H21/00;;C12N15/1135;;C12N15/1135;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,C07H21/04;;A61K9/10;;A61K31/337;;A61K31/7088;;A61K31/711;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K38/00;;A61K45/00;;A61K48/00;;A61P35/00;;A61P43/00;;C07H21/00;;C12N15/00;;C12N15/09;;C12N15/113;;C12P21/04;;C12Q1/68,,4,3,021-849-999-191-396;;001-537-947-431-812;;014-399-256-774-591,10587640;;10.1038/70242;;10496530;;10.1074/jbc.273.18.11177;;9556606,"LI F ET AL: ""PLEIOTROPIC CELL-DIVISION DEFECTS AND APOPTOSIS INDUCED BY INTERFERENCE WITH SURVIVIN FUNCTION"", NATURE CELL BIOLOGY, MACMILLAN PUBLISHERS, GB, vol. 1, December 1999 (1999-12-01), pages 461 - 466, XP001034788, ISSN: 1465-7392;;GROSSMAN D ET AL: ""EXPRESSION OF THE APOPTOSIS INHIBITOR, SURVIVIN, IN NONMELANOMA SKIN CANCER AND GENE TARGETING IN A KERATINOCYTE CELL LINE"", LABORATORY INVESTIGATION, UNITED STATES AND CANADIAN ACADEMY OF PATHOLOGY, BALTIMORE,, US, vol. 29, no. 9, 1999, pages 1121 - 1126, XP002926502, ISSN: 0023-6837;;AMBROSINI G ET AL: ""INDUCTION OF APOPTOSIS AND INHIBITION OF CELL PROLIFERATION BY SURVIVIN GENE TARGETING"", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 273, no. 18, 1996, pages 11177 - 11182, XP002926501, ISSN: 0021-9258;;DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; July 2003 (2003-07-01), WANG XIAO-JUAN ET AL: ""[Survivin antisense RNA enhances taxol-induced apoptosis in leukemia cell line HL-60]"", XP002579803, Database accession no. NLM12941188",DISCONTINUED
199,WO,A3,WO 2004/089243 A3,037-445-835-371-50X,2005-07-07,2005,US 2004/0010226 W,2004-04-02,US 40786103 A,2003-04-04,TAMPON APPLICATOR ASSEMBLY HAVING AN IMPROVED PLUNGER AND METHODS OF MAKING,"A plunger having a first end, a second end, and a main body is provided. The first end of the plunger is about 10 % to about 15 % larger than the main body and the second end is more than about 50 % larger than the main body.",PLAYTEX PRODUCTS INC;;LEMAY JESSICA ELIZABETH;;EDGETT KEITH J;;BENNETT KATHRYN G;;MELVIN WAYNE DAVID,LEMAY JESSICA ELIZABETH;;EDGETT KEITH J;;BENNETT KATHRYN G;;MELVIN WAYNE DAVID,,https://lens.org/037-445-835-371-50X,Search Report,yes,2,0,12,12,0,A61F13/26;;A61F13/2097;;A61F13/26;;A61F13/2097,A61F13/26,,0,0,,,,PENDING
200,CY,T1,CY 1110633 T1,035-964-864-372-378,2015-04-29,2015,CY 091101270 T,2009-12-02,EP 99948416 A;;US 16316298 A;;US 28640799 A,1998-09-29,ΤΡΟΠΟΠΟΙΗΣΗ ΑΝΤΙΘΕΤΗΣ ΦΟΡΑΣ ΤΗΣ ΕΚΦΡΑΣΗΣ ΣΟΥΡΒΙΒΙΝΗΣ,"Παρέχονται ενώσεις αντίθετης φοράς, συνθέσεις και μέθοδοι για την τροποποίηση της έκφρασης Σουρβιβίνης. Οι συνθέσεις περιλαμβάνουν ενώσεις αντίθετης φοράς, ειδικότερα δε ολιγονουκλεοτίδια αντίθετης φοράς, στοχευμένα σε πυρηνικά οξέα που εγκωδικεύουν την Σουρβιβίνη. Παρέχονται μέθοδοι χρήσης αυτών των ενώσεων για την τροποποίηση της έκφρασης Σουρβιβίνης και για την αγωγή παθήσεων που συσχετίζονται με την έκφραση Σουρβιβίνης.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/035-964-864-372-378,Granted Patent,no,0,0,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;C12N15/11;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,0,0,,,,ACTIVE
201,PT,E,PT 1117672 E,137-762-513-569-753,2009-12-09,2009,PT 99948416 T,1999-09-23,US 16316298 A;;US 28640799 A,1998-09-29,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/137-762-513-569-753,Granted Patent,no,0,0,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;C12N15/11;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,0,0,,,,EXPIRED
202,CA,A1,CA 2343102 A1,148-910-217-256-526,2000-04-06,2000,CA 2343102 A,1999-09-23,US 16316298 A;;US 28640799 A;;US 9922076 W,1998-09-29,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating th e expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC,SWAYZE ERIC E;;BENNETT C FRANK;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/148-910-217-256-526,Patent Application,no,0,5,18,34,47,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,0,0,,,,EXPIRED
203,AU,B2,AU 2003/205017 B2,189-582-593-146-272,2005-12-15,2005,AU 2003/205017 A,2003-06-27,AU 1999/061598 A;;AU 2003/205017 A,1999-09-23,Antisense modulation of survivin expression,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;SWAYZE ERIC E;;ACKERMANN ELIZABETH J;;COWSERT LEX M,,https://lens.org/189-582-593-146-272,Granted Patent,no,1,0,1,1,0,,C07H21/02;;A61K48/00;;C07C21/04;;C12Q1/68,,0,0,,,,EXPIRED
204,CA,A1,CA 2398889 A1,018-600-320-274-004,2001-08-09,2001,CA 2398889 A,2001-01-30,US 49669400 A;;US 0102939 W,2000-02-02,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating th e expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/018-600-320-274-004,Patent Application,no,0,0,12,34,249,A61K38/00;;A61K38/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P43/00;;C12N15/113;;C12N15/113;;C07B2200/11;;C07B2200/11;;C07H21/00;;C07H21/00;;C12N15/1135;;C12N15/1135;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,C07H21/04;;A61K9/10;;A61K31/337;;A61K31/7088;;A61K31/711;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K38/00;;A61K45/00;;A61K48/00;;A61P35/00;;A61P43/00;;C07H21/00;;C12N15/09;;C12N15/113;;C12P21/04,,0,0,,,,DISCONTINUED
205,EP,A4,EP 1117672 A4,152-118-634-491-32X,2004-03-31,2004,EP 99948416 A,1999-09-23,US 9922076 W;;US 16316298 A;;US 28640799 A,1998-09-29,ANTISENSE MODULATION OF SURVIVIN EXPRESSION,,ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,"ISIS PHARMACEUTICALS, INC. (2011-09-28)",https://lens.org/152-118-634-491-32X,Search Report,no,0,0,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,1,0,,,No further relevant documents disclosed,EXPIRED
206,AU,A,AU 2000/021807 A,045-827-517-001-419,2000-07-24,2000,AU 2000/021807 A,1999-12-14,US 22656899 A;;US 9929593 W,1999-01-07,Antisense modulation of novel anti-apoptotic bcl-2-related proteins,,ISIS PHARMACEUTICALS INC,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;DEAN NICHOLAS M;;MARCUSSON ERIC G,,https://lens.org/045-827-517-001-419,Patent Application,no,0,0,8,286,0,A61P35/00;;C12N15/1135;;C12N15/1135;;C12N15/113;;C12N15/113;;C12N2310/315;;C12N2310/315;;C12N2310/318;;C12N2310/318;;C12N2310/3181;;C12N2310/3181;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/345;;C12N2310/345;;C12N2310/346;;C12N2310/346;;Y02P20/582;;Y02P20/582,C12N15/09;;A61K31/7105;;A61K31/711;;A61K31/712;;A61K31/7125;;A61K33/24;;A61K45/00;;A61K48/00;;A61P35/00;;C12N5/10;;C12N15/113,,0,0,,,,DISCONTINUED
207,ES,T3,ES 2332296 T3,143-735-651-311-391,2010-02-01,2010,ES 99948416 T,1999-09-23,US 16316298 A;;US 28640799 A,1998-09-29,MODULACION ANTISENTIDO DE LA EXPRESION DE SURVIVINA.,"Un oligonucleótido antisentido con una longitud de hasta 30 nucleótidos dirigido a una molécula de ácido nucleico que codifica la survivina humana, que comprende una secuencia seleccionada del grupo que consiste en SEQ ID NO:10, 12, 15, 16, 18, 20, 21, 23, 28, 31, 32, 34, 38, 39, 40, 41, 42, 43 y 47, o su sal farmacéuticamente aceptable.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,,https://lens.org/143-735-651-311-391,Granted Patent,no,0,0,18,34,0,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;C12N15/11;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,,0,0,,,,EXPIRED
208,US,A,US 6077709 A,157-758-142-446-423,2000-06-20,2000,US 16316298 A,1998-09-29,US 16316298 A,1998-09-29,Antisense modulation of Survivin expression,"Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.",ISIS PHARMACEUTICALS INC,BENNETT C FRANK;;ACKERMANN ELIZABETH J;;SWAYZE ERIC E;;COWSERT LEX M,IONIS PHARMACEUTICALS INC (1998-09-28),https://lens.org/157-758-142-446-423,Granted Patent,yes,1,27,18,34,47,C07B2200/11;;C07H21/00;;A61P35/00;;Y02P20/582;;C07H21/00;;C07B2200/11,C07H21/04;;A61K31/7088;;A61K31/712;;A61K48/00;;A61P35/00;;C07H21/00;;C12P21/04,435/375;;435/6;;435/377;;435/455;;536/23.1;;536/24.1;;536/24.5,8,8,040-020-176-260-711;;082-930-617-454-05X;;036-796-541-068-079;;000-086-958-485-588;;097-682-313-785-241;;014-399-256-774-591;;041-609-157-035-98X;;011-212-836-532-853,9538686;;10.1016/s0968-0004(97)01155-9;;8987636;;10.1016/0167-7799(96)10053-6;;9181575;;10.1038/nbt0697-537;;10.1016/s0140-6736(05)70294-4;;9525374;;10.1038/nm0897-917;;9256286;;10.1074/jbc.273.18.11177;;9556606;;9337844;;pmc1218630;;10.1042/bj3260001;;9581817,"Branch, A. A Good Antisense Molecule is Hard to Find TIBS vol. 23:45 50, Feb. 1998.;;Agrawal, S. Antisense oligonucleotides: Towards Clinical Trials TIBTECH vol. 14:376 387, Oct. 1996.;;Milner et al. Selecting Effective Antisense Reagents on Combinitorial Arrays Nature Biotechnology vol. 14: 537 541, Jun. 1997.;;Adida et al., Anti apoptosis gene, survivin, and prognosis of neuroblastoma, Lancet, 1998, 351:882 883.;;Ambrosini et al., A novel anti apoptosis gene, survivin, expressed in cancer and lymphoma, Nat. Med ., 1997, 3:917 921.;;Ambrosini et al., Induction of Apoptosis and Inhibition of Cell Proliferation by Survivin Gene Targeting, J. Bio. Chem ., 1998, 273:11177 11182.;;Cohen, Caspases: the executioners of apoptosis, Biochemistry Journal , 1997, 326:1 6.;;Lu et al., Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas, Cancer Res., 1998, 58:1808 1812.",EXPIRED
209,US,A1,US 2009/0254445 A1,042-736-618-435-459,2009-10-08,2009,US 9959408 A,2008-04-08,US 9959408 A,2008-04-08,SYSTEMS AND METHODS FOR AGGREGATING PACKAGES IN A SHIPPING ENVIRONMENT,"Various embodiments for aggregating packages into a pouch in a shipping environment are disclosed. For example, package details associated with a package are compared to one or more incompatibility factors, and if the package details do not match the one or more incompatibility factors, a package identifier uniquely identifying the package is added to a pouch manifest. If the package is not compatible with the pouch, an error message may be displayed to a user indicating that the package is incompatible. In addition, package details may be compared with compatibility factors identifying criteria for packages that are compatible with the pouch and questionable compatibility factors identifying criteria for packages that may be compatible with the pouch. Compatibility factors and questionable compatibility factors may include, for example, service options, delivery notification options, or destination zip code(s).",UNITED PARCEL SERVICE INC,BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;MOON LORY ELIZABETH;;SMITH III WILLIAM W,UNITED PARCEL SERVICE OF AMERICA INC (2008-04-03),https://lens.org/042-736-618-435-459,Patent Application,yes,52,30,2,2,0,G06Q10/08;;G06Q10/083;;G06Q10/0832;;G06Q30/0601;;G06Q10/08;;G06Q30/0601;;G06Q10/0832;;G06Q10/083,G06Q30/00,705/26,0,0,,,,ACTIVE
210,US,B2,US 8065237 B2,032-430-950-025-932,2011-11-22,2011,US 9959408 A,2008-04-08,US 9959408 A,2008-04-08,Systems and methods for aggregating packages in a shipping environment,"Various embodiments for aggregating packages into a pouch in a shipping environment are disclosed. For example, package details associated with a package are compared to one or more incompatibility factors, and if the package details do not match the one or more incompatibility factors, a package identifier uniquely identifying the package is added to a pouch manifest. If the package is not compatible with the pouch, an error message may be displayed to a user indicating that the package is incompatible. In addition, package details may be compared with compatibility factors identifying criteria for packages that are compatible with the pouch and questionable compatibility factors identifying criteria for packages that may be compatible with the pouch. Compatibility factors and questionable compatibility factors may include, for example, service options, delivery notification options, or destination zip code(s).",BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;MOON LORY ELIZABETH;;SMITH III WILLIAM W;;UNITED PARCEL SERVICE INC,BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;MOON LORY ELIZABETH;;SMITH III WILLIAM W,UNITED PARCEL SERVICE OF AMERICA INC (2008-04-03),https://lens.org/032-430-950-025-932,Granted Patent,yes,54,7,2,2,0,G06Q10/08;;G06Q10/083;;G06Q10/0832;;G06Q30/0601;;G06Q10/08;;G06Q30/0601;;G06Q10/0832;;G06Q10/083,G06Q30/00,705/332;;705/330,3,0,,,"""DHL's New 'Break-Bulk-Express' Service Means Faster, More Convenient Shipping Across U.S.-Mexican Border"", PR Newswire, Mar. 13, 2007.;;Notice of Allowance and Fees Due Dated May 5, 2008, for U.S. Appl. No. 10/357,971, filed Feb. 4, 2003.;;About FedEx, FedEx Archives: 2003 Press Releases: FedEx Ground Launches FedEx Consolidated Return Service; Low-Cost, Convenient Service Meets High-Volume Return Needs of Customer-Direct Retailers; www.fedex.com/us; Mar. 13, 2008.",ACTIVE
211,ES,T3,ES 2227611 T3,052-814-788-171-832,2005-04-01,2005,ES 96936052 T,1996-09-27,US 462295 P;;US 9615593 W;;US 72265996 A,1995-09-29,USO DE HEPARINAS PARA DISMINUIR REPUESTAS INFLAMATORIAS.,"LAS ENZIMAS HEPARINASAS PUEDEN UTILIZARSE COMO TRATAMIENTO MEDICO PARA REDUCIR LAS RESPUESTAS INFLAMATORIAS LOCALIZADAS. EL TRATAMIENTO CON HEPARINASA DEL ENDOTELIO ACTIVADO INHIBE EL MOVIMIENTO, LA ADHESION Y LA EXTRAVASACION DE LEUCITOS. LA MAYOR PARTE DE LA HEPARINA Y DEL SULFATO DE HEPARANO SOBRE LAS SUPERFICIES CELULARES DEL ENDOTELIO Y EN MEMBRANAS BASALES SE DEGRADA POR LA EXPOSICION A LA HEPARINASA. ADEMAS, LAS QUIMOCINAS INMOVILIZADAS, QUE ESTAN UNIDAS A LA HEPARINA/SULFATO DE HEPARANO SOBRE EL ENDOTELIO ACTIVADO, SON SOLUBILIZADAS POR LA DIGESTION CON HEPARINASA. LA HEPARINASA PUEDE INFUSIONARSE HACIA EL SISTEMA VASCULAR PARA INHIBIR LA ACUMULACION DE LEUCOCITOS EN UN TEJIDO INFLAMADO Y DISMINUIR LAS LESIONES PROVOCADAS POR INFLAMACIONES LOCALIZADAS. PUEDE LOGRARSE LA ADMINISTRACION DIRIGIDA DE HEPARINASA AL ENDOTELIO ACTIVADO MEDIANTE LA ADMINISTRACION LOCALIZADA Y/O EL USO DE HEPARINASA FORMADA MEDIANTE INGENIERIA GENETICA QUE CONTIENE DOMINIOS DE UNION A LIGANDOS DEL ENDOTELIO.",BIOMARIN PHARM INC,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA,,https://lens.org/052-814-788-171-832,Granted Patent,no,0,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,EXPIRED
212,NL,B1,NL 2025868 B1,097-338-569-827-334,2022-02-17,2022,NL 2025868 A,2020-06-19,NL 2025868 A,2020-06-19,POWER KEY AND FINGERPRINT READER,"Examples are disclosed that relate to computing devices and methods for authenticating a user. In one example, a method for authenticating a user at a computing device comprises activating a fingerprint reader integrated into a power key of the 5 computing device, and activating a visual indicator at the power key to indicate a status of the fingerprint reader. Based at least in part on activating the fingerprint reader, a standby function of the power key is disabled. A fingerprint of the user is received via the fingerprint reader and used to authenticate the user. After authenticating the user, the visual indicator is deactivated and the standby function of the power key is re- 10 enabled.",MICROSOFT TECHNOLOGY LICENSING LLC,DAVID EARL WASHINGTON;;NATALIA JANINA URBANOWICZ;;ALEXANDER NORMAN BENNETT;;ELIZABETH ANN PINA;;SHUNJIRO EGUCHI,,https://lens.org/097-338-569-827-334,Granted Patent,no,1,0,5,5,0,G06F21/32;;G06V40/1365;;G06V40/1306;;G06F21/32;;G06F21/44,G06F21/32,,2,0,,,"DELL: ""Inspiron 3481 Setup and Specifications"", 1 December 2018 (2018-12-01), XP055778304, Retrieved from the Internet <URL:https://gzhls.at/blob/ldb/f/6/d/6/d53a963d574c9a7f0b493bfc82550b6b9648.pdf> [retrieved on 20210222];;DELL: ""XPS 15 2-in-1 Setup and Specifications"", 1 July 2018 (2018-07-01), XP055778307, Retrieved from the Internet <URL:https://cdn.cnetcontent.com/syndication/mediaserverredirect/0035c8d391aea340adef6c47ab66081a/original.pdf> [retrieved on 20210222]",ACTIVE
213,WO,A1,WO 2015/089208 A1,086-075-679-020-688,2015-06-18,2015,US 2014/0069587 W,2014-12-10,US 201361914082 P;;US 201361914054 P,2013-12-10,CELL DESIGN FOR AN ALKALINE BATTERY WITH CHANNELS IN ELECTRODES TO REMOVE GAS,"Provided is an alkaline battery comprising at least one positive electrode and at least one negative electrode with a separator disposed therebetween, with at least one of the electrodes having alternating areas that are raised and lowered to create gaps between the electrode and the separator. In one embodiment, the battery comprises a positive nickel electrode and a negative iron electrode.",ENCELL TECHNOLOGY INC,OGG RANDY GENE;;MEESE MICHAEL;;BENNETT PHIL;;SMITH KEITH BRYAN;;RODERS MICHAEL;;MARTIN ELIZABETH,,https://lens.org/086-075-679-020-688,Patent Application,yes,6,0,2,2,0,H01M4/24;;H01M10/26;;H01M4/248;;H01M4/244;;H01M4/622;;H01M4/808;;H01M4/661;;H01M2004/021;;Y02E60/10;;H01M50/417;;H01M4/24;;H01M10/26;;H01M4/248;;H01M4/244;;H01M4/622;;H01M4/808;;H01M4/661;;H01M2004/021;;H01M50/417,H01M50/417,,0,0,,,,PENDING
214,CA,A1,CA 2663947 A1,064-966-773-279-929,2008-03-20,2008,CA 2663947 A,2007-09-13,US 84480906 P;;US 2007/0019901 W,2006-09-15,AZETIDINE AND AZETIDONE DERIVATIVES USEFUL IN TREATING PAIN AND DISORDERS OF LIPID METABOLISM,"Disclosed are compounds of formula (I) wherein Z1 is -CH2- or -C(O)-, R4 and R5 are carbon chains (and optionally, together can form a C2 bridge), u and v are independently an integer of 0-3 such that there sum is from 3 to 5 , and R2 is heteroaryl, and R1 and R3 are as defined herein. Also disclosed are methods of treating pain using a compound of formula (I).",SCHERING CORP,BENNETT CHAD E;;SMITH ELIZABETH M;;BURNETT DUANE A;;MCKITTRICK BRIAN;;KNUTSON CHAD E,,https://lens.org/064-966-773-279-929,Patent Application,no,0,0,9,9,0,C07D471/10;;C07D487/10;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/06;;A61P43/00;;C07D471/10;;C07D487/10,A61K31/397;;A61K31/438;;A61P29/00;;C07D471/10;;C07D487/10,,0,0,,,,DISCONTINUED
215,EP,A1,EP 4168906 A1,090-435-181-631-36X,2023-04-26,2023,EP 21746907 A,2021-06-08,NL 2025868 A;;US 2021/0070672 W,2020-06-19,POWER KEY AND FINGERPRINT READER,,MICROSOFT TECHNOLOGY LICENSING LLC,WASHINGTON DAVID EARL;;URBANOWICZ NATALIA JANINA;;EGUCHI SHUNJIRO;;BENNETT ALEXANDER NORMAN;;PINA ELIZABETH ANN,,https://lens.org/090-435-181-631-36X,Patent Application,yes,0,0,5,5,0,G06F21/32;;G06V40/1365;;G06V40/1306;;G06F21/32;;G06F21/44,G06F21/32,,0,0,,,,PENDING
216,US,A1,US 2015/0162570 A1,039-397-228-738-161,2015-06-11,2015,US 201414566336 A,2014-12-10,US 201414566336 A;;US 201361914108 P;;US 201361914036 P,2013-12-10,BEVELED CELL DESIGN FOR AN ALKALINE BATTERY TO REMOVE GAS,"Provided is an alkaline battery comprising an electrode stack having at least one positive electrode and at least one negative electrode with a separator disposed therebetween and a spacer between the tabs of similarly polarized electrodes of the electrode stack, which battery is contained in a cell casing that applies greater pressure to the electrode towards the bottom of the electrode stack and less pressure towards the top of the electrode stack. In one embodiment, the spacers between the tabs of similarly polarized electrodes are the teeth of a comb structure.",ENCELL TECHNOLOGY INC,OGG RANDY GENE;;MEESE MICHAEL;;BENNETT PHIL;;SMITH KEITH BRYAN;;RODERS MICHAEL;;MARTIN ELIZABETH,,https://lens.org/039-397-228-738-161,Patent Application,yes,12,2,1,3,0,H01M4/62;;H01M10/26;;H01M10/281;;H01M4/248;;H01M4/244;;H01M4/24;;H01M4/622;;H01M4/661;;H01M4/808;;Y02E60/10;;Y02P70/50;;H01M50/417;;H01M50/477;;H01M50/474;;H01M10/26;;H01M10/281;;H01M4/248;;H01M4/244;;H01M4/24;;H01M4/622;;H01M4/661;;H01M4/808;;H01M4/62;;H01M50/417;;H01M50/474;;H01M50/477,H01M4/24;;H01M4/62;;H01M4/66;;H01M4/80;;H01M10/26;;H01M10/28;;H01M50/417;;H01M50/474;;H01M50/477,,1,0,,,WO 1994/020995,DISCONTINUED
217,WO,A1,WO 2015/089205 A1,066-060-467-774-982,2015-06-18,2015,US 2014/0069583 W,2014-12-10,US 201361914069 P;;US 201361914068 P;;US 201361914108 P;;US 201361914036 P,2013-12-10,BEVELED CELL DESIGN FOR AN ALKALINE BATTERY TO REMOVE GAS,"Provided is an alkaline battery comprising an electrode stack having at least one positive electrode and at least one negative electrode with a separator disposed therebetween, which battery is contained in a cell casing that applies greater pressure to the electrode towards the bottom of the electrode stack and less pressure towards the top of the electrode stack. In one embodiment, spacers are between the tabs of similarly polarized electrodes of the electrode stack. In one embodiment, the spacers between the tabs of similarly polarized electrodes are the teeth of a comb structure.",ENCELL TECHNOLOGY INC,OGG RANDY GENE;;MEESE MICHAEL;;BENNETT PHIL;;SMITH KETIH BRYAN;;RODERS MICHAEL;;MARTIN ELIZABETH,,https://lens.org/066-060-467-774-982,Patent Application,yes,5,0,1,3,0,H01M4/38;;H01M4/62;;H01M10/0468;;H01M10/24;;H01M10/288;;Y02E60/10;;H01M50/103;;H01M50/102;;H01M50/102,H01M50/102,,0,0,,,,PENDING
218,CN,A,CN 114727889 A,092-563-607-990-28X,2022-07-08,2022,CN 201980102363 A,2019-12-20,US 2019/0067783 W,2019-12-20,Absorbent articles with refastenable side seams and methods of making same,"Absorbent articles and methods of making the same are disclosed. An absorbent article can include a backsheet including a body-side liner, an outer cover, and an absorbent body; and an elastomeric rear side panel and an elastomeric front side panel, the elastomeric rear side panel and the elastomeric front side panel attached to the longitudinally extending side edges of the backsheet, a portion of each of the elastomeric front side panel and the elastomeric rear side panel and the backsheet forming a front waist edge and a rear waist edge, respectively. A first mechanical fastening component and a second mechanical fastening component are coupleable to the front waist region and are configured to releasably couple the front waist region to the rear waist region. Each of the back waist edge and the front waist edge can also have a width, and a ratio of the back waist edge width to the front waist edge width can be between about 1.5 and about 3.0.",KIMBERLY CLARK CO,BUJARSKI DAVID M;;SINA JOSEPH J;;LANCELOT CLAUDE;;BENNETT KATHLEEN IRENE;;COLLINS JANINE ELIZABETH,,https://lens.org/092-563-607-990-28X,Patent Application,no,7,0,9,9,0,A61F13/4963;;A61F13/565;;A61F13/4963;;A61F13/565;;A61F13/4963;;A61F13/565;;A61F13/493;;A61F13/496;;A61F13/565,A61F13/496,,0,0,,,,PENDING
219,WO,A1,WO 2015/089200 A1,139-545-304-380-833,2015-06-18,2015,US 2014/0069576 W,2014-12-10,US 201361914053 P;;US 201361914013 P;;US 201361914024 P;;US 201361914096 P,2013-12-10,CELL DESIGN FOR AN ALKALINE BATTERY TO REMOVE GAS,"Provided is an alkaline battery wherein the cell casing has a concave shape and the middle of the cell casing creates greater pressure on the middle of the electrode stack than at the edges of the electrode stack. In one embodiment, the battery comprises a positive nickel electrode and a negative iron electrode.",ENCELL TECHNOLOGY INC,OGG RANDY GENE;;MEESE MICHAEL;;BENNETT PHIL;;SMITH KEITH BRYAN;;RODERS MICHAEL;;MARTIN ELIZABETH,,https://lens.org/139-545-304-380-833,Patent Application,yes,5,0,1,3,0,H01M10/24;;Y02E60/10;;H01M50/102;;H01M50/102;;H01M10/24,H01M50/102,,0,0,,,,PENDING
220,US,A1,US 2015/0162571 A1,169-077-499-520-712,2015-06-11,2015,US 201414566382 A,2014-12-10,US 201414566382 A;;US 201361914013 P;;US 201361914024 P,2013-12-10,CONCAVE CELL DESIGN FOR AN ALKALINE BATTERY WITH A COMB SPACER,"Provided is an alkaline battery comprising an electrode stack having at least one positive electrode and at least one negative electrode with a separator disposed therebetween and a spacer between the tabs of similarly polarized electrodes of the electrode stack, which is contained in a cell casing that applies greater pressure to the middle of the electrodes and less pressure to the edges of the electrode stack. In one embodiment, the battery is a nickel-iron battery. In one embodiment, the spacers between the tabs of similarly polarized electrodes are the teeth of a comb structure.",ENCELL TECHNOLOGY INC,OGG RANDY GENE;;MEESE MICHAEL;;BENNETT PHIL;;SMITH KEITH BRYAN;;RODERS MICHAEL;;MARTIN ELIZABETH,,https://lens.org/169-077-499-520-712,Patent Application,yes,9,9,1,3,0,H01M4/62;;H01M10/281;;H01M10/26;;H01M4/24;;H01M4/248;;H01M4/244;;H01M4/622;;Y02E60/10;;Y02P70/50;;H01M50/417;;H01M50/477;;H01M50/474;;H01M10/281;;H01M10/26;;H01M4/24;;H01M4/248;;H01M4/244;;H01M4/622;;H01M4/62;;H01M50/417;;H01M50/474;;H01M50/477,H01M4/24;;H01M4/62;;H01M10/26;;H01M10/28;;H01M50/417;;H01M50/474;;H01M50/477,,1,0,,,WO 1994/020995,DISCONTINUED
221,WO,A1,WO 2021/258094 A1,106-521-722-549-474,2021-12-23,2021,US 2021/0070672 W,2021-06-08,NL 2025868 A,2020-06-19,POWER KEY AND FINGERPRINT READER,"Examples are disclosed that relate to computing devices and methods for authenticating a user. In one example, a method for authenticating a user at a computing device comprises activating a fingerprint reader integrated into a power key of the computing device, and activating a visual indicator at the power key to indicate a status of the fingerprint reader. Based at least in part on activating the fingerprint reader, a standby function of the power key is disabled. A fingerprint of the user is received via the fingerprint reader and used to authenticate the user. After authenticating the user, the visual indicator is deactivated and the standby function of the power key is re-enabled.",MICROSOFT TECHNOLOGY LICENSING LLC,WASHINGTON DAVID EARL;;URBANOWICZ NATALIA JANINA;;EGUCHI SHUNJIRO;;BENNETT ALEXANDER NORMAN;;PINA ELIZABETH ANN,,https://lens.org/106-521-722-549-474,Patent Application,yes,1,0,5,5,0,G06F21/32;;G06V40/1365;;G06V40/1306;;G06F21/32;;G06F21/44,G06F21/32,,2,0,,,"DELL: ""Inspiron 3481 Setup and Specifications"", 1 December 2018 (2018-12-01), XP055778304, Retrieved from the Internet <URL:https://gzhls.at/blob/ldb/f/6/d/6/d53a963d574c9a7f0b493bfc82550b6b9648.pdf> [retrieved on 20210222];;DELL: ""XPS 15 2-in-1 Setup and Specifications"", 1 July 2018 (2018-07-01), XP055778307, Retrieved from the Internet <URL:https://cdn.cnetcontent.com/syndication/mediaserverredirect/0035c8d391aea340adef6c47ab66081a/original.pdf> [retrieved on 20210222]",PENDING
222,DE,D1,DE 69633127 D1,142-582-199-170-551,2004-09-16,2004,DE 69633127 T,1996-09-27,US 462295 P;;US 9615593 W;;US 72265996 A,1995-09-29,VERWENDUNG VON HEPARINASEN ZUR VERMINDERUNG VON ENTZÜNDUNGSREAKTIONEN,,BIOMARIN PHARM INC,BENNETT CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,,https://lens.org/142-582-199-170-551,Granted Patent,no,0,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,EXPIRED
223,US,A1,US 2015/0162601 A1,019-039-245-099-511,2015-06-11,2015,US 201414566300 A,2014-12-10,US 201414566300 A;;US 201361914054 P;;US 201361914082 P,2013-12-10,CELL DESIGN FOR AN ALKALINE BATTERY WITH CHANNELS IN ELECTRODES TO REMOVE GAS,"Provided is an alkaline battery comprising at least one positive electrode and at least one negative electrode with a separator disposed therebetween, with at least one of the electrodes having alternating areas that are raised and lowered to create gaps between the electrode and the separator. In one embodiment, the battery comprises a positive nickel electrode and a negative iron electrode.",ENCELL TECHNOLOGY INC,OGG RANDY GENE;;MEESE MICHAEL;;BENNETT PHIL;;SMITH KEITH BRYAN;;RODERS MICHAEL;;MARTIN ELIZABETH,,https://lens.org/019-039-245-099-511,Patent Application,yes,5,4,2,2,0,H01M4/24;;H01M10/26;;H01M4/248;;H01M4/244;;H01M4/622;;H01M4/808;;H01M4/661;;H01M2004/021;;Y02E60/10;;H01M50/417;;H01M4/24;;H01M10/26;;H01M4/248;;H01M4/244;;H01M4/622;;H01M4/808;;H01M4/661;;H01M2004/021;;H01M50/417,H01M4/24;;H01M4/62;;H01M4/66;;H01M4/80;;H01M10/26;;H01M50/417,,1,0,,,WO 1994/020995,DISCONTINUED
224,MX,A,MX 2009002919 A,049-690-593-536-600,2009-04-01,2009,MX 2009002919 A,2007-09-13,US 84480906 P;;US 2007/0019901 W,2006-09-15,AZETIDINE AND AZETIDONE DERIVATIVES USEFUL IN TREATING PAIN AND DISORDERS OF LIPID METABOLISM.,"Disclosed are compounds of formula (I) wherein Z1 is -CH2- or -C(O)-, R4 and R5 are carbon chains (and optionally, together can form a C2 bridge), u and v are independently an integer of 0-3 such that there sum is from 3 to 5, and R2 is heteroaryl, and R1 and R3 are as defined herein. Also disclosed are methods of treating pain using a compound of formula (I).",SCHERING CORP,MCKITTRICK BRIAN;;BURNETT DUANE A;;SMITH ELIZABETH M;;KNUTSON CHAD E;;BENNETT CHAD E,,https://lens.org/049-690-593-536-600,Patent Application,no,0,0,9,9,0,C07D471/10;;C07D487/10;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/06;;A61P43/00;;C07D471/10;;C07D487/10,A61K31/397;;A61K31/438;;A61P29/00;;C07D471/10;;C07D487/10,,0,0,,,,DISCONTINUED
225,US,A1,US 2015/0162572 A1,052-784-470-718-83X,2015-06-11,2015,US 201414566414 A,2014-12-10,US 201414566414 A;;US 201361914053 P;;US 201361914096 P,2013-12-10,CELL DESIGN FOR AN ALKALINE BATTERY TO REMOVE GAS,"Provided is an alkaline battery wherein the cell casing has a concave shape and the middle of the cell casing creates greater pressure on the middle of the electrode stack than at the edges of the electrode stack. In one embodiment, the battery comprises a positive nickel electrode and a negative iron electrode.",ENCELL TECHNOLOGY INC,OGG RANDY GENE;;MEESE MICHAEL;;BENNETT PHIL;;SMITH KEITH BRYAN;;RODERS MICHAEL;;MARTIN ELIZABETH,,https://lens.org/052-784-470-718-83X,Patent Application,yes,7,0,1,3,0,H01M4/62;;H01M10/28;;H01M10/26;;H01M4/24;;H01M4/248;;H01M4/244;;H01M4/622;;Y02E60/10;;H01M50/417;;H01M50/103;;H01M10/24;;H01M10/26;;H01M4/24;;H01M4/248;;H01M4/244;;H01M4/622;;H01M4/62;;H01M10/28;;H01M50/103;;H01M50/417,H01M4/24;;H01M4/62;;H01M10/24;;H01M10/26;;H01M50/103;;H01M50/417,,1,0,,,WO 1994/020995,DISCONTINUED
226,DE,T2,DE 69633127 T2,115-084-483-294-307,2005-08-04,2005,DE 69633127 T,1996-09-27,US 462295 P;;US 9615593 W;;US 72265996 A,1995-09-29,VERWENDUNG VON HEPARINASEN ZUR VERMINDERUNG VON ENTZÜNDUNGSREAKTIONEN,,BIOMARIN PHARM INC,BENNETT CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,,https://lens.org/115-084-483-294-307,Granted Patent,no,0,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,EXPIRED
227,US,A1,US 2023/0214468 A1,076-772-352-167-865,2023-07-06,2023,US 202118001000 A,2021-06-08,NL 2025868 A;;US 2021/0070672 W,2020-06-19,POWER KEY AND FINGERPRINT READER,"Examples are disclosed that relate to computing devices and methods for authenticating a user. In one example, a method for authenticating a user at a computing device comprises activating a fingerprint reader integrated into a power key of the computing device, and activating a visual indicator at the power key to indicate a status of the fingerprint reader. Based at least in part on activating the fingerprint reader, a standby function of the power key is disabled. A fingerprint of the user is received via the fingerprint reader and used to authenticate the user. After authenticating the user, the visual indicator is deactivated and the standby function of the power key is re-enabled.",MICROSOFT TECHNOLOGY LICENSING LLC,WASHINGTON DAVID EARL;;URBANOWICZ NATALIA JANINA;;EGUCHI SHUNJIRO;;BENNETT ALEXANDER NORMAN;;PINA ELIZABETH ANN,MICROSOFT TECHNOLOGY LICENSING LLC (2020-06-03),https://lens.org/076-772-352-167-865,Patent Application,yes,0,0,5,5,0,G06F21/32;;G06V40/1365;;G06V40/1306;;G06F21/32;;G06F21/44,G06F21/32;;G06F21/44;;G06V40/12;;G06V40/13,,0,0,,,,PENDING
228,WO,A1,WO 2008/033447 A1,148-218-445-170-416,2008-03-20,2008,US 2007/0019901 W,2007-09-13,US 84480906 P,2006-09-15,AZETIDINE AND AZETIDONE DERIVATIVES USEFUL IN TREATING PAIN AND DISORDERS OF LIPID METABOLISM,"Disclosed are compounds of formula (I) wherein Z 1 is -CH 2 - or -C(O)-, R 4 and R 5 are carbon chains (and optionally, together can form a C 2 bridge), u and v are independently an integer of 0-3 such that there sum is from 3 to 5, and R 2 is heteroaryl, and R 1 and R 3 are as defined herein. Also disclosed are methods of treating pain using a compound of formula (I).",SCHERING CORP;;MCKITTRICK BRIAN;;SMITH ELIZABETH M;;BENNETT CHAD E;;BURNETT DUANE A;;KNUTSON CHAD E,MCKITTRICK BRIAN;;SMITH ELIZABETH M;;BENNETT CHAD E;;BURNETT DUANE A;;KNUTSON CHAD E,,https://lens.org/148-218-445-170-416,Patent Application,yes,4,16,9,9,0,C07D471/10;;C07D487/10;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/06;;A61P43/00;;C07D471/10;;C07D487/10,A61K31/438;;A61K31/397;;A61P29/00;;C07D471/10;;C07D487/10,,0,0,,,,PENDING
229,US,A1,US 2015/0162573 A1,162-526-777-028-16X,2015-06-11,2015,US 201414566439 A,2014-12-10,US 201414566439 A;;US 201361914068 P;;US 201361914069 P,2013-12-10,BEVELED CELL DESIGN FOR AN ALKALINE BATTERY,"Provided is an alkaline battery comprising at least one positive electrode and at least one negative electrode with a separator disposed there between, which are contained in a cell casing that applies greater pressure to the electrodes toward the bottom of the electrode stack and less pressure towards the top of the electrode stack. In one embodiment, the battery comprises a positive nickel electrode and a negative iron electrode.",ENCELL TECHNOLOGY INC,OGG RANDY GENE;;MEESE MICHAEL;;BENNETT PHIL;;SMITH KEITH BRYAN;;RODERS MICHAEL;;MARTIN ELIZABETH,,https://lens.org/162-526-777-028-16X,Patent Application,yes,4,0,1,3,0,H01M4/62;;H01M10/28;;H01M10/26;;H01M4/248;;H01M4/244;;H01M4/622;;H01M4/808;;H01M4/661;;Y02E60/10;;H01M10/26;;H01M4/248;;H01M4/244;;H01M4/622;;H01M4/808;;H01M4/661;;H01M4/62;;H01M10/28,H01M2/02;;H01M4/24;;H01M4/62;;H01M4/66;;H01M4/80;;H01M10/24;;H01M10/26,,0,0,,,,DISCONTINUED
230,EP,A1,EP 2066316 A1,175-192-125-157-366,2009-06-10,2009,EP 07838156 A,2007-09-13,US 2007/0019901 W;;US 84480906 P,2006-09-15,AZETIDINE AND AZETIDONE DERIVATIVES USEFUL IN TREATING PAIN AND DISORDERS OF LIPID METABOLISM,,SCHERING CORP,MCKITTRICK BRIAN;;SMITH ELIZABETH M;;BENNETT CHAD E;;BURNETT DUANE A;;KNUTSON CHAD E,,https://lens.org/175-192-125-157-366,Patent Application,yes,0,0,9,9,0,C07D471/10;;C07D487/10;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/06;;A61P43/00;;C07D471/10;;C07D487/10,A61K31/397;;A61K31/438;;A61P29/00;;C07D471/10;;C07D487/10,,0,0,,,,DISCONTINUED
231,CA,A1,CA 2233343 A1,113-009-722-475-453,1997-04-03,1997,CA 2233343 A,1996-09-27,US 462295 P;;US 72265996 A,1995-09-29,USE OF HEPARINASES TO DECREASE INFLAMMATORY RESPONSES,"Heparinase enzymes can be used as a medical treatment to reduce localized inflammatory responses. Treatment of activated endothelium with heparinase inhibits leukocyte rolling, adhesion and extravasation. Most of the heparin and heparan sulfate on endothelial cell sufaces and in basement membranes is degraded by exposure to heparinase. In addition, immobilized chemokines, which are attached to heparin/heparan sulfate on activated endothelium are solubilized by heparinase digestion. Heparinase can be infused into the vascular system to inhibit accumulation of leukocytes in inflamed tissue and decrease damage resulting from localized inflammations. Targeting of heparinase to activated endothelium can be accomplished through localized administration and/or use of genetically engineered heparinase containing endothelium ligand-binding domains.",CAUCHON ELIZABETH;;DANAGHER PAMELA;;BENNETT D;;HSIA ARIANE;;GROUIX BRIGETTE;;FINK DOMINIQUE;;ZIMMERMAN JOSEPH;;IBEX TECH INC,CAUCHON ELIZABETH;;DANAGHER PAMELA;;BENNETT D CLARK;;HSIA ARIANE;;GROUIX BRIGETTE;;FINK DOMINIQUE;;ZIMMERMAN JOSEPH,,https://lens.org/113-009-722-475-453,Patent Application,no,0,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,DISCONTINUED
232,AT,T1,AT E273020 T1,138-012-843-389-468,2004-08-15,2004,AT 96936052 T,1996-09-27,US 462295 P;;US 9615593 W;;US 72265996 A,1995-09-29,VERWENDUNG VON HEPARINASEN ZUR VERMINDERUNG VON ENTZÜNDUNGSREAKTIONEN,,BIOMARIN PHARM INC,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,,https://lens.org/138-012-843-389-468,Granted Patent,no,0,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,DISCONTINUED
233,US,A1,US 2005/0191288 A1,044-423-278-391-036,2005-09-01,2005,US 11847705 A,2005-05-02,US 11847705 A;;US 72265996 A;;US 462295 P,1995-09-29,Use of heparinase to decrease inflammatory responses,"Heparinase enzymes can be used as a medical treatment to reduce localized inflammatory responses. Treatment of activated endothelium with heparinase inhibits leukocyte rolling, adhesion and extravasation. Most of the heparin and heparan sulfate on endothelial cell surfaces and in basement membranes is degraded by exposure to heparinase. In addition, immobilized chemokines, which are attached to heparin/heparan sulfate on activated endothelium are solubilized by heparinase digestion. Heparinase can be infused into the vascular system to inhibit accumulation of leukocytes in inflamed tissue and decrease damage resulting from localized inflammations. Targeting of heparinase to activated endothelium can be accomplished through localized administration and/or use of genetically engineered heparinase containing endothelium ligand-binding domains.",BIOMARIN PHARM INC,BENNETT D C;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMANN JOSEPH,,https://lens.org/044-423-278-391-036,Patent Application,yes,1,14,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K9/14;;A61K38/00;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,424/94.61,0,0,,,,DISCONTINUED
234,US,A1,US 2001/0006635 A1,022-116-338-701-326,2001-07-05,2001,US 72265996 A,1996-09-27,US 72265996 A;;US 462295 P,1995-09-29,USE OF HEPARINASE TO DECREASE INFLAMMATORY RESPONSES,"
   Heparinase enzymes can be used as a medical treatment to reduce localized inflammatory responses. Treatment of activated endothelium with heparinase inhibits leukocyte rolling, adhesion and extravasation. Most of the heparin and heparan sulfate on endothelial cell surfaces and in basement membranes is degraded by exposure to heparinase. In addition, immobilized chemokines, which are attached to heparin/heparan sulfate on activated endothelium are solubilized by heparinase digestion. Heparinase can be infused into the vascular system to inhibit accumulation of leukocytes in inflamed tissue and decrease damage resulting from localized inflammations. Targeting of heparinase to activated endothelium can be accomplished through localized administration and/or use of genetically engineered heparinase containing endothelium ligand-binding domains. 
",BENNETT D. CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMANN JOSEPH,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMANN JOSEPH,BIOMARIN PHARMACEUTICALS INC (2003-08-07),https://lens.org/022-116-338-701-326,Patent Application,yes,0,37,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K38/00;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,424/94.1;;424/85.1;;424/130.1;;424/192.1,0,0,,,,DISCONTINUED
235,US,A1,US 2003/0055186 A1,159-911-676-369-064,2003-03-20,2003,US 82446101 A,2001-04-02,US 82446101 A;;US 27709599 A;;US 7973398 P,1998-03-27,Polymers of substituted cyclopentenes,"
   Substituted cyclopentenes, such as alkyl cyclopentenes, are polymerized by selected -imine complexes of nickel and palladium. The polymers are useful as molding resins or elastomers. Also disclosed herein are novel catalysts for the polymerization of cyclopentenes to form novel higher melting homopolycyclopentenes. 
",MCLAIN STEPHAN J.;;MCCORD ELIZABETH F.;;BENNETT ALISON M.;;ITTEL STEVEN D.;;TEASLEY MARK F.,MCLAIN STEPHAN J;;MCCORD ELIZABETH F;;BENNETT ALISON M;;ITTEL STEVEN D;;TEASLEY MARK F,,https://lens.org/159-911-676-369-064,Patent Application,yes,0,0,7,7,0,C07F15/045;;C08F32/04;;C08F132/04;;C08F32/04;;C07F15/045;;C08F132/04,C07F15/04;;C08F32/04;;C08F132/04,526/172;;526/308;;556/32;;556/33;;556/34,0,0,,,,EXPIRED
236,TW,A,TW 200820969 A,003-884-770-874-229,2008-05-16,2008,TW 96134363 A,2007-09-14,US 84480906 P,2006-09-15,Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism,"Disclosed are compounds of the formula wherein Z1 is -CH2- or-C(O)-, R4 and R5 are carbon chains (and optionally, together can form a C2 bridge), u and v are independently an integer of 0-3 such that there sum is from 3 to 5, and R2 is heteroaryl, and R1 and R3 are as defined herein. Also disclosed are methods of treating pain using a compound of formula I.",SCHERING CORP,MCKITTRICK BRIAN A;;SMITH ELIZABETH M;;BENNETT CHAD E;;BURNETT DUANE A;;KNUTSON CHAD E,,https://lens.org/003-884-770-874-229,Patent of Addition,no,0,0,9,9,0,C07D471/10;;C07D487/10;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/06;;A61P43/00;;C07D471/10;;C07D487/10,A61K31/438;;A61K31/397;;A61P25/02;;A61P29/00;;C07D471/10;;C07D487/10,,0,0,,,,PENDING
237,AU,A,AU 1994/054074 A,097-445-661-901-748,1995-03-27,1995,AU 1994/054074 A,1993-10-19,US 11837293 A;;US 9309985 W,1993-09-08,Gasket material for use in plate and frame apparatus and method for making and using same,,GORE & ASS,HAMILTON ELIZABETH MARIE;;LALLI ERIC WILLIAM;;LUBIN CINDY BENNETT;;SPARKS WANDA FAYE;;WATERLAND ALFRED FITZGERALD,,https://lens.org/097-445-661-901-748,Patent Application,no,0,0,5,5,0,B29C53/58;;B29C55/005;;B29C63/08;;B29K2027/18;;B29L2031/26;;F28F3/10;;F16J15/104,B29C53/58;;B29C55/00;;B29C63/08;;B32B37/00;;F16J15/10;;F28F3/10,,0,0,,,,PENDING
238,AU,B2,AU 703394 B2,105-918-786-680-18X,1999-03-25,1999,AU 1996/073791 A,1996-09-27,US 462295 P;;US 9615593 W;;US 72265996 A,1995-09-29,Use of heparinases to decrease inflammatory responses,,IBEX TECHNOLOGIES,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,BIOMARIN PHARMACEUTICALS INC. (2004-03-25),https://lens.org/105-918-786-680-18X,Granted Patent,no,0,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,EXPIRED
239,EP,A4,EP 0852491 A4,148-091-949-599-587,2002-08-07,2002,EP 96936052 A,1996-09-27,US 9615593 W;;US 462295 P;;US 72265996 A,1995-09-29,USE OF HEPARINASES TO DECREASE INFLAMMATORY RESPONSES,,IBEX TECHNOLOGIES,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,BIOMARIN PHARMACEUTICAL INC (2004-06-09),https://lens.org/148-091-949-599-587,Search Report,no,3,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,1,0,,,See also references of WO 9711684A1,EXPIRED
240,EP,A2,EP 1552846 A2,055-944-578-486-38X,2005-07-13,2005,EP 04076600 A,1996-09-27,EP 96936052 A;;US 462295 P;;US 72265996 A,1995-09-29,Use of heparinases to decrease inflammatory responses,"Heparinase enzymes can be used as a medical treatment to reduce localized inflammatory responses. Treatment of activated endothelium with heparinase inhibits leukocyte rolling, adhesion and extravasation. Most of the heparin and heparan sulfate on endothelial cell surfaces and in basement membranes is degraded by exposure to heparinase. In addition, immobilized chemokines, which are attached to heparin/heparan sulfate on activated endothelium are solubilized by heparinase digestion. Heparinase can be infused into the vascular system to inhibit accumulation of leukocytes in inflamed tissue and decrease damage resulting from localized inflammations. Targeting of heparinase to activated endothelium can be accomplished through localized administration and/or use of genetically engineered heparinase containing endothelium ligand-binding domains.",BIOMARIN PHARM INC,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIKQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMEMERMAN JOSEPH,,https://lens.org/055-944-578-486-38X,Patent Application,yes,0,5,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,DISCONTINUED
241,EP,A1,EP 0717820 A1,119-800-409-730-465,1996-06-26,1996,EP 93924359 A,1993-10-19,US 9309985 W;;US 11837293 A,1993-09-08,GASKET MATERIAL FOR USE IN PLATE AND FRAME APPARATUS AND METHOD FOR MAKING AND USING SAME,,GORE & ASS,HAMILTON ELIZABETH MARIE;;LALLI ERIC WILLIAM;;LUBIN CINDY BENNETT;;SPARKS WANDA FAYE;;WATERLAND ALFRED FITZGERALD,,https://lens.org/119-800-409-730-465,Patent Application,yes,0,0,5,5,0,B29C53/58;;B29C55/005;;B29C63/08;;B29K2027/18;;B29L2031/26;;F28F3/10;;F16J15/104,B29C53/58;;B29C55/00;;B29C63/08;;B32B37/00;;F16J15/10;;F28F3/10,,1,0,,,See references of WO 9507422A1,DISCONTINUED
242,EP,A1,EP 0852491 A1,148-223-562-912-809,1998-07-15,1998,EP 96936052 A,1996-09-27,US 9615593 W;;US 462295 P;;US 72265996 A,1995-09-29,USE OF HEPARINASES TO DECREASE INFLAMMATORY RESPONSES,,IBEX TECHNOLOGIES,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,BIOMARIN PHARMACEUTICAL INC (2004-06-09),https://lens.org/148-223-562-912-809,Patent Application,yes,0,5,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,EXPIRED
243,EP,B1,EP 0852491 B1,004-488-134-454-006,2004-08-11,2004,EP 96936052 A,1996-09-27,US 9615593 W;;US 462295 P;;US 72265996 A,1995-09-29,USE OF HEPARINASES TO DECREASE INFLAMMATORY RESPONSES,,BIOMARIN PHARM INC,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,BIOMARIN PHARMACEUTICAL INC (2004-06-09),https://lens.org/004-488-134-454-006,Granted Patent,yes,6,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,5,0,,,"THE JOURNAL OF IMMUNOLOGY, 01 December 1994, Vol. 153, No. 11, GILAT et al., ""Regulation of Adhesion of CD4+ T Lymphocyes to Intact or Heparinase-Treated Subendothelial Extracellular Matrix by Diffusible or Anchored RANTES and MIP-1B"", pages 4899-4906.;;BLOOD, 01 December 1993, Vol. 82, No. 11, NELSON et al., ""Heparin Oligosaccharides Bind L- and P-Selectin and Inhibit Acute Inflammation"", pages 3253-3258.;;J. EXP. MED., July 1995, Vol. 182, LUSTER et al., ""The IP-10 Chemokine Binds to a Specific Cell Surface Heparan Sulfate Site Shared with Platelet Factor 4 and Inhibits Endothelial Cell Proliferation"", pages 219-231.;;PROC. NATL. ACAD. SCI. U.S.A., April 1993, Vol. 90, SASISEKHARAN et al., ""Cloning and Expression of Heparinase I Gene from Flavobacterium Heparinum"", pages 3660-3664.;;IMMUNOLOGICAL REVIEWS, December 1992, Vol. 130, HABER, ""Engineered Antibodies as Pharmacological Tools"", pages 189-212.",EXPIRED
244,PT,E,PT 852491 E,020-487-501-912-917,2004-11-30,2004,PT 96936052 T,1996-09-27,US 462295 P;;US 9615593 W;;US 72265996 A,1995-09-29,UTILIZACAO DE HEPARINASES PARA DIMINUIR RESPOSTAS INFLAMATORIAS,,BIOMARIN PHARM INC,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,,https://lens.org/020-487-501-912-917,Granted Patent,no,0,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,EXPIRED
245,EP,B1,EP 0695405 B1,164-495-469-120-101,1997-07-30,1997,EP 93914236 A,1993-06-01,US 9305099 W;;US 5090393 A,1993-04-20,WRAPPED COMPOSITE GASKET MATERIAL,,GORE & ASS,HAMILTON ELIZABETH MARIE;;LALLI ERIC WILLIAM;;LUBIN CINDY BENNETT;;SPARKS WANDA FAYE;;WATERLAND ALFRED FITZGERALD,,https://lens.org/164-495-469-120-101,Granted Patent,yes,5,1,10,12,0,B29C53/58;;B29C53/58;;B29C55/005;;B29C55/005;;B29C55/023;;B29C55/023;;B29C63/00;;B29C63/00;;B29K2027/18;;B29K2027/18;;F28F3/10;;F28F3/10;;F16J15/022;;F16J15/022;;F16J15/104;;F16J15/104;;Y10S277/944;;Y10S277/944;;Y10S277/946;;Y10S277/946,B29C53/58;;B29C55/00;;B29C55/02;;B29C63/00;;B32B37/00;;C09K3/10;;F16J15/02;;F16J15/10;;F28F3/10,,1,0,,,"DATABASE WPI Week 8218, Derwent Publications Ltd., London, GB; AN 82-36216E & JP,A,57 051 450 (JUNKO-SHA KK) 26 March 1982",EXPIRED
246,WO,A1,WO 1997/011684 A1,161-629-074-175-513,1997-04-03,1997,US 9615593 W,1996-09-27,US 462295 P;;US 72265996 A,1995-09-29,USE OF HEPARINASES TO DECREASE INFLAMMATORY RESPONSES,"Heparinase enzymes can be used as a medical treatment to reduce localized inflammatory responses. Treatment of activated endothelium with heparinase inhibits leukocyte rolling, adhesion and extravasation. Most of the heparin and heparan sulfate on endothelial cell sufaces and in basement membranes is degraded by exposure to heparinase. In addition, immobilized chemokines, which are attached to heparin/heparan sulfate on activated endothelium are solubilized by heparinase digestion. Heparinase can be infused into the vascular system to inhibit accumulation of leukocytes in inflamed tissue and decrease damage resulting from localized inflammations. Targeting of heparinase to activated endothelium can be accomplished through localized administration and/or use of genetically engineered heparinase containing endothelium ligand-binding domains.",IBEX TECH INC;;BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,,https://lens.org/161-629-074-175-513,Patent Application,yes,3,12,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K38/00;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,6,5,109-967-138-574-422;;019-620-032-838-818;;000-248-765-965-517;;022-797-144-659-728;;002-268-743-462-346,7525718;;7694675;;10.1182/blood.v82.11.3253.3253;;7790818;;10.1084/jem.182.1.219;;pmc2192102;;8475114;;10.1073/pnas.90.8.3660;;pmc46361;;1286870;;10.1111/j.1600-065x.1992.tb01526.x,"THE JOURNAL OF IMMUNOLOGY, 01 December 1994, Vol. 153, No. 11, GILAT et al., ""Regulation of Adhesion of CD4+ T Lymphocyes to Intact or Heparinase-Treated Subendothelial Extracellular Matrix by Diffusible or Anchored RANTES and MIP-1B"", pages 4899-4906.;;BLOOD, 01 December 1993, Vol. 82, No. 11, NELSON et al., ""Heparin Oligosaccharides Bind L- and P-Selectin and Inhibit Acute Inflammation"", pages 3253-3258.;;J. EXP. MED., July 1995, Vol. 182, LUSTER et al., ""The IP-10 Chemokine Binds to a Specific Cell Surface Heparan Sulfate Site Shared with Platelet Factor 4 and Inhibits Endothelial Cell Proliferation"", pages 219-231.;;PROC. NATL. ACAD. SCI. U.S.A., April 1993, Vol. 90, SASISEKHARAN et al., ""Cloning and Expression of Heparinase I Gene from Flavobacterium Heparinum"", pages 3660-3664.;;IMMUNOLOGICAL REVIEWS, December 1992, Vol. 130, HABER, ""Engineered Antibodies as Pharmacological Tools"", pages 189-212.;;See also references of EP 0852491A4",PATENTED
247,DK,T3,DK 0852491 T3,171-979-520-743-529,2004-12-20,2004,DK 96936052 T,1996-09-27,EP 96936052 A;;US 462295 P;;US 72265996 A,1995-09-29,Anvendelse af heparinaser til at mindske inflammatoriske responser,,BIOMARIN PHARM INC,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,,https://lens.org/171-979-520-743-529,Granted Patent,no,0,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,EXPIRED
248,WO,A1,WO 1994/024467 A1,147-926-036-821-370,1994-10-27,1994,US 9305099 W,1993-06-01,US 5090393 A,1993-04-20,WRAPPED COMPOSITE GASKET MATERIAL,A composite gasket material (10) composed of a core of elongated polytetrafluoroethylene (11) wrapped with a high strength porous expanded polytetrafluoroethylene film (12) is provided. The composite gasket material exhibits increased resistance to creep while in use so that thickness of the composite gasket material and thus gasket stress is maintained.,GORE & ASS,HAMILTON ELIZABETH MARIE;;LALLI ERIC WILLIAM;;LUBIN CINDY BENNETT;;SPARKS WANDA FAYE;;WATERLAND ALFRED FITZGERALD,,https://lens.org/147-926-036-821-370,Patent Application,yes,5,214,10,12,0,B29C53/58;;B29C53/58;;B29C55/005;;B29C55/005;;B29C55/023;;B29C55/023;;B29C63/00;;B29C63/00;;B29K2027/18;;B29K2027/18;;F28F3/10;;F28F3/10;;F16J15/022;;F16J15/022;;F16J15/104;;F16J15/104;;Y10S277/944;;Y10S277/944;;Y10S277/946;;Y10S277/946,B29C53/58;;B29C55/00;;B29C55/02;;B29C63/00;;B32B37/00;;C09K3/10;;F16J15/02;;F16J15/10;;F28F3/10,,2,0,,,"DATABASE WPI Week 8218, Derwent World Patents Index; AN 82-36216E;;See also references of EP 0695405A1",PATENTED
249,US,A1,US 2008/0070888 A1,001-987-845-796-835,2008-03-20,2008,US 85462007 A,2007-09-13,US 85462007 A;;US 84480906 P,2006-09-15,AZETIDINE AND AZETIDONE DERIVATIVES USEFUL IN TREATING PAIN AND DISORDERS OF LIPID METABOLISM,"Disclosed are compounds of the formula wherein Z 1 is —CH 2 — or —C(O)—, R 4 and R 5 are carbon chains (and optionally, together can form a C 2 bridge), u and v are independently an integer of 0-3 such that there sum is from 3 to 5, and R 2 is heteroaryl, and R 1 and R 3 are as defined herein. Also disclosed are methods of treating pain using a compound of formula I.",MCKITTRICK BRIAN A;;SMITH ELIZABETH M;;BENNETT CHAD E;;BURNETT DUANE A;;KNUTSON CHAD E,MCKITTRICK BRIAN A;;SMITH ELIZABETH M;;BENNETT CHAD E;;BURNETT DUANE A;;KNUTSON CHAD E,SCHERING CORPORATION (2007-10-30),https://lens.org/001-987-845-796-835,Patent Application,yes,0,27,9,9,0,C07D471/10;;C07D487/10;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/06;;A61P43/00;;C07D471/10;;C07D487/10,A61K31/438;;A61K31/397;;A61K31/506;;A61P25/04;;C07D239/42;;C07D471/10,514/210.02;;514/275;;514/278;;540/200;;544/230;;546/16,0,0,,,,DISCONTINUED
250,EP,A3,EP 1552846 A3,054-271-745-068-020,2008-05-07,2008,EP 04076600 A,1996-09-27,EP 96936052 A;;US 462295 P;;US 72265996 A,1995-09-29,Use of heparinases to decrease inflammatory responses,"Heparinase enzymes can be used as a medical treatment to reduce localized inflammatory responses. Treatment of activated endothelium with heparinase inhibits leukocyte rolling, adhesion and extravasation. Most of the heparin and heparan sulfate on endothelial cell surfaces and in basement membranes is degraded by exposure to heparinase. In addition, immobilized chemokines, which are attached to heparin/heparan sulfate on activated endothelium are solubilized by heparinase digestion. Heparinase can be infused into the vascular system to inhibit accumulation of leukocytes in inflamed tissue and decrease damage resulting from localized inflammations. Targeting of heparinase to activated endothelium can be accomplished through localized administration and/or use of genetically engineered heparinase containing endothelium ligand-binding domains.",BIOMARIN PHARM INC,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIKQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMEMERMAN JOSEPH,,https://lens.org/054-271-745-068-020,Search Report,yes,4,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K38/47;;A61K9/14;;A61K31/00;;A61K38/46;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,DISCONTINUED
251,AU,A,AU 1996/073791 A,041-356-927-214-704,1997-04-17,1997,AU 1996/073791 A,1996-09-27,US 462295 P;;US 9615593 W;;US 72265996 A,1995-09-29,Use of heparinases to decrease inflammatory responses,,BIOMARIN PHARM INC,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMAN JOSEPH,BIOMARIN PHARMACEUTICALS INC. (2004-03-25),https://lens.org/041-356-927-214-704,Patent Application,no,0,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,,0,0,,,,EXPIRED
252,EP,A1,EP 0695405 A1,149-203-457-246-267,1996-02-07,1996,EP 93914236 A,1993-06-01,US 9305099 W;;US 5090393 A,1993-04-20,WRAPPED COMPOSITE GASKET MATERIAL,,GORE & ASS,HAMILTON ELIZABETH MARIE;;LALLI ERIC WILLIAM;;LUBIN CINDY BENNETT;;SPARKS WANDA FAYE;;WATERLAND ALFRED FITZGERALD,,https://lens.org/149-203-457-246-267,Patent Application,yes,0,0,10,12,0,B29C53/58;;B29C53/58;;B29C55/005;;B29C55/005;;B29C55/023;;B29C55/023;;B29C63/00;;B29C63/00;;B29K2027/18;;B29K2027/18;;F28F3/10;;F28F3/10;;F16J15/022;;F16J15/022;;F16J15/104;;F16J15/104;;Y10S277/944;;Y10S277/944;;Y10S277/946;;Y10S277/946,B29C53/58;;B29C55/00;;B29C55/02;;B29C63/00;;B32B37/00;;C09K3/10;;F16J15/02;;F16J15/10;;F28F3/10,,6,0,,,EP-A- 0 159 942;;EP-A- 0 304 141;;WO-A-93/04227;;US-A- 4 187 390;;US-A- 4 576 861;;See also references of WO 9424467A1,EXPIRED
253,WO,A1,WO 1995/007422 A1,055-171-243-170-509,1995-03-16,1995,US 9309985 W,1993-10-19,US 11837293 A,1993-09-08,GASKET MATERIAL FOR USE IN PLATE AND FRAME APPARATUS AND METHOD FOR MAKING AND USING SAME,"Improved material and method for use in sealing plate and frame apparatus, such as a plate and frame heat exchanger, are provided. The gasket material comprises a core of elongated polytetrafluoroethylene (PTFE) contained within a tight wrap of high strength film. The gasket material has the exceptional operational properties of PTFE, while being resistant to cold flow or 'creep' which distorts most PTFE seals under heavy unconfined compression. The preferred material is pre-compressed to aid in installation.",GORE & ASS,HAMILTON ELIZABETH MARIE;;LALLI ERIC WILLIAM;;LUBIN CINDY BENNETT;;SPARKS WANDA FAYE;;WATERLAND ALFRED FITZGERALD,,https://lens.org/055-171-243-170-509,Patent Application,yes,7,3,5,5,0,B29C53/58;;B29C55/005;;B29C63/08;;B29K2027/18;;B29L2031/26;;F28F3/10;;F16J15/104,B29C53/58;;B29C55/00;;B29C63/08;;B32B37/00;;F16J15/10;;F28F3/10,,4,0,,,"PATENT ABSTRACTS OF JAPAN vol. 17, no. 172 (M - 1392) 2 April 1993 (1993-04-02);;PATENT ABSTRACTS OF JAPAN vol. 4, no. 114 (M - 026) 15 August 1980 (1980-08-15);;PATENT ABSTRACTS OF JAPAN vol. 8, no. 238 (M - 335)<1675> 31 October 1984 (1984-10-31);;PATENT ABSTRACTS OF JAPAN vol. 17, no. 447 (M - 1464) 17 August 1993 (1993-08-17)",PENDING
254,US,A,US 5175735 A,152-260-387-964-608,1992-12-29,1992,US 58976190 A,1990-09-28,US 58976190 A,1990-09-28,Method and apparatus for handling object faults in an electronic reprographic printing system,"A method and apparatus for handling software object faults in an electronic reprographic system for scanning and synchronously or asynchronously processing and printing a plurality of jobs are described. The system is monitored for the occurrence of software object faults in a job, and when such faults are identified, the operator is informed of such software object faults prior to processing of the object. The system is provided with the means to process another object without operator intervention prior to correction of the faulted object, and to proceed with processing the faulted object after correction of the fault.",XEROX CORP,DAHLBY KAREN L;;BENNETT ELIZABETH A;;GAURONSKI JOHN F;;HURTZ ROBERT W;;ROWOLD ALANE H,XEROX CORPORATION (1990-09-17),https://lens.org/152-260-387-964-608,Granted Patent,yes,8,26,3,3,0,G03G15/50;;G03G15/55;;G03G2215/00126;;G06F11/0733;;G06F11/0793;;G06F11/321;;G06F11/327;;G06F2201/865;;H04N1/00408;;H04N1/00416;;H04N1/00424;;H04N1/00432;;H04N1/00474;;H04N1/00482;;H04N1/32609;;H04N1/32625;;H04N1/32646;;H04N1/32657;;G03G15/502;;H04N1/00416;;H04N1/00482;;H04N1/32657;;H04N1/00432;;H04N1/32625;;G03G15/55;;G03G2215/00126;;G06F11/321;;H04N1/00408;;H04N1/00474;;H04N1/32609;;H04N1/32646;;G03G15/50;;G06F11/0733;;H04N1/00424;;G06F2201/865;;G06F11/327;;G06F11/0793;;G03G15/502,G03G15/00;;G03G21/00;;G03G15/04;;G06F3/12;;G06F11/00;;G06F11/07;;G06F11/32;;H04N1/00;;H04N1/32,371/16.4;;355/205;;395/575,0,0,,,,EXPIRED
255,CA,C,CA 2157283 C,101-956-030-553-270,2001-08-14,2001,CA 2157283 A,1993-06-01,US 5090393 A;;US 9305099 W,1993-04-20,WRAPPED COMPOSITE GASKET MATERIAL,A composite gasket material (10) composed of a core elongated polytetrafluoroethylene (11) wrapped with a high strength porous expanded polytetrafluoroethylene film (12) is provided. The composite gasket material exhibits increased resistance to creep while in use so that thickness of the composite gasket material and thus gasket stress is maintained.,,HAMILTON ELIZABETH MARIE;;LALLI ERIC WILLIAM;;LUBIN CINDY BENNETT;;SPARKS WANDA FAYE;;WATERLAND ALFRED FITZGERALD II,,https://lens.org/101-956-030-553-270,Granted Patent,no,0,0,10,12,0,B29C53/58;;B29C53/58;;B29C55/005;;B29C55/005;;B29C55/023;;B29C55/023;;B29C63/00;;B29C63/00;;B29K2027/18;;B29K2027/18;;F28F3/10;;F28F3/10;;F16J15/022;;F16J15/022;;F16J15/104;;F16J15/104;;Y10S277/944;;Y10S277/944;;Y10S277/946;;Y10S277/946,B29C53/58;;B29C55/00;;B29C55/02;;B29C63/00;;B32B37/00;;C09K3/10;;F16J15/02;;F16J15/10;;F28F3/10,,0,0,,,,EXPIRED
256,US,B2,US 7264799 B2,018-472-308-133-782,2007-09-04,2007,US 35796706 A,2006-02-22,US 35796706 A;;US 11847705 A;;US 72265996 A;;US 462295 P,1995-09-29,Use of heparinases to decrease inflammatory response,"Heparinase enzymes can be used as a medical treatment to reduce localized inflammatory responses. Treatment of activated endothelium with heparinase inhibits leukocyte rolling, adhesion and extravasation. Most of the heparin and heparan sulfate on endothelial cell surfaces and in basement membranes is degraded by exposure to heparinase. In addition, immobilized chemokines, which are attached to heparin/heparan sulfate on activated endothelium are solubilized by heparinase digestion. Heparinase can be infused into the vascular system to inhibit accumulation of leukocytes in inflamed tissue and decrease damage resulting from localized inflammations. Targeting of heparinase to activated endothelium can be accomplished through localized administration and/or use of genetically engineered heparinase containing endothelium ligand-binding domains.",BIOMARIN PHARM INC,BENNETT D CLARK;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMANN JOSEPH F,,https://lens.org/018-472-308-133-782,Granted Patent,yes,11,0,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K38/51;;A61K31/00;;A61K38/46;;A61K38/47;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,424/94.5;;424/94.1;;424/810;;435/232;;514/2,68,65,061-194-023-501-854;;002-983-256-106-849;;041-415-990-766-963;;050-179-713-690-74X;;080-349-420-414-677;;047-880-230-924-852;;129-563-138-834-508;;100-286-864-518-416;;092-728-381-525-205;;045-690-938-437-881;;095-393-305-210-698;;109-315-112-329-29X;;028-261-468-768-173;;030-973-267-227-917;;036-044-766-129-950;;118-592-463-603-512;;109-892-386-570-216;;046-264-726-630-457;;023-834-271-850-775;;024-898-552-434-785;;033-886-741-336-779;;010-209-989-351-46X;;009-596-875-470-281;;032-520-841-423-308;;034-302-212-204-724;;063-401-244-265-797;;103-232-302-435-809;;107-664-672-460-651;;010-338-422-243-928;;099-565-211-180-719;;016-416-627-147-613;;019-536-149-914-368;;032-431-433-840-87X;;004-058-060-447-267;;040-370-250-368-465;;041-035-847-889-261;;088-481-971-696-075;;086-651-023-846-56X;;013-053-096-292-416;;049-870-755-210-071;;152-158-408-443-772;;001-686-516-548-17X;;024-082-155-942-24X;;078-700-664-731-12X;;027-229-686-476-148;;029-470-269-197-571;;112-565-459-197-88X;;022-797-144-659-728;;024-592-817-694-936;;000-841-437-298-038;;144-611-873-728-08X;;044-118-413-024-79X;;076-716-448-549-204;;091-540-104-771-95X;;009-236-228-647-133;;023-022-970-824-935;;041-201-705-604-807;;010-002-467-294-332;;036-513-356-056-401;;005-351-276-332-054;;146-772-036-090-891;;109-967-138-574-422;;002-268-743-462-346;;000-248-765-965-517;;019-620-032-838-818,10.1084/jem.178.1.367;;8315393;;pmc2191067;;1650230;;1327803;;10.1002/eji.1830221034;;1760836;;10.1016/0092-8674(91)90279-8;;10.1182/blood.v84.7.2068.bloodjournal8472068;;7522621;;10.1111/j.1600-065x.1990.tb00559.x;;2196221;;pmc426879;;10.1073/pnas.69.8.2110;;4559594;;1458545;;3086451;;1460288;;8429650;;10.1016/s0022-5223(19)33806-1;;pmc243699;;10.1128/aem.41.2.360-365.1981;;7235692;;10.1146/annurev.bi.55.070186.002411;;3017194;;8500276;;10.1006/clin.1993.1079;;7852412;;10.1074/jbc.270.7.3268;;6326110;;pmc345463;;10.1073/pnas.81.7.2191;;1718038;;10.1126/science.1718038;;2703527;;10.1172/jci113992;;pmc303798;;1313977;;10.1016/0952-3278(92)90226-9;;7919340;;10.1182/blood.v84.7.2229.2229;;2553811;;2551036;;10.1126/science.2551036;;pmc2289445;;10.1083/jcb.117.3.565;;1315317;;10.1016/0960-9822(93)90203-z;;15335733;;10.1182/blood.v85.12.3727.bloodjournal85123727;;7540070;;pmc303822;;2467922;;10.1172/jci114016;;3276781;;pmc2190843;;1709677;;10.1084/jem.173.6.1493;;10.1016/s0021-9258(18)35772-7;;1332952;;pmc2289934;;10.1083/jcb.115.1.223;;1717478;;10.1126/science.2452484;;2452484;;8318745;;8260704;;10.1182/blood.v82.12.3668.3668;;1381398;;8226930;;10.1016/s0021-9258(20)80470-0;;1567543;;10.1159/000420761;;8003341;;10.1165/ajrcmb.10.6.8003341;;10.1165/ajrcmb/8.1.28;;8417754;;pmc323260;;10.1073/pnas.83.7.2204;;3457383;;10.1084/jem.176.6.1739;;pmc2119476;;1460429;;1418604;;pmc266526;;3384902;;10.1128/jcm.26.5.1070-1071.1988;;7687382;;10.1126/science.7687382;;1972715;;10.1096/fasebj.6.7.1532945;;1532945;;10.1016/0167-5699(92)90039-a;;1510812;;10.1126/science.2820055;;2820055;;8475114;;10.1073/pnas.90.8.3660;;pmc46361;;2557663;;10.1093/clinids/11.supplement_7.s1532;;pmc170684;;10.1128/aem.33.2.319-322.1977;;848954;;10.1172/jci115037;;pmc296350;;1991844;;1974032;;10.1038/346425a0;;2648570;;10.1126/science.2648570;;10.1083/jcb.119.4.935;;1385447;;pmc2289699;;7678446;;10.1038/361079a0;;10.1126/science.7682337;;7682337;;10.1073/pnas.90.15.7158;;pmc47095;;8346230;;10.1172/jci116686;;pmc288254;;8104195;;10.1016/s0960-9822(00)00088-9;;7922353;;pmc2116010;;2153685;;10.1083/jcb.110.2.529;;pmc298107;;2678107;;10.1073/pnas.86.19.7571;;7525718;;1286870;;10.1111/j.1600-065x.1992.tb01526.x;;7790818;;10.1084/jem.182.1.219;;pmc2192102;;7694675;;10.1182/blood.v82.11.3253.3253,"Bargatze et al., ""Rapid G Protein-regulated Activation Event Involed in Lymphocyte Binding to Hight Endothelian Venules"" The Journal of Experimental Medicine, vol. 178, pp. 367-373 (1993).;;Bohn et al., ""Fragmentation of Heparin by Enzymes from Newly Isolated Microorganisms"" Drug Res. 41(1), Nr. 4, pp. 456-460 (1991).;;Brach et al., ""Leukotriene B<SUB>4 </SUB>Transcriptionally Activates Interleukin-6 Expression Involving NK-<SUB>chi</SUB>B and NF-IL6*"" Eur. J. Immunol., vol. 22, pp. 2705-2711, (1992).;;Butcher, ""Leukocyte-Endothelian Cell Recognition: Three (or More) Steps to Specificity and Diversity"" Cell, 67, pp. 1033-1036 (1991).;;Carlos et al., ""Leukocyte-Endothelial Adhesion Molecules"" Blood, vol. 84, No. 7, pp. 2068-2101 (1994).;;Carlos et al., ""Membrane Proteins Involved in Phagocyte Adherence to Endothelium"" Immunol. Rev., No. 114,pp. 5-28 (1990).;;Cohen et al., ""Nonchromosomal Antibiotic Resistance in Bacteria: Genetic Transformation of Escherichia coli by R-Factor DNA*"" Proc. Natl. Acad. Sci., vol. 69, No. 8, pp. 2110-2114 (1972).;;Delgado et al., ""The Uses and properties of PEG-Linked Proteins"" Critical Rev. Ther. Drug Carrier Syst. vol. 9, Nos. 3-4, pp. 249-304 (1992).;;Dustin et al., ""Induction by IL 1 and Interferon-gamma: Tissue Distribution, Biochemistry, and Function of a Natural Adherence Molecule (ICAM-1)<SUP>1</SUP>"" J. Immunol., vol. 137, No. 1, pp. 245-254 (1986).;;Ebisawa et al., ""Eosinophil Transendothelial Migration Induced by Cytokines"" J. Immunol., vol. 149, No. 12, pp. 4021-4028 (1992).;;Finn et al., ""Interleukin-8 Release and Neutrophil Degranulation After Pediatric Cardiopulmonary Bypass"" J. Thorac. J. Surg., vol. 105, No. 2, pp. 234-241 (1993).;;Galliher et al., ""Heparinase Production by Flavobacterium Hepanium"" Appl. Environ. Microbiol., vol. 41, No. 2, pp. 360-365 (1981).;;Hanahan et al., ""Platelet Activating Factor: A Biologically Active Phosphoglyceride"" Ann. Rev. Biochem., vol. 55, pp. 283-509, (1986).;;Harlan, ""Leukocyte Adhesion Deficiency Syndrome: Insights into the Molecular Basis of Leukocyte Emigration"" Clin. Immunol. Immunopath., vol. 67, No. 3, pp. S16-S24, (1993).;;Hoogewerf et al., ""CXC Chemokines Connective Tissue Activating Peptide-III and Neutrophil Activating Peptide-2 are Heparin/Heparan Sulfate-degrading Enxymes*"" J. Biol. Chem., vol. 270, No. 7, pp. 3268-3277 (1995).;;Hoover et al., ""Leukotriene B<SUB>4 </SUB>Action on Endothelium Mediates Augmented Neutrophil/Endothelial Adhesion"" Proc. Natl. Acad. Sci. USA, vol. 81, pp. 2191-2193 (1984).;;Huber et al., ""Regulation of Transendothelial Neutrophil Migration by Endogenous Interleukin-8"" Science, vol. 254, pp. 99-102 (1991).;;Huber et al., ""Disruption of the Subendothelial Basement Membrane During Neutrophil Diapedesis in an In Vitro Construct of a Blood Vessel Wall"" J. Clin. Invest., vol. 83, pp. 1122-1136 (1989).;;Hughes et al., ""Role of Leukotriene B<SUB>4 </SUB>in the Pathogenesis of Hepatic Ischemia-Reperfusion Injury in the Rat"" Prost. Leuk. Essent. F. A., vol. 45, pp. 113-119 (1992).;;Jeannin et al., ""Histamine Induces Interleukin-8 Secretion by Endothelial Cells"" Blood, vol. 84, No. 7, pp. 2229-2233 (1994).;;Jutila et al., ""Function and Regulation of the Neutrophil Mel-14 Antigen in Vivo: Comparison With LFA-1 and MAC-1<SUP>1</SUP>"" J. Immunol., vol. 143, No. 10, pp. 3318-3324 (1989).;;Kishimoto et al., ""Neutrophil Mac-1 and MEL-14 Adhesion Proteins Inversely Regulated by Chemotactic Factors"" Science, vol. 245, vol. 1238-124 (1989).;;Kuijpers et al., ""Neutropil Migration Across Monolayers of Cytokine-Prestimulated Endothelial Cells: A Role for Platelet-Activating Factor and IL-8"" J. Cell Biol., vol. 117, No. 3, pp. 565-572 (1992).;;Lasky, ""Combinatorial Mediators of Inflammation?"" Current Biol., vol. 3, No. 6, pp. 366-368 (1993).;;Ley, et al., ""Sialylated O-Glycans and L-Selectin Sequentially Mediate Myeloid Cell Rolling In Vivo"" Blood, vol. 85, No. 12, pp. 3727-3735 (1995).;;Lindemann, et al., ""Granulocyte-Macrophage Colony-Stimulating Factor Induces Cytokine Secretion by Human Polymorphonuclear Leukocytes"" J. Clin. Invest., vol. 83, pp. 1308-1312 (1989).;;Lindemann et al., ""Granulocyte-Macrophage Colny-Stimulating Factor Induces Interleukin 1 Production by Human Polymorphonuclear Neutrophils<SUP>1</SUP>"" J. Immunol., vol. 140, No. 3, pp. 837-839 (1988).;;Lo et al. ""Endothelial-Leukocyte Adhesion Molecule 1 Stimulates the Adhesive Activity of Leukocyte Integrin CR3 (CD11b/CD18, Mac-1, alpha<SUB>m</SUB>beta<SUB>2</SUB>)"" J. Exp. Med., vol. 173, pp. 1493-1500 (1991).;;Lohse et al., ""Purification and Characterization of Heparin Lyases from Flavobacterium heparinum*"" J. Biol. Chem., vol. 267, No. 34, pp. 24347-24355 (1992).;;Lorant et al., ""Coexpression of GMP-140 and PAF by Endothelium Stimulated by Histamine or Thrombin: A Juxtacrine System for Adhesion and Activation of Neutrophils"" J. Biol. Chem., vol. 115, No. 1, pp. 223-234 (1991).;;Lowell, et al., ""Proteosome-Lipopeptide Vaccines: Enhancement of Immunogenicity for Malaria CS Peptides"" Science, vol. 240, pp. 800-802 (1988).;;Lu, et al., ""Pegylated Peptides I: Solid-Phase Synthesis of N<SUP>alpha</SUP>-Pegylated Peptides Using Fmoc Strategy"" Pept. Res. Vo. 6, No. 3, 140-146 (1993).;;Lukacs, et al., ""Interleukin-1 Receptor Antagonist Blocks Chemokine Production in the Mixed Lymphocyte Reaction"" Blood, vol. 82, No. 12, pp. 3668-3674 (1993).;;Luscinaskas et al., ""Inn Vitro Inhibitory Effect of IL-8 and Other Chemoattractants on Neutrophil-Endothelial Adhesive Interactions<SUP>1</SUP>"" J. Immunol., vol. 149, No. 6, pp. 2163-2171 (1992).;;Maccarana, et al., ""Minimal Sequence in Heparin/Heparan Sulfate Required for Binding of Basic Fibroblast Growth Factor*"" J. Biol. Chem., vol. 268, No. 32, pp. 23898-23905 (1993).;;Matsushima, et al., ""Interleukin-8 and MCAF: Nevel Leukocyte Recruitment and Activating Cytokines"" Interleukins: Molec. Biol. Immunol., ed. Kistimoto, Karger, Basel, vol. 51pp. 236-265 (1992).;;McCain, et al., ""Leukotriene B<SUB>4 </SUB>Stimulates Human Polymorphonuclear Leukocytes to Synthesize and Release Interleukin-8 In Vitro"" Am. J. Respir. Cell Molec. Biol., vol. 10, pp. 651-657 (1994).;;McCain, et al., ""Granulocyte/Macrophage Colony-Stimulating Factor Stimulates Human Polymorphonuclear Leukocytes to Produce Interleukin-8 In Vitro"" Am. J. Respir. Cell Molec. Biol., vol. 8, pp. 28-34 (1993).;;McIntyre, et al., ""Leukotrienes C<SUB>4 </SUB>and D<SUB>4 </SUB>Stimulate Human Endothelial Cells to Synthesize Platelet-Activating Factor and Bind Neutrophils"" Proc. Natl. Acad. Sci. USA, vol. 83, pp. 2204-2208 (1986).;;Miller et al., ""Vaccination of Rhesus Monkeys with Synthetic Peptide in a Fusogenic Proteoliposome Elicits Simian Immunodeficiency Virus-Specific CD8<SUP>+ </SUP>Cytotoxic T Lymphocytes"" J. Exp. Med., vol. 176, pp. 1739-1744 (1992).;;Miller, et al., ""Bio9logy and Biochemistry of the Chemokines: A Family of Chemotactic and Inflammatory Cytokines"" Crit. Rev. Immunol., vol. 12, Nos. 1-2, pp. 17-46 (1992).;;Nakamura, et al., ""Purification and Properties of Bacteroides Heparinolyticus Heparinase (Heparin Lyase, EC 4.2.2.7)"" J. Clin. Microbiol. vol. 26, No. 5, pp. 1070-1071 (1988).;;Norgard-Sumnicht et al., ""Calcium-Dependent Heparin-Like Ligands for L-Selectin in Nonlymphoid Endothelial Cells"" Science, vol. 261, pp. 480-483 (1993).;;Oppenheimer-Marks, et al., ""Human T Lymphocyte Adhesion to Endothelial Cells and Transendothelial Migration"" J. Immunol., vol. 145, No. 1, pp. 140-148 (1990).;;Porat, et al., ""Interleukin-1 (IL-1) Receptor Blockade Reduces Endotoxin and Borrelia Burgdorferi-Stimulated IL-8 Synthesis in Human Mononuclear Cells"" FASEB J., vol. 6, pp. 2482-2486 (1992);;Rot, ""Endothelial Cell Binding of NAP-1/IL-8: Role in Neutrophil Emigration"" Immunol. Today, vol. 13, No. 8m pp. 291-294 (1992).;;Samuelsson, et al., ""Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects"" Science, vol. 237, pp. 1171-1176 (1987).;;Sasisekharan, et al., ""Cloning and Expression of Heparinase I Gene From Flavobacterium Heparinum"" Proc. Natl. Acad. Sci. USA, vol. 90, pp. 3660-3664 (1993).;;Sawyer, et al., Polymorphonuclear Neutrophils: An Effective Antimicrobial Force Rev. Infect. Dis., vol. 11, Suppl. 7, pp. S1532-1544 (1989).;;Saylers, et al., ""Fermentation of Mucin and Plant Polysaccharides by Strains of Bacteroids from the Human Colon"" Appl. Environ. Microbiol., vol. 33, No. 2, pp. 319-322 (1977).;;Smith, et al., ""Chemotactic Factors Regulate Lectin Adhesion Molecule 1 (LECAM-1)-Dependent Neutrophil Adhesion to Cytokine-Stimulated Endothelial Cells In Vitro"" Clin. Invest., vol. 87, pp. 609-618 (1991).;;Springer, ""Adhesion Receptors of the Immune System"" Nature, vol. 346, pp. 425-434 (1990).;;Strieter, et al., ""Endothelial Cell Gene Expression of a Neutrophil Chemotactic Factor by TNF-alpha, LPS, and IL-1beta"" Science, vol. 243, pp. 1467-1469 (1989).;;Sugama et al., ""Thrombin-Induced Expression of Endothelial P-Selectin and Intercullular Adhesion Molecule-1: A Mechanism for Stabilizing Neutrophil Adhesion"" J. Cell Biol., vol. 119, No. 4, pp. 935-944 (1992).;;Tanaka, et al., ""T-Cell Adhesion Induced by Proteoglycan-Immobilized Cytokine MIP-1beta"" Nature, vol. 361, pp. 79-82 (1993).;;Taub, et al., ""Preferential Migration of Activated CD4<SUP>+</SUP> and CD8<SUP>+</SUP> T Cells in Response to MIP-1alpha and MIP-1beta"" Science, vol. 260, pp. 355-358 (1993).;;Webb et al., ""Binding to Heparan Sulfate or Heparin enhances Neutrophil Responses to Interleukin 8"" Proc. Natl. Acad. Sci. USA, vol. 90, pp. 7158-7162 (1993).;;Winn et al., ""CD18-Independent Neutrophil and Mononuclear Leukocyte Emigration Into the Peritoneum of Rabbits"" J. Clin. Invest., vol. 92, pp. 1168-1173(1993).;;Witt et al., ""Differential Binding of Chemokines to Glycosaminoglycan Subpopulations"" Curr. Biol., vol. 4, No. 5, pp. 394-400 (1994).;;Yoshida, et al., 10th Annual Symposium of Glycoconjugates, Jerusalem (1989).;;Zimmerman, et al., ""Endothelial Cell-Associated Platelet-Activating Factor: A Novel Mechanism for Signaling Intercellular Adhesion"" J. Cell Biol. vol. 110, pp. 529-540 (1990).;;Zimmerman et al., ""Leukocyte-Endothelial Cell Interactions"" Immunol. Today, vol. 13 (1992).;;Zucker, et al., ""Immunoregulatory Activity of Peptides Related to Platelet Factor 4"" Proc. Natl. Acad. Sci. USA, vol. 86, pp. 7571-7574 (1989).;;Gilat et al., ""Regulation of Adhesion of CD4 + T Lymphocyes to Intact or Heparinase-Treated Subendothelial Extracellular Matrix by Diffusible or Anchored RANTES and MIP-1B,"" J. Immun., 153(11):4899-4906 (1994).;;Haber, ""Engineered Antibodies as Pharmacological Tools,"" Immun. Rev., 130:189-212 (1992).;;Luster et al., ""The IP-10 Chemoklne Binds to a Specific Cell Surface Heparan Sulfate Site Shared with Platelet Factor 4 and Inhibits Endothelial Cell Proliferation,"" J. Exp. Med., 182:219-231 (1995).;;Nelson et al., ""Heparin Oligosaccharides Bind L- and P- Selection and Inhibit Acute Inflammation,"" Blood, 82(11):3253-3258 (1993).;;International Search Report for International Application No. PCT/US96/15593, dated Jan. 21, 1997.",EXPIRED
257,US,A1,US 2004/0254137 A1,072-771-159-201-371,2004-12-16,2004,US 69556803 A,2003-10-27,US 69556803 A;;US 66626900 A,2000-09-20,Antisense modulation of FLIP-c expression,"
   Antisense compounds, compositions and methods are provided for modulating the expression of FLIP-c. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding FLIP-c. Methods of using these compounds for modulation of FLIP-c expression and for treatment of diseases associated with expression of FLIP-c are provided. 
",ACKERMANN ELIZABETH J.;;BENNETT C. FRANK;;ZHANG HONG;;WATT ANDREW T.;;RICKETTS WILLIAM;;DEAN NICHOLAS M.,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;ZHANG HONG;;WATT ANDREW T;;RICKETTS WILLIAM;;DEAN NICHOLAS M,,https://lens.org/072-771-159-201-371,Patent Application,yes,3,114,5,286,133,A61K38/00;;A61K48/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P31/12;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;A61K48/00;;C12N2310/315;;C12N2310/3341;;C12N2310/321;;C12N2310/346;;A61K38/00;;C12N2310/341;;Y02P20/582,C12N15/09;;A61K9/10;;A61K31/7088;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P31/12;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,514/44;;536/23.1,0,0,,,,DISCONTINUED
258,WO,A1,WO 2002/024717 A1,013-823-821-972-341,2002-03-28,2002,US 0128732 W,2001-09-14,US 66626900 A,2000-09-20,ANTISENSE MODULATION OF FLIP-C EXPRESSION,"Antisense compounds, compositions and methods are provided for modulating the expression of FLIP-c. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding FLIP-c. Methods of using these compounds for modulation of FLIP-c expression and for treatment of diseases associated with expression of FLIP-c are provided.",ISIS PHARMACEUTICALS INC;;ACKERMANN ELIZABETH J;;BENNETT C FRANK;;ZHANG HONG;;WATT ANDREW T;;RICKETTS WILLIAM;;DEAN NICHOLAS M,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;ZHANG HONG;;WATT ANDREW T;;RICKETTS WILLIAM;;DEAN NICHOLAS M,,https://lens.org/013-823-821-972-341,Patent Application,yes,0,3,5,286,0,A61K38/00;;A61K48/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P31/12;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;A61K48/00;;C12N2310/315;;C12N2310/3341;;C12N2310/321;;C12N2310/346;;A61K38/00;;C12N2310/341;;Y02P20/582,C12N15/09;;A61K9/10;;A61K31/7088;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P31/12;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,,2,2,052-978-684-789-970;;009-799-729-000-329,10.4049/jimmunol.164.10.5459;;10799913;;10.4049/jimmunol.165.11.6262;;11086061,"NAGARAJU ET AL.: ""The inhibition of apoptosis in myositis and in normal muscle cells"", THE JOURNAL OF IMMUNOLOGY, vol. 164, no. 10, 15 May 2000 (2000-05-15), pages 5459 - 5465, XP002949032;;YOSHIKAWA ET AL.: ""Enhanced expression of fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to fas-mediated apoptosis in activated mast cells"", THE JOURNAL OF IMMUNOLOGY, vol. 165, no. 11, May 2000 (2000-05-01), pages 6262 - 6269, XP002949031",PENDING
259,EP,A1,EP 1319014 A1,157-588-059-169-42X,2003-06-18,2003,EP 01968874 A,2001-09-14,US 0128732 W;;US 66626900 A,2000-09-20,ANTISENSE MODULATION OF FLIP-C EXPRESSION,,ISIS PHARMACEUTICALS INC,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;ZHANG HONG;;WATT ANDREW T;;RICKETTS WILLIAM;;DEAN NICHOLAS M,,https://lens.org/157-588-059-169-42X,Patent Application,yes,0,0,5,286,133,A61K38/00;;A61K48/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P31/12;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;A61K48/00;;C12N2310/315;;C12N2310/3341;;C12N2310/321;;C12N2310/346;;A61K38/00;;C12N2310/341;;Y02P20/582,C12N15/09;;A61K9/10;;A61K31/7088;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P31/12;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,,0,0,,,,DISCONTINUED
260,US,A1,US 2006/0140928 A1,039-145-077-380-156,2006-06-29,2006,US 35796706 A,2006-02-22,US 35796706 A;;US 11847705 A;;US 72265996 A;;US 462295 P,1995-09-29,Use of heparinases to decrease inflammatory response,"Heparinase enzymes can be used as a medical treatment to reduce localized inflammatory responses. Treatment of activated endothelium with heparinase inhibits leukocyte rolling, adhesion and extravasation. Most of the heparin and heparan sulfate on endothelial cell surfaces and in basement membranes is degraded by exposure to heparinase. In addition, immobilized chemokines, which are attached to heparin/heparan sulfate on activated endothelium are solubilized by heparinase digestion. Heparinase can be infused into the vascular system to inhibit accumulation of leukocytes in inflamed tissue and decrease damage resulting from localized inflammations. Targeting of heparinase to activated endothelium can be accomplished through localized administration and/or use of genetically engineered heparinase containing endothelium ligand-binding domains.",BIOMARIN PHARM INC,BENNETT D C;;CAUCHON ELIZABETH;;FINK DOMINIQUE;;GROUIX BRIGETTE;;HSIA ARIANE;;DANAGHER PAMELA;;ZIMMERMANN JOSEPH F,,https://lens.org/039-145-077-380-156,Patent Application,yes,8,12,21,21,0,A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50;;A61P29/00;;A61P43/00;;A61P9/10;;A61K38/51;;C07K2319/00;;C12N9/88;;Y10S424/81;;A61K47/50,A61K38/00;;A61K9/14;;A61K38/47;;A61K31/00;;A61K38/46;;A61K39/395;;A61K45/00;;A61K47/48;;A61P9/10;;A61P29/00;;A61P43/00;;C12N9/24;;C12N9/88;;C12N9/96,424/94.61,0,0,,,,EXPIRED
261,CA,A1,CA 2157283 A1,042-374-910-351-388,1994-10-27,1994,CA 2157283 A,1993-06-01,US 5090393 A;;US 9305099 W,1993-04-20,WRAPPED COMPOSITE GASKET MATERIAL,A composite gasket material (10) composed of a core elongated polytetrafluoroethylene (11) wrapped with a high strength porous expanded polytetrafluoroethylene film (12) is provided. The composite gasket material exhibits increased resistance to creep while in use so that thickness of the composite gasket material and thus gasket stress is maintained.,GORE & ASS,HAMILTON ELIZABETH MARIE;;LALLI ERIC WILLIAM;;LUBIN CINDY BENNETT;;SPARKS WANDA FAYE;;WATERLAND ALFRED FITZGERALD II,,https://lens.org/042-374-910-351-388,Patent Application,no,0,0,10,12,0,B29C53/58;;B29C53/58;;B29C55/005;;B29C55/005;;B29C55/023;;B29C55/023;;B29C63/00;;B29C63/00;;B29K2027/18;;B29K2027/18;;F28F3/10;;F28F3/10;;F16J15/022;;F16J15/022;;F16J15/104;;F16J15/104;;Y10S277/944;;Y10S277/944;;Y10S277/946;;Y10S277/946,B29C53/58;;B29C55/00;;B29C55/02;;B29C63/00;;B32B37/00;;C09K3/10;;F16J15/02;;F16J15/10;;F28F3/10,,0,0,,,,EXPIRED
262,CA,A1,CA 2169749 A1,097-904-542-506-024,1995-03-16,1995,CA 2169749 A,1993-10-19,US 11837293 A,1993-09-08,GASKET MATERIAL FOR USE IN PLATE AND FRAME APPARATUS AND METHOD FOR MAKING AND USING SAME,"Improved material and method for use in sealing plate and frame apparatus, such as a plate and frame heat exchanger, are provided. The gasket material comprises a core of elongated polytetrafluoroethylene (PTFE) contained within a tight wrap of high strength film. The gasket material has the exceptional operational properties of PTFE, while being resistant to cold flow or ""creep"" which distorts most PTFE seals under heavy unconfined compression. The preferred material is pre-compressed to aid in installation.",GORE & ASS,HAMILTON ELIZABETH MARIE;;LALLI ERIC WILLIAM;;LUBIN CINDY BENNETT;;SPARKS WANDA FAYE;;WATERLAND ALFRED FITZGERALD II,,https://lens.org/097-904-542-506-024,Patent Application,no,0,0,5,5,0,B29C53/58;;B29C55/005;;B29C63/08;;B29K2027/18;;B29L2031/26;;F28F3/10;;F16J15/104,B29C53/58;;B29C55/00;;B29C63/08;;B32B37/00;;F16J15/10;;F28F3/10,,0,0,,,,DISCONTINUED
263,AU,A,AU 2001/089085 A,078-591-099-276-266,2002-04-02,2002,AU 2001/089085 A,2001-09-14,US 66626900 A;;US 0128732 W,2000-09-20,Antisense modulation of flip-c expression,,ISIS PHARMACEUTICALS INC,ACKERMANN ELIZABETH J;;BENNETT C FRANK;;ZHANG HONG;;WATT ANDREW T;;RICKETTS WILLIAM;;DEAN NICHOLAS M,,https://lens.org/078-591-099-276-266,Patent Application,no,0,0,5,286,0,A61K38/00;;A61K48/00;;C12N15/113;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;A61P31/12;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113;;A61K48/00;;C12N2310/315;;C12N2310/3341;;C12N2310/321;;C12N2310/346;;A61K38/00;;C12N2310/341;;Y02P20/582,C12N15/09;;A61K9/10;;A61K31/7088;;A61K31/7115;;A61K31/712;;A61K31/7125;;A61K38/00;;A61K48/00;;A61P31/12;;A61P35/00;;A61P37/02;;A61P43/00;;C12N15/113,,0,0,,,,PENDING
264,US,B2,US 8357679 B2,033-989-958-841-612,2013-01-22,2013,US 46513409 A,2009-05-13,US 46513409 A;;EP 08156246 A;;US 5345408 P,2008-05-15,Hexafluoroisopropanol derivatives,The present invention relates to hexafluoroisopropanol derivatives having the general formula I to pharmaceutical compositions comprising the same and to the use of these hexafluoroisopropanol derivatives in the treatment of atherosclerosis.,MSD OSS BV;;COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;CARSWELL EMMA LOUISE,COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;CARSWELL EMMA LOUISE,ORGANON BIOSCIENCES NEDERLAND B.V (2013-01-01);;MERCK SHARP & DOHME B.V (2013-01-02);;MSD OSS B.V (2011-10-31),https://lens.org/033-989-958-841-612,Granted Patent,yes,10,9,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,A61K31/50;;A01N43/54;;A61K31/4965;;A61K31/497;;A61K31/51;;A61K31/55;;C07D239/02;;C07D241/04;;C07D243/00;;C07D295/00;;C07D403/00,514/218;;514/252.01;;514/252.12;;514/255.01;;514/255.02;;514/275;;540/492;;544/238;;544/332;;544/384;;544/389;;544/399;;544/400,7,4,145-412-346-561-999;;002-813-777-548-894;;044-992-436-914-577;;039-812-740-681-825,10.1517/13543776.16.12.1673;;10.1161/01.atv.0000150044.84012.68;;15539622;;10.1038/nm820;;12524534;;12697904;;10.1073/pnas.0830671100;;pmc154360,"International Search Report (PCT/EP2009/055790) mail date Aug. 11, 2009, 3 pages.;;Written Opinion (PCT/EP2009/055790) mail date Aug. 11, 2009, 5 pages.;;Bennett, et. al.; ""An update on non-steroidal liver X receptor agaonists and their potential use in the treatment of atherosclerosis""; Expert Opinion On Therapeutic Patents, vol. 16; No. 12; 2006; pp. 1673-1699.;;Levin, Nancy, et. al.; "" Macrophage Liver X Receptor is Required for Antiatherogenic Activity of LXR Agonists""; Arterioscler Thromb Vasc Biol; Jan. 2005; pp. 135-142.;;Joseph, Sean B.; et. al.; ""Reciprocal regulation of inflammation and lipid metabolism by liver X receptors"", Nature Medicine, vol. 9, No. 2; pp. 213-219, (2003).;;Laffitte, Bryan A, et. al. ""Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue"", Proceedings Natl Acad Sci, vol. 100, No. 9, pp. 5419-5424, (2003).;;International Search Report (PCT/EP2010/066157) mail date Mar. 2, 2011, 2 pages.",ACTIVE
265,AR,A1,AR 071799 A1,125-520-324-376-058,2010-07-14,2010,AR P090101750 A,2009-05-15,EP 08156246 A,2008-05-15,DERIVADOS DE HEXAFLUOROISOPROPANOL,"Composiciones farmaceuticas que la comprenden y al uso de esos derivados de hexafluoroisopropanol en el tratamiento de la ateroesclerosis y trastornos relacionados. Reivindicacion 1: Un derivado de hexafluoroisopropanol que tiene la formula general (1)caracterizado porque B representa un anillo arom tico de cinco o seis miembros, que est  sustituido en un  tomo de carbono por una parte hexafluoroisopropanol, y el anillo comprende, opcionalmente, uno o dos nitrogenos, azufre u ox¡geno; n es 1 o 2; Z es CH2 o CO; Y es CO, SO2, CHz o un enlace; y puede ser un patron de sustitucion de meta o para; A es un anillo arom tico de 6 miembros que contiene opcionalmente 1 o 2  tomos de nitrogeno; X es NR4, O o un enlace; W es NH, O o CH2, R1 es alquilo C1-8, cicloalquilo C3-8 o cicloalquil C3-8-alquilo C1-4, cada uno de los grupos alquilo est  opcionalmente sustituido por hidroxilo, hidroximetilo, alquiloxi C1-3), ciano, halogeno, CF3, NR7R8, NR7R8CO o R9OCO; o R1 es un anillo arom tico de 5 o 6 miembros que comprende, opcionalmente, de 1 a 3 hetero tomos seleccionados entre O, S y N, el anillo est  opcionalmente sustituido por alquilo C1-3, cicloalquilo C3-6, alquiloxi C1-3, alquilsulfonilo C1-3, ciano, CF3, OCF3, halogeno o R9OCO, y el anillo est  opcionalmente unido a X mediante un grupo alquileno C1-3 que est  opcionalmente sustituido por hidroxilo; o R1 es un anillo heteroc¡clico de 5 o 6 miembros saturado o insaturado, que comprende 1 o 2 hetero tomos seleccionados entre NR10, O, S, SO y SO2, el anillo est  opcionalmente sustituido por alquilo C1-3, hidroxilo, oxo, NR11R12CH2 o R9OCO, y el anillo est  opcionalmente unido a X mediante un grupo alquileno C1-3 que est  opcionalmente sustituido por hidroxilo; o cuando X es NR4, R1 puede formar junto con R4 y N al que est n unidos un anillo de 4 a 8 miembros, que puede estar opcionalmente sustituido por hidroxilo o hidroximetilo; R2 representa opcionalmente de 1 a 3 sustituyentes seleccionados independientemente entre alquilo C1-4, alquiloxi C1-4, CF3, OCF3 y halogeno; R3 representa opcionalmente de 1 a 4 sustituyentes seleccionados independientemente entre alquilo C1-4, y alquilo C1-4 sustituido por OH o 1 o m s halogenos; o R3 representa oxo o COOR5; R4, cuando est  presente es H o alquilo C1-3; R5, cuando est  presente es H o alquilo C1-3, R6, cuando est  presente es H o alquilo C1-3; R7 y R8, cuando est n presentes son independientemente H, alquilo C1-3 o cicloalquilo C3-5; R9, cuando est  presente es H, alquilo C1-3 o cicloalquil C3-5-alquilo C1-3; R10 cuando est  presente es H, alquilo C1-3 o alquilo C1-3-CO; R11 y R12 cuando est n presentes son independientemente H o alquilo C1-3; o una de sus sales farmaceuticamente aceptable.",ORGANON NV,NIMZ O;;BENNETT D J;;COOKE A J;;EDWARDS A S;;ANDREWS FIONA ELIZABETH;;CARSWELL EMMA LOUISE,,https://lens.org/125-520-324-376-058,Patent Application,no,0,0,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,,,0,0,,,,PENDING
266,CA,C,CA 2723826 C,132-864-822-969-836,2016-08-16,2016,CA 2723826 A,2009-05-14,EP 08156246 A;;EP 2009055790 W,2008-05-15,"N-(1, 1, 1, 3, 3, 3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL) BENZYL-N'-ARYLCARBONYLPIPERAZINE DERIVATIVES",The present invention relates tohexafluoroisopropanol derivativeshaving the general formula I X O N N Y OH F 3 C CF 3 A R 1 R 2 R 3 () n W Z B R 6 5 Formula I to pharmaceutical compositions comprising the same and to the use of these hexafluoroisopropanol derivatives inthe treatment of atherosclerosis,N V ORGANON,COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;CARSWELL EMMA LOUISE,,https://lens.org/132-864-822-969-836,Granted Patent,no,0,0,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,C07D243/08;;A61K31/551;;A61P9/10;;C07D295/192,,0,0,,,,INACTIVE
267,AU,A1,AU 2009/248058 A1,020-727-921-721-666,2009-11-19,2009,AU 2009/248058 A,2009-05-14,EP 08156246 A;;EP 2009055790 W,2008-05-15,"N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives",,ORGANON NV,ANDREWS FIONA ELIZABETH;;NIMZ OLAF;;BENNETT DAVID JONATHAN;;COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;CARSWELL EMMA LOUISE,,https://lens.org/020-727-921-721-666,Patent Application,no,0,0,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,C07D243/08;;A61K31/551;;A61P9/10;;C07D295/192,,0,0,,,,INACTIVE
268,US,A1,US 2005/0214202 A1,047-757-939-126-82X,2005-09-29,2005,US 7784905 A,2005-03-11,US 7784905 A;;US 77429804 A,2004-02-06,Control of pressurized microchannel processes,"A method of starting up and shutting down a microchannel process is provided. Included are the steps of providing a first multi-planar process unit, preferably adapted to process an endothermic reaction, a second multi-planar process unit, preferably adapted to process an exothermic reaction, providing a containment vessel, the containment vessel containing at least a portion of the first, and preferably the second, process unit. In startup, the microchannel process is first checked for pressure integrity by pressurizing and checking the important components of the process for leaks. Subsequently, the process units are heated by introducing a dilute low-thermal energy density material, preferably to the second process unit, followed by the introduction of a dilute high-thermal energy density material, and adjusting the proportion of high-thermal energy density material as required. In shutdown, a purge material from the containment vessel is introduced into the first, and preferably the second, process unit.",BATTELLE MEMORIAL INSTITUTE,WEIL CHRISTOPHER P;;LITT ROBERT D;;ROGERS W A JR;;BENNETT RICHARD K;;DE LUCIA ELIZABETH A,VELOCYS INC (2005-04-08);;BATTELLE MEMORIAL INSTITUTE (2005-04-07),https://lens.org/047-757-939-126-82X,Patent Application,yes,21,4,24,24,0,B01J2219/0081;;B01J2219/00835;;B01J2219/00867;;B01J2219/00869;;B01J2219/00873;;B01J2219/00891;;B01J2219/00963;;B01J2219/00986;;C01B3/384;;C01B2203/0227;;C01B2203/0283;;C01B2203/0811;;C01B2203/1604;;B01J3/046;;B01J2219/00817;;C10G2/00;;C10G2300/4031;;Y02P20/52;;B01J19/0093;;Y10T29/49948;;Y10T29/49345;;Y10T29/49815;;Y10T29/49826;;Y10T137/0335;;Y10T29/49948;;Y10T29/49345;;Y10T29/49815;;Y10T29/49826;;Y10T137/0335;;B01J2219/0081;;B01J2219/00835;;B01J2219/00867;;B01J2219/00869;;B01J2219/00873;;B01J2219/00891;;B01J2219/00963;;B01J2219/00986;;C01B3/384;;C01B2203/0227;;C01B2203/0283;;C01B2203/0811;;C01B2203/1604;;C10G2/00;;C10G2300/4031;;B01J3/046;;B01J2219/00817;;Y02P20/52;;B01J19/0093;;C07C1/0485;;B01J2219/00957;;B01J2219/00961;;C01B3/382;;C07C1/0475,B01J3/00;;B01J8/02;;B01J8/04;;B01J10/00;;B01J19/00;;B01J19/24;;C01B3/24;;C01B3/38;;C07C27/00,423/651;;423/650,0,0,,,,EXPIRED
269,CA,A1,CA 2723826 A1,037-011-960-663-300,2009-11-19,2009,CA 2723826 A,2009-05-14,EP 08156246 A;;EP 2009055790 W,2008-05-15,"N- (1, 1, 1, 3, 3, 3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL) BENZYL-N' -ARYLCARBONYLPIPERAZINE DERIVATIVES",101 Abstract. The present invention relates tohexafluoroisopropanol derivativeshaving the general formula I X O N N Y OH F 3 C CF 3 A R 1 R 2 R 3 ( ) n W Z B R 6 5 Formula I to pharmaceutical compositions comprising the same and to the use of these hexafluoroisopropanol derivatives inthe treatment of atherosclerosis,ORGANON NV,COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;CARSWELL EMMA LOUISE,,https://lens.org/037-011-960-663-300,Patent Application,no,0,0,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,C07D243/08;;A61K31/551;;A61P9/10;;C07D295/192,,0,0,,,,INACTIVE
270,CN,A,CN 102026986 A,004-588-240-294-040,2011-04-20,2011,CN 200980117130 A,2009-05-14,EP 2009055790 W;;EP 08156246 A,2008-05-15,Hexafluoroisopropanol derivatives,The present invention relates to hexafluoroisopropanol derivatives having the general formula I to pharmaceutical compositions comprising the same and to the use of these hexafluoroisopropanol derivatives in the treatment of atherosclerosis.,ORGANON NV,JOHN COOKE ANDREW;;STANLEY EDWARDS ANDREW;;ELIZABETH ANDREWS FIONA;;JONATHAN BENNETT DAVID;;OLAF NIMZ;;LOUISE CARSWELL EMMA,"ORGANON BIOLOGICAL NETHERLANDS CO., LTD. (2013-10-16);;MERCK SHARP + DOHME CORP. (2013-10-16)",https://lens.org/004-588-240-294-040,Patent Application,no,1,1,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,C07D243/08;;A61K31/551;;A61P9/10;;C07D295/192,,0,0,,,,INACTIVE
271,AU,B2,AU 2009/248058 B2,146-583-229-382-011,2014-03-13,2014,AU 2009/248058 A,2009-05-14,EP 08156246 A;;EP 2009055790 W,2008-05-15,"N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperazine derivatives",101 Abstract. The present invention relates tohexafluoroisopropanol derivativeshaving the general formula I X O N N Y OH F 3 C CF 3 A R 1 R 2 R 3 ( ) n W Z B R 6 5 Formula I to pharmaceutical compositions comprising the same and to the use of these hexafluoroisopropanol derivatives inthe treatment of atherosclerosis,MERCK SHARP & DOHME,CARSWELL EMMA LOUISE;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;EDWARDS ANDREW STANLEY;;COOKE ANDREW JOHN,,https://lens.org/146-583-229-382-011,Granted Patent,no,2,0,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,C07D243/08;;A61K31/551;;A61P9/10;;C07D295/192,,0,0,,,,INACTIVE
272,EP,B1,EP 2297118 B1,021-548-845-301-522,2011-10-05,2011,EP 09745770 A,2009-05-14,EP 2009055790 W;;EP 08156246 A;;EP 09745770 A,2008-05-15,"N- (1, 1, 1, 3, 3, 3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL) BENZYL-N' -ARYLCARBONYLPIPERAZ INE DERIVATIVES AS LXR MODULATORS",,ORGANON NV,COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;CARSWELL EMMA LOUISE,"MERCK SHARP & DOHME B.V., NL (2013-07-05);;MERCK SHARP AND DOHME B.V., NL (2013-05-31);;ORGANON BIO SCIENCES NEDERLAND B.V., NL (2013-05-31);;MSD OSS B.V. (2012-01-11)",https://lens.org/021-548-845-301-522,Granted Patent,yes,4,0,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,C07D241/04;;A61K31/551;;A61P9/10;;C07D241/08;;C07D243/08;;C07D295/192;;C07D401/12;;C07D403/12;;C07D405/12,,1,0,,,"BENNETT ET AL: ""An update on non-steroidal liver X receptor agonists and their potential use in the treatment of atherosclerosis"" EXPERT OPINION ON THERAPEUTIC PATENTS, INFORMA HEALTHCARE, GB, vol. 16, no. 12, 2006, pages 1673-1699, XP002500308 ISSN: 1354-3776 cited in the application",ACTIVE
273,TW,A,TW 201006816 A,117-568-020-271-110,2010-02-16,2010,TW 98115152 A,2009-05-07,EP 08156246 A,2008-05-15,Hexafluoroisopropanol derivatives,The present invention relates to hexafluoroisopropanol derivatives having the general formula I to pharmaceutical compositions comprising the same and to the use of these hexafluoroisopropanol derivatives in the treatment of atherosclerosis.,ORGANON NV,COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;CARSWELL EMMA LOULSE,,https://lens.org/117-568-020-271-110,Patent of Addition,no,0,0,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,C07D401/12;;A61K31/496;;A61K31/501;;A61K31/506;;A61P9/10;;C07D403/12,,0,0,,,,PENDING
274,WO,A1,WO 2009/138438 A1,030-160-405-561-510,2009-11-19,2009,EP 2009055790 W,2009-05-14,EP 08156246 A,2008-05-15,"N- (1, 1, 1, 3, 3, 3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL) BENZYL-N' -ARYLCARBONYLPIPERAZ INE DERIVATIVES",101 Abstract. The present invention relates tohexafluoroisopropanol derivativeshaving the general formula I X O N N Y OH F 3 C CF 3 A R 1 R 2 R 3 ( ) n W Z B R 6 5 Formula I to pharmaceutical compositions comprising the same and to the use of these hexafluoroisopropanol derivatives inthe treatment of atherosclerosis,ORGANON NV;;COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;CARSWELL EMMA LOUISE,COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;CARSWELL EMMA LOUISE,,https://lens.org/030-160-405-561-510,Patent Application,yes,4,31,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,A61K31/551;;C07D243/08;;A61P9/10;;C07D295/192,,1,1,145-412-346-561-999,10.1517/13543776.16.12.1673,"BENNETT ET AL: ""An update on non-steroidal liver X receptor agonists and their potential use in the treatment of atherosclerosis"", EXPERT OPINION ON THERAPEUTIC PATENTS, INFORMA HEALTHCARE, GB, vol. 16, no. 12, 2006, pages 1673 - 1699, XP002500308, ISSN: 1354-3776",PENDING
275,US,B2,US 7445650 B2,027-999-148-115-08X,2008-11-04,2008,US 7784905 A,2005-03-11,US 7784905 A;;US 77429804 A,2004-02-06,Control of pressurized microchannel processes,"A method of starting up and shutting down a microchannel process is provided. Included are the steps of providing a first multi-planar process unit, preferably adapted to process an endothermic reaction, a second multi-planar process unit, preferably adapted to process an exothermic reaction, providing a containment vessel, the containment vessel containing at least a portion of the first, and preferably the second, process unit. In startup, the microchannel process is first checked for pressure integrity by pressurizing and checking the important components of the process for leaks. Subsequently, the process units are heated by introducing a dilute low-thermal energy density material, preferably to the second process unit, followed by the introduction of a dilute high-thermal energy density material, and adjusting the proportion of high-thermal energy density material as required. In shutdown, a purge material from the containment vessel is introduced into the first, and preferably the second, process unit.",VELOCYS INC,WEIL CHRISTOPHER P;;LITT ROBERT D;;ROGERS JR WILLIAM ALLEN;;BENNETT RICHARD K;;DE LUCIA ELIZABETH A,VELOCYS INC (2005-04-08);;BATTELLE MEMORIAL INSTITUTE (2005-04-07),https://lens.org/027-999-148-115-08X,Granted Patent,yes,24,8,24,24,0,B01J2219/0081;;B01J2219/00835;;B01J2219/00867;;B01J2219/00869;;B01J2219/00873;;B01J2219/00891;;B01J2219/00963;;B01J2219/00986;;C01B3/384;;C01B2203/0227;;C01B2203/0283;;C01B2203/0811;;C01B2203/1604;;B01J3/046;;B01J2219/00817;;C10G2/00;;C10G2300/4031;;Y02P20/52;;B01J19/0093;;Y10T29/49948;;Y10T29/49345;;Y10T29/49815;;Y10T29/49826;;Y10T137/0335;;Y10T29/49948;;Y10T29/49345;;Y10T29/49815;;Y10T29/49826;;Y10T137/0335;;B01J2219/0081;;B01J2219/00835;;B01J2219/00867;;B01J2219/00869;;B01J2219/00873;;B01J2219/00891;;B01J2219/00963;;B01J2219/00986;;C01B3/384;;C01B2203/0227;;C01B2203/0283;;C01B2203/0811;;C01B2203/1604;;C10G2/00;;C10G2300/4031;;B01J3/046;;B01J2219/00817;;Y02P20/52;;B01J19/0093;;C07C1/0485;;B01J2219/00957;;B01J2219/00961;;C01B3/382;;C07C1/0475,C01B3/24;;B01J3/00;;B01J8/02;;B01J8/04;;B01J10/00;;B01J19/00;;B01J19/24;;B01L3/00;;C01B3/02;;C01B3/36;;C01B3/38;;C07C27/00;;F01N3/20,48/198.1;;X 48197 R;;48/198.7;;422/102;;422/105;;422/130;;422/198;;423/648.1;;423/650;;423/651,10,0,,,"Driscol, et al., 300 MWe Supercritical CO2 Plant Layout and Design, Topical Report, Report No. MIT-GFR-014, Jun. 2004, Center for Advanced Nuclear Energy Systems, MIT Nuclear Engineering Department, Cambridge, MA, USA.;;Freemantle, Michael, Microprocessing on a Large Scale, Chemical & Engineering News, Oct. 11, 2004, CR 2004, pp. 39-43, vol. 82, No. 41, American Chemical Society, USA.;;Thayer, Ann M., Harnessing Microreactions, Chemical & Engineering News, May 30, 2005, CR 2005, pp. 43-52, vol. 83, No. 22, American Chemical Society, USA.;;Wang, et al., Intensification of Gas-to-Liquid (GTL) Process Using Microchannel Technology, May 5, 2003, Pacific Northwest National Laboratory, Richland, WA and Velocys, Inc. Columbus, OH, USA.;;Merkling, U.S. Appl. No. 10/774,298, USPTO OA, filed Jan. 30, 2008.;;Merkling, U.S. Appl. No. 10/774,298, USPTO OA, filed Jun. 16, 2008.;;Merkling, U.S. Appl. No. 10/774,298, USPTO OA, filed Aug. 9, 2007.;;Young, U.S. Appl. No. 11/052,455, USPTO OA, filed Jul. 28, 2008.;;Young, U.S. Appl. No. 11/052,455, USPTO OA, filed Dec. 27, 2007.;;Leung, PCT/US05/03904 Written Opinion of the International Searching Authority May 17, 2005.",INACTIVE
276,MX,A,MX 2010012440 A,105-479-922-734-313,2010-12-06,2010,MX 2010012440 A,2009-05-14,EP 08156246 A;;EP 2009055790 W,2008-05-15,"N- (1, 1, 1, 3, 3, 3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL) BENZYL-N' -ARYLCARBONYLPIPERAZ INE DERIVATIVES.",101 Abstract. The present invention relates tohexafluoroisopropanol derivativeshaving the general formula I X O N N Y OH F 3 C CF 3 A R 1 R 2 R 3 ( ) n W Z B R 6 5 Formula I to pharmaceutical compositions comprising the same and to the use of these hexafluoroisopropanol derivatives inthe treatment of atherosclerosis.,ORGANON NV,NIMZ OLAF;;BENNETT DAVID JONATHAN;;COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;CARSWELL EMMA LOUISE,,https://lens.org/105-479-922-734-313,Patent Application,no,0,0,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,C07D243/08;;A61K31/551;;A61P9/10;;C07D295/192,,0,0,,,,DISCONTINUED
277,US,A1,US 2010/0029621 A1,160-829-503-553-472,2010-02-04,2010,US 46513409 A,2009-05-13,US 46513409 A;;EP 08156246 A;;US 5345408 P,2008-05-15,HEXAFLUOROISOPROPANOL DERIVATIVES,The present invention relates to hexafluoroisopropanol derivatives having the general formula I to pharmaceutical compositions comprising the same and to the use of these hexafluoroisopropanol derivatives in the treatment of atherosclerosis.,COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;CARSWELL EMMA LOUISE,COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;CARSWELL EMMA LOUISE,ORGANON BIOSCIENCES NEDERLAND B.V (2013-01-01);;MERCK SHARP & DOHME B.V (2013-01-02);;MSD OSS B.V (2011-10-31),https://lens.org/160-829-503-553-472,Patent Application,yes,4,16,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,A61K31/551;;A61K31/495;;A61K31/496;;A61K31/506;;A61P9/10;;C07D241/04;;C07D243/08;;C07D401/02;;C07D403/02,514/218;;544/399;;514/252.12;;544/360;;514/253.01;;540/575;;544/295;;514/252.14,0,0,,,,ACTIVE
278,EP,A1,EP 2297118 A1,064-773-023-267-100,2011-03-23,2011,EP 09745770 A,2009-05-14,EP 2009055790 W;;EP 08156246 A;;EP 09745770 A,2008-05-15,"N- (1, 1, 1, 3, 3, 3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL) BENZYL-N' -ARYLCARBONYLPIPERAZ INE DERIVATIVES AS LXR MODULATORS",,ORGANON NV,COOKE ANDREW JOHN;;EDWARDS ANDREW STANLEY;;ANDREWS FIONA ELIZABETH;;BENNETT DAVID JONATHAN;;NIMZ OLAF;;CARSWELL EMMA LOUISE,"MERCK SHARP & DOHME B.V., NL (2013-07-05);;MERCK SHARP AND DOHME B.V., NL (2013-05-31);;ORGANON BIO SCIENCES NEDERLAND B.V., NL (2013-05-31);;MSD OSS B.V. (2012-01-11)",https://lens.org/064-773-023-267-100,Patent Application,yes,0,0,18,18,0,C07D207/14;;C07D207/22;;C07D211/72;;C07D213/75;;C07D213/81;;C07D231/40;;C07D233/36;;C07D237/20;;C07D239/42;;C07D241/04;;C07D241/08;;C07D261/08;;C07D261/14;;C07D277/28;;C07D285/08;;C07D295/135;;C07D295/192;;C07D295/26;;C07D307/14;;C07D307/52;;C07D309/06;;C07D319/12;;C07D333/48;;C07D335/02;;C07D401/12;;C07D403/12;;C07D405/12;;C07D243/08;;C07D295/192;;A61P3/04;;A61P3/06;;A61P9/10;;A61P3/10;;C07D295/192;;C07D243/08,C07D241/04;;A61K31/551;;A61P9/10;;C07D241/08;;C07D243/08;;C07D295/192;;C07D401/12;;C07D403/12;;C07D405/12,,0,0,,,,ACTIVE
279,US,B1,US 8131651 B1,198-078-786-664-096,2012-03-06,2012,US 68065400 A,2000-10-06,US 68065400 A;;US 15817999 P;;US 17018699 P;;US 17050499 P;;US 19269200 P;;US 19272300 P;;US 19389900 P;;US 19574800 P,1999-10-06,"Apparatus, systems and methods for online, multi-carrier, multi-service parcel shipping management featuring shipping rate and delivery schedule comparison for multiple carriers","The present invention provides apparatus, systems and methods for displaying to each of a plurality of users, upon each user's request, as to each particular parcel to be shipped by each user, an online interactive graphic comparison of a plurality of shipping rates calculated for each of a plurality of services offered by each of a plurality of carriers to ship a particular parcel, each shipping rate corresponding to a particular service offered by a particular carrier for delivering the particular parcel to a particular delivery destination at a particular parcel delivery time on a particular parcel delivery date, wherein each user accesses the computer system over a global communications network using a client computer device, and wherein each user has an individual electronic connection to the global communications network. The present invention provides apparatus, systems and methods for regenerating an online interactive graphic comparison of a plurality of shipping rates calculated for each of a plurality of services offered by each of a plurality of carriers, at any particular remote user client computer device of a plurality of remote user client computer devices, based on modified input by a user at a particular remote user client computer device, wherein the present invention communicates with each remote user client computer device over a global communications network.",BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;KRETT LORY ELIZABETH;;SMITH III WILLIAM W;;BILIBIN PAUL;;MENTZER CHARLES D;;STAMPS COM INC;;ISHIP INC,BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;KRETT LORY ELIZABETH;;SMITH III WILLIAM W;;BILIBIN PAUL;;MENTZER CHARLES D,AUCTANE INC (2000-11-27),https://lens.org/198-078-786-664-096,Granted Patent,yes,106,20,12,43,0,G06Q10/025;;G06Q10/063;;G06Q10/0631;;G06Q10/06311;;G06Q10/08;;G06Q10/083;;G06Q10/0833;;G06Q10/0834;;G06Q10/08345;;G06Q10/0835;;G06Q10/10;;G06Q10/1093;;G06Q10/10;;G06Q10/025;;G06Q10/08345;;G06Q10/0833;;G06Q10/0631;;G06Q10/1093;;G06Q10/06311;;G06Q10/063;;G06Q10/0834;;G06Q10/083;;G06Q10/08;;G06Q10/0835,G06Q30/00;;G06Q10/00,705/335;;705/333,101,0,,,"FedEx(R) Services, (www.fedex.com) Archived on Jan. 16, 1997.;;UPS Service Guide, (www.ups.com) Archived on Dec. 06, 1998.;;Kewill Systems, Inc., ""Kewill Systems PLC Acquires Leading U.S. Shipping and Receiving E-Commerce Software Firm for $18 Million"", Aristo Computers Press Releases and Product Development, Jul. 27, 1999, pp. 1-3 of 13, Marlborough, Mass.;;Kewill Systems, Inc., ""USPS Delivery Confirmation Support Now Available in Aristo's Economical APSS® Lite Shipping System"", Aristo Computers Press Releases and Product Development, Jun. 23, 1999, p. 3 of 13. , Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified by USPS to Support New Express Mail Manifesting"", Aristo Computers Press Releases and Product Development, Jun. 21, 1999, pp. 3 and 4 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified UPS OnLine®Compatible to Support UPS International Shipping"", Aristo Computers Press Releases and Product Development, May 12, 1999, pp. 4 and 5 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System®Certified to Fully Support FedEx PowerShip®Server,"" Aristo Computers Press Releases and Product Development, May 10, 1999, pp. 5 and 6 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Names AllPoints Systems Strategic Partner"" AllPoints Systems to Integrate Aristo shipping functionality into its Demand Chian Software, Aristo Computers Press Releases and Product Development, Apr. 13, 1999, pp. 6 and 7 of 13, Beaverton, Oregon and Dedham, Massatuchutes.;;Kewill Systems, Inc., ""Midgard Information Systems and Aristo-Integrated Shipping Solutions for Today's Marketplace"", Aristo Computers Press Releases and Product Development Jan. 19, 1999, pp. 7-9 of 13, Charlotte, North Carolina.;;Kewill Systems, Inc., ""Aristo's OLE Server Provides Shipping & Manifesting Engine for Third Party Developers"", Aristo Computers Press Releases and Product Development, Jul. 28, 1998, pp. 9 and 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Adds New Economical Shipping Solution to Its Product Line"", Aristo Computers Press Releases and Product Development, Apr. 30, 1998, p. 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo announces latest APSS®developments!"", Aristo Computers Press Releases and Product Development, Jun. 9, 1997, pp. 10 and 11 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo launches APSS®for Windows"", Aristo Computers Press Releases and Product Development, Oct. 20, 1996, pp. 11-13 of 13, Beaverton, Oregon.;;""Netscape and FDX Unveil Plans for Next Generation Internet Package Delivery Center"", Netscape Press Release, Apr. 7, 1999, 3 pages, Mt.View, California and Memphis, Tennessee.;;""TanData Announces Release of ChainLink(TM) Applications Suite"" TanData Press Release, Dec. 8, 1999, 2 pages, Tulsa, Oklahoma.;;UPS Extends Capability of iCat Electronic Commerce Software, TanData Press Release, Oct. 26, 1998, 2 pages, Atlanta, Georgia.;;Andy Wang, ""FedEx and Netscape Build Shipping Portal"", E-Commerce Times, Apr. 8, 1999, 2 pages.;;Mary Hillebrand, ""From2.Com Gives International E-Commerce A Hand"", E-Commerce Times, Jul. 9, 1993, 3 pages.;;Tim Wilson, ""Shippers Repackaged As E-Providers"", InformationWeek, Issue: 758, Section: Transportation Transformation: A Special Report From Internetweek, Oct. 25, 1999, 6 pages.;;James Hollander, UPS Boosts E-Commerce Strategy with New Web Tools, E-Commerce Times, Apr. 6, 1999, 3 pages.;;Collection of Screen Printouts (undated) from ""anythingovernight.com"" referring to shipping product Shiplet, entitled ""Shiplet"", 4 pages, ""About Us"", 1 page, ""Shipping"", 1 page, ""Reporting"", 1 page, ""User Profile"" 1 page, ""Shipments to Me"", 1 page, and ""API"", 1 page.;;Lisa Corbin, ""Electronic Commerce Strategies"", Govemment Executive Magazine, Aug. 30, 1999, 5 pages.;;Computer Support, Inc. (CSI), p. 10 of 117 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;TradePoint Systems LLC, International Trade and Transportion, and Transportation Concepts and Services, Inc. (TCS), p. 19 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Carrier Quality Performance Software, p. 39 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Late Delivery Quality Monitor Software (for Federal Exress Shipments) p. 97 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Scheme Software Order Entry/Billing 5.0 p. 156 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Software for International Trade p. 157 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Brandon Fleminq, ""Hot ,List for Electronic Data Interchange (EDI)"", http://www.usatrade.gov/us/annarbor/hot-list-for-EDI.htm, 9 pages, © 1999; Revised Feb. 1, 2000.;;Microsoft Corporation, ""Microsoft Internet Commerce Strategy: A Foundation for Doing Business on the Internet"", May 1997, 27 pages.;;Survey of E-Commerce Companies & Products: Business Logistics, Customer Service, Supply Chain Management, http://pages.hotbot.com/biz/jayml/BP9.html, 28 pages, Richard Karpinski, Appendix II Feb. 9, 1999 on p. 26.;;FedEx Standardizes on Netscape, News Source: Mountain View, Calif., Jun. 11/PRNewswire; News Date Jun. 12, 1996 12:55 pm; Keywords: Federal Express, Electronic Commerce; 3 pages.;;Email Message; From SmartShip Online Support, To: smartshippers@smartship.com; subject: You can ship online now! Sent: Tuesday, Dec. 15, 1998 11:53 am; 1 page.;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine California.;;Williams, et al; Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Parcel Returns Shipping Management; U.S. Appl. No. 09/820,292, filed Mar. 27, 2001; pages-throughout.;;Williams, et al.; Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Enterprise Parcel Shipping Management U.S. Appl. No. 09/820,377, filed Mar. 27, 2001; pages-throughout.;;Smith, III, et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 3000; pp. 1-3 and 98-106.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871 , filed Oct. 6, 2000; pp. 1-3 and 98-104.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000; pp. 1-3 an 98-108.;;Hu, et al.; Apparatus, Systems and Methods for Interfacing with Digital Scales Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000; pp. 1-3 and 98-103.;;Bennett, et al.; Reporting Shipping Rates and Delivery Schedules for Multiple Service and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2009; pp. 1-3 and 98-112.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000; pp. 1-6 and 100-117.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Delivery Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/680,649, filed Oct. 6, 2000; pp. 1-7 and 102-123.;;Bennett, et al.; Apparatus, Systems and Methods for Applying Billing Options for Multiple Carriers for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,865, filed Oct. 6, 2000; pp. 1-3 and 98-104.;;Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000; pp. 1-5 and 100-116.;;Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6, 2000; pp. 1-3 and 97-100.;;Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000; pp. 1-3 and 97-100.;;Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accurate Symbologies on Laser Printers Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,152, filed Oct. 6, 2000; pp. 1-3 and 98-110.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,866, filed Oct. 6, 2000; pp. 1-2 and 97-112.;;Appendix A (throughout) to U.S. Appl. No. 09/820,377, Williams et al. titled: Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Enterprise Parcel Shipping Management filed Mar. 27, 2001, submitted in Accordance with MPEP § 724.02 showing in brackets material redacted under 37 C.F. R.§ 1.217.;;The Gale Group, ""A 'Blue Chip' Mailroom Investment"", Modern Office Technology, Aug. 1984, p. 98., vol. 29.;;ABF Freight System, Inc. Announces the Release of Q-Rate® for Windows, May 26, 1999 (www.abfs.com/about/news/1999/p052699.asp?bhcp=1).;;""After Disconnection from Internet of Recovery from Error, Return to Unitform Resource Locator"": 1B Technical Disclosure Bulleti, Oct. 1, 1997, vol. 40, No. 10, pp. 153-154.;;Material Logistics System, (NN86091526) IBM Technical Disclosure Bulletin, Sep. 1986, US, vol. 26, Issue 4, p. Nos. 1526-1530.;;PRNewswire:""Tan Data(TM) Corporation Announces Progistics CS(TM), Their Newest Internet-Enabled shipping and Rating Software""; Jul. 21, 1997.;;PR Newswire: ""Worldwide Merchant Announces InterShipper 4.0 'The Internet Shipping Center'""; Mar. 23, 1999.;;United States Patent Office; Office Action dated Jul. 12, 2004 for Smith, et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Oct. 21, 2003 for Smith, et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 24, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684 871, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 25, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 23, 2004 for Bennett, et al,; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jan. 13, 2004 for Bennett, et al; Reporting Shipping Rates and Delivery Schedules for Multiple Services and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 25, 2003 for Bennett, et al.;Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Delivery Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/680,649, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jul. 19, 2004 for Bennett, et al.;Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Delivery Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/680,649, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 18, 2002 for Bennett, et al.; Apparatus, Systems and Methods for Applying Billing Options for Multiple Carriers for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,865, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 26, 2004 for Bilbin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/684,077, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Feb. 18, 2004 for Bilbin, et al.; Apparatus. Systems and Methods for Zone Level Rating for Each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6 2000.;;United States Patent Office; Office Action dated Dec. 24, 2003 for Bilbin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for Each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Sep. 13, 2004 for Bilbin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for Each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jul. 6, 2004 for Sean Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accurate Symbologies on Laser Printers Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,152, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 11, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,866, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Apr. 5, 2004 for Williams, et al.; Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Enterprise Parcel Shipping Management; U.S. Appl. No. 09/820,377, filed Mar. 27, 2001.;;United States Patent Office: Office Action dated Feb. 2, 2005 for Smith, et, al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Dec. 7, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 7, 2005 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 29, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Apr. 25, 2005 for Husean, et al.; Apparatus, Systems and Methods for Interfacing With Digital Scales Configured With Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jan. 13, 2005 for Bennett, et al; Reporting Shipping Rates and Delivery Schedules for Multiple Services and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 30, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000.;;United States Patent Office: Office Action dated Mar. 7, 2005 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 29, 2004 for Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Dec. 7, 2004 for Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for Each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6, 2000.;;United States Patent Office: Office Action dated Mar. 4, 2005 for Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for Each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jan. 11, 2005 for Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for Each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Feb. 10, 2005 for Sean Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accurate Symbologies on Laser Printers Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,152, filed Oct. 6, 2000.;;United States Patent Office: Office Action dated Mar. 7, 2005 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,866, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Aug. 1, 2005 for Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated May 27, 2005 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000.;;United States Patent Office: Office Action dated Aug. 1, 2005 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated May 20, 2005 for Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000.;;United States Patent Office: Office Action dated Jul. 6, 2005 for Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for Each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000.;;United States Patent Office: Office Action dated Aug. 1, 2005 for Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accrete Symbologies on Laser Printers Configured With Remote Client Computer Devices; U.S. Appl. No. 09/684,152, filed Oct. 6, 2000.;;Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for each of Multiple Carriers; U.S. Appl. No. 11/123,536, filed May 7, 2005 (a divisional of U.S. Appl. No. 09/684,014); pp. 1-3 and 97-100.;;Microsoft and iShip.com make comparing shipping services Easy on MSN.com, PR Newswire, Nov. 4, 1998 (retreived Jun. 29, 2005) pp. 1-2, retreived from: Dialog, file 20.;;U.S. Postal Service, www.usps.com, Apr. 28, 1999, pp. 1-20, [reported in PTO-892 form, U.S. Patent Office, for U.S. Appl. No. 09/684,861 as retrieved Jun. 29, 2005; reported as retrieved from: Google.com and archive.org].;;UPS Offers Free Shipping Cost Calculator Software, Newsbytes News Network, Feb. 8, 1996, pp. 1-2, [reported in PTO-892 form, U.S. Patent Office, for U.S. Appl. No. 09/684,861 as retrieved Jun. 29, 2005; reported as retrieved from Dialog, file 9].;;""iship.com raises 3.4 Million"", PR Newswire, Jul. 20, 1998, pp. 1-2, [reported in PTO-892 form, U.S. Patent Office, for U.S. Appl. No. 09/684,861 as retrieved Jun. 29, 2005; reported as retrieved from Dialog, file 20].;;iship.com launches first complete web-based shipping service, PR Newswire, Jan. 18, 1999, pp. 1-4, [reported in PTO-892 form, U.S. Patent Office, for U.S. Appl. No. 09/684,861, as retrieved Jun. 29, 2005; reported as retrieved from: Proquest Direct].;;United States Patent Office; Office Action dated Dec. 7, 2005 for Smith et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 18, 2005 for Bennett et al.; Apparatus, Systems, and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 17, 2005 for Hu, et al.; Apparatus, Systems and Methods for Interfacing With Digital Scales Configured With Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000.",ACTIVE
280,WO,A2,WO 1999/050320 A2,072-521-523-912-398,1999-10-07,1999,US 9906458 W,1999-03-26,US 7973398 P,1998-03-27,POLYMERS OF SUBSTITUTED CYCLOPENTENES,"Substituted cyclopentenes, such as alkyl cyclopentenes, are polymerized by selected alpha -imine complexes of nickel and palladium. The polymers are useful as molding resins or elastomers. Also disclosed herein are novel catalysts for the polymerization of cyclopentenes to form novel higher melting homopolycyclopentenes.",DU PONT;;MCLAIN STEPHAN JAMES;;MCCORD ELIZABETH FORRESTER;;BENNETT ALISON MARGARET ANNE;;ITTEL STEVEN DALE;;SWEETMAN KARL JEFFREY;;TEASLEY MARK F,MCLAIN STEPHAN JAMES;;MCCORD ELIZABETH FORRESTER;;BENNETT ALISON MARGARET ANNE;;ITTEL STEVEN DALE;;SWEETMAN KARL JEFFREY;;TEASLEY MARK F,,https://lens.org/072-521-523-912-398,Patent Application,no,0,8,7,7,0,C07F15/045;;C08F32/04;;C08F132/04;;C08F32/04;;C07F15/045;;C08F132/04,C07F15/04;;C08F32/04;;C08F132/04,,0,0,,,,PENDING
281,EP,A2,EP 1068247 A2,134-099-874-510-792,2001-01-17,2001,EP 99915012 A,1999-03-26,US 9906458 W;;US 7973398 P,1998-03-27,POLYMERS OF SUBSTITUTED CYCLOPENTENES,,DU PONT,MCLAIN STEPHAN JAMES;;MCCORD ELIZABETH FORRESTER;;BENNETT ALISON MARGARET ANNE;;ITTEL STEVEN DALE;;SWEETMAN KARL JEFFREY;;TEASLEY MARK F,,https://lens.org/134-099-874-510-792,Patent Application,yes,0,0,7,7,0,C07F15/045;;C08F32/04;;C08F132/04;;C08F32/04;;C07F15/045;;C08F132/04,C07F15/04;;C08F32/04;;C08F132/04,,0,0,,,,DISCONTINUED
282,WO,A3,WO 1999/050320 A3,011-303-902-234-576,1999-11-18,1999,US 9906458 W,1999-03-26,US 7973398 P,1998-03-27,POLYMERS OF SUBSTITUTED CYCLOPENTENES,"Substituted cyclopentenes, such as alkyl cyclopentenes, are polymerized by selected α-imine complexes of nickel and palladium. The polymers are useful as molding resins or elastomers. Also disclosed herein are novel catalysts for the polymerization of cyclopentenes to form novel higher melting homopolycyclopentenes.",DU PONT;;MCLAIN STEPHAN JAMES;;MCCORD ELIZABETH FORRESTER;;BENNETT ALISON MARGARET ANNE;;ITTEL STEVEN DALE;;SWEETMAN KARL JEFFREY;;TEASLEY MARK F,MCLAIN STEPHAN JAMES;;MCCORD ELIZABETH FORRESTER;;BENNETT ALISON MARGARET ANNE;;ITTEL STEVEN DALE;;SWEETMAN KARL JEFFREY;;TEASLEY MARK F,,https://lens.org/011-303-902-234-576,Search Report,yes,5,0,7,7,0,C07F15/045;;C08F32/04;;C08F132/04;;C08F32/04;;C07F15/045;;C08F132/04,C07F15/04;;C08F32/04;;C08F132/04,,0,0,,,,PENDING
283,WO,A1,WO 2023/177659 A1,111-549-670-302-415,2023-09-21,2023,US 2023/0015177 W,2023-03-14,US 202263319975 P,2022-03-15,"LOW-MELTING GLASS COMPOSITIONS, ARTICLES, AND METHODS OF MAKING THE SAME","Disclosed herein are glass compositions, articles made from the disclosed glass compositions, and methods of making the same. More specifically disclosed herein is a glass composition comprising: about 25 to about 55 mol% of P 2 O 5 ; about 5 to about 45 mol% of SiO 2 ; about 5 to about 22 mol% of Al 2 O 3 ; about 5 to about 30 mol% of ZnO; greater than 0 to about 20 mol% a total amount of Na 2 O, K 2 O, and/or Li 2 O; about 2 to about 8 mol% of CaO, and/or about 2 to about 8 mol% of MgO .",PENN STATE RES FOUND;;CLARK NICHOLAS;;TRAUGH SHAYLEE;;ASTLE SIERRA,CLARK NICHOLAS;;TRAUGH SHAYLEE;;ASTLE SIERRA;;MAURO JOHN CHRISTOPHER;;MANCINI MATTHEW FRANCIS LANE;;COOK GLEN BENNETT;;GALLAGHER COLLEEN ELIZABETH,,https://lens.org/111-549-670-302-415,Patent Application,yes,5,0,1,1,0,C03C3/062,C03C3/04;;C03C3/066;;C03C3/083;;C03C3/097,,0,0,,,,PENDING
284,US,B2,US 6670433 B2,187-525-251-519-012,2003-12-30,2003,US 82446101 A,2001-04-02,US 82446101 A;;US 27709599 A;;US 7973398 P,1998-03-27,Polymers of substituted cyclopentenes,"
    Substituted cyclopentenes, such as alkyl cyclopentenes, are polymerized by selected -imine complexes of nickel and palladium. The polymers are useful as molding resins or elastomers. Also disclosed herein are novel catalysts for the polymerization of cyclopentenes to form novel higher melting homopolycyclopentenes. 
",DU PONT,MCLAIN STEPHAN JAMES;;MCCORD ELIZABETH FORRESTER;;BENNETT ALISON MARGARET ANNE;;ITTEL STEVEN DALE;;SWEETMAN KARL JEFFREY;;TEASLEY MARK F,,https://lens.org/187-525-251-519-012,Granted Patent,yes,8,0,7,7,0,C07F15/045;;C08F32/04;;C08F132/04;;C08F32/04;;C07F15/045;;C08F132/04,C07F15/04;;C08F32/04;;C08F132/04,526/161;;526/308;;526/169.1;;526/217;;526/236;;526/133;;526/141;;502/200;;502/229,2,1,027-541-666-632-63X,10.1002/macp.1966.020900103,"Boor, J. et al., Polymerization of Cyclopenetene, 3-Methylcyclopentene, and 3-Methylcyclohexene, Die Makromolekulare Chemie, 1966, 26-37, 90.;;PCT International Search Report dated Nov. 18, 1999 for PCT/US99/06458.",EXPIRED
285,US,B1,US 6258908 B1,134-927-288-167-435,2001-07-10,2001,US 27709599 A,1999-03-26,US 27709599 A;;US 7973398 P,1998-03-27,Polymers of substituted cyclopentenes,"Substituted cyclopentenes, such as alkyl cyclopentenes, are polymerized by selected .alpha.-imine complexes of nickel and palladium. The polymers are useful as molding resins or elastomers. Also disclosed herein are novel catalysts for the polymerization of cyclopentenes to form novel higher melting homopolycyclopentenes.",DU PONT,MCLAIN STEPHAN JAMES;;MCCORD ELIZABETH FORRESTER;;BENNETT ALISON MARGARET ANNE;;ITTEL STEVEN DALE;;SWEETMAN KARL JEFFREY;;TEASLEY MARK F,E. I. DU PONT DE NEMOURS AND COMPANY (1999-03-30),https://lens.org/134-927-288-167-435,Granted Patent,yes,7,3,7,7,0,C07F15/045;;C08F32/04;;C08F132/04;;C08F32/04;;C07F15/045;;C08F132/04,C07F15/04;;C08F32/04;;C08F132/04,526/308;;526/169.1;;526/217;;526/236;;502/200;;502/229,3,2,049-434-420-066-011;;027-541-666-632-63X,10.1021/ma00094a008;;10.1002/macp.1966.020900103,"Kelly et al., Macromolecules, 27, 4477-4485, 1994.*;;J. Boor, et al., Polymerization of Cyclopenetene, 3-Methylcyclopentene, and 3-Methylcyclohexene, Die Makromolekulare Chemie, 90, 26-37, 1966.;;PCT International Search Report dated Nov. 18, 1999 for PCT/US99/06458.",EXPIRED
286,US,A1,US 2018/0155236 A1,003-072-735-388-82X,2018-06-07,2018,US 201615578055 A,2016-06-01,US 201615578055 A;;US 201562169939 P;;US 2016/0035235 W,2015-06-02,LIGHT-SCATTERING GLASS ARTICLES AND METHODS FOR THE PRODUCTION THEREOF,"According to embodiments disclosed herein, light-scattering laminated glass articles may include a first glass layer, a second glass layer, and a light-scattering component. The first glass layer may be formed from a first glass composition. The second glass layer may be formed from a second glass composition and fused to the first glass layer. The light-scattering component may be disposed at an interface of the first glass layer and the second glass layer. The light-scattering component may include a different composition or material phase than the first glass layer and the second glass layer. Also disclosed herein are methods for producing light-scattering laminated glass articles.",CORNING INC,DELAMIELLEURE MEGAN AURORA;;DOHN PAUL BENNETT;;KICZENSKI TIMOTHY JAMES;;PETERSON IRENE MONA;;SCHAUT ROBERT ANTHONY;;STURDEVANT ELIZABETH MARY;;VENKATARAMAN NATESAN,CORNING INCORPORATED (2017-10-23),https://lens.org/003-072-735-388-82X,Patent Application,yes,5,4,8,8,0,C03C3/091;;C03C2214/16;;C03C2214/30;;B32B17/06;;C03B17/02;;C03B17/064;;C03B5/16;;C03B5/163;;C03C14/006;;B32B17/10036;;C03C3/091;;C03C14/006;;C03C2214/16;;C03C2214/30;;C03C2214/16;;C03C2214/30;;C03B17/02;;C03B17/064;;C03C3/091;;C03B5/163;;C03B5/16;;B32B17/06;;C03C14/006;;B32B2307/418,C03C14/00;;B32B17/10;;C03B17/02;;C03B17/06,,1,0,,,e.g. F010307,DISCONTINUED
287,KR,A,KR 20180014728 A,182-369-115-220-215,2018-02-09,2018,KR 20177035973 A,2016-06-01,US 201562169939 P;;US 2016/0035235 W,2015-06-02,광 산란 유리 제품 및 이를 제조하는 방법,"본 명세서에 개시된 구체예들에 따르면, 광 산란 적층 유리 제품은 제 1 유리 층, 제 2 유리 층 및 광 산란 요소를 포함할 수있다. 제 1 유리 층은 제 1 유리 조성물로 형성될 수 있다. 제 2 유리 층은 제 2 유리 조성물로 형성되고 제 1 유리 층에 융합될 수 있다. 광 산란 요소는 제 1 유리 층과 제 2 유리 층의 계면에 배치될 수 있다. 광산란 요소는 제 1 유리 층 및 제 2 유리 층과 상이한 조성 또는 재료 상(phase)을 포함할 수 있다. 또한, 광 산란 적층 유리 제품의 제조 방법이 개시된다.",CORNING INC,DELAMIELLEURE MEGAN AURORA;;DOHN PAUL BENNETT;;KICZENSKI TIMOTHY JAMES;;PETERSON IRENE MONA;;SCHAUT ROBERT ANTHONY;;STURDEVANT ELIZABETH MARY;;VENKATARAMAN NATESAN,,https://lens.org/182-369-115-220-215,Patent Application,no,0,0,8,8,0,C03C3/091;;C03C2214/16;;C03C2214/30;;B32B17/06;;C03B17/02;;C03B17/064;;C03B5/16;;C03B5/163;;C03C14/006;;B32B17/10036;;C03C3/091;;C03C14/006;;C03C2214/16;;C03C2214/30;;C03C2214/16;;C03C2214/30;;C03B17/02;;C03B17/064;;C03C3/091;;C03B5/163;;C03B5/16;;B32B17/06;;C03C14/006;;B32B2307/418,C03C14/00;;C03C3/091,,0,0,,,,PENDING
288,CN,A,CN 107922253 A,112-595-825-840-140,2018-04-17,2018,CN 201680045127 A,2016-06-01,US 201562169939 P;;US 2016/0035235 W,2015-06-02,Light-scattering glass articles and methods for the production thereof,"According to embodiments disclosed herein, light-scattering laminated glass articles may include a first glass layer, a second glass layer, and a light-scattering component. The first glass layer maybe formed from a first glass composition. The second glass layer may be formed from a second glass composition and fused to the first glass layer. The light-scattering component may be disposed at aninterface of the first glass layer and the second glass layer. The light-scattering component may include a different composition or material phase than the first glass layer and the second glass layer. Also disclosed herein are methods for producing light-scattering laminated glass articles.",CORNING INC,DELAMIELLEURE MEGAN AURORA;;DOHN PAUL BENNETT;;KICZENSKI TIMOTHY JAMES;;PETERSON IRENE MONA;;SCHAUT ROBERT ANTHONY;;STURDEVANT ELIZABETH MARY;;VENKATARAMAN NATESAN,,https://lens.org/112-595-825-840-140,Patent Application,no,4,0,8,8,0,C03C3/091;;C03C2214/16;;C03C2214/30;;B32B17/06;;C03B17/02;;C03B17/064;;C03B5/16;;C03B5/163;;C03C14/006;;B32B17/10036;;C03C3/091;;C03C14/006;;C03C2214/16;;C03C2214/30;;C03C2214/16;;C03C2214/30;;C03B17/02;;C03B17/064;;C03C3/091;;C03B5/163;;C03B5/16;;B32B17/06;;C03C14/006;;B32B2307/418,C03C14/00;;C03C3/091,,0,0,,,,DISCONTINUED
289,EP,A1,EP 3303240 A1,040-307-243-796-54X,2018-04-11,2018,EP 16735955 A,2016-06-01,US 201562169939 P;;US 2016/0035235 W,2015-06-02,LIGHT-SCATTERING GLASS ARTICLES AND METHODS FOR THE PRODUCTION THEREOF,,CORNING INC,DELAMIELLEURE MEGAN AURORA;;DOHN PAUL BENNETT;;KICZENSKI TIMOTHY JAMES;;PETERSON IRENE MONA;;SCHAUT ROBERT ANTHONY;;STURDEVANT ELIZABETH MARY;;VENKATARAMAN NATESAN,,https://lens.org/040-307-243-796-54X,Patent Application,yes,0,0,8,8,0,C03C3/091;;C03C2214/16;;C03C2214/30;;B32B17/06;;C03B17/02;;C03B17/064;;C03B5/16;;C03B5/163;;C03C14/006;;B32B17/10036;;C03C3/091;;C03C14/006;;C03C2214/16;;C03C2214/30;;C03C2214/16;;C03C2214/30;;C03B17/02;;C03B17/064;;C03C3/091;;C03B5/163;;C03B5/16;;B32B17/06;;C03C14/006;;B32B2307/418,C03C14/00;;C03C3/091,,0,0,,,,DISCONTINUED
290,WO,A1,WO 2016/196611 A1,058-711-637-853-621,2016-12-08,2016,US 2016/0035235 W,2016-06-01,US 201562169939 P,2015-06-02,LIGHT-SCATTERING GLASS ARTICLES AND METHODS FOR THE PRODUCTION THEREOF,"According to embodiments disclosed herein, light-scattering laminated glass articles may include a first glass layer, a second glass layer, and a light-scattering component. The first glass layer may be formed from a first glass composition. The second glass layer may be formed from a second glass composition and fused to the first glass layer. The light-scattering component may be disposed at an interface of the first glass layer and the second glass layer. The light-scattering component may include a different composition or material phase than the first glass layer and the second glass layer. Also disclosed herein are methods for producing light-scattering laminated glass articles.",CORNING INC,DELAMIELLEURE MEGAN AURORA;;DOHN PAUL BENNETT;;KICZENSKI TIMOTHY JAMES;;PETERSON IRENE MONA;;SCHAUT ROBERT ANTHONY;;STURDEVANT ELIZABETH MARY;;VENKATARAMAN NATESAN,,https://lens.org/058-711-637-853-621,Patent Application,yes,8,1,8,8,0,C03C3/091;;C03C2214/16;;C03C2214/30;;B32B17/06;;C03B17/02;;C03B17/064;;C03B5/16;;C03B5/163;;C03C14/006;;B32B17/10036;;C03C3/091;;C03C14/006;;C03C2214/16;;C03C2214/30;;C03C2214/16;;C03C2214/30;;C03B17/02;;C03B17/064;;C03C3/091;;C03B5/163;;C03B5/16;;B32B17/06;;C03C14/006;;B32B2307/418,C03C14/00;;C03C3/091,,0,0,,,,PENDING
291,TW,B,TW I695819 B,049-110-245-105-894,2020-06-11,2020,TW 105117241 A,2016-06-01,US 201562169939 P,2015-06-02,Light-scattering glass articles and methods for the production thereof,,CORNING INC,DELAMIELLEURE MEGAN AURORA;;DOHN PAUL BENNETT;;KICZENSKI TIMOTHY JAMES;;PETERSON IRENE MONA;;SCHAUT ROBERT ANTHONY;;STURDEVANT ELIZABETH MARY;;VENKATARAMAN NATESAN,,https://lens.org/049-110-245-105-894,Granted Patent,no,3,0,8,8,0,C03C3/091;;C03C2214/16;;C03C2214/30;;B32B17/06;;C03B17/02;;C03B17/064;;C03B5/16;;C03B5/163;;C03C14/006;;B32B17/10036;;C03C3/091;;C03C14/006;;C03C2214/16;;C03C2214/30;;C03C2214/16;;C03C2214/30;;C03B17/02;;C03B17/064;;C03C3/091;;C03B5/163;;C03B5/16;;B32B17/06;;C03C14/006;;B32B2307/418,,,0,0,,,,INACTIVE
292,TW,A,TW 201710206 A,167-950-113-105-286,2017-03-16,2017,TW 105117241 A,2016-06-01,US 201562169939 P,2015-06-02,Light-scattering glass articles and methods for the production thereof,"According to embodiments disclosed herein, light-scattering laminated glass articles may include a first glass layer, a second glass layer, and a light-scattering component. The first glass layer may be formed from a first glass composition. The second glass layer may be formed from a second glass composition and fused to the first glass layer. The light-scattering component may be disposed at an interface of the first glass layer and the second glass layer. The light-scattering component may include a different composition or material phase than the first glass layer and the second glass layer. Also disclosed herein are methods for producing light-scattering laminated glass articles.",CORNING INC,DELAMIELLEURE MEGAN AURORA;;DOHN PAUL BENNETT;;KICZENSKI TIMOTHY JAMES;;PETERSON IRENE MONA;;SCHAUT ROBERT ANTHONY;;STURDEVANT ELIZABETH MARY;;VENKATARAMAN NATESAN,,https://lens.org/167-950-113-105-286,Patent of Addition,no,0,0,8,8,0,C03C3/091;;C03C2214/16;;C03C2214/30;;B32B17/06;;C03B17/02;;C03B17/064;;C03B5/16;;C03B5/163;;C03C14/006;;B32B17/10036;;C03C3/091;;C03C14/006;;C03C2214/16;;C03C2214/30;;C03C2214/16;;C03C2214/30;;C03B17/02;;C03B17/064;;C03C3/091;;C03B5/163;;C03B5/16;;B32B17/06;;C03C14/006;;B32B2307/418,C03C14/00;;B32B17/06;;B32B37/04;;C03C3/091,,0,0,,,,INACTIVE
293,WO,A9,WO 2012/112642 A9,156-901-722-183-853,2016-08-04,2016,US 2012/0025178 W,2012-02-15,US 201161463323 P;;US 201161580680 P;;US 201213372902 A,2011-02-15,ORTHOPEDIC COMPRESSION PLATE,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10° to about 70° with a longitudinal axis of the plate. In a further embodiment, the plate also includes a second end with a chamfer for insertion of the plate into bone, and in a still further embodiment, the plate is an MTP plate.",ORTHOHELIX SURGICAL DES INC;;LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;JOHNSON JEFFREY;;KAY DAVID B;;HOCKETT BRIAN,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;JOHNSON JEFFREY;;KAY DAVID B;;HOCKETT BRIAN,,https://lens.org/156-901-722-183-853,Search Report,yes,0,1,7,22,0,A61B17/8061;;A61B17/8061;;A61B17/8014;;A61B17/8014;;A61B17/8095;;A61B17/8095,A61B17/80,,0,0,,,,PENDING
294,US,B2,US 9005255 B2,031-459-477-936-863,2015-04-14,2015,US 201213372902 A,2012-02-14,US 201213372902 A;;US 201161463323 P;;US 201161580680 P,2011-02-15,Orthopedic compression plate,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10° to about 70° with a longitudinal axis of the plate. In a further embodiment, the plate also includes a second end with a chamfer for insertion of the plate into bone, and in a still further embodiment, the plate is an MTP plate.",LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;JOHNSON JEFFREY;;KAY DAVID B;;HOCKETT BRIAN;;ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;JOHNSON JEFFREY;;KAY DAVID B;;HOCKETT BRIAN,ORTHOHELIX SURGICAL DESIGNS INC (2012-03-26),https://lens.org/031-459-477-936-863,Granted Patent,yes,22,19,7,22,0,A61B17/8061;;A61B17/8061;;A61B17/8014;;A61B17/8014;;A61B17/8095;;A61B17/8095,A61B17/88;;A61B17/66;;A61B17/80,606/286;;606/287;;606/291;;606/282;;606/281,0,0,,,,ACTIVE
295,EP,A1,EP 2675377 A1,169-609-288-844-340,2013-12-25,2013,EP 12746929 A,2012-02-15,US 201161463323 P;;US 201161580680 P;;US 201213372902 A;;US 2012/0025178 W,2011-02-15,ORTHOPEDIC COMPRESSION PLATE,,ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;JOHNSON JEFFREY;;KAY DAVID B;;HOCKETT BRIAN,,https://lens.org/169-609-288-844-340,Patent Application,yes,0,0,7,22,0,A61B17/8061;;A61B17/8061;;A61B17/8014;;A61B17/8014;;A61B17/8095;;A61B17/8095,A61B17/80,,0,0,,,,ACTIVE
296,US,A1,US 2012/0209334 A1,049-345-566-533-247,2012-08-16,2012,US 201213372902 A,2012-02-14,US 201213372902 A;;US 201161463323 P;;US 201161580680 P,2011-02-15,ORTHOPEDIC COMPRESSION PLATE,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10° to about 70° with a longitudinal axis of the plate. In a further embodiment, the plate also includes a second end with a chamfer for insertion of the plate into bone, and in a still further embodiment, the plate is an MTP plate.",LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;JOHNSON JEFFREY;;KAY DAVID B;;HOCKETT BRIAN;;ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;JOHNSON JEFFREY;;KAY DAVID B;;HOCKETT BRIAN,ORTHOHELIX SURGICAL DESIGNS INC (2012-03-26),https://lens.org/049-345-566-533-247,Patent Application,yes,14,37,7,22,0,A61B17/8061;;A61B17/8061;;A61B17/8014;;A61B17/8014;;A61B17/8095;;A61B17/8095,A61B17/80,606/286,0,0,,,,ACTIVE
297,EP,B1,EP 2675377 B1,058-646-846-549-978,2017-12-20,2017,EP 12746929 A,2012-02-15,US 201161463323 P;;US 201161580680 P;;US 201213372902 A;;US 2012/0025178 W,2011-02-15,ORTHOPEDIC COMPRESSION PLATE,,ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;JOHNSON JEFFREY;;KAY DAVID B;;HOCKETT BRIAN,,https://lens.org/058-646-846-549-978,Granted Patent,yes,9,0,7,22,0,A61B17/8014;;A61B17/8095;;A61B17/8061;;A61B17/8014;;A61B17/8095;;A61B17/8061,A61B17/80,,0,0,,,,ACTIVE
298,WO,A1,WO 2012/112642 A1,112-998-406-244-789,2012-08-23,2012,US 2012/0025178 W,2012-02-15,US 201161463323 P;;US 201161580680 P;;US 201213372902 A,2011-02-15,ORTHOPEDIC COMPRESSION PLATE,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10° to about 70° with a longitudinal axis of the plate. In a further embodiment, the plate also includes a second end with a chamfer for insertion of the plate into bone, and in a still further embodiment, the plate is an MTP plate.",ORTHOHELIX SURGICAL DES INC;;LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;JOHNSON JEFFREY;;KAY DAVID B;;HOCKETT BRIAN,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;JOHNSON JEFFREY;;KAY DAVID B;;HOCKETT BRIAN,,https://lens.org/112-998-406-244-789,Patent Application,yes,4,3,7,22,0,A61B17/8014;;A61B17/8095;;A61B17/8061;;A61B17/8014;;A61B17/8095;;A61B17/8061,A61B17/80,,0,0,,,,PENDING
299,EP,A4,EP 2675377 A4,058-985-589-905-228,2015-12-23,2015,EP 12746929 A,2012-02-15,US 201161463323 P;;US 201161580680 P;;US 201213372902 A;;US 2012/0025178 W,2011-02-15,ORTHOPEDIC COMPRESSION PLATE,,ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;JOHNSON JEFFREY;;KAY DAVID B;;HOCKETT BRIAN,,https://lens.org/058-985-589-905-228,Search Report,no,5,0,7,22,0,A61B17/8061;;A61B17/8061;;A61B17/8014;;A61B17/8014;;A61B17/8095;;A61B17/8095,A61B17/80,,1,0,,,See also references of WO 2012112642A1,ACTIVE
300,CN,A,CN 102369288 A,194-090-582-849-749,2012-03-07,2012,CN 200980153209 A,2009-11-13,US 2009/0064488 W;;US 11501308 P,2008-11-14,Compositions and methods for engineering cells,"The disclosure relates generally to genetic manipulation of stem and primary cells and to reprogramming of somatic cells, more specifically, human cells. In particular, compositions and methods are disclosed for the generation and maintenance of such engineered cells.",LIFE TECHNOLOGIES CORP,UMA LAKSHMIPATHY;;BHASKAR THYAGARAJAN;;JONATHAN CHESNUT;;VASILIKI ANEST;;ROBERT BENNETT;;PAULINE LIEU;;GEORGE HANSON;;DAVID THOMPSON;;LUCAS CHASE;;GARY SHIPLEY;;ELIZABETH WILSON,,https://lens.org/194-090-582-849-749,Patent Application,no,0,1,8,8,0,C12N2799/022;;C12N2799/026;;C12N2799/027;;C12N2800/108;;C12N15/86;;C12N2799/027;;C12N2799/022;;C12N2799/026;;C12N2800/108;;C12N15/86;;C12N2710/16221;;C12N2710/16222;;C12N2710/16243;;C12N2820/002;;C12N2820/007;;C12N2820/60,C12N15/86,,0,0,,,,DISCONTINUED
301,EP,A1,EP 2362912 A1,091-182-071-908-421,2011-09-07,2011,EP 09850164 A,2009-11-13,US 2009/0064488 W;;US 11501308 P,2008-11-14,COMPOSITIONS AND METHODS FOR ENGINEERING CELLS,,LIFE TECHNOLOGIES CORP,LAKSHMIPATHY UMA;;THYAGARAJAN BHASKAR;;CHESNUT JONATHAN;;ANEST VASILIKI;;BENNETT ROBERT;;LIEU PAULINE;;HANSON GEORGE;;THOMPSON DAVID;;CHASE LUCAS;;SHIPLEY GARY;;WILSON ELIZABETH,,https://lens.org/091-182-071-908-421,Patent Application,yes,0,0,8,8,0,C12N2799/022;;C12N2799/026;;C12N2799/027;;C12N2800/108;;C12N15/86;;C12N2799/027;;C12N2799/022;;C12N2799/026;;C12N2800/108;;C12N15/86;;C12N2710/16221;;C12N2710/16222;;C12N2710/16243;;C12N2820/002;;C12N2820/007;;C12N2820/60,C12N15/86,,0,0,,,,DISCONTINUED
302,US,A1,US 2016/0010113 A1,138-306-215-102-220,2016-01-14,2016,US 201514801757 A,2015-07-16,US 201514801757 A;;US 201213571141 A;;US 201213540539 A;;US 61870009 A;;US 11501308 P,2008-11-14,COMPOSITIONS AND METHODS FOR ENGINEERING CELLS,"The disclosure relates generally to genetic manipulation of stem and primary cells and to reprogramming of somatic cells, more specifically, human cells. In particular, compositions and methods are disclosed for the generation and maintenance of such engineered cells.",LIFE TECHNOLOGIES CORP,LAKSHMIPATHY UMA;;THYAGARAJAN BHASKAR;;CHESNUT JONATHAN;;ANEST VASILIKI;;BENNETT ROBERT;;LIEU PAULINE;;HANSON GEORGE;;THOMPSON DAVID;;CHASE LUCAS;;SHIPLEY GARY;;WILSON ELIZABETH,,https://lens.org/138-306-215-102-220,Patent Application,yes,0,0,8,8,50,C12N2799/022;;C12N2799/026;;C12N2799/027;;C12N2800/108;;C12N15/86;;C12N2799/027;;C12N2799/022;;C12N2799/026;;C12N2800/108;;C12N15/86;;C12N2710/16221;;C12N2710/16222;;C12N2710/16243;;C12N2820/002;;C12N2820/007;;C12N2820/60,C12N15/86,,0,0,,,,DISCONTINUED
303,WO,A1,WO 2023/086917 A1,144-319-754-192-624,2023-05-19,2023,US 2022/0079689 W,2022-11-11,US 202163278689 P,2021-11-12,SYSTEMS AND METHODS FOR GENERATING HEALTH REPORTS BASED ON VETERINARY ORAL CARE HEALTH TEST,"Methods, systems, and non-transitory computer readable mediums are disclosed for generating health reports. Pet data associated with an entity is received from one or more data sources. Genetic test results data is received from a genetic test results database. The pet data received from the one or more data sources is analyzed with the genetic test results data received from the genetic test results database using an interpretation logic data structure. A result value associated with the pet data and the genetic test results data is determined based on the analysis. One or more result statements associated with the result value are determined and one or more health reports based on the one or more result statements are generated.",MARS INC,BENNETT MARIE-LOUISE AMANDA;;CAMERON GORDON CRAIG;;HOLCOMBE LUCY JANE;;MCGENITY PHILIP MARTIN;;RUPARELL AVIKA KISHORLAL;;WALLIS CORRYN VICTORIA;;DAVIES AMANDA ELIZABETH,,https://lens.org/144-319-754-192-624,Patent Application,yes,2,0,1,1,0,G16H10/60;;G16H15/00;;G16H50/20;;G16H50/30;;G16H50/70;;G06N20/00;;G06N5/045,G16H10/60;;G06N3/08;;G06N20/00;;G16H15/00;;G16H50/20;;G16H50/30;;G16H50/70,,1,0,,,"BELLOWS JAN: ""Halitosis in Dogs | VCA Animal Hospital"", 22 October 2021 (2021-10-22), XP093031234, Retrieved from the Internet <URL:https://web.archive.org/web/20211022040903/https://vcahospitals.com/know-your-pet/halitosis-in-dogs> [retrieved on 20230313]",PENDING
304,US,A1,US 2011/0263001 A1,131-314-250-298-340,2011-10-27,2011,US 61870009 A,2009-11-13,US 61870009 A;;US 11501308 P,2008-11-14,Compositions and Methods for Engineering Cells,"The disclosure relates generally to genetic manipulation of stem and primary cells and to reprogramming of somatic cells, more specifically, human cells. In particular, compositions and methods are disclosed for the generation and maintenance of such engineered cells.",LIFE TECHNOLOGIES CORP,LAKSHMIPATHY UMA;;THYAGARAJAN BHASKAR;;CHESNUT JONATHAN;;ANEST VASILIKI;;BENNETT ROBERT;;LIEU PAULINE;;HANSON GEORGE;;THOMPSON DAVID;;CHASE LUCAS;;SHIPLEY GARY;;WILSON ELIZABETH,LIFE TECHNOLOGIES CORPORATION (2011-06-01),https://lens.org/131-314-250-298-340,Patent Application,yes,1,16,8,8,50,C12N2799/022;;C12N2799/026;;C12N2799/027;;C12N2800/108;;C12N15/86;;C12N2799/027;;C12N2799/022;;C12N2799/026;;C12N2800/108;;C12N15/86;;C12N2710/16221;;C12N2710/16222;;C12N2710/16243;;C12N2820/002;;C12N2820/007;;C12N2820/60,C12N5/10;;C12N15/85;;C12N7/01,435/235.1;;435/320.1;;435/366,1,1,088-756-150-999-298,15798361,"Zeng et al (Restorative Neurology and Neuroscience, 2004. Vol.22, No.6, pages 421-428).",DISCONTINUED
305,US,A1,US 2013/0040304 A1,026-126-118-686-579,2013-02-14,2013,US 201213571141 A,2012-08-09,US 201213571141 A;;US 201213540539 A;;US 61870009 A;;US 11501308 P,2008-11-14,Compositions and Methods for Engineering Cells,"The disclosure relates generally to genetic manipulation of stem and primary cells and to reprogramming of somatic cells, more specifically, human cells. In particular, compositions and methods are disclosed for the generation and maintenance of such engineered cells.",LIFE TECHNOLOGIES CORP;;LAKSHMIPATHY UMA;;THYAGARAJAN BHASKAR;;CHESNUT JONATHAN;;ANEST VASILIKI;;BENNETT ROBERT;;LIEU PAULINE;;HANSON GEORGE;;THOMPSON DAVID;;CHASE LUCAS;;SHIPLEY GARY;;WILSON ELIZABETH,LAKSHMIPATHY UMA;;THYAGARAJAN BHASKAR;;CHESNUT JONATHAN;;ANEST VASILIKI;;BENNETT ROBERT;;LIEU PAULINE;;HANSON GEORGE;;THOMPSON DAVID;;CHASE LUCAS;;SHIPLEY GARY;;WILSON ELIZABETH,,https://lens.org/026-126-118-686-579,Patent Application,yes,0,0,8,8,50,C12N2799/022;;C12N2799/026;;C12N2799/027;;C12N2800/108;;C12N15/86;;C12N2799/027;;C12N2799/022;;C12N2799/026;;C12N2800/108;;C12N15/86;;C12N2710/16221;;C12N2710/16222;;C12N2710/16243;;C12N2820/002;;C12N2820/007;;C12N2820/60,C12N15/79;;C12N5/10;;C12Q1/04;;C12Q1/68,435/6.12;;435/320.1;;435/325;;435/366;;435/349;;435/363;;435/354;;435/353;;435/352;;435/419;;435/412;;435/417;;435/34,0,0,,,,DISCONTINUED
306,WO,A2,WO 2011/071476 A2,128-601-853-470-860,2011-06-16,2011,US 2009/0064488 W,2009-11-13,US 11501308 P,2008-11-14,COMPOSITIONS AND METHODS FOR ENGINEERING CELLS,"The disclosure relates generally to genetic manipulation of stem and primary cells and to reprogramming of somatic cells, more specifically, human cells. In particular, compositions and methods are disclosed for the generation and maintenance of such engineered cells.",LIFE TECHNOLOGIES CORP;;LAKSHMIPATHY UMA;;THYAGARAJAN BHASKAR;;CHESNUT JONATHAN;;ANEST VASILIKI;;BENNETT ROBERT;;LIEU PAULINE;;HANSON GEORGE;;THOMPSON DAVID;;CHASE LUCAS;;SHIPLEY GARY;;WILSON ELIZABETH,LAKSHMIPATHY UMA;;THYAGARAJAN BHASKAR;;CHESNUT JONATHAN;;ANEST VASILIKI;;BENNETT ROBERT;;LIEU PAULINE;;HANSON GEORGE;;THOMPSON DAVID;;CHASE LUCAS;;SHIPLEY GARY;;WILSON ELIZABETH,,https://lens.org/128-601-853-470-860,Patent Application,yes,17,20,8,8,50,C12N2799/022;;C12N2799/026;;C12N2799/027;;C12N2800/108;;C12N15/86;;C12N2799/027;;C12N2799/022;;C12N2799/026;;C12N2800/108;;C12N15/86;;C12N2710/16221;;C12N2710/16222;;C12N2710/16243;;C12N2820/002;;C12N2820/007;;C12N2820/60,C12N15/86,,48,38,041-689-592-143-013;;024-468-778-808-575;;001-834-413-032-383;;049-114-242-659-195;;032-657-166-395-311;;049-114-242-659-195;;094-523-177-647-954;;111-021-791-844-813;;041-295-508-814-485;;010-454-484-095-949;;024-724-806-667-643;;038-838-014-938-373;;002-082-828-523-966;;009-357-190-179-274;;037-396-041-244-359;;006-150-065-114-087;;027-729-693-408-38X;;103-721-744-176-506;;083-861-774-663-410;;003-868-349-458-23X;;135-979-001-142-590;;040-303-025-188-468;;024-836-196-901-573;;061-444-349-075-997;;119-594-164-800-87X;;127-877-275-670-203;;042-061-188-331-058;;002-082-828-523-966;;015-796-279-595-874;;017-663-784-990-481;;003-786-150-572-757;;008-700-949-134-493;;080-462-410-826-330;;035-525-222-155-668;;073-175-025-788-651;;050-235-602-448-567;;026-711-813-145-35X;;020-389-350-768-356,10.1016/0958-1669(94)90068-x;;7765467;;10.1016/s0959-437x(05)80086-3;;8274851;;12016301;;10.1126/science.1072249;;10580476;;10.1017/s1355838299991264;;pmc1369869;;10.1016/s0966-842x(98)01379-1;;10068996;;10580476;;10.1017/s1355838299991264;;pmc1369869;;9478132;;10.1016/s0968-0004(97)01159-6;;11737633;;10.1046/j.1365-2958.2001.02701.x;;7242681;;10.1038/292154a0;;6717601;;10.1038/309255a0;;3024164;;pmc387075;;10.1073/pnas.83.23.9065;;10.1038/323445a0;;3762693;;10.1016/0168-9525(87)90286-1;;10.1016/s0070-2153(08)60675-4;;3514144;;2822260;;10.1016/0092-8674(87)90646-5;;pmc53004;;10.1073/pnas.88.23.10730;;1720548;;10.1007/bf02513027;;1284480;;8402909;;10.1016/0092-8674(93)80065-m;;9278050;;10.1038/42264;;9634795;;10.1038/nbt0695-565;;10.1126/science.8493529;;8493529;;6286828;;10.1016/0092-8674(82)90129-5;;6297762;;10.1038/290304a0;;6259538;;pmc347256;;6294669;;10.1073/pnas.79.22.6971;;10.1016/0092-8674(90)90512-d;;2257626;;1915772;;10.1007/bf01929879;;10.1016/0168-9525(87)90286-1;;2985274;;10.1016/s0092-8674(85)80004-0;;3892305;;10.1038/315680a0;;10.1126/science.2499927;;2499927;;2482230;;10.1016/0378-1119(89)90515-5;;10.1016/0165-1110(89)90023-7;;2538738;;10.2174/1566523023347814;;12189722;;11482983;;10.1006/mthe.2001.0429;;10.1046/j.1432-1327.2000.01645.x;;10971576;;10075999;;10.1093/nar/27.7.1674;;pmc148371;;19317643;;10.2217/17460751.4.2.239,"SAUER, B., CURR. OPIN. BIOTECH., vol. 5, 1994, pages 521 - 527;;LANDY, CURR. OPIN. BIOTECH., vol. 3, 1993, pages 699 - 707;;STORZ, SCIENCE, vol. 296, 2002, pages 1260 - 3;;ILLANGASEKARE ET AL., RNA, vol. 5, 1999, pages 1482 - 1489;;WASSARMAN ET AL., TRENDS MICROBIOL., vol. 7, 1999, pages 37 - 45;;ILLANGASKARE ET AL., RNA, vol. 5, 1999, pages 1482 - 1489;;MUTO ET AL., TRENDS BIOCHEM. SCI., vol. 23, 1998, pages 25 - 29;;GILLET ET AL., MOL. MICROBIOL., vol. 42, 2001, pages 879 - 885;;EVANS, M. J. ET AL., NATURE, vol. 292, 1981, pages 154 156;;BRADLEY, M. 0. ET AL., NATURE, vol. 309, 1984, pages 255 258;;GOSSLER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 83, 1986, pages 9065 - 9069;;ROBERTSON ET AL., NATURE, vol. 322, 1986, pages 445 448;;""Teratocarcinomas and Embryonic Stem Cells, a Practical Approach"", 1987, IRL PRESS;;BRADLEY ET AL., CURRENT TOPICS IN DEVEL. BIOL., vol. 20, 1986, pages 357 371;;HOGAN ET AL.: ""Manipulating the Mouse Embryo"", 1986, COLD SPRING HARBOR LABORATORY PRESS;;THOMAS ET AL., CELL, vol. 51, 1987, pages 503;;KOLLER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 10730;;DORIN ET AL., TRANSGENIC RES., vol. 1, 1992, pages 101;;VEIS ET AL., CELL, vol. 75, 1993, pages 229;;MIYAWAKI ET AL., NATURE, vol. 388, no. 6645, 1997, pages 882 - 7;;PROC. NATL. ACAD. SCI. USA, vol. 93, 1996, pages 2348;;HUBBELL ET AL., BIO/TECHNOLOGY, vol. 13, 1995, pages 565 - 576;;LANGER, VACANTI, SCIENCE, vol. 260, 1993, pages 920 - 925;;MACPHERSON ET AL.: ""PCR: A Practical Approach"", 1991, IRL PRESS AT OXFORD UNIVERSITY PRESS;;HAMER ET AL., J MOL. APPL. GEN., vol. 1, 1982, pages 273 - 288;;MCKNIGHT, CELL, vol. 31, 1982, pages 355 - 365;;BENOIST ET AL., NATURE (LONDON), vol. 290, 1981, pages 304 - 310;;JOHNSTON ET AL., PROC. NATL. ACAD. SCI. (USA), vol. 79, 1982, pages 6971 - 6975;;SILVER ET AL., PROC. NATL. ACAD SCI. (USA), vol. 81, 1984, pages 5951 - 59SS;;HAMMER ET AL., CELL, vol. 63, 1990, pages 1099 - 1112;;HOUDEBINE, CHOURROUT, EXPERIENTIA, vol. 47, 1991, pages 897 - 905;;""Teratocarcinomas and Embryonic Stem Cells, A Practical Approach"", 1987, IRL PRESS;;HOGAN ET AL.: ""Manipulating the Mouse Embryo"", 1986, COLD SPRING HARBOR PRESS;;KRIMPENFORT ET AL., BIOLTECHNOLOGY, vol. 9, 1991, pages 86;;PALMITER ET AL., CELL, vol. 41, 1985, pages 343;;KRAEMER ET AL.: ""Genetic Manipulation of the Early Mammalian Embryo"", 1985, COLD SPRING HARBOR LABORATORY PRESS;;HAMMER ET AL., NATURE, vol. 315, 1985, pages 680;;PURCEL ET AL., SCIENCE, vol. 244, 1986, pages 1281;;PURCEL ET AL., SCIENCE, vol. 244, 1989, pages 1281 - 1288;;SIMMS ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 179 - 183;;BELT ET AL., GENE, vol. 84, 1989, pages 407 - 417;;JAMES ET AL., MUTANT RES., vol. 220, 1989, pages 169 - 185;;MAZDA ET AL., CURR. GENE THER, vol. 2, 2002, pages 379 - 392;;STOLL ET AL., MOL. THER, vol. 4, 2001, pages 122 - 129;;VAN CRAENENBROECK ET AL., EUR J BIOCHEM, vol. 267, 2000, pages 5665 - 5678;;WADE-MARTINS ET AL., NUC. ACID RES., vol. 27, 1999, pages 1674 - 1682;;THYAGARAJAN, B., REGENERATIVE MEDICINE, vol. 4, no. 2, 2009, pages 239 - 250;;THYAGARAJAN ET AL., REGENERATIVE MEDICINE, 2009",PENDING
307,WO,A1,WO 2023/086915 A1,017-492-126-474-692,2023-05-19,2023,US 2022/0079684 W,2022-11-11,US 202163278693 P,2021-11-12,SYSTEMS AND METHODS FOR VETERINARY ORAL CARE HEALTH TEST,"Methods and systems are disclosed for providing pet health diagnostic and aftercare information. Pet metadata associated with an activation code is received from a pet profile server, wherein the pet metadata and the activation code have been input by a first user using a first user device. Quantitative polymerase chain reaction (qPCR) results associated with the activation code are then received from a qPCR results server. A correlation is determined between the pet metadata and the qPCR results based on the activation code. One or more reports containing a diagnosis and/or a health recommendation are generated based on processing the pet metadata and the qPCR results. The generated one or more reports are transmitted to at least the pet profile server, the first user device, or a veterinarian device for display.",MARS INC,BENNETT MARIE-LOUISE AMANDA;;CAMERON GORDON CRAIG;;HOLCOMBE LUCY JANE;;MCGENITY PHILIP MARTIN;;RUPARELL AVIKA KISHORLAL;;WALLIS CORRYN VICTORIA;;DAVIES AMANDA ELIZABETH,,https://lens.org/017-492-126-474-692,Patent Application,yes,2,0,1,1,0,G16H50/20;;G16H10/40;;G16H15/00;;G16H40/67;;G16H50/30;;G16H20/00,G16H10/40;;G16H10/60;;G16H15/00;;G16H40/63;;G16H40/67;;G16H50/20,,0,0,,,,PENDING
308,WO,A3,WO 2011/071476 A3,075-896-291-130-732,2011-12-08,2011,US 2009/0064488 W,2009-11-13,US 11501308 P,2008-11-14,COMPOSITIONS AND METHODS FOR ENGINEERING CELLS,"The disclosure relates generally to genetic manipulation of stem and primary cells and to reprogramming of somatic cells, more specifically, human cells. In particular, compositions and methods are disclosed for the generation and maintenance of such engineered cells.",LIFE TECHNOLOGIES CORP;;LAKSHMIPATHY UMA;;THYAGARAJAN BHASKAR;;CHESNUT JONATHAN;;ANEST VASILIKI;;BENNETT ROBERT;;LIEU PAULINE;;HANSON GEORGE;;THOMPSON DAVID;;CHASE LUCAS;;SHIPLEY GARY;;WILSON ELIZABETH,LAKSHMIPATHY UMA;;THYAGARAJAN BHASKAR;;CHESNUT JONATHAN;;ANEST VASILIKI;;BENNETT ROBERT;;LIEU PAULINE;;HANSON GEORGE;;THOMPSON DAVID;;CHASE LUCAS;;SHIPLEY GARY;;WILSON ELIZABETH,,https://lens.org/075-896-291-130-732,Search Report,yes,5,0,8,8,0,C12N2799/022;;C12N2799/026;;C12N2799/027;;C12N2800/108;;C12N15/86;;C12N2799/027;;C12N2799/022;;C12N2799/026;;C12N2800/108;;C12N15/86;;C12N2710/16221;;C12N2710/16222;;C12N2710/16243;;C12N2820/002;;C12N2820/007;;C12N2820/60,C12N15/86,,13,12,022-760-388-186-892;;015-107-067-012-28X;;036-813-229-877-076;;020-296-879-062-588;;032-080-228-990-72X;;050-744-514-797-201;;051-076-139-709-120;;039-162-677-993-727;;000-913-870-711-276;;020-389-350-768-356;;042-506-738-304-839;;062-288-591-133-82X,10.1038/313812a0;;2983224;;12732203;;10.1016/s0006-291x(03)00689-2;;10.1096/fj.05-5543fje;;16790525;;18640161;;10.1016/j.jbiotec.2008.06.006;;10.1016/j.jbiotec.2005.02.021;;17467576;;10.1016/j.drudis.2007.02.017;;10.1634/stemcells.2007-0283;;17962703;;10.1126/science.1151526;;18029452;;10.1016/j.jbiotec.2007.05.022;;17617485;;pmc3610534;;15877075;;10.1038/nbt1095;;19317643;;10.2217/17460751.4.2.239;;10.1126/science.1172482;;19325077;;pmc2758053;;10.1007/978-1-60761-999-4_34;;21431539,"YATES J L ET AL: ""STABLE REPLICATION OF PLASMIDS DERIVED FROM EPSTEIN-BARR VIRUS IN VARIOUS MAMMALIAN CELLS"", NATURE (LONDON), vol. 313, no. 6005, 1985, pages 812 - 815, XP002638217, ISSN: 0028-0836;;MIN KYOUNG AH ET AL: ""Prolonged gene expression in primary porcine pancreatic cells using an Epstein-Barr virus-based episomal vector."", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 23 MAY 2003 LNKD- PUBMED:12732203, vol. 305, no. 1, 23 May 2003 (2003-05-23), pages 108 - 115, XP002638218, ISSN: 0006-291X;;PAN G ET AL: ""A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal"", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, US, vol. 20, no. 10, 1 August 2006 (2006-08-01), pages 1730 - 1732, XP008117420, ISSN: 0892-6638, [retrieved on 20060621], DOI: DOI:10.1096/FJ.05-5543FJE;;SONE T ET AL: ""Multi-gene gateway clone design for expression of multiple heterologous genes in living cells: Modular construction of multiple cDNA expression elements using recombinant cloning"", JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 136, no. 3-4, 10 September 2008 (2008-09-10), pages 113 - 121, XP024338583, ISSN: 0168-1656, [retrieved on 20080628], DOI: DOI:10.1016/J.JBIOTEC.2008.06.006;;KOST ET AL: ""Implementation of BacMam virus gene delivery technology in a drug discovery setting"", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, vol. 12, no. 9-10, 27 April 2007 (2007-04-27), pages 396 - 403, XP022063934, ISSN: 1359-6446, DOI: DOI:10.1016/J.DRUDIS.2007.02.017;;THYAGARAJAN BHASKAR ET AL: ""Creation of engineered human embryonic stem cell lines using phiC31 integrase"", STEM CELLS (MIAMISBURG), vol. 26, no. 1, 26 October 2007 (2007-10-26), pages 119 - 126, XP002638220, ISSN: 1066-5099;;YU JUNYING ET AL: ""Induced pluripotent stem cell lines derived from human somatic cells"", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 318, no. 5858, 21 December 2007 (2007-12-21), pages 1917 - 1920, XP009105055, ISSN: 1095-9203, DOI: DOI:10.1126/SCIENCE.1151526;;MAHONEN ET AL: ""Post-transcriptional regulatory element boosts baculovirus-mediated gene expression in vertebrate cells"", JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 131, no. 1, 13 July 2007 (2007-07-13), pages 1 - 8, XP022151834, ISSN: 0168-1656, DOI: DOI:10.1016/J.JBIOTEC.2007.05.022;;KOST THOMAS A ET AL: ""Baculovirus as versatile vectors for protein expression in insect and mammalian cells"", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 23, no. 5, 1 May 2005 (2005-05-01), pages 567 - 575, XP002479902, ISSN: 1087-0156, [retrieved on 20050505], DOI: DOI:10.1038/NBT1095;;THYAGARAJAN BHASKAR ET AL: ""A single EBV-based vector for stable episomal maintenance and expression of GFP in human embryonic stem cells"", REGENERATIVE MEDICINE, FUTURE MEDICINE LTD, GB, vol. 4, no. 2, 1 March 2009 (2009-03-01), pages 239 - 250, XP009148438, ISSN: 1746-0751;;YU JUNYING ET AL: ""Human induced pluripotent stem cells free of vector and transgene sequences"", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 324, no. 5928, 8 May 2009 (2009-05-08), pages 797 - 801, XP002596377, ISSN: 1095-9203, [retrieved on 20090326], DOI: DOI:10.1126/SCIENCE.1172482;;O'GRADY MICHAEL ET AL: ""BacMam-mediated gene delivery into multipotent mesenchymal stromal cells."", METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.) 2011 LNKD- PUBMED:21431539, vol. 698, 2011, pages 485 - 504, XP009148542, ISSN: 1940-6029;;QUINTANILLA R., ET AL.: ""Platform for efficient delivery of genes into embryonic and adult stem cells"", 19 May 2011 (2011-05-19), XP002638221, Retrieved from the Internet <URL:http://cellnetwork.community.invitrogen.com/servlet/JiveServlet/previewBody/1010-102-1-1020/2010%20Platform%20For%20Efficient%20Delivery%20of%20Genes%20into%20Embryoinc%20and%20Adult%20Stem%20Cells.pdf> [retrieved on 20110519]",PENDING
309,CA,A1,CA 2663500 A1,188-985-430-610-819,2008-03-20,2008,CA 2663500 A,2007-09-13,US 84507706 P;;US 2007/0019918 W,2006-09-15,"SPIRO-CONDENSED AZETIDINE DERIVATIVES USEFUL IN TREATING PAIN, DIABETES AND DISORDERS OF LIPID METABOLISM","Disclosed are compounds of the formula (I): and compounds of the formula (IIA): wherein R1, R2, R3, R4, R5, u and v are as defined herein. These comp ounds can be used in methods of treating pain (e.g., inflammatory pain, chro nic pain, and neuropathic pain), methods of treating diabetes, and methods o f inhibiting the absorption of cholesterol.",SCHERING CORP,MCKITTRICK BRIAN;;KNUTSON CHAD E;;BENNETT CHAD E;;KISELGOF EUGENIA Y;;HARRIS JOEL M;;SMITH ELIZABETH M;;TULSHIAN DEEN;;KIM HYUNJIN;;KORAKAS PETER,,https://lens.org/188-985-430-610-819,Patent Application,no,0,0,10,10,0,A61P3/00;;A61P3/06;;A61P3/10;;A61P25/02;;A61P25/04;;A61P29/00;;C07D471/08;;C07D471/08,C07D471/08;;A61K31/438;;A61P3/00,,0,0,,,,DISCONTINUED
310,MX,A,MX 2009002923 A,101-160-575-157-717,2009-03-31,2009,MX 2009002923 A,2007-09-13,US 84507706 P;;US 2007/0019918 W,2006-09-15,"SPIRO-CONDENSED AZETIDINE DERIVATIVES USEFUL IN TREATING PAIN, DIABETES AND DISORDERS OF LIPID METABILISM.","Disclosed are compounds of the formula (I): and compounds of the formula (IIA): wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup>, u and v are as defined herein. These compounds can be used in methods of treating pain (e.g., inflammatory pain, chronic pain, and neuropathic pain), methods of treating diabetes, and methods of inhibiting the absorption of cholesterol.",SCHERING CORP,TULSHIAN DEEN;;MCKITTRICK BRIAN;;SMITH ELIZABETH M;;HARRIS JOEL M;;KORAKAS PETER;;KNUTSON CHAD E;;BENNETT CHAD E;;KISELGOF EUGENIA Y;;KIM HYUNJIN,,https://lens.org/101-160-575-157-717,Patent Application,no,0,0,10,10,0,A61P3/00;;A61P3/06;;A61P3/10;;A61P25/02;;A61P25/04;;A61P29/00;;C07D471/08;;C07D471/08,C07D471/08;;A61K31/438;;A61P3/00,,0,0,,,,PENDING
311,EP,A1,EP 2061791 A1,068-217-740-915-076,2009-05-27,2009,EP 07838173 A,2007-09-13,US 2007/0019918 W;;US 84507706 P,2006-09-15,"SPIRO-CONDENSED AZETIDINE DERIVATIVES USEFUL IN TREATING PAIN, DIABETES AND DISORDERS OF LIPID METABILISM",,SCHERING CORP,MCKITTRICK BRIAN;;SMITH ELIZABETH M;;BENNETT CHAD E;;HARRIS JOEL M;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;KORAKAS PETER;;TULSHIAN DEEN;;KIM HYUNJIN,,https://lens.org/068-217-740-915-076,Patent Application,yes,0,0,10,10,0,A61P3/00;;A61P3/06;;A61P3/10;;A61P25/02;;A61P25/04;;A61P29/00;;C07D471/08;;C07D471/08,C07D471/08;;A61K31/438;;A61P3/00,,1,0,,,See references of WO 2008033456A1,DISCONTINUED
312,WO,A1,WO 2008/033456 A1,127-978-299-360-026,2008-03-20,2008,US 2007/0019918 W,2007-09-13,US 84507706 P,2006-09-15,"SPIRO-CONDENSED AZETIDINE DERIVATIVES USEFUL IN TREATING PAIN, DIABETES AND DISORDERS OF LIPID METABILISM","Disclosed are compounds of the formula (I): and compounds of the formula (IIA): wherein R 1 , R 2 , R 3 , R 4 , R 5 , u and v are as defined herein. These compounds can be used in methods of treating pain (e.g., inflammatory pain, chronic pain, and neuropathic pain), methods of treating diabetes, and methods of inhibiting the absorption of cholesterol.",SCHERING CORP;;MCKITTRICK BRIAN;;SMITH ELIZABETH M;;BENNETT CHAD E;;HARRIS JOEL M;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;KORAKAS PETER;;TULSHIAN DEEN;;KIM HYUNJIN,MCKITTRICK BRIAN;;SMITH ELIZABETH M;;BENNETT CHAD E;;HARRIS JOEL M;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;KORAKAS PETER;;TULSHIAN DEEN;;KIM HYUNJIN,,https://lens.org/127-978-299-360-026,Patent Application,yes,2,43,10,10,0,A61P3/00;;A61P3/06;;A61P3/10;;A61P25/02;;A61P25/04;;A61P29/00;;C07D471/08;;C07D471/08,C07D471/08;;A61K31/438;;A61P3/00,,0,0,,,,PENDING
313,TW,A,TW 200819451 A,152-063-358-259-165,2008-05-01,2008,TW 96134362 A,2007-09-14,US 84507706 P,2006-09-15,"Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism","Disclosed are compounds of the formula: and compounds of the formula: wherein R1, R2, R3, R4, R5, u and v are as defined herein. Also disclosed are methods of treating pain (e.g., inflammatory pain, chronic pain, and neuropathic pain), methods of treating diabetes, and methods of inhibiting the absorption of cholesterol using compounds of formula I or IIA.",SCHERING CORP,MCKITTRICK BRIAN A;;SMITH ELIZABETH M;;BENNETT CHAD E;;HARRIS JOEL M;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;KORAKAS PETER;;TULSHIAN DEEN;;KIM HYUNJIN,,https://lens.org/152-063-358-259-165,Patent of Addition,no,0,1,10,10,0,A61P3/00;;A61P3/06;;A61P3/10;;A61P25/02;;A61P25/04;;A61P29/00;;C07D471/08;;C07D471/08,C07D471/10;;A61K31/397;;A61K31/438;;A61P3/06;;A61P25/02,,0,0,,,,PENDING
314,US,A1,US 2008/0089858 A1,179-991-676-030-384,2008-04-17,2008,US 85460007 A,2007-09-13,US 85460007 A;;US 84507706 P,2006-09-15,"AZETIDINE DERIVATIVES USEFUL IN TREATING PAIN, DIABETES AND DISORDERS OF LIPID METABOLISM","Disclosed are compounds of the formula: and compounds of the formula: wherein R 1 , R 2 , R 3 , R 4 , R 5 , u and v are as defined herein. Also disclosed are methods of treating pain (e.g., inflammatory pain, chronic pain, and neuropathic pain), methods of treating diabetes, and methods of inhibiting the absorption of cholesterol using compounds of formula I or IIA.",MCKITTRICK BRIAN A;;SMITH ELIZABETH M;;BENNETT CHAD E;;HARRIS JOEL M;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;KORAKAS PETER;;TULSHIAN DEEN;;KIM HYUNJIN,MCKITTRICK BRIAN A;;SMITH ELIZABETH M;;BENNETT CHAD E;;HARRIS JOEL M;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;KORAKAS PETER;;TULSHIAN DEEN;;KIM HYUNJIN,SCHERING CORPORATION (2007-10-30),https://lens.org/179-991-676-030-384,Patent Application,yes,18,17,10,10,0,A61P3/00;;A61P3/06;;A61P3/10;;A61P25/02;;A61P25/04;;A61P29/00;;C07D471/08;;C07D471/08,A61K31/438;;A61K31/565;;A61K31/57;;A61K31/573;;A61K31/675;;A61K38/20;;A61P3/10;;C07D471/10,424/85.2;;514/110;;514/161;;514/171;;514/210.16;;514/226.5;;544/230;;544/70;;546/16,0,0,,,,INACTIVE
315,US,B2,US 7638526 B2,035-464-041-221-252,2009-12-29,2009,US 85460007 A,2007-09-13,US 85460007 A;;US 84507706 P,2006-09-15,"Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism","Disclosed are compounds of the formula: and compounds of the formula: wherein R 1 , R 2 , R 3 , R 4 , R 5 , u and v are as defined herein. Also disclosed are methods of treating pain (e.g., inflammatory pain, chronic pain, and neuropathic pain), methods of treating diabetes, and methods of inhibiting the absorption of cholesterol using compounds of formula I or IIA.",SCHERING CORP,MCKITTRICK BRIAN A;;SMITH ELIZABETH M;;BENNETT CHAD E;;HARRIS JOEL M;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;KORAKAS PETER;;TULSHIAN DEEN;;KIM HYUNJIN,SCHERING CORPORATION (2007-10-30),https://lens.org/035-464-041-221-252,Granted Patent,yes,30,6,10,10,0,A61P3/00;;A61P3/06;;A61P3/10;;A61P25/02;;A61P25/04;;A61P29/00;;C07D471/08;;C07D471/08,A61K31/438;;C07D471/10,514/278;;546/16,16,7,037-380-318-993-63X;;102-999-400-280-537;;020-426-301-835-209;;109-296-681-056-155;;072-226-712-614-902;;015-894-508-198-83X;;029-288-776-852-330,16092847;;10.1021/ol051214u;;11559183;;10.1021/jo015714m;;16388623;;10.1021/jo0517287;;15307755;;10.1021/jo049430o;;10.1021/jo040163w.s001;;15471445;;10.1021/jo040163w;;16995679;;10.1021/jo061189l;;10.1021/ja00292a040,"PCT International Search Report mail date Feb. 25, 2008 for corresponding PCT Application No. PCT/US2007/019918.;;Cignarella et al., ""Synthesis of a new series of 2,7-diazaspiro[3.5]nonan-1-ones and study of their cholinergic properties"", Eur J Med Chem 29:115-120, (1994).;;Clayden et al., ""Cyclization of Lithiated Pyridine and Quinoline Carboxamides: Synthesis of Partially Saturated Pyrrolopyridines and Spirocyclic beta-Lactams"", Organic Letters 7 (17):3673-3676, (2005).;;Alonso et al., ""Spiro beta-Lactams as beta-Turn Mimetics. Design, Synthesis, and NMR Conformational Analysis"", J. Org. Chem. 66(19):6333-6338, (2001).;;Bittermann et al., ""Chirospecific Synthesis of Spirocyclic beta-Lactams and Their Characterization as Potent Type II beta-Turn Inducing Peptide Mimetics"", J. Org. Chem. 71:97-102, (2006).;;Khasanov et al., ""Novel Asymmetric Approach to Proline-Derived Spiro-beta-Lactams"", J. Org. Chem. 69(17):5766-5769, (2004).;;Macias et al., ""Diastereoselective [2+2]-Cycloaddition Reactions of Unsymmetrical Cyclic ketens with Imines: Synthesis of Modified Prolines and Theoretical Study of the Reaction Mechanism"", J. Org. Chem. 69:7004-7012, (2004).;;Macias et al., ""Synthesis of Enantiopure Pyrrolidine-Derived Peptidomimetics and Oligo-beta-peptides via Nucleophilic Ring-Opening of beta-Lactams"", J. Org. Chem. 71:7721-7730, (2004).;;Overman et al., ""A Convenient Synthesis of 4-Unsubstituted beta-Lactams"", J. Am. Chem. Soc. 107:1698-1701, (1985).;;Database WPI, Thomson Scientific, 1985-138995 & JP 60075457A, Osaka Soda Co. Ltd., Apr. 17, 1985, Abstract.;;PCT International Search Report dated Mar. 31, 2008 for corresponding PCT Application No. PCT/US2007/019930.;;PCT International Search Report dated Feb. 25, 2008 for corresponding PCT Application No. PCT/US2007/019931.;;PCT International Search Report dated Feb. 14, 2008 for corresponding PCT Application No. PCT/US2007/019871.;;PCT International Search Report date Feb. 28, 2008 for corresponding PCT Application No. PCT/US2007/019901.;;PCT International Search Report mailed Jun. 5, 2008 for counterpart PCT Application No. PCT/US2007/019934.;;PCT International Search Report dated Dec. 12, 2008 for corresponding PCT Application No. PCT/US2007/019925.",INACTIVE
316,US,A,US 5130806 A,017-884-698-617-268,1992-07-14,1992,US 58962790 A,1990-09-28,US 58962790 A,1990-09-28,JOB COMMENT/OPERATOR MESSAGES FOR AN ELECTRONIC REPROGRAPHIC PRINTING SYSTEM,"An electronic reprographic printing system that allows the sending of messages with a print job from remote user workstations to a central reprographic printing machine. The messages can be displayed on a User Interface, such as a video monitor, and additionally printed on a break page of the print job. Also disclosed is a system for sending messages that is capable of faulting a print job until the reprographic system operator acknowledges receipt of the message. The various messages can instruct the system operator to use a particular medium for the print job, for example, or instruct the system operator how to finish (bind, wrap, etc.) a print job.",XEROX CORP,REED JEFFREY G;;PROKOP PATRICIA;;REES NANCY K M;;LEGG ERNIE L;;ZELL THOMAS;;RULLI PAUL;;BENNETT ELIZABETH;;CARTER HARRIET;;HUBE RANDY;;VALLIERE PAUL J,XEROX CORPORATION A CORP. OF NY (1991-04-29),https://lens.org/017-884-698-617-268,Granted Patent,yes,12,49,8,8,0,H04N1/00352;;H04N1/00397;;H04N1/00408;;H04N1/00411;;H04N1/00416;;H04N1/00424;;H04N1/00432;;H04N1/00437;;H04N1/00474;;H04N1/00477;;H04N1/00482;;H04N1/32101;;H04N1/32122;;H04N1/32609;;H04N1/32635;;H04N1/32657;;H04N2201/3222;;H04N2201/3242;;H04N2201/3261;;H04N2201/3271;;H04N2201/3273;;H04N2201/3278;;H04N1/00352;;H04N2201/3278;;H04N1/32609;;H04N1/00482;;H04N1/00424;;H04N1/00432;;H04N2201/3222;;H04N1/00477;;H04N1/32657;;H04N1/00416;;H04N1/00474;;H04N2201/3242;;H04N2201/3273;;H04N1/32101;;H04N1/00437;;H04N1/00411;;H04N2201/3271;;H04N1/32635;;H04N1/00397;;H04N1/00408;;H04N1/32122;;H04N2201/3261,B41J29/38;;G03G15/00;;B41J2/44;;G03G15/04;;G03G15/22;;G03G15/36;;G03G21/00;;G06F3/12;;H04N1/00;;H04N1/04;;H04N1/23;;H04N1/32,358/296;;358/434;;358/438;;358/468,0,0,,,,EXPIRED
317,MX,A,MX 9705627 A,157-678-708-492-876,1998-07-31,1998,MX 9705627 A,1996-01-24,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P;;US 9601282 W,1995-01-24,'alpha'-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR.,"Disclosed herein are processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic esters or carboxylic acids, and other monomers. The polymerizations are catalysed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described herein is the synthesis of linear 'alpha'-olefins by the oligomerization of ethylene using as a catalyst system a combination of a nickel compound having a selected 'alpha'-diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected $(a)-diimine nickel complexes with ethylene.",DU PONT;;UNIV NORTH CAROLINA AT;;CHAPEL HILL,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN,,https://lens.org/157-678-708-492-876,Patent Application,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07C251/08;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,DISCONTINUED
318,EP,A1,EP 3189802 A1,067-327-375-726-461,2017-07-12,2017,EP 17158160 A,2012-12-28,US 201161580680 P;;US 201213372902 A;;US 201213728532 A;;EP 12862889 A;;US 2012/0071911 W,2011-12-28,ORTHOPEDIC COMPRESSION PLATE,"The present invention relates to a plate and screw system which is capable of fixation of bone comprising a plate and a locking screw and a compression screw, the plate having a to surface opposing a bone facing surface in a z direction which opposes a bone surface, and the plate extending along a first length along a longitudinal axis and having a body extending along the longitudinal axis and defining a first end and a second end, wherein the first end includes a first compression slot and two tabs each including a locking hole, the tabs are offset with respect to each other in the direction of the longitudinal axis, and wherein the second end has only two tabs which each include a locking hole.
",ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,,https://lens.org/067-327-375-726-461,Patent Application,yes,4,0,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80,,0,0,,,,ACTIVE
319,AU,A1,AU 2022/252487 A1,177-696-542-814-672,2023-10-12,2023,AU 2022/252487 A,2022-03-28,US 202163167341 P;;US 202163167343 P;;US 202163220848 P;;US 202117508349 A;;US 2022/0071386 W,2021-03-29,INTEGRATED HYDROGEN PRODUCTION AND BIO-RENEWABLE CONVERSION PROCESS,A bio-renewable conversion process for making fuel from bio-renewable feedstocks is combined with a hydrogen production process that includes recovery of CO2. The integrated process uses a purge gas stream comprising hydrogen from the bio-renewable hydrocarbon production process in the hydrogen production process.,UOP LLC,CADY WILLIAM;;CARTER ELIZABETH;;RUSSELL BRADLEY;;WEXLER JAMES T;;CRUZ ADDISON;;BENNETT ERICK J;;KRAUS KURT;;CUELLAR KYLE;;KAYODE OLUWASEYI;;VENKATA SURYANARAYANA MURTHY KONDA NAGA;;BIETTO STEFANO,,https://lens.org/177-696-542-814-672,Patent Application,no,0,0,9,14,0,C10G3/42;;C10G3/52;;F25J3/0266;;F25J2200/02;;F25J2270/12;;F25J2200/40;;F25J2270/80;;F25J2270/02;;F25J2200/70;;F25J2205/02;;F25J3/0223;;F25J3/0252;;F25J2215/04;;F25J2270/66;;F25J2200/74;;C01B3/38;;C01B3/56;;C01B2203/0233;;C01B2203/0244;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/0822;;C01B2203/0827;;C01B2203/0283;;C01B2203/0405;;C01B2203/06;;C01B2203/025;;C01B2203/142;;C01B2203/146;;C01B3/501;;C01B3/38;;C01B3/56;;C10G3/42;;C10G3/52;;F25J3/0223;;F25J3/0252;;F25J3/0266;;C01B2203/0216;;C01B2203/0233;;C01B2203/0244;;C01B2203/025;;C01B2203/0283;;C01B2203/0405;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/06;;C01B2203/0822;;C01B2203/0827;;C01B2203/142;;C01B2203/146;;F25J2200/02;;F25J2200/40;;F25J2200/70;;F25J2200/74;;F25J2205/02;;F25J2215/04;;F25J2270/02;;F25J2270/12;;F25J2270/66;;F25J2270/80;;C01B3/48;;C10G2300/42;;C10G3/52;;C01B3/508;;C01B3/501;;C10G2300/1011;;C10G2300/4043;;C10G2400/04;;C10G2400/08;;C01B2203/0216;;C01B2203/0283;;C01B2203/0405;;C01B2203/043;;C01B2203/065;;C01B2203/1235;;C01B2203/86;;C10G3/42,C01B3/34;;C01B3/12;;C01B3/50;;C01B3/56,,0,0,,,,PENDING
320,US,A1,US 2015/0272639 A1,047-614-974-686-912,2015-10-01,2015,US 201514713401 A,2015-05-15,US 201514713401 A;;US 201213728532 A;;US 201213372902 A;;US 201161580680 P,2011-12-28,ORTHOPEDIC COMPRESSION PLATE AND METHOD OF SURGERY,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a closed compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10° to about 70° with a longitudinal axis of the plate. The compression housing is not located on the medial line of the plate, but is peripheral to the medial line, either in the longitudinal or the medial direction of the plate.",ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,ORTHOHELIX SURGICAL DESIGNS INC (2015-05-06),https://lens.org/047-614-974-686-912,Patent Application,yes,3,4,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80,,0,0,,,,DISCONTINUED
321,WO,A1,WO 2013/101979 A1,148-618-837-427-711,2013-07-04,2013,US 2012/0071911 W,2012-12-28,US 201161580680 P;;US 201213372902 A;;US 201213728532 A,2011-12-28,ORTHOPEDIC COMPRESSION PLATE AND METHOD OF SURGERY,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a closed compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10 to about 70 with a longitudinal axis of the plate. The compression housing is not located on the medial line of the plate, but is peripheral to the medial line, either in the longitudinal or the medial direction of the plate.",ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,,https://lens.org/148-618-837-427-711,Patent Application,yes,11,4,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80,,1,0,,,See also references of EP 2797531A4,PENDING
322,WO,A1,WO 2022/213054 A1,035-947-130-605-633,2022-10-06,2022,US 2022/0071386 W,2022-03-28,US 202163167341 P;;US 202163167343 P;;US 202163220848 P;;US 202117508349 A,2021-03-29,INTEGRATED HYDROGEN PRODUCTION AND BIO-RENEWABLE CONVERSION PROCESS,A bio-renewable conversion process for making fuel from bio-renewable feedstocks is combined with a hydrogen production process that includes recovery of CO2. The integrated process uses a purge gas stream comprising hydrogen from the bio-renewable hydrocarbon production process in the hydrogen production process.,UOP LLC,CADY WILLIAM;;CARTER ELIZABETH;;RUSSELL BRADLEY;;WEXLER JAMES T;;CRUZ ADDISON;;BENNETT ERICK J;;KRAUS KURT;;CUELLAR KYLE;;KAYODE OLUWASEYI;;VENKATA SURYANARAYANA MURTHY KONDA NAGA;;BIETTO STEFANO,,https://lens.org/035-947-130-605-633,Patent Application,yes,5,0,9,14,0,C10G3/42;;C10G3/52;;F25J3/0266;;F25J2200/02;;F25J2270/12;;F25J2200/40;;F25J2270/80;;F25J2270/02;;F25J2200/70;;F25J2205/02;;F25J3/0223;;F25J3/0252;;F25J2215/04;;F25J2270/66;;F25J2200/74;;C01B3/38;;C01B3/56;;C01B2203/0233;;C01B2203/0244;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/0822;;C01B2203/0827;;C01B2203/0283;;C01B2203/0405;;C01B2203/06;;C01B2203/025;;C01B2203/142;;C01B2203/146;;C01B3/501;;C01B3/38;;C01B3/56;;C10G3/42;;C10G3/52;;F25J3/0223;;F25J3/0252;;F25J3/0266;;C01B2203/0216;;C01B2203/0233;;C01B2203/0244;;C01B2203/025;;C01B2203/0283;;C01B2203/0405;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/06;;C01B2203/0822;;C01B2203/0827;;C01B2203/142;;C01B2203/146;;F25J2200/02;;F25J2200/40;;F25J2200/70;;F25J2200/74;;F25J2205/02;;F25J2215/04;;F25J2270/02;;F25J2270/12;;F25J2270/66;;F25J2270/80;;C01B3/48;;C10G2300/42;;C10G3/52;;C01B3/508;;C01B3/501;;C10G2300/1011;;C10G2300/4043;;C10G2400/04;;C10G2400/08;;C01B2203/0216;;C01B2203/0283;;C01B2203/0405;;C01B2203/043;;C01B2203/065;;C01B2203/1235;;C01B2203/86;;C10G3/42,C01B3/34;;C01B3/12;;C01B3/50;;C01B3/56,,0,0,,,,PENDING
323,US,A1,US 2013/0172942 A1,090-273-583-706-548,2013-07-04,2013,US 201213728532 A,2012-12-27,US 201213728532 A;;US 201213372902 A;;US 201161580680 P,2011-12-28,ORTHOPEDIC COMPRESSION PLATE AND METHOD OF SURGERY,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a dosed compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10° to about 70° with a longitudinal axis of the plate. The compression housing is not located on the medial line of the plate, but is peripheral to the medial line, either in the longitudinal or the medial direction of the plate.",ORTHOHELIX SURGICAL DES INC;;ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,ORTHOHELIX SURGICAL DESIGNS INC (2013-01-22),https://lens.org/090-273-583-706-548,Patent Application,yes,17,159,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80,606/281;;606/286,0,0,,,,ACTIVE
324,EP,B1,EP 3189802 B1,100-680-056-402-859,2022-05-25,2022,EP 17158160 A,2012-12-28,US 201161580680 P;;US 201213372902 A;;US 201213728532 A;;EP 12862889 A;;US 2012/0071911 W,2011-12-28,ORTHOPEDIC COMPRESSION PLATE,,ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,,https://lens.org/100-680-056-402-859,Granted Patent,yes,4,0,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80,,0,0,,,,ACTIVE
325,US,A1,US 2019/0150994 A1,001-699-216-955-470,2019-05-23,2019,US 201916251891 A,2019-01-18,US 201916251891 A;;US 201715445242 A;;US 201514713401 A;;US 201213728532 A;;US 201213372902 A;;US 201161580680 P,2011-12-28,ORTHOPEDIC COMPRESSION PLATE AND METHOD OF SURGERY,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a closed compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10° to about 70° with a longitudinal axis of the plate. The compression housing is not located on the medial line of the plate, but is peripheral to the medial line, either in the longitudinal or the medial direction of the plate.",ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,,https://lens.org/001-699-216-955-470,Patent Application,yes,0,4,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80;;A61B17/86,,0,0,,,,ACTIVE
326,US,B2,US 10213236 B2,171-629-580-295-879,2019-02-26,2019,US 201715445242 A,2017-02-28,US 201715445242 A;;US 201514713401 A;;US 201213728532 A;;US 201213372902 A;;US 201161580680 P,2011-12-28,Orthopedic compression plate and method of surgery,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a closed compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10° to about 70° with a longitudinal axis of the plate. The compression housing is not located on the medial line of the plate, but is peripheral to the medial line, either in the longitudinal or the medial direction of the plate.",ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,,https://lens.org/171-629-580-295-879,Granted Patent,yes,37,4,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80;;A61B17/86,,3,0,,,"European Search Report issued for European patent application No. 12862889.8, dated Nov. 23, 2015, 8 pages.;;Supplementary European Search Report issued for European patent application No. 12746929, dated Nov. 12, 2015, 3 pages.;;Extended European Search Report issued for European patent application No. 17158160.6, dated Apr. 12, 2017, 8 pages.",ACTIVE
327,EP,B1,EP 2797531 B1,194-877-079-292-41X,2017-04-19,2017,EP 12862889 A,2012-12-28,US 201161580680 P;;US 201213372902 A;;US 201213728532 A;;US 2012/0071911 W,2011-12-28,ORTHOPEDIC COMPRESSION PLATE,,ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,,https://lens.org/194-877-079-292-41X,Granted Patent,yes,11,0,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80,,0,0,,,,ACTIVE
328,EP,A4,EP 2797531 A4,107-320-763-061-657,2015-12-23,2015,EP 12862889 A,2012-12-28,US 201161580680 P;;US 201213372902 A;;US 201213728532 A;;US 2012/0071911 W,2011-12-28,ORTHOPEDIC COMPRESSION PLATE AND METHOD OF SURGERY,,ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,,https://lens.org/107-320-763-061-657,Search Report,no,5,0,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80,,1,0,,,See also references of WO 2013101979A1,ACTIVE
329,US,A1,US 2017/0238978 A1,029-337-093-829-13X,2017-08-24,2017,US 201715445242 A,2017-02-28,US 201715445242 A;;US 201514713401 A;;US 201213728532 A;;US 201213372902 A;;US 201161580680 P,2011-12-28,ORTHOPEDIC COMPRESSION PLATE AND METHOD OF SURGERY,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a closed compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10° to about 70° with a longitudinal axis of the plate. The compression housing is not located on the medial line of the plate, but is peripheral to the medial line, either in the longitudinal or the medial direction of the plate.",ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,,https://lens.org/029-337-093-829-13X,Patent Application,yes,6,3,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80;;A61B17/86,,0,0,,,,ACTIVE
330,EP,A1,EP 2797531 A1,056-444-678-508-043,2014-11-05,2014,EP 12862889 A,2012-12-28,US 201161580680 P;;US 201213372902 A;;US 201213728532 A;;US 2012/0071911 W,2011-12-28,ORTHOPEDIC COMPRESSION PLATE,,ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,,https://lens.org/056-444-678-508-043,Patent Application,yes,0,0,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80,,0,0,,,,ACTIVE
331,US,A1,US 2021/0236182 A1,022-652-061-282-120,2021-08-05,2021,US 202117233828 A,2021-04-19,US 202117233828 A;;US 201916251891 A;;US 201715445242 A;;US 201514713401 A;;US 201213728532 A;;US 201213372902 A;;US 201161580680 P,2011-12-28,ORTHOPEDIC COMPRESSION PLATE AND METHOD OF SURGERY,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a closed compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10° to about 70° with a longitudinal axis of the plate. The compression housing is not located on the medial line of the plate, but is peripheral to the medial line, either in the longitudinal or the medial direction of the plate.",ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,,https://lens.org/022-652-061-282-120,Patent Application,yes,8,0,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/80;;A61B17/86,,0,0,,,,DISCONTINUED
332,US,B2,US 9060822 B2,128-088-935-362-965,2015-06-23,2015,US 201213728532 A,2012-12-27,US 201213728532 A;;US 201213372902 A;;US 201161580680 P,2011-12-28,Orthopedic compression plate and method of surgery,"An orthopedic plate has a first end including a locking screw hole that receives a locking screw and spaced from that hole is a closed compression housing that extends from the bone-facing side of the plate and which receives a compression screw that forms an angle of from about 10° to about 70° with a longitudinal axis of the plate. The compression housing is not located on the medial line of the plate, but is peripheral to the medial line, either in the longitudinal or the medial direction of the plate.",ORTHOHELIX SURGICAL DES INC,LEWIS DEREK S;;ALTENAU ELIZABETH;;BENNETT GORDON;;DEN HARTOG BRYAN D;;HEAVENER JACKSON R;;HOCKETT BRIAN;;JOHNSON JEFFREY;;KAY DAVID B;;LEITHER ANDREW;;POKORNEY ELLEN;;WRIGHT ALLISON,ORTHOHELIX SURGICAL DESIGNS INC (2013-01-22),https://lens.org/128-088-935-362-965,Granted Patent,yes,23,74,15,22,0,A61B17/8095;;A61B17/8057;;A61B17/8061;;A61B17/8014;;A61B17/8061;;A61B17/8095;;A61B17/8057;;A61B17/8014;;A61B17/8605,A61B17/66;;A61B17/80,,0,0,,,,ACTIVE
333,CA,A1,CA 3213355 A1,080-829-459-602-846,2022-10-06,2022,CA 3213355 A,2022-03-28,US 202163167341 P;;US 202163167343 P;;US 202163220848 P;;US 202117508349 A;;US 2022/0071386 W,2021-03-29,INTEGRATED HYDROGEN PRODUCTION AND BIO-RENEWABLE CONVERSION PROCESS,A bio-renewable conversion process for making fuel from bio-renewable feedstocks is combined with a hydrogen production process that includes recovery of CO2. The integrated process uses a purge gas stream comprising hydrogen from the bio-renewable hydrocarbon production process in the hydrogen production process.,UOP LLC,CADY WILLIAM;;CARTER ELIZABETH;;RUSSELL BRADLEY;;WEXLER JAMES T;;CRUZ ADDISON;;BENNETT ERICK J III;;KRAUS KURT;;CUELLAR KYLE;;KAYODE OLUWASEYI;;VENKATA SURYANARAYANA MURTHY KONDA NAGA;;BIETTO STEFANO,,https://lens.org/080-829-459-602-846,Patent Application,no,0,0,9,14,0,C10G3/42;;C10G3/52;;F25J3/0266;;F25J2200/02;;F25J2270/12;;F25J2200/40;;F25J2270/80;;F25J2270/02;;F25J2200/70;;F25J2205/02;;F25J3/0223;;F25J3/0252;;F25J2215/04;;F25J2270/66;;F25J2200/74;;C01B3/38;;C01B3/56;;C01B2203/0233;;C01B2203/0244;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/0822;;C01B2203/0827;;C01B2203/0283;;C01B2203/0405;;C01B2203/06;;C01B2203/025;;C01B2203/142;;C01B2203/146;;C01B3/501;;C01B3/38;;C01B3/56;;C10G3/42;;C10G3/52;;F25J3/0223;;F25J3/0252;;F25J3/0266;;C01B2203/0216;;C01B2203/0233;;C01B2203/0244;;C01B2203/025;;C01B2203/0283;;C01B2203/0405;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/06;;C01B2203/0822;;C01B2203/0827;;C01B2203/142;;C01B2203/146;;F25J2200/02;;F25J2200/40;;F25J2200/70;;F25J2200/74;;F25J2205/02;;F25J2215/04;;F25J2270/02;;F25J2270/12;;F25J2270/66;;F25J2270/80;;C01B3/48;;C10G2300/42;;C10G3/52;;C01B3/508;;C01B3/501;;C10G2300/1011;;C10G2300/4043;;C10G2400/04;;C10G2400/08;;C01B2203/0216;;C01B2203/0283;;C01B2203/0405;;C01B2203/043;;C01B2203/065;;C01B2203/1235;;C01B2203/86;;C10G3/42,C01B3/34;;C01B3/12;;C01B3/50;;C01B3/56,,0,0,,,,PENDING
334,US,A1,US 2022/0306468 A1,174-720-880-138-804,2022-09-29,2022,US 202117508349 A,2021-10-22,US 202117508349 A;;US 202163220848 P;;US 202163167343 P;;US 202163167341 P,2021-03-29,INTEGRATED HYDROGEN PRODUCTION AND BIO-RENEWABLE CONVERSION PROCESS,A bio-renewable conversion process for making fuel from bio-renewable feedstocks is combined with a hydrogen production process that includes recovery of CO 2 . The integrated process uses a purge gas stream comprising hydrogen from the bio-renewable hydrocarbon production process in the hydrogen production process.,UOP LLC,CADY WILLIAM;;CARTER ELIZABETH;;RUSSELL BRADLEY;;WEXLER JAMES T;;CRUZ ADDISON;;BENNETT III ERICK J;;KRAUS KURT;;BIETTO STEFANO;;CUELLAR KYLE;;KAYODE OLUWASEYI;;KONDA NAGA VENKATA SURYANARAYANA MURTHY,UOP LLC (2021-02-01),https://lens.org/174-720-880-138-804,Patent Application,yes,2,4,9,14,0,C10G3/42;;C10G3/52;;F25J3/0266;;F25J2200/02;;F25J2270/12;;F25J2200/40;;F25J2270/80;;F25J2270/02;;F25J2200/70;;F25J2205/02;;F25J3/0223;;F25J3/0252;;F25J2215/04;;F25J2270/66;;F25J2200/74;;C01B3/38;;C01B3/56;;C01B2203/0233;;C01B2203/0244;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/0822;;C01B2203/0827;;C01B2203/0283;;C01B2203/0405;;C01B2203/06;;C01B2203/025;;C01B2203/142;;C01B2203/146;;C01B3/501;;C01B3/38;;C01B3/56;;C10G3/42;;C10G3/52;;F25J3/0223;;F25J3/0252;;F25J3/0266;;C01B2203/0216;;C01B2203/0233;;C01B2203/0244;;C01B2203/025;;C01B2203/0283;;C01B2203/0405;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/06;;C01B2203/0822;;C01B2203/0827;;C01B2203/142;;C01B2203/146;;F25J2200/02;;F25J2200/40;;F25J2200/70;;F25J2200/74;;F25J2205/02;;F25J2215/04;;F25J2270/02;;F25J2270/12;;F25J2270/66;;F25J2270/80;;C01B3/48;;C10G2300/42;;C10G3/52;;C01B3/508;;C01B3/501;;C10G2300/1011;;C10G2300/4043;;C10G2400/04;;C10G2400/08;;C01B2203/0216;;C01B2203/0283;;C01B2203/0405;;C01B2203/043;;C01B2203/065;;C01B2203/1235;;C01B2203/86;;C10G3/42,C01B3/48;;C01B3/50;;C10G3/00,,0,0,,,,ACTIVE
335,EP,A2,EP 4321480 A2,105-161-702-426-263,2024-02-14,2024,EP 23219289 A,2022-03-28,US 202163167341 P;;US 202163167343 P;;US 202163220848 P;;US 202117508349 A;;EP 22782394 A;;US 2022/0071386 W,2021-03-29,INTEGRATED HYDROGEN PRODUCTION AND BIO-RENEWABLE CONVERSION PROCESS,"A bio-renewable conversion process for making fuel from bio-renewable feedstocks is combined with a hydrogen production process that includes recovery of CO 2 . The integrated process uses a purge gas stream comprising hydrogen from the bio-renewable hydrocarbon production process in the hydrogen production process.
",UOP LLC,CADY WILLIAM;;CARTER ELIZABETH;;RUSSELL BRADLEY;;WEXLER JAMES T;;CRUZ ADDISON;;BENNETT ERICK J III;;KRAUS KURT;;CUELLAR KYLE;;KAYODE OLUWASEYI;;VENKATA SURYANARAYANA MURTHY KONDA NAGA;;BIETTO STEFANO,,https://lens.org/105-161-702-426-263,Patent Application,yes,12,0,9,14,0,C10G3/42;;C10G3/52;;F25J3/0266;;F25J2200/02;;F25J2270/12;;F25J2200/40;;F25J2270/80;;F25J2270/02;;F25J2200/70;;F25J2205/02;;F25J3/0223;;F25J3/0252;;F25J2215/04;;F25J2270/66;;F25J2200/74;;C01B3/38;;C01B3/56;;C01B2203/0233;;C01B2203/0244;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/0822;;C01B2203/0827;;C01B2203/0283;;C01B2203/0405;;C01B2203/06;;C01B2203/025;;C01B2203/142;;C01B2203/146;;C01B3/501;;C01B3/38;;C01B3/56;;C10G3/42;;C10G3/52;;F25J3/0223;;F25J3/0252;;F25J3/0266;;C01B2203/0216;;C01B2203/0233;;C01B2203/0244;;C01B2203/025;;C01B2203/0283;;C01B2203/0405;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/06;;C01B2203/0822;;C01B2203/0827;;C01B2203/142;;C01B2203/146;;F25J2200/02;;F25J2200/40;;F25J2200/70;;F25J2200/74;;F25J2205/02;;F25J2215/04;;F25J2270/02;;F25J2270/12;;F25J2270/66;;F25J2270/80;;C01B3/48;;C10G2300/42;;C10G3/52;;C01B3/508;;C01B3/501;;C10G2300/1011;;C10G2300/4043;;C10G2400/04;;C10G2400/08;;C01B2203/0216;;C01B2203/0283;;C01B2203/0405;;C01B2203/043;;C01B2203/065;;C01B2203/1235;;C01B2203/86;;C10G3/42,C01B3/50,,0,0,,,,PENDING
336,EP,A1,EP 4313852 A1,158-080-082-564-865,2024-02-07,2024,EP 22782394 A,2022-03-28,US 202163167341 P;;US 202163167343 P;;US 202163220848 P;;US 202117508349 A;;US 2022/0071386 W,2021-03-29,INTEGRATED HYDROGEN PRODUCTION AND BIO-RENEWABLE CONVERSION PROCESS,,UOP LLC,CADY WILLIAM;;CARTER ELIZABETH;;RUSSELL BRADLEY;;WEXLER JAMES T;;CRUZ ADDISON;;BENNETT ERICK J III;;KRAUS KURT;;CUELLAR KYLE;;KAYODE OLUWASEYI;;VENKATA SURYANARAYANA MURTHY KONDA NAGA;;BIETTO STEFANO,,https://lens.org/158-080-082-564-865,Patent Application,yes,0,0,9,14,0,C10G3/42;;C10G3/52;;F25J3/0266;;F25J2200/02;;F25J2270/12;;F25J2200/40;;F25J2270/80;;F25J2270/02;;F25J2200/70;;F25J2205/02;;F25J3/0223;;F25J3/0252;;F25J2215/04;;F25J2270/66;;F25J2200/74;;C01B3/38;;C01B3/56;;C01B2203/0233;;C01B2203/0244;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/0822;;C01B2203/0827;;C01B2203/0283;;C01B2203/0405;;C01B2203/06;;C01B2203/025;;C01B2203/142;;C01B2203/146;;C01B3/501;;C01B3/38;;C01B3/56;;C10G3/42;;C10G3/52;;F25J3/0223;;F25J3/0252;;F25J3/0266;;C01B2203/0216;;C01B2203/0233;;C01B2203/0244;;C01B2203/025;;C01B2203/0283;;C01B2203/0405;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/06;;C01B2203/0822;;C01B2203/0827;;C01B2203/142;;C01B2203/146;;F25J2200/02;;F25J2200/40;;F25J2200/70;;F25J2200/74;;F25J2205/02;;F25J2215/04;;F25J2270/02;;F25J2270/12;;F25J2270/66;;F25J2270/80;;C01B3/48;;C10G2300/42;;C10G3/52;;C01B3/508;;C01B3/501;;C10G2300/1011;;C10G2300/4043;;C10G2400/04;;C10G2400/08;;C01B2203/0216;;C01B2203/0283;;C01B2203/0405;;C01B2203/043;;C01B2203/065;;C01B2203/1235;;C01B2203/86;;C10G3/42,C01B3/34;;C01B3/12;;C01B3/50;;C01B3/56,,0,0,,,,PENDING
337,US,A1,US 2023/0202841 A1,167-109-422-941-974,2023-06-29,2023,US 202318176022 A,2023-02-28,US 202318176022 A;;US 202117508349 A;;US 202163220848 P;;US 202163167343 P;;US 202163167341 P,2021-03-29,INTEGRATED HYDROGEN PRODUCTION AND BIO-RENEWABLE CONVERSION PROCESS,A bio-renewable conversion process for making fuel from bio-renewable feedstocks is combined with a hydrogen production process that includes recovery of CO 2 . The integrated process uses a purge gas stream comprising hydrogen from the bio-renewable hydrocarbon production process in the hydrogen production process.,UOP LLC,CADY WILLIAM;;CARTER ELIZABETH;;RUSSELL BRADLEY;;WEXLER JAMES T;;CRUZ ADDISON;;BENNETT III ERICK J;;KRAUS KURT;;BIETTO STEFANO;;CUELLAR KYLE;;KAYODE OLUWASEYI;;KONDA NAGA VENKATA SURYANARAYANA MURTHY,UOP LLC (2021-10-26),https://lens.org/167-109-422-941-974,Patent Application,yes,2,0,9,14,0,C10G3/42;;C10G3/52;;F25J3/0266;;F25J2200/02;;F25J2270/12;;F25J2200/40;;F25J2270/80;;F25J2270/02;;F25J2200/70;;F25J2205/02;;F25J3/0223;;F25J3/0252;;F25J2215/04;;F25J2270/66;;F25J2200/74;;C01B3/38;;C01B3/56;;C01B2203/0233;;C01B2203/0244;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/0822;;C01B2203/0827;;C01B2203/0283;;C01B2203/0405;;C01B2203/06;;C01B2203/025;;C01B2203/142;;C01B2203/146;;C01B3/501;;C01B3/38;;C01B3/56;;C10G3/42;;C10G3/52;;F25J3/0223;;F25J3/0252;;F25J3/0266;;C01B2203/0216;;C01B2203/0233;;C01B2203/0244;;C01B2203/025;;C01B2203/0283;;C01B2203/0405;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/06;;C01B2203/0822;;C01B2203/0827;;C01B2203/142;;C01B2203/146;;F25J2200/02;;F25J2200/40;;F25J2200/70;;F25J2200/74;;F25J2205/02;;F25J2215/04;;F25J2270/02;;F25J2270/12;;F25J2270/66;;F25J2270/80;;C01B3/48;;C10G2300/42;;C10G3/52;;C01B3/508;;C01B3/501;;C10G2300/1011;;C10G2300/4043;;C10G2400/04;;C10G2400/08;;C01B2203/0216;;C01B2203/0283;;C01B2203/0405;;C01B2203/043;;C01B2203/065;;C01B2203/1235;;C01B2203/86;;C10G3/42,C01B3/48;;C01B3/50;;C10G3/00,,0,0,,,,PENDING
338,KR,A,KR 20230159891 A,144-080-401-871-427,2023-11-22,2023,KR 20237036933 A,2022-03-28,US 202163167341 P;;US 202163167343 P;;US 202163220848 P;;US 202117508349 A;;US 2022/0071386 W,2021-03-29,통합 수소 생산 및 생체-재생가능한 전환 프로세스,생체-재생가능한 공급원료로부터 연료를 만들기 위한 생체-재생가능한 전환 프로세스는 CO2의 회수를 포함하는 수소 생산 프로세스와 조합된다. 통합 프로세스는 수소 생산 프로세스에서 생체-재생가능한 탄화수소 생산 프로세스로부터의 수소를 포함하는 퍼지 가스 스트림을 사용한다.,UOP LLC,CADY WILLIAM;;CARTER ELIZABETH;;RUSSELL BRADLEY;;WEXLER JAMES T;;CRUZ ADDISON;;BENNETT ERICK J III;;KRAUS KURT;;CUELLAR KYLE;;KAYODE OLUWASEYI;;VENKATA SURYANARAYANA MURTHY KONDA NAGA;;BIETTO STEFANO,,https://lens.org/144-080-401-871-427,Patent Application,no,0,0,9,14,0,C10G3/42;;C10G3/52;;F25J3/0266;;F25J2200/02;;F25J2270/12;;F25J2200/40;;F25J2270/80;;F25J2270/02;;F25J2200/70;;F25J2205/02;;F25J3/0223;;F25J3/0252;;F25J2215/04;;F25J2270/66;;F25J2200/74;;C01B3/38;;C01B3/56;;C01B2203/0233;;C01B2203/0244;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/0822;;C01B2203/0827;;C01B2203/0283;;C01B2203/0405;;C01B2203/06;;C01B2203/025;;C01B2203/142;;C01B2203/146;;C01B3/501;;C01B3/38;;C01B3/56;;C10G3/42;;C10G3/52;;F25J3/0223;;F25J3/0252;;F25J3/0266;;C01B2203/0216;;C01B2203/0233;;C01B2203/0244;;C01B2203/025;;C01B2203/0283;;C01B2203/0405;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/06;;C01B2203/0822;;C01B2203/0827;;C01B2203/142;;C01B2203/146;;F25J2200/02;;F25J2200/40;;F25J2200/70;;F25J2200/74;;F25J2205/02;;F25J2215/04;;F25J2270/02;;F25J2270/12;;F25J2270/66;;F25J2270/80;;C01B3/48;;C10G2300/42;;C10G3/52;;C01B3/508;;C01B3/501;;C10G2300/1011;;C10G2300/4043;;C10G2400/04;;C10G2400/08;;C01B2203/0216;;C01B2203/0283;;C01B2203/0405;;C01B2203/043;;C01B2203/065;;C01B2203/1235;;C01B2203/86;;C10G3/42,C01B3/38;;C01B3/56;;C10G3/00;;F25J3/02,,0,0,,,,PENDING
339,US,B2,US 11772966 B2,130-708-258-481-110,2023-10-03,2023,US 202117508349 A,2021-10-22,US 202117508349 A;;US 202163220848 P;;US 202163167343 P;;US 202163167341 P,2021-03-29,Integrated hydrogen production and bio-renewable conversion process,A bio-renewable conversion process for making fuel from bio-renewable feedstocks is combined with a hydrogen production process that includes recovery of CO 2 . The integrated process uses a purge gas stream comprising hydrogen from the bio-renewable hydrocarbon production process in the hydrogen production process.,UOP LLC,CADY WILLIAM;;CARTER ELIZABETH;;RUSSELL BRADLEY;;WEXLER JAMES T;;CRUZ ADDISON;;BENNETT III ERICK J;;KRAUS KURT;;BIETTO STEFANO;;CUELLAR KYLE;;KAYODE OLUWASEYI;;KONDA NAGA VENKATA SURYANARAYANA MURTHY,UOP LLC (2021-02-01),https://lens.org/130-708-258-481-110,Granted Patent,yes,29,0,9,14,0,C10G3/42;;C10G3/52;;F25J3/0266;;F25J2200/02;;F25J2270/12;;F25J2200/40;;F25J2270/80;;F25J2270/02;;F25J2200/70;;F25J2205/02;;F25J3/0223;;F25J3/0252;;F25J2215/04;;F25J2270/66;;F25J2200/74;;C01B3/38;;C01B3/56;;C01B2203/0233;;C01B2203/0244;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/0822;;C01B2203/0827;;C01B2203/0283;;C01B2203/0405;;C01B2203/06;;C01B2203/025;;C01B2203/142;;C01B2203/146;;C01B3/501;;C01B3/38;;C01B3/56;;C10G3/42;;C10G3/52;;F25J3/0223;;F25J3/0252;;F25J3/0266;;C01B2203/0216;;C01B2203/0233;;C01B2203/0244;;C01B2203/025;;C01B2203/0283;;C01B2203/0405;;C01B2203/0415;;C01B2203/043;;C01B2203/0475;;C01B2203/06;;C01B2203/0822;;C01B2203/0827;;C01B2203/142;;C01B2203/146;;F25J2200/02;;F25J2200/40;;F25J2200/70;;F25J2200/74;;F25J2205/02;;F25J2215/04;;F25J2270/02;;F25J2270/12;;F25J2270/66;;F25J2270/80;;C01B3/48;;C10G2300/42;;C10G3/52;;C01B3/508;;C01B3/501;;C10G2300/1011;;C10G2300/4043;;C10G2400/04;;C10G2400/08;;C01B2203/0216;;C01B2203/0283;;C01B2203/0405;;C01B2203/043;;C01B2203/065;;C01B2203/1235;;C01B2203/86;;C10G3/42,C10G3/00;;C01B3/48;;C01B3/50,,7,0,,,"International Search Report from corresponding PCT application No. PCT/US2022/071386, dated Jul. 13, 2022.;;Written Opinion from corresponding PCT application No. PCT/US2022/071386, dated Jul. 13, 2022.;;International Search Report from PCT application No. PCT/US2022/071388.;;Written Opinion from PCT application No. PCT/US2022/071388.;;Kraus, Kurt el al., U.S. Appl. No. 17/451,932 entitled “Active and Passive Combustion Stabilization For Burners For Highly And Rapidly Varying Fuel Gas Compositions” filed on Oct. 22, 2021.;;International Search Report from PCT application No. PCT/US2022/071385.;;International Search Report from PCT application No. PCT/US2022/071384.",ACTIVE
340,EP,A3,EP 0478340 A3,162-261-877-170-066,1992-10-14,1992,EP 91308819 A,1991-09-27,US 58962790 A,1990-09-28,ELECTRONIC REPROGRAPHIC PRINTING SYSTEM,"An electronic reprographic printing system that allows the sending of messages with a print job from remote user workstations to a central reprographic printing machine. The messages can be displayed on a User Interface, such as a video monitor, and additionally printed on a break page of the print job. Also disclosed is a system for sending messages that is capable of faulting a print job until the reprographic system operator acknowledges receipt of the message. The various messages can instruct the system operator to use a particular medium for the print job, for example, or instruct the system operator how to finish (bind, wrap, etc.) a print job.",XEROX CORPORATION,"REED, JEFFREY;;ZELL, THOMAS B.;;HUBE, RANDALL R.;;PROKOP, PATRICIA A.;;RULLI, PAUL;;VALLIERE, PAUL J.;;MCENTERFER REES, NANCY K.;;BENNETT, ELIZABETH A.;;LEGG, ERNEST L.;;CARTER, HARRIET H.",,https://lens.org/162-261-877-170-066,Search Report,yes,5,0,8,8,0,H04N1/00352;;H04N1/00397;;H04N1/00408;;H04N1/00411;;H04N1/00416;;H04N1/00424;;H04N1/00432;;H04N1/00437;;H04N1/00474;;H04N1/00477;;H04N1/00482;;H04N1/32101;;H04N1/32122;;H04N1/32609;;H04N1/32635;;H04N1/32657;;H04N2201/3222;;H04N2201/3242;;H04N2201/3261;;H04N2201/3271;;H04N2201/3273;;H04N2201/3278;;H04N1/00352;;H04N2201/3278;;H04N1/32609;;H04N1/00482;;H04N1/00424;;H04N1/00432;;H04N2201/3222;;H04N1/00477;;H04N1/32657;;H04N1/00416;;H04N1/00474;;H04N2201/3242;;H04N2201/3273;;H04N1/32101;;H04N1/00437;;H04N1/00411;;H04N2201/3271;;H04N1/32635;;H04N1/00397;;H04N1/00408;;H04N1/32122;;H04N2201/3261,B41J2/44;;B41J29/38;;G03G15/00;;G03G15/04;;G03G15/22;;G03G15/36;;G03G21/00;;G06F3/12;;H04N1/00;;H04N1/04;;H04N1/23;;H04N1/32,,0,0,,,,EXPIRED
341,EP,A2,EP 0478340 A2,073-243-986-427-240,1992-04-01,1992,EP 91308819 A,1991-09-27,US 58962790 A,1990-09-28,Electronic reprographic printing system.,"An electronic reprographic printing system that allows the sending of messages with a print job from remote user workstations to a central reprographic printing machine. The messages can be displayed on a User Interface, such as a video monitor, and additionally printed on a break page of the print job. Also disclosed is a system for sending messages that is capable of faulting a print job until the reprographic system operator acknowledges receipt of the message. The various messages can instruct the system operator to use a particular medium for the print job, for example, or instruct the system operator how to finish (bind, wrap, etc.) a print job.",XEROX CORP,REED JEFFREY;;ZELL THOMAS B;;HUBE RANDALL R;;PROKOP PATRICIA A;;RULLI PAUL;;VALLIERE PAUL J;;MCENTERFER REES NANCY K;;BENNETT ELIZABETH A;;LEGG ERNEST L;;CARTER HARRIET H,,https://lens.org/073-243-986-427-240,Patent Application,yes,0,13,8,8,0,H04N1/00352;;H04N1/00397;;H04N1/00408;;H04N1/00411;;H04N1/00416;;H04N1/00424;;H04N1/00432;;H04N1/00437;;H04N1/00474;;H04N1/00477;;H04N1/00482;;H04N1/32101;;H04N1/32122;;H04N1/32609;;H04N1/32635;;H04N1/32657;;H04N2201/3222;;H04N2201/3242;;H04N2201/3261;;H04N2201/3271;;H04N2201/3273;;H04N2201/3278;;H04N1/00352;;H04N2201/3278;;H04N1/32609;;H04N1/00482;;H04N1/00424;;H04N1/00432;;H04N2201/3222;;H04N1/00477;;H04N1/32657;;H04N1/00416;;H04N1/00474;;H04N2201/3242;;H04N2201/3273;;H04N1/32101;;H04N1/00437;;H04N1/00411;;H04N2201/3271;;H04N1/32635;;H04N1/00397;;H04N1/00408;;H04N1/32122;;H04N2201/3261,B41J2/44;;B41J29/38;;G03G15/00;;G03G15/04;;G03G15/22;;G03G15/36;;G03G21/00;;G06F3/12;;H04N1/00;;H04N1/04;;H04N1/23;;H04N1/32,,0,0,,,,EXPIRED
342,DK,T3,DK 3448419 T3,004-284-561-507-163,2023-06-26,2023,DK 17733171 T,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,Interferon-beta-antistoffer og anvendelser deraf,,PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAME PERRY;;COYLE ANTHONY JOHN,,https://lens.org/004-284-561-507-163,Granted Patent,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,0,0,,,,ACTIVE
343,HU,T2,HU E063621 T2,123-235-513-002-041,2024-01-28,2024,HU E17733171 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,,PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAME PERRY;;COYLE ANTHONY JOHN,,https://lens.org/123-235-513-002-041,Amended Patent,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,0,0,,,,PENDING
344,EP,A2,EP 4273165 A2,191-037-613-188-014,2023-11-08,2023,EP 23177086 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;EP 17733171 A;;US 2017/0030089 W,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNβ). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/191-037-613-188-014,Patent Application,yes,8,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24,,25,17,045-100-665-600-475;;066-749-017-721-197;;009-792-357-114-461;;062-200-278-153-884;;038-383-743-124-048;;026-164-216-541-151;;082-474-862-036-218;;010-916-105-450-247;;026-048-786-530-595;;085-727-974-637-837;;005-119-615-003-591;;024-995-475-936-443;;017-150-654-990-340;;002-264-966-090-625;;001-467-559-709-949;;095-334-545-560-259;;019-130-383-424-869,10.1073/pnas.1510944112;;pmc4687607;;26621728;;8341653;;10.1073/pnas.90.14.6444;;pmc46948;;10.1016/j.ab.2003.12.025;;15081905;;2314296;;10.1016/0076-6879(90)83041-7;;10.1093/bioinformatics/5.2.151;;2720464;;3382986;;10.1093/bioinformatics/4.1.11;;pmc393452;;6572363;;10.1073/pnas.80.3.726;;10.1038/nbt0792-779;;1368267;;10.1016/0378-1119(95)00821-7;;8647439;;7897213;;10.4049/jimmunol.154.7.3310;;10.1016/0022-2836(92)90639-2;;1507232;;10.1038/342877a0;;2687698;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;10.1016/s0969-2126(94)00113-8;;7704521;;10.1006/jmbi.1996.0548;;8876650;;17947238;;10.1074/jbc.m706190200,"TOWNSEND ET AL.: ""Augmented Binary Substitution: Single-pass CDR germlining and stabilization of therapeutic antibodies"", PNAS, vol. 112, 2015, pages 15354 - 15359, XP055513906, DOI: 10.1073/pnas.1510944112;;CACECI, BYTE, vol. 9, 1984, pages 340 - 362;;HOLLIGER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 6444 - 6448;;DRAKE ET AL., ANALYTICAL BIOCHEMISTRY, vol. 328, 2004, pages 35 - 43;;DAYHOFF, M.O.: ""Atlas of Protein Sequence and Structure"", vol. 5, 1978, NATIONAL BIOMEDICAL RESEARCH FOUNDATION, article ""A model of evolutionary change in proteins - Matrices for detecting distant relationships"", pages: 345 - 358;;HEIN J.: ""Methods in Enzymology"", vol. 183, 1990, ACADEMIC PRESS, INC., article ""Unified Approach to Alignment and Phylogenes"", pages: 626 - 645;;HIGGINS, D.G.SHARP, P.M., CABIOS, vol. 5, 1989, pages 151 - 153;;MYERS, E.W.MULLER W., CABIOS, vol. 4, 1988, pages 11 - 17;;ROBINSON, E.D., COMB. THEOR., vol. 11, 1971, pages 105;;SANTOU, N.NES, M., MOL. BIOL. EVOL., vol. 4, 1987, pages 406 - 425;;SNEATH, P.H.A.SOKAL, R.R.: ""Numerical Taxonomy the Principles and Practice of Numerical Taxonomy"", 1973, FREEMAN PRESS;;WILBUR, W.J.LIPMAN, D.J., PROC., vol. 80, 1983, pages 726 - 730;;BARBAS ET AL., PROC NAT. ACAD. SCI, 1994;;MARKS ET AL., BIO/TECHNOLOGY, vol. 10, 1992, pages 779 - 783;;SCHIER ET AL., GENE, vol. 169, 1995, pages 147 - 155;;JACKSON ET AL., J. IMMUNOL., vol. 154, no. 7, 1995, pages 3310 - 2004;;HAWKINS ET AL., J. MOL. BIOL., vol. 226, 1992, pages 889 - 896;;""Remington: The Science and practice of Pharmacy"", 2000, LIPPINCOTT WILLIAMS AND WILKINS;;CHOTHIA ET AL., NATURE, vol. 342, 1989, pages 877 - 883;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;POLJAK ET AL., STRUCTURE, vol. 2, 1994, pages 1121 - 1123;;KABAT ET AL.: ""Sequences of Proteins of Immunological Interest"", 1991, PUBLIC HEALTH SERVICE, NATIONAL INSTITUTES OF HEALTH;;MACCALLUM ET AL., J. MOL. BIOL., vol. 262, 1996, pages 732 - 745;;MAKABE ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 283, 2008, pages 1156 - 1166",PENDING
345,BR,A,BR 0206683 A,064-865-385-321-045,2004-02-10,2004,BR 0206683 A,2002-11-15,US 33279901 P;;US 33279801 P;;US 40792402 P;;US 0236889 W,2001-11-16,Processo de copolimerização e copolìmero,"""PROCESSO DE COPOLIMERIZAçãO E COPOLìMERO"". Etileno e alil ou vinilsilanos são eficientemente copolimerizados por certos complexos metálicos de transição lenta que contêm ligantes bidentados ou tridentados selecionados. Os polímeros inovadores resultantes podem ser reticulados pela umidade quando vinilsilano contiver grupos ligados a silício que sejam hidrolisáveis. Os polímeros são úteis para revestimento de fios, espumas reticuladas, canos e outras utilizações.",DU PONT,JOHNSON LYNDA KAYE;;MCLAIN STEPHAN J;;SWEETMAN KARL J;;WANG YING;;BENNETT ALISON M A;;WANG LIN;;MCCORD ELIZABETH FORRESTER;;IONKIN ALEX;;ITTEL STEVEN DALE;;RADZEWICH CATHERINE E;;SCHIFFINO RINALDO S,,https://lens.org/064-865-385-321-045,Patent Application,no,0,0,22,22,0,C08F4/65908;;C08F4/65912;;C08F4/65916;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/02;;C08F210/16;;C08F2410/07;;C08F210/02;;C08F8/00;;C08F10/00;;C08F4/44;;C08F210/02;;C08F210/16;;C08F4/65916;;C08F4/65912;;C08F10/00;;C08F4/65908;;C08F110/02;;C08F10/02,C08F4/659;;C08F4/70;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/00;;C08F210/02;;C08F210/16;;C08F230/08,,0,0,,,,DISCONTINUED
346,EP,A2,EP 1448628 A2,080-523-864-868-398,2004-08-25,2004,EP 02803647 A,2002-11-15,US 0236889 W;;US 33279901 P;;US 33279801 P;;US 40792402 P,2001-11-16,COPOLYMERS OF OLEFINS AND VINYL- AND ALLYLSILANES,,DU PONT,JOHNSON LYNDA KAYE;;MCLAIN STEPHAN J;;SWEETMAN KARL J;;WANG YING;;BENNETT ALISON M A;;WANG LIN;;MCCORD ELIZABETH FORRESTER;;IONKIN ALEX;;ITTEL STEVEN DALE;;RADZEWICH CATHERINE E;;SCHIFFINO RINALDO S,,https://lens.org/080-523-864-868-398,Patent Application,yes,5,0,22,22,0,C08F4/65908;;C08F4/65912;;C08F4/65916;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/02;;C08F210/16;;C08F2410/07;;C08F210/02;;C08F8/00;;C08F10/00;;C08F4/44;;C08F210/02;;C08F210/16;;C08F4/65916;;C08F4/65912;;C08F10/00;;C08F4/65908;;C08F110/02;;C08F10/02,C08F4/659;;C08F4/70;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/00;;C08F210/02;;C08F210/16;;C08F230/08,,0,0,,,,DISCONTINUED
347,ES,T3,ES 2950288 T3,089-261-517-475-813,2023-10-06,2023,ES 17733171 T,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,Anticuerpos interferón beta y usos de los mismos,"La invención se refiere a anticuerpos, o fragmentos de unión a antígeno de los mismos, que se unen específicamente al interferón beta (IFNp). Dichos anticuerpos, o fragmentos de unión a antígeno de los mismos, son útiles para diversos fines terapéuticos o de diagnóstico. (Traducción automática con Google Translate, sin valor legal)",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAME PERRY;;COYLE ANTHONY JOHN,,https://lens.org/089-261-517-475-813,Granted Patent,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,0,0,,,,ACTIVE
348,CA,A1,CA 2433042 A1,015-243-562-940-602,2003-05-30,2003,CA 2433042 A,2002-11-15,US 33279901 P;;US 33279801 P;;US 40792402 P;;US 0236889 W,2001-11-16,COPOLYMERS OF OLEFINS AND VINYL- AND ALLYLSILANES,"Ethylene and allyl- or vinylsilanes are efficiently copolymerized by certain late transition metal complexes containing selected bidentate or tridentate ligands. The resulting novel polymers may be crosslinked by moisture when vinylsilane contains groups bound to silicon which are hydrolyzable. The polymers are useful for wire coating, crosslinked foams, pipes, and other us es.",DU PONT,SWEETMAN KARL J;;WANG YING;;LONKIN ALEX;;BENNETT ALISON M A;;MCCORD ELIZABETH FORRESTER;;ITTEL STEVEN DALE;;JOHNSON LYNDA KAYE;;SCHIFFINO RINALDO S;;RADZEWICH CATHERINE E;;WANG LIN;;MCLAIN STEPHAN J,,https://lens.org/015-243-562-940-602,Patent Application,no,0,0,22,22,0,C08F4/65908;;C08F4/65912;;C08F4/65916;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/02;;C08F210/16;;C08F2410/07;;C08F210/02;;C08F8/00;;C08F10/00;;C08F4/44;;C08F210/02;;C08F210/16;;C08F4/65916;;C08F4/65912;;C08F10/00;;C08F4/65908;;C08F110/02;;C08F10/02,C08F4/659;;C08F4/70;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/00;;C08F210/02;;C08F210/16;;C08F230/08,,0,0,,,,DISCONTINUED
349,AU,B2,AU 2017/258492 B2,137-805-694-197-684,2023-12-07,2023,AU 2017/258492 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,Interferon beta antibodies and uses thereof,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNp). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/137-805-694-197-684,Granted Patent,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24;;A61K39/00,,0,0,,,,ACTIVE
350,TW,B,TW I776808 B,128-381-238-590-535,2022-09-11,2022,TW 106114362 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P,2016-04-29,Interferon beta antibodies and uses thereof,,PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/128-381-238-590-535,Granted Patent,no,1,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,,,3,0,,,"期刊 Sominanda, Ajith, et al.""Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta."" Archives of neurology 67.9, American Medical Association,2010, p.1095-1101.;;期刊 Sheehan, Kathleen CF, et al. ""Selective blockade of interferon-α and-β reveals their non-redundant functions in a mouse model of West Nile virus infection."" PloS one 10.5, e0128636, Public Library of Science, 2015, p.1-19.;;期刊 Runkel, Laura, et al. ""Mapping of IFN-β epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis."" Journal of Interferon & Cytokine Research 21.11, Mary Ann Liebert, Inc.,2001, p.931-941.",ACTIVE
351,PH,A1,PH 12018502275 A1,008-674-849-157-122,2019-09-09,2019,PH 12018502275 A,2018-10-25,US 201662339709 P;;US 201662329327 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNp). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.",BRIGHAM & WOMENS HOSPITAL INC;;PFIZER,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/008-674-849-157-122,Patent Application,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,0,0,,,,PENDING
352,EP,A1,EP 1023679 A1,151-578-238-731-222,2000-08-02,2000,EP 98953805 A,1998-10-20,US 9822215 W;;US 6313697 P,1997-10-22,COMPUTER THESAURUS MANAGER,,GLAXO GROUP LTD,ABED SAMIR IBRAHIM;;BARRY COYLA BELL;;BENNETT PAUL NATHAN;;GADBOIS DAVID GREGORY;;GOOLSBEY KEITH MICHAEL;;MCKAY ALBERTA SPROTT;;MURRAY KENNETH S;;PITTMAN KAREN ELIZABETH;;SIEGEL NICHOLAS PAUL;;THOMPSON REUBIN C JR,,https://lens.org/151-578-238-731-222,Patent Application,yes,0,0,4,4,0,G06F16/374,G06F17/30,,1,0,,,See references of WO 9921110A1,DISCONTINUED
353,WO,A1,WO 2017/189983 A1,198-403-297-107-172,2017-11-02,2017,US 2017/0030089 W,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNp). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/198-403-297-107-172,Patent Application,yes,11,2,46,47,166,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,32,23,019-888-090-725-288;;057-456-035-417-644;;061-628-132-124-045;;004-740-182-961-805;;045-100-665-600-475;;156-505-198-248-90X;;062-200-278-153-884;;038-383-743-124-048;;026-164-216-541-151;;082-474-862-036-218;;010-916-105-450-247;;016-251-721-517-200;;026-048-786-530-595;;085-727-974-637-837;;005-119-615-003-591;;074-817-300-512-106;;017-150-654-990-340;;002-264-966-090-625;;066-749-017-721-197;;001-467-559-709-949;;024-995-475-936-443;;095-334-545-560-259;;019-130-383-424-869,20837854;;10.1001/archneurol.2010.218;;pmc4444312;;26010249;;10.1371/journal.pone.0128636;;11747625;;10.1089/107999001753289541;;10.2210/pdb1au1/pdb;;10.1073/pnas.94.22.11813;;9342320;;pmc23607;;10.1073/pnas.1510944112;;pmc4687607;;26621728;;8516284;;10.1073/pnas.90.12.5428;;pmc46733;;2314296;;10.1016/0076-6879(90)83041-7;;10.1093/bioinformatics/5.2.151;;2720464;;3382986;;10.1093/bioinformatics/4.1.11;;pmc393452;;6572363;;10.1073/pnas.80.3.726;;10.1038/nbt0792-779;;1368267;;10.1073/pnas.91.9.3809;;pmc43671;;8170992;;10.1016/0378-1119(95)00821-7;;8647439;;7897213;;10.4049/jimmunol.154.7.3310;;10.1016/0022-2836(92)90639-2;;1507232;;10.1038/341544a0;;2677748;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;8341653;;10.1073/pnas.90.14.6444;;pmc46948;;10.1016/s0969-2126(94)00113-8;;7704521;;10.1038/342877a0;;2687698;;10.1006/jmbi.1996.0548;;8876650;;17947238;;10.1074/jbc.m706190200,"AJITH SOMINANDA ET AL: ""Inhibition of Endogenous Interferon Beta by Neutralizing Antibodies Against Recombinant Interferon Beta"", ARCHIVES OF NEUROLOGY., vol. 67, no. 9, 1 September 2010 (2010-09-01), US, XP055399988, ISSN: 0003-9942, DOI: 10.1001/archneurol.2010.218;;KATHLEEN C. F. SHEEHAN ET AL: ""Selective Blockade of Interferon-[alpha] and -[beta] Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection"", PLOS ONE, vol. 10, no. 5, 26 May 2015 (2015-05-26), pages e0128636, XP055400161, DOI: 10.1371/journal.pone.0128636;;RUNKEL L ET AL: ""MAPPING OF IFN-BETA EPITOPES IMPORTANT FOR RECEPTOR BINDING AND BIOLOGIC ACTIVATION: COMPARISON OF RESULTS ACHIEVED USING ANTIBODY-BASED METHODS AND ALANINE SUBSTITUTION MUTAGENESIS"", JOURNAL OF INTERFERON AND CYTOKINE RESEA, MARY ANN LIEBERT, NEW YORK, NY, US, vol. 21, no. 11, 1 November 2001 (2001-11-01), pages 931 - 941, XP009011507, ISSN: 1079-9907, DOI: 10.1089/107999001753289541;;KARPUSAS MICHAEL ET AL: ""The crystal structure of human interferon beta at 2.2-A resolution"", PROCEEDINGS NATIONAL ACADEMY OF SCIENCES PNAS, NATIONAL ACADEMY OF SCIENCES, US, vol. 94, no. 22, 28 October 1997 (1997-10-28), pages 11813 - 11818, XP002160243, ISSN: 0027-8424, DOI: 10.1073/PNAS.94.22.11813;;TOWNSEND ET AL.: ""Augmented Binary Substitution: Single-pass CDR germlining and stabilization of therapeutic antibodies"", PNAS, vol. 112, 2015, pages 15354 - 15359;;WONG; LOHMAN, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5428 - 5432;;DAYHOFF, M.O.: ""Atlas of Protein Sequence and Structure"", vol. 5, 1978, NATIONAL BIOMEDICAL RESEARCH FOUNDATION, article DAYHOFF, M.O.: ""A model of evolutionary change in proteins - Matrices for detecting distant relationships"", pages: 345 - 358;;HEIN J.: ""Methods in Enzymology"", vol. 183, 1990, ACADEMIC PRESS, INC., article ""Unified Approach to Alignment and Phylogenes"", pages: 626 - 645;;HIGGINS, D.G.; SHARP, P.M., CABIOS, vol. 5, 1989, pages 151 - 153;;MYERS, E.W.; MULLER W., CABIOS, vol. 4, 1988, pages 11 - 17;;ROBINSON, E.D., COMB. THEOR., vol. 11, 1971, pages 105;;SANTOU, N.; NES, M., MOL. BIOL. EVOL., vol. 4, 1987, pages 406 - 425;;SNEATH, P.H.A.; SOKAL, R.R.: ""Numerical Taxonomy the Principles and Practice of Numerical Taxonomy"", 1973, FREEMAN PRESS;;WILBUR, W.J.; LIPMAN, D.J., PROC. NATL. ACAD. SCI. USA, vol. 80, 1983, pages 726 - 730;;MULLIS ET AL.: ""PCR: The Polymerase Chain Reaction"", 1994, BIRKAUSWER PRESS;;MARKS ET AL., BIO/TECHNOLOGY, vol. 10, 1992, pages 779 - 783;;BARBAS ET AL., PROC NAT. ACAD. SCI, USA, vol. 91, 1994, pages 3809 - 3813;;SCHIER ET AL., GENE, vol. 169, 1995, pages 147 - 155;;YELTON ET AL., J. IMMUNOL., vol. 155, 1995, pages 1994 - 2004;;JACKSON ET AL., J. IMMUNOL., vol. 154, no. 7, 1995, pages 3310 - 9;;HAWKINS ET AL., J. MOL. BIOL., vol. 226, 1992, pages 889 - 896;;K. E. HOOVER: ""Remington: The Science and practice of Pharmacy, 20th ed"", 2000, LIPPINCOTT WILLIAMS AND WILKINS;;WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;HOLLIGER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 6444 - 6448;;POLJAK ET AL., STRUCTURE, vol. 2, 1994, pages 1121 - 1123;;KABAT ET AL.: ""Sequences of Proteins of Immunological Interest, 5th ed"", 1991;;CHOTHIA ET AL., NATURE, vol. 342, 1989, pages 877 - 883;;MACCALLUM ET AL., J. MOL. BIOL., vol. 262, 1996, pages 732 - 745;;MAKABE ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 283, 2008, pages 1156 - 1166;;KABAT ET AL.: ""Sequences of Proteins of Immunological Interest, 5th ed"", 1991, NATIONAL INSTITUTES OF HEALTH",PENDING
354,WO,A1,WO 1999/021110 A1,105-658-466-882-091,1999-04-29,1999,US 9822215 W,1998-10-20,US 6313697 P,1997-10-22,COMPUTER THESAURUS MANAGER,"A system for integrated access to information from a number of separate thesaurus subsets includes an input subsystem for accepting a thesaurus query; a processing subsystem that collects, from the subsets, entries that correspond to the request, treating the subsets as a single integrated thesaurus; and an output subsystem for displaying the retrieved entries. HTML user interface allows user access to the system via a web browser. The retrieved are displayed entries and, optionally, related terms or details of the thesaurus subset from which they were retrieved are also displayed. The thesaurus subsets may be integrated as a single thesaurus either literally or virtually. The thesaurus subsets may form a single integrated thesaurus by using concepts to establish relationships among terms in the thesaurus. Entries or terms stored in the thesaurus subset can be correlated to eliminate multiple entries with a shared or highly similar meaning in a particular thesaurus subset or across multiple subsets. Restrictions may also be placed on the relations between terms in a particular thesaurus subset or across multiple thesauri subsets in order to maintain the integrity of the thesaurus.",GLAXO GROUP LTD;;ABED SAMIR IBRAHIM;;BARRY COYLA BELL;;BENNETT PAUL NATHAN;;GADBOIS DAVID GREGORY;;GOOLSBEY KEITH MICHAEL;;MCKAY ALBERTA SPROTT;;MURRAY KENNETH S;;PITTMAN KAREN ELIZABETH;;SIEGEL NICHOLAS PAUL;;THOMPSON REUBIN CLIFTON JR,ABED SAMIR IBRAHIM;;BARRY COYLA BELL;;BENNETT PAUL NATHAN;;GADBOIS DAVID GREGORY;;GOOLSBEY KEITH MICHAEL;;MCKAY ALBERTA SPROTT;;MURRAY KENNETH S;;PITTMAN KAREN ELIZABETH;;SIEGEL NICHOLAS PAUL;;THOMPSON REUBIN CLIFTON JR,,https://lens.org/105-658-466-882-091,Patent Application,yes,0,6,4,4,0,G06F16/374,G06F17/30,,3,2,152-969-583-037-981;;040-179-284-695-67X,10.1007/s007990050009;;10.1145/258525.258551,"KRAMER R. ET AL: ""Thesaurus federations: loosely integrated thesauri for document retrieval in networks based on Internet technologies"", INTERNATIONAL JOURNAL ON DIGITAL LIBRARIES, vol. 1, no. 2, September 1997 (1997-09-01), http://link.springer.de/link/service/journals/00799/papers/7001002/70010122.pdf, XP002094377;;NISHIKAWA N ET AL: ""Allowing multiple experts to revise a thesaurus database"", DESIGN OF COMPUTING SYSTEMS: COGNITIVE CONSIDERATIONS. PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE ON HUMAN-COMPUTER INTERACTION (HCI INTERNATIONAL '97), PROCEEDINGS OF HCI INTERNATIONAL 97. 7TH INTERNATIONAL CONFERENCE ON HUMAN COMPUTER INTE, ISBN 0-444-82183-X, 1997, Amsterdam, Netherlands, Elsevier, Netherlands, pages 371 - 374 vol.2, XP002094378;;M. SINTICHAKIS AND P. CONSTANTOPOULOS: ""A Method for Monolingual Thesauri Merging"", PROC. 20TH INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, ACM SIGIR, 27 JULY 1997, PHILADELPHIA, PA, USA., http://www.ics.forth.gr/proj/isst/Publications/paperlink/A_method_for_Monoling_Thesauri_Merg.ps.gz, pages 129 - 138, XP000775964",PENDING
355,SI,T1,SI 3448419 T1,121-710-370-259-866,2023-10-30,2023,SI 201731384 T,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W;;EP 17733171 A,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,,PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAME PERRY;;COYLE ANTHONY JOHN,,https://lens.org/121-710-370-259-866,Granted Patent,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/00,,0,0,,,,ACTIVE
356,EP,A1,EP 3448419 A1,160-707-090-577-429,2019-03-06,2019,EP 17733171 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,,PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,"PFIZER INC. (2023-04-19);;THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (2023-04-19)",https://lens.org/160-707-090-577-429,Patent Application,yes,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,0,0,,,,ACTIVE
357,US,A1,US 2021/0163588 A1,198-278-453-859-190,2021-06-03,2021,US 202017092998 A,2020-11-09,US 202017092998 A;;US 201715581079 A;;US 201762483669 P;;US 201662339709 P;;US 201662329327 P,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNβ). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/198-278-453-859-190,Patent Application,yes,1,0,46,47,166,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24,,6,5,062-311-117-599-22X;;042-994-275-708-524;;059-333-473-231-906;;015-630-305-390-881;;060-059-082-853-608,29559718;;10.1038/nrrheum.2018.31;;pmc6625751;;33869112;;pmc8044321;;10.3389/fped.2021.631329;;10.1681/asn.2004111014;;16221871;;14734823;;10.1385/mb:26:1:39;;6170512;;10.1111/j.1432-1033.1981.tb05539.x,"(Muskardin, Theresa L Wampler, and Timothy B Niewold. Nature reviews. Rheumatology vol. 14,4 (2018): 214-228. doi:10.1038/nrrheum.2018.31 (Year: 2018);;d'Angelo, Debora M., et al. Frontiers in Pediatrics 9 (2021): 631329 (Year: 2021);;Schwarting, Andreas, et al. Journal of the American Society of Nephrology 16.11 (2005): 3264-3272 (Year: 2005);;Kipriyanov, Sergey M., and Fabrice Le Gall. ""Generation and production of engineered antibodies."" Molecular biotechnology 26.1 (2004): 39-60. (Year: 2004);;Janeway, Charles A. ""Immunobiology: The Immune System in Health and Disease."" 2001 (Year: 2001);;HOCHKEPPEL, Heinz‐Kurt, Ullrich MENGE, and John COLLINS. ""Monoclonal antibodies against human fibroblast interferon."" European Journal of Biochemistry 118.3 (1981): 437-442. (Year: 1981)",ACTIVE
358,EP,B1,EP 0478340 B1,004-491-785-506-073,1997-07-16,1997,EP 91308819 A,1991-09-27,US 58962790 A,1990-09-28,Electronic reprographic printing system,,XEROX CORP,REED JEFFREY G;;ZELL THOMAS B;;HUBE RANDALL R;;PROKOP PATRICIA A;;RULLI PAUL A;;VALLIERE PAUL J;;MCENTERFER REES NANCY K;;BENNETT ELIZABETH A;;LEGG ERNEST L;;CARTER HARRIET H,,https://lens.org/004-491-785-506-073,Granted Patent,yes,5,0,8,8,0,H04N1/00352;;H04N1/00397;;H04N1/00408;;H04N1/00411;;H04N1/00416;;H04N1/00424;;H04N1/00432;;H04N1/00437;;H04N1/00474;;H04N1/00477;;H04N1/00482;;H04N1/32101;;H04N1/32122;;H04N1/32609;;H04N1/32635;;H04N1/32657;;H04N2201/3222;;H04N2201/3242;;H04N2201/3261;;H04N2201/3271;;H04N2201/3273;;H04N2201/3278;;H04N1/00352;;H04N2201/3278;;H04N1/32609;;H04N1/00482;;H04N1/00424;;H04N1/00432;;H04N2201/3222;;H04N1/00477;;H04N1/32657;;H04N1/00416;;H04N1/00474;;H04N2201/3242;;H04N2201/3273;;H04N1/32101;;H04N1/00437;;H04N1/00411;;H04N2201/3271;;H04N1/32635;;H04N1/00397;;H04N1/00408;;H04N1/32122;;H04N2201/3261,B41J2/44;;B41J29/38;;G03G15/00;;G03G15/04;;G03G15/22;;G03G15/36;;G03G21/00;;G06F3/12;;H04N1/00;;H04N1/04;;H04N1/23;;H04N1/32,,0,0,,,,EXPIRED
359,WO,A3,WO 2003/044066 A3,136-203-752-335-228,2004-02-12,2004,US 0236889 W,2002-11-15,US 33279901 P;;US 33279801 P;;US 40792402 P,2001-11-16,COPOLYMERS OF OLEFINS AND VINYL- AND ALLYLSILANES,"Ethylene and allyl- or vinylsilanes are efficiently copolymerized by certain late transition metal complexes containing selected bidentate or tridentate ligands. The resulting novel polymers may be crosslinked by moisture when vinylsilane contains groups bound to silicon which are hydrolyzable. The polymers are useful for wire coating, crosslinked foams, pipes, and other uses.",DU PONT;;JOHNSON LYNDA KAYE;;MCLAIN STEPHAN J;;SWEETMAN KARL J;;WANG YING;;BENNETT ALISON M A;;WANG LIN;;MCCORD ELIZABETH FORRESTER;;IONKIN ALEX;;ITTEL STEVEN DALE;;RADZEWICH CATHERINE E;;SCHIFFINO RINALDO S,JOHNSON LYNDA KAYE;;MCLAIN STEPHAN J;;SWEETMAN KARL J;;WANG YING;;BENNETT ALISON M A;;WANG LIN;;MCCORD ELIZABETH FORRESTER;;IONKIN ALEX;;ITTEL STEVEN DALE;;RADZEWICH CATHERINE E;;SCHIFFINO RINALDO S,,https://lens.org/136-203-752-335-228,Search Report,yes,3,0,22,22,0,C08F4/65908;;C08F4/65912;;C08F4/65916;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/02;;C08F210/16;;C08F2410/07;;C08F210/02;;C08F8/00;;C08F10/00;;C08F4/44;;C08F210/02;;C08F210/16;;C08F4/65916;;C08F4/65912;;C08F10/00;;C08F4/65908;;C08F110/02;;C08F10/02,C08F4/659;;C08F4/70;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/00;;C08F210/02;;C08F210/16;;C08F230/08,,0,0,,,,PENDING
360,JP,A,JP 2021040642 A,116-246-924-775-17X,2021-03-18,2021,JP 2020192541 A,2020-11-19,US 201662339709 P;;US 201662329327 P;;US 201762483669 P,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,"To provide antibodies useful for various therapeutic or diagnostic purposes.SOLUTION: The invention relates to isolated nucleic acids encoding antibodies or antigen-binding fragments thereof that specifically bind to interferon beta (IFNβ), and use thereof and related methods.SELECTED DRAWING: None",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,STEFANO V GULLA;;CHRISTINE HUARD;;JANET ELIZABETH BUHLMANN;;JUAN CARLOS ALMAGRO;;SREEKUMAR R KODANGATTIL;;STEVEN A GREENBERG;;EDWARD ROLAND LAVALLIE;;ERIC M BENNETT;;LIDIA MOSYAK;;JAMES PERRY HALL;;ANTHONY JOHN COYLE,,https://lens.org/116-246-924-775-17X,Patent Application,no,1,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C12N15/13;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/63,,3,0,,,"ARCH. NEUROL., vol. 67, no. 9, JPN6020000758, September 2010 (2010-09-01), pages 1095 - 1101, ISSN: 0004657490;;PLOS ONE, vol. 10, no. 5, JPN6020000760, 26 May 2015 (2015-05-26), pages 0128636 - 1, ISSN: 0004657491;;J. INTERFERON CYTOKINE RES., vol. 21, no. 11, JPN7020000055, November 2001 (2001-11-01), pages 931 - 941, ISSN: 0004657492",ACTIVE
361,DE,T2,DE 69126837 T2,145-765-355-407-719,1998-02-05,1998,DE 69126837 T,1991-09-27,US 58962790 A,1990-09-28,Elektronisches Vervielfältigungs-Drucksystem,,XEROX CORP,REED JEFFREY G;;ZELL THOMAS B;;HUBE RANDALL R;;PROKOP PATRICIA A;;RULLI PAUL A;;VALLIERE PAUL J;;MCENTERFER REES NANCY K;;BENNETT ELIZABETH A;;LEGG ERNEST L;;CARTER HARRIET H,,https://lens.org/145-765-355-407-719,Granted Patent,no,0,0,8,8,0,H04N1/00352;;H04N1/00397;;H04N1/00408;;H04N1/00411;;H04N1/00416;;H04N1/00424;;H04N1/00432;;H04N1/00437;;H04N1/00474;;H04N1/00477;;H04N1/00482;;H04N1/32101;;H04N1/32122;;H04N1/32609;;H04N1/32635;;H04N1/32657;;H04N2201/3222;;H04N2201/3242;;H04N2201/3261;;H04N2201/3271;;H04N2201/3273;;H04N2201/3278;;H04N1/00352;;H04N2201/3278;;H04N1/32609;;H04N1/00482;;H04N1/00424;;H04N1/00432;;H04N2201/3222;;H04N1/00477;;H04N1/32657;;H04N1/00416;;H04N1/00474;;H04N2201/3242;;H04N2201/3273;;H04N1/32101;;H04N1/00437;;H04N1/00411;;H04N2201/3271;;H04N1/32635;;H04N1/00397;;H04N1/00408;;H04N1/32122;;H04N2201/3261,B41J2/44;;B41J29/38;;G03G15/00;;G03G15/04;;G03G15/22;;G03G15/36;;G03G21/00;;G06F3/12;;H04N1/00;;H04N1/04;;H04N1/23;;H04N1/32,,0,0,,,,EXPIRED
362,US,B2,US 10829553 B2,153-990-119-885-285,2020-11-10,2020,US 201715581079 A,2017-04-28,US 201715581079 A;;US 201762483669 P;;US 201662339709 P;;US 201662329327 P,2016-04-29,Interferon beta antibodies and uses thereof,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNβ). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/153-990-119-885-285,Granted Patent,yes,3,1,46,47,166,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24;;A61K39/00,,4,3,004-740-182-961-805;;061-628-132-124-045;;019-888-090-725-288,10.2210/pdb1au1/pdb;;10.1073/pnas.94.22.11813;;9342320;;pmc23607;;11747625;;10.1089/107999001753289541;;20837854;;10.1001/archneurol.2010.218,"Karpusas, et al., “The crystal structure of human interferon beta at 2.2—A resolution,” PNAS, 94(22):11813-11818 (1997).;;Runkel, et al., “Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis,” Journal of Interferon and Cytokine Research, 21(11):931-941 (2001).;;Sheehan, et al., “Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection,” PLOS One, 10(5):e0128636 (2015).;;Sominanda, et al., “Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta,” Archives of Neurology, 67(9):1095-1101 (2010).",ACTIVE
363,BR,A2,BR 112018072118 A2,039-633-355-496-822,2019-03-19,2019,BR 112018072118 A,2017-04-28,US 2017/0030089 W;;US 201662329327 P;;US 201662339709 P;;US 201762483669 P,2016-04-29,anticorpos de interferona beta e usos dos mesmos,"a presente invenção refere-se a anticorpos, ou fragmentos de ligação de antígeno dos mesmos, que especificamente liga a interferona beta (ifnß). tais anticorpos, ou fragmentos de ligação de antígeno dos mesmos, são úteis para vários propósitos terapêuticos ou diagnósticos.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,ANTHONY JOHN COYLE;;CHRISTINE HUARD;;EDWARD ROLAND LAVALLIE;;ERIC M BENNETT;;JAMES PERRY HALL;;JANET ELIZABETH BUHLMANN;;JUAN CARLOS ALMAGRO;;LIDIA MOSYAK;;SREEKUMAR R KODANGATTIL;;STEFANO V GULLA;;STEVEN A GREENBERG,,https://lens.org/039-633-355-496-822,Patent Application,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24;;A61K39/00,,0,0,,,,PENDING
364,US,A1,US 2017/0313769 A1,167-284-202-658-163,2017-11-02,2017,US 201715581079 A,2017-04-28,US 201715581079 A;;US 201762483669 P;;US 201662339709 P;;US 201662329327 P,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNβ). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.",PFIZER;;THE BRIGHAM AND WOMEN?S HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/167-284-202-658-163,Patent Application,yes,0,3,46,47,166,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24,,0,0,,,,ACTIVE
365,SA,B1,SA 518400327 B1,001-935-532-977-702,2022-12-03,2022,SA 518400327 A,2018-10-28,US 201662329327 P;;US 2017/0030089 W;;US 201762483669 P;;US 201662339709 P,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,EDWARD ROLAND LAVALLIE;;ERIC M BENNETT;;ANTHONY JOHN COYLE;;JANET ELIZABETH BUHLMANN;;JAMES PERRY HALL;;JUAN CARLOS ALMAGRO;;STEFANO V GULLA;;STEVEN A GREENBERG;;SREEKUMAR R KODANGATTIL;;CHRISTINE HUARD;;LIDIA MOSYAK,,https://lens.org/001-935-532-977-702,Granted Patent,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,,,0,0,,,,ACTIVE
366,AU,A1,AU 2017/258492 A1,021-768-521-477-956,2018-10-25,2018,AU 2017/258492 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,Interferon beta antibodies and uses thereof,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNp). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/021-768-521-477-956,Patent Application,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24;;A61K39/00,,0,0,,,,ACTIVE
367,KR,A,KR 20190003625 A,135-104-333-795-270,2019-01-09,2019,KR 20187034153 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,인터페론 베타 항체 및 그의 용도,"본 발명은 인터페론 베타 (IFNβ)에 특이적으로 결합하는 항체, 또는 그의 항원-결합 단편에 관한 것이다. 이러한 항체, 또는 그의 항원-결합 단편은 다양한 치료적 또는 진단적 목적에 유용하다.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/135-104-333-795-270,Patent Application,no,1,0,46,47,332,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24;;A61K39/00;;A61P17/00;;A61P19/02;;A61P29/00;;A61P37/04,,2,2,019-888-090-725-288;;061-628-132-124-045,20837854;;10.1001/archneurol.2010.218;;11747625;;10.1089/107999001753289541,"Sominanda, Ajith et al. “Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta.” Archives of neurology vol. 67,9 (2010): 1095-101.(2010.09.01.)*;;Runkel, L et al. “Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis.*",ACTIVE
368,HR,T1,HR P20230605 T1,081-503-774-160-861,2023-09-29,2023,HR P20230605 T,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;EP 17733171 A;;US 2017/0030089 W,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,,PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAME PERRY;;COYLE ANTHONY JOHN,,https://lens.org/081-503-774-160-861,Granted Patent,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,0,0,,,,ACTIVE
369,AU,A,AU 1999/011081 A,110-680-609-902-996,1999-05-10,1999,AU 1999/011081 A,1998-10-20,US 6313697 P;;US 9822215 W,1997-10-22,Computer thesaurus manager,,GLAXO GROUP LTD,ABED SAMIR IBRAHIM;;BARRY COYLA BELL;;BENNETT PAUL NATHAN;;GADBOIS DAVID GREGORY;;GOOLSBEY KEITH MICHAEL;;MCKAY ALBERTA SPROTT;;MURRAY KENNETH S;;PITTMAN KAREN ELIZABETH;;SIEGEL NICHOLAS PAUL;;THOMPSON REUBIN CLIFTON JR,,https://lens.org/110-680-609-902-996,Patent Application,no,0,0,4,4,0,G06F16/374,G06F17/30,,0,0,,,,DISCONTINUED
370,DE,D1,DE 69126837 D1,000-236-295-170-358,1997-08-21,1997,DE 69126837 T,1991-09-27,US 58962790 A,1990-09-28,Elektronisches Vervielfältigungs-Drucksystem,,XEROX CORP,REED JEFFREY G;;ZELL THOMAS B;;HUBE RANDALL R;;PROKOP PATRICIA A;;RULLI PAUL A;;VALLIERE PAUL J;;MCENTERFER REES NANCY K;;BENNETT ELIZABETH A;;LEGG ERNEST L;;CARTER HARRIET H,,https://lens.org/000-236-295-170-358,Granted Patent,no,0,0,8,8,0,H04N1/00352;;H04N1/00397;;H04N1/00408;;H04N1/00411;;H04N1/00416;;H04N1/00424;;H04N1/00432;;H04N1/00437;;H04N1/00474;;H04N1/00477;;H04N1/00482;;H04N1/32101;;H04N1/32122;;H04N1/32609;;H04N1/32635;;H04N1/32657;;H04N2201/3222;;H04N2201/3242;;H04N2201/3261;;H04N2201/3271;;H04N2201/3273;;H04N2201/3278;;H04N1/00352;;H04N2201/3278;;H04N1/32609;;H04N1/00482;;H04N1/00424;;H04N1/00432;;H04N2201/3222;;H04N1/00477;;H04N1/32657;;H04N1/00416;;H04N1/00474;;H04N2201/3242;;H04N2201/3273;;H04N1/32101;;H04N1/00437;;H04N1/00411;;H04N2201/3271;;H04N1/32635;;H04N1/00397;;H04N1/00408;;H04N1/32122;;H04N2201/3261,B41J2/44;;B41J29/38;;G03G15/00;;G03G15/04;;G03G15/22;;G03G15/36;;G03G21/00;;G06F3/12;;H04N1/00;;H04N1/04;;H04N1/23;;H04N1/32,,0,0,,,,EXPIRED
371,PL,T3,PL 3448419 T3,160-078-853-500-683,2023-09-04,2023,PL 17733171 T,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,,PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAME PERRY;;COYLE ANTHONY JOHN,,https://lens.org/160-078-853-500-683,Patent Application,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,0,0,,,,PENDING
372,CN,A,CN 109069606 A,018-172-832-068-820,2018-12-21,2018,CN 201780025961 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNp). Such antibodies, or antigen-binding fragments thereof, are are useful forvarious therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/018-172-832-068-820,Patent Application,no,5,1,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,5,0,,,"SHEEHAN KC等: ""“Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection”"", 《PLOS ONE》;;张登央等: ""“重组人β干扰素1a(rhIFN-β1a)单克隆抗体的制备”"", 《细胞与分子免疫学杂志》;;钦伦秀: ""《肿瘤的分子诊断与预防》"", 31 December 2004, 上海科技教育出版社;;SOMINANDA A等: ""“Inhibition of Endogenous Interferon Beta by Neutralizing Antibodies Against Recombinant Interferon Beta”"", 《ARCH NEUROL》;;RUNKEL L等: ""“Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis”"", 《JOURNAL INTERFERON CYTOKINE RES》",ACTIVE
373,MX,A,MX 2018013222 A,057-118-779-238-639,2019-04-22,2019,MX 2018013222 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF.,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNp). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.",PFIZER,EDWARD ROLAND LAVALLIE;;LIDIA MOSYAK;;ERIC M BENNETT;;STEFANO V GULLA;;CHRISTINE HUARD;;JANET ELIZABETH BUHLMANN;;JUAN CARLOS ALMAGRO;;SREEKUMAR R KODANGATTIL;;STEVEN A GREENBERG;;JAMES PERRY HALL;;ANTHONY JOHN COYLE,,https://lens.org/057-118-779-238-639,Patent Application,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,0,0,,,,PENDING
374,ZA,B,ZA 201806682 B,077-711-108-219-843,2022-05-25,2022,ZA 201806682 A,2018-10-08,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,,PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,HUARD CHRISTINE;;GULLA STEFANO V;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/077-711-108-219-843,Granted Patent,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,,,0,0,,,,ACTIVE
375,CO,A2,CO 2018012497 A2,126-719-491-504-234,2018-12-14,2018,CO 2018012497 A,2018-11-21,US 2017/0030089 W;;US 201662329327 P;;US 201662339709 P;;US 201762483669 P,2016-04-29,Anticuerpos de interferón beta y usos de los mismos,"La presente invención se relaciona con anticuerpos, o fragmentos de los mismos de enlace al antígeno, que de manera específica enlazan el interferón beta (IFNβ). Dichos anticuerpos, o fragmentos de los mismos de enlace al antígeno, son útiles para varios propósitos terapéuticos o de diagnóstico.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/126-719-491-504-234,Patent Application,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,0,0,,,,PENDING
376,MY,A,MY 194084 A,064-863-474-386-802,2022-11-11,2022,MY PI2018703975 A,2017-04-28,US 2017/0030089 W;;US 201662329327 P;;US 201662339709 P;;US 201762483669 P,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,BENNETT ERIC M;;GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/064-863-474-386-802,Granted Patent,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,0,0,,,,ACTIVE
377,AU,A1,AU 2002/363810 A1,062-194-651-811-665,2004-08-12,2004,AU 2002/363810 A,2002-11-15,US 40792402 P;;US 33279801 P;;US 33279901 P;;US 0236889 W,2001-11-16,Copolymers of olefins and vinyl- and allylsilanes,,DU PONT,SHIFFINO RINALDO S;;RADZEWICH CATHERINE E;;ITTEL STEVEN DALE;;LONKIN ALEX;;MCCORD ELIZABETH FORRESTER;;WANG LIN;;BENNETT ALISON M A;;WANG YING;;SWEETMAN KARL J;;MCLAIN STEPHAN J;;JOHNSON LYNDA KAYE,,https://lens.org/062-194-651-811-665,Patent Application,no,0,0,22,22,0,C08F4/65908;;C08F4/65912;;C08F4/65916;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/02;;C08F210/16;;C08F2410/07;;C08F210/02;;C08F8/00;;C08F10/00;;C08F4/44;;C08F210/02;;C08F210/16;;C08F4/65916;;C08F4/65912;;C08F10/00;;C08F4/65908;;C08F110/02;;C08F10/02,C08F4/659;;C08F4/70;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/00;;C08F210/02;;C08F210/16;;C08F230/08,,0,0,,,,DISCONTINUED
378,CN,A,CN 102050904 A,105-924-048-494-327,2011-05-11,2011,CN 201010550380 A,2002-11-15,US 33279801 P;;US 33279901 P;;US 40792402 P,2001-11-16,Copolymers of olefins and vinyl- and allylsilanes,"Ethylene and allyl- or vinylsilanes are efficiently copolymerized by certain late transition metal complexes containing selected bidentate or tridentate ligands. The resulting novel polymers may be crosslinked by moisture when vinylsilane contains groups bound to silicon which are hydrolyzable. The polymers are useful for wire coating, crosslinked foams, pipes, and other uses.",DU PONT,SHIFFINO RINALDO S;;RADZEWICH CATHERINE E;;DALE ITTEL STEVEN;;ALEX LONKIN;;FORRESTER MCCORD ELIZABETH;;LIN WANG;;BENNETT ALISON M A;;YING WANG;;SWEETMAN KARL J;;MCLAIN STEPHAN J;;KAYE JOHNSON LYNDA,,https://lens.org/105-924-048-494-327,Patent Application,no,0,4,22,22,0,C08F4/65908;;C08F4/65912;;C08F4/65916;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/02;;C08F210/16;;C08F2410/07;;C08F210/02;;C08F8/00;;C08F10/00;;C08F4/44;;C08F210/02;;C08F210/16;;C08F4/65916;;C08F4/65912;;C08F10/00;;C08F4/65908;;C08F110/02;;C08F10/02,C08F210/02;;C08F4/659;;C08F4/70;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/00;;C08F210/16;;C08F230/08,,0,0,,,,DISCONTINUED
379,FI,T3,FI 3448419 T3,111-305-851-987-90X,2023-08-02,2023,FI 17733171 T,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,,PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAME PERRY;;COYLE ANTHONY JOHN,,https://lens.org/111-305-851-987-90X,Unknown,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,0,0,,,,PENDING
380,EP,A3,EP 4273165 A3,149-255-044-738-92X,2023-12-20,2023,EP 23177086 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;EP 17733171 A;;US 2017/0030089 W,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNβ). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/149-255-044-738-92X,Search Report,yes,3,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24;;A61K39/00,,4,4,019-888-090-725-288;;057-456-035-417-644;;061-628-132-124-045;;004-740-182-961-805,20837854;;10.1001/archneurol.2010.218;;pmc4444312;;26010249;;10.1371/journal.pone.0128636;;11747625;;10.1089/107999001753289541;;10.2210/pdb1au1/pdb;;10.1073/pnas.94.22.11813;;9342320;;pmc23607,"AJITH SOMINANDA ET AL: ""Inhibition of Endogenous Interferon Beta by Neutralizing Antibodies Against Recombinant Interferon Beta"", ARCHIVES OF NEUROLOGY., vol. 67, no. 9, 1 September 2010 (2010-09-01), US, XP055399988, ISSN: 0003-9942, DOI: 10.1001/archneurol.2010.218;;KATHLEEN C. F. SHEEHAN ET AL: ""Selective Blockade of Interferon-[alpha] and -[beta] Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection"", PLOS ONE, vol. 10, no. 5, 26 May 2015 (2015-05-26), pages e0128636, XP055400161, DOI: 10.1371/journal.pone.0128636;;RUNKEL L ET AL: ""MAPPING OF IFN-BETA EPITOPES IMPORTANT FOR RECEPTOR BINDING AND BIOLOGIC ACTIVATION: COMPARISON OF RESULTS ACHIEVED USING ANTIBODY-BASED METHODS AND ALANINE SUBSTITUTION MUTAGENESIS"", JOURNAL OF INTERFERON AND CYTOKINE RESEA, MARY ANN LIEBERT, NEW YORK, NY, US, vol. 21, no. 11, 1 November 2001 (2001-11-01), pages 931 - 941, XP009011507, ISSN: 1079-9907, DOI: 10.1089/107999001753289541;;KARPUSAS MICHAEL ET AL: ""The crystal structure of human interferon beta at 2.2-A resolution"", PROCEEDINGS NATIONAL ACADEMY OF SCIENCES PNAS, NATIONAL ACADEMY OF SCIENCES, US, vol. 94, no. 22, 28 October 1997 (1997-10-28), pages 11813 - 11818, XP002160243, ISSN: 0027-8424, DOI: 10.1073/PNAS.94.22.11813",PENDING
381,WO,A2,WO 2003/044066 A2,165-304-389-994-556,2003-05-30,2003,US 0236889 W,2002-11-15,US 33279901 P;;US 33279801 P;;US 40792402 P,2001-11-16,COPOLYMERS OF OLEFINS AND VINYL- AND ALLYLSILANES,"Ethylene and allyl- or vinylsilanes are efficiently copolymerized by certain late transition metal complexes containing selected bidentate or tridentate ligands. The resulting novel polymers may be crosslinked by moisture when vinylsilane contains groups bound to silicon which are hydrolyzable. The polymers are useful for wire coating, crosslinked foams, pipes, and other uses.",DU PONT;;JOHNSON LYNDA KAYE;;MCLAIN STEPHAN J;;SWEETMAN KARL J;;WANG YING;;BENNETT ALISON M A;;WANG LIN;;MCCORD ELIZABETH FORRESTER;;LONKIN ALEX;;ITTEL STEVEN DALE;;RADZEWICH CATHERINE E;;SCHIFFINO RINALDO S,JOHNSON LYNDA KAYE;;MCLAIN STEPHAN J;;SWEETMAN KARL J;;WANG YING;;BENNETT ALISON M A;;WANG LIN;;MCCORD ELIZABETH FORRESTER;;LONKIN ALEX;;ITTEL STEVEN DALE;;RADZEWICH CATHERINE E;;SCHIFFINO RINALDO S,,https://lens.org/165-304-389-994-556,Patent Application,yes,0,0,22,22,0,C08F4/65908;;C08F4/65912;;C08F4/65916;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/02;;C08F210/16;;C08F2410/07;;C08F210/02;;C08F8/00;;C08F10/00;;C08F4/44;;C08F210/02;;C08F210/16;;C08F4/65916;;C08F4/65912;;C08F10/00;;C08F4/65908;;C08F110/02;;C08F10/02,C08F4/659;;C08F4/70;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/00;;C08F210/02;;C08F210/16;;C08F230/08,,0,0,,,,PENDING
382,US,B2,US 11858986 B2,122-154-909-950-274,2024-01-02,2024,US 202017092998 A,2020-11-09,US 202017092998 A;;US 201715581079 A;;US 201762483669 P;;US 201662339709 P;;US 201662329327 P,2016-04-29,Interferon beta antibodies and uses thereof,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNβ). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/122-154-909-950-274,Granted Patent,yes,11,0,46,47,166,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24;;A61K39/00,,15,11,062-311-117-599-22X;;042-994-275-708-524;;059-333-473-231-906;;015-630-305-390-881;;060-059-082-853-608;;018-438-400-597-679;;004-740-182-961-805;;061-628-132-124-045;;019-888-090-725-288;;027-477-313-726-928;;088-581-950-418-154,29559718;;10.1038/nrrheum.2018.31;;pmc6625751;;33869112;;pmc8044321;;10.3389/fped.2021.631329;;10.1681/asn.2004111014;;16221871;;14734823;;10.1385/mb:26:1:39;;6170512;;10.1111/j.1432-1033.1981.tb05539.x;;10.1007/s00228-015-1921-0;;26268445;;10.2210/pdb1au1/pdb;;10.1073/pnas.94.22.11813;;9342320;;pmc23607;;11747625;;10.1089/107999001753289541;;20837854;;10.1001/archneurol.2010.218;;10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10.4049/jimmunol.164.3.1432;;10640759,"Muskardin, Theresa L Wampler, and Timothy B Niewold. Nature reviews. Rheumatology vol. 14,4 (2018): 214-228. doi:10.1038/nrrheum.2018.31 (Year: 2018).;;D'Angelo, Debora M., et al. Frontiers in Pediatrics 9 (2021): 631329 (Year: 2021).;;Schwarting, Andreas, et al. Journal of the American Society of Nephrology 16.11 (2005): 3264-3272 (Year: 2005).;;Kipriyanov, Sergey M., and Fabrice Le Gall. “Generation and production of engineered antibodies.” Molecular biotechnology 26.1 (2004): 39-60. (Year: 2004).;;Janeway, Charles A. “Immunobiology: The Immune System in Health and Disease.” 2001 (Year: 2001).;;Hochkeppel, Heinz-Kurt, Ullrich Menge, and John Collins. “Monoclonal antibodies against human fibroblast interferon.” European Journal of Biochemistry 118.3 (1981): 437-442. (Year: 1981).;;Govindappa et al., “Development of interferon beta-neutralising antibodies in multiple sclerosis—a systematic review and meta-analysis,” European Journal of Clinical Pharmacology, 71(11):1287-98 (2015).;;Dengyang et al., “Preparation of monoclonal antibody against recombinant human interferon-β1a,” Journal of Cellular and Molecular Immunology, vol. 11, No. 31 (2015) (English Abstract Only).;;Lunxiu, “Molecular Diagnosis and Prevention of Tumors,” Shanghai Science and Technology Education Press (2004) (English Abstract Only).;;Karpusas, et al., “The crystal structure of human interferon beta at 2.2-A resolution,” PNAS, 94(22):11813-11818 (1997).;;Runkel, et al., “Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis,” Journal of Interferon and Cytokine Research, 21(11):931-941 (2001).;;Sheehan, et al., “Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection,” PLOS One, 10(5):e0128636 (2015).;;Sominanda, et al., “Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta,” Archives of Neurology, 67(9):1095-1101 (2010).;;Rudikoff, S., et al., “Single amino acid substitution altering antigen-binding specificity,” Proc. Natl. Acad, Sci, vol. 79, pp. 1979-1983, Mar. 1982.;;Tamura et al., “Structural Correlates of an Anticarcinoma Antibody: Identification of Specificity-Determining Residues (SDRs) and Development of a Minimally Immunogenic Antibody Variant by Retention of SDRs Only”, J. Immunol., 164:1432-1441 (2000).",ACTIVE
383,CA,A1,CA 2965652 A1,129-617-738-576-064,2017-10-29,2017,CA 2965652 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P,2016-04-29,INTERFERON BETA ANTIBODIES,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN.beta.).",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/129-617-738-576-064,Patent Application,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C12N15/13;;C07K16/24;;C12P21/08,,0,0,,,,PENDING
384,EP,B1,EP 3448419 B1,027-372-039-944-12X,2023-06-07,2023,EP 17733171 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,INTERFERON BETA ANTIBODIES AND USES THEREOF,,PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAME PERRY;;COYLE ANTHONY JOHN,"PFIZER INC. (2023-04-19);;THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (2023-04-19)",https://lens.org/027-372-039-944-12X,Granted Patent,yes,3,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,A61K39/00;;C07K16/24,,4,0,,,"AJITH SOMINANDA ET AL: ""Inhibition of Endogenous Interferon Beta by Neutralizing Antibodies Against Recombinant Interferon Beta"", ARCHIVES OF NEUROLOGY., vol. 67, no. 9, 1 September 2010 (2010-09-01), XP055399988, US ISSN: 0003-9942, DOI: 10.1001/archneurol.2010.218;;KATHLEEN C. F. SHEEHAN ET AL: ""Selective Blockade of Interferon-[alpha] and -[beta] Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection"", PLOS ONE, vol. 10, no. 5, 26 May 2015 (2015-05-26), page e0128636, XP055400161, DOI: 10.1371/journal.pone.0128636;;RUNKEL L ET AL: ""MAPPING OF IFN-BETA EPITOPES IMPORTANT FOR RECEPTOR BINDING AND BIOLOGIC ACTIVATION: COMPARISON OF RESULTS ACHIEVED USING ANTIBODY-BASED METHODS AND ALANINE SUBSTITUTION MUTAGENESIS"", JOURNAL OF INTERFERON AND CYTOKINE RESEA, MARY ANN LIEBERT, NEW YORK, NY, US, vol. 21, no. 11, 1 November 2001 (2001-11-01), pages 931-941, XP009011507, ISSN: 1079-9907, DOI: 10.1089/107999001753289541;;KARPUSAS MICHAEL ET AL: ""The crystal structure of human interferon beta at 2.2-A resolution"", PROCEEDINGS NATIONAL ACADEMY OF SCIENCES PNAS, NATIONAL ACADEMY OF SCIENCES, US, vol. 94, no. 22, 28 October 1997 (1997-10-28), pages 11813-11818, XP002160243, ISSN: 0027-8424, DOI: 10.1073/PNAS.94.22.11813",ACTIVE
385,RU,C2,RU 2750454 C2,033-990-393-695-256,2021-06-28,2021,RU 2018141839 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P;;US 2017/0030089 W,2016-04-29,ANTI-INTERFERON BETA ANTIBODIES AND THEIR USE,"FIELD: biotechnology; immunology.SUBSTANCE: invention relates to biotechnology and immunology, in particular to antibodies or their antigen-binding fragments that specifically bind to interferon beta (IFNβ). Such antibodies or their antigen-binding fragments are applicable for various therapeutic or diagnostic purposes, namely, to reduce the activity of IFNβ in an individual, to treat rheumatoid diseases, to treat systemic lupus erythematosus.EFFECT: obtaining anti-interferon beta antibodies for treating various diseases.27 cl, 20 dwg, 18 tbl, 8 ex",PFIZER,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/033-990-393-695-256,Granted Patent,no,2,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24;;A61K39/00,,1,1,019-888-090-725-288,20837854;;10.1001/archneurol.2010.218,"AJITH SOMINANDA et al. Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta, Arch Neurol. 2010 Sep; 67(9): 1095-101.",ACTIVE
386,TW,A,TW 201739764 A,127-135-608-478-525,2017-11-16,2017,TW 106114362 A,2017-04-28,US 201662329327 P;;US 201662339709 P;;US 201762483669 P,2016-04-29,Interferon beta antibodies and uses thereof,"The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN[beta]). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.",PFIZER;;BRIGHAM & WOMENS HOSPITAL INC,GULLA STEFANO V;;HUARD CHRISTINE;;BUHLMANN JANET ELIZABETH;;ALMAGRO JUAN CARLOS;;KODANGATTIL SREEKUMAR R;;GREENBERG STEVEN A;;LAVALLIE EDWARD ROLAND;;BENNETT ERIC M;;MOSYAK LIDIA;;HALL JAMES PERRY;;COYLE ANTHONY JOHN,,https://lens.org/127-135-608-478-525,Patent of Addition,no,0,0,46,47,0,A61K2039/505;;C07K2317/24;;C07K2317/55;;C07K2317/565;;C07K2317/94;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/76;;C07K2317/92;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P37/02;;A61P37/04;;A61P43/00;;C07K16/24;;C07K2317/34;;C07K2317/92;;C07K2317/565;;C07K2317/515;;C07K2317/24;;C07K2317/76;;C07K16/249;;C07K2317/94;;C07K2317/55;;C07K2317/51;;A61K2039/505;;C07K2317/33;;A61P37/04;;A61P17/00;;A61P19/02;;A61P29/00;;C07K16/249;;A61K2039/505;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/76;;A61P17/00;;A61P19/02;;A61P21/00;;A61P29/00;;C07K16/249;;C07K2317/55;;C07K2317/565;;C07K2317/24;;C07K2317/94;;A61K2039/505;;C07K16/249;;C07K2317/33;;C07K2317/34;;C07K2317/51;;C07K2317/515;;C07K2317/76;;C07K2317/92,C07K16/24;;A61K39/395;;A61P37/02;;C07K16/28;;C12N15/13,,0,0,,,,ACTIVE
387,WO,A3,WO 2023/283211 A3,121-901-106-059-488,2023-04-13,2023,US 2022/0036166 W,2022-07-06,US 202163219485 P,2021-07-08,CD21 ANTIBODIES AND USES THEREOF,Provided herein are anti-CD21 antibodies or antigen binding fragments thereof and their use in the treatment of autoimmune diseases or disorders.,CHILDRENS MEDICAL CT CORP;;PFIZER;;GAO HULIAN,GAO HULIAN;;CARROLL MICHAEL C;;KOVALENKO OLEG VICTOROVICH;;BENNETT ERIC MATTHEW;;BUHLMANN JANET ELIZABETH;;MIN DEBARTOLO JESSICA HAEWON;;GULLA STEFANO VINCENZO;;HIGGINSON-SCOTT NATHAN;;KARLSSON FRIDRIK JENSEN;;SOLER-FERRAN DULCE;;TANG XIANCHUN,,https://lens.org/121-901-106-059-488,Search Report,yes,2,0,2,2,128,C07K16/2896;;C07K2317/622;;C07K2317/92;;C07K2317/76;;C07K2317/33,C07K16/30;;A61P35/00;;C07K16/28,,0,0,,,,PENDING
388,US,B2,US 7348388 B2,147-850-555-720-688,2008-03-25,2008,US 29560602 A,2002-11-15,US 29560602 A;;US 40792402 P;;US 33279801 P;;US 33279901 P,2001-11-16,Copolymers of olefins and vinyl- and allylsilanes,"Ethylene and allyl- or vinylsilanes are efficiently copolymerized by certain late transition metal complexes containing selected bidentate or tridentate ligands. The resulting novel polymers may be crosslinked by moisture when vinylsilane contains groups bound to silicon which are hydrolyzable. The polymers are useful for wire coating, crosslinked foams, pipes, and other uses.",DU PONT,ITTEL STEVEN DALE;;JOHNSON LYNDA KAYE;;WANG LIN;;WANG YING;;MCCORD ELIZABETH FORRESTER;;RADZEWICH CATHERINE E;;MCLAIN STEPHAN J;;SWEETMAN KARL J;;BENNETT ALISON MARGARET ANNE;;IONKIN ALEX SERGEY;;SCHIFFINO RINALDO S,E. I. DU PONT DE NEMOURS AND COMPANY (2002-12-04),https://lens.org/147-850-555-720-688,Granted Patent,yes,24,4,22,22,0,C08F4/65908;;C08F4/65912;;C08F4/65916;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/02;;C08F210/16;;C08F2410/07;;C08F210/02;;C08F8/00;;C08F10/00;;C08F4/44;;C08F210/02;;C08F210/16;;C08F4/65916;;C08F4/65912;;C08F10/00;;C08F4/65908;;C08F110/02;;C08F10/02,C08F4/659;;C08F4/70;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/00;;C08F210/02;;C08F210/16;;C08F230/08,526/279;;526/242,1,1,101-579-530-746-406,10.1021/ma00139a022,"Usami, Takao and Takayama, Shigeru, Fine-Branching Structure in High-Pressure, Low-Density Polyethylenes by 50.10-MHz <SUP>13</SUP>C NMR Analysis, Macromolecules 1984, 17, 1756-1761.",EXPIRED
389,WO,A2,WO 2023/283211 A2,109-103-207-468-685,2023-01-12,2023,US 2022/0036166 W,2022-07-06,US 202163219485 P,2021-07-08,CD21 ANTIBODIES AND USES THEREOF,Provided herein are anti-CD21 antibodies or antigen binding fragments thereof and their use in the treatment of autoimmune diseases or disorders.,CHILDRENS MEDICAL CT CORP;;PFIZER;;GAO HULIAN,GAO HULIAN;;CARROLL MICHAEL C;;KOVALENKO OLEG VICTOROVICH;;BENNETT ERIC MATTHEW;;BUHLMANN JANET ELIZABETH;;MIN DEBARTOLO JESSICA HAEWON;;GULLA STEFANO VINCENZO;;HIGGINSON-SCOTT NATHAN;;KARLSSON FRIDRIK JENSEN;;SOLER-FERRAN DULCE;;TANG XIANCHUN,,https://lens.org/109-103-207-468-685,Patent Application,yes,0,0,2,2,128,C07K16/2896;;C07K2317/622;;C07K2317/92;;C07K2317/76;;C07K2317/33,C07K16/28;;A61K39/395,,0,0,,,,PENDING
390,US,A1,US 2003/0212226 A1,100-090-171-952-215,2003-11-13,2003,US 29560602 A,2002-11-15,US 29560602 A;;US 40792402 P;;US 33279801 P;;US 33279901 P,2001-11-16,Copolymers of olefins and vinyl- and allylsilanes,"
   Ethylene and allyl- or vinylsilanes are efficiently copolymerized by certain late transition metal complexes containing selected bidentate or tridentate ligands. The resulting novel polymers may be crosslinked by moisture when vinylsilane contains groups bound to silicon which are hydrolyzable. The polymers are useful for wire coating, crosslinked foams, pipes, and other uses. 
",ITTEL STEVEN DALE;;JOHNSON LYNDA KAYE;;WANG LIN;;WANG YING;;MCCORD ELIZABETH FORRESTER;;RADZEWICH CATHERINE E.;;MCLAIN STEPHAN J.;;SWEETMAN KARL J.;;BENNETT ALISON MARGARET ANNE;;IONKIN ALEX SERGEY;;SCHIFFINO RINALDO S.,ITTEL STEVEN DALE;;JOHNSON LYNDA KAYE;;WANG LIN;;WANG YING;;MCCORD ELIZABETH FORRESTER;;RADZEWICH CATHERINE E;;MCLAIN STEPHAN J;;SWEETMAN KARL J;;BENNETT ALISON MARGARET ANNE;;IONKIN ALEX SERGEY;;SCHIFFINO RINALDO S,E. I. DU PONT DE NEMOURS AND COMPANY (2002-12-04),https://lens.org/100-090-171-952-215,Patent Application,yes,23,6,22,22,0,C08F4/65908;;C08F4/65912;;C08F4/65916;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/02;;C08F210/16;;C08F2410/07;;C08F210/02;;C08F8/00;;C08F10/00;;C08F4/44;;C08F210/02;;C08F210/16;;C08F4/65916;;C08F4/65912;;C08F10/00;;C08F4/65908;;C08F110/02;;C08F10/02,C08F4/659;;C08F4/70;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/00;;C08F210/02;;C08F210/16;;C08F230/08,526/279,0,0,,,,EXPIRED
391,WO,A1,WO 2020/163317 A1,177-524-674-277-88X,2020-08-13,2020,US 2020/0016562 W,2020-02-04,US 201962801245 P;;US 201962801257 P;;US 201962864663 P;;US 201962885673 P;;US 201962939946 P,2019-02-05,PATIENT-SPECIFIC SIMULATION DATA FOR ROBOTIC SURGICAL PLANNING,A method for creating a patient-specific surgical plan includes receiving one or more pre-operative images of a patient having one or more infirmities affecting one or more anatomical joints. three-dimensional anatomical model of the one or more anatomical joints is created based on the one or more pre-operative images. One or more transfer functions and the three-dimensional anatomical model are used to identify a patient-specific implantation geometry that corrects the one or more infirmities. The transfer functions model performance of the one or more anatomical joints as a function of anatomical geometry and anatomical implantation features. surgical plan comprising the patient-specific implantation geometry may then be displayed.,SMITH & NEPHEW INC;;SMITH & NEPHEW ORTHOPAEDICS AG;;SMITH & NEPHEW PTE LTD,MCKINNON BRIAN W;;MARINESCU TANASOCA RUXANDRA CRISTIANA;;WINEBARGER RANDY C;;BOWERS JR;;WIEBE III JAMES BENNETT;;LENZ NATHANIEL MILTON;;HADDOCK SEAN M;;LANDON RYAN LLOYD;;MCGUAN SHAWN P;;NIKOU CONSTANTINOS;;DUXBURY ELIZABETH,,https://lens.org/177-524-674-277-88X,Patent Application,yes,25,3,53,53,0,A61B2034/105;;A61B2034/108;;A61B2034/107;;A61B34/10;;A61B2034/104;;A61B34/30;;A61B17/1764;;A61B17/154;;A61B2034/2055;;A61B2034/2051;;A61B2034/2065;;A61B2034/2063;;A61B90/96;;A61B2090/376;;A61B2090/378;;A61B2090/365;;A61B2090/372;;A61B2090/502;;A61B2034/252;;A61B2034/254;;A61B2017/00221;;A61B34/25;;A61B2034/258;;A61B2034/256;;A61B2090/371;;A61B34/20;;A61B2017/00207;;A61B2034/2048;;A61B2034/2057;;A61B2090/3983;;A61B2034/102;;A61B2034/2068;;G16H20/40;;G16H50/50;;G06N5/046;;G06N3/08;;G06N20/10;;A61B2505/05;;A61B5/4585;;A61B5/0077;;A61B5/064;;A61B5/1118;;A61B5/004;;A61B5/1072;;Y02A90/10;;G16H15/00;;G16H50/00;;G06N5/01;;G06N3/044;;A61B34/10;;A61B34/25;;A61B2034/256;;G16H20/40;;G16H50/50;;G16H10/60;;G16H50/70;;A61B17/1764;;A61B2017/00199;;A61B2034/104;;A61B2034/105;;A61B2034/108;;A61B34/20;;A61B34/30;;A61B90/96;;G06N20/00;;A61B17/15;;A61B17/17;;A61B2017/00526;;A61B2034/102;;A61B90/361;;A61B90/37;;A61B2034/107;;A61B2034/252;;A61B2034/258;;G16H40/63;;G06N20/10;;G06N5/046;;A61B2034/2072;;A61B2090/376;;A61F2/461;;A61F2002/4633;;A61B2034/2048;;A61B2034/2057;;A61B2034/2063;;A61B2034/2065;;A61B2034/2068;;A61B2034/2074;;A61B2034/254;;A61B2090/365;;A61B2090/502;;A61B2090/363;;A61B2090/371;;A61B90/39;;A61B2090/3916;;G02B27/0172;;G02B2027/0138;;G06N3/08;;G16H30/40;;G09B19/003;;G09B19/24;;A61F2002/30952;;G09B5/02,A61B34/10,,0,0,,,,PENDING
392,US,B2,US 8022152 B2,173-976-243-395-675,2011-09-20,2011,US 292507 A,2007-12-19,US 292507 A;;US 29560602 A;;US 40792402 P;;US 33279801 P;;US 33279901 P,2001-11-16,Copolymers of vinyl- and allylsilanes,"Ethylene and allyl- or vinylsilanes are efficiently copolymerized by certain late transition metal complexes containing selected bidentate or tridentate ligands. The resulting novel polymers may be crosslinked by moisture when vinylsilane contains groups bound to silicon which are hydrolyzable. The polymers are useful for wire coating, crosslinked foams, pipes, and other uses.",DU PONT,ITTEL STEVEN DALE;;JOHNSON LYNDA KAYE;;WANG LIN;;WANG YING;;MCCORD ELIZABETH FORRESTER;;RADZEWICH CATHERINE E;;MCLAIN STEPHAN JAMES;;SWEETMAN KARL JEFFREY;;BENNETT ALISON MARGARET ANNE;;IONKIN ALEX SERGEY;;SCHIFFINO RINALDO SORIA,,https://lens.org/173-976-243-395-675,Granted Patent,yes,39,2,22,22,0,C08F4/65908;;C08F4/65912;;C08F4/65916;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/02;;C08F210/16;;C08F2410/07;;C08F210/02;;C08F8/00;;C08F10/00;;C08F4/44;;C08F210/02;;C08F210/16;;C08F4/65916;;C08F4/65912;;C08F10/00;;C08F4/65908;;C08F110/02;;C08F10/02,C08F2/38;;C08F4/00;;C08F4/659;;C08F4/70;;C08F10/00;;C08F10/02;;C08F30/08;;C08F110/02;;C08F210/00;;C08F210/02;;C08F210/16;;C08F230/08,526/82;;526/90;;526/279;;526/348,20,1,101-579-530-746-406,10.1021/ma00139a022,"Notice of Allowance issued Nov. 7, 2007 in U.S. Appl. No. 10/295,606.;;Final Office Action issued Aug. 16, 2007 in U.S. Appl. No. 10/295,606.;;Non-Final Office Action issued Mar. 5, 2007 in U.S. Appl. No. 10/295,606.;;Final Office Action issued Aug. 21, 2006, in U.S. Appl. No. 10/295,606.;;Non-Final Office Action issued Feb. 1, 2006 in U.S. Appl. No. 10/295,606.;;Final Office Action mailed Jul. 20, 2005, in U.S. Appl. No. 10/295,606.;;Non-Final Office Action issued Feb. 8, 2005, in U.S. Appl. No. 10/295,606.;;Final Office Action issued Sep. 1, 2004, in U.S. Appl. No. 10/295,606.;;Non-Final Office Action issued Mar. 22, 2004, in U.S. Appl. No. 10/295,606.;;Restriction Requirement issued Jan. 21, 2004, in U.S. Appl. No. 10/295,606.;;Issued Notification dated Jan. 8, 2004 in U.S. Appl. No. 10/295,319.;;Non-Final Office Action issued Jul. 30, 2003, in U.S. Appl. No. 10/295,319.;;PCT International Search Report, Dated Mar. 20, 2003, International Application No. PCT/US02/36890, International Filing Date Nov. 15, 2002.;;U.S. Appl. No. 10/295,319, filed Aug. 24, 2004.;;U.S. Appl. No. 08/899,017, filed Jul. 23, 1997.;;Notice of Allowance issued Apr. 8, 2003 in U.S. Appl. No. 09/496,114.;;Non-Final Office Action issued Oct. 23, 2002, in U.S. Appl. No. 09/496,114.;;Notice of Allowance issued Dec. 3, 2003 in U.S. Appl. No. 10/437,685.;;Usami, Takao and Takayama, Shigeru, Fine-Branching Structure in High-Pressure, Low-Density Polyethylenes by 50.10-MHz 12C NMR Analysis, Macromolecules 1964, 17, 1758-1761, (1984).;;PCT/US02/36890 International Search Report (Mar. 2003).",INACTIVE
393,US,A1,US 2009/0143550 A1,183-606-056-157-131,2009-06-04,2009,US 292507 A,2007-12-19,US 292507 A;;US 29560602 A;;US 40792402 P;;US 33279801 P;;US 33279901 P,2001-11-16,Copolymers of vinyl-and allylsilanes,"Ethylene and allyl- or vinylsilanes are efficiently copolymerized by certain late transition metal complexes containing selected bidentate or tridentate ligands. The resulting novel polymers may be crosslinked by moisture when vinylsilane contains groups bound to silicon which are hydrolyzable. The polymers are useful for wire coating, crosslinked foams, pipes, and other uses.",ITTEL STEVEN DALE;;JOHNSON LYNDA KAYE;;WANG LIN;;WANG YING;;MCCORD ELIZABETH FORRESTER;;RADZEWICH CHATHERINE E;;MCLAIN STEPHAN J;;SWEETMAN KARL J;;BENNETT ALISON MARGARET ANNE;;IONKIN ALEX SERGEY;;SCHIFFINO RINALDO S,ITTEL STEVEN DALE;;JOHNSON LYNDA KAYE;;WANG LIN;;WANG YING;;MCCORD ELIZABETH FORRESTER;;RADZEWICH CHATHERINE E;;MCLAIN STEPHAN J;;SWEETMAN KARL J;;BENNETT ALISON MARGARET ANNE;;IONKIN ALEX SERGEY;;SCHIFFINO RINALDO S,,https://lens.org/183-606-056-157-131,Patent Application,yes,13,1,22,22,0,C08F4/65908;;C08F4/65912;;C08F4/65916;;C08F10/00;;C08F10/02;;C08F110/02;;C08F210/02;;C08F210/16;;C08F2410/07;;C08F210/02;;C08F8/00;;C08F10/00;;C08F4/44;;C08F210/02;;C08F210/16;;C08F4/65916;;C08F4/65912;;C08F10/00;;C08F4/65908;;C08F110/02;;C08F10/02,C08F4/42;;C08F4/659;;C08F4/70;;C08F10/00;;C08F10/02;;C08F30/08;;C08F110/02;;C08F210/00;;C08F210/02;;C08F210/16;;C08F230/08,526/126;;526/90;;526/170,0,0,,,,EXPIRED
394,US,A1,US 2020/0157212 A1,083-096-005-115-449,2020-05-21,2020,US 201816614701 A,2018-06-08,US 201816614701 A;;US 201762517233 P;;US 2018/0036629 W,2017-06-09,"ANTI-ROBO2 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF","The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to ROBO2, as well as uses, and methods thereof.",PFIZER;;BOSTON MEDICAL CT CORP,BERASI STEPHEN;;BUHLMANN JANET ELIZABETH;;BENNETT ERIC M;;HIGGINSON-SCOTT NATHAN;;GAO HUILAN;;JUO ZONG SEAN;;GULLA STEFANO V;;HUARD CHRISTINE;;KODANGATTIL SREEKUMAR R;;LI JIAN;;LU WEINING;;FAN XUEPING;;SALANT DAVID J,,https://lens.org/083-096-005-115-449,Patent Application,yes,0,2,9,9,146,C07K16/2803;;C07K2317/21;;C07K2317/33;;C07K2317/34;;C07K2317/622;;C07K2317/76;;C07K2317/92;;A61P13/12;;A61P13/12;;C07K16/2803;;C07K2317/21;;C07K2317/33;;C07K2317/34;;C07K2317/565;;C07K2317/622;;C07K2317/76;;C07K2317/92;;C12N15/85;;C12N2015/8518,C07K16/28;;A61P13/12;;C12N15/85,,0,0,,,,ACTIVE
395,EP,A1,EP 3635008 A1,053-535-042-217-931,2020-04-15,2020,EP 18734732 A,2018-06-08,US 201762517233 P;;US 2018/0036629 W,2017-06-09,"ANTI-ROBO2 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF",,PFIZER;;BOSTON MEDICAL CT CORP,BERASI STEPHEN;;BUHLMANN JANET ELIZABETH;;BENNETT ERIC M;;HIGGINSON-SCOTT NATHAN;;GAO HUILAN;;JUO ZONG SEAN;;GULLA STEFANO V;;HUARD CHRISTINE;;KODANGATTIL SREEKUMAR R;;LI JIAN;;LU WEINING;;FAN XUEPING;;SALANT DAVID J,BOSTON MEDICAL CENTER CORPORATION (2023-04-19);;PFIZER INC. (2023-04-19),https://lens.org/053-535-042-217-931,Patent Application,yes,0,0,9,9,0,C07K16/2803;;C07K2317/21;;C07K2317/33;;C07K2317/34;;C07K2317/622;;C07K2317/76;;C07K2317/92;;A61P13/12;;A61P13/12;;C07K16/2803;;C07K2317/21;;C07K2317/33;;C07K2317/34;;C07K2317/565;;C07K2317/622;;C07K2317/76;;C07K2317/92;;C12N15/85;;C12N2015/8518,C07K16/28;;A61P13/12,,0,0,,,,PENDING
396,US,B2,US 11365253 B2,027-435-618-377-807,2022-06-21,2022,US 201816614701 A,2018-06-08,US 201816614701 A;;US 201762517233 P;;US 2018/0036629 W,2017-06-09,"Anti-ROBO2 antibodies, compositions, methods and uses thereof","The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to ROBO2, as well as uses, and methods thereof.",PFIZER;;BOSTON MEDICAL CT CORP,BERASI STEPHEN;;BUHLMANN JANET ELIZABETH;;BENNETT ERIC M;;HIGGINSON-SCOTT NATHAN;;GAO HUILAN;;JUO ZONG SEAN;;GULLA STEFANO V;;HUARD CHRISTINE;;KODANGATTIL SREEKUMAR R;;LI JIAN;;LU WEINING;;FAN XUEPING;;SALANT DAVID J,BOSTON MEDICAL CENTER CORPORATION (2017-07-12);;PFIZER INC (2017-06-15),https://lens.org/027-435-618-377-807,Granted Patent,yes,2,0,9,9,146,C07K16/2803;;C07K2317/21;;C07K2317/33;;C07K2317/34;;C07K2317/622;;C07K2317/76;;C07K2317/92;;A61P13/12;;A61P13/12;;C07K16/2803;;C07K2317/21;;C07K2317/33;;C07K2317/34;;C07K2317/565;;C07K2317/622;;C07K2317/76;;C07K2317/92;;C12N15/85;;C12N2015/8518,C07H21/04;;A61K39/00;;A61K39/395;;A61P13/12;;C07K16/00;;C07K16/28;;C12N1/20;;C12N15/74;;C12N15/85;;C12N15/87;;C12P21/06,,14,11,027-880-661-246-429;;032-427-821-815-367;;087-523-165-177-47X;;005-251-111-154-677;;009-080-969-021-48X;;084-068-994-774-254;;098-845-616-440-398;;056-659-933-697-143;;053-519-394-609-859;;039-824-898-130-458;;010-893-066-446-923,10.1016/j.jmb.2003.09.054;;14596803;;18974080;;10.1093/protein/gzn058;;10.4049/jimmunol.173.12.7358;;15585860;;30718829;;10.1038/s41577-019-0126-7;;15496984;;10.1038/sj.emboj.7600446;;pmc526463;;26186094;;10.7554/elife.08407;;pmc4505356;;10.1038/nrn.2015.3;;26656254;;27882344;;10.1172/jci.insight.86934;;pmc5111509;;pmc7100438;;17516710;;10.2165/00063030-200721030-00002;;14689480;;10.1002/cne.10984;;10.1038/ncomms9806;;pmc4674765;;26608094,"Edwards et al., The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein, BLyS. J Mol Biol. Nov. 14, 2003;334(1): 103-18. (Year: 2003).;;Lloyd et al., Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. Protein Eng Des Sel. Mar. 2009;22(3):159-68. (Year: 2009).;;Goel et al., Plasticity within the antigen-combining site may manifest as molecular mimicry in the humoral immune response. J Immunol. Dec. 15, 2004; 173(12):7358-67. (Year: 2004).;;Kanyavuz et al., Breaking the law: unconventional strategies for antibody diversification. Nat Rev Immunol. Jun. 2019; 19(6):355-368. (Year: 2019).;;Howitt et al. Binding site for Robo receptors revealed by dissection of the leucine-rich repeat region of Slit. EMBO J (2004)23:4406-4412|. (Year: 2004).;;Evans et al. Robo2 acts in trans to inhibit Slit-Robo1 repulsion in pre-crossing commissural axons. Evans et al. eLife 2015;4:e08407 . (Year: 2015).;;Anonymous, “Anti-Robo2 antibody ab85278,” (https://www.abcam.com/Robo2-antibodv-ab85278.pdf) (retrieved Jul. 26, 2018) (3 pages).;;Anonymous, “Human ROBO2 Antibody, MAB3147,” Feb. 7, 2018 (https://www.resources.rndsystems.com/pdfs/datasheets/mab3147.pdf) (retrieved Jul. 26, 2018).;;De Wit, et al., “Specification of synaptic connectivity by cell surface interactions,” Nature Reviews. Neuroscience, 17(1):22-35 (2016).;;Fan et al., “SLIT2/ROBO2 signaling pathway inhibits nonmuscle myosin IIA activity and destabilizes kidney podocyte adhesion,” JCI Insight, 1(19):e86934 (2016).;;Gershoni, et al., “Epitope mapping: the first step in developing epitope-based vaccines,” Biodmgs, ADIS International Ltd., 21(3):145-156 (2007).;;Mather, “The Chick Embryo; A new drug delivery model for neuroblastoma,” Thesis, University of Liverpool, Aug. 1, 2014 (138 pages).;;Sundaresan, et al., “Dynamic expression patterns of Robo (Robol and Robo2) in the developing murine central nervous system,” Journal of Comparative Neurology, 468(4):467-481 (2004).;;Xu et al., “Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes,” Nature Communications, 6(8806) (2015).",ACTIVE
397,AU,A1,AU 2018/279705 A1,175-690-284-071-908,2019-11-14,2019,AU 2018/279705 A,2018-06-08,US 201762517233 P;;US 2018/0036629 W,2017-06-09,"Anti-ROBO2 antibodies, compositions, methods and uses thereof","The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to ROBO2, as well as uses, and methods thereof.",BOSTON MEDICAL CT CORP;;PFIZER,BERASI STEPHEN;;BUHLMANN JANET ELIZABETH;;BENNETT ERIC M;;HIGGINSON-SCOTT NATHAN;;GAO HUILAN;;JUO ZONG SEAN;;GULLA STEFANO V;;HUARD CHRISTINE;;KODANGATTIL SREEKUMAR R;;LI JIAN;;LU WEINING;;FAN XUEPING;;SALANT DAVID J,,https://lens.org/175-690-284-071-908,Patent Application,no,0,0,9,9,0,C07K16/2803;;C07K2317/21;;C07K2317/33;;C07K2317/34;;C07K2317/622;;C07K2317/76;;C07K2317/92;;A61P13/12;;A61P13/12;;C07K16/2803;;C07K2317/21;;C07K2317/33;;C07K2317/34;;C07K2317/565;;C07K2317/622;;C07K2317/76;;C07K2317/92;;C12N15/85;;C12N2015/8518,C07K16/28;;A61P13/12,,0,0,,,,PENDING
398,CA,A1,CA 3061986 A1,171-783-221-315-837,2018-12-13,2018,CA 3061986 A,2018-06-08,US 201762517233 P;;US 2018/0036629 W,2017-06-09,"ANTI-ROBO2 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF","The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to ROBO2, as well as uses, and methods thereof.",PFIZER;;BOSTON MEDICAL CT CORP,BERASI STEPHEN;;BUHLMANN JANET ELIZABETH;;BENNETT ERIC M;;HIGGINSON-SCOTT NATHAN;;GAO HUILAN;;JUO ZONG SEAN;;GULLA STEFANO V;;HUARD CHRISTINE;;KODANGATTIL SREEKUMAR R;;LI JIAN;;LU WEINING;;FAN XUEPING;;SALANT DAVID J,,https://lens.org/171-783-221-315-837,Patent Application,no,0,0,9,9,146,C07K16/2803;;C07K2317/21;;C07K2317/33;;C07K2317/34;;C07K2317/622;;C07K2317/76;;C07K2317/92;;A61P13/12;;A61P13/12;;C07K16/2803;;C07K2317/21;;C07K2317/33;;C07K2317/34;;C07K2317/565;;C07K2317/622;;C07K2317/76;;C07K2317/92;;C12N15/85;;C12N2015/8518,C07K16/28;;A61P13/12,,0,0,,,,PENDING
399,US,A1,US 2023/0000556 A1,046-068-243-838-167,2023-01-05,2023,US 202217748607 A,2022-05-19,US 202217748607 A;;US 202117428466 A;;US 2020/0016562 W;;US 201962939946 P;;US 201962885673 P;;US 201962864663 P;;US 201962801257 P;;US 201962801245 P,2019-02-05,PATIENT-SPECIFIC SIMULATION DATA FOR ROBOTIC SURGICAL PLANNING,A method for creating a patient-specific surgical plan includes receiving one or more pre-operative images of a patient having one or more infirmities affecting one or more anatomical joints. three-dimensional anatomical model of the one or more anatomical joints is created based on the one or more pre-operative images. One or more transfer functions and the three-dimensional anatomical model are used to identify a patient-specific implantation geometry that corrects the one or more infirmities. The transfer functions model performance of the one or more anatomical joints as a function of anatomical geometry and anatomical implantation features. surgical plan comprising the patient-specific implantation geometry may then be displayed.,SMITH & NEPHEW INC;;SMITH & NEPHEW ASIA PACIFIC PTE LTD;;SMITH & NEPHEW ORTHOPAEDICS AG,MCKINNON BRIAN W;;MARINESCU TANASOCA RUXANDRA CRISTIANA;;WINEBARGER RANDY C;;BOWERS JR WILLIAM L;;WIEBE III JAMES BENNETT;;LENZ NATHANIEL MILTON;;HADDOCK SEAN M;;LANDON RYAN LLOYD;;MCGUAN SHAWN P;;NIKOU CONSTANTINOS;;DUXBURY ELIZABETH,SMITH & NEPHEW ORTHOPAEDICS AG (2021-08-02);;SMITH & NEPHEW INC (2021-08-02);;SMITH & NEPHEW ASIA PACIFIC PTE. LIMITED (2021-08-02),https://lens.org/046-068-243-838-167,Patent Application,yes,0,0,53,53,0,A61B2034/105;;A61B2034/108;;A61B2034/107;;A61B34/10;;A61B2034/104;;A61B34/30;;A61B17/1764;;A61B17/154;;A61B2034/2055;;A61B2034/2051;;A61B2034/2065;;A61B2034/2063;;A61B90/96;;A61B2090/376;;A61B2090/378;;A61B2090/365;;A61B2090/372;;A61B2090/502;;A61B2034/252;;A61B2034/254;;A61B2017/00221;;A61B34/25;;A61B2034/258;;A61B2034/256;;A61B2090/371;;A61B34/20;;A61B2017/00207;;A61B2034/2048;;A61B2034/2057;;A61B2090/3983;;A61B2034/102;;A61B2034/2068;;G16H20/40;;G16H50/50;;G06N5/046;;G06N3/08;;G06N20/10;;A61B2505/05;;A61B5/4585;;A61B5/0077;;A61B5/064;;A61B5/1118;;A61B5/004;;A61B5/1072;;Y02A90/10;;G16H15/00;;G16H50/00;;G06N5/01;;G06N3/044;;A61B34/10;;A61B34/25;;A61B2034/256;;G16H20/40;;G16H50/50;;G16H10/60;;G16H50/70;;A61B17/1764;;A61B2017/00199;;A61B2034/104;;A61B2034/105;;A61B2034/108;;A61B34/20;;A61B34/30;;A61B90/96;;G06N20/00;;A61B17/15;;A61B17/17;;A61B2017/00526;;A61B2034/102;;A61B90/361;;A61B90/37;;A61B2034/107;;A61B2034/252;;A61B2034/258;;G16H40/63;;G06N20/10;;G06N5/046;;A61B2034/2072;;A61B2090/376;;A61F2/461;;A61F2002/4633;;A61B2034/2048;;A61B2034/2057;;A61B2034/2063;;A61B2034/2065;;A61B2034/2068;;A61B2034/2074;;A61B2034/254;;A61B2090/365;;A61B2090/502;;A61B2090/363;;A61B2090/371;;A61B90/39;;A61B2090/3916;;G02B27/0172;;G02B2027/0138;;G06N3/08;;G16H30/40;;G09B19/003;;G09B19/24;;A61F2002/30952;;G09B5/02,A61B17/17;;A61B34/10;;A61B34/00;;A61B90/00;;A61F2/46;;G02B27/01;;G06N3/08;;G06N5/04;;G06N20/00;;G06N20/10;;G09B19/00;;G09B19/24;;G16H10/60;;G16H20/40;;G16H30/40;;G16H40/63;;G16H50/50;;G16H50/70,,0,0,,,,PENDING
400,US,B2,US 11337762 B2,028-999-923-267-831,2022-05-24,2022,US 202017428466 A,2020-02-04,US 202017428466 A;;US 201962939946 P;;US 201962885673 P;;US 201962864663 P;;US 201962801245 P;;US 201962801257 P;;US 2020/0016562 W,2019-02-05,Patient-specific simulation data for robotic surgical planning,"A method for creating a patient-specific surgical plan includes receiving one or more pre-operative images of a patient having one or more infirmities affecting one or more anatomical joints, three-dimensional anatomical model of the one or more anatomical joints is created based on the one or more pre-operative images. One or more transfer functions and the three-dimensional anatomical model are used to identify a patient-specific implantation geometry that corrects the one or more infirmities. The transfer functions model performance of the one or more anatomical joints as a function of anatomical geometry and anatomical implantation features, surgical plan comprising the patient-specific implantation geometry may then be displayed.",SMITH & NEPHEW INC;;SMITH & NEPHEW ASIA PACIFIC PTE LTD;;SMITH & NEPHEW ORTHOPAEDICS AG,MCKINNON BRIAN W;;MARINESCU TANASOCA RUXANDRA CRISTIANA;;WINEBARGER RANDY C;;BOWERS JR WILLIAM L;;WIEBE III JAMES BENNETT;;LENZ NATHANIEL MILTON;;HADDOCK SEAN M;;LANDON RYAN LLOYD;;MCGUAN SHAWN P;;NIKOU CONSTANTINOS;;DUXBURY ELIZABETH,SMITH & NEPHEW ORTHOPAEDICS AG (2021-08-02);;SMITH & NEPHEW INC (2021-08-02);;SMITH & NEPHEW ASIA PACIFIC PTE. LIMITED (2021-08-02),https://lens.org/028-999-923-267-831,Granted Patent,yes,65,2,53,53,0,A61B2034/105;;A61B2034/108;;A61B2034/107;;A61B34/10;;A61B2034/104;;A61B34/30;;A61B17/1764;;A61B17/154;;A61B2034/2055;;A61B2034/2051;;A61B2034/2065;;A61B2034/2063;;A61B90/96;;A61B2090/376;;A61B2090/378;;A61B2090/365;;A61B2090/372;;A61B2090/502;;A61B2034/252;;A61B2034/254;;A61B2017/00221;;A61B34/25;;A61B2034/258;;A61B2034/256;;A61B2090/371;;A61B34/20;;A61B2017/00207;;A61B2034/2048;;A61B2034/2057;;A61B2090/3983;;A61B2034/102;;A61B2034/2068;;G16H20/40;;G16H50/50;;G06N5/046;;G06N3/08;;G06N20/10;;A61B2505/05;;A61B5/4585;;A61B5/0077;;A61B5/064;;A61B5/1118;;A61B5/004;;A61B5/1072;;Y02A90/10;;G16H15/00;;G16H50/00;;G06N5/01;;G06N3/044;;A61B34/10;;A61B34/25;;A61B2034/256;;G16H20/40;;G16H50/50;;G16H10/60;;G16H50/70;;A61B17/1764;;A61B2017/00199;;A61B2034/104;;A61B2034/105;;A61B2034/108;;A61B34/20;;A61B34/30;;A61B90/96;;G06N20/00;;A61B17/15;;A61B17/17;;A61B2017/00526;;A61B2034/102;;A61B90/361;;A61B90/37;;A61B2034/107;;A61B2034/252;;A61B2034/258;;G16H40/63;;G06N20/10;;G06N5/046;;A61B2034/2072;;A61B2090/376;;A61F2/461;;A61F2002/4633;;A61B2034/2048;;A61B2034/2057;;A61B2034/2063;;A61B2034/2065;;A61B2034/2068;;A61B2034/2074;;A61B2034/254;;A61B2090/365;;A61B2090/502;;A61B2090/363;;A61B2090/371;;A61B90/39;;A61B2090/3916;;G02B27/0172;;G02B2027/0138;;G06N3/08;;G16H30/40;;G09B19/003;;G09B19/24;;A61F2002/30952;;G09B5/02,A61B34/10;;A61B34/30;;A61B90/00;;G16H20/40,,10,0,,,"International Search Report and Written Opinion for PCT/US2020/016562 dated May 20, 2020.;;International Search Report and Written Opinion for PCT/US2020/016612 dated Jun. 2, 2020.;;International Search Report and Written Opinion for PCT/US2020/016609 dated May 25, 2020.;;International Search Report and Written Opinion for PCT/US2020/016605 dated May 27, 2020.;;International Search Report and Written Opinion for PCT/US2020/016579 dated Apr. 23, 2020.;;International Search Report and Written Opinion for PCT/US2020/016575 dated Apr. 29, 2020.;;International Search Report and Written Opinion for PCT/US2020/016569 dated May 12, 2020.;;International Search Report and Written Opinion for PCT/US2020/016563 dated Jun. 3, 2020.;;International Search Report and Written Opinion for PCT/US2020/016561 dated Jun. 3, 2020.;;International Search Report and Written Opinion for PCT/US2020/016559 dated Jun. 19, 2020.",ACTIVE
401,US,A1,US 2022/0079678 A1,182-812-232-336-747,2022-03-17,2022,US 202017428466 A,2020-02-04,US 202017428466 A;;US 201962939946 P;;US 201962885673 P;;US 201962864663 P;;US 201962801245 P;;US 201962801257 P;;US 2020/0016562 W,2019-02-05,PATIENT-SPECIFIC SIMULATION DATA FOR ROBOTIC SURGICAL PLANNING,A method for creating a patient-specific surgical plan includes receiving one or more pre-operative images of a patient having one or more infirmities affecting one or more anatomical joints. three-dimensional anatomical model of the one or more anatomical joints is created based on the one or more pre-operative images. One or more transfer functions and the three-dimensional anatomical model are used to identify a patient-specific implantation geometry that corrects the one or more infirmities. The transfer functions model performance of the one or more anatomical joints as a function of anatomical geometry and anatomical implantation features. surgical plan comprising the patient-specific implantation geometry may then be displayed.,SMITH & NEPHEW INC;;SMITH & NEPHEW ASIA PACIFIC PTE LTD;;SMITH & NEPHEW ORTHOPAEDICS AG,MCKINNON BRIAN W;;MARINESCU TANASOCA RUXANDRA CRISTIANA;;WINEBARGER RANDY C;;BOWERS JR WILLIAM L;;WIEBE III JAMES BENNETT;;LENZ NATHANIEL MILTON;;HADDOCK SEAN M;;LANDON RYAN LLOYD;;MCGUAN SHAWN P;;NIKOU CONSTANTINOS;;DUXBURY ELIZABETH,SMITH & NEPHEW ORTHOPAEDICS AG (2021-08-02);;SMITH & NEPHEW INC (2021-08-02);;SMITH & NEPHEW ASIA PACIFIC PTE. LIMITED (2021-08-02),https://lens.org/182-812-232-336-747,Patent Application,yes,0,4,53,53,0,A61B2034/105;;A61B2034/108;;A61B2034/107;;A61B34/10;;A61B2034/104;;A61B34/30;;A61B17/1764;;A61B17/154;;A61B2034/2055;;A61B2034/2051;;A61B2034/2065;;A61B2034/2063;;A61B90/96;;A61B2090/376;;A61B2090/378;;A61B2090/365;;A61B2090/372;;A61B2090/502;;A61B2034/252;;A61B2034/254;;A61B2017/00221;;A61B34/25;;A61B2034/258;;A61B2034/256;;A61B2090/371;;A61B34/20;;A61B2017/00207;;A61B2034/2048;;A61B2034/2057;;A61B2090/3983;;A61B2034/102;;A61B2034/2068;;G16H20/40;;G16H50/50;;G06N5/046;;G06N3/08;;G06N20/10;;A61B2505/05;;A61B5/4585;;A61B5/0077;;A61B5/064;;A61B5/1118;;A61B5/004;;A61B5/1072;;Y02A90/10;;G16H15/00;;G16H50/00;;G06N5/01;;G06N3/044;;A61B34/10;;A61B34/25;;A61B2034/256;;G16H20/40;;G16H50/50;;G16H10/60;;G16H50/70;;A61B17/1764;;A61B2017/00199;;A61B2034/104;;A61B2034/105;;A61B2034/108;;A61B34/20;;A61B34/30;;A61B90/96;;G06N20/00;;A61B17/15;;A61B17/17;;A61B2017/00526;;A61B2034/102;;A61B90/361;;A61B90/37;;A61B2034/107;;A61B2034/252;;A61B2034/258;;G16H40/63;;G06N20/10;;G06N5/046;;A61B2034/2072;;A61B2090/376;;A61F2/461;;A61F2002/4633;;A61B2034/2048;;A61B2034/2057;;A61B2034/2063;;A61B2034/2065;;A61B2034/2068;;A61B2034/2074;;A61B2034/254;;A61B2090/365;;A61B2090/502;;A61B2090/363;;A61B2090/371;;A61B90/39;;A61B2090/3916;;G02B27/0172;;G02B2027/0138;;G06N3/08;;G16H30/40;;G09B19/003;;G09B19/24;;A61F2002/30952;;G09B5/02,A61B34/10;;A61B90/00;;G16H20/40,,0,0,,,,ACTIVE
402,US,S,US D0685180 S,113-437-210-462-326,2013-07-02,2013,US 201129403444 F,2011-10-06,US 201129403444 F,2011-10-06,Tote,,BAEKGAARD BARBARA BRADLEY;;BENNETT REBECCA ANN;;COLBY KIMBERLY FRENZEL;;DESCHNER KATE ELIZABETH;;DIEHL TIFFANY;;DOVE KELLI ANN;;HOFFHERR STEPHANIE LANEE;;NAFZIGER KENDRA M;;POUDRIER VERONIQUE;;SCHRANK TONI MEADOR;;WALTERS RENEE MARIE;;WERNKE WENDY CHAPMAN;;VERA BRADLEY DESIGNS INC,BAEKGAARD BARBARA BRADLEY;;BENNETT REBECCA ANN;;COLBY KIMBERLY FRENZEL;;DESCHNER KATE ELIZABETH;;DIEHL TIFFANY;;DOVE KELLI ANN;;HOFFHERR STEPHANIE LANEE;;NAFZIGER KENDRA M;;POUDRIER VERONIQUE;;SCHRANK TONI MEADOR;;WALTERS RENEE MARIE;;WERNKE WENDY CHAPMAN,VERA BRADLEY DESIGNS INC (2011-10-20),https://lens.org/113-437-210-462-326,Design Right,no,0,1,1,1,0,,,0301;;D 3232,0,0,,,,ACTIVE
403,EP,A1,EP 3920824 A1,136-864-695-266-999,2021-12-15,2021,EP 20709039 A,2020-02-04,US 201962801245 P;;US 201962801257 P;;US 201962864663 P;;US 201962885673 P;;US 201962939946 P;;US 2020/0016562 W,2019-02-05,PATIENT-SPECIFIC SIMULATION DATA FOR ROBOTIC SURGICAL PLANNING,,SMITH & NEPHEW INC;;SMITH & NEPHEW ORTHOPAEDICS AG;;SMITH & NEPHEW ASIA PACIFIC PTE LTD,MCKINNON BRIAN W;;MARINESCU TANASOCA RUXANDRA CRISTIANA;;WINEBARGER RANDY C;;BOWERS JR WILLIAM L;;WIEBE III JAMES BENNETT;;LENZ NATHANIEL MILTON;;HADDOCK SEAN M;;LANDON RYAN LLOYD;;MCGUAN SHAWN P;;NIKOU CONSTANTINOS;;DUXBURY ELIZABETH,,https://lens.org/136-864-695-266-999,Patent Application,yes,0,0,53,53,0,A61B2034/105;;A61B2034/108;;A61B2034/107;;A61B34/10;;A61B2034/104;;A61B34/30;;A61B17/1764;;A61B17/154;;A61B2034/2055;;A61B2034/2051;;A61B2034/2065;;A61B2034/2063;;A61B90/96;;A61B2090/376;;A61B2090/378;;A61B2090/365;;A61B2090/372;;A61B2090/502;;A61B2034/252;;A61B2034/254;;A61B2017/00221;;A61B34/25;;A61B2034/258;;A61B2034/256;;A61B2090/371;;A61B34/20;;A61B2017/00207;;A61B2034/2048;;A61B2034/2057;;A61B2090/3983;;A61B2034/102;;A61B2034/2068;;G16H20/40;;G16H50/50;;G06N5/046;;G06N3/08;;G06N20/10;;A61B2505/05;;A61B5/4585;;A61B5/0077;;A61B5/064;;A61B5/1118;;A61B5/004;;A61B5/1072;;Y02A90/10;;G16H15/00;;G16H50/00;;G06N5/01;;G06N3/044;;A61B34/10;;A61B34/25;;A61B2034/256;;G16H20/40;;G16H50/50;;G16H10/60;;G16H50/70;;A61B17/1764;;A61B2017/00199;;A61B2034/104;;A61B2034/105;;A61B2034/108;;A61B34/20;;A61B34/30;;A61B90/96;;G06N20/00;;A61B17/15;;A61B17/17;;A61B2017/00526;;A61B2034/102;;A61B90/361;;A61B90/37;;A61B2034/107;;A61B2034/252;;A61B2034/258;;G16H40/63;;G06N20/10;;G06N5/046;;A61B2034/2072;;A61B2090/376;;A61F2/461;;A61F2002/4633;;A61B2034/2048;;A61B2034/2057;;A61B2034/2063;;A61B2034/2065;;A61B2034/2068;;A61B2034/2074;;A61B2034/254;;A61B2090/365;;A61B2090/502;;A61B2090/363;;A61B2090/371;;A61B90/39;;A61B2090/3916;;G02B27/0172;;G02B2027/0138;;G06N3/08;;G16H30/40;;G09B19/003;;G09B19/24;;A61F2002/30952;;G09B5/02,A61B34/10,,0,0,,,,PENDING
404,CN,A,CN 113395944 A,125-571-365-924-495,2021-09-14,2021,CN 202080012808 A,2020-02-04,US 201962801245 P;;US 201962801257 P;;US 201962864663 P;;US 201962885673 P;;US 201962939946 P;;US 2020/0016562 W,2019-02-05,PATIENT-SPECIFIC SIMULATION DATA FOR ROBOTIC SURGICAL PLANNING,A method for creating a patient-specific surgical plan includes receiving one or more pre-operative images of a patient having one or more infirmities affecting one or more anatomical joints. three-dimensional anatomical model of the one or more anatomical joints is created based on the one or more pre-operative images. One or more transfer functions and the three-dimensional anatomical model are used to identify a patient-specific implantation geometry that corrects the one or more infirmities. The transfer functions model performance of the one or more anatomical joints as a function of anatomical geometry and anatomical implantation features. surgical plan comprising the patient-specific implantation geometry may then be displayed.,SMITH & NEPHEW INC;;SMITH & NEPHEW ORTHOPAEDICS AG;;SMITH & NEPHEW ASIA PACIFIC PTE LTD,MCKINNON BRIAN W;;MARINESCU TANASOCA RUXANDRA CRISTIANA;;WINEBARGER RANDY C;;BOWERS JR WILLIAM L;;WIEBE III JAMES BENNETT;;LENZ NATHANIEL MILTON;;HADDOCK SEAN M;;LANDON RYAN LLOYD;;MCGUAN SHAWN P;;NIKOU CONSTANTINOS;;DUXBURY ELIZABETH,,https://lens.org/125-571-365-924-495,Patent Application,no,5,0,53,53,0,A61B2034/105;;A61B2034/108;;A61B2034/107;;A61B34/10;;A61B2034/104;;A61B34/30;;A61B17/1764;;A61B17/154;;A61B2034/2055;;A61B2034/2051;;A61B2034/2065;;A61B2034/2063;;A61B90/96;;A61B2090/376;;A61B2090/378;;A61B2090/365;;A61B2090/372;;A61B2090/502;;A61B2034/252;;A61B2034/254;;A61B2017/00221;;A61B34/25;;A61B2034/258;;A61B2034/256;;A61B2090/371;;A61B34/20;;A61B2017/00207;;A61B2034/2048;;A61B2034/2057;;A61B2090/3983;;A61B2034/102;;A61B2034/2068;;G16H20/40;;G16H50/50;;G06N5/046;;G06N3/08;;G06N20/10;;A61B2505/05;;A61B5/4585;;A61B5/0077;;A61B5/064;;A61B5/1118;;A61B5/004;;A61B5/1072;;Y02A90/10;;G16H15/00;;G16H50/00;;G06N5/01;;G06N3/044;;A61B34/10;;A61B34/25;;A61B2034/256;;G16H20/40;;G16H50/50;;G16H10/60;;G16H50/70;;A61B17/1764;;A61B2017/00199;;A61B2034/104;;A61B2034/105;;A61B2034/108;;A61B34/20;;A61B34/30;;A61B90/96;;G06N20/00;;A61B17/15;;A61B17/17;;A61B2017/00526;;A61B2034/102;;A61B90/361;;A61B90/37;;A61B2034/107;;A61B2034/252;;A61B2034/258;;G16H40/63;;G06N20/10;;G06N5/046;;A61B2034/2072;;A61B2090/376;;A61F2/461;;A61F2002/4633;;A61B2034/2048;;A61B2034/2057;;A61B2034/2063;;A61B2034/2065;;A61B2034/2068;;A61B2034/2074;;A61B2034/254;;A61B2090/365;;A61B2090/502;;A61B2090/363;;A61B2090/371;;A61B90/39;;A61B2090/3916;;G02B27/0172;;G02B2027/0138;;G06N3/08;;G16H30/40;;G09B19/003;;G09B19/24;;A61F2002/30952;;G09B5/02,A61B34/10,,0,0,,,,PENDING
405,AU,B2,AU 759997 B2,163-974-423-116-571,2003-05-01,2003,AU 2000/071835 A,2000-11-24,AU 2000/071835 A;;AU 1996/050208 A,1996-01-24,Alpha-olefins and olefin polymers and processes therefor,,DU PONT;;UNIV NORTH CAROLINA CHAPEL HILL,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/163-974-423-116-571,Granted Patent,no,0,0,2,3,0,,C07C249/02;;C07C251/08;;C07C251/24;;C08F4/602;;C08F4/70;;C08F4/80;;C08F110/02;;C08F110/06;;C08F110/08;;C08F120/22;;C08F132/04;;C08F210/02,,3,0,,,"J.AM.CHEM.SOC.VOL 88,NO 22,20 NOV 66, SAITO ET AL,P5198-5201;;MACROMOL.RAP COMM,VOL 16, NO 1, JAN 95,HEIDELBERG, P 9-14;;MACROMOL,VOL 27,NO 10,9 MAY 94,WASHINGTON,JIANG ,P2694-2700",EXPIRED
406,AU,B2,AU 2003/204611 B2,148-155-726-604-932,2006-03-02,2006,AU 2003/204611 A,2003-06-10,AU 2000/071835 A;;AU 1996/050208 A,1996-01-24,Alpha-olefins and olefin polymers and processes therefor,,DU PONT;;UNIV OF NORTH CAROLINA CHAPEL HILL,KILLAN CHRISTOPHER MOORE;;MCLAIN STEPHAN JAMES;;ITTEL STEVEN DALE;;COUGHLIN EDWARD BRYAN;;ARTHUR SAMUEL DAVID;;KREUTZER KRISTINA ANN;;BROOKHART MAURICE S;;BENNETT MARGARET ANNE;;FELDMAN JERALD;;JOHNSON LYNDA KAYE;;TEMPEL DANIEL JOSEPH;;MCCORD ELIZABETH;;PARTHASARATHY ANJU,,https://lens.org/148-155-726-604-932,Granted Patent,no,5,2,1,3,0,,C08F110/02;;C07C249/02;;C07C251/08;;C07C251/24;;C08F4/80;;C08F110/08;;C08F120/22;;C08F132/04;;C08F210/02,,0,0,,,,EXPIRED
407,AU,A,AU 2000/071835 A,145-848-137-196-523,2001-03-08,2001,AU 2000/071835 A,2000-11-24,AU 2000/071835 A;;AU 1996/050208 A,1996-01-24,Alpha-olefins and olefin polymers and processes therefor,,DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;BROOKHART MAURICE S;;TEMPEL DANIEL JOSEPH;;PARTHASARATHY ANJU;;ITTEL STEVEN DALE;;COUGHLIN EDWARD BRYAN;;BENNETT MARGARET ANNE;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;MCCORD ELIZABETH;;FELDMAN JERALD;;ARTHUR SAMUEL DAVID;;KILLIAN CHRISTOPHER MOORE,,https://lens.org/145-848-137-196-523,Patent Application,no,0,1,2,3,0,,C07C249/02;;C07C251/08;;C07C251/24;;C08F4/602;;C08F4/70;;C08F4/80;;C08F110/02;;C08F110/06;;C08F110/08;;C08F120/22;;C08F132/04;;C08F210/02,,0,0,,,,EXPIRED
408,TW,A,TW 200819450 A,159-710-482-986-573,2008-05-01,2008,TW 96134360 A,2007-09-14,US 84507506 P,2006-09-15,Azetidinone derivatives and methods of use thereof,"The present invention relates to Azetidinone Derivatives, compositions comprising an Azetidinone Derivative and methods for treating or preventing a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease, comprising administering to a patient an effective amount of an Azetidinone Derivative.",SCHERING CORP,ASLANIAN ROBERT G;;BENNETT CHAD E;;BURNETT DUANE A;;CHAN TIN-YAU;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;HARRIS JOEL M;;MCKITTRICK BRIAN A;;PALANI ANANDAN;;SMITH ELIZABETH M;;VACCARO HENRY M;;XIAO DONG;;KIM HYUNJIN,,https://lens.org/159-710-482-986-573,Patent of Addition,no,0,0,11,11,0,C07D471/10;;A61P1/00;;A61P1/04;;A61P1/08;;A61P1/12;;A61P1/16;;A61P13/02;;A61P15/00;;A61P17/00;;A61P17/02;;A61P17/06;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/00;;A61P3/06;;A61P9/00;;A61P3/10;;C07D471/10,A61K31/438;;C07D471/10;;A61P25/02;;C07D487/10,,0,0,,,,PENDING
409,EP,A2,EP 1348723 A2,198-634-281-117-34X,2003-10-01,2003,EP 03075669 A,1996-01-24,EP 96907020 A;;US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,Ethylen Copolymers,"Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH 2 =CH(CH 2 ) m CO 2 R 1 , wherein R 1  is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH 2 ) n CO 2 R 1 , in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHEN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/198-634-281-117-34X,Patent Application,yes,0,2,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/08;;C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,DISCONTINUED
410,CA,C,CA 2338526 C,121-954-280-749-088,2003-12-09,2003,CA 2338526 A,1996-01-24,CA 2211108 A;;US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,.ALPHA.-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR,"Disclosed heroin arc processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic eaters a carboxylic acids, and other monomers. The polymerizations are catalysed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described here in is the synthesis of linear a.olefins by the oligomerization of ethylene using as a catalyst system a combination of a nickel compound having a selected .alpha.-diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected $(a)diimine nickel complexes with ethylene.",DU PONT;;UNIV NORTH CAROLINA,KILLIAN CHRISTOPHER MOORE;;JOHNSON LYNDA KAYE;;COUGHLIN EDWARD BRYAN;;BENNETT MARGARET ANNE;;ITTEL STEVEN DALE;;KREUTZER KRISTINA ANN;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;BROOKHART MAURICE S;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES,,https://lens.org/121-954-280-749-088,Granted Patent,no,0,0,5,75,0,,C07F15/00;;C08F4/52;;C08F4/60;;C08F4/64;;C08F4/80;;C08F10/00;;C08F110/00;;C08F132/04;;C08F214/18;;C08F220/14;;C08F232/04;;C08L23/02;;C08L33/08;;C09J123/02;;C09J133/08,,0,0,,,,EXPIRED
411,NO,L,NO 973310 L,165-917-903-037-161,1997-09-23,1997,NO 973310 A,1997-07-17,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P;;US 9601282 W,1995-01-24,"<alfa>-olefiner og olefinpolymerer, og fremgangsmåte for fremstilling av slike polymerer","Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANN;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARTHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE C,,https://lens.org/165-917-903-037-161,Abstract,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07C251/08;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,DISCONTINUED
412,JP,A,JP 2005307218 A,000-190-551-995-674,2005-11-04,2005,JP 2005151691 A,2005-05-24,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,CATALYST COMPOSITIONS,"<P>PROBLEM TO BE SOLVED: To provide novel catalyst compositions useful for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic esters or carboxylic acids, and other monomers. <P>SOLUTION: Transition metal compounds such as Ni, Co, Fe, and Pd, and two nitrogen atoms, or nitrogen and phosphorus atoms are used as ligands. Compositions on rectangular plane steric configuration for a ligand with two seats having enough three-dimensional bulk on both sides of a coordination plane as a catalyst. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. <P>COPYRIGHT: (C)2006,JPO&NCIPI",DU PONT;;UNIV NORTH CAROLINA CHAPEL HILL,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/000-190-551-995-674,Patent Application,no,0,9,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C07C251/08;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,INACTIVE
413,CZ,A3,CZ 235197 A3,161-293-540-848-062,1997-12-17,1997,CZ 235197 A,1996-01-24,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P;;US 9601282 W,1995-01-24,"ALPHA OLEFINS, OLEFIN POLYMERS AND PROCESS FOR PREPARING THEREOF","Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/161-293-540-848-062,Patent Application,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/08;;C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,PENDING
414,WO,A3,WO 1996/023010 A3,090-412-469-517-054,1996-08-01,1996,US US9601282,1996-01-24,"US 8/378,044;;US 8/415,283;;US 8/473,590;;US 60/0/002,654;;US 60/0/007,375",1995-01-24,'alpha'-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR,"Disclosed herein are processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic esters or carboxylic acids, and other monomers. The polymerizations are catalysed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described herein is the synthesis of linear α-olefins by the oligomerization of ethylene using as a catalyst system a combination of a nickel compound having a selected α-diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected $(a)-diimine nickel complexes with ethylene.",E.I. DU PONT DE NEMOURS AND COMPANY;;UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL,"JOHNSON, Lynda, Kaye;;KILLIAN, Christopher, Moore;;ARTHUR, Samuel, David;;FELDMAN, Jerald;;McCORD, Elizabeth, Forrester;;McLAIN, Stephan, James;;KREUTZER, Kristina, Ann;;BENNETT, Margaret, Anne;;COUGHLIN, Edward, Bryan;;ITTEL, Steven, Dale;;PARTHASARATHY, Anju;;TEMPEL, Daniel, Joseph;;BROOKHART, Maurice, S.",,https://lens.org/090-412-469-517-054,Search Report,yes,0,0,1,1,0,,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02,,0,0,,,,UNKNOWN
415,FI,A,FI 973096 A,057-020-282-251-373,1997-09-23,1997,FI 973096 A,1997-07-23,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P;;US 9601282 W,1995-01-24,Alfa-olefiinejä ja olefiinipolymeereja ja menetelmiä niiden valmistamiseksi,"Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/057-020-282-251-373,Patent Application,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/00;;C07C251/08;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,DISCONTINUED
416,BR,A,BR 9607485 A,108-413-334-774-21X,1997-12-23,1997,BR 9607485 A,1996-01-24,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P;;US 9601282 W,1995-01-24,Polieolefina polímero processo para a polimeriyação de olefinas processo para a copolimerização de uma olefina fluroada copolímero catalisador composto homopolimero homopolipropileno melhorador de aderência aditivo de óleo resina de base modificador de viscosidade agente de revestimento ou de pentração agente de endurecimento modificador para asfalto isolamento de fio ou revestimento base eliminador película aditivo resina extrusão ou co-extrusãono peça folha laminado fibra espuma composição bolde ponto de congelação tela membrana diluente ionómero plastificador mistura polietileno polipropile adesivo objeto esponjoso pó mangueria rebaixador sa,"Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHEN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/108-413-334-774-21X,Patent Application,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/08;;C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,EXPIRED
417,CA,A1,CA 2338526 A1,068-402-257-849-990,1996-08-01,1996,CA 2338526 A,1996-01-24,CA 2211108 A;;US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,.ALPHA.-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR,"Disclosed heroin arc processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic eaters a carboxylic acids, and other monomers. The polymerizations are catalysed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described here in is the synthesis of linear a.olefins by the oligomerization of ethylene using as a catalyst system a combination of a nickel compound having a selected .alpha.-diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected $(a)diimine nickel complexes with ethylene.",UNIV NORTH CAROLINA;;DU PONT,ITTEL STEVEN DALE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;COUGHLIN EDWARD BRYAN;;KILLIAN CHRISTOPHER MOORE;;BROOKHART MAURICE S;;TEMPEL DANIEL JOSEPH;;PARTHASARATHY ANJU;;MCCORD ELIZABETH FORRESTER;;BENNETT MARGARET ANNE;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;JOHNSON LYNDA KAYE,,https://lens.org/068-402-257-849-990,Patent Application,no,0,0,5,75,0,,C07F15/00;;C08F4/52;;C08F4/60;;C08F4/64;;C08F4/80;;C08F10/00;;C08F110/00;;C08F132/04;;C08F214/18;;C08F220/14;;C08F232/04;;C08L23/02;;C08L33/08;;C09J123/02;;C09J133/08,,0,0,,,,EXPIRED
418,NO,D0,NO 973310 D0,089-074-488-226-864,1997-07-17,1997,NO 973310 A,1997-07-17,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P;;US 9601282 W,1995-01-24,"<alfa>-olefiner og olefinpolymerer, og fremgangsmåte for fremstilling av slike polymerer","Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANN;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARTHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE C,,https://lens.org/089-074-488-226-864,Patent Application,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/00;;C07C251/08;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,DISCONTINUED
419,AT,T1,AT E238360 T1,043-703-226-825-277,2003-05-15,2003,AT 96907020 T,1996-01-24,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P;;US 9601282 W,1995-01-24,POLYOLEFINE,"Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/043-703-226-825-277,Granted Patent,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/08;;C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,DISCONTINUED
420,NZ,A,NZ 303800 A,003-000-766-796-946,2000-05-26,2000,NZ 30380096 A,1996-01-24,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P;;US 9601282 W,1995-01-24,"Olefin polymers and block polymers, preparation, use, catalysts and catalyst intermediates","Two polyolefins: i) A polyolefin that contains about 80 to 150 branches per 1000 methylene groups. For every 100 methyl branches, there are about 30-90 ethyl branches, 4-20 propyl branches, 15-50 butyl branches, 3-15 amyl branches and 30-140 hexyl or longer branches. ii) A polyolefin, which contains about 20 to 150 branches per 1000 methylene groups. For every 100 methyl branches, there are about 4-20 ethyl branches, 1-12 propyl branches, 1-12 butyl branches, 1-10 amyl branches and 0-20 hexyl or longer branches. Also claimed is an ethylene homopolymer with a density of 0.86 g/ml or less, a polymer of one or more alpha-olefins of the formula CH2=CH2(CH2)aH which contains the above formula (XXV), wherein R35 is an alkyl group and R36 is an alkyl group containing two or more carbon atoms. In addition, a polypropylene containing one or both of the above formulas (XXVII) and (XXIX), provided that, if (XXIX) is present, it has to be in a greater than or equal amount to 0.5 of (XXIX) per 1000 methylene groups, or the polymer contains at least 0.5 or more of (XXVIII) per 1000 methylene groups.",UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGRET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPLE DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/003-000-766-796-946,Patent Application,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07C251/08;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,PENDING
421,US,A1,US 2002/0032573 A1,050-317-803-797-367,2002-03-14,2002,US 82037701 A,2001-03-27,US 82037701 A;;US 19272300 P;;US 19389900 P,2000-03-27,"Apparatus, systems and methods for online, multi-parcel, multi-carrier, multi-service enterprise parcel shipping management","
   The present invention provides a plurality of Enterprises with a single online user interface with which the Enterprise can provide Enterprise Shippers, shipping origination users and shipping intermediary users with an automated parcel management system for a plurality of supported Carriers for a plurality of services. The present invention provides for the hierarchical definition of users, including the establishment of at least one user for each Enterprise as a Super-Administrator with the highest level of privileges and authority for the Enterprise, and the identification of other users as Sub-Administrators, Desktop Users and Shipping Station Users. The present invention also provides for the hierarchical definition of organizational units within each Enterprise, including the definition of sites, groups within a site, and users within a group. The present invention further provides for a distinct definition of policies, privileges, and other types of specifications for each user level, each user, and each organizational unit. The present invention applies the user and organizational policies, privileges and other specifications as they apply to each particular user to drive the interactive interface with each particular user and to provide among other things, shipping options, shipping services, shipping rates, traveler and/or shipping label preparation, and shipment tracking. 
",WILLIAMS DANIEL F.;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D.;;TEGLOVIC STEPHEN M.;;DIETZ JOHN M.;;SMITH WILLIAM W.;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R.;;MEYER SCOTT;;HU SEAN,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN,AUCTANE INC (2001-06-20),https://lens.org/050-317-803-797-367,Patent Application,yes,37,346,9,43,0,G06Q10/0835;;G06Q10/0835;;G06Q10/08;;G06Q10/08;;G06Q10/083;;G06Q10/083;;G06Q10/0834;;G06Q10/0834;;G06Q10/08345;;G06Q10/08345;;G06Q10/10;;G06Q10/10;;G06Q10/101;;G06Q10/101;;G06Q30/0282;;G06Q30/0282;;G06Q30/0601;;G06Q30/0601,G06Q10/08;;G06Q10/10;;G06Q30/02;;G06Q30/06,705/1,0,0,,,,EXPIRED
422,US,B2,US 7884080 B2,060-301-932-594-634,2011-02-08,2011,US 85475407 A,2007-09-13,US 85475407 A;;US 84507506 P,2006-09-15,Azetidinone derivatives and methods of use thereof,"The present invention relates to Azetidinone Derivatives of structural formula 1: and compositions comprising an Azetidinone Derivative and methods for treating or preventing a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease, comprising administering to a patient an effective amount of an Azetidinone Derivative.",SCHERING PLOUGH CORP,ASLANIAN ROBERT G;;BENNETT CHAD E;;BURNETT DUANE A;;CHAN TIN-YAU;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;HARRIS JOEL M;;MCKITTRICK BRIAN A;;PALANI ANANDAN;;SMITH ELIZABETH M;;VACCARO HENRY M;;XIAO DONG;;KIM HYUNJIN M,MERCK SHARP & DOHME CORP (2007-11-01),https://lens.org/060-301-932-594-634,Granted Patent,yes,46,42,11,11,0,C07D471/10;;A61P1/00;;A61P1/04;;A61P1/08;;A61P1/12;;A61P1/16;;A61P13/02;;A61P15/00;;A61P17/00;;A61P17/02;;A61P17/06;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/00;;A61P3/06;;A61P9/00;;A61P3/10;;C07D471/10,C07D471/10;;A61K31/397;;A61P3/06;;A61P3/10,514/23;;514/210.05;;540/203;;536/29.2,9,7,102-999-400-280-537;;020-426-301-835-209;;037-380-318-993-63X;;109-296-681-056-155;;072-226-712-614-902;;015-894-508-198-83X;;029-288-776-852-330,11559183;;10.1021/jo015714m;;16388623;;10.1021/jo0517287;;16092847;;10.1021/ol051214u;;15307755;;10.1021/jo049430o;;10.1021/jo040163w.s001;;15471445;;10.1021/jo040163w;;16995679;;10.1021/jo061189l;;10.1021/ja00292a040,"Alonso et al., ""Spiro beta-Lactams as beta-Turn Mimetics. Design, Synthesis, and NMR Conformational Analysis"", J. Org. Chem. 66(19):6333-6338, (2001).;;Bittermann et al., ""Chirospecific Synthesis of Spirocyclic beta-Lactams and Their Characterization as Potent Type II beta-Turn Inducing Peptide Mimetics"", J. Org. Chem. 71:97-102, (2006).;;Cignarella et al., ""Synthesis of a new series of 2,7-diazaspiro[3.5]nonan-1-ones and study of their cholinergic properties"", Eur J Med Chem 29:115-120, (1994).;;Clayden et al., ""Cyclization of Lithiated Pyridine and Quinoline Carboxamides: Synthesis of Partially Saturated Pyrrolopyridines and Spirocyclic beta-Lactams"", Organic Letters 7 (l7):3673-3676, (2005).;;Khasanov et al., ""Novel Asymmetric Approach to Proline-Derived Spiro-beta-Lactams"", J. Org. Chem. 69(17):5766-5769, (2004).;;Macias et al., ""Diastereoselective [2+2]-Cycloaddition Reactions of Unsymmetrical Cyclic ketenes with Imines: Synthesis of Modified Prolines and Theoretical Study of the Reaction Mechanism"", J. Org. Chem. 69:7004-7012, (2004).;;Macias et al., ""Synthesis of Enantiopure Pyrrolidine-Derived Peptidomimetics and Oligo-beta-peptides via Nucleophilic Ring-Opening of beta-Lactams"", J. Org. Chem. 71:7721-7730, (2004).;;Overman et al., ""A Convenient Synthesis of 4-Unsubstituted beta-Lactams"", J. Am. Chem. Soc. 107:1698-1701, (1985).;;PCT International Search Report dated Mar. 31, 2008 for corresponding PCT Application No. PCT/US2007/019930.",INACTIVE
423,CA,A1,CA 2211108 A1,148-687-209-663-878,1996-08-01,1996,CA 2211108 A,1996-01-24,US 265495 P;;US 737595 P;;US 47359095 A;;US 41528395 A;;US 37804495 A;;US 9601282 W,1995-01-24,.ALPHA.-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR,"Disclosed herein are processes for polymerizing ethylene, acyclic olefins, a nd/or selected cyclic olefins, and optionally selected o lefinic esters or carboxylic acids, and other monomers. The polymerizations are cata lysed by selected transition metal compounds, and someti mes other co-catalysts. Since some of the polymerizations exhibit some character istics of living polymerizations, block copolymers can b e readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of the m unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described here in is the synthesis of linear .alpha.-olefins by the oli gomerization of ethylene using as a catalyst system a combination of a nickel compound ha ving a selected .alpha.-diimine ligand and a selected Le wis or Bronsted acid, or by contacting selected $(a)-diimine nickel complexes with ethylene.",DU PONT;;UNIV NORTH CAROLINA,ITTEL STEVEN DALE;;BROOKHART MAURICE S;;JOHNSON LYNDA KAYE;;MCLAIN STEPHAN JAMES;;MCCORD ELIZABETH FORRESTER;;PARTHASARATHY ANJU;;FELDMAN JERALD;;KILLIAN CHRISTOPHER MOORE;;BENNETT MARGARET ANNE;;KREUTZER KRISTINA ANN;;ARTHUR SAMUEL DAVID;;TEMPEL DANIEL JOSEPH;;COUGHLIN EDWARD BRYAN,,https://lens.org/148-687-209-663-878,Patent Application,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/08;;C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,EXPIRED
424,PL,A1,PL 322446 A1,013-405-771-129-759,1998-02-02,1998,PL 32244696 A,1996-01-24,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,ALPHA-OLEFINES AND OLEFINIC POLYMERS AND METHODS OF OBTAINING THEM,"Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/013-405-771-129-759,Patent Application,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/00;;C07F5/00;;C07F7/00;;C07C251/08;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,PENDING
425,EP,A3,EP 1348723 A3,120-490-245-040-381,2004-09-29,2004,EP 03075669 A,1996-01-24,EP 96907020 A;;US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,Alpha-olefins and olefin polymers and processes for their preparation,"Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH 2 =CH(CH 2 ) m CO 2 R 1 , wherein R 1  is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH 2 ) n CO 2 R 1 , in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHEN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/120-490-245-040-381,Search Report,yes,4,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/08;;C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,1,1,004-397-567-739-425,10.1016/0304-5102(87)80023-8,"KLABUNDE U ET AL: ""NICKEL CATALYSIS FOR ETHYLENE HOMO- AND CO-POLYMERIZATION"", JOURNAL OF MOLECULAR CATALYSIS, LAUSANNE, CH, vol. 41, no. 1/2, 2 July 1987 (1987-07-02), pages 123 - 134, XP008002524",DISCONTINUED
426,CA,C,CA 2338542 C,168-759-442-723-123,2004-05-18,2004,CA 2338542 A,1996-01-24,CA 2211108 A;;US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,.ALPHA.-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR,"Disclosed herein are processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic esters or carboxylic acids, and other monomers. The polymerizations are catalysed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are uxful as elastomers, molding resins, in adhesives, etc. Also described herei n is the synthesis of linear a-olefins by the oligomerization of ethylene using as a catalyst system a combination of a nickel compound having a xlected .alpha.-diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected $(a)-diimine nickel complexes with ethylene.",DU PONT;;UNIV NORTH CAROLINA,FELDMAN JERALD;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S;;MCLAIN STEPHAN JAMES;;MCCORD ELIZABETH FORRESTER;;ARTHUR SAMUEL DAVID;;BENNETT MARGARET ANNE;;ITTEL STEVEN DALE;;KREUTZER KRISTINA ANN;;COUGHLIN EDWARD BRYAN;;KILLIAN CHRISTOPHER MOORE;;JOHNSON LYNDA KAYE,,https://lens.org/168-759-442-723-123,Granted Patent,no,0,0,5,75,0,,C07F15/00;;C08F4/52;;C08F4/60;;C08F4/64;;C08F4/80;;C08F10/00;;C08F110/00;;C08F132/04;;C08F214/18;;C08F220/14;;C08F232/04;;C08L23/02;;C08L33/08;;C09J123/02;;C09J133/08,,0,0,,,,EXPIRED
427,AU,B2,AU 729324 B2,188-828-626-137-200,2001-02-01,2001,AU 1996/050208 A,1996-01-24,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P;;US 9601282 W,1995-01-24,Alpha-olefins and olefin polymers and processes therefor,"Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/188-828-626-137-200,Granted Patent,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/08;;C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,3,1,099-058-421-181-908,10.1021/ma00088a007,"J.AMERICAN CHEM.SOC,VOL 88,NO.22,1996,SAITO ET AL P5198-5201;;MACROMOL RAPID COMMUN,VOL 16, NO.1, 1995,BARTOLININI, P.9-14;;MACROMOLECULES,VOL.27, NO.10, 1994, JIANG ET AL, P.2694-2700",EXPIRED
428,CA,A1,CA 2338542 A1,048-891-608-712-561,1996-08-01,1996,CA 2338542 A,1996-01-24,CA 2211108 A;;US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,.ALPHA.-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR,"Disclosed herein are processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic esters or carboxylic acids, and other monomers. The polymerizations are catalysed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described here in is the synthesis of linear .alpha.-olefins by the oligomerization of ethylene using as a catalyst system a combination of a nickel compound having a selected .alpha.-diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected ~(a)-diimine nickel complexes with ethylene.",DU PONT;;UNIV NORTH CAROLINA,ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;BROOKHART MAURICE S;;TEMPEL DANIEL JOSEPH;;PARTHASARATHY ANJU;;ITTEL STEVEN DALE;;MCLAIN STEPHAN JAMES;;MCCORD ELIZABETH FORRESTER;;KILLIAN CHRISTOPHER MOORE;;JOHNSON LYNDA KAYE;;KREUTZER KRISTINA ANN;;COUGHLIN EDWARD BRYAN;;BENNETT MARGARET ANNE,,https://lens.org/048-891-608-712-561,Patent Application,no,0,4,5,75,0,,C07F15/00;;C08F4/52;;C08F4/60;;C08F4/64;;C08F4/80;;C08F10/00;;C08F110/00;;C08F132/04;;C08F214/18;;C08F220/14;;C08F232/04;;C08L23/02;;C08L33/08;;C09J123/02;;C09J133/08,,0,0,,,,EXPIRED
429,US,A1,US 2008/0076751 A1,058-222-264-972-208,2008-03-27,2008,US 85475407 A,2007-09-13,US 85475407 A;;US 84507506 P,2006-09-15,Azetidinone Derivatives and Methods of Use Thereof,"The present invention relates to Azetidinone Derivatives, compositions comprising an Azetidinone Derivative and methods for treating or preventing a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease, comprising administering to a patient an effective amount of an Azetidinone Derivative.",ASLANIAN ROBERT G;;BENNETT CHAD E;;BURNETT DUANE A;;CHAN TIN-YAU;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;HARRIS JOEL M;;MCKITTRICK BRIAN A;;PALANI ANANDAN;;SMITH ELIZABETH M;;VACCARO HENRY M;;XIAO DONG;;KIM HYUNJIN M,ASLANIAN ROBERT G;;BENNETT CHAD E;;BURNETT DUANE A;;CHAN TIN-YAU;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;HARRIS JOEL M;;MCKITTRICK BRIAN A;;PALANI ANANDAN;;SMITH ELIZABETH M;;VACCARO HENRY M;;XIAO DONG;;KIM HYUNJIN M,MERCK SHARP & DOHME CORP (2007-11-01),https://lens.org/058-222-264-972-208,Patent Application,yes,34,10,11,11,0,C07D471/10;;A61P1/00;;A61P1/04;;A61P1/08;;A61P1/12;;A61P1/16;;A61P13/02;;A61P15/00;;A61P17/00;;A61P17/02;;A61P17/06;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/00;;A61P3/06;;A61P9/00;;A61P3/10;;C07D471/10,A61K31/397;;A61P3/00;;A61P25/04;;C07D471/10,514/210.02;;540/200,0,0,,,,INACTIVE
430,WO,A3,WO 1996/023010 A3,093-513-028-661-167,1996-12-05,1996,US 9601282 W,1996-01-24,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,ALPHA -OLEFINS AND OLEFIN POLYMERS AND PROCESSES TALPHA -OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR HEREFOR,"Disclosed herein are processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic esters or carboxylic acids, and other monomers. The polymerizations are catalysed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described herein is the synthesis of linear α-olefins by the oligomerization of ethylene using as a catalyst system a combination of a nickel compound having a selected α-diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected $(a)-diimine nickel complexes with ethylene.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/093-513-028-661-167,Search Report,yes,21,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07C251/08;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,14,7,093-805-713-932-396;;083-137-309-271-641;;099-058-421-181-908;;162-040-217-658-278;;036-680-143-987-323;;029-243-457-817-264;;069-936-621-235-710,10.1021/ja953247i;;10.1002/marc.1995.030160102;;10.1021/ma00088a007;;10.1021/ja00087a077;;10.1021/ma00027a039;;10.1016/0022-328x(91)86318-k;;10.1515/znb-1990-1209,"JOHNSON ET AL.: ""New Pd(II)- and Ni(II)-Based catalysts for Polymerization of Ethylene and alpha-Olefins"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 117, no. 23, 14 June 1995 (1995-06-14), WASHINGTON, XP002003543;;JOHNSON ET AL.: ""Copolymerization of Ethylene and Propylene with Funktionalized Vinyl Monomers by Palladium(II)Catalysts"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 118, no. 1, 10 January 1996 (1996-01-10), WASHINGTON, XP002003542;;SAITO, T. ET AL.: ""Diethyldipyridylnickel. Preparation, Characterization, and Reactions"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 88, no. 22, 20 November 1966 (1966-11-20), WASHINGTON, XP002004034;;BARTOLINI, S. ET AL: ""Enantioselective isotactic alternating copolymerization of styrene and 4-methylstyrene with carbon monoxide catalyzed by a cationic bioxazoline Pd(II) complex"", MACROMOLECULAR RAPID COMMUNICATIONS, vol. 16, no. 1, January 1995 (1995-01-01), HEIDELBERG, XP002004035;;JIANG, Z. ET AL: ""Stereo- and Enantioselective Alternating Copolymerization of alpha-Olefins with Carbon Monoxide. Synthesis of Chiral Polymers"", MACROMOLUCULES, vol. 27, no. 10, 9 May 1994 (1994-05-09), WASHINGTON, pages 2694 - 2700, XP002003921;;BROOKHART, M. ET AL: ""Polymers with Main-Chain Chirality. Synthesis of Highly Isotactic, Optically Active Poly (4-tert.-butylstyrene-alt-CO) Using Pd (II) Catalysts Based on C2-Symmetric Bioxazoline Ligands"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 116, no. 8, 20 April 1994 (1994-04-20), WASHINGTON, pages 3641 - 3642, XP002003922;;R. DIERCKS, H. TOM DIECK: ""Katalytische Cyclotetramerisierung von Propiolsäureestern"", CHEMISCHE BERICHTE, vol. 118, 1985, WEINHEIM, XP002003541;;TOM DIECK ET AL.: ""Diazadienes as Control Ligands in Catalysis Part 12* The Nickel Catalyzed Cyclotetramerization of Propargylic Alcohol to Substituted Cyclooctatetraenes and the Structure of 1,3,5,7-Tetrakis(hydroxymethyl)cyclooctatetraene"", JOURNAL OF MOLECULAR CATALYSTS, vol. 35, no. 3, June 1986 (1986-06-01), LAUSANNE, XP002003923;;DATABASE WPI Section Ch Week 9428, Derwent World Patents Index; Class A18, AN 94-231215, XP002015135;;CHEMICAL ABSTRACTS, vol. 77, no. 8, 21 August 1972, Columbus, Ohio, US; abstract no. 49803, ""MONTECATINI"" SOCIETA GENERALE PER L'INDUSTRIA MINERIA E CHIMICA: ""Catalytic manufacture of olefin copolymers with three or more monomer components"" XP002015133;;COLLINS, S. , KELLY, W.M.: ""The Microstructure of Poly(cyclopentene) Produced by Polymerization of Cyclopentene with Homogeneous Ziegler-Natta Catalysts"", MACROMOLECULES, vol. 25, no. 1, January 1992 (1992-01-01), WASHINGTON, XP002015130;;CHEMICAL ABSTRACTS, vol. 121, no. 11, 12 September 1994, Columbus, Ohio, US; abstract no. 134322, WISSING, E ET AL.: ""Influence of bulky substituents on the regioselective group-transfer reactions of diorganozinc compounds with N,N'-bis(2,6-di-isopropenyl)-1,4-diaza-1,3-butadiene"" XP002015134;;MUNZ, C., STEPHAN, C., TOM DIECK, H.: ""Diazadiene-stabilized palladacyclopent-2-enes and the catalytic addition of various allylic systems to dimethyl acetylenedicarboxylate"", JOURNAL OF ORGANOMETALLIC CHEMISTRY, LAUSANNE, XP002015131;;BONRATH, W. ET AL.: ""Synthese und Struktur von Ni(2,6-iPr2C6H3N=CH-CH=NC6H3-2,6-iPr2)2"", ZEITSCHRIFT FÜR NATURFORSCHUNG, vol. 45b, - 1990, TÜBINGEN, XP002015132",PATENTED
431,WO,A2,WO 1996/023010 A2,042-178-017-894-015,1996-08-01,1996,US 9601282 W,1996-01-24,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,alpha -OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR,"Disclosed herein are processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic esters or carboxylic acids, and other monomers. The polymerizations are catalysed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described herein is the synthesis of linear alpha -olefins by the oligomerization of ethylene using as a catalyst system a combination of a nickel compound having a selected alpha -diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected DOLLAR (a)-diimine nickel complexes with ethylene.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/042-178-017-894-015,Patent Application,no,0,372,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07C251/08;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,PATENTED
432,EP,A2,EP 0805826 A2,153-069-212-828-496,1997-11-12,1997,EP 96907020 A,1996-01-24,US 9601282 W;;US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,ALPHA-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR,"Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/153-069-212-828-496,Patent Application,yes,0,3,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/08;;C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,EXPIRED
433,FI,A0,FI 973096 A0,150-098-139-648-23X,1997-07-23,1997,FI 973096 A,1997-07-23,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P;;US 9601282 W,1995-01-24,Alfa-olefiinejä ja olefiinipolymeereja ja menetelmiä niiden valmistamiseksi,"Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/150-098-139-648-23X,Patent Application,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/00;;C07C251/08;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,DISCONTINUED
434,AU,A,AU 1996/050208 A,163-235-205-377-758,1996-08-14,1996,AU 1996/050208 A,1996-01-24,US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P;;US 9601282 W,1995-01-24,Alpha-olefins and olefin polymers and processes therefor,"Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/163-235-205-377-758,Patent Application,no,0,0,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/08;;C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,EXPIRED
435,CA,C,CA 2211108 C,175-103-768-935-080,2001-05-29,2001,CA 2211108 A,1996-01-24,US 265495 P;;US 737595 P;;US 47359095 A;;US 41528395 A;;US 37804495 A;;US 9601282 W,1995-01-24,.ALPHA.-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR,"Disclosed herein are processes for polymerizing ethylene, acyclic olefins, a nd/or selected cyclic olefins, and optionally selected o lefinic esters or carboxylic acids, and other monomers. The polymerizations are cata lysed by selected transition metal compounds, and someti mes other co-catalysts. Since some of the polymerizations exhibit some character istics of living polymerizations, block copolymers can b e readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of the m unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described here in is the synthesis of linear .alpha.-olefins by the oli gomerization of ethylene using as a catalyst system a combination of a nickel compound ha ving a selected .alpha.-diimine ligand and a selected Le wis or Bronsted acid, or by contacting selected $(a)-diimine nickel complexes with ethylene.",DU PONT;;UNIV NORTH CAROLINA,BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;KILLIAN CHRISTOPHER MOORE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;KREUTZER KRISTINA ANN;;MCLAIN STEPHAN JAMES;;MCCORD ELIZABETH FORRESTER;;JOHNSON LYNDA KAYE,,https://lens.org/175-103-768-935-080,Granted Patent,no,0,1,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/08;;C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,0,0,,,,EXPIRED
436,EP,B1,EP 0805826 B1,001-765-331-344-467,2003-04-23,2003,EP 96907020 A,1996-01-24,US 9601282 W;;US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,OLEFIN POLYMERS,"Polymers are disclosed consisting essentially of units derived from the monomers ethylene and a compound of the formula CH2=CH(CH2)mCO2R<1>, wherein R<1> is hydrogen, hydrocarbyl or substituted hydrocarbyl, and m is 0 or an integer from 1 to 16, and which contains about 0.01 to about 40 mole percent of repeat units derived from said compound, and provided that said repeat units derived from said compound are in branches of the formula -CH(CH2)nCO2R<1>, in about 30 to about 70 mole percent of said branches n is 5 or more, in about 0 to about 20 mole percent n is 4, in about 3 to 60 mole percent n is 1, 2 and 3, and in about 1 to about 60 mole percent n is 0.The polymers made are useful as elastomers, molding resins, in adhesives, etc.",DU PONT;;UNIV NORTH CAROLINA,JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH;;BROOKHART MAURICE S,,https://lens.org/001-765-331-344-467,Granted Patent,yes,21,3,36,75,0,C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F210/02;;C08F210/14;;C08F210/16;;C08F232/00;;C08L23/02;;C09J123/06;;C09J123/20;;C08F110/08;;C08F4/70,C07C251/08;;C07C251/00;;C07F5/00;;C07F7/00;;C07F9/00;;C07F11/00;;C07F15/00;;C07F15/02;;C07F15/04;;C07F15/06;;C08F/;;C08F4/04;;C08F4/42;;C08F4/52;;C08F4/60;;C08F4/622;;C08F4/639;;C08F4/70;;C08F10/00;;C08F10/02;;C08F10/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/06;;C08F210/14;;C08F210/16;;C08F232/00;;C08F232/04;;C08G61/04;;C08J5/18;;C08L23/02;;C08L23/16;;C09D123/00;;C09J123/00;;C09J123/02;;C10M107/02;;C10M119/00;;C10M143/04,,14,0,,,"JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 117, no. 23, 14 June 1995, WASHINGTON, XP002003543 JOHNSON ET AL.: ""New Pd(II)- and Ni(II)-Based catalysts for Polymerization of Ethylene and alpha-Olefins"";;JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 118, no. 1, 10 January 1996, WASHINGTON, XP002003542 JOHNSON ET AL.: ""Copolymerization of Ethylene and Propylene with Funktionalized Vinyl Monomers by Palladium(II)Catalysts"";;JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 88, no. 22, 20 November 1966, WASHINGTON, XP002004034 SAITO, T. ET AL.: ""Diethyldipyridylnickel. Preparation, Characterization, and Reactions"";;MACROMOLECULAR RAPID COMMUNICATIONS, vol. 16, no. 1, January 1995, HEIDELBERG, XP002004035 BARTOLINI, S. ET AL: ""Enantioselective isotactic alternating copolymerization of styrene and 4-methylstyrene with carbon monoxide catalyzed by a cationic bioxazoline Pd(II) complex"";;MACROMOLUCULES, vol. 27, no. 10, 9 May 1994, WASHINGTON, pages 2694-2700, XP002003921 JIANG, Z. ET AL: ""Stereo- and Enantioselective Alternating Copolymerization of alpha-Olefins with Carbon Monoxide. Synthesis of Chiral Polymers"";;JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 116, no. 8, 20 April 1994, WASHINGTON, pages 3641-3642, XP002003922 BROOKHART, M. ET AL: ""Polymers with Main-Chain Chirality. Synthesis of Highly Isotactic, Optically Active Poly (4-tert.-butylstyrene-alt-CO) Using Pd (II) Catalysts Based on C2-Symmetric Bioxazoline Ligands"";;CHEMISCHE BERICHTE, vol. 118, 1985, WEINHEIM, XP002003541 R. DIERCKS, H. TOM DIECK: ""Katalytische Cyclotetramerisierung von Propiolsäureestern"";;JOURNAL OF MOLECULAR CATALYSTS, vol. 35, no. 3, June 1986, LAUSANNE, XP002003923 TOM DIECK ET AL.: ""Diazadienes as Control Ligands in Catalysis Part 12* The Nickel Catalyzed Cyclotetramerization of Propargylic Alcohol to Substituted Cyclooctatetraenes and the Structure of 1,3,5,7-Tetrakis(hydroxymethyl)cyclooctate traene"";;DATABASE WPI Section Ch, Week 9428 Derwent Publications Ltd., London, GB; Class A18, AN 94-231215 XP002015135 & JP 06 168 625 A (NIPPON ZEON KK) , 14 June 1994;;CHEMICAL ABSTRACTS, vol. 77, no. 8, 21 August 1972 Columbus, Ohio, US; abstract no. 49803, ""MONTECATINI"" SOCIETA GENERALE PER L'INDUSTRIA MINERIA E CHIMICA: ""Catalytic manufacture of olefin copolymers with three or more monomer components"" XP002015133 & IT 630 410 A;;MACROMOLECULES, vol. 25, no. 1, January 1992, WASHINGTON, XP002015130 COLLINS, S. , KELLY, W.M.: ""The Microstructure of Poly(cyclopentene) Produced by Polymerization of Cyclopentene with Homogeneous Ziegler-Natta Catalysts"";;CHEMICAL ABSTRACTS, vol. 121, no. 11, 12 September 1994 Columbus, Ohio, US; abstract no. 134322, WISSING, E ET AL.: ""Influence of bulky substituents on the regioselective group-transfer reactions of diorganozinc compounds with N,N'-bis(2,6-di-isopropenyl)-1,4-diaza-1,3 -butadiene"" XP002015134 & INORG. CHIM. ACTA, vol. 220, no. 1-2, 1994, pages 55-61,;;JOURNAL OF ORGANOMETALLIC CHEMISTRY, LAUSANNE, XP002015131 MUNZ, C., STEPHAN, C., TOM DIECK, H.: ""Diazadiene-stabilized palladacyclopent-2-enes and the catalytic addition of various allylic systems to dimethyl acetylenedicarboxylate"";;ZEITSCHRIFT FÜR NATURFORSCHUNG, vol. 45b, - 1990 TÜBINGEN, XP002015132 BONRATH, W. ET AL.: ""Synthese und Struktur von Ni(2,6-iPr2C6H3N=CH-CH=NC6H3-2,6-iPr2)2""",EXPIRED
437,CA,A1,CA 2663502 A1,078-360-695-697-114,2008-03-20,2008,CA 2663502 A,2007-09-13,US 84507506 P;;US 2007/0019930 W,2006-09-15,AZETIDINONE DERIVATIVES AND METHODS OF USE THEREOF,"The present invention relates to Azetidinone Derivatives, compositions co mprising an Azetidinone Derivative and methods for treating or preventing a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelin ation or nonalcoholic fatty liver disease, comprising administering to a pat ient an effective amount of an Azetidinone Derivative.",SCHERING CORP,BENNETT CHAD E;;ASLANIAN ROBERT G;;PALANI ANANDAN;;MCKITTRICK BRIAN A;;HARRIS JOEL M;;SMITH ELIZABETH M;;XIAO DONG;;BURNETT DUANE A;;VACCARO HENRY M;;KIM HYUNJIN M;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;CHAN TIN-YAU,,https://lens.org/078-360-695-697-114,Patent Application,no,0,0,11,11,0,C07D471/10;;A61P1/00;;A61P1/04;;A61P1/08;;A61P1/12;;A61P1/16;;A61P13/02;;A61P15/00;;A61P17/00;;A61P17/02;;A61P17/06;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/00;;A61P3/06;;A61P9/00;;A61P3/10;;C07D471/10,C07D471/10;;A61K31/438;;A61P3/00,,0,0,,,,DISCONTINUED
438,CA,A1,CA 2338581 A1,130-254-581-449-627,1996-08-01,1996,CA 2338581 A,1996-01-24,CA 2211108 A;;US 37804495 A;;US 41528395 A;;US 47359095 A;;US 737595 P;;US 265495 P,1995-01-24,.ALPHA.-OLEFINS AND OLEFIN POLYMERS AND PROCESSES THEREFOR,"Disclosed herein are processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic esters or carboxylic acids, and other monomers. The polymerizations ate catalysed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described here in is the synthesis of linear .alpha.-olefins by the oligomerization of ethylene using as a catalyst system a combination of a nickel compound having a selected .alpha.-diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected S(a)-diimine nickel complexes with ethylene.",DU PONT;;UNIV NORTH CAROLINA,KREUTZER KRISTINA ANN;;ARTHUR SAMUEL DAVID;;BROOKHART MAURICE S;;TEMPEL DANIEL JOSEPH;;PARTHASARATHY ANJU;;MCCORD ELIZABETH FORRESTER;;KILLIAN CHRISTOPHER MOORE;;FELDMAN JERALD;;COUGHLIN EDWARD BRYAN;;BENNETT MARGARET ANNE;;JOHNSON LYNDA KAYE;;MCLAIN STEPHAN JAMES;;ITTEL STEVEN DALE,,https://lens.org/130-254-581-449-627,Patent Application,no,0,0,5,75,0,,C07F15/00;;C08F4/52;;C08F4/60;;C08F4/64;;C08F4/80;;C08F10/00;;C08F110/00;;C08F132/04;;C08F214/18;;C08F220/14;;C08F232/04;;C08L23/02;;C08L33/08;;C09J123/02;;C09J133/08,,0,0,,,,DISCONTINUED
439,WO,A2,WO 2008/033464 A2,091-786-375-862-642,2008-03-20,2008,US 2007/0019930 W,2007-09-13,US 84507506 P,2006-09-15,AZETIDINONE DERIVATIVES AND METHODS OF USE THEREOF,"The present invention relates to Azetidinone Derivatives, compositions comprising an Azetidinone Derivative and methods for treating or preventing a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease, comprising administering to a patient an effective amount of an Azetidinone Derivative.",SCHERING CORP;;ASLANIAN ROBERT G;;BENNETT CHAD E;;BURNETT DUANE A;;CHAN TIN-YAU;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;HARRIS JOEL M;;MC KITTRICK BRIAN A;;PALANI ANANDAN;;SMITH ELIZABETH M;;VACCARO HENRY M;;XIAO DONG;;KIM HYUNJIN M,ASLANIAN ROBERT G;;BENNETT CHAD E;;BURNETT DUANE A;;CHAN TIN-YAU;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;HARRIS JOEL M;;MC KITTRICK BRIAN A;;PALANI ANANDAN;;SMITH ELIZABETH M;;VACCARO HENRY M;;XIAO DONG;;KIM HYUNJIN M,,https://lens.org/091-786-375-862-642,Patent Application,yes,0,33,11,11,0,C07D471/10;;A61P1/00;;A61P1/04;;A61P1/08;;A61P1/12;;A61P1/16;;A61P13/02;;A61P15/00;;A61P17/00;;A61P17/02;;A61P17/06;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/00;;A61P3/06;;A61P9/00;;A61P3/10;;C07D471/10,,,0,0,,,,PENDING
440,US,B2,US 8489519 B2,090-307-970-142-458,2013-07-16,2013,US 51080106 A,2006-08-24,US 51080106 A;;US 82037701 A;;US 19272300 P;;US 19389900 P,2000-03-27,"Apparatus, systems and methods for online, multi-parcel, multi-carrier, multi-service enterprise parcel shipping management","The present invention provides a plurality of Enterprises with a single online user interface with which the Enterprise can provide Enterprise Shippers, shipping origination users and shipping intermediary users with an automated parcel management system for a plurality of supported Carriers for a plurality of services. The present invention provides for the hierarchical definition of users, including the establishment of at least one user for each Enterprise as a Super-Administrator with the highest level of privileges and authority for the Enterprise, and the identification of other users as Sub-Administrators, Desktop Users and Shipping Station Users. The present invention also provides for the hierarchical definition of organizational units within each Enterprise, including the definition of sites, groups within a site, and users within a group and for a distinct definition of policies, privileges, and other types of specifications for each user level, each user, and each organizational unit.",WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;STAMPS COM INC;;ISHIP INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN,AUCTANE INC (2001-06-20),https://lens.org/090-307-970-142-458,Granted Patent,yes,52,4,9,43,0,G06Q10/0835;;G06Q10/0835;;G06Q10/08;;G06Q10/08;;G06Q10/083;;G06Q10/083;;G06Q10/0834;;G06Q10/0834;;G06Q10/08345;;G06Q10/08345;;G06Q10/10;;G06Q10/10;;G06Q10/101;;G06Q10/101;;G06Q30/0282;;G06Q30/0282;;G06Q30/0601;;G06Q30/0601,G06Q30/00;;G06F17/00;;G06G7/00;;G06Q10/08;;G06Q10/10;;G06Q30/02;;G06Q30/06,705/330;;705/400,65,0,,,"Material Logistics System, (NN86091526) IBM Technical Disclosure Bulletin, Sep. 1986, US, Volumn 26, Isue 4, pp. 1526-1530.;;Kewill Systems, Inc., ""Kewill Systems PLC Acquires Leading U.S. Shipping and Receiving E-Commerce Software Firm for $18 Million"", Aristo Computers Press Releases and Product Developments, Jul. 27, 1999, pp. 1-3 of 13, Marlborough, Mass.;;Kewill Systems, Inc., ""USPS Delivery Confirmation Support Now Available in Aristo's Economical APSS® Lite Shipping System"", Aristo Computers Press Releases and Product Developments, Jun. 23, 1999, p. 3 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified by USPS to Support New Express Mail Manifesting"", Aristo Computers Press Releases and Product Developments, Jun. 21, 1999, pp. 3 and 4 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified UPS OnLine® Compatible to Support UPS International Shipping"", Aristo Computers Press Releases and Product Developments, May 12, 1999, pp. 4 and 5 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified to Fully Support FedEx PowerShip® Server,""Aristo Computers Press Releases and Product Developments, May 10, 1999, pp. 5 and 6 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Names AllPoints Systems Strategic Partner"" AllPoints Systems to Integrate Aristo shipping functionality into its Demand Chian Software, Aristo Computers Press Releases and. Product Developments, Apr. 13, 1999, pp. 6 and 7 of 13, Beaverton, Oregon and Dedham, Massatuchutes.;;Kewill Systems, Inc., ""Midgard Information Systems and Aristo-Integrated Shipping Solutions for Today's Marketplace"", Aristo Computers Press Releases and Product Developments, Jan. 19, 1999, pp. 7-9 of 13, Charlotte, North Carolina.;;Kewill Systems, Inc., ""Aristo's OLE Server Provides Shipping & Manifesting Engine for Third Party Developers"", Aristo Computers Press Releases and Product Developments, Jul. 28, 1998, pp. 9 and 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Adds New Economical Shipping Solution to Its Product Line"", Aristo Computers Press Releases and Product Developments, Apr. 30, 1998, p. 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo announces latest APSS® developments!"", Aristo Computers Press Releases and Product Developments, Jun. 9, 1997, pp. 10 and 11 of 13, Beaverton, Oregon.;;Kewill Systems, Inc. ""Aristo launches APSS® for Windows"", Aristo Computers Press Releases and Product Developments, Oct. 20, 1996, pp. 11-13 of 13, Beaverton, Oregon.;;""Netscape and FDX Unveil Plans for Next Generation Internet Package Delivery Center"", Netscape Press Release, Apr. 7, 1999, 3 pages, Mt.View, California and Memphis, Tennessee.;;""TanData Announces Release of ChainLink(TM) Applications Suite"" TanData Press Releases, Dec. 8, 1999, 2 pages, Tulsa, Oklahoma.;;UPS Extends Capability of iCat Electronic Commerce Software, TanData Press Releases, Oct. 26, 1998, 2 pages, Atlanta.;;Andy Wang, ""FedEx and Netscape Build Shipping Portal"", E-Commerce Times, Apr. 8, 1999, 2 pages.;;Mary Hillebrand, ""From2.Com Gives International E-Commerce a Hand"",E-Commerce Times, Jul. 9, 1999, 3 pages.;;Tim Wilson, ""Shippers Repackaged as E-Providers"", InformationWeek, Issue: 758, Section: Transportation Transformation: A Special Report From Internetweek, Oct. 25, 1999, 6 pages.;;James Hollander, UPS Boosts E-Commerce Strategy with New Web Tools, E-Commerce Times, Apr. 6, 1999, 3 pages.;;Collection of Screen Printouts (copyright © 2000) from ""anythingovernight.com"" referring to shipping product Shiplet, entitled ""Shiplet"", 4 pages, ""About Us"", 1 page, ""Shipping"", 1 page, ""Reporting"", 1 page, ""User Profile"" 1 page, ""Shipments to Me"", 1 page, and ""API"", 1 page.;;Lisa Corbin, ""Electronic Commerce Strategies"", Govemment Executive Magazine, Aug. 30, 1999, 5 pages.;;Computer Support, Inc. (CSI), p. 10 of 117 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;TradePoint Systems LLC, International Trade and Transportion, and Transportation Concepts and Services, Inc. (TCS), p. 19 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Carrier Quality Performance Software, p. 39 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Late Delivery Quality Monitor Software (for Federal Exress Shipments), p. 97 of 177 listed in ""Electrdnic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Scheme Software Order Entry/Billing 5.0, p. 156 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Software for International Trade, p. 157 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Brandbrandon Fleming, ""Hot List for Electronic Data Interchange (EDI)"", http://www.usatrade.gov/us/annarbor/hot-list-for-EDI.htm, 9 pages, Copyright © 1999; Revised Feb. 1, 2000.;;Microsoft Corporation, ""Microsoft Internet Commerce Strategy: A Foundation for Doing Business on the Internet"", May 1997, 27 pages.;;Survey of E-Commerce Companies & Products: Business Logistics, Customer Service, Supply Chain Management, http://pages.hotbot.com/biz/jayml/BP9.html, 28 pages, Richard Karpinski, Appendix II Feb. 9, 1999 on p. 26.;;FedEx Standardizes on Netscape, News Source: Mountain View, Calif., Jun. 11/PRNewswire; News Date Jun. 12, 1996 12:55 pm; Keywords: Federal Express, Electronic Commerce; 3 pages.;;Email Message; From SmartShip Online Support to: smartshippers@smartship.com; Subject: You can ship online now! Sent: Tuesday, Dec. 15, 1998 11:53 AM; 1 page.;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine, California.;;Material Logistics System, (NN86091526) IBM Technical Disclosure Bulletin, Sep. 1986, US, vol. 26, Isue 4, p. 1526-1530.;;Office Action for U.S. Appl. No. 09/820,377, dated Apr. 5, 2004, pp. 1-9.;;Office Communication for U.S. Appl. No. 09/820,377, dated Dec. 14, 2004, pp. 1-4.;;Final Office Action for U.S. Appl. No. 09/820,377, dated Apr. 21, 2005, pp. 1-10.;;Office Action for U.S. Appl. No. 09/820,377, dated Oct. 21, 2005, pp. 1-8.;;Office Action for U.S. Appl. No. 09/820,377, dated May 26, 2006, pp. 1-10.;;Examiner's Answer for U.S. Appl. No. 09/820,377, dated Apr. 3, 2007, pp. 1-15.;;BPAI Decision on Appeal for U.S. Appl. No. 09/820,377, dated May 29, 2009, pp. 1-16.;;Decision on Request for Rehearing for U.S. Appl. No. 09/820,377, dated Oct. 30, 2009, pp. 1-8.;;Notice of Allowance for U.S. Appl. No. 09/820,377, dated Mar. 25, 2010, pp. 1-6.;;Ogg, et al.; U.S. Appl. No. 09/651,390, (titled ""Virtualized Printing of Indicia, Logos and Graphics"") filed Aug. 29, 2000; pages-throughout; and.;;Ogg, et al.; U.S. Appl. No. 09/651,389, (titled ""Method and Apparatus for Printing Indicia Logos and Graphics Onto Print Media"") filed Aug. 29, 2000; pages-throughout.;;Williams, et al; Apparatus, Systems and Methods for Online Multi-Parcel, Multi-Carrier, Multi-Service Parcel Returns Shipping Management; U.S. Appl. No. 09/820,292, filed Mar. 27, 2001; pages-throughout.;;Smith, III, et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 3000; pages throughout.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed Oct. 6, 2000; pp. 1-3 and 98-104.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000; pp. 1-3 and 98-108.;;Hu, et al.; Apparatus, Systems and Methods for Interfacing with Digital Scales Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000; pp. 1-3 and 98-103.;;Bennett, et al.; Reporting Shipping Rates and Delivery Schedules for Multiple Service and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2000; pp. 1-3 and 98-112.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000; pp. 1-6 and 100-117.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Delivery Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/680,649, filed Oct. 6, 2000; pp. 1-7 and 102-123.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Rate and Delivery Schedule Comparison for Multiple Carriers; U.S. Appl. No. 09/680,654, filed Oct. 6, 2000; pp. 14 and 100-124.;;Bennett, et al.; Apparatus, Systems and Methods for Applying Billing Options for Multiple Carriers for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,865, filed Oct. 6, 2000; pp. 1-3 and 98-104.;;Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000; pp. 1-5 and 100-116.;;Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6, 2000; pp. 1-3 and 97-100.;;Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000; pp. 1-3 and 97-100.;;Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accurate Symbologies on Laser Printers Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,152, filed Oct. 6, 2000; pp. 1-3 and 98-110.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,866, filed Oct. 6, 2000; pp. 1-2 and 97-112.;;Declaration by John Dietz, entitled ""Verified Statement (Declaration) No. 1 in Support of Information Disclosure Statement in U.S. Appl. Nos. 09/684,010, 09/684,871, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,152, 09/684,866, 09/820,377, and 09/820,292"", executed Jul. 20, 2001, pp. 1-8 (with Exhibits A-J attached).;;Declaration by John Dietz, entitled ""Verified Statement (Declaration) No. 2 in Support of Information Disclosure Statement in U.S. Appl. Nos. 09/684,010, 09/684,871, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,152, 09/684,866, 09/820,377, and 09/820,292"", executed Jul. 20, 2001, pp. 1-6 (with Exhibits A and B attached).;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine California.;;""New Web site offers quick shipping-rate comparisons"", SmartShip.com, Philadelphia Inquirer Jan. 13, 2000, Henry J. Holcomb, 3 pages.;;Office Action for U.S. Appl. No. 13/093,551, dated Jan. 3, 2012, pp. 1-24.",ACTIVE
441,US,A1,US 2011/0246384 A1,148-548-485-799-309,2011-10-06,2011,US 201113093551 A,2011-04-25,US 201113093551 A;;US 51080106 A;;US 82037701 A;;US 19272300 P;;US 19389900 P,2000-03-27,"Apparatus, Systems and Methods For Online, Multi-Parcel, Multi-Carrier, Multi-Service Enterprise Parcel Shipping Management","The present invention provides a plurality of Enterprises with a single online user interface with which the Enterprise can provide Enterprise Shippers, shipping origination users and shipping intermediary users with an automated parcel management system for a plurality of supported Carriers for a plurality of services. The present invention provides for the hierarchical definition of users, including the establishment of at least one user for each Enterprise as a Super-Administrator with the highest level of privileges and authority for the Enterprise, and the identification of other users as Sub-Administrators, Desktop Users and Shipping Station Users. The present invention also provides for the hierarchical definition of organizational units within each Enterprise, including the definition of sites, groups within a site, and users within a group. The present invention further provides for a distinct definition of policies, privileges, and other types of specifications for each user level, each user, and each organizational unit. The present invention applies the user and organizational policies, privileges and other specifications as they apply to each particular user to drive the interactive interface with each particular user and to provide among other things, shipping options, shipping services, shipping rates, traveler and/or shipping label preparation, and shipment tracking.",STAMPS COM INC;;ISHIP INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN,,https://lens.org/148-548-485-799-309,Patent Application,yes,2,9,9,43,0,G06Q10/0835;;G06Q10/0835;;G06Q10/08;;G06Q10/08;;G06Q10/083;;G06Q10/083;;G06Q10/0834;;G06Q10/0834;;G06Q10/08345;;G06Q10/08345;;G06Q10/10;;G06Q10/10;;G06Q10/101;;G06Q10/101;;G06Q30/0282;;G06Q30/0282;;G06Q30/0601;;G06Q30/0601,G06Q10/08;;G06Q10/10;;G06Q30/02;;G06Q30/06,705/335;;705/347;;705/330,0,0,,,,EXPIRED
442,US,A1,US 2003/0171508 A1,090-191-335-309-78X,2003-09-11,2003,US 88727301 A,2001-06-22,US 88727301 A;;US 89900297 A;;US 59065096 A;;US 47359095 A;;US 41528395 A;;US 37804495 A;;US 265495 P;;US 737595 P,1995-01-24,Alpha-olefins and olefin polymers and processes therefor,"
   Disclosed herein are processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic esters or carboxylic acids, and other monomers. The polymerizations are catalyzed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described herein is the synthesis of linear -olefins by the oligomerization of ethylene using as a catalyst system a combination a nickel compound having a selected -diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected -diimine nickel complexes with ethylene. 
",BROOKHART MAURICE S.;;JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT ALISON MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH,BROOKHART MAURICE S;;JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT ALISON MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH,,https://lens.org/090-191-335-309-78X,Patent Application,yes,0,5,17,75,0,C08F110/02;;C08F110/02;;C08F10/00;;C08F10/00;;C08F10/02;;C08F10/02;;C08F10/06;;C08F10/06;;C08F110/06;;C08F110/06;;C08F110/14;;C08F110/14;;C08F210/02;;C08F210/02;;C08F210/14;;C08F210/14;;C08F210/16;;C08F210/16;;C08F232/00;;C08F232/00;;C08L23/02;;C08L23/02;;Y10S430/165;;Y10S430/165;;Y10T428/1352;;Y10T428/1352;;Y10T428/1386;;Y10T428/1386;;Y10T428/139;;Y10T428/139;;Y10T428/24942;;Y10T428/24942;;Y10T428/2878;;Y10T428/2878;;Y10T428/31692;;Y10T428/31692;;Y10T428/31855;;Y10T428/31855;;Y10T428/31895;;Y10T428/31895;;Y10T428/31938;;Y10T428/31938;;Y10T442/20;;Y10T442/20;;Y10T442/60;;Y10T442/60;;Y10T442/626;;Y10T442/626,B01J31/00;;B01J37/00;;C07C2/32;;C07C69/52;;C07C251/08;;C07F7/00;;C07F15/00;;C07F19/00;;C08F4/02;;C08F4/06;;C08F4/60;;C08F4/70;;C08F4/80;;C08F10/00;;C08F10/02;;C08F10/06;;C08F10/08;;C08F12/30;;C08F20/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/14;;C08F210/16;;C08F220/10;;C08F232/00;;C08F232/04;;C08F255/00;;C08L23/02,526 9;;526/348;;526/351;;526/352,0,0,,,,EXPIRED
443,MX,A,MX 2009002921 A,123-984-846-461-965,2009-04-01,2009,MX 2009002921 A,2007-09-13,US 84507506 P;;US 2007/0019930 W,2006-09-15,AZETIDINONE DERIVATIVES FOR THE TREATMENT OF DISORDERS OF THE LIPID METABOLISM.,"The present invention relates to Azetidinone Derivatives, compositions comprising an Azetidinone Derivative and methods for treating or preventing a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease, comprising administering to a patient an effective amount of an Azetidinone Derivative.",SCHERING CORP,XIAO DONG;;CHAN TIN-YAU;;BURNETT DUANE A;;SMITH ELIZABETH M;;HARRIS JOEL M;;PALANI ANANDAN;;ASLANIAN ROBERT G;;KNUTSON CHAD E;;BENNETT CHAD E;;KISELGOF EUGENIA Y;;MC KITTRICK BRIAN A;;VACCARO HENRY M;;KIM HYUNJIN M,,https://lens.org/123-984-846-461-965,Patent Application,no,0,0,11,11,0,C07D471/10;;A61P1/00;;A61P1/04;;A61P1/08;;A61P1/12;;A61P1/16;;A61P13/02;;A61P15/00;;A61P17/00;;A61P17/02;;A61P17/06;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/00;;A61P3/06;;A61P9/00;;A61P3/10;;C07D471/10,C07D471/10;;A61K31/438;;A61P3/00,,0,0,,,,PENDING
444,US,A1,US 2014/0337246 A1,102-082-950-121-544,2014-11-13,2014,US 201414281691 A,2014-05-19,US 201414281691 A;;US 201213710302 A;;US 201113093551 A;;US 51080106 A;;US 82037701 A;;US 19272300 P;;US 19389900 P,2000-03-27,"Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Enterprise Parcel Shipping Management","The present invention provides a plurality of Enterprises with a single online user interface with which the Enterprise can provide Enterprise Shippers, shipping origination users and shipping intermediary users with an automated parcel management system for a plurality of supported Carriers for a plurality of services. The present invention provides for the hierarchical definition of users, including the hierarchical definition of organizational units within each Enterprise. The present invention further provides for a distinct definition of policies, privileges, and other types of specifications for each user level, each user, and each organizational unit. The present invention applies the user and organizational policies, privileges and other specifications as they apply to each particular user to drive the interactive interface with each particular user and to provide among other things, shipping options, shipping services, shipping rates, traveler and/or shipping label preparation, and shipment tracking.",STAMPS COM INC;;ISHIP INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;MOON LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN,,https://lens.org/102-082-950-121-544,Patent Application,yes,3,16,9,43,0,G06Q10/0835;;G06Q10/0835;;G06Q10/08;;G06Q10/08;;G06Q10/083;;G06Q10/083;;G06Q10/0834;;G06Q10/0834;;G06Q10/08345;;G06Q10/08345;;G06Q10/10;;G06Q10/10;;G06Q10/101;;G06Q10/101;;G06Q30/0282;;G06Q30/0282;;G06Q30/0601;;G06Q30/0601,G06Q10/08;;G06Q10/10;;G06Q30/02;;G06Q30/06,705/336,0,0,,,,DISCONTINUED
445,US,B2,US 7774284 B2,126-216-295-744-64X,2010-08-10,2010,US 82037701 A,2001-03-27,US 82037701 A;;US 19272300 P;;US 19389900 P,2000-03-27,"Apparatus, systems and methods for online, multi-parcel, multi-carrier, multi-service enterprise parcel shipping management","The present invention provides a plurality of Enterprises with a single online user interface with which the Enterprise can provide Enterprise Shippers, shipping origination users and shipping intermediary users with an automated parcel management system for a plurality of supported Carriers for a plurality of services. The present invention provides for the hierarchical definition of users, including the establishment of at least one user for each Enterprise as a Super-Administrator with the highest level of privileges and authority for the Enterprise, and the identification of other users as Sub-Administrators, Desktop Users and Shipping Station Users. The present invention also provides for the hierarchical definition of organizational units within each Enterprise, including the definition of sites, groups within a site, and users within a group. The present invention further provides for a distinct definition of policies, privileges, and other types of specifications for each user level, each user, and each organizational unit. The present invention applies the user and organizational policies, privileges and other specifications as they apply to each particular user to drive the interactive interface with each particular user and to provide among other things, shipping options, shipping services, shipping rates, traveler and/or shipping label preparation, and shipment tracking.",STAMPS COM INC;;ISHIP INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN,AUCTANE INC (2001-06-20),https://lens.org/126-216-295-744-64X,Granted Patent,yes,41,40,9,43,0,G06Q10/0835;;G06Q10/0835;;G06Q10/08;;G06Q10/08;;G06Q10/083;;G06Q10/083;;G06Q10/0834;;G06Q10/0834;;G06Q10/08345;;G06Q10/08345;;G06Q10/10;;G06Q10/10;;G06Q10/101;;G06Q10/101;;G06Q30/0282;;G06Q30/0282;;G06Q30/0601;;G06Q30/0601,G06Q10/08;;G06Q10/10;;G06Q30/02;;G06Q30/06,705/300,66,0,,,"Material Logistics System, (NN86091526) IBM Technical Disclosure Bulletin, Sep. 1986, US, vol. 26, Isue 4, p. No. 1526-1530.;;Ogg, et al.; U.S. Appl. No. 09/651,390 (titled ""Virtualized Printing of Indicia, Logos and Graphics"") filed Aug. 29, 2000; pages-throughout; and.;;Ogg, et al.; U.S. Appl. No. 09/651,389 (titled ""Method and Apparatus for Printing Indicia Logos and Graphics Onto Print Media"") filed Aug. 29, 2000; pages-throughout.;;Williams, et al.; Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Parcel Returns Shipping Management; U.S. Appl. No. 09/820,292; filed on Mar. 27, 2001; pages-throughout.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pages-throughout.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pp. 1-3 and 98-104.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pp. 1-3 and 98-108.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pp. 1-3 and 98-103.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pp. 1-3 and 98-112.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pp. 1-6 and 100-117.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pp. 1-7 and 102-123.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pp. 1-4 and 100-124.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pp. 1-5 and 100-116.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pp. 1-3 and 97-100.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pp. 1-3 and 98-110.;;[Redacted Under 37 C.F.R. Section 1.217(d)]; pp. 1-2 and 97-112.;;[Smith, III, et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010; filed on Oct. 6, 3000]; pages-throughout.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871; filed on Oct. 6, 2000]; pp. 1-3 and 98-104.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870; filed on Oct. 6, 2000]; pp. 1-3 and 98-108.;;[Hu, et al.; Apparatus, Systems and Methods for Interfacing with Digital Scales Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,808; filed Oct. 6, 2000]; pp. 1-3 and 98-103.;;[Bennett, et al.; Reporting Shipping Rates and Delivery Schedules for Multiple Service and Multiple Carriers; U.S. Appl. No. 09/684,869; filed Oct. 6, 2000]; p. 1-3 and 98-112.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078; filed Oct. 6, 2000]; pp. 1-6 and 100-117.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Delivery Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/680,649; filed Oct. 6, 2000]; pp. 1-7 and 102-123.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Rate and Delivery Schedule Comparison for Multiple Carriers; U.S. Appl. No. 09/680,654; filed Oct. 6, 2000]; pp. 1-4 and 100-124.;;[Bennett, et al.; Apparatus, Systems and Methods for Applying Billing Options for Multiple Carriers for Online, Multi-Carrier, Muiti-Service Parcel Shipping Management; U.S. Appl. No. 09/684,865; filed Oct. 6, 2000]; pp. 1-3 and 98-104.;;[Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077; filed Oct. 6, 2000]; pp. 1-5 and 100-116.;;[Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for each of Multiple Carriers; U.S. Appl. No. 09/684,014; filed Oct. 6, 2000]; pp. 1-3 and 97-100.;;[Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for each of Multiple Carriers; U.S. Appl. No. 09/684,861; filed Oct. 6, 2000]; pp. 1-3 and 97-100.;;[Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accurate Symbologies on Laser Printers Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,152; filed Oct. 6, 2000]; pp. 1-3 and 98-110.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Seivice Parcel Shipping Management; U.S. Appl. No. 09/684,866; filed Oct. 6, 2000]; pp. 1-2 and 97-112.;;Kewill Systems, Inc., ""Kewill Systems PLC Acquires Leading U.S. Shipping and Receiving E-Commerce Software Firm for $18 Million"", Aristo Computers Press Releases and Product Developments, Jul. 27, 1999, pp. 1-3 of 13, Marlborough, Mass.;;Kewill Systems, Inc., ""USPS Delivery Confirmation Support Now Available in Aristo's Economical APSS® Lite Shipping System"", Aristo Computers Press Releases and Product Developments, Jun. 23, 1999, p. 3 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified by USPS to Support New Express Mail Manifesting"", Aristo Computers Press Releases and Product Developments, Jun. 21, 1999, pp. 3 and 4 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified UPS OnLine® Compatible to Support UPS International Shipping"", Aristo Computers Press Releases and Product Developments, May 12, 1999, pp. 4 and 5 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified to Fully Support FedEx PowerShip® Server, ""Aristo Computers Press Releases and Product Developments, May 10, 1999, pp. 5 and 6 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Names AllPoints Systems Strategic Partner"" AllPoints Systems to Integrate Aristo shipping functionality into its Demand Chian Software, Aristo Computers Press Releases and Product Developments, Apr. 13, 1999, pp. 6 and 7 of 13, Beaverton, Oregon and Dedham, Massatuchutes.;;Kewill Systems, Inc., ""Midgard Information Systems and Aristo-Integrated Shipping Solutions for Today's Marketplace"", Aristo Computers Press Releases and Product Developments, Jan. 19, 1999, pp. 7-9 of 13, Charlotte, North Carolina.;;Kewill Systems, Inc., ""Aristo's OLE Server Provides Shipping & Manifesting Engine for Third Party Developers"", Aristo Computers Press Releases and Product Developments, Jul. 28, 1998, pp. 9 and 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Adds New Economical Shipping Solution to Its Product Line"", Aristo Computers Press Releases and Product Developments, Apr. 30, 1998, p. 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo announces latest APSS® developments!"", Aristo Computers Press Releases and Product Developments, Jun. 9, 1997, pp. 10 and 11 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo launches APSS® for Windows"", Aristo Computers Press Releases and Product Developments, Oct. 20, 1996, pp. 11-13 of 13, Beaverton, Oregon.;;""Netscape and FDX Unveil Plans for Next Generation Internet Package Delivery Center"", Netscape Press Release, Apr. 7, 1999, 3 pages, Mt.View, California and Memphis, Tennessee.;;""TanData Announces Release of ChainLink(TM) Applications Suite"" TanData Press Releases, Dec. 8, 1999, 2 pages, Tulsa, Oklahoma.;;UPS Extends Capability of iCat Electronic Commerce Software, TanData Press Releases, Oct. 26, 1998, 2 pages, Atlanta.;;Andy Wang, ""FedEx and Netscape Build Shipping Portal"", E-Commerce Times, Apr. 8, 1999, 2 pages.;;Mary Hillebrand, ""From2.Com Gives International E-Commerce A Hand"", E-Commerce Times, Jul. 9, 1999, 3 pages.;;Tim Wilson, ""Shippers Repackaged As E-Providers"", InformationWeek, Issue: 758, Section: Transportation Transformation: A Special Report From Internetweek, Oct. 25, 1999, 6 pages.;;James Hollander, UPS Boosts E-Commerce Strategy with New Web Tools, E-Commerce Times, Apr. 6, 1999, 3 pages.;;Collection of Screen Printouts (copyright © 2000) from ""anythingovernight.com"" referring to shipping product Shiplet, entitled ""Shiplet"", 4 pages, ""About Us"", 1 page, ""Shipping"", 1 page, ""Reporting"", 1 page, ""User Profile"" 1 page, ""Shipments to Me"", 1 page, and ""API"", 1 page.;;Lisa Corbin, ""Electronic Commerce Strategies"", Government Executive Magazine, Aug. 30, 1999, 5 pages.;;Computer Support, Inc. (CSI), p. 10 of 117 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;TradePoint Systems LLC, International Trade and Transportion, and Transportation Concepts and Services, Inc. (TCS), p. 19 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Carrier Quality Performance Software, p. 39 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Late Delivery Quality Monitor Software (for Federal Exress Shipments), p. 97 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Scheme Software Order Entry/Billing 5.0, p. 156 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Software for International Trade, p. 157 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Brandon Fleming, ""Hot List for Electronic Data Interchange (EDI)"", http://www.usatrade.gov/us/annarbor/hot-list-for-EDI.htm, 9 pages, Copyright © 1999; Revised Feb. 1, 2000.;;Microsoft Corporation, ""Microsoft Internet Commerce Strategy: A Foundation for Doing Business on the Internet"", May 1997, 27 pages.;;Survey of E-Commerce Companies & Poducts: Business Logistics, Customer Service, Supply Chain Management, http://pages.hotbot.com/biz/jaym1/BP9.html, 28 pages, Richard Karpinski, Appendix II Feb. 9, 1999 on p. 26.;;FedEx Standardizes on Netscape, News Source: Mountain View, Calif., Jun. 11/PRNewswire; News Date Jun. 12, 1996 12:55 pm; Keywords: Federal Express, Electronic Commerce; 3 pages.;;Email Message; From SmartShip Online Support, To: smartshippers@smartship.com; Subject: You can ship online now!Sent: Tuesday, Dec. 15, 1998 11:53 AM; 1 page.;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine, California.;;Declaration by John Dietz, entitled ""Verified Statement (Declaration) No. 1 in Support of Information Disclosure Statement in U.S. Appl. Nos. [09/684,010, 09/684,871, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,152, 09/684,866], 09/820,377, and 09/820,292"", executed Jul. 20, 2001, pp. 1-8 (with Exhibits A-J attached).;;Declaration by John Dietz, entitled ""Verified Statement (Declaration) No. 2 in Support of Information Disclosure Statement in U.S. Appl. Nos. [09/684,010, 09/684,871, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,152, 09/684,866], 09/820,377, and 09/820,292"", executed Jul. 20, 2001, pp. 1-6 (with Exhibits A and B attached).;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine California.;;""New Web site offers quick shipping-rate comparisons"", SmartShip.com, Philadelphia Inquirer Jan. 13, 2000, Henry J. Holcomb, 3 pages.",ACTIVE
446,US,B2,US 8762290 B2,027-812-707-351-140,2014-06-24,2014,US 201213710302 A,2012-12-10,US 201213710302 A;;US 201113093551 A;;US 51080106 A;;US 82037701 A;;US 19389900 P;;US 19272300 P,2000-03-27,"Apparatus, systems and methods for online, multi-parcel, multi-carrier, multi-service enterprise parcel shipping management","The present invention provides a plurality of Enterprises with a single online user interface with which the Enterprise can provide Enterprise Shippers, shipping origination users and shipping intermediary users with an automated parcel management system for a plurality of supported Carriers for a plurality of services. The present invention provides for the hierarchical definition of users, including the hierarchical definition of organizational units within each Enterprise. The present invention further provides for a distinct definition of policies, privileges, and other types of specifications for each user level, each user, and each organizational unit. The present invention applies the user and organizational policies, privileges and other specifications as they apply to each particular user to drive the interactive interface with each particular user and to provide among other things, shipping options, shipping services, shipping rates, traveler and/or shipping label preparation, and shipment tracking.",STAMPS COM INC;;ISHIP INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN,,https://lens.org/027-812-707-351-140,Granted Patent,yes,72,2,9,43,0,G06Q10/0835;;G06Q10/0835;;G06Q10/08;;G06Q10/08;;G06Q10/083;;G06Q10/083;;G06Q10/0834;;G06Q10/0834;;G06Q10/08345;;G06Q10/08345;;G06Q10/10;;G06Q10/10;;G06Q10/101;;G06Q10/101;;G06Q30/0282;;G06Q30/0282;;G06Q30/0601;;G06Q30/0601,G06Q30/00;;G06Q10/00;;G06Q10/08;;G06Q10/10;;G06Q30/02;;G06Q30/06,705/334;;705/330;;705/337;;705/1.1,39,0,,,"Decision on Request for Rehearing for U.S. Appl. No. 09/820,377, dated Oct. 30, 2009, pp. 1-8.;;Office Action for U.S. Appl. No. 11/510,801, dated Jan. 4, 2012, pp. 1-40.;;Office Action for U.S. Appl. No. 13/093,551, dated Jan. 3, 2012, pp. 1-24.;;Kewill Systems, Inc., ""Kewill Systems PLC Acquires Leading U.S. Shipping and Receiving E-Commerce Software firm for $18 Million"", Aristo Computers Press Releases and Product Developments, Jul. 27, 1999, pp. 1-3 of 13, Marlborough, Mass.;;Kewill Systems, Inc., ""USPS Delivery Confirmation Support Now Availbe in Aristo's Economical APSS® Lite Shipping System"", Aristo Computers Press Releases and Product Developments, Jun. 23, 1999, p. 3 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified by USPS to Support New Express Mail Manifesting"", Aristo Computers Press Releases and Product Developments, Jun. 21, 1999, p. 3 and 4 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping Systems® Certifed by USPS Online® Compatible to Support UPS International Shipping"", Aristo Computers Press Releases and Products Developments, May 12, 1999, pp. 4 of 5 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified to Fully Support FedEd PowerShip® Server"", Aristo Computers Press Releases and Products Developments, May 10, 1999, pp. 5 and 6 of 13, Beaverton, Oregon.;;Kewill System, Inc., ""Aristo Computers Names AllPoints Systems Strategic Partner"", AllPoints Systems to Integrate Aristo shipping functionality into its Demand Chain Software, Aristo Computer Press Releases and Product Developments, Apr. 13, 1999, pp. 6 and 7 of 13, Beaverton, Oregon, and Dedham, Massatuchutes.;;Kewill Systems, Inc., ""Midgard Information Systems and Aristo-Integrated Shipping Solutions for Today's Marketplace"", Aristo Computers Press Release and Product Developments, Jan. 19, 1999, pp. 7-9 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo's OLE Server Provides Shipping & Manifesting Engine for Third Party Developers"", Aristo Computers Press Releases and Product Developments, Jul. 28, 1998, pp. 9 and 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Adds New Economical Shipping Solution to Its Product Line"", Aristo Computers Press Releases and Product Developments, Apr. 30, 1998, p. 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo announces latest APSS® developments!"", Aristo Computers Press Releases and Product Developments, Jun. 9, 1997, pp. 10 and 11 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo launches APSS® for Windows"", Aristo Computers Press Releases and Product Developments, Oct. 20, 1996, pp. 11-13 of 13, Beaverton, Oregon.;;""Netscape and FDX Unveil Plans for Next Generation Internet Package Delivery Center"", Netscape Press Release, Apr. 7, 1999, 3 pages, Mt.View, California and Memphis, Tennessee.;;""TanData Announces Release of ChainLink® Applications Suite"" TanData Press Releases, Dec. 8, 1999, 2 pages, Tulsa, Oklahoma.;;UPS Extends Capability of iCat Electronic Commerce Software, TanData Press Releases, Oct. 26, 1998, 2 pages, Atlanta.;;Andy Wang, ""FedEx and Netscape Build Shipping Portal"", E-Commerce Times, Apr. 8, 1999, 2 pages.;;Mary Hillebrand, ""From2.Com Gives International E-Commerce A Hand"", E-Commerce Times, Jul. 9, 1999, 3 pages.;;Tim Wilson, ""Shippers Repackaged As E-Providers"", InformationWeek, Issue: 758, Section: Transportation Transformation: A Special Report From Internetweek, Oct. 25, 1999, 6 pages.;;James Hollander, UPS Boosts E-Commerce Strategy with New Web Tools, E-Commerce Times, Apr. 6, 1999, 3 pages.;;Collection of Screen Printouts (copyright © 2000) from ""anythingovernight.com"" referring to shipping product Shiplet, entitled ""Shiplet"", 4 pages, ""About Us"", 1 page, ""Shipping"", 1 page, ""Reporting"", 1 page, ""User Profile"" 1 page, ""Shipments to Me"", 1 page, and ""API"", 1 page, 10 pages total.;;Lisa Corbin, ""Electronic Commerce Strategies"", Government Executive Magazine, Aug. 30, 1999, 5 pages.;;Computer Support, Inc. (CSI), p. 10 of 117 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul., 1998).;;TradePoint Systems LLC, International Trade and Transportion, and Transportation Concepts and Services, Inc. (TCS), p. 19 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul., 1998).;;Carrier Quality Performance Software, p. 39 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul., 1998).;;Late Delivery Quality Monitor Software (for Federal Exress Shipments), p. 97 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul., 1998).;;Scheme Software Order Entry/Billing 5.0, p. 156 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul., 1998).;;Software for International Trade, p. 157 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul., 1998).;;Brandon Fleming, ""Hot List for Electronic Data Interchange (EDI)"", http://www.usatrade.gov/us/annarbor/hot-listfor-EDI.htm, 9 pages., Copyright © 1999; Revised Feb. 1, 2000.;;Microsoft Corporation, ""Microsoft Internet Commerce Strategy: A Foundation for Doing Business on the Internet"", May 1997, 27 pages.;;Survey of E-Commerce Companies & Products: Business Logistics, Customer Service, Supply Chain Management, http://pages.hotbot.com/biz/jayml/BP9.html, 28 pages, Richard Karpinski, Appendix II Feb. 9, 1999 on p. 26.;;FedEx Standardizes on Netscape, News Source: Mountain View, Calif., Jun. 11/PRNewswire; News Date Jun. 12, 1996 12:55 pm; Keywords: Federal Express, Electronic Commerce; 3 pages.;;Email Message; From SmartShip Online Support, to: smartshippers@smartship.com; Subject: You can ship online now! Sent: Tuesday, Dec. 15, 1998 11:53 AM; 1 page.;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine, California.;;""New Web site offers quick shipping-rate comparisons"", SmartShip.com, Philadelphia Inquirer Jan. 13, 2000, Henry J. Holcomb, 3 pages.;;Material Logistics System, (NN86091526) IBM Technical Disclosure Bulletin, Sep. 1986, US, Volumn 26, !Isue 4, page Nos. 1526-1530.;;Declaration by John Dietz entitled ""Verified Statement (Declaration) No. 1 in Support of Information Disclosure Statement in U.S. Appl. No. 09/684,0110, U.S. Appl. No. 09/684,871, U.S. Appl. No. 09/684,870, U.S. Appl. No. 09/684,808, U.S. Appl. No. 09/684,869, U.S. Appl. No. 09/685,078, U.S. Appl. No. 09/680,649, U.S. Appl. No. 09/680,654, U.S. Appl. No.09/684,865, U.S. Appl. No. 09/685,077, U.S. Appl. No. 09/684,014, U.S. Appl. No. 09/684,861, U.S. Appl. No. 09/684,152, U.S. Appl. No. 09/684,866, U.S. Appl. No. 09/820,377, and U.S. Appl. No. 09/820,292"", executed Jul. 20, 2001, pp. 1-8 (with Exhibits A-J attached).;;Declaration by John Dietz entitled ""Verified Statement (Declaration) No. 2 in Support of Information Disclosure Statement in U.S. Appl. No. 09/684,010, U.S. Appl. No. 09/684,871, U.S. Appl. No. 09/684,870, U.S. Appl. No. 09/684,808, U.S. Appl. No. 09/684,869, U.S. Appl. No. 09/685,078, U.S. Appl. No. 09/680,649, U.S. Appl. No. 09/680,654, U.S. Appl. No.09/684,865, U.S. Appl. No. 09/685,077, U.S. Appl. No. 09/684,014, U.S. Appl. No. 09/684,861, U.S. Appl. No. 09/684,152, U.S. Appl. No. 09/684,866, U.S. Appl. No. 09/820,377, and U.S. Appl. No. 09/820,292"", executed Jul. 20, 2001, pp. 1-6 (with Exhibits A and B attached).",EXPIRED
447,WO,A3,WO 2008/033464 A3,057-817-341-179-112,2008-05-15,2008,US 2007/0019930 W,2007-09-13,US 84507506 P,2006-09-15,AZETIDINONE DERIVATIVES FOR THE TREATMENT OF DISORDERS OF THE LIPID METABOLISM,"The present invention relates to Azetidinone Derivatives, compositions comprising an Azetidinone Derivative and methods for treating or preventing a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease, comprising administering to a patient an effective amount of an Azetidinone Derivative.",SCHERING CORP;;ASLANIAN ROBERT G;;BENNETT CHAD E;;BURNETT DUANE A;;CHAN TIN-YAU;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;HARRIS JOEL M;;MC KITTRICK BRIAN A;;PALANI ANANDAN;;SMITH ELIZABETH M;;VACCARO HENRY M;;XIAO DONG;;KIM HYUNJIN M,ASLANIAN ROBERT G;;BENNETT CHAD E;;BURNETT DUANE A;;CHAN TIN-YAU;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;HARRIS JOEL M;;MC KITTRICK BRIAN A;;PALANI ANANDAN;;SMITH ELIZABETH M;;VACCARO HENRY M;;XIAO DONG;;KIM HYUNJIN M,,https://lens.org/057-817-341-179-112,Search Report,yes,2,0,11,11,0,C07D471/10;;A61P1/00;;A61P1/04;;A61P1/08;;A61P1/12;;A61P1/16;;A61P13/02;;A61P15/00;;A61P17/00;;A61P17/02;;A61P17/06;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/00;;A61P3/06;;A61P9/00;;A61P3/10;;C07D471/10,C07D471/10;;A61K31/438;;A61P3/00,,8,8,015-894-508-198-83X;;020-426-301-835-209;;037-380-318-993-63X;;072-226-712-614-902;;109-296-681-056-155;;102-999-400-280-537;;016-914-631-993-160;;029-288-776-852-330,16995679;;10.1021/jo061189l;;16388623;;10.1021/jo0517287;;16092847;;10.1021/ol051214u;;10.1021/jo040163w.s001;;15471445;;10.1021/jo040163w;;15307755;;10.1021/jo049430o;;11559183;;10.1021/jo015714m;;10.1016/0223-5234(94)90207-0;;10.1021/ja00292a040,"MACIAS, ALBERTO ET AL: ""Synthesis of Enantiopure Pyrrolidine-Derived Peptidomimetics and Oligo-.beta.-peptides via Nucleophilic Ring-Opening of .beta.-Lactams"", JOURNAL OF ORGANIC CHEMISTRY , 71(20), 7721-7730 CODEN: JOCEAH; ISSN: 0022-3263, 2006, XP002472746;;BITTERMANN, HOLGER ET AL: ""Chirospecific Synthesis of Spirocyclic .beta.-Lactams and Their Characterization as Potent Type II .beta.-Turn Inducing Peptide Mimetics"", JOURNAL OF ORGANIC CHEMISTRY , 71(1), 97-102 CODEN: JOCEAH; ISSN: 0022-3263, 2006, XP002472747;;CLAYDEN J ET AL: ""Cyclization of lithiated pyridine and quinoline carboxamides: synthesis of partially saturated pyrrolopyridines and spirocyclic beta-lactams"", ORGANIC LETTERS, ACS, WASHINGTON, DC, US, vol. 7, no. 17, 18 August 2005 (2005-08-18), pages 3673 - 3676, XP002467924, ISSN: 1523-7060;;MACIAS, ALBERTO ET AL: ""Diastereoselective [2+2]-Cycloaddition Reactions of Unsymmetrical Cyclic Ketenes with Imines: Synthesis of Modified Prolines and Theoretical Study of the Reaction Mechanism"", JOURNAL OF ORGANIC CHEMISTRY , 69(21), 7004-7012 CODEN: JOCEAH; ISSN: 0022-3263, 2004, XP002472748;;KHASANOV ALISHER B ET AL: ""Novel Asymmetric Approach to Proline-Derived Spiro-.beta.-lactams"", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 69, no. 17, 2004, pages 5766 - 5769, XP002467266, ISSN: 0022-3263;;ALONSO EDUARDO ET AL: ""Spiro .beta.-lactams as .beta.-turn mimetics. Design, synthesis, and NMR conformational analysis"", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 66, no. 19, 2001, pages 6333 - 6338, XP002467267, ISSN: 0022-3263;;CIGNARELLA G ET AL: ""Synthesis of a new series of 2,7-diazaspiro(3.5)nonan-1-ones and study of their cholinergic properties"", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 29, no. 2, 1994, pages 115 - 120, XP002467925, ISSN: 0223-5234;;OVERMAN, LARRY E. ET AL: ""A convenient synthesis of 4-unsubstituted .beta.-lactams"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY , 107(6), 1698-701 CODEN: JACSAT; ISSN: 0002-7863, 1985, XP002472749",PENDING
448,EP,A2,EP 2061792 A2,107-107-366-512-087,2009-05-27,2009,EP 07838185 A,2007-09-13,US 2007/0019930 W;;US 84507506 P,2006-09-15,AZETIDINONE DERIVATIVES FOR THE TREATMENT OF DISORDERS OF THE LIPID METABOLISM,,SCHERING CORP,ASLANIAN ROBERT G;;BENNETT CHAD E;;BURNETT DUANE A;;CHAN TIN-YAU;;KISELGOF EUGENIA Y;;KNUTSON CHAD E;;HARRIS JOEL M;;MC KITTRICK BRIAN A;;PALANI ANANDAN;;SMITH ELIZABETH M;;VACCARO HENRY M;;XIAO DONG;;KIM HYUNJIN M,MERCK SHARP & DOHME CORP. (2012-08-15),https://lens.org/107-107-366-512-087,Patent Application,yes,0,0,11,11,0,C07D471/10;;A61P1/00;;A61P1/04;;A61P1/08;;A61P1/12;;A61P1/16;;A61P13/02;;A61P15/00;;A61P17/00;;A61P17/02;;A61P17/06;;A61P25/02;;A61P25/04;;A61P29/00;;A61P3/00;;A61P3/06;;A61P9/00;;A61P3/10;;C07D471/10,C07D471/10;;A61K31/438;;A61P3/00,,0,0,,,,DISCONTINUED
449,US,A1,US 2013/0179361 A1,177-871-350-744-281,2013-07-11,2013,US 201213710302 A,2012-12-10,US 201213710302 A;;US 201113093551 A;;US 51080106 A;;US 82037701 A;;US 19389900 P;;US 19272300 P,2000-03-27,"Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Enterprise Parcel Shipping Management","The present invention provides a plurality of Enterprises with a single online user interface with which the Enterprise can provide Enterprise Shippers, shipping origination users and shipping intermediary users with an automated parcel management system for a plurality of supported Carriers for a plurality of services. The present invention provides for the hierarchical definition of users, including the hierarchical definition of organizational units within each Enterprise. The present invention further provides for a distinct definition of policies, privileges, and other types of specifications for each user level, each user, and each organizational unit. The present invention applies the user and organizational policies, privileges and other specifications as they apply to each particular user to drive the interactive interface with each particular user and to provide among other things, shipping options, shipping services, shipping rates, traveler and/or shipping label preparation, and shipment tracking.",STAMPS COM INC;;ISHIP INC;;ISHIP INC;;STAMPS COM INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN,,https://lens.org/177-871-350-744-281,Patent Application,yes,2,18,9,43,0,G06Q10/0835;;G06Q10/0835;;G06Q10/08;;G06Q10/08;;G06Q10/083;;G06Q10/083;;G06Q10/0834;;G06Q10/0834;;G06Q10/08345;;G06Q10/08345;;G06Q10/10;;G06Q10/10;;G06Q10/101;;G06Q10/101;;G06Q30/0282;;G06Q30/0282;;G06Q30/0601;;G06Q30/0601,G06Q10/08;;G06Q10/10;;G06Q30/02;;G06Q30/06,705/330,0,0,,,,EXPIRED
450,US,B2,US 8374970 B2,055-646-698-775-009,2013-02-12,2013,US 201113093551 A,2011-04-25,US 201113093551 A;;US 51080106 A;;US 82037701 A;;US 19272300 P;;US 19389900 P,2000-03-27,"Apparatus, systems and methods for online, multi-parcel, multi-carrier, multi-service enterprise parcel shipping management","The present invention provides a plurality of Enterprises with a single online user interface with which the Enterprise can provide Enterprise Shippers, shipping origination users and shipping intermediary users with an automated parcel management system for a plurality of supported Carriers for a plurality of services. The present invention provides for the hierarchical definition of users, including the hierarchical definition of organizational units within each Enterprise. The present invention further provides for a distinct definition of policies, privileges, and other types of specifications for each user level, each user, and each organizational unit. The present invention applies the user and organizational policies, privileges and other specifications as they apply to each particular user to drive the interactive interface with each particular user and to provide among other things, shipping options, shipping services, shipping rates, traveler and/or shipping label preparation, and shipment tracking.",STAMPS COM INC;;ISHIP INC;;WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN,,https://lens.org/055-646-698-775-009,Granted Patent,yes,51,2,9,43,0,G06Q10/0835;;G06Q10/0835;;G06Q10/08;;G06Q10/08;;G06Q10/083;;G06Q10/083;;G06Q10/0834;;G06Q10/0834;;G06Q10/08345;;G06Q10/08345;;G06Q10/10;;G06Q10/10;;G06Q10/101;;G06Q10/101;;G06Q30/0282;;G06Q30/0282;;G06Q30/0601;;G06Q30/0601,G06Q10/00;;G01G19/413;;G06F17/00;;G06Q10/08;;G06Q10/10;;G06Q30/02;;G06Q30/06;;G07B17/02,705/300;;705/407;;705/301,68,0,,,"Material Logistics System, (NN86091526) IBM Technical Disclosure Bulletin, Sep. 1986, US, Volumn 26, Isue 4, p. 1526-1530.;;Office Action for U.S. Appl. No. 09/820,377, dated Apr. 5, 2005, pp. 1-10.;;Office Communication for U.S. Appl. No. 09/820,377, dated Dec. 14, 2004, pp. 1-4.;;Final Office Action for U.S. Appl. No. 09/820,377, dated Apr. 21, 2005, pp. 1-10.;;Office Action for U.S. Appl. No. 09/820,377, dated Oct. 21, 2005, pp. 1-8.;;Office Action for U.S. Appl. No. 09/820,377, dated May 26, 2006, pp. 1-10.;;Examiner's Answer for U.S. Appl. No. 09/820,377, dated Apr. 3, 2007, pp. 1-15, Art Unit 3629.;;BPAI Decision on Appeal for U.S. Appl. No. 09/820,377, dated May 29, 2009, pp. 1-16.;;Decision on Request for Rehearing for U.S. Appl. No. 09/820,377, dated Oct. 30, 2009, pp. 1-8.;;Notice of Allowance for U.S. Appl. No. 09/820,377, dated Mar. 25, 2010, pp. 1-6.;;Ogg, et al.; U.S. Appl. No. 09/651,390, (titled ""Virtualized Printing of Indicia, Logos and Graphics"") filed Aug. 29, 2000; pages-throughout; and.;;Ogg, et al.; U.S. Appl. No. 09/651,389, (titled ""Method and Apparatus for Printing Indicia Logos and Graphics Onto Print Media"") filed Aug. 29, 2000; pages-throughout.;;Williams, et al.; Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Parcel Returns Shipping Management; U.S. Appl. No. 09/820,292; filed Mar. 27, 2001; pages-throughout.;;Smith, III, et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010; flied Oct. 6, 3000; pages throughout.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871; filed Oct. 6, 2000; pp. 1-3 and 98-104.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870; filed Oct. 6, 2000; pp. 1-3 and 98-108.;;Hu, et al.; Apparatus, Systems and Methods for Interfacing with Digital Scales Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,808; filed Oct. 6, 2000; pp. 1-3 and 98-103.;;Bennett, et al.; Reporting Shipping Rates and Delivery Schedules for Multiple Service and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2000; pp. 1-3 and 98-112.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000; pp. 1-6 and 100-117.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Delivery Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/680,649, filed Oct. 6, 2000; pp. 1-7 and 102-123.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Rate and Delivery Schedule Comparison for Multiple Carriers; U.S. Appl. No. 09/680,654, filed Oct. 6, 2000; pp. 1-4 and 100-124.;;Bennett, et al.; Apparatus, Systems and Methods for Applying Billing Options for Multiple Carriers for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,865, filed Oct. 6, 2000; pp. 1-3 and 98-104.;;Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000; pp. 1-5 and 100-116.;;Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6, 2000; pp. 1-3 and 97-100.;;Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000; pp. 1-3 and 97-100.;;Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accurate Symbologies on Laser Printers Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,152, filed Oct. 6, 2000; pp. 1-3 and 98-110.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,866, filed Oct. 6, 2000; pp. 1-2 and 97-112.;;Office Action for U.S. Appl. No. 11/510,801, dated Aug. 3, 2010, pp. 1-22, USPTO.;;Office Action for U.S. Appl. No. 11/510,801, dated Jan. 19, 2011, pp. 1-30, USPTO.;;Office Action for U.S. Appl. No. 11/510,801, dated Aug. 16, 2011, pp. 1-34, USPTO.;;Office Action for U.S. Appl. No. 11/510,801, dated Jan. 4, 2012, pp. 1-40, USPTO.;;Kewill Systems, Inc., ""Kewill Systems PLC Acquires Leading U.S. Shipping and Receiving E-Commerce Software Firm for $18 Million"", Aristo Computers Press Releases and Product Developments, Jul. 27, 1999, pp. 1-3 of 13, Marlborough, Mass.;;Kewill Systems, Inc. ""USPS Delivery Confirmation Support Now Available in Aristo's Economical APSS® Lite Shipping System"", Aristo Computers Press Releases and Product Developments, Jun. 23, 1999, p. 3 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified by USPS to Support New Express Mail Manifesting"", Aristo Computers Press Releases and Product Developments, Jun. 21, 1999, pp. 3 and 4 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified UPS OnLine® Compatible to Support UPS International Shipping"", Aristo Computers Press Releases and Product Developments, May 12, 1999, pp. 4 and 5 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Stripping System® Certified to Fully Support FedEx PowerShip®Server,"" Aristo Computers Press Releases and Product Developments, May 10, 1999, pp. 5 and 6 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Names AllPoints Systems Strategic Partner"" AllPoints Systems to Integrate Aristo shipping functionality into its Demand Chian Software, Aristo Computers Press Releases and. Product Developments, Apr. 13, 1999, pp. 6 and 7 of 13, Beaverton, Oregon and Dedham, Massatuchutes.;;Kewill Systems, Inc., ""Midgard Information Systems and Aristo-Integrated Shipping Solutions for Today's Marketplace"", Aristo Computers Press Releases and Product Developments, Jan. 19, 1999, pp. 7-9 of 13, Charlotte, North Carolina.;;Kewill Systems, Inc., ""Aristo's OLE Server Provides Shipping & Manifesting Engine for Third Party Developers"", Aristo Computers Press Releases and Product Developments, Jul. 28, 1998, pp. 9 and 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Adds New Economical Shipping Solution to Its Product Line"", Aristo Computers Press Releases and Product Developments, Apr. 30, 1998, p. 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo announces latest APSS® developments!"", Aristo Computers Press Releases and Product Developments, Jun. 9, 1997, pp. 10 and 11 of 13, Beaverton, Oregon.;;Kewill Systems, Inc. ""Aristo launches APSS® for Windows"", Aristo Computers Press Releases and Product Developments, Oct. 20, 1996, pp. 11-13 of 13, Beaverton, Oregon.;;""Netscape and FDX Unveil Plans for Next Generation Internet Package Delivery Center"", Netscape Press Release, Apr. 7, 1999, 3 pages, Mt. Vlow, California and Memphis, Tennessee.;;""TanData Announces Release of ChainLink(TM) Applications Suite"" TanData Press Releases, Dec. 8, 1999, 2 pages, Tulsa, Oklahoma.;;UPS Extends Capability of iCat Electronic Commerce Software, TanData Press Releases, Oct. 26, 1998, 2 pages, Atlanta.;;Andy Wang, ""FedEx and Netscape Build Shipping Portal"", E-Commerce Times, Apr. 8, 1999, 2 pages.;;Mary Hillebrand, ""From2.Com Gives International E-Commerce a Hand"", E-Commerce Times, Jul. 9, 1999, 3 pages.;;Tim Wilson, ""Shippers Repackaged As E-Providers"", InformationWeek, Issue: 758, Section: Transportation Transformation: A Special Report From Internetweek, Oct. 25, 1999, 6 pages.;;James Hollander, UPS Boosts E-Commerce Strategy with New Web Tools, E-Commerce Times, Apr. 6, 1999, 3 pages.;;Collection of Screen Printouts (copyright © 2000) from ""anythingovernight.com"" referring to shipping product Shiplet, entitled ""Shiplet"", 4 pages, ""About Us"", 1 page, ""Shipping"", 1 page, ""Reporting"", 1 page, ""User Profile"" 1 page, ""Shipments to Me"", 1 page, and ""API"", 1 page.;;Lisa Corbin, ""Electronic Commerce Strategies"", Government Executive Magazine, Aug. 30, 1999, 5 pages.;;Computer Support, Inc. (CSI), p. 10 of 117 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;TradePoint Systems LLC, International Trade and Transportion, and Transportation Concepts and Services, Inc. (TCS), p. 19 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Carrier Quality Performance Software, p. 39 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Late Delivery Quality Monitor Software (for Federal Exress Shipments), p. 97 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Scheme Software Order Entry/Billing 5.0, p. 156 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro Jul. 1998).;;Software for International Trade, p. 157 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Brandon Fleming, ""Hot List for Electronic Data Interchange (EDI)"", http://www.usatrade.gov/us/annarbor/hot-list-for-EDI.htm, 9 pages, Copyright © 1999; Revised Feb. 1, 2000.;;Microsoft Corporation, ""Microsoft Internet Commerce Strategy: A Foundation for Doing Business on the Internet"", May 1997, 27 pages.;;Survey of E-Commerce Companies & Products: Business Logistics, Customer Service, Supply Chain Management, http://pages.hotbot.com/biz/jayml/BP9.html, 28 pages, Richard Karpinski, Appendix II Feb. 9, 1999 on p. 26.;;FedEx Standardizes on Netscape, News Source: Mountain View, Calif., Jun. 11/PRNewswire; News Date Jun. 12, 1996 12:55 pm; Keywords: Federal Express, Electronic Commerce; 3 pages.;;Email Message; From SmartShip Online Support, To: smartshippers@smartship.com; Subject: You can ship online now! Sent: Tuesday, Dec. 15, 1998 11:53 AM; 1 page.;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine, California.;;Declaration by John Dietz, entitled ""Verified Statement (Declaration) No. 1 in Support of Information Disclosure Statement in U.S. Appl. Nos. 09/684,010, 09/684,871, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,152, 09/684,866, 09/820,377, and 09/820,292"", executed Jul. 20, 2001, pp. 1-8 (with Exhibits A-J attached).;;Declaration by John Dietz. entitled ""Verified Statement (Declaration) No. 2 in Support of Information Disclosure Statement in U.S. Appl. Nos. 09/684,010, 09/684,871, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,866, 09/820,377, and 09/820,292"", executed Jul. 20, 2011, pp. 1-6 (with Exhibits A and B attached).;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine California.;;""New Web site offers quick shipping-rate comparisons"", SmartShip.com, Philadelphia Inquirer Jan. 13, 2000, Henry J. Holcomb, 3 pages.;;Material Logistics System, (NN86091526) IBM Technical Disclosure Bulletin, Sep. 1986, US, Volumn 26, Isue 4, Page Numbers 1526-1530.",EXPIRED
451,US,B1,US 6310163 B1,049-930-140-021-751,2001-10-30,2001,US 89900297 A,1997-07-10,US 89900297 A;;US 59065096 A;;US 47359095 A;;US 41528395 A;;US 37804495 A;;US 265495 P;;US 737595 P,1995-01-24,alpha-olefins and olefin polymers and processes therefor,"Disclosed herein are processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic esters or carboxylic acids, and other monomers. The polymerizations are catalyzed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described herein is the synthesis of linear .alpha.-olefins by the oligomerization of ethylene using as a catalyst system a combination a nickel compound having a selected .alpha.-diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected .alpha.-diimine nickel complexes with ethylene.",DU PONT,BROOKHART MAURICE S;;JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT ALISON MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;TEMPEL DANIEL JOSEPH,,https://lens.org/049-930-140-021-751,Granted Patent,yes,40,27,17,75,0,C08F110/02;;C08F110/02;;C08F10/00;;C08F10/00;;C08F10/02;;C08F10/02;;C08F10/06;;C08F10/06;;C08F110/06;;C08F110/06;;C08F110/14;;C08F110/14;;C08F210/02;;C08F210/02;;C08F210/14;;C08F210/14;;C08F210/16;;C08F210/16;;C08F232/00;;C08F232/00;;C08L23/02;;C08L23/02;;Y10S430/165;;Y10S430/165;;Y10T428/1352;;Y10T428/1352;;Y10T428/1386;;Y10T428/1386;;Y10T428/139;;Y10T428/139;;Y10T428/24942;;Y10T428/24942;;Y10T428/2878;;Y10T428/2878;;Y10T428/31692;;Y10T428/31692;;Y10T428/31855;;Y10T428/31855;;Y10T428/31895;;Y10T428/31895;;Y10T428/31938;;Y10T428/31938;;Y10T442/20;;Y10T442/20;;Y10T442/60;;Y10T442/60;;Y10T442/626;;Y10T442/626,B01J31/00;;B01J37/00;;C07C2/32;;C07C69/52;;C07C251/08;;C07F7/00;;C07F15/00;;C07F19/00;;C08F4/02;;C08F4/06;;C08F4/60;;C08F4/70;;C08F4/80;;C08F10/00;;C08F10/02;;C08F10/06;;C08F10/08;;C08F12/30;;C08F20/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/14;;C08F210/16;;C08F220/10;;C08F232/00;;C08F232/04;;C08F255/00;;C08L23/02,526/318.6;;526/329;;526/331;;430/199;;430/252;;430/964;;428/36.9;;521/38;;521/149,49,41,177-347-884-688-64X;;101-579-530-746-406;;030-879-648-911-287;;050-373-888-844-623;;063-039-280-300-669;;039-142-183-108-89X;;042-522-701-231-875;;111-111-698-171-49X;;005-063-002-453-864;;076-405-685-873-413;;006-637-028-209-17X;;077-759-882-145-137;;135-659-417-443-693;;045-904-068-319-830;;165-789-127-128-402;;072-647-548-538-586;;031-235-936-595-146;;069-686-239-154-208;;047-388-678-146-759;;006-627-900-407-680;;114-216-909-982-55X;;046-925-223-398-487;;027-541-666-632-63X;;141-962-524-305-949;;133-199-484-001-468;;049-434-420-066-011;;164-831-587-786-422;;013-459-583-169-642;;116-598-384-747-643;;051-135-574-887-615;;093-805-713-932-396;;098-076-046-369-775;;083-137-309-271-641;;099-058-421-181-908;;162-040-217-658-278;;129-574-938-069-043;;022-507-155-586-191;;036-680-143-987-323;;083-064-288-336-703;;029-243-457-817-264;;069-936-621-235-710,10.1021/ma60067a010;;10.1021/ma00139a022;;10.1002/app.1994.070510102;;10.1021/ma00206a027;;10.1002/anie.198101161;;10.1002/anie.198510011;;10.2116/bunsekikagaku.29.11_774;;10.1002/pol.1968.110060504;;10.1016/s0040-4020(01)80757-2;;10.1039/c39930001203;;10.1021/ja00082a020;;10.1002/recl.19941130204;;10.1021/om00014a049;;10.1016/s0022-328x(00)88576-9;;10.1016/0014-3057(92)90322-s;;10.1002/pol.1969.110070411;;10.1021/ma00238a039;;10.1021/ja00105a088;;10.1002/anie.198003961;;10.1002/cber.19841170222;;10.1021/ma00026a017;;10.1002/recl.19911101207;;10.1002/macp.1966.020900103;;10.1021/ma60012a027;;10.1002/macp.1989.021900308;;10.1021/ma00094a008;;10.1021/ma00125a010;;10.1016/s0020-1693(00)85976-9;;10.1002/cber.19761090508;;10.1021/ja00128a054;;10.1021/ja953247i;;10.1021/ja00974a030;;10.1002/marc.1995.030160102;;10.1021/ma00088a007;;10.1021/ja00087a077;;10.1002/cber.19851180203;;10.1016/0304-5102(86)87079-1;;10.1021/ma00027a039;;10.1016/0020-1693(94)03854-6;;10.1016/0022-328x(91)86318-k;;10.1515/znb-1990-1209,"D. E. Axelson, et al., A Quantitative Analysis of Low-Density (Branched) Polyethylenes by Carbon-13 Fourier Transform Nuclear Magnetic Resonance at 67.9 MHz, Macromolecules, 12, 41-52, 1979.;;T. Usami, et al., Fine-Branching Structure in High-Pressure, Low-Density Polyethylenes by 50.10-MHz 13C NMR Analysis, Macromolecules, 17, 1757-1761, 1984.;;J. P. Blitz, et al., The Characterization of Short Chain Branching in Polyethylene Using Fourier Transform Infrared Spectroscopy, Journal of Applied Polymer Science, 51, 1, 13-20, 1994.;;E. Nordmeier, et al., The Molecular Structure of Low-Density Polyethylene. 1. Long-Chain Branching and Solution Properties, Macromolecules, 23, 4, 1072-1076, 1990.;;F. A. Bovey, et al., C-13 NMR Observations of Chain Branching in Vinyl Polymers, Polym. Preprs Am Chem Soc Div Polym Chem, 20, 2, 160-163, 1979.;;W. Keim, et al., Novel Nickel- and Palladium-Complexes with Aminobis(imino)phosphorane Ligands for the Polymerization of Ethylene, Angew. Chem. Int. Ed. Engl., 20, 116-117, 1981.;;V. M. Mohring, et al., Novel Polymerization of alpha-Olefins with the Catalyst System Nickel/Aminobis(imino)phosphorane, Angew. Chem. Int. Ed. Engl., 24, 1001-1003, 1985.;;Nishioka, et al., Assignment of Chain Branching . . . , Bunseki Kagaku, 29, 11, 774-780, 1980.;;A. D. Ketley, et al., The 1,3-Polymerization of Propylene by Palladium Cyanide, Polymer Letters, 6, 341-343, 1968.;;R. van Asselt, et al., Palladium Complexes Containing Rigid Bidentate Nitrogen Ligands as Catalysts for Carbon-Carbon Bond Formation, Tetrahedron, 50, 2, 323-334, 1994.;;R. van Asselt, et al., Isolation of Alkyl- and Acyl-palladium Complexes containing Rigid Bidentate Nitrogen Ligands by Stepwise Successive Insertion of CO and Alkenes, J. Chem. Soc. Chem. Commun., 15, 1203-1205, 1993.;;R. van Asselt, et al., Insertion of Carbon Monoxide and Alkenes in Palladium-Carbon Bonds of Complexes Containing Rigid Bidentate Nitrogen Ligands: The First Example of Isolated Complexes in Stepwise Successive Insertion Reactions on the Way to Polyketones, J. Am. Chem. Soc., 116, 3, 977-985, 1994.;;R. van Asselt, et al., Synthesis and characterization of rigid bidentate nitrogen ligands and some examples of coordination to divalent palladium. X-ray crystal structures of bis(rho-tolylimino)acenaphthene and methylchloro[bis(o,o'-diisopropylphenyl-imino)acenaphthene]palladium(II), Recl. Trav. Chim. Pays-Bas, 113, 2, 88-98, 1994.;;R. van Asselt, Stabilization of High Oxidation States by Rigid Bidentate Bidentate Nitrogen Ligands; Synthesis and Characterization of Diorgano- and Triorganopalladium(IV) and Cationic Triorganoplatinum(IV) Complexes, Organometallics, 13, 2, 706-720, 1994.;;M. Svoboda, et al., Diazadien-Nickel-Alkyle, J. Organometal Chem, 191, 1, 321-328, 1980.;;N. Alberola, et al., Mechanical gamma and beta Relaxations in Polyethylene-I. Glass Transitions of Polyethylene, Eur. Polym. J., 28, 8, 935-948, 1992.;;E. W. Fischer, et al., Effect of Filtration Conditions on the Apparent Density of the Intercrystalline Layers of Polyethylene Single Crystal Mats, Polymer Letters, 7, 307-311, 1969.;;David R. Burfield, et al., Differential Scanning Calerimetry Characteristics of Polypropylene. Dependence of Tg on Polymer Tacticity and Molecular Weight, Macromolecules, 16, 702-704, 1983.;;Piet, W. N. M. van Leeuwen, et al., Migration versus Insertion in Square-Planar Platinum and Palladium Complexes, J. Am. Chem. Soc., 116, 12117-12118, 1994.;;Heindirk tom Dieck, et al., Rigid Phenyl-Group Conformation in Complexes, Angew. Chem. Intl. Ed. Engl, 19, 396-397, 1980.;;Heindirk tom Dieck, et al., Synthesis of Chiral Diazadienes R* -N =CR'-CR'=N -R*, Chem. Ber., 117, 694-701, 1984.;;K. Zemke, et al., Conformational Exchange near the Glass Transition: Two Dimensional 13C NMR Study of Atactic Polypropylene, Macromolecules, 24, 6874-6876, 1991.;;J. C. Randall, et al. 13C NMR microstructure determinations of low-density polyethylene homopolymers and copolymers, Recl. Trav. Chim. Pays-Bas, 110, 543-552, 1991.;;Jan Tecl, Studium vetveni polyethylenu nuklearni magnetickou resonancni spektroskopii, Chemicky prumyal, roc., 37/62, 196-200, 1987.;;G. Natta, et al. Crystalline Alternating Ethylene-Cyclopentene Copolymers and Other Ethylene-Cycloolefin Copolymers, Makromol. Chem., 54, 95-101, 1962.;;J. Boor, et al., Polymerization of Cyclopentene, 3-Methylcyclopentene, and 3-Methylcyclohexene, Die Makromolekulare Chemie, 90, 26-37, 1966.;;B. C. Anderson, et al., Polymerization of Internal Olefins, Macromolecules, 2, No. 6, 686-687, 1969.;;Walter Kaminsky, et al., Copolymerization of cycloalkenes with ethylene in presence of chiral zirconocene catalysts, Makromol. Chem., 190, 515-526, 1989.;;W. Kaminsky, et al., in T. Keii, et al. Eds., Polymerization of Cyclic Olefins with Homogeneous Catalysts, Catalytic Olefin Polymerization, 929, 425-438, 1990.;;W. Mark Kelly, et al., Polymerization of Cyclopenetene Using Metallocene Catalysts: Polymer Tacticity and Properties, Macromolecule, 27, 4477-4485, 1994.;;Alexej Jerschow, et al., Nuclear Magnetic Resonance Evidence for a New Microstructure in Ethene-Cyclopentene Copolymers, Macromolecules, 28, 7095-7099, 1995.;;Heindirk tom Dieck, et al., Diazadiene complexes of Group 4 metals I. Synthesis of mono-, bis- and tris(diazadiene) titanium complexes and the structure of diazadienedichlorotitanium, Inorganica Chimica Acta., 177, 191-197, 1990.;;Heindirk tom Dieck, et al., Metallierung einer nichtaktivierten Alkyl-Gruppe im Nickelkomplex 1, Chem. Ber., 109, 1657-1664, 1976.;;Lynda K. Johnson, et al., New Pd(II)- and Ni(II)-Based Catalysts for Polymerization of Ethylene and alpha-Olefins, J. Am Chem. Soc., 117, 6414-6415, 1995.;;Lynda K. Johnson, et al., Copolymerization of Ethylene and Propylene with Functionalized Vinyl Monomers by Palladium(II) Catalysts, J. Am. Chem. Soc., 118, 267-268, 1996.;;Saito, et al., Diethyldipyridylnickel. Preparation, Characterization, and Reactions, J. Am. Chem. Soc., 88:22, 5198-5201, 1966.;;Bartolini, et al., Enantioselective isotactic alternating copolymerization of styrene and 4-methylstyrene with carbon monoxide catalyzed by a cationic bioxazoline Pd(II) complex,Macromol.Rapid Commun., 16, 9-14, 1995.;;Jiang, et al., Stereo- and Enantioselective Alternating Copolymerization of alpha-Olefins with Carbon Monoxide. Synthesis of Chiral Polymers, Macromolecules, 27,2694-2700, 1994.;;Brookhart, et al., Polymers with Main-Chain Chirality. Synthesis of Highly Isotactic, Optically Active Poly(4-tert-butylstyrene-alt-CO) Using Pd(II) Catalysts Based on C2-Symmetic Bisoxazoline Ligands, J. Am. Chem. Soc., 116, 3641-3642, 1994.;;Diercks, et al., Katalytische Cyclotetramerisierung von Propiolsäureestern, Chem. Ger., 118, 428-435, 1985.;;Dierck, et al., Diazadienes as Control Ligands in Catalysis Part 12.* The Nickel-Catalyzed Cyclotetramerization of Propargylic Alcohol to Substituted Cyclooctatetraenes and the Structure of 1,3,5,7-Tetrakis(Hydroxymethyl)Cyclooctatetraene, Journal of Molecular Catalysis, 35, 317-328, 1986.;;""Montecatini"" Societa Generale Per L'Industria Mineria E Chimica: ""Catalytic Manufacture of Olefin Copolymers with Three or More Monomer Components"", Chemical Abstracts, 77, No. 8, 1972, Abstract No. 49803t.;;Scott Collins & W. Mark Kelly, The Microstructure of Poly(cyclopentene) Produced by Polymerization of Cyclopenetene with Homogeneous Ziegler-Natta Catalysts, Macromolecules, 25, 233-237, 1992.;;Wissing, e et al., Influence of bulky substituents on the regioselective group-transfer reactions of diorganozinc compounds with N,N'-bis(2,6-di-isopropenyl)-1,4-diaza-1,3-butadiene, Chemical Abstracts, 121, No. 11, 1055, 1994, Abstract No. 134322g.;;Christina Munz, Constantin Stephan and Heindirk tom Dieck, Diazadiene-stabilized palladacyclopent-2-enes and the catalytic additon of various allylic systems to dimethyl acetylenedicarboxylate, Journal of Organometallic Chemistry, 407, 413-420, 1991.;;Werner Bonrath, Klaus R. Pörschke, Richard Mynott and Carl Krüger, Synthesis and Structure of Ni(92,6-iPr2C6H3N=CH-CH=NC6H3-2,6-iPr2)2, Zeitschrift Für Naturforschung, 456, 1647-1650, 1990.;;Emulsion Polymerization to Fibers, Manufacture, Encyclopedia of Polymer Science and Engineering, vol. 6, pp. 385-387, Copyright 1986.;;Editors: Barbara Elvers, Stephen Hawkins, Gail Schulz, Plastics, Properties and Testing to Polyvinyl Compounds, Ullmann's Encyclopedia of Industrial Chemistry, vol. A 21, pp. 488-493, 1992.;;Polymer Technology Dictionary, Tony Whelan MSc, Consultant, Chapman & Hall, 1994, pp1, 282, 312.",EXPIRED
452,US,A,US 5866663 A,072-993-235-707-301,1999-02-02,1999,US 89133297 A,1997-07-10,US 89133297 A;;US 59065096 A;;US 47359095 A;;US 41528395 A;;US 37804495 A;;US 737595 P;;US 265495 P,1995-01-24,Processes of polymerizing olefins,"Disclosed herein are processes for polymerizing ethylene, acyclic olefins, and/or selected cyclic olefins, and optionally selected olefinic esters or carboxylic acids, and other monomers. The polymerizations are catalyzed by selected transition metal compounds, and sometimes other co-catalysts. Since some of the polymerizations exhibit some characteristics of living polymerizations, block copolymers can be readily made. Many of the polymers produced are often novel, particularly in regard to their microstructure, which gives some of them unusual properties. Numerous novel catalysts are disclosed, as well as some novel processes for making them. The polymers made are useful as elastomers, molding resins, in adhesives, etc. Also described herein is the synthesis of linear .alpha.-olefins by the oligomerization of ethylene using as a catalyst system a combination a nickel compound having a selected .alpha.-diimine ligand and a selected Lewis or Bronsted acid, or by contacting selected .alpha.-diimine nickel complexes with ethylene.",DU PONT;;UNIV NORTH CAROLINA,BROOKHART MAURICE S;;JOHNSON LYNDA KAYE;;KILLIAN CHRISTOPHER MOORE;;ARTHUR SAMUEL DAVID;;FELDMAN JERALD;;MCCORD ELIZABETH FORRESTER;;MCLAIN STEPHAN JAMES;;KREUTZER KRISTINA ANN;;BENNETT ALISON MARGARET ANNE;;COUGHLIN EDWARD BRYAN;;ITTEL STEVEN DALE;;PARTHASARATHY ANJU;;WANG LIN;;YANG ZHEN-YU,E.I. DU PONT DE NEMOURS AND COMPANY (1997-07-16),https://lens.org/072-993-235-707-301,Granted Patent,yes,37,252,17,75,0,C08F110/02;;C08F110/02;;C08F10/00;;C08F10/00;;C08F10/02;;C08F10/02;;C08F10/06;;C08F10/06;;C08F110/06;;C08F110/06;;C08F110/14;;C08F110/14;;C08F210/02;;C08F210/02;;C08F210/14;;C08F210/14;;C08F210/16;;C08F210/16;;C08F232/00;;C08F232/00;;C08L23/02;;C08L23/02;;Y10S430/165;;Y10S430/165;;Y10T428/1352;;Y10T428/1352;;Y10T428/1386;;Y10T428/1386;;Y10T428/139;;Y10T428/139;;Y10T428/24942;;Y10T428/24942;;Y10T428/2878;;Y10T428/2878;;Y10T428/31692;;Y10T428/31692;;Y10T428/31855;;Y10T428/31855;;Y10T428/31895;;Y10T428/31895;;Y10T428/31938;;Y10T428/31938;;Y10T442/20;;Y10T442/20;;Y10T442/60;;Y10T442/60;;Y10T442/626;;Y10T442/626,B01J31/00;;B01J37/00;;C07C2/32;;C07C69/52;;C07C251/08;;C07F7/00;;C07F15/00;;C07F19/00;;C08F4/02;;C08F4/06;;C08F4/60;;C08F4/70;;C08F4/80;;C08F10/00;;C08F10/02;;C08F10/06;;C08F10/08;;C08F12/30;;C08F20/06;;C08F110/02;;C08F110/06;;C08F110/14;;C08F132/04;;C08F210/02;;C08F210/14;;C08F210/16;;C08F220/10;;C08F232/00;;C08F232/04;;C08F255/00;;C08L23/02,526/170;;526/134;;526/131;;526/160;;526/161;;526/171;;526/172;;526/120;;526/122;;526/145;;526/352;;526/352.2;;526/351;;526/348.6;;526/348.2;;526/348.3;;526/348;;526/308;;526/243;;526/245;;526/247;;526/281;;526/318.6;;526/329;;526/316;;525/268;;525/269;;525/270;;525/319;;525/297;;525/539;;528/392,54,42,177-347-884-688-64X;;101-579-530-746-406;;030-879-648-911-287;;050-373-888-844-623;;063-039-280-300-669;;039-142-183-108-89X;;042-522-701-231-875;;111-111-698-171-49X;;005-063-002-453-864;;076-405-685-873-413;;006-637-028-209-17X;;077-759-882-145-137;;135-659-417-443-693;;045-904-068-319-830;;165-789-127-128-402;;072-647-548-538-586;;031-235-936-595-146;;069-686-239-154-208;;047-388-678-146-759;;006-627-900-407-680;;114-216-909-982-55X;;046-925-223-398-487;;031-235-936-595-146;;027-541-666-632-63X;;141-962-524-305-949;;133-199-484-001-468;;049-434-420-066-011;;164-831-587-786-422;;013-459-583-169-642;;116-598-384-747-643;;051-135-574-887-615;;093-805-713-932-396;;051-135-574-887-615;;093-805-713-932-396;;098-076-046-369-775;;083-137-309-271-641;;099-058-421-181-908;;162-040-217-658-278;;129-574-938-069-043;;022-507-155-586-191;;036-680-143-987-323;;029-243-457-817-264,10.1021/ma60067a010;;10.1021/ma00139a022;;10.1002/app.1994.070510102;;10.1021/ma00206a027;;10.1002/anie.198101161;;10.1002/anie.198510011;;10.2116/bunsekikagaku.29.11_774;;10.1002/pol.1968.110060504;;10.1016/s0040-4020(01)80757-2;;10.1039/c39930001203;;10.1021/ja00082a020;;10.1002/recl.19941130204;;10.1021/om00014a049;;10.1016/s0022-328x(00)88576-9;;10.1016/0014-3057(92)90322-s;;10.1002/pol.1969.110070411;;10.1021/ma00238a039;;10.1021/ja00105a088;;10.1002/anie.198003961;;10.1002/cber.19841170222;;10.1021/ma00026a017;;10.1002/recl.19911101207;;10.1021/ma00238a039;;10.1002/macp.1966.020900103;;10.1021/ma60012a027;;10.1002/macp.1989.021900308;;10.1021/ma00094a008;;10.1021/ma00125a010;;10.1016/s0020-1693(00)85976-9;;10.1002/cber.19761090508;;10.1021/ja00128a054;;10.1021/ja953247i;;10.1021/ja00128a054;;10.1021/ja953247i;;10.1021/ja00974a030;;10.1002/marc.1995.030160102;;10.1021/ma00088a007;;10.1021/ja00087a077;;10.1002/cber.19851180203;;10.1016/0304-5102(86)87079-1;;10.1021/ma00027a039;;10.1016/0022-328x(91)86318-k,"D. E. Axelson, et al., A Quantitative Analysis of Low Density (Branched) Polyethylenes by Carbon 13 Fourier Transform Nuclear Magnetic Resonance at 67.9 MHz, Macromolecules, 12, 41 52, 1979.;;T. Usami, et al., Fine Branching Structure in High Pressure, Low Density Polyethylenes by 50.10 MHz 13 C NMR Analysis, Macromolecules, 17, 1757 1761, 1984.;;J. P. Blitz, et al., The Characterization of Short Chain Branching in Polyethylene Using Fourier Transform Infrared Spectroscopy, Journal of Applied Polymer Science, 51, 1, 13 20, 1994.;;E. Nordmeier, et al., The Molecular Structure of Low Density Polyethylene. 1. Long Chain Branching and Solution Properties, Macromolecules, 23, 4, 1072 1076, 1990.;;F. A. Bovey, et al., C 13 NMR Observations of Chain Branching in Vinyl Polymers, Polym. Preprs Am Chem Soc. Div Polym. Chem, 20, 2, 160 163, 1979.;;W. Keim, et al., Novel Nickel and Palladium Complexes with Aminobis(imino)phosphorane Ligands for the Polymerization of Ethylene, Angew. Chem. Int. Ed. Engl., 20, 116 117, 1981.;;V. M. Mohring, et al., Novel Polymerization of Olefins with the Catalyst System Nickel/Aminobis(imino)phosphorane, Angew. Chem. Int. Ed. Engl., 24, 1001 1003, 1985.;;Nishioka, et al., Assignment of Chain Branching . . . , Bunseki Kagaku, 29, 11, 774 780, 1980.;;A. D. Ketley, et al., The 1,3 Polymerization of Propylene by Palladium Cyanide, Polymer Letters, 6, 341 343, 1968.;;R. van Asselt, et al., Palladium Complexes Containing Rigid Bidentate Nitrogen Ligands as Catalysts for Carbon Carbon Bond Formation, Tetrahedron, 50, 2, 323 334, 1994.;;R. van Asselt, et al., Isolation of Alkyl and Acyl palladium Complexes containing Rigid Bidentate Nitrogen Ligands by Stepwise Successive Insertion of CO and Alkanes, J. Chem. Soc. Chem. Commun., 15, 1203 1205,1993.;;R. van Asselt, et al., Insertion of Carbon Monoxide and Alkenes in Palladium Carbon Bonds of Complexes Containing Rigid Bidentate Nitrogen Ligands: The First Example of Isolated Complexes in Stepwise Successive Insertion Reactions on the Way to Polyketones, J. Am. Chem. Soc., 116, 3, 977 985, 1994.;;R. van Asselt, et al., Synthesis and characterization of rigid bidentate nitrogen ligands and some examples of coordination to divalent palladium. X ray crystal structures of bis( tolylimino)acenaphthene and methylchloro bis(o,o diisopropylphenyl imino)acenaphthene palladium(II), Recl. Trav. Chim. Pays Bas, 113, 2, 88 98, 1994.;;R. van Asselt, Stabilization of High Oxidation States by Rigid Bidentate Nitrogen Ligands; Synthesis and Characterization of Diorgano and Triorganopalladium(IV) and Cationic Triorganoplatinum(IV) Complexes , Organometallics, 13, 2, 706 720, 1994.;;M. Svoboda, et al., Diazadien Nickel Alkyle, J. Oranometal Chem, 191, 1, 321 328, 1980.;;N. Alberola, et al., Mechanical and Relaxations in Polyethylene 1. Glass Transitions of Polyethylene. Eur. Polym. J., 28, 8, 935 948, 1992.;;E. W. Fischer, et al., Effect of Filtration Conditions on the Apparent Density of the Intercrystalline Layers of Polyethylene Single Crystal Mats, Polymer Letters, 7, 307 311, 1969.;;David R. Burfield, et al., Differential Scanning Calerimetry Characteristics of Polypropylene. Dependence of Tg on Polymer Tacticity and Molecular Weight, Macromolecules, 16, 702 704, 1983.;;iet W. N. M. van Leeuwen, et al., Migration versus Insertion in Square Planar Platinum and Palladium Complexes, J. Am. Chem. Soc., 116, 12117 12118, 1994.;;Heindirk tom Dieck, et al., Rigid Phenyl Group Conformation in Complexes, Angew. Chem. Intl. Ed. Engl, 19, 396 397, 1980.;;Heindirk tom Dieck, et al., Synthesis of Chiral Diazadienes R a N CR CR N R*, Chem. Ber., 117, 694 701, 1984.;;K. Zemke, et al., Conformational Exchange near the Glass Transition: Two Dimensional 13 C NMR Study of Atatic Polypropylene, Macromolecules, 24, 6874 6876, 1991.;;J. C. Randall, et al., 13 C NMR microstructure determinations of low density polyethylene homopolymers and copolymers, Recl. Trav. Chim. Pays Bas, 110, 543 552, 1991.;;David R. Burfield, et al., Differential Scanning Calorimetry Characterization of Polypropylene. Dependence of Tg on Polymer Tacticity and Molecular Weight, Macromolecules, 16, 702 704, 1983.;;Jan Tecl, Studium vetveni polyethylenu nuklearni magnetickou resonancnl spektroskopil, Chemicky prumyal, roc., 37/62, 196 200, 1987.;;G. Natta, et al., Crystalline Alternating Ethylene Cyclopentene Copolymers and Other Ethylene Cycloolefin Copolymers, Makromol. Chem., 54, 95 101, 1962.;;J. Boor, et al., Polymerization of Cyclopenten, 3 Methylcyclopentene, and 3 Methylcyclohexene, Die Makromolekulare Chemie, 90, 26 37, 1966.;;B. C. Anderson, et al., Polymerization of Internal Olefins, Macromolecules, 2, No. 6, 686 687, 1969.;;Walter Kaminsky, et al., Copolymerization of cycloalkenes with ethylene in presence of chiral zirconocene catalysts, Makromol. Chem., 190, 515 526, 1989.;;W. Kaminsky, et al., in T. Keii, et al. Eds., Polymerization of Cyclic Olefins with Homogeneous Catalysts, Catalytic Olefin Polymerization, 929, 425 438, 1990.;;W. Mark Kelly, et al., Polymerization of Cyclopentene Using Metallocene Catalysts: Polymer Tacticity and Properties, Macromolecule, 27, 4477 4485, 1994.;;Alexej Jerschow, et al., Nuclear Magnetic Resonance Evidence for a New Microstructure in Ethene Cyclopentene Copolymers, Macromolecules, 28, 7095 7099, 1995.;;Heindirk tom Dieck, et al., Diazadiene complexes of Group 4 metals I. Synthesis of mono , bis and tris(diazadiene) titanium complexes and the structure of diazadienedichlorotitanium, Inorganica Chimica Acta., 177, 191 107, 1990.;;Heindirk tom Dieck, et al., Metallierung einer nichtaktivierten Alkyl Gruppe im Nickelkomplex 1, Chem. Ber., 109, 1657 1664, 1976.;;Lynda K. Johnson, et al., New Pd(II) and Ni(II) Based Catalysts for Polymerization of Ethylene and Olefins, J. Am. Chem. Soc., 117, 6414 6415, 1995.;;Lynda K. Johnson, et al., Copolymerization of Ethylene and Propylene with Functionalized Vinyl Monomers by Palladium(II) Catalysts, J. Am. Chem. Soc., 118, 267 268, 1996.;;PCT/US 96/01282 Partial International Search.;;Johnson, et al., New Pd(II) and Ni(II) Based Catalysts for Polymerization of Ethylene and Olefins, J. Am. Chem. Soc., 117, 6414 6415, 1995.;;Johnson, et al. Copolymerization of Ethylene and Propylene with Functionalized Vinyl Monomers by Palladium (II) Catalysts, J. Am. Chem. Soc., 118, 267 268, 1996.;;Saito, et al., Diethyldipyridylnickel. Preparation, Characterizatio, and Reactions, J. Am. Chem. Soc., 88:22, 5198 5201, 1966.;;Bartolini, et al., Enantioselective isotactic alternating copolymerization of styrene and 4 methylstyrene with carbon monoxide catalyzed by a cationic bioxazoline Pd(II) complex, Macromol. Rapid Commun., 16, 9 14. 1995.;;Jiang, et al., Stereo and Enantioselective Alternating Copolymerization of Olefins with Carbon Monoxide. Synthesis of Chiral Polymers, Macromolecules, 27, 2694 2700, 1994.;;Brookhart, et al., Polymers with Main Chain Chirality. Synthesis of Highly Isotactic, Optically Active Poly(4 tert butylstyrene alt CO) Using Pd(II) Catalysted Based on C 2 Symmetic Bisoxazoline Ligands, J. Am. Chem. Soc., 116, 3641 3642, 1994.;;Diercks, et al., Katalytische Cyclotetramerisierung von Propiols a ureestern, Chem. Ger., 118, 428 435, 1985.;;Dierck, et al., Diazadienes as Control Ligands in Catalysis Part 12.* The Nickel Catalyzed Cyclotetramerization of Propargylic Alcohol to Substituted Cyclooctaretraenes and the Structure of 1,3,5,7 Tetrakis(Hydroxymethyl)Cyclooctatetraene, Journal of Molecular Catalysis, 35, 317 328, 1986.;;PCT International Search Report dated Oct. 21, 1996 for PCT/US96/01282 (CR 9608 D).;;Montecatini Societa Generale Per L Industria Mineria E Chimica: Catalytic Manufacture of Olefin Copolymers with Three or More Monomer Components, Chemical Abstracts, 77, No. 8, 1972, Abstract No. 49803t.;;Scott Collins & W. Mark Kelly, The Microstructure of Poly(cyclopentene) Produced by Polymerization of Cyclopentene with Homogeneous Ziegler Natta Catalysts, Macromolecules, 25, 233 237, 1992.;;Wissing, e et al., Influence of bulky substituents on the regioselective group transfer reactions of diorganozinc compounds with N,N bis(2,6 di isopropenyl) 1,4 diaza 1,3 butandiene, Chemical Abstracts, 121, No. 11, 1055, 1994, Abstract No. 134322g.;;Christina Munz, Constantin Stephan and Heindirk tom Dieck, Diazadiene stabilized palladacyclopent 2 enes and the catalytic addition of various allylic systems to dimethyl acetylenedicarboxylate, Journal of Organomettalic Chemistry, 407, 413 420, 1991.;;Werner Bonrath, Klaus R. P o rschke, Richard Mynott and Carl Kr u ger, Synthesis and Structure of Ni(2,6 Pr 2 C 6 H 3 N CH CH NC 6 H 3 2,6 i Pr 2 ) 2 , Zeitschrifrt F u r Naturf o rschung, 456, 1647 1650, 1990.;;Emulsion Polymerization to Fibers, Manufacture, Encyclopedia of Polymer Science and Engineering, vol. 6, pp. 385 387, Copyright 1986.;;Editors: Barbara Elvers, Stephen Hawkins, Gail Schulz, Plastics, Properties and Testing to Polyvinyl Compounds, Ullmann s Encyclopedia of Industrial Chemistry, vol. A 21, pp. 488 493, 1992.;;Polymer Technology Dictionary, Tony Whelan MSc, Consultant, Chapman & Hall, 1994, pp. 282, 312.",EXPIRED
453,US,A1,US 2002/0032612 A1,090-813-283-547-228,2002-03-14,2002,US 82029201 A,2001-03-27,US 82029201 A;;US 19269200 P;;US 19574800 P;;US 23210300 P,2000-03-28,"Apparatus, systems and methods for online, multi-parcel, multi-carrier, multi-service parcel returns shipping management","
   The present invention provides a computer system (the System, or the Return System) that is configured and programmed to provide online stores with a fast, simple, convenient way for eCommerce customers of an online store to return merchandise purchased from that store from within that online store. The Return System provides multi-carrier shipment rating, shipment labeling, shipment tracking, shipment tracking management reports, returns analysis and returns management reporting In an exemplary embodiment, the Return System has three major components: 1.) A Returns Manager Subsystem that provides a user interface to each Merchant to setup the Merchant's account, setup the Merchant's return policy and rules, and to monitor the status and movement of return shipments; 2.) A Consumer Returns Subsystem (also sometimes referred to as a Customer Returns Subsystem) that provides each consumer using the Returns System with an online user interface that leads the consumer through the returns process, displays the return policies and rules to the consumer, provides shipping document to ship the return package if appropriate, and permits the consumer to track their return shipments; and 3.) a Returns Processing Subsystem that, in the exemplary embodiment, provides background shipping and tracking functionality. In one exemplary embodiment of the present invention, the Online Merchant integrates the Merchant's online system with the Returns Processing Subsystem. In another exemplary embodiment, the Returns Processing Subsystem is provided as an independent web-based application service (referred to as a Return Merchant Service System) operated by a common provider. In such an embodiment, the Merchant's system interacts with the Return Merchant Service System through Application Program Interfaces (API). 
",WILLIAMS DANIEL F.;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D.;;TEGLOVIC STEPHEN M.;;DIETZ JOHN M.;;SMITH WILLIAM W.;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R.;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M.;;BEAN SCOTT JOSEPH,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,AUCTANE INC (2001-05-28),https://lens.org/090-813-283-547-228,Patent Application,yes,41,360,15,43,0,G06Q10/08;;G06Q10/083;;G06Q10/0837;;G06Q30/0601;;G06Q10/08;;G06Q10/083;;G06Q30/0601;;G06Q10/0837,G06Q10/00;;B65G61/00,705/26;;705/27,0,0,,,,EXPIRED
454,WO,A9,WO 2001/072109 A9,158-065-718-387-468,2003-01-23,2003,US 0109852 W,2001-03-27,US 19269200 P;;US 19574800 P;;US 23210300 P,2000-03-28,"APPARATUS, SYSTEMS AND METHODS FOR ONLINE, MULTI-PARCEL, MULTI-CARRIER, MULTI-SERVICE PARCEL RETURNS SHIPPING MANAGEMENT",,STAMPS COM INC;;WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH WILLIAM W III;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH WILLIAM W III;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,,https://lens.org/158-065-718-387-468,Patent Application,no,0,0,15,43,0,G06Q10/08;;G06Q10/083;;G06Q10/0837;;G06Q30/0601;;G06Q10/08;;G06Q10/083;;G06Q30/0601;;G06Q10/0837,G06Q10/00;;B65G61/00,,0,0,,,,PENDING
455,WO,A2,WO 2001/072109 A2,059-325-861-004-983,2001-10-04,2001,US 0109852 W,2001-03-27,US 19269200 P;;US 19574800 P;;US 23210300 P,2000-03-28,"APPARATUS, SYSTEMS AND METHODS FOR ONLINE, MULTI-PARCEL, MULTI-CARRIER, MULTI-SERVICE PARCEL RETURNS SHIPPING MANAGEMENT",,STAMPS COM INC;;WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH WILLIAM W III;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH WILLIAM W III;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,,https://lens.org/059-325-861-004-983,Patent Application,yes,0,58,15,43,0,G06Q10/08;;G06Q10/083;;G06Q10/0837;;G06Q30/0601;;G06Q10/08;;G06Q10/083;;G06Q30/0601;;G06Q10/0837,G06Q10/00;;B65G61/00,,0,0,,,,PENDING
456,EP,A1,EP 1277148 A1,034-423-106-982-11X,2003-01-22,2003,EP 01924379 A,2001-03-27,US 0109852 W;;US 19269200 P;;US 19574800 P;;US 23210300 P,2000-03-28,"APPARATUS, SYSTEMS AND METHODS FOR ONLINE, MULTI-PARCEL, MULTI-CARRIER, MULTI-SERVICE PARCEL RETURNS SHIPPING MANAGEMENT",,STAMPS COM INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH WILLIAM W III;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,"ISHIP, INC. (2003-02-05)",https://lens.org/034-423-106-982-11X,Patent Application,yes,0,0,15,43,0,G06Q10/08;;G06Q10/083;;G06Q10/0837;;G06Q30/0601;;G06Q10/08;;G06Q10/083;;G06Q30/0601;;G06Q10/0837,B65G61/00;;G06Q10/00,,0,0,,,,DISCONTINUED
457,US,A1,US 2010/0131420 A1,105-218-004-080-837,2010-05-27,2010,US 62648709 A,2009-11-25,US 62648709 A;;US 82029201 A;;US 19269200 P;;US 19574800 P;;US 23210300 P,2000-03-28,"APPARATUS, SYSTEMS AND METHODS FOR ONLINE, MULTI-PARCEL, MULTI-CARRIER, MULTI-SERVICE PARCEL RETURNS SHIPPING MANAGEMENT","The present invention provides a computer system (the “System”, or the “Return System”) that is configured and programmed to provide online stores with a fast, simple, convenient way for eCommerce customers of an online store to return merchandise purchased from that store from within that online store. The Return System provides multi-carrier shipment rating, shipment labeling, shipment tracking, shipment tracking management reports, returns analysis and returns management reporting In an exemplary embodiment, the Return System has three major components: 1.) A Returns Manager Subsystem that provides a user interface to each Merchant to setup the Merchant's account, setup the Merchant's return policy and rules, and to monitor the status and movement of return shipments; 2.) A Consumer Returns Subsystem (also sometimes referred to as a “Customer Returns Subsystem”) that provides each consumer using the Returns System with an online user interface that leads the consumer through the returns process, displays the return policies and rules to the consumer, provides shipping document to ship the return package if appropriate, and permits the consumer to track their return shipments; and 3.) a Returns Processing Subsystem that, in the exemplary embodiment, provides background shipping and tracking functionality. In one exemplary embodiment of the present invention, the Online Merchant integrates the Merchant's online system with the Returns Processing Subsystem. In another exemplary embodiment, the Returns Processing Subsystem is provided as an independent web-based application service (referred to as a “Return Merchant Service System”) operated by a common provider. In such an embodiment, the Merchant's system interacts with the Return Merchant Service System through Application Program Interfaces (“API”).",WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,,https://lens.org/105-218-004-080-837,Patent Application,yes,8,28,15,43,0,G06Q10/08;;G06Q10/083;;G06Q10/0837;;G06Q30/0601;;G06Q10/08;;G06Q10/083;;G06Q30/0601;;G06Q10/0837,G06F3/048;;B65G61/00;;G06Q10/00,705/340;;715/810,0,0,,,,EXPIRED
458,US,B2,US 7660721 B2,073-654-318-036-734,2010-02-09,2010,US 82029201 A,2001-03-27,US 82029201 A;;US 19269200 P;;US 19574800 P;;US 23210300 P,2000-03-28,"Apparatus, systems and methods for online, multi-parcel, multi-carrier, multi-service parcel returns shipping management","The present invention provides a computer system (the “System”, or the “Return System”) that is configured and programmed to provide online stores with a fast, simple, convenient way for eCommerce customers of an online store to return merchandise purchased from that store from within that online store. The Return System provides multi-carrier shipment rating, shipment labeling, shipment tracking, shipment tracking management reports, returns analysis and returns management reporting In an exemplary embodiment, the Return System has three major components: 1.) A Returns Manager Subsystem that provides a user interface to each Merchant to setup the Merchant's account, setup the Merchant's return policy and rules, and to monitor the status and movement of return shipments; 2.) A Consumer Returns Subsystem (also sometimes referred to as a “Customer Returns Subsystem”) that provides each consumer using the Returns System with an online user interface that leads the consumer through the returns process, displays the return policies and rules to the consumer, provides shipping document to ship the return package if appropriate, and permits the consumer to track their return shipments; and 3.) a Returns Processing Subsystem that, in the exemplary embodiment, provides background shipping and tracking functionality. In one exemplary embodiment of the present invention, the Online Merchant integrates the Merchant's online system with the Returns Processing Subsystem. In another exemplary embodiment, the Returns Processing Subsystem is provided as an independent web-based application service (referred to as a “Return Merchant Service System”) operated by a common provider. In such an embodiment, the Merchant's system interacts with the Return Merchant Service System through Application Program Interfaces (“API”).",STAMPS COM INC;;ISHIP INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,AUCTANE INC (2001-05-28),https://lens.org/073-654-318-036-734,Granted Patent,yes,48,76,15,43,0,G06Q10/08;;G06Q10/083;;G06Q10/0837;;G06Q30/0601;;G06Q10/08;;G06Q10/083;;G06Q30/0601;;G06Q10/0837,G06Q10/00;;B65G61/00,705/1;;705/26,78,1,077-054-936-811-415,10.1016/b978-1-85573-345-9.50021-2,"FedEx(R) Services, (www.fedex.com) Archived on Jan. 16, 1997.;;UPS Service Guide, (www.ups.com) Archived on Dec. 6, 1998.;;Caldwell, Bryce, Reverse Logistics-Untapped Oppotunities Exist in Returned Products, A Side of Logistics Few Businesses Have Thought About-Until Now, Apr. 12, 1999, Information Week, pp. 1-6.;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine California.;;""New Web site offers quick shipping-rate comparisons"", SmartShip.com, Philadelphia Inquirer Jan. 13, 2000, Henry J. Holcomb, 3 pages.;;Kewill Systems, Inc., ""Kewill Systems PLC Acquires Leading U.S. Shipping and Receiving E-Commerce Software Firm for $18 Million"", Aristo Computers Press Releases and Product Developments, Jul. 27, 1999, pp. 1-3 of 13, Marlborough, Mass.;;Kewill Systems, Inc., ""USPS Delivery Confirmation Support Now Available in Aristo's Economical APSS(R) Lite Shipping System"", Aristo Computers Press Release and Product Developments, Jun. 23, 1999, p. 3 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System(R) Certified by USPS to Support New Express Mail Manifesting"", Aristo Computers Press Releases and Product Developments, Jun. 21, 1999, p. 3 and 4 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System(R) Certified UPS OnLine(R) Compatible to Support UPS International Shipping"", Aristo Computers Press Releases and Product Developments, May 12, 1999, pp. 4 and 5 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System(R) Certified to Fully Support FedEx PowerShip(R) Server,"" Aristo Computers Press Releases and Product Developments, May 10, 1999, pp. 5 and 6 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Names AllPoints Systems Strategic Partner"" AllPoints Systems to Integrate Aristo shipping functionality into its Demand Chian Software, Aristo Computers Press Releases and Product Developments, Apr. 13, 1999, pp. 6 and 7 of 13, Beaverton, Oregon and Dedham, Massatuchutes.;;Kewill Systems, Inc., ""Midgard Information Systems and Aristo-Integrated Shipping Solutions for Today's Marketplace"", Aristo Computers Press Releases and Product Developments, Jan. 19, 1999, pp. 7-9 of 13, Charlotte, North Carolina.;;Kewill Systems, Inc., ""Aristo's OLE Server Provides Shipping & Manifesting Engine for Third Party Developers"", Aristo Computers Press Releases and Product Developments, Jul. 28, 1998, pp. 9 and 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Adds New Economical Shipping Solution to Its Product Line"", Aristo Computers Press Releases and Product Development, Apr. 30, 1998, p. 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo announces latest APSS(R) developments!"", Aristo Computers Press Releases and Product Developments, Jun. 9, 1997, pp. 10 and 11 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo launches APSS(R) for Windows"", Aristo Computers Press Releases and Product Developments, Oct. 20, 1996, pp. 11-13 of 13, Beaverton, Oregon.;;""Netscape and FDX Unveil Plans for Next Generation Internet Package Delivery Center"", Netscape Press Releases, Apr. 7, 1999, 3 pages, Mt.View, California and Memphis, Tennessee.;;""TanData Announces Releases of ChainLink(TM) Applications Suite"" TanData Press Releases, Dec. 8, 1999, 2 pages, Tulsa, Oklahoma.;;UPS Extends Capability of iCat Electronic Commerce Software, TanData Press Releases, Oct. 26, 1998, 2 pages, Atlanta.;;Andy Wang, ""FedEx and Netscape Build Shipping Portal"", E-Commerce Times, Apr. 8, 1999, 2 pages.;;Mary Hillebrand, ""From2.Com Gives International E-Commerce A Hand"", E-Commerce Times, Jul. 9, 1999, 3 pages.;;Tim Wilson, ""Shippers Repackaged As E-Providers"", InformationWeek, Issue: 758, Section: Transportation Transformation: A Special Report From Internetweek, Oct. 25, 1999, 6 pages.;;James Hollander, UPS Boosts E-Commerce Strategy with New Web Tools, E-Commerce Times, Apr. 6, 1999, 3 pages.;;Collection of Screen Printouts (Copyright (C) 2000) from ""anythingovernight.com"" referring to shipping product Shiplet, entitled ""Shiplet"", 4 pages, ""About Us"", 1 page, ""Shipping"", 1 page, ""Reporting"", 1 page, ""User Profile"" 1 page, ""Shipments to Me"", 1 page, and ""API"", 1 page.;;Lisa Corbin, ""Electronic Commerce Strategies"", Government Executive Magazine, Aug. 30, 1999, 5 pages.;;Computer Support, Inc. (CSI), p. 10 of 117 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;TradePoint Systems LLC, International Trade and Transportation, and Transportation Concepts and Services, Inc. (TCS), p. 19 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Carrier Quality Performance Software, p. 39 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Late Delivery Quality Performance Software, p. 39 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Scheme Software Order Entry/Billing 5.0, p. 156 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Software for International Trade, p. 157 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Brandon Fleming, ""Hot List for Electronic Data Interchange (EDI)"", http://www.usatrade.gov/us/annarbor/hot-list-for-EDI.htm, 9 pages, Copyright (C) 1999; Revised Feb. 1, 2000.;;Microsoft Corporation, ""Microsoft Internet Commerce Strategy: A Foundation for Doing Business on the Internet"", May 1997, 27 pages.;;Survey of E-Commerce Companies & Products: Business Logistics, Customer Service, Supply Chain Management, http://pages.hotbot.com/biz/jayml/BP9.html, 28 pages, Richard Karpinski, Appendix II Feb. 9, 1999 on p. 26.;;FedEx Standardizes on Netscape, News Source: Mountain View, Calif., Jun. 11/PRNewswire: News Date Jun. 12, 1996 12:55 pm; Keywords: Federal Express, Electronic Commerce; 3 pages.;;Email Message; From SmartShip Online Support, To: smartshippers@smartship.com; Subject: You can ship online now! Sent: Tuesday, Dec. 15, 1998 11:52 AM; 1 page.;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine, California.;;OGG, et al.; U.S. Appl. No. 09/651,390, (titled ""Virtualized Printing of Indicia, Logos and Graphics"") filed Aug. 29, 2000; pages-throughout.;;OGG, et al.; U.S. Appl. No. 09/651,389 (titled ""Method and Apparatus for Printing Indicia Logos and Graphics Onto Print Media"") filed Aug. 29, 2000; pages-throughout.;;Williams, et al.; Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Enterprise Parcel Shipping Management; U.S. Appl. No. 09/820,377, filed Mar. 27, 2001: pages-throughout.;;[Smith, III, et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 2000]; pages-throughout.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed Oct. 6, 2000]; pp. 1-3 and 98-104.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Mutli-Carrier, Multi-Service parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000]; pp. 1-3 and 98-108.;;[Hu, et al.; Apparatus, Systems and Methods for Interfacing with Digital Scales Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000]; pp. 1-3 and 98-103.;;[Bennett, et al.; Reporting Shipping Rates and Delivery Schedules for Multiple Service and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2000]; pp. 1-3 and 98-112.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000]; pp. 1-6 and 100-117.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Delivery Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/680,649, filed Oct. 6, 2000]; pp. 1-7 and 102-123.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Rate and Delivery Schedule Comparison for Multiple Carriers; U.S. Appl. No. 09/680,654, filed Oct. 6, 2000]; pp. 1-4 and 100-124.;;[Bennett, et al.; Apparatus, Systems and Methods for Applying Billing Options for Multiple Carriers for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,865, filed Oct. 6, 2000]; pp. 1-3 and 98-104.;;[Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000]; pp. 1-5 and 100-116.;;[Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6, 2000]; pp. 1-3 and 97-100.;;[Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for each of Multiple Carriers; U.S. Appl. No. 09/684,681, filed Oct. 6, 2000]; pp. 1-3 and 97-100.;;[Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accurate Symbologies on Laser Printers Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,152, filed Oct. 6, 2000]; pp. 1-3 and 98-110.;;[Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,866, filed Oct. 6, 2000]; pp. 1-2 and 97-112.;;Declaration of John Dietz, entitled ""Verified Statement (Declaration) No. 1 in Support of Information Disclosure Statement in U.S. Appl. Nos. 09/684,010, 09/684,871, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,152, 09/684,866, 09/820,377, and 09/820,292"", executed Jul. 20, 2001, pp. 1-8 (with Exhibits A-J attached).;;Declaration of John Dietz, entitled ""Verified Statement (Declaration) No. 2 in Support of Information Disclosure Statement in U.S. Appl. Nos. 09/684,871, 09/684,671, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,152, 09/684,866, 09/820,377, and 09/820,292"", executed Jul. 20, 2001, pp. 1-6 (with Exhibits A and B attached).;;McCandless, Michael, ""Let's Go Shopping"", IEEE Intelligent Systems, Jan./Feb. 1999, pp. 2-4, United States.;;Yesil, Magdalena, Creating the Virtual Store, John Wiley & Sons, Inc., 1997, pp. 188-189, United States.;;Kosiur, David, ""Understanding Electronic Commerce"", Strategic Technology Series, Microsoft Press, 1997, pp. 16-18, Redmond, Washington, United States.;;Williams, Martyn, Internet Update, Feb. 18, 1998, Newsbytes, pp. 1-3.;;Brown, Judy, As web pages proliferate, finding what . . . ; Feb. 8, 1999, Milwaukee Journal Sentinel (Wisconson), Business p. 2 Connected, pp. 1-2.;;Business Wire, ""Web Site Offers Money-Saving Services for Free . . . "" Feb. 16, 1998; pp. 1-2.;;""UPS on Call Air Pickup"", http://web.archive.org/web/19990508182528/wwwapps.ups.com/servlet/ODSServlet/, Copyright 1994-1999, 1 page, United Parcel Service of America, Inc.;;""UPS Ground"", http://web.archive.org/web/20040304152132/ups.com/using/services/domestic/gnd-guide.html, Copyright 1994-2000, 2 pages, United Parcel Service of America, Inc.;;""UPS World Wide Time-In-Transit/World Wide Delivery Times"", http://web.archive.org/web/20000301031405/ups.com/wwtransit/engtimetran.html, Copyright 1994-2000, 1 page, United Parcel Service of America, Inc.;;Quick Cost Calculator, http://web.archive.org/web/19981203124546/ups.com/using/services/rave/rate.html, Copyright 1994-1998, 2 pages, United Parcel Service of America, Inc.;;""UPS Quick Cost Calculator(TM)"", http://web.archive.org/web/19990220223708/ups.com/using/services/rave/rate.html, Copyright 1994-1999, 1 page, United Parcel Service of America, Inc.;;""UPS Quick Cost Calculator(TM)"", http://web.archive.org/web/20000229184425/ups.com/using/services/rave/rate.html, Copyright 1994-2000, 1 page, United Parcel Service of America, Inc.;;Notice of Allowance for co-pending case U.S. Appl. No. 09/684,808; Now U.S. Patent 7,359,887, dated May 8, 2007, pp. 1-8, USPTO.;;Notice of Allowance for co-pending case U.S. Appl. No. 09/684,865; Now U.S. Patent 7,117,170, dated Dec. 22, 2004, pp. 1-5, USPTO.;;Notice of Allowance for co-pending case U.S. Appl. No. 09/684,152; Now U.S. Patent 7,197,465, dated Aug. 10, 2006, pp. 1-8, USPTO.;;Notice of Allowance for co-pending case U.S. Appl. No. 11/123,536; Now U.S. Patent 7,421,400, dated Jan. 7, 2008, pp. 1-6, USPTO.;;Office Action for co-pending case Canadian Patent Application No. 2,404,814, dated Mar. 27, 2006, pp. 1-11, Canadian Intellectual Property Office, ""CIPO"".;;Office Action for co-pending case Canadian Patent Application No. 2,404,814, dated Dec. 18, 2006, pp. 1-8, Canadian Intellectual Property Office, ""CIPO"".;;Office Action for co-pending case Japanese Patent Application No. 2001-570080, dated Nov. 28, 2006, pp. 1-15 (English Translation).;;""Notice of The First Office Action,"" for co-pending case Chinese Patent Application No. 01810223.9, dated Apr. 6, 2007, pp. 1-3, The Patent Office of the People's Republic of China.;;""Notification of Second Office Action,"" for co-pending case Chinese Patent Application No. 01810223.9, dated Jan. 18, 2008, pp. 1-3, The Patent Office of the People's Republic of China.;;""Communication Pursuant to Article 94(3) EPC,"" for co-pending European Patent Application No. 01924379.9, dated Nov. 12, 2008, pp. 1-5, The European Patent Office.",EXPIRED
459,CA,C,CA 2404814 C,103-209-925-225-300,2016-10-11,2016,CA 2404814 A,2001-03-27,US 19269200 P;;US 19574800 P;;US 23210300 P;;US 0109852 W,2000-03-28,"APPARATUS, SYSTEMS AND METHODS FOR ONLINE, MULTI-PARCEL, MULTI-CARRIER, MULTI-SERVICE PARCEL RETURNS SHIPPING MANAGEMENT","A computer system is configured and programmed to provide online stores with a way for ecommerce customers of an online store to return merchandise purchased from that store from within that online store. The Return System provides multi-carrier shipment rating, shipment labeling, shipment tracking, shipment tracking management reports, returns analysis and returns management reporting. The Return System has three major components: 1.) A Returns Manager Subsystem that provides a user interface to each Merchant to setup the Merchant's account, return policy and rules, and to monitor the status and movement of return shipments; 2.) A Consumer Returns Subsystem that provides each consumer using the System with an online user interface that leads through the returns process, displays the return policies and rules to the consumer, provides shipping document to ship the return package if appropriate, and permits the consumer to track their return shipments; and 3.) a Returns Processing Subsystem that provides background shipping and tracking functionality. The Online Merchant may integrate the Merchant's online system with the Returns Processing Subsystem. Alternatively, the Returns Processing Subsystem is an independent web-based application service operated by a common provider. In such an embodiment, the Merchant's system interacts with the Return Merchant Service System through Application Program Interfaces (""API"").",STAMPS COM INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH WILLIAM W III;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,,https://lens.org/103-209-925-225-300,Granted Patent,no,0,0,15,43,0,G06Q10/08;;G06Q10/083;;G06Q10/0837;;G06Q30/0601;;G06Q10/08;;G06Q10/083;;G06Q30/0601;;G06Q10/0837,B65G61/00;;G06Q10/08;;G06Q10/00,,0,0,,,,EXPIRED
460,AU,A,AU 2001/051037 A,133-219-698-502-01X,2001-10-08,2001,AU 2001/051037 A,2001-03-27,US 19269200 P;;US 19574800 P;;US 23210300 P;;US 0109852 W,2000-03-28,"Apparatus, systems and methods for online, multi-parcel, multi-carrier, multi-service parcel returns shipping management",,STAMPS COM INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH WILLIAM W JR;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,,https://lens.org/133-219-698-502-01X,Patent Application,no,0,0,15,43,0,G06Q10/08;;G06Q10/083;;G06Q10/0837;;G06Q30/0601;;G06Q10/08;;G06Q10/083;;G06Q30/0601;;G06Q10/0837,B65G61/00;;G06Q10/00,,0,0,,,,PENDING
461,US,B2,US 8600913 B2,110-206-381-929-35X,2013-12-03,2013,US 62648709 A,2009-11-25,US 62648709 A;;US 82029201 A;;US 19269200 P;;US 19574800 P;;US 23210300 P,2000-03-28,"Apparatus, systems and methods for online, multi-parcel, multi-carrier, multi-service parcel returns shipping management","The present invention provides a computer system (the “Return System”) that provides multi-carrier shipment rating, shipment labeling, shipment tracking, shipment tracking management reports, returns analysis and returns management reporting. In an exemplary embodiment, the Return System has three major components: 1.) A Returns Manager Subsystem that provides a user interface to each Merchant to setup the Merchant's account, setup the Merchant's return policy and rules, and to monitor the status and movement of return shipments; 2.) A Consumer Returns Subsystem that provides each consumer using the Returns System with an online user interface that leads the consumer through the returns process, displays the return policies and rules to the consumer, provides shipping document to ship the return package if appropriate, and permits the consumer to track their return shipments; and 3.) a Returns Processing Subsystem that, in the exemplary embodiment, provides background shipping and tracking functionality.",WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH;;STAMPS COM INC;;ISHIP INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,,https://lens.org/110-206-381-929-35X,Granted Patent,yes,57,31,15,43,0,G06Q10/08;;G06Q10/083;;G06Q10/0837;;G06Q30/0601;;G06Q10/08;;G06Q10/083;;G06Q30/0601;;G06Q10/0837,G06Q10/00;;B65G61/00;;G06Q30/00,705/340,82,0,,,"FedEx(R) Services, (www.fedex.com) Archived on Jan. 16, 1997.;;UPS Service Guide, (www.ups.com) Archived on Dec. 6, 1998.;;Caldwell, Bryce, Reverse Logistics-Untapped Oppotunities Exist in Returned Products, A Side of Logistics Few Businesses Have Thought About-Until Now, Apr. 12, 1999, Information Week, pp. 1-6.;;""UPS on Call Air Pickup"", http://web.archive.org/web/19990508182528/wwwapps.ups.com/servlet/ODSServlet/, Copyright 1994-1999, 1 page, United Parcel Service of America, Inc.;;""UPS Ground"", http://web.archive.org./web/20040304152132/ups.com/using/services/domestic/gnd-guide.html, Copyright 1994-2000, 2 pages, United Parcel Service of America, Inc.;;""UPS World Wide Time-In-Transit/World Wide Delivery Times"", http://web.archive.org/web/20000301031405/ups.com/wwtransit/engtimetran.html, Copyright 1994-2000, 1 page, United Parcel Service of America, Inc.;;Quick Cost Calculator, http://web.archive.org/web/19981203124546/ups.com/using/services/rave/rate.html, Copyright 1994-1998, 2 pages, United Parcel Service of America, Inc.;;""UPS Quick Cost Calculator(TM)"", http://web.archive.org/web/19990220223708/ups.com/using/services/rave/rate.html, Copyright 1994-1999, 1 page, United Parcel Service of America, Inc.;;""UPS Quick Cost Calculator(TM)"", http://web.archive.org/web/20000229184425/ups.com/using/services/rave/rate.html, Copyright 1994-2000, 1 page, United Parcel Service of America, Inc.;;Notice of Allowance for co-pending case U.S. Appl. No. 09/684,808; Now U.S. Patent 7,359,887, dated May 8, 2007, pp. 1-8, USPTO.;;Notice of Allowance for co-pending case U.S. Appl. No. 09/684,865; Now U.S. Patent 7,117,170, dated Dec. 22, 2004, pp. 1-5. USPTO.;;Notice of Allowance for co-pending case U.S. Appl. No. 09/684,152; Now U.S. Patent 7,197,465, dated Aug. 10, 2006, pp. 1-8, USPTO.;;Notice of Allowance for co-pending case U.S. Appl. No. 11/123,536; Now U.S. Patent 7,421,400, dated Jan. 7, 2008, pp. 1-6, USPTO.;;Office Action for co-pending case Canadian Patent Application No. 2,404,814, dated Mar. 27, 2006, pp. 1-11, Canadian Intellectual Property Office, ""CIPO"".;;Office Action for co-pending case Canadian Patent Application No. 2,404,814, dated Dec. 18, 2006, pp. 1-8, Canadian Intellectual Property Office, ""CIPO"".;;Office Action for co-pending case Japanese Patent Application No. 2001-570080, dated Nov. 28, 2006, pp. 1-15 (English Translation).;;""Notification of The First Office Action,"" for co-pending case Chinese Patent Application No. 01810223.9, dated Apr. 6, 2007, pp. 1-3, The Patent Office of the People's Republic of China.;;""Notification of Second Office Action,"" for co-pending case Chinese Patent Application No. 01810223.9, dated Jan. 18, 2008, pp. 1-3, The Patent Office of the People's Republic of China.;;""Communication Pursuant to Article 94(3) EPC,"" for co-pending European Patent Application No. 01924379.9, dated Nov. 12, 2008, pp. 1-5, The European Patent Office.;;Williams, Martyn, Internet Update, Feb. 18, 1998, Newsbytes, pp. 1-3.;;Brown, Judy. As web pages proliferate, finding what . . . ; Feb. 8, 1999, Milwaukee Journal Sentinel (Wisconson), Business page 2 connected, pp. 1-2.;;Business Wire, ""Web Site Offers Money-Saving Services for Free . . . "" Feb. 16, 1998; pp. 1-2.;;McCandless, Michael, ""Let's Go Shopping"", IEEE Intelligent Systems, Jan./Feb, 1999, pp. 24, United States.;;Yesil, Magdalena, Creating the Virtual Store, John Wiley & Sons, Inc., 1997, pp. 188-189, United States.;;Kosiur, David, ""Understanding Electronic Commerce"", Strategic Technology Series, Microsoft Press, 1997, pp. 16-18, Redmond, Washington, United States.;;Declaration by John Dietz, entitled ""Verified Statement (Declaration) No. 1 in Support of Information Disclosure Statement in U.S. Appl. No. 09/684,010, U.S. Appl. No. 09/684,871, U.S. Appl. No. 09/684,870, U.S. Appl. No. 09/684,808, U.S. Appl. No. 09/684,869, U.S. Appl. No. 09/685,078, U.S. Appl. No. 09/680,649, U.S. Appl. No. 09/680,654, U.S. Appl. No. 09/684,865, U.S. Appl. No. 09/685,077, U.S. Appl. No. 09/684,014, U.S. Appl. No. 09/684,861, U.S. Appl. No. 09/684,152, U.S. Appl. No. 09/684,866, U.S. Appl. No. 09/820,377, and U.S. Appl. No. 09/820,292"", executed Jul. 20, 2001, pp. 1-8 (with Exhibits A-J attached).;;Declaration by John Dietz, entitled ""Verified Statement (Declaration) No. 1 in Support of Information Disclosure Statement in U.S. Appl. No. 09/684,010, U.S. Appl. No. 09/684,871, U.S. Appl. No. 09/684,870, U.S. Appl. No. 09/684,808, U.S. Appl. No. 09/684,869, U.S. Appl. No. 09/685,078, U.S. Appl. No. 09/680,649, U.S. Appl. No. 09/680,654, U.S. Appl. No. 09/684,865, U.S. Appl. No. 09/685,077, U.S. Appl. No. 09/684,014, U.S. Appl. No. 09/684,861, U.S. Appl. No. 09/684,152, U.S. Appl. No. 09/684,866, U.S. Appl. No. 09/820,377, and U.S. Appl. No. 09/820,292"", executed Jul. 20, 2001, pp. 1-6 (with Exhibits A and B attached).;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine California.;;""New Web site offers quick shipping-rate comparisons"", SrnartShip.com, Philadelphia Inquirer Jan. 13, 2000, Henry J. Holcomb, 3 pages.;;Ogg, et al.; U.S. Appl. No. 09/651,390, titled ""Virtualizecl Printing of Indicia, Logos and Graphics"") filed Aug. 29, 2000; pages-throughout.;;Ogg, et al.; U.S. Appl. No. 09/651,389, titled ""Method and Apparatus for Printing Indicia Logos and Graphics Onto Print Media"") fled Aug. 29, 2000; pages-throughout.;;Williams, et al.; Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Enterprise Parcel Shipping Management; U.S. Appl. No. 09/820,377, filed Mar. 27, 2001; pages-throughout.;;Smith, III, et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 3000; pages-throughout.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed Oct. 6, 2000; pp. 1-3 and 98-104.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000; pp. 1-3 and 98-108.;;Hu, et al.; Apparatus, Systems and Methods for Interfacing with Digital Scales Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000; pp. 1-3 and 98-103.;;Bennett, et al.; Reporting Shipping Rates and Delivery Schedules for Multiple Service and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2000; pp. 1-3 and 98-112.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000; pp. 1-6 and 100-117.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Delivery Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/680,649, filed Oct. 6, 2000; pp. 1-7 and 102-123.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shiping Management Featuring Shipping Rate and Delivery Schedule Comparison for Multiple Carriers; U.S. Appl. No. 09/680,654, filed Oct. 6, 2000; pp. 1-4 and 100-124.;;Bennett, et al.; Apparatus, Systems and Methods for Applying Billing Options for Multiple Carriers for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,865, filed Oct. 6, 2000; pp. 1-3 and 98-104.;;Bilibin, et at.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,877, filed Oct. 6, 2000; pp. 1-5 and 100-116.;;Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6, 2000; pp. 1-3 and 97-100.;;Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000; pp. 1-3 and 97-100.;;Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accurate Syrnbologies on Laser Printers Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,152, filed Oct. 6, 2000; pp. 1-3 and 98-110.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,866, filed Oct. 6, 2000; pp. 1-2 and 97-112.;;Kewill Systems, Inc., ""Kewill Systems PLC Acquires Leading U.S. Shipping and Receiving E-Commerce Software Firm for $18 Million"", Aristo Computers Press Releases and Product Developments, Jul. 27, 1999, pp. 1-3 of 13, Marlborough, Mass.;;Kewill Systems, Inc., ""USPS Delivery Confirmation Support Now Available in Aristo's Economical APSS® Lite Shipping System"", Aristo Computers Press Releases and Product Developments, Jun. 23, 1999, p. 3 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified by USPS to Support New Express Mail Manifesting"", Aristo Computers Press Releases and Product Developments, Jun. 21, 1999, pp. 3 and 4 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified UPS OnLine®Compatible to Support UPS International Shipping"", Aristo Computers Press Releases and Product Developments, May 12, 1999, pp. 4 and 5 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified to Fully Supoort FedEx PowerShip® Server, ""Aristo Computers Press Releases and Product Developments, May 10, 1999, pp. 5 and 6 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Names AliPoints Systems Strategic Partner"" AliPoints Systems to Integrate Aristo shipping functionality into its Demand Chian Soilware, Aristo Computers Press Releases and Product Developments, Apr. 13, 1999, pp. 6 and 7 of 13, Beaverton, Oregon and Dedham, Massatuchutes.;;Kewill Systems, Inc., ""Midgard Information Systems and Aristo-integrated Shipping Solutions for Today's Marketplace"", Aristo Computers Press Releases and Product Developments, Jan. 19, 1999, pp. 7-9 of 13, Charlotte, North Carolina.;;Kewill Systems, Inc., ""Aristo's OLE Server Provides Shipping & Manifesting Engine for Third Party Developers"", Aristo Computers Press Releases and Product Developments, Jul. 28, 1998, pp. 9 and 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Adds New Economical Shipping Solution to Its Product Line"", Aristo Computers Press Releases and Product Development, Apr. 30, 1998, p. 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo announces latest APSS® developments!"", Aristo Computers Press Releases and Product Developments, Jun. 9, 1997, pp. 10 and 11 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo launches APSS® for Windows"", Aristo Computers Press Releases and Product Developments, Oct. 20, 1996, pp. 11-13 of 13, Beaverton, Oregon.;;""Netscape and FDX Unveil Plans for Next Generation Internet Package Delivery Center"", Netscape Press Releases, Apr. 7, 1999, 3 pages, Mt.View, California and Memphis, Tennessee.;;""TanData Announces Release of ChainLink(TM) Applications Suite"" TanData Press Releases, Dec. 8, 1999, 2 pages, Tulsa, Oklahoma.;;UPS Extends Capability of ICat Electronic Commerce Software, TanData Press Releases, Oct. 26, 1998, 2 pages, Atlanta.;;Andy Wang, ""FedEx and Netscape Build Shipping Portal"", E-Commerce Times, Apr. 8, 1999, 2 pages.;;Mary Hillebrand, ""Frorn2.Com Gives International E-Commerce A Hand"", E-Commerce Times, Jul. 9, 1999. 3 pages.;;Tim Wilson, ""Shippers Repackaged As E-Providers"", InformationWeek, Issue: 758, Section: Transportation Transformation: A Special Report From Internetweek, Oct. 25, 1999, 6 pages.;;James Hollander, UPS Boosts E-Commerce Strategy with New Web Tools, E-Commerce times, Apr. 6, 1999, 3 pages.;;Collection of Screen Printouts (Copyright © 2000) from ""anythingovernight.com"" referring to shipping product Shiplet, entitled ""Shiplet"", 4 pages, ""About Us"", 1 page, ""Shipping"", 1 page, ""Reporting"", 1 page, ""User Profile"" 1 page, ""Shipments to Me"", 1 page, and ""API"", 1 page.;;Lisa Corbin, ""Electronic Commerce Strategies"", Government Executive Magazine, Aug. 30, 1999, 5 pages.;;Computer Support, Inc. (CSI), p. 10 of 117 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;TradePoint Systems LLC, International Trade and Transportion, and Transportation Concepts and Services, Inc, (TCS), p. 19 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Carrier Quality Performance Software, p. 39 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Late Delivery Quality Monitor Software (for Federal Exress Shipments), p. 97 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Scheme Software Order Entry/Billing 5.0, p. 156 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Software for International Trade, p. 157 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998).;;Brandon Fleming, ""Hot List for Electronic Data Interchange (EDI)"", http://www.usatrade.gov/us/annarbor/hot-list-for EDI.htm. 9 pages, Copyright © 1999; Revised Feb. 1, 2000.;;Microsoft Corporation, ""Microsoft Internet Commerce Strategy: A Foundation for Doing Business on the Internet"", May 1997, 27 pages.;;Survey of E-Commerce Companies & Products: Business Logistics, Customer Service, Supply Chain Management, http://pages.hotbot.com/biz/jayml/BP9.html, 28 pages, Richard Karpinski, Appendix II Feb. 9, 1999 on p. 26.;;FedEx Standardizes on Netscape, News Source: Mountain View, Calif., Jane 11/PRNewswire; News Date Jun. 12, 1996 12:55 pm; Keywords: Federal Express, Electronic Commerce; 3 pages.;;Email Message; From SmartShip Online Support, To: smartshippers@smartship.com; Subject: You can ship online now! Sent: Tuesday, Dec. 15, 1998 11:53 AM: 1 page.;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine, California.;;Notice of Allowance for U.S. Appl. No. 09/820,292 dated Aug. 21, 2009, pp. 1-7, USPTO.;;Office Action for co-pending Canadian Patent Application No. 2,404,814, dated Mar. 18, 2010, pp. 1-12, Canadian Intellectual Property Office (CIPO).;;Office Action for co-pending Canadian Patent Application No. 2,404,814, dated Aug. 9, 2011, pp. 1-13, Canadian Intellectual Property Office (CIPO).;;Office Action for co-pending Canadian Patent Application No. 2,404,814, dated Jun. 18, 2012, pp. 1-5, Canadian Intellectual Property Office (CIPO).",EXPIRED
462,CA,A1,CA 2404814 A1,092-180-710-666-164,2001-10-04,2001,CA 2404814 A,2001-03-27,US 19269200 P;;US 19574800 P;;US 23210300 P;;US 0109852 W,2000-03-28,"APPARATUS, SYSTEMS AND METHODS FOR ONLINE, MULTI-PARCEL, MULTI-CARRIER, MULTI-SERVICE PARCEL RETURNS SHIPPING MANAGEMENT",Published without an,STAMPS COM INC,BILIBIN PAUL;;BENNETT DAVID ALLISON;;DIETZ JOHN M;;SMITH WILLIAM W III;;KRETT LORY ELIZABETH;;BEAN SCOTT JOSEPH;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;TEGLOVIC STEPHEN M;;ANTUSH RICHARD M;;MENTZER CHARLES D;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;WILLIAMS DANIEL F;;HU SEAN;;LIU JINYUE,,https://lens.org/092-180-710-666-164,Patent Application,no,0,5,15,43,0,G06Q10/08;;G06Q10/083;;G06Q10/0837;;G06Q30/0601;;G06Q10/08;;G06Q10/083;;G06Q30/0601;;G06Q10/0837,B65G61/00;;G06Q10/00,,0,0,,,,EXPIRED
463,JP,A,JP 2007328779 A,121-109-224-315-316,2007-12-20,2007,JP 2007141108 A,2007-05-28,US 19269200 P;;US 19574800 P;;US 23210300 P,2000-03-28,"APPARATUS, SYSTEM AND METHOD FOR ONLINE, MULTI-PARCEL, MULTI-CARRIER, MULTI-SERVICE PARCEL RETURNS SHIPPING MANAGEMENT","<P>PROBLEM TO BE SOLVED: To provide a computer system (System or Return System) that is configured and programmed to provide online stores with a fast, simple, convenient way for e-commerce customers of an online store to return merchandise purchased from that store from within that online store. <P>SOLUTION: The Return System 1 provides shipment estimate of multi-carriers 4a to 4n, shipment labeling, shipment tracking, shipment tracking management reports, returns analysis and returns management reporting. The Return System 1 has: (1) a Return Manager Subsystem; (2) a Consumer Return Subsystem (also sometimes referred to as a ""Customer Return Subsystem""); and (3) a Return Processing Subsystem that, in an exemplary embodiment, provides background shipping and tracking functionality. <P>COPYRIGHT: (C)2008,JPO&INPIT",ISHIP INC,WILLIAMS DANIEL F;;BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;GLAVIN DENNIS;;KRETT LORY ELIZABETH;;MENTZER CHARLES D;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH WILLIAM W III;;BILIBIN PAUL;;LIU JINYUE;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;ANTUSH RICHARD M;;BEAN SCOTT JOSEPH,,https://lens.org/121-109-224-315-316,Patent Application,no,0,7,15,43,0,G06Q10/08;;G06Q10/083;;G06Q10/0837;;G06Q30/0601;;G06Q10/08;;G06Q10/083;;G06Q30/0601;;G06Q10/0837,B65G61/00;;G06Q10/00,,0,0,,,,DISCONTINUED
464,US,A1,US 2005/0261228 A1,065-121-564-862-896,2005-11-24,2005,US 8919105 A,2005-03-23,US 8919105 A;;US 47696003 A;;US 0213871 W;;US 85152001 A;;US 66723603 A;;US 3833502 A;;US 29905899 A;;US 40388895 A;;US 9309297 W;;US 95418592 A;;US 0318312 W;;US 51273904 A;;US 0318320 W;;US 0318258 W;;US 18888302 A;;US 46415803 A;;US 85727801 A;;US 9913624 W;;US 20520498 A;;US 4827105 A;;US 19729002 A;;US 85729901 A;;US 9922083 W;;US 20514498 A;;US 7078902 A;;US 0000583 W;;US 39258099 A;;US 38810002 P;;US 38807402 P;;US 38811802 P,1992-09-29,Antisense modulation of interleukin 12 P35 subunit expression,"Compounds, compositions and methods are provided for modulating the expression of Interleukin 12 p35 subunit. The compositions comprise chemically modified antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Interleukin 12 p35 subunit. Methods of using these compounds for modulation of Interleukin 12 p35 subunit expression and for treatment of diseases associated with expression of Interleukin 12 p35 subunit are provided.",BENNETT C F;;BAKER BRENDA F;;FREIER SUSAN M;;GREGORY SUSAN;;HANECAK RONNIE C;;ANDERSON KEVIN P;;CHIANG MING-YI;;BROWN-DRIVER VICKIE L;;ECKER DAVID J;;VICKERS TIMOTHY;;WYATT JACQUELINE R;;MARCUSSON ERIC G;;DEAN NICHOLAS M;;BHANOT SANJAY;;ACKERMANN ELIZABETH J;;COWSERT LEX M,BENNETT C F;;BAKER BRENDA F;;FREIER SUSAN M;;GREGORY SUSAN;;HANECAK RONNIE C;;ANDERSON KEVIN P;;CHIANG MING-YI;;BROWN-DRIVER VICKIE L;;ECKER DAVID J;;VICKERS TIMOTHY;;WYATT JACQUELINE R;;MARCUSSON ERIC G;;DEAN NICHOLAS M;;BHANOT SANJAY;;ACKERMANN ELIZABETH J;;COWSERT LEX M,ISIS PHARMACEUTICALS INC (2005-04-29),https://lens.org/065-121-564-862-896,Patent Application,yes,0,0,5,286,88,A61K38/00;;C12N15/1136;;C12N2310/315;;C12N2310/321;;C12N2310/3341;;C12N2310/341;;C12N2310/346;;Y02P20/582;;C12N15/1136;;C12N2310/341;;C12N2310/346;;C12N2310/321;;C12N2310/3341;;A61K38/00;;C12N2310/315;;Y02P20/582,A61K38/00;;A61K48/00;;C07H21/04;;C12N15/113;;C12N15/85,514/44;;435/455;;536/23.5,0,0,,,,DISCONTINUED
465,US,B1,US 8255337 B1,160-190-299-767-152,2012-08-28,2012,US 65271010 A,2010-01-05,US 65271010 A;;US 68486600 A;;US 15817999 P;;US 17018699 P;;US 17050499 P;;US 19269200 P;;US 19272300 P;;US 19389900 P;;US 19574800 P,1999-10-06,"Apparatus, systems and methods for online, multi-carrier, multi-service parcel shipping management","The present invention provides apparatus, systems and methods providing a single system available over a global communications network for shipping management for each parcel from a plurality of parcels that each Shipper of a plurality of Shippers ships using any one of a plurality of services offered by any one of a plurality of carriers.",BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;BILIBIN PAUL;;LIU JINYUE;;MENTZER CHARLES D;;KRETT LORY ELIZABETH;;BEAN SCOTT JOSEPH;;WILLIAMS DANIEL F;;GLAVIN DENNIS;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;MAIER JR HARLAND FRED;;INGRAM GARY RHOE;;STAMPS COM INC;;ISHIP INC,BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;BILIBIN PAUL;;LIU JINYUE;;MENTZER CHARLES D;;KRETT LORY ELIZABETH;;BEAN SCOTT JOSEPH;;WILLIAMS DANIEL F;;GLAVIN DENNIS;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;MAIER JR HARLAND FRED;;INGRAM GARY RHOE,,https://lens.org/160-190-299-767-152,Granted Patent,yes,114,18,12,43,0,G06Q10/025;;G06Q10/063;;G06Q10/0631;;G06Q10/06311;;G06Q10/08;;G06Q10/083;;G06Q10/0833;;G06Q10/0834;;G06Q10/08345;;G06Q10/0835;;G06Q10/10;;G06Q10/1093;;G06Q10/10;;G06Q10/025;;G06Q10/08345;;G06Q10/0833;;G06Q10/0631;;G06Q10/1093;;G06Q10/06311;;G06Q10/063;;G06Q10/0834;;G06Q10/083;;G06Q10/08;;G06Q10/0835,G06Q30/00;;G06Q10/00,705/333,107,0,,,"""Payne Debuts Network"" Traffic World, v 249, n 3, p. 48. Jan. 13, 1997.;;PRNewswire: ""TanData(TM) Corporation Announces Progistics CS(TM), Their Newest, Internet-Enabled Shipping and Rating Software""; Jul. 21, 1997.;;""After Disconnection from Internet or Recovery from Error, Return to Uniform Resource Locator"": IBM Technical Disclosure Bulletin, October 1, 1997, vol. 40, No. 10, pp. 153-154.;;PRNewswire: ""WorldWide Merchant Announces InterShipper 4.0 'The Internet Sipping Center'""; Mar. 23, 1999.;;iShip.com: ""Enterprise Desktop Client Functional Specifications""; iShip.com Inc., Fifth Floor 3535 FActoria Blvd. Bellevue, Washington 98006, pp. 1-108, No Date, showing in brackets material redacted under 37 CFR 1.217.;;Williams, Martyn, Internet Update, Feb. 18, 1998, Newsbytes, pp. 1-3.;;Brown, Judy, As Web pages proliferate, finding what you're after gets more difficult, Feb. 8, 1999, Milwaukee Journal Sentinel (Wisconsin), Business p. 2 Connected, pp. 1-2.;;Web Site Offers Money-Saving Service for Free; Save Money by Calculating Actual Shipping Costs, Feb. 16, 1998, Business Wire, pp. 1-2.;;David Allison Bennett, et al., ""Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management,"" U.S. Appl. No. 12/683,071, filed Jan. 6, 2010, pp. 1-211 (specification pp. 1-96, claims p. 97-111; abstract p. 112, drawings 113-204, and preliminary amendment pp. 205-211).;;Telemanagement software: buyers guide (includes related articles on specific products and software selection tips) (Teleconnect Roundup) (Buyers Guide). Teleconnect, v10, n6, p. 108 (33), Jun. 1992; ISSN 0740-9354; pp. 1-28.;;Justin Hibbard, Outsourcing: A Web Site Option-Vendors Offer Services Such as Payment Processing And Shipping (Company Business and Marketing). Information Week, p. 20(1), Jan, 25, 1999; ISSN 8750-6874; pp. 1-3.;;Office Action for U.S. Appl. No. 09/684,010 dated Sep. 1, 2009, pp. 1-19, USPTO.;;Interview Summary for U.S. Appl. No. 09/684,010 dated Nov. 3, 2009, pp. 1-4, USPTO.;;Notice of Allowance for U.S. Appl. No. 09/684,010 dated May 3, 2010, pp. 1-10, USPTO.;;Appeal Decision for U.S. Appl. No. 09/684,871 dated May 28, 2010, pp. 1-11, USPTO.;;Office Action for U.S. Appl. No. 09/684,869 dated Aug. 18, 2009, pp. 1-18, USPTO.;;Office Action for U.S. Appl. No. 09/684,869 dated Dec. 23, 2009, pp. 1-14, USPTO.;;Office Action for U.S. Appl. No. 09/684,869 dated Jul. 7, 2010, pp. 1-27, USPTO.;;Administrative Patent Judge Hubert C. Lorin, Board of Patent Appeals and Interferences, Decision on Appeal for U.S. Appl. No. 09/685,077, dated Jan. 21, 2010, pp. 1-24, USPTO.;;Notice of Allowance for U.S. Appl. No. 09/685,077, dated May 19, 2010, pp. 1-10, USPTO.;;Administrative Patent Judge Joseph A. Fischetti, Board of Patent Appeals and Interferences, Decision on Appeal for U.S. Appl. No. 09/684,861, dated Nov. 30, 2009, pp. 1-19, USPTO.;;Administrative Patent Judge Joseph A. Fischetti, Board of Patent Appeals and Interferences, Decision on Request for Rehearing for U.S. Appl. No. 09/684,861, dated Aug. 5, 2010, pp. 1-12, USPTO.;;Office Action for U.S. Appl. No. 09/684,866, dated Mar. 11, 2004, pp. 1-43, USPTO.;;Office Action for U.S. Appl. No. 09/684,866, dated Mar. 7, 2005, pp. 1-73, USPTO.;;Office Action for U.S. Appl. No. 09/684,866, dated Jan. 11, 2006, pp. 1-83, USPTO.;;Office Action for U.S. Appl. No. 09/684,866, dated May 4, 2006, pp. 1-17, USPTO.;;Office Action for U.S. Appl. No. 09/684,866, dated Nov. 30, 2006, pp. 1-20, USPTO.;;Office Action for U.S. Appl. No. 09/684,866, dated Jun. 4, 2007, pp. 1-22, USPTO.;;Office Action for U.S. Appl. No. 09/684,866, dated Mar. 6, 2008, pp. 1-24, USPTO.;;Office Action for U.S. Appl. No. 09/684,866, dated Mar. 31, 2009, pp. 1-18, USPTO.;;Notice of Allowance for U.S. Appl. No. 09/684,866, dated Oct. 1, 2009, pp. 1-14, USPTO.;;Office Action for U.S. Appl. No. 10/838,031, dated Jun. 10, 2009, pp. 1-34, USPTO.;;Office Action for U.S. Appl. No. 10/838,031, dated Dec. 23, 2009, pp. 1-18, USPTO.;;Office Action for U.S. Appl. No. 10/838,031, dated Apr. 13, 2010, pp. 1-11, USPTO.;;Office Action for U.S. Appl. No. 11/895,994, dated Sep. 2, 2009, pp. 1-36, USPTO.;;Notice of Allowance for U.S. Appl. No. 11/895,994, dated Feb. 24, 2010, pp. 1-11, USPTO.;;Notice of Allowance for U.S. Appl. No. 11/895,994, dated Apr. 28, 2010, pp. 1-9, USPTO.;;Business Wire; ""InterShipper Shares Website with BusinessWeek Online Magazine;"" Oct. 9, 1998; pp. 1-3.;;Canna, Elizabeth; ""A supermarket for transport services,"" American Shipper; May 1992; p. 45(4) (online reprint pp. 1-6); vol. 34, No. 5; Howard Publications Inc.;;Press Releases, http://web.archive.org/web/20000325012459/http://www.wwmerchant.com/pressreleases.asp, (dated Oct. 13, 1997; Feb. 16, 1998; May 15, 1998; Mar. 4, 1999); World Wide Merchant; Tempe AZ; pp. 1-4.;;""TanData and iCat allow you to 'pick how you ship'; TanData announces Progistics.Merchant shipping and handling component for latest version of iCat's Electronic Commerce Suite, 3.0,"" Business Wire, Feb. 10, 1997, Tulsa, Okla.; http://www.thefreelibrary.com/-/print/PrintArticle.aspx?id=19102027, pp. 1-2.;;Kranberg, Susan, ""Online Retailing Explosion Hits the Tranquil College Textbook Market,"" Publishers Weekly, New York, NY; May 3, 1998, vol. 246, Iss. 18; p. 20, 3 pgs, (online reprint pp. 1-5).;;Ogg, et al.; U.S. Appl. No. 09/651,390 (titled ""Virtualized Printing of Indicia, Logos and Graphics""), filed Aug. 29, 2000; pages-throughout.;;Ogg, et al.; U.S. Appl. No. 09/651,389 (titled ""Method and Apparatus for Printing Indicia Logos and Graphics Onto Print Media""), filed Aug. 29, 2000; pages-throughout.;;Williams, et al.; Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Parcel Returns Shipping Management; U.S. Appl. No. 09/820,292, filed on Mar. 27, 2001; pages-throughout.;;Williams, et al.; Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Enterprise Parcel Shipping Management; U.S. Appl. No. 09/820,377, filed Mar. 27, 2001; pages-throughout.;;Smith, III, et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed on Oct. 6, 3000; pp. 1-3 and 98-106.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed on Oct. 6, 2000; pp. 1-3 and 98-104.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multl-Service parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed on Oct. 6, 2000; pp. 1-3 and 98-108.;;Hu, et al.; Apparatus, Systems and Methods for Interfacing with Digital Scales Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000; pp. 1-3 and 98-103.;;Bennett, et al.; Reporting Shipping Rates and Delivery Schedules for Multiple Service and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2000; pp. 1-3 and 98-112.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000; pp. 1-6 and 100-117.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Delivery Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/680,649, filed Oct. 6, 2000; pp. 1-7 and 102-123.;;Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Rate and Delivery Schedule Comparison for Multiple Carriers; U.S. Appl. No. 09/680,654, filed Oct. 6, 2000; pp. 1-4 and 100-124.;;Bennett, et al.; Apparatus, Systems and Methods for Applying Billing Options for Multiple Carriers for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,865, filed Oct. 6, 2000; pp. 1-3 and 98-104.;;Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000; pp. 1-5 and 100-116.;;Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6, 2000; pp. 1-3 and 97-100.;;Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000; pp. 1-3 and 97-100.;;Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accurate Symbologies on Laser Printers Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,152, filed Oct. 6, 2000; pp. 1-3 and 98-110.;;Appendix A (throughout) to U.S. Appl. No. 09/820,377, Williams et al. (titled: Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Enterprise Parcel Shipping Management) filed Mar. 27, 2001, submitted in Accordance with MPEP § 724.02 showing in brackets material redacted under 37 C.F. R.§ 1.217.;;Declaration by John Dietz, entitled ""Verified Statemnet (Declaration) Number 1 in Support of Information Disclosure Statement in U.S. Appl. Nos. 09/684,010, 09/684,871, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,152, 09/684,866, 09/820,377, and 09/820,292"", executed Jul. 20, 2001, pp. 1-8 (with Exhibits A-J attached).;;Declaration by John Dietz, entitled ""Verified Statement (Declaration) Number 2 in Support of Information Disclosure Statement in U.S. Appl. Nos. 09/684,010, 09/684,871, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,152, 09/684,866, 09/820,377, and 09/820,292"" executed Jul. 20, 2011, pp. 1-6 (with Exhibits A and B attached).;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", SmartShip.com Press Release, Apr. 3, 2000, 2 pages, Irvine California.;;Kewill Systems, Inc., ""Kewill Systems PLC Acquires Leading U.S. Shipping and Receiving E-Commerce Software Firm for $18 Million"", Aristo Computers Press Releases and Product Development, Jul. 27, 1999, pp. 1-3 of 13, Marlborough, Mass.;;Kewill Systems, Inc.""USPS Delivery Confirmation Support Now Available in Aristo's Economical APSS® Lite Shipping System"", Aristo Computers Press Releases and Product Development, Jun. 23, 1999, p. 3 of 13., Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified by USPS to Support New Express Mail Manifesting"", Aristo Computers Press Releases and Product Development, Jun. 21, 1999, pp. 3 and 4 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified UPS OnLine® Compatible to Support UPS International Shipping"", Aristo Computers Press Releases and Product Development, May 12, 1999, pp. 4 and 5 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System® Certified to Fully Support FedEx PowerShip®Server, "" Aristo Computers Press Releases and Product Development, May 10, 1999, pp. 5 and 6 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Names AllPoints Systems Strategic Partner"" AllPoints Systems to Integrate Aristo shipping functionality into its Demand Chian Software, Aristo Computers Press Releases and Product Development, Apr. 13, 1999, pp. 6 and 7 of 13, Beaverton, Oregon and Dedham, Massatuchutes.;;Kewill Systems, Inc., ""Midgard Information Systems and Aristo-Integrated Shipping Solutions for Today's Marketplace"" Aristo Computers Press Releases and Product Development Jan. 19, 1999, pp. 7-9 of 13, Charlotte, North Carolina.;;Kewill Systems, Inc., ""Aristo's OLE Server Provides Shipping & Manifesting Engine for Third Party Developers"", Aristo Computers Press Releases and Product Development, Jul. 28, 1998, pp. 9 and 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Adds New Economical Shipping Solution to Its Product Line"", Aristo Computers Press Releases and Product Development, Apr. 30, 1998, p. 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo announces latest APSS® developments!"", Aristo Computers Press Releases and Product Development, Jun. 9, 1997, pp. 10 and 11 of 13, Beaverton, Oregon.;;Kewill Systems, Inc. ""Aristo launches APSS® for Windows"", Aristo Computers Press Releases and Product Development, Oct. 20, 1996, pp. 11-13 of 13, Beaverton, Oregon.;;""Netscape and FDX Unveil Plans for Next Generation Internet Package Delivery Center"", Netscape Press Release, Apr. 7, 1999, 3 pages, Mt.View, California and Memphis, Tennessee.;;""TanData Announces Release of ChainLink(TM) Applications Suite"" TanData Press Release, Dec. 8, 1999, 2 pages, Tulsa, Oklahoma.;;UPS Extends Capability of iCat Electronic Commerce Software, TanData Press Release, Oct. 26, 1998, 2 pages, Atlanta, Georgia.;;Andy Wang, ""FedEx and Netscape Build Shipping Portal"", E-Commerce Times, Apr. 8, 1999, 2 pages.;;Mary Hillebrand, ""From2.Com Gives International E-Commerce A Hand"", E-Commerce Times, Jul. 9, 1999, 3 pages.;;Tim Wilson, ""Shippers Repackaged As E-Providers"", InformationWeek, Issue: 758, Section: Transportation Transformation: A Special Report From Internetweek, Oct. 25, 1999, 6 pages.;;James Hollander, UPS Boosts E-Commerce Strategy with New Web Tools, E-Commerce Times, Apr. 6, 1999, 3 pages.;;Collection of Screen Printouts (undated) from ""anythingovernight.com"" referring to shipping product Shiplet, entitled ""Shiplet"", 4 pages, ""About Us"", 1 page, ""Shipping"", 1 page, ""Reporting"", 1 page, ""User Profile"" 1 page, ""Shipments to Me"", 1 page, and ""API"", 1 page.;;Lisa Corbin, ""Electronic Commerce Strategies"", Government Executive Magazine, Aug. 30, 1999, 5 pages.;;Computer Support, Inc. (CSI), p. 10 of 117 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;TradePoint Systems LLC, International Trade and Transportion, and Transportation Concepts and Services, Inc. (TCS), p. 19 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Carrier Quality Per formance Software, p. 39 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Late Delivery Quality Monitor Software (for Federal Exress Shipments) p. 97 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Scheme Software Order Entry/Billing 5.0 p. 156 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Software for International Trade p. 157 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Brandon Fleming, ""Hot List for Electronic Data Interchange (EDI)"", http://www.usatrade.gov/us/annarbor/hot-list-for-EDI.htm, 9 pages, © 1999; Revised Feb. 1, 2000.;;Microsoft Corporation, ""Microsoft Internet Commerce Strategy: A Foundation for Doing Business on the Internet"", May 1997, 27 pages.;;Survey of E-Commerce Companies & Products: Business Logistics, Customer Service, Supply Chain Management, http://pages.hotbot.com/biz/jayml/BP9.html, 28 pages, Richard Karpinski, Appendix II Feb. 9, 1999 on p. 26.;;FedEx Standardizes on Netscape, News Source: Mountain View, Calif., Jun. 11/PRNewswire; News Date Jun. 12, 1996 12:55 pm; Keywords: Federal Express, Electronic Commerce; 3 pages.;;Email Message; From SmartShip Online Support, To: smartshippers@smartship.com; subject: You can ship online now! Sent: Tuesday, Dec. 15, 1998 11:53 am; 1 page.;;Examiner Michael A. Cuff, Art Unit 3627, United States Patent Office; Office Action dated May 3, 2006 for Hu, et al.; Apparatus, Systems And Methods For Interfacing With Digital Scales Configured With Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 13, 2006 for Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Dec. 7, 2005 for Smith et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jan. 27; 2006 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684, 871, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 18, 2005 for Bennett et al.; Apparatus, Systems, and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 17, 2005 for Hu, et al.; Apparatus, Systems and Methods for Interfacing With Digital Scales Configured With Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Dec. 9, 2005 for Bennett, et al.; Reporting Shipping Rates and Delivery Schedules for Multiple Services and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jan. 27, 2006; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Rate and Delivery Schedule Comparison for Multiple Carriers; U.S. Appl. No. 09/680,654, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 17, 2005 for Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Dec. 20, 2005 for Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for Each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000.;;White, Ron; ""How Computers Work""; 1999, pp. 214-215.;;FedEx, www.FedEx.com, Jan. 12, 1998 [retrieved Dec. 12, 2005], pp. 1-15, retrieved from: Google.com and archive.org.;;Microsoft and iShip.com make comparing shipping services Easy on MSN.com, PR Newswire, Nov. 4, 1998 (retreived Jun. 29, 2005) pp. 1-2, retreived from: Dialog, file 20.",EXPIRED
466,US,B1,US 7664651 B1,043-467-496-973-85X,2010-02-16,2010,US 68486600 A,2000-10-06,US 68486600 A;;US 15817999 P;;US 17018699 P;;US 17050499 P;;US 19269200 P;;US 19272300 P;;US 19389900 P;;US 19574800 P,1999-10-06,"Apparatus, systems and methods for online, multi-carrier, multi-service parcel shipping management","The present invention provides apparatus, systems and methods providing a single system available over a global communications network for shipping management for each parcel from a plurality of parcels that each Shipper of a plurality of Shippers ships using any one of a plurality of services offered by any one of a plurality of carriers.",STAMPS COM INC;;ISHIP INC,BENNETT DAVID ALLISON;;GOLDHABER LYNN SHAINDELL;;BILIBIN PAUL;;LIU JINYUE;;MENTZER CHARLES D;;KRETT LORY ELIZABETH;;BEAN SCOTT JOSEPH;;WILLIAMS DANIEL F;;GLAVIN DENNIS;;TEGLOVIC STEPHEN M;;DIETZ JOHN M;;SMITH III WILLIAM W;;MCLAUGHLIN PAUL R;;MEYER SCOTT;;HU SEAN;;MAIER JR HARLAND FRED;;INGRAM GARY RHOE,STAMPS.COM INC (2000-11-29),https://lens.org/043-467-496-973-85X,Granted Patent,yes,106,38,12,43,0,G06Q10/025;;G06Q10/063;;G06Q10/0631;;G06Q10/06311;;G06Q10/08;;G06Q10/083;;G06Q10/0833;;G06Q10/0834;;G06Q10/08345;;G06Q10/0835;;G06Q10/10;;G06Q10/1093;;G06Q10/10;;G06Q10/025;;G06Q10/08345;;G06Q10/0833;;G06Q10/0631;;G06Q10/1093;;G06Q10/06311;;G06Q10/063;;G06Q10/0834;;G06Q10/083;;G06Q10/08;;G06Q10/0835,G06Q30/00;;G06F17/00;;G06Q10/00,705/1;;705/401,106,1,077-054-936-811-415,10.1016/b978-1-85573-345-9.50021-2,"PRNewswire: ""TanData(TM) Corporation Announces Progistics CS(TM), Their Newest, Internet-Enabled Shipping and Rating Software""; Jul. 21, 1997.;;""After Disconnection from Internet or Recovery from Error, Return to Uniform Resource Locator"": IBM Technical Disclosure Bulletin, Oct. 1, 1997, vol. 40, No. 10, pp. 153-154.;;PRNewswire: ""WorldWide Merchant Announces InterShipper 4.0 'The Internet Sipping Center'""; Mar. 23, 1999.;;iShip.com: ""Enterprise Desktop Client Functional Specifications""; iShip.com Inc., Fifth Floor 3535 FActoria Blvd. Bellevue, Washington 98006, pp. 1-108, No Date, showing in brackets material redacted under 37 CFR 1.217.;;Williams, Martyn, Internet Update, Feb. 18, 1998, Newsbytes, pp. 1-3.;;Brown, Judy, As Web pages proliferate, finding what you're after gets more difficult, Feb. 8, 1999, Milwaukee Journal Sentinel (Wisconsin), Business p. 2 Connected, pp. 1-2.;;Web Site Offers Money-Saving Service for Free; Save Money by Calculating Actual Shipping Costs, Feb. 16, 1998, Business Wire, pp. 1-2.;;Declaration by John Dietz, entitled ""Verified Statement (Declaration) No. 1 in Support of Information Disclosure Statement in U.S. Appl. Nos. 09/684,010, 09/684,871, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,152, 09/684,866, 09/820,377, and 09/820,292"", executed Jul. 20, 2001, pp. 1-8 (with Exhibits A-J attached).;;Declaration by John Dietz, entitled ""Verified Statement (Declaration) No. 2 in Support of Information Disclosure Statement in U.S. Appl. Nos. 09/684,010, 09/684,871, 09/684,870, 09/684,808, 09/684,869, 09/685,078, 09/680,649, 09/680,654, 09/684,865, 09/685,077, 09/684,014, 09/684,861, 09/684,152, 09/684,866, 09/820,377, and 09/820,292"", executed Jul. 20, 2001, pp. 1-6 (with Exhibits A and B attached).;;""Smartship.com Announces Multi-Carrier Shipping and Tracking Function for E-Commerce"", Smartship.com Press Release, Apr. 3, 2000, 2 pages, Irvine California.;;Kewill Systems, Inc., ""Kewill Systems PLC Acquires Leading U.S. Shipping and Receiving E-Commerce Software Firm for $18 Million"", Aristo Computers Press Releases and Product Development, Jul. 27, 1999, pp. 1-3 of 13, Marlborough, Mass.;;Kewill Systems, Inc., ""USPS Delivery Confirmation Support Now Available in Aristo's Economical APSS(R) Lite Shipping System"", Aristo Computers Press Releases and Product Development, Jun. 23, 1999, p. 3 of 13. , Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System(R) Certified by USPS to Support New Express Mail Manifesting"", Aristo Computers Press Releases and Product Development, Jun. 21, 1999, pp. 3 and 4 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System(R) Certified UPS OnLine(R) Compatible to Support UPS International Shipping"", Aristo Computers Press Releases and Product Development, May 12, 1999, pp. 4 and 5 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Parcel Shipping System(R) Certified to Fully Support FedEx PowerShip(R) Server,""Aristo Computers Press Releases and Product Development, May 10, 1999, pp. 5 and 6 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Names AllPoints Systems Strategic Partner"" AllPoints Systems to Integrate Aristo shipping functionality into its Demand Chian Software, Aristo Computers Press Releases and Product Development, Apr. 13, 1999, pp. 6 and 7 of 13, Beaverton, Oregon and Dedham, Massatuchutes.;;Kewill Systems, Inc., ""Midgard Information Systems and Aristo-Integrated Shipping Solutions for Today's Marketplace"", Aristo Computers Press Releases and Product Development Jan. 19, 1999, pp. 7-9 of 13, Charlotte, North Carolina.;;Kewill Systems, Inc., ""Aristo's OLE Server Provides Shipping & Manifesting Engine for Third Party Developers"", Aristo Computers Press Releases and Product Development, Jul. 28, 1998, pp. 9 and 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo Computers Adds New Economical Shipping Solution to Its Product Line"", Aristo Computers Press Releases and Product Development, Apr. 30, 1998, p. 10 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo announces latest APSS(R) developments!"", Aristo Computers Press Releases and Product Development, Jun. 9, 1997, pp. 10 and 11 of 13, Beaverton, Oregon.;;Kewill Systems, Inc., ""Aristo launches APSS(R) for Windows"", Aristo Computers Press Releases and Product Development, Oct. 20, 1996, pp. 11-13 of 13, Beaverton, Oregon.;;""Netscape and FDX Unveil Plans for Next Generation Internet Package Delivery Center"", Netscape Press Release, Apr. 7, 1999, 3 pages, Mt.View, California and Memphis, Tennessee.;;""TanData Announces Release of ChainLink(TM) Applications Suite"" TanData Press Release, Dec. 8, 1999, 2 pages, Tulsa, Oklahoma.;;UPS Extends Capability of iCat Electronic Commerce Software, TanData Press Release, Oct. 26, 1998, 2 pages, Atlanta, Georgia.;;Andy Wang, ""FedEx and Netscape Build Shipping Portal"", E-Commerce Times, Apr. 8, 1999, 2 pages.;;Mary Hillebrand, ""From2.Com Gives International E-Commerce A Hand"", E-Commerce Times, Jul. 9, 1999, 3 pages.;;Tim Wilson, ""Shippers Repackaged As E-Providers"", InformationWeek, Issue: 758, Section: Transportation Transformation: A Special Report From Internetweek, Oct. 25, 1999, 6 pages.;;James Hollander, UPS Boosts E-Commerce Strategy with New Web Tools, E-Commerce Times, Apr. 6, 1999, 3 pages.;;Collection of Screen Printouts (undated) from ""anythingovernight.com"" referring to shipping product Shiplet, entitled ""Shiplet"", 4 pages, ""About Us"", 1 page, ""Shipping"", 1 page, ""Reporting"", 1 page, ""User Profile"" 1 page, ""Shipments to Me"", 1 page, and ""API"", 1 page, Dec. 12, 2000.;;Lisa Corbin, ""Electronic Commerce Strategies"", Government Executive Magazine, Aug. 30, 1999, 5 pages.;;Computer Support, Inc. (CSI), p. 10 of 117 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;TradePoint Systems LLC, International Trade and Transportion, and Transportation Concepts and Services, Inc. (TCS), p. 19 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Carrier Quality Performance Software, p. 39 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Late Delivery Quality Monitor Software (for Federal Exress Shipments) p. 97 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Scheme Software Order Entry/Billing 5.0 p. 156 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Software for International Trade p. 157 of 177 listed in ""Electronic Data Interchange (EDI): Software Profiles"" Datapro, Jul. 1998) 177 pages.;;Brandon Fleming, ""Hot List for Electronic Data Interchange (EDI)"", satrade.gov/us/annarbor/hot-list-for -EDI.htm, 9 pages, (C) 1999; Revised Feb. 1, 2000.;;Microsoft Corporation, ""Microsoft Internet Commerce Strategy: A Foundation for Doing Business on the Internet"", May 1997, 27 pages.;;Survey of E-Commerce Companies & Products: Business Logistics, Customer Service, Supply Chain Management, pages.hotbot.com/biz/jayml/BP9.html, 28 pages, Richard Karpinski, Appendix II Feb. 9, 1999 on p. 26.;;FedEx Standardizes on Netscape, News Source: Mountain View, Calif., Jun. 11/PRNewswire; News Date Jun. 12, 1996 12:55 pm; Keywords: Federal Express, Electronic Commerce; 3 pages.;;Email Message; From SmartShip Online Support, To: smartshippers@smartship.com; subject: You can ship online now! Sent: Tuesday, Dec. 15, 1998 11:53 am; 1 page.;;The Gale Group, ""A 'Blue Chip' Mailroom Investment"", Modem Office Technology, Aug. 1984, p. 98., vol. 29.;;ABF Freight System, Inc. Announces the Release of Q-Rate(R) for Windows, May 26, 1999 (www.abfs.com/about/news/1999/p052699.asp?bhcp=1).;;FedEx(R) Services (.fedex. com) Archived on Jan. 16, 1997.;;Material Logistics System, (NN86091526) IBM Technical Disclosure Bulletin, Sep. 1986, US, vol. 26, Issue 4, Page Nos. 1526-1530.;;UPS Service Guide, (.upd.com) Archived on Dec. 6, 1998.;;United States Patent Office; Office Action dated Jul. 12, 2004 for Smith, et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Pct. 6, 2000.;;United States Patent Office; Office Action dated Oct. 21, 2003 for Smith, et al.; Online Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 24, 2004 for Bennett, et al.; Apparatus, Systems And Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 25, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jan. 13, 2004 for Bennett, et al; Reporting Shipping Rates and Delivery Schedules For Multiple Services and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 23, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 25, 2003 for Bennett, et al.;Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Delivery Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/680,649, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jul. 19, 2004 for Bennett, et al.;Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Delivery Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/680,649, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 31, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Rate and Delivery Schedule Comparison for Multiple Carriers; U.S. Appl. No. 09/680,654, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 18, 2002 for Bennett, et al.; Apparatus, Systems, and Methods for Applying Billing Options for Multiple Carriers for Online, Multi-Carrier, Multi-Service Parcel Shipping Management; U.S. Appl. No. 09/684,865, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 26, 2004 for Bilbin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/684,077, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Feb. 18, 2004 for Bilbin, et al.; Apparatus, Systems and Methods for Zone Level Rating for Each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Dec. 24, 2003 for Bilbin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for Each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Sep. 13, 2004 for Bilbin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for Each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jul. 6, 2004 for Sean Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accurate Symbologies on Laser Printers Configured with Remote Client Computer Devices; U.S. Appl. No. 09/684,152, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Apr. 5, 2004 for Williams, et al.; Apparatus, Systems and Methods for Online, Multi-Parcel, Multi-Carrier, Multi-Service Enterprise Parcel Shipping Management; U.S. Appl. No. 09/820,377, filed Mar. 27, 2001.;;United States Patent Office; Office Action dated Dec. 7, 2005 for Smith et al.: Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jan. 27, 2006 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 18, 2005 for Bennett et al.; Apparatus, Systems, and Methods For Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 17, 2005 for Hu, et al.; Apparatus, Systems And Methods For Interfacing With Digital Scales Configured With Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Dec. 9, 2005 for Bennett, et al.; Reporting Shipping Rates and Delivery Schedules for Multiple Services and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jan. 27, 2006; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Rate and Delivery Schedule Comparison for Multiple Carriers; U.S. Appl. No. 09/680,654, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 17, 2005 for Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Dec. 20, 2005 for Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for Each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000.;;White, Ron; ""How Computers Work""; 1999, pp. 214-215.;;FedEx, www.FedEx.com, Jan. 12, 1998 [retrieved Dec. 12, 2005], pp. 1-15, retrieved from: Google.com and archive.org.;;Microsoft and iShip.com make comparing shipping services Easy on MSN.com, PR Newswire, Nov. 4, 1998 (retreived Jun. 29, 2005) pp. 1-2, retreived from: Dialog, file 20.;;U.S. Postal Service, www.usps.com, Apr. 28, 1999, pp. 1-20, [reported in PTO-892 for, U.S. Patent Office, form U.S. Appl. No. 09/684,861 as retrieved Jun. 29, 2005; reported as retrieved from: Google.com and archive.org].;;UPS Offers Free Shipping Cost Calculator Software, Newsbytes News Network, Feb. 8, 1996, pp. 1-2, [reported in PTO-892 form, U.S. Patent Office, for U.S. Appl. No. 09/684,861 as retrieved Jun. 29, 2005; reported as retrieved from Dialog, file 9].;;""iship.com raises 3.4 Million"", PR Newswire, Jul. 20, 1998, pp. 1-2, [reported in PTO-892 form, U.S. Patent Office, for U.S. Appl. No. 09/684,861 as retrieved Jun. 29, 2005; reported as retrieved from Dialog, file 20].;;iship.com launches first complete web-based shipping service, PR Newswire, Jan. 18, 1999, pp. 1-4, [reported in PTO-892 form, U.S. Patent Office, for U.S. Appl. No. 09/684,861, as retrieved Jun. 29, 2005; reported as retrieved from: Proquest Direct].;;United States Patent Office; Office Action dated Aug. 1, 2005 for Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed Oct. 6, 2000.;;United States Patent Office: Office Action dated Aug. 1, 2005 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000.;;United States Patent Office: Office Action dated Aug. 3, 2005 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Rate and Delivery Schedule Comparison for Multiple Carriers; U.S. Appl. No. 09/680,654, filed Oct. 6, 2000.;;United States Patent Office: Office Action dated Jul. 6, 2005 for Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for Each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000.;;United States Patent Office: Office Action dated Aug. 1, 2005 for Hu, et al.; Apparatus, Systems and Methods for Printing Dimensionally Accrate Symbologies On Laser Printers Configured With Remote Client Computer Devices; U.S. Appl. No. 09/684,152, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 7, 2005 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated May 27, 2005 for Bennett, et al.; Apparatus, Systems and Methods For Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Apr. 25, 2005 for Hu, et al.; Apparatus, Systems, And Methods For Interfacing With Digital Scales Configured With Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 7, 2005 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison for Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated May 20, 2005 for Bilibin, et al.; Apparatus, Systems and Methods fo Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000.;;United States Patent Office: Office Action dated Mar. 4, 2005 for Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for Each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6, 2000.;;Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for Each of Multiple Carriers; U.S. Appl. No. 11/123,536, filed May 7, 2005 (a divisional of U.S. Appl. No. 09/684,014); pp. 1-3 and 97-100.;;United States Patent Office; Office Action dated May 3, 2006 for Hu, et al.; Apparatus, Systems And Methods For Interfacing With Digital Scales Configured With Remote Client Computer Devices; U.S. Appl. No. 09/684,808, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Mar. 13, 2006 for Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000.;;McCandless, Michael, Let's Go Shopping, IEEE Intelligent Systems, Jan./Feb. 1999, pp. 2-4, United States.;;Yesil, Magdalena, Creating the Virtual Store, 1997, pp. 188-189, United States.;;Kosiur, David, Understanding Electronic Commerce, Strategic Technology Series, 1997, pp. 16-18, United States.;;Office Action for co-pending case U.S. Appl. No. 09/684,869, dated Dec. 10, 2008, pp. 1-13, USPTO.;;Examiner's Answer for co-pending case U.S. Appl. No. 09/685,078, dated Dec. 16, 2008, pp. 1-18, USPTO.;;Second Examiner's Answer for co-pending case U.S. Appl. No. 09/685,077, dated Dec. 9, 2008, pp. 1-16, USPTO.;;United States Patent Office: Office Action dated Feb. 2, 2005 for Smith, et al.; Online, Multi-Carrier, Multi-Service Parcel Shipping Management Functional Alignment of Computer Devices; U.S. Appl. No. 09/684,010, filed Oct. 6, 2000.;;United States Patent Offie; Office Action dated Dec. 7, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Location Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,871, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 29, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Parcel Handling Rules Comparison Across Multiple Carriers; U.S. Appl. No. 09/684,870, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jan. 13, 2005 for Bennett, et al; Reporting Shipping Rates and Delivery Schedules For Multiple Services and Multiple Carriers; U.S. Appl. No. 09/684,869, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 30, 2004 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Notification Service Option Comparison For Multiple Carriers; U.S. Appl. No. 09/685,078, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Feb. 4, 2005 for Bennett, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Featuring Shipping Rate and Delivery Schedule Comparison for Multiple Carriers; U.S. Appl. No. 09/680,654, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Nov. 29, 2004 for Bilibin, et al.; Apparatus, Systems and Methods for Online, Multi-Carrier, Multi-Service Parcel Shipping Management Determination of Ratable Weight for Multiple Carriers; U.S. Appl. No. 09/685,077, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Dec. 7, 2004 for Bilibin, et al.; Apparatus, Systems and Methods for Zone Level Rating for Each of Multiple Carriers; U.S. Appl. No. 09/684,014, filed Oct. 6, 2000.;;United States Patent Office; Office Action dated Jan. 11, 2005 for Bilibin, et al.; Apparatus, Systems and Methods for Determining Delivery Time Schedules for Each of Multiple Carriers; U.S. Appl. No. 09/684,861, filed Oct. 6, 2000.",EXPIRED
467,US,A1,US 2006/0154885 A1,018-694-756-687-707,2006-07-13,2006,US 7284605 A,2005-03-04,US 7284605 A;;US 17291102 A;;US 31724902 A;;US 64313003 A;;US 87000201 A;;US 57555400 A;;US 12849498 A;;US 88929697 A;;US 41173495 A;;US 9309346 W;;US 95813492 A;;US 799693 A;;US 6712502 A;;US 16710998 A;;US 11151003 A;;US 0029223 W;;US 42909399 A;;US 43019603 A;;US 92351701 A;;US 36441699 A;;US 83720197 A;;US 69556803 A;;US 66626900 A;;US 84447004 A;;US 86989402 A;;US 9929593 W;;US 22656899 A;;US 0318707 W;;US 63930003 A;;US 19967602 A;;US 18847002 A;;US 66345103 A;;US 65986000 A;;US 64303803 A;;US 86586601 A;;US 44637303 A;;US 95331801 A;;US 90615801 A;;US 31651502 A;;US 18877702 A;;US 66702203 A;;US 16078602 A;;US 99114704 A;;US 34875003 A;;US 16049702 A;;US 46415803 A;;US 85727801 A;;US 9913624 W;;US 20520498 A;;US 46700804 A;;US 0202805 W;;US 78004501 A;;US 46712604 A;;US 0203848 W;;US 78004901 A;;US 47602104 A;;US 0213141 W;;US 84463401 A,1992-10-05,Modulation of SLC26A2 expression,"Compounds, compositions and methods are provided for modulating the expression of SLC26A2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding SLC26A2. Methods of using these compounds for modulation of SLC26A2 expression and for diagnosis and treatment of disease associated with expression of SLC26A2 are provided.",BENNETT C F;;MONIA BRETT P;;DEAN NICHOLAS M;;XU XIAOXING S;;BHANOT SANJAY;;BAKER BRENDA F;;FREIER SUSAN M;;COWSERT LEX M;;MCKAY ROBERT;;MANOHARAN MUTHIAH;;DORR F A;;HOLMLUND JON;;BORCHERS ALEXANDER H;;BROWN-DRIVER VICKIE L;;WYATT JACQUELINE R;;FLOURNOY SHIN C;;ACKERMANN ELIZABETH J;;ZHANG HONG;;WATT ANDREW T;;MARACUSSON ERIC G;;COOPER SCOTT;;KOLLER ERICH;;MIRAGLIA LOREN;;RICKETTS WILLIAM;;DOBIE KENNETH W;;SIPES TAMARA B,BENNETT C F;;MONIA BRETT P;;DEAN NICHOLAS M;;XU XIAOXING S;;BHANOT SANJAY;;BAKER BRENDA F;;FREIER SUSAN M;;COWSERT LEX M;;MCKAY ROBERT;;MANOHARAN MUTHIAH;;DORR F A;;HOLMLUND JON;;BORCHERS ALEXANDER H;;BROWN-DRIVER VICKIE L;;WYATT JACQUELINE R;;FLOURNOY SHIN C;;ACKERMANN ELIZABETH J;;ZHANG HONG;;WATT ANDREW T;;MARACUSSON ERIC G;;COOPER SCOTT;;KOLLER ERICH;;MIRAGLIA LOREN;;RICKETTS WILLIAM;;DOBIE KENNETH W;;SIPES TAMARA B,,https://lens.org/018-694-756-687-707,Patent Application,yes,0,2,1,286,164,A61K48/00;;A61K48/00;;C12N15/1138;;C12N15/1138;;C12N2310/11;;C12N2310/11;;C12N2310/315;;C12N2310/315;;C12N2310/321;;C12N2310/321;;C12N2310/3341;;C12N2310/3341;;C12N2310/341;;C12N2310/341;;C12N2310/346;;C12N2310/346,A61K48/00;;C07H21/02,514/44;;536/23.1,0,0,,,,DISCONTINUED
468,WO,A1,WO 2021/154761 A1,132-638-467-778-983,2021-08-05,2021,US 2021/0015143 W,2021-01-26,US 202062966448 P;;US 202062985822 P;;US 2020/0024526 W;;US 202062994272 P;;US 202063059054 P;;US 202063059960 P;;US 202063074807 P;;US 202063074827 P;;US 2020/0049415 W;;US 202063085890 P;;US 202063105198 P;;US 202063114517 P;;US 202063124693 P;;US 202063127109 P,2020-01-27,METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY,"The present invention relates to methods, uses, and compositions for the treatment of cancer (e.g., a lung cancer; a cervical cancer; a breast cancer; a head and neck cancer; a liver cancer; a bladder cancer; a gastric cancer; an esophageal cancer; a pancreatic cancer; a kidney or renal cancer; a melanoma; an ovarian cancer; or a colorectal cancer). More specifically, the invention concerns the treatment of patients having cancer with an anti-TIGIT antagonist antibody, including treatment with an anti-TIGIT antagonist antibody in a combination therapy.",GENENTECH INC;;HOFFMANN LA ROCHE;;HOFFMANN LA ROCHE,LAI CATHERINE;;LAU JANET;;LEE ANTHONY JONGHA;;LI SHI;;LIN-LIU YVONNE GAIL;;MATHENY CHRISTINA JEANNE;;MENDUS DIANA;;MENG RAYMOND D;;NGUYEN DUC ANH;;PATEL JILPA BHUPENDRA;;PHAM THINH QUANG;;ROONEY ISABELLE ANNE;;STEVENS HEATHER BLYTHE;;TROUTMAN SARAH MARIE;;WANG LIJIA;;WANG YULEI;;WILLIAMS PATRICK GEORGES ROBERT;;WU BENJAMIN;;YAN YIBING;;ZHANG AIJING;;ZHANG XIAOSONG;;BALLINGER MARCUS DALE;;BARAK HILA;;BENNETT ELIZABETH ALEXANDRA;;CASTRO MARCELA LUCIA;;CHA EDWARD NAMSERK;;CHAN HUI MIN PHYLLIS;;CHUI STEPHEN;;COTTER CHRISTOPHER ROLAND;;DEGAONKAR VIRAJ VINAY;;GITLITZ BARBARA JENNIFER;;HOANG TIEN;;KOMATSUBARA KIMBERLY MAYUMI,,https://lens.org/132-638-467-778-983,Patent Application,yes,49,9,10,15,34,C07K16/2827;;C07K16/2803;;A61K31/337;;A61K33/243;;A61K45/06;;A61K2039/505;;A61K2039/507;;A61K2039/54;;A61K2039/545;;A61P35/00;;C07K2317/90;;A61K39/395;;C07K16/2827;;A61K33/243;;C07K2317/90;;A61K2039/507;;A61K2039/545;;A61K31/337;;A61K2039/54;;A61K39/395;;A61K45/06;;A61P35/00;;A61K2300/00;;A61K2039/505;;C07K16/2803;;A61K39/395;;A61K31/365;;A61K31/555;;A61K33/243;;A61K31/7068;;A61K31/337;;A61K45/06;;A61P35/00;;C07K16/2803;;C07K16/2827;;A61K2300/00;;A61K2039/505;;A61K2039/507;;A61K2039/545;;A61K2039/54;;C07K2317/90,A61K31/00;;A61K31/136;;A61K31/337;;A61K31/473;;A61K31/519;;A61K31/555;;A61K31/704;;A61K31/7068;;A61K33/243;;A61K39/395;;A61K45/06;;A61P35/00;;C07K16/28,,57,26,055-825-830-184-403;;044-532-401-626-703;;021-485-212-364-595;;042-204-626-457-327;;049-134-753-209-354;;156-501-805-490-709;;095-334-545-560-259;;076-090-519-318-074;;173-572-222-412-05X;;030-607-398-087-475;;020-855-322-534-259;;003-984-734-905-938;;170-311-024-328-514;;006-574-964-805-278;;162-646-650-680-173;;065-608-090-342-50X;;077-495-150-106-187;;002-490-451-363-036;;087-127-298-511-406;;004-567-541-146-145;;018-721-858-092-772;;120-738-288-740-114;;046-624-833-541-771;;049-592-079-311-194;;098-390-678-920-567;;120-738-288-740-114,pmc6136875;;30221069;;10.1080/2162402x.2018.1466769;;10.1158/2159-8290.cd-nb2020-063;;32576590;;10.1093/protein/8.10.1057;;8771187;;3127726;;10.1038/332323a0;;10.1016/0022-2836(87)90412-8;;3681981;;10.1146/annurev.immunol.9.1.457;;10.1146/annurev.iy.09.040191.002325;;1910686;;10.1006/jmbi.1996.0548;;8876650;;9143687;;10.1146/annurev.immunol.15.1.203;;7561440;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;1748994;;10.1016/0022-2836(91)90498-u;;10.4049/jimmunol.147.1.86;;2051030;;16505368;;10.1073/pnas.0511285103;;pmc1383494;;10.1038/321522a0;;3713831;;10.1016/0959-440x(92)90091-k;;8654676;;10.1042/bst0231035;;10.1016/0958-1669(94)90053-1;;7765176;;17161664;;10.1016/j.jchromb.2006.11.018;;10.1097/00000421-198212000-00014;;7165009;;10.1177/1758834016687262;;pmc5349427;;28344665;;29488330;;10.1111/1759-7714.12613;;pmc5879058;;19097774;;10.1016/j.ejca.2008.10.026;;10.3322/caac.21590;;31912902;;2681557;;10.1200/jco.1989.7.11.1748;;12234695;;10.1016/s0169-5002(02)00072-7;;19097774;;10.1016/j.ejca.2008.10.026,"ANONYMOUS: ""Safety and Pharmacokinetics (PK) of Escalating Doses of MTIG7192A as a Single Agent and in Combination With Atezolizumab With and Without Chemotherapy in Locally Advanced or Metastatic Tumors - Full Text View - ClinicalTrials.gov"", 9 June 2016 (2016-06-09), XP055758364, Retrieved from the Internet <URL:https://clinicaltrials.gov/ct2/show/study/NCT02794571> [retrieved on 20201209];;ALICE L. HUNG ET AL: ""TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM"", ONCOIMMUNOLOGY, 24 May 2018 (2018-05-24), pages e1466769, XP055688548, DOI: 10.1080/2162402X.2018.1466769;;CARUSO: ""Tiragolumab Impresses in Multiple Trials"", CANCER DISCOVERY, vol. 10, no. 8, 23 June 2020 (2020-06-23), US, pages 1086.2 - 1087, XP055758449, ISSN: 2159-8274, DOI: 10.1158/2159-8290.CD-NB2020-063;;VAN DIJKVAN DE WINKEL, CURR. OPIN. PHARMACOL., vol. 5, 2001, pages 368 - 74;;""Methods in Enzymology"", 2003, ACADEMIC PRESS, INC., article ""Current Protocols in Molecular Biology"";;ZAPATA ET AL., PROTEIN ENG, vol. 8, no. 10, 1995, pages 1057 - 1062;;ANTIBODIES, A LABORATORY MANUAL, AND ANIMAL CELL CULTURE, 1987;;OLIGONUCLEOTIDE SYNTHESIS, 1984;;VASWANIHAMILTON, ANN. ALLERGY, ASTHMA & IMMUNOL., vol. 1, 1998, pages 105 - 115;;ANIMAL CELL CULTURE, 1987;;HANDBOOK OF EXPERIMENTAL IMMUNOLOGY;;GENE TRANSFER VECTORS FOR MAMMALIAN CELLS, 1987;;PCR: THE POLYMERASE CHAIN REACTION, 1994;;CURRENT PROTOCOLS IN IMMUNOLOGY, 1991;;E. HARLOWD. LANE: ""Using Antibodies: A Laboratory Manual"", 1999, COLD SPRING HARBOR LABORATORY PRESS;;C.A. JANEWAYP. TRAVERS, IMMUNOBIOLOGY, 1997;;P. FINCH, ANTIBODIES, 1997;;RIECHMANN ET AL., NATURE, vol. 332, 1988, pages 323 - 329;;WHO DRUG INFORMATION, INTERNATIONAL NONPROPRIETARY NAMES FOR PHARMACEUTICAL SUBSTANCES, vol. 14, no. 2, 2000, pages 107;;HOLLINGER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 6444 - 6448;;CURRENT PROTOCOLS IN MOLECULAR BIOLOGY;;""UniProtKB"", Database accession no. Q9BQ51;;""Uniprot"", Database accession no. Q9NZQ7-3;;WHO DRUG INFORMATION, INTERNATIONAL NONPROPRIETARY NAMES FOR PHARMACEUTICAL SUBSTANCES, vol. 28, no. 4, 16 January 2015 (2015-01-16), pages 485;;WHO DRUG INFORMATION, INTERNATIONAL NONPROPRIETARY NAMES FOR PHARMACEUTICAL SUBSTANCES, vol. 28, no. 3, 2014, pages 407;;WHO DRUG INFORMATION, INTERNATIONAL NONPROPRIETARY NAMES FOR PHARMACEUTICAL SUBSTANCES, vol. 31, no. 2, 7 July 2017 (2017-07-07), pages 343;;ANGEW CHEM. INTL. ED. ENGL., vol. 33, 1994, pages 183 - 186;;HIRSCH ET AL., JOURNAL OF THORACIC ONCOLOGY, vol. 12, no. 2, 2016, pages 208 - 222;;ABBAS ET AL.: ""Cellular and Mol. Immunology"", 2000, W.B. SAUNDERS, CO.;;CAPEL ET AL., IMMUNOMETHODS, vol. 113, 1994, pages 269 - 315;;CHOTHIALESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;RAVETCHKINET, ANNU. REV. IMMUNOL., vol. 9, 1991, pages 457 - 92;;MACCALLUM ET AL., J. MOL. BIOL., vol. 262, 1996, pages 732 - 745;;M. DAERON, ANNU. REV. IMMUNOL., vol. 15, 1997, pages 203 - 234;;DE HAAS ET AL., J. LAB. CLIN. MED., vol. 126, 1995, pages 330 - 41;;MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 6851 - 6855;;HOOGENBOOMWINTER, J. MOL. BIOL., vol. 222, 1991, pages 581;;COLE ET AL.: ""Monoclonal Antibodies and Cancer Therapy"", 1985, ALAN R. LISS, pages: 77;;BOERNER ET AL., J. IMMUNOL., vol. 147, no. 1, 1991, pages 86 - 95;;LI ET AL., PROC. NATL. ACAD. SCI. USA, vol. 103, 2006, pages 3557 - 3562;;JONES ET AL., NATURE, vol. 321, 1986, pages 522 - 525;;PRESTA, CURR. OP. STRUCT. BIOL., vol. 2, 1992, pages 593 - 596;;HARRIS, BIOCHEM. SOC. TRANSACTIONS, vol. 23, 1995, pages 1035 - 1038;;HURLEGROSS, CURR. OP. BIOTECH., vol. 5, 1994, pages 428 - 433;;FLATMAN ET AL., J. CHROMATOGR. B, vol. 848, 2007, pages 79 - 87;;GALSKY ET AL., LANCET ONCOL, vol. 12, no. 3, 2011, pages 211 - 4;;OKEN ET AL., AM. J. CLIN. ONCOL., vol. 5, 1982, pages 649 - 655;;FRAMPTON ET AL., NATURE BIOTECHNOLOGY, vol. 31, no. 11, 2013, pages 1023 - 1033;;JUAN ET AL., THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, vol. 9, no. 3, 2017, pages 201 - 216;;DU ET AL., THORACIC CANCER, vol. 9, 2018, pages 423 - 430;;EISENHAUER ET AL., EUR. J. CANCER., vol. 45, 2009, pages 228 - 47;;SIEGEL ET AL.: ""Cancer Statistics"", CA CANCER J CLIN, vol. 70, 2020, pages 7 - 30;;OSMANI ET AL., SEMIN CANCER BIOL, vol. 52, 2018, pages 103 - 9;;CALVERT ET AL., J. CLIN. ONCOL., vol. 7, 1989, pages 1748 - 56;;MICKE ET AL., LUNG CANCER, vol. 37, 2002, pages 271 - 6;;EISENHAUER ET AL., EUR. J. CANCER, vol. 45, 2009, pages 228 - 247;;YAMADA ET AL., CANCER SCI, vol. 104, 2013, pages 14 - 21",PENDING
469,KR,A,KR 20220133243 A,048-793-195-667-141,2022-10-04,2022,KR 20227029306 A,2021-01-26,US 202062966448 P;;US 202062985822 P;;US 202062994272 P;;US 2020/0024526 W;;US 202063059054 P;;US 202063059960 P;;US 2020/0049415 W;;US 202063074807 P;;US 202063074827 P;;US 202063085890 P;;US 202063105198 P;;US 202063114517 P;;US 202063124693 P;;US 202063127109 P;;US 2021/0015143 W,2020-01-27,항 TIGIT 길항제 항체를 이용한 암의 치료 방법,"본 발명은 암(예컨대, 폐암; 자궁경부암; 유방암; 두경부암; 간암; 위암; 방광암; 식도암; 췌장암; 신장암; 흑색종; 난소암; 또는 결장직장암)의 치료를 위한 방법, 사용 및 조성물에 관한 것이다. 더 구체적으로, 본 발명은 병용 요법에서의 항 TIGIT 길항제 항체를 이용한 치료를 포함하여, 암을 가진 환자를 항 TIGIT 길항제 항체를 이용해 치료하는 것에 관한 것이다.",GENENTECH INC;;HOFFMANN LA ROCHE,LAI CATHERINE;;LAU JANET;;LEE ANTHONY JONGHA;;LI SHI;;LIN LIU YVONNE GAIL;;MATHENY CHRISTINA JEANNE;;MENDUS DIANA;;MENG RAYMOND D;;NGUYEN DUC ANH;;PATEL JILPA BHUPENDRA;;PHAM THINH QUANG;;ROONEY ISABELLE ANNE;;STEVENS HEATHER BLYTHE;;TROUTMAN SARAH MARIE;;WANG LIJIA;;WANG YULEI;;WILLIAMS PATRICK GEORGES ROBERT;;WU BENJAMIN;;YAN YIBING;;ZHANG AIJING;;ZHANG XIAOSONG;;BALLINGER MARCUS DALE;;BARAK HILA;;BENNETT ELIZABETH ALEXANDRA;;CASTRO MARCELA LUCIA;;CHA EDWARD NAMSERK;;CHAN HUI MIN PHYLLIS;;CHUI STEPHEN;;COTTER CHRISTOPHER ROLAND;;DEGAONKAR VIRAJ VINAY;;GITLITZ BARBARA JENNIFER;;HOANG TIEN;;KOMATSUBARA KIMBERLY MAYUMI,,https://lens.org/048-793-195-667-141,Patent Application,no,0,0,10,15,68,C07K16/2827;;C07K16/2803;;A61K31/337;;A61K33/243;;A61K45/06;;A61K2039/505;;A61K2039/507;;A61K2039/54;;A61K2039/545;;A61P35/00;;C07K2317/90;;A61K39/395;;C07K16/2827;;A61K33/243;;C07K2317/90;;A61K2039/507;;A61K2039/545;;A61K31/337;;A61K2039/54;;A61K39/395;;A61K45/06;;A61P35/00;;A61K2300/00;;A61K2039/505;;C07K16/2803;;A61K39/395;;A61K31/365;;A61K31/555;;A61K33/243;;A61K31/7068;;A61K31/337;;A61K45/06;;A61P35/00;;C07K16/2803;;C07K16/2827;;A61K2300/00;;A61K2039/505;;A61K2039/507;;A61K2039/545;;A61K2039/54;;C07K2317/90,A61K39/395;;A61K31/337;;A61K31/365;;A61K31/555;;A61K31/7068;;A61K33/243;;A61K39/00;;A61K45/06;;A61P35/00;;C07K16/28,,0,0,,,,PENDING
470,CA,A1,CA 3165187 A1,107-958-558-357-195,2021-08-05,2021,CA 3165187 A,2021-01-26,US 202062966448 P;;US 202063127109 P;;US 202062994272 P;;US 2020/0049415 W;;US 202063074807 P;;US 202062985822 P;;US 2020/0024526 W;;US 202063085890 P;;US 202063074827 P;;US 202063059054 P;;US 202063105198 P;;US 202063114517 P;;US 202063059960 P;;US 202063124693 P;;US 2021/0015143 W,2020-01-27,METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY,"The present invention relates to methods, uses, and compositions for the treatment of cancer (e.g., a lung cancer; a cervical cancer; a breast cancer; a head and neck cancer; a liver cancer; a bladder cancer; a gastric cancer; an esophageal cancer; a pancreatic cancer; a kidney or renal cancer; a melanoma; an ovarian cancer; or a colorectal cancer). More specifically, the invention concerns the treatment of patients having cancer with an anti-TIGIT antagonist antibody, including treatment with an anti-TIGIT antagonist antibody in a combination therapy.",GENENTECH INC;;HOFFMANN LA ROCHE,LAI CATHERINE;;LAU JANET;;LEE ANTHONY JONGHA;;LI SHI;;LIN-LIU YVONNE GAIL;;MATHENY CHRISTINA JEANNE;;MENDUS DIANA;;MENG RAYMOND D;;NGUYEN DUC ANH;;PATEL JILPA BHUPENDRA;;PHAM THINH QUANG;;ROONEY ISABELLE ANNE;;STEVENS HEATHER BLYTHE;;TROUTMAN SARAH MARIE;;WANG LIJIA;;WANG YULEI;;WILLIAMS PATRICK GEORGES ROBERT;;WU BENJAMIN;;YAN YIBING;;ZHANG AIJING;;ZHANG XIAOSONG;;BALLINGER MARCUS DALE;;BARAK HILA;;BENNETT ELIZABETH ALEXANDRA;;CASTRO MARCELA LUCIA;;CHA EDWARD NAMSERK;;CHAN HUI MIN PHYLLIS;;CHUI STEPHEN;;COTTER CHRISTOPHER ROLAND;;DEGAONKAR VIRAJ VINAY;;GITLITZ BARBARA JENNIFER;;HOANG TIEN;;KOMATSUBARA KIMBERLY MAYUMI,,https://lens.org/107-958-558-357-195,Patent Application,no,0,0,10,15,0,C07K16/2827;;C07K16/2803;;A61K31/337;;A61K33/243;;A61K45/06;;A61K2039/505;;A61K2039/507;;A61K2039/54;;A61K2039/545;;A61P35/00;;C07K2317/90;;A61K39/395;;C07K16/2827;;A61K33/243;;C07K2317/90;;A61K2039/507;;A61K2039/545;;A61K31/337;;A61K2039/54;;A61K39/395;;A61K45/06;;A61P35/00;;A61K2300/00;;A61K2039/505;;C07K16/2803;;A61K39/395;;A61K31/365;;A61K31/555;;A61K33/243;;A61K31/7068;;A61K31/337;;A61K45/06;;A61P35/00;;C07K16/2803;;C07K16/2827;;A61K2300/00;;A61K2039/505;;A61K2039/507;;A61K2039/545;;A61K2039/54;;C07K2317/90,A61K31/00;;A61K31/136;;A61K31/337;;A61K31/473;;A61K31/519;;A61K31/555;;A61K31/704;;A61K31/7068;;A61K33/243;;A61K39/395;;A61K45/06;;A61P35/00;;C07K16/28,,0,0,,,,PENDING
471,AU,A1,AU 2021/212662 A1,062-034-287-623-162,2022-08-11,2022,AU 2021/212662 A,2021-01-26,US 202062966448 P;;US 202063127109 P;;US 202062994272 P;;US 2020/0049415 W;;US 202063074807 P;;US 202062985822 P;;US 2020/0024526 W;;US 202063085890 P;;US 202063074827 P;;US 202063059054 P;;US 202063105198 P;;US 202063114517 P;;US 202063059960 P;;US 202063124693 P;;US 2021/0015143 W,2020-01-27,Methods for treatment of cancer with an anti-TIGIT antagonist antibody,"The present invention relates to methods, uses, and compositions for the treatment of cancer (e.g., a lung cancer; a cervical cancer; a breast cancer; a head and neck cancer; a liver cancer; a bladder cancer; a gastric cancer; an esophageal cancer; a pancreatic cancer; a kidney or renal cancer; a melanoma; an ovarian cancer; or a colorectal cancer). More specifically, the invention concerns the treatment of patients having cancer with an anti-TIGIT antagonist antibody, including treatment with an anti-TIGIT antagonist antibody in a combination therapy.",HOFFMANN LA ROCHE;;GENENTECH INC,LAI CATHERINE;;LAU JANET;;LEE ANTHONY JONGHA;;LI SHI;;LIN-LIU YVONNE GAIL;;MATHENY CHRISTINA JEANNE;;MENDUS DIANA;;MENG RAYMOND D;;NGUYEN DUC ANH;;PATEL JILPA BHUPENDRA;;PHAM THINH QUANG;;ROONEY ISABELLE ANNE;;STEVENS HEATHER BLYTHE;;TROUTMAN SARAH MARIE;;WANG LIJIA;;WANG YULEI;;WILLIAMS PATRICK GEORGES ROBERT;;WU BENJAMIN;;YAN YIBING;;ZHANG AIJING;;ZHANG XIAOSONG;;BALLINGER MARCUS DALE;;BARAK HILA;;BENNETT ELIZABETH ALEXANDRA;;CASTRO MARCELA LUCIA;;CHA EDWARD NAMSERK;;CHAN HUI MIN PHYLLIS;;CHUI STEPHEN;;COTTER CHRISTOPHER ROLAND;;DEGAONKAR VIRAJ VINAY;;GITLITZ BARBARA JENNIFER;;HOANG TIEN;;KOMATSUBARA KIMBERLY MAYUMI,,https://lens.org/062-034-287-623-162,Patent Application,no,0,0,10,15,0,C07K16/2827;;C07K16/2803;;A61K31/337;;A61K33/243;;A61K45/06;;A61K2039/505;;A61K2039/507;;A61K2039/54;;A61K2039/545;;A61P35/00;;C07K2317/90;;A61K39/395;;C07K16/2827;;A61K33/243;;C07K2317/90;;A61K2039/507;;A61K2039/545;;A61K31/337;;A61K2039/54;;A61K39/395;;A61K45/06;;A61P35/00;;A61K2300/00;;A61K2039/505;;C07K16/2803;;A61K39/395;;A61K31/365;;A61K31/555;;A61K33/243;;A61K31/7068;;A61K31/337;;A61K45/06;;A61P35/00;;C07K16/2803;;C07K16/2827;;A61K2300/00;;A61K2039/505;;A61K2039/507;;A61K2039/545;;A61K2039/54;;C07K2317/90,A61K31/00;;A61K31/136;;A61K31/337;;A61K31/473;;A61K31/519;;A61K31/555;;A61K31/704;;A61K31/7068;;A61K33/243;;A61K39/395;;A61K45/06;;A61P35/00;;C07K16/28,,0,0,,,,PENDING
472,US,A1,US 2022/0016243 A1,189-954-736-224-456,2022-01-20,2022,US 202117159128 A,2021-01-26,US 202117159128 A;;US 202063127109 P;;US 202063124693 P;;US 202063114517 P;;US 202063105198 P;;US 202063085890 P;;US 202063074827 P;;US 202063074807 P;;US 202063059960 P;;US 202063059054 P;;US 202062994272 P;;US 202062985822 P;;US 202062966448 P,2020-01-27,METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY,"The present invention relates to methods, uses, and compositions for the treatment of cancer (e.g., a lung cancer; a cervical cancer; a breast cancer; a head and neck cancer; a liver cancer; a bladder cancer; a gastric cancer; an esophageal cancer; a pancreatic cancer; a kidney or renal cancer; a melanoma; an ovarian cancer; or a colorectal cancer). More specifically, the invention concerns the treatment of patients having cancer with an anti-TIGIT antagonist antibody, including treatment with an anti-TIGIT antagonist antibody in a combination therapy.",GENENTECH INC;;HOFFMANN LA ROCHE,LAI CATHERINE;;LAU JANET;;LEE ANTHONY JONGHA;;LI SHI;;LIN-LIU YVONNE GAIL;;MATHENY CHRISTINA JEANNE;;MENDUS DIANA;;MENG RAYMOND D;;NGUYEN DUC ANH;;PATEL JILPA BHUPENDRA;;PHAM THINH QUANG;;ROONEY ISABELLE ANNE;;STEVENS HEATHER BLYTHE;;TROUTMAN SARAH MARIE;;WANG LIJIA;;WANG YULEI;;WILLIAMS PATRICK GEORGES ROBERT;;WU BENJAMIN;;YAN YIBING;;ZHANG AIJING;;ZHANG XIAOSONG;;BALLINGER MARCUS DALE;;BARAK HILA;;BENNETT ELIZABETH ALEXANDRA;;CASTRO MARCELA LUCIA;;CHA EDWARD NAMSERK;;CHAN HUI MIN PHYLLIS;;CHUI STEPHEN;;COTTER CHRISTOPHER ROLAND;;DEGAONKAR VIRAJ VINAY;;GITLITZ BARBARA JENNIFER;;HOANG TIEN;;KOMATSUBARA KIMBERLY MAYUMI,GENENTECH INC (2020-12-11),https://lens.org/189-954-736-224-456,Patent Application,yes,1,2,1,15,34,A61K31/282;;A61K33/243;;A61P35/04;;A61K31/519;;A61P35/00;;A61K31/7068;;A61K38/193;;A61K31/7048;;A61K31/675;;A61K31/337;;A61K31/513;;A61K2039/505;;A61K39/39541;;C07K16/22;;C07K16/2803;;C07K2317/76;;C07K2317/24;;A61K2039/507;;C07K16/2827;;A61K45/06;;A61K39/3955;;C07K2317/24;;A61K31/282;;A61K31/7048;;A61K31/519;;A61K31/7068;;A61K31/337;;A61K38/193;;A61K47/60;;A61K31/675;;A61P35/04;;A61K33/243;;A61K47/6801;;A61K47/6849;;A61K31/513;;C07K16/2809;;C07K16/2827;;A61K2039/545;;C07K2317/76;;C07K2317/56;;A61K2039/507;;A61P35/00,A61K39/395;;A61K31/282;;A61K31/337;;A61K31/513;;A61K31/519;;A61K31/675;;A61K31/7048;;A61K31/7068;;A61K33/243;;A61K38/19;;A61K47/60;;A61K47/68;;A61P35/00;;A61P35/04;;C07K16/28,,8,6,051-208-529-712-079;;082-596-938-068-845;;027-880-661-246-429;;006-222-272-206-638;;022-608-838-432-215;;052-758-464-207-743,17981654;;10.2741/2786;;10.4049/jimmunol.152.1.146;;8254187;;10.1016/j.jmb.2003.09.054;;14596803;;10.1093/annonc/mdy424.066;;25465800;;10.1016/j.ccell.2014.10.018;;10.1016/s0140-6736(16)32517-x;;pmc6886121;;27979383,"Almagro JC, Fransson J. Humanization of antibodies. Front Biosci. 2008 Jan 1;13:1619-33. (Year: 2008);;Kussie et al. A single engineered amino acid substitution changes antibody fine specificity.J Immunol.1994 Jan 1;152(1):146-52. (Year: 1994);;Edwards et al. The remarkable flexibility of the human antibody repertoire;isolation of over one thousand different antibodies to a single protein,BLyS. J Mol Biol 2003 Nov 14;334(1):103-18. (Year: 2003);;A study of MTIG7192A in combination with atezolizumab in chemotherapy-naïve patients with locally advanced or metastatic non-small cell. ClinicalTrials.gov identifier: NCT03563716. First posted June 20, 201. Accessed May 11, 2023. https://clinicaltrials.gov/ct2/history/NCT03563716?V_1=View#StudyPageTo (Year: 2018);;Barlesi F et al. IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC). Annals of Oncology, Vol 29, Suppl 8, Oct 2018, pg viii743-viii744. (Year: 2018);;Johnston RJ et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell. 2014 Dec 8;26(6):923-937. (Year: 2014);;de Latrigue, J. Interest Builds for Targeting TIGIT Checkpoint. OncPathways. Sept 2020. Vol 21, No 18, pg 76-78. (Year: 2020);;Rittmeyer, A et al. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet. 2017 Jan 21;389(10066):255-265. (Year: 2017)",PENDING
473,MX,A,MX 2022009170 A,051-126-085-774-842,2022-08-17,2022,MX 2022009170 A,2021-01-26,US 202062966448 P;;US 202062985822 P;;US 2020/0024526 W;;US 202062994272 P;;US 202063059054 P;;US 202063059960 P;;US 2020/0049415 W;;US 202063074807 P;;US 202063074827 P;;US 202063085890 P;;US 202063105198 P;;US 202063114517 P;;US 202063124693 P;;US 202063127109 P;;US 2021/0015143 W,2020-01-27,METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY.,"The present invention relates to methods, uses, and compositions for the treatment of cancer (e.g., a lung cancer; a cervical cancer; a breast cancer; a head and neck cancer; a liver cancer; a bladder cancer; a gastric cancer; an esophageal cancer; a pancreatic cancer; a kidney or renal cancer; a melanoma; an ovarian cancer; or a colorectal cancer). More specifically, the invention concerns the treatment of patients having cancer with an anti-TIGIT antagonist antibody, including treatment with an anti-TIGIT antagonist antibody in a combination therapy.",GENENTECH INC,CHA EDWARD NAMSERK;;WANG YULEI;;CHUI STEPHEN;;MENG RAYMOND D;;LAI CATHERINE;;LAU JANET;;LEE ANTHONY JONGHA;;LI SHI;;LIN-LIU YVONNE GAIL;;MATHENY CHRISTINA JEANNE;;MENDUS DIANA;;NGUYEN DUC ANH;;PATEL JILPA BHUPENDRA;;PHAM THIN QUANG;;ROONEY ISABELLE ANNE;;STEVENS HEATHER BLYTHE;;TROUTMAN SARAH MARIE;;WANG LIJIA;;WILLIAMS PATRICK GEORGES ROBERT;;WU BENJAMIN;;YAN YIBING;;ZHANG AIJING;;ZHANG XIAOSONG;;BALLINGER MARCUS DALE;;BARAK HILA;;BENNETT ELIZABETH ALEXANDRA;;CASTRO MARCELA LUCIA;;CHAN HUI MIN PHYLLIS;;COTTER CHRISTOPHER ROLAND;;DEGAONKAR VIRAJ VINAY;;GITLITZ BARBARA JENNIFER;;HOANG TIEN;;KOMATSUBARA KIMBERLY MAYUMI,,https://lens.org/051-126-085-774-842,Patent Application,no,0,0,10,15,0,C07K16/2827;;C07K16/2803;;A61K31/337;;A61K33/243;;A61K45/06;;A61K2039/505;;A61K2039/507;;A61K2039/54;;A61K2039/545;;A61P35/00;;C07K2317/90;;A61K39/395;;C07K16/2827;;A61K33/243;;C07K2317/90;;A61K2039/507;;A61K2039/545;;A61K31/337;;A61K2039/54;;A61K39/395;;A61K45/06;;A61P35/00;;A61K2300/00;;A61K2039/505;;C07K16/2803;;A61K39/395;;A61K31/365;;A61K31/555;;A61K33/243;;A61K31/7068;;A61K31/337;;A61K45/06;;A61P35/00;;C07K16/2803;;C07K16/2827;;A61K2300/00;;A61K2039/505;;A61K2039/507;;A61K2039/545;;A61K2039/54;;C07K2317/90,A61K39/395;;A61K31/136;;A61K31/337;;A61K31/473;;A61K31/519;;A61K31/555;;A61K31/704;;A61K31/7068;;A61K33/243;;A61K45/06;;A61P35/00;;C07K16/28,,0,0,,,,PENDING
474,TW,A,TW 202142230 A,136-187-987-746-091,2021-11-16,2021,TW 110102913 A,2021-01-26,US 202062966448 P;;US 202062985822 P;;US 202062994272 P;;US 2020/0024526 W;;US 202063059054 P;;US 202063059960 P;;US 202063074807 P;;US 2020/0049415 W;;US 202063074827 P;;US 202063085890 P;;US 202063105198 P;;US 202063114517 P;;US 202063124693 P;;US 202063127109 P,2020-01-27,Methods for treatment of cancer with an anti-TIGIT antagonist antibody,"The present invention relates to methods, uses, and compositions for the treatment of cancer (e.g., a lung cancer; a cervical cancer; a breast cancer; a head and neck cancer; a liver cancer; a bladder cancer; a gastric cancer; an esophageal cancer; a pancreatic cancer; a kidney or renal cancer; a melanoma; an ovarian cancer; or a colorectal cancer). More specifically, the invention concerns the treatment of patients having cancer with an anti-TIGIT antagonist antibody, including treatment with an anti-TIGIT antagonist antibody in a combination therapy.",GENENTECH INC;;HOFFMANN LA ROCHE,LAI CATHERINE;;LAU JANET;;LEE ANTHONY JONGHA;;LI SHI;;LIN-LIU YVONNE GAIL;;MATHENY CHRISTINA JEANNE;;MENDUS DIANA;;MENG RAYMOND D;;NGUYEN DUC ANH;;PATEL JILPA BHUPENDRA;;PHAM THINH QUANG;;ROONEY ISABELLE ANNE;;STEVENS HEATHER BLYTHE;;TROUTMAN SARAH MARIE;;WANG LI-JIA;;WANG YULEI;;WILLIAMS PATRICK GEORGES ROBERT;;WU BENJAMIN;;YAN YIBING;;ZHANG AIJING;;ZHANG XIAOSONG;;BALLINGER MARCUS DALE;;BARAK HILA;;BENNETT ELIZABETH ALEXANDRA;;CASTRO MARCELA LUCIA;;CHA EDWARD NAMSERK;;CHAN HUI MIN PHYLLIS;;CHUI STEPHEN;;COTTER CHRISTOPHER ROLAND;;DEGAONKAR VIRAJ VINAY;;GITLITZ BARBARA JENNIFER;;HOANG TIEN;;KOMATSUBARA KIMBERLY MAYUMI,,https://lens.org/136-187-987-746-091,Patent of Addition,no,0,0,10,15,0,C07K16/2827;;C07K16/2803;;A61K31/337;;A61K33/243;;A61K45/06;;A61K2039/505;;A61K2039/507;;A61K2039/54;;A61K2039/545;;A61P35/00;;C07K2317/90;;A61K39/395;;C07K16/2827;;A61K33/243;;C07K2317/90;;A61K2039/507;;A61K2039/545;;A61K31/337;;A61K2039/54;;A61K39/395;;A61K45/06;;A61P35/00;;A61K2300/00;;A61K2039/505;;C07K16/2803;;A61K39/395;;A61K31/365;;A61K31/555;;A61K33/243;;A61K31/7068;;A61K31/337;;A61K45/06;;A61P35/00;;C07K16/2803;;C07K16/2827;;A61K2300/00;;A61K2039/505;;A61K2039/507;;A61K2039/545;;A61K2039/54;;C07K2317/90,A61K31/336;;A61K31/282;;A61K31/7048;;A61K39/395;;A61K45/06;;A61P35/00,,0,0,,,,PENDING
475,EP,A1,EP 4096646 A1,093-674-838-547-654,2022-12-07,2022,EP 21705841 A,2021-01-26,US 202062966448 P;;US 202062985822 P;;US 202062994272 P;;US 2020/0024526 W;;US 202063059054 P;;US 202063059960 P;;US 2020/0049415 W;;US 202063074807 P;;US 202063074827 P;;US 202063085890 P;;US 202063105198 P;;US 202063114517 P;;US 202063124693 P;;US 202063127109 P;;US 2021/0015143 W,2020-01-27,METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY,,GENENTECH INC;;HOFFMANN LA ROCHE,LAI CATHERINE;;LAU JANET;;LEE ANTHONY JONGHA;;LI SHI;;LIN-LIU YVONNE GAIL;;MATHENY CHRISTINA JEANNE;;MENDUS DIANA;;MENG RAYMOND D;;NGUYEN DUC ANH;;PATEL JILPA BHUPENDRA;;PHAM THINH QUANG;;ROONEY ISABELLE ANNE;;STEVENS HEATHER BLYTHE;;TROUTMAN SARAH MARIE;;WANG LIJIA;;WANG YULEI;;WILLIAMS PATRICK GEORGES ROBERT;;WU BENJAMIN;;YAN YIBING;;ZHANG AIJING;;ZHANG XIAOSONG;;BALLINGER MARCUS DALE;;BARAK HILA;;BENNETT ELIZABETH ALEXANDRA;;CASTRO MARCELA LUCIA;;CHA EDWARD NAMSERK;;CHAN HUI MIN PHYLLIS;;CHUI STEPHEN;;COTTER CHRISTOPHER ROLAND;;DEGAONKAR VIRAJ VINAY;;GITLITZ BARBARA JENNIFER;;HOANG TIEN;;KOMATSUBARA KIMBERLY MAYUMI,,https://lens.org/093-674-838-547-654,Patent Application,yes,0,0,10,15,0,C07K16/2827;;C07K16/2803;;A61K31/337;;A61K33/243;;A61K45/06;;A61K2039/505;;A61K2039/507;;A61K2039/54;;A61K2039/545;;A61P35/00;;C07K2317/90;;A61K39/395;;C07K16/2827;;A61K33/243;;C07K2317/90;;A61K2039/507;;A61K2039/545;;A61K31/337;;A61K2039/54;;A61K39/395;;A61K45/06;;A61P35/00;;A61K2300/00;;A61K2039/505;;C07K16/2803;;A61K39/395;;A61K31/365;;A61K31/555;;A61K33/243;;A61K31/7068;;A61K31/337;;A61K45/06;;A61P35/00;;C07K16/2803;;C07K16/2827;;A61K2300/00;;A61K2039/505;;A61K2039/507;;A61K2039/545;;A61K2039/54;;C07K2317/90,A61K31/00;;A61K31/136;;A61K31/337;;A61K31/473;;A61K31/519;;A61K31/555;;A61K31/704;;A61K31/7068;;A61K33/243;;A61K39/395;;A61K45/06;;A61P35/00;;C07K16/28,,0,0,,,,PENDING
